Final Program

www.accscientificsession.org/acc12

Join us for a whole new learning experience in a whole new city as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.

www.accscientificsession.org

2012 American College of Cardiology A1304

ACC.12

Table of Contents
Welcome to ACC.12 ................................................................................................................................................................... 3 ACC.12 Officials and Committees................................................................................................................................................ 4 ACC.12 Acknowledgments .................................................................................................................................................. 6 10
ACC.11 Of cials ACC.11 Acknowl i2 Summit Of cia i2 Summit Ackno i2 Summit Af lia ACC.11 Grantor A

ACC.12 Elite FIT Rising Star Acknowledgments .......................................................................................................................... 11 Grantor Acknowledgments................................................................................................................................................. 12 15 ACCF Donor Recognition ................................................................................................................................................... 16 20 TAB 1: General Information General Meeting Information Directory .......................................................... 27 28 Logistic Information ......................................... 29 37 Convention Center Map ............................................ 38 Poster Session Maps ........................................ 39 41 Hotel List and Map ........................................... 42 43 General Education Information ................................. 44 46 Disclosure of Financial Relationships ....................... 47 48 Scientific Session Descriptions ................................ 49 51 ACC.12 Expo ACC.12 Expo Highlights .................................... 52 53 ACC.12 Exhibitor List ....................................... 54 56 ACC.12 Learning Destinations .............................. 57 59 Non-Accredited Educational Events ......................... 60 62 Independent CME/CNE-Certified Pre Conference & Evening Programs ................ 63 64 TAB 4: Sunday, March 25 ACC.12 Educational Sessions ................................ 137 172 Learning Destination Presentations ................... 173 175 TAB 5: Monday, March 26 ACC.12 Educational Sessions ............................... 177 205 Learning Destination Presentations .................. 206 207 TAB 6: Tuesday, March 27 ACC.12 Educational Sessions ............................... 209 211 TAB 7: Author Index Author Index ......................................................... 217 238
ACC.12 Final Program 1

Access, View and PRINT!

TAB 2: Your Road Map To ACC.12 Your Roadmap to ACC.12 ......................................... 65 69 Schedule-At-A-Glance ............................................. 70 71 Program-At-A-Glance Daily Schedule ................................................. 72 86 Topic Schedule ............................................... 87 103 TAB 3: Friday, March 23 and Saturday, March 24 ACC.12 Educational Sessions Friday, March 23 ....... 105 106 ACC.12 Educational Sessions Satuday, March 24 ..... 107 131 Learning Destination Presentations ................... 131 132

AMERICAN COLLEGE of CARDIOLOGY

Helping Cardiovascular Professionals Learn. Advance. Heal.
Join a network of CV professionals committed to quality cardiovascular care & advance your career: - Physicians - Cardiovascular Administrators - Nurses - Physician Assistants - Cardiovascular Technicians - Pharmacists

Visit ACC BOOTH #10027 to join & discover the value of ACC membership!
2012 American College of Cardiology. F1224

Welcome to ACC.12
Welcome to Chicago for the American College of Cardiologys 61st Annual Scientific Session and ACC-i2 with TCT: Innovation in Intervention. This years program reflects the passion for science, education and peer-to-peer networking that ACC President David R. Holmes, Jr., MD, FACC, has brought to his administration. Weve enriched ACC.12 to enhance your learning experience and provide you with a dynamic, individualized experience that meets all your learning needs.
Dont miss: The new daily schedule focus on science each morning with late-breakers, poster abstracts and new findings, and focus on practical clinical applications each afternoon with case-based sessions, review sessions, and MOC. The Legends of Cardiovascular Medicine a series of five sessions featuring true legends in the field of cardiology. The Innovators of Cardiology an all-new closing session which brings together top leaders in cardiology to discuss driving forces behind innovation and creativity. Your chance to earn up to 70 MOC points with the Maintenance of Certification sessions and the Competency-Based Learning System helping you select the sessions that best fill your knowledge gaps in the Lifelong Learning Pathway. Collaborative efforts with subspecialty societies to create a Family of Cardiology with co-branded sessions and abstracts throughout the meeting. Cutting-edge technology including a new ACC.12 eMeeting Planner App (search ACC.12 in your app marketplace), and ACC.12 Online live webcasts of 60 sessions plus an additional 18 on demand sessions from the Legends of CV Medicine and Core Curriculum series available to attendees for free during the meeting! To learn more about these sessions and additional features of ACC.12 check out Your Road Map to ACC.12 (page 65). Cant make it to all the sessions you want to attend? Purchase iScience, a comprehensive digital library of presentations from ACC.12. Order iScience on site in Chicago to save $1,000 or more visit the iScience sales kiosk in Grand Concourse Lobby, Level 3 or ACC Central, Booth #10027.

ACC.12 Final Program

ACC.12

Officials and Committees

The College is most grateful to all program participants who have given freely of their time to participate in the 60th Annual Scientific Session.
President, 2011 2012 David R. Holmes, Jr., MD, FACC President-Elect William A. Zoghbi, MD, FACC Co-chairs, Annual Scientific Session Program Committee Rick A. Nishimura, MD, FACC Patrick T. OGara, MD, FACC Annual Scientific Session Program Committee Karthikeyan Ananthasubramaniam, MBBS, FACC Alex J. Auseon, DO, FACC Alison Bailey, MD, FACC Christie M. Ballantyne, MD, FACC R. Michael Benitez, MD, FACC Lisa Bergersen, MD, MPH, FACC Tandeep Bhatti, MD, FACC Michael S. Blum, MD, FACC Biykem Bozkurt, MD, PhD, FACC John E. Brush, Jr., MD, FACC Matthew J. Budoff, MD, FACC Jean A. Connor, NP Rhonda M. Cooper-DeHoff, PharmD, FACC Salvatore P. Costa, MD, FACC Michael H. Crawford, MD, FACC Mark G. Davies, MB, BCh, PhD, FACC James A. de Lemos, MD, FACC G. William Dec, Jr., MD, FACC Akshay S. Desai, MD, FACC Caroline Lloyd Doherty, MSN, CRNP, AACC Maurice Enriquez-Sarano, MD, FACC John P. Erwin, III, MD, FACC Derek V. Exner, MD, FACC Barbara Fletcher, RN Federico Gentile, MD, FACC Maya E. Guglin, MD, FACC Melanie T. Gura, RN, MSN, CNS, CCDS, AACC Stephen C. Hammill, MD, FACC Jerome L. Hines, MD, PhD, FACC Julia H. Indik, MD, PhD, FACC Elizabeth A. Jackson, MD, FACC Henri Justino, MD, CM, FACC Joshua Kanter, MD Sanjay Kaul, MBBS, FACC Jerry D. Kennett, MD, FACC Amit Khera, MD, MSc, FACC Henry E. Kim, MD, MPH, FACC Annapoorna Subhash Kini, MBBS, FACC Ajay J. Kirtane, MD, FACC Neal S. Kleiman, MD, FACC Eva M. Kline-Rogers, RN Jeffrey T. Kuvin, MD, FACC Richard A. Lange, MD, FACC Michele Langenfeld, RN, MS Gregory M. Lanza, MD, FACC Christine E. Lawless, MD, FACC Randall J. Lee, MD, PhD, FACC Byron Kwock Lee, MD, FACC Ms. Carolyn Lekavich, NP Gregory D. Lewis, MD Jane A. Linderbaum, MS, CNP, AACC Bruce D. Lindsay, MD, FACC Janet B. Long, MSN, ACNP Thomas M. Maddox, MD, MSc, FACC Frederick A. Masoudi, MD, MSPH, FACC Michael A. Mathier, MD, FACC Doff B. McElhinney, MD Dennis M. McNamara, MD, FACC Edward J. McNulty, MD, FACC Issam A. Mikati, MD, FACC Todd D. Miller, MD, FACC David A. Morrow, MD, MPH, FACC Debabrata Mukherjee, MD, FACC

GO for ACC.12!

ACC.12 Officials and Committees

Steve R. Ommen, MD, FACC Narith Ou, PharmD Ronald J. Oudiz, MD, FACC Douglas L. Packer, MD, FACC Hamang M. Patel, MD, FACC Donna M. Polk, MD, MPH, FACC Miguel A. Quinones, MD, FACC Nalini Marie Rajamannan, MD, FACC Sunil V. Rao, MD, FACC George P. Rodgers, MD, FACC Frances A. Rogers, NP John S. Rumsfeld, MD, PhD, FACC Thomas John Ryan, MD, FACC Arwa Saidi, MB, BCh, FACC Michael K. Schroyer, RN, AACC Bindi K. Shah, MD, FACC Prem Soman, MBBS, FACC Paul Sorajja, MD, FACC Anthony E. Steimle, MD, FACC Karen K. Stout, MD, FACC E. Murat Tuzcu, MD, FACC Anne Marie Valente, MD, FACC C. Michael Valentine, MD, FACC Paul D. Varosy, MD, FACC Hector O. Ventura, MD, FACC Ralph J. Verdino, MD, FACC Wanpen Vongpatanasin, MD, FACC Mary Norine Walsh, MD, FACC Andrew Wang, MD, FACC Tracy Wang, MD, FACC Suzanne J. Wingate, PhD, CRNP Stephen D. Wiviott, MD, FACC R. Scott Wright, MD, FACC Robert W. Yeh, MD ACC-i2 with TCT Program Executive Committee E. Murat Tuzcu, MD, FACC, Chair Gary S. Mintz, MD, FACC, Co-chair George D. Dangas, MD, PhD, FACC Howard C. Herrmann, MD, FACC Martin B. Leon, MD, FACC David J. Moliterno, MD, FACC Gregg W. Stone, MD, FACC Janet Fredal Wyman, MSN, NP, ACNSBC, AACC, Nurse Planner ACC-i2 with TCT Program Committee Karthikeyan Ananthasubramaniam, MBBS, FACC Dominick J. Angiolillo, MD, PhD, FACC Raoul Bonan, MD, FACC Sorin J. Brener, MD, FACC Emmanouil S. Brilakis, MD, PhD, FACC Nora Brown, M.S.N., R.N. Douglas E. Drachman, MD, FACC Caroline Lloyd Doherty, MSN, CRNP, AACC William Fuller Fearon, MD, FACC Lee R. Goldberg, MD, MPH, FACC James Aaron Grantham, MD, FACC Rebecca T. Hahn, MD, FACC Robert A. Harrington, MD, FACC James Bernard Hermiller, Jr, MD, FACC Michael R. Jaff, DO, FACC Ik-Kyung Jang, MD, PhD, F.A.C.C Allen Jeremias, MD, FACC David E. Kandzari, MD, FACC Samir R. Kapadia, MBBS, FACC A. Pieter Kappetein, MD, PhD Saibal Kar, MD, FACC Dean J. Kereiakes, MD, FACC Carey D. Kimmelstiel, MD, FACC Ajay J. Kirtane, MD, FACC Eva M. Kline-Rogers, RN, MS Susheel K. Kodali, MD, FACC Raghu Kolluri, MBBS, FACC Michael J. Landzberg, MD, FACC Michael J. Lim, MD, FACC Jane A. Linderbaum, MS, CNP, AACC Julie A. Logan, RN Akiko Maehara, MD Raj R. Makkar, MD, FACC Tift Mann, III, MD, FACC Roxana Mehran, MD, FACC Venu Menon, MBBS, FACC Jeffrey W. Moses, MD, FACC Debabrata Mukherjee, MD, FACC Hilary M. Nierenberg, NP Masahiko Ochiai, MD, Ph.D, FACC Sandra M. OliverMcNeil, NP, AACC John A. Ormiston, MB, ChB, FACC Sahil A. Parikh, MD, FACC Nicolo Piazza, MD Duane S. Pinto, MD, MPH, FACC Abhiram Prasad, MD, FRCP, FACC Sunil V. Rao, MD, FACC Lisa A. Riggs, CNS, AACC Charanjit S. Rihal, MD, FACC Eric Roselli, MD Timothy A. Sanborn, MD, FACC Paul Schoenhagen, MD Mehdi H. Shishehbor, DO, MPH Frank E. Silvestry, MD, FACC Lars G. Svensson, MBBCh, PhD, FACC Jonathan M. Tobis, MD, FACC Zoltan G. Turi, MD, FACC Szilard Voros, MD, FACC Christopher J. White, MD, FACC Giora Weisz, MD, FACC Mathew Williams, MD, FACC Alan Zajarias, MD, MSc, FACC Khaled M. Ziada, MD, FACC
ACC.12 Final Program 5

ACC.12

Acknowledgments
The ACC.12 and ACC-i2 with TCT Program Committees gratefully acknowledge the assistance of the following individuals as Abstract Reviewers and Chairs for the 61st Annual Scientific Session.
Suhny Abbara, MD Aamer Abbas, MBBS, FACC J. Dawn Abbott, MD, FACC Alex Abou-Chebl, MD Theodore P. Abraham, MBBS, FACC Mazen S. Abu-Fadel, MD, FACC Stephan Achenbach, MD, FACC Michael John Ackerman, MD, PhD, FACC Evan C. Adelstein, MD, FACC Ali Ahmed, MD, MPH Karen P. Alexander, MD, FACC Jeffrey D. Alexis, MD, FACC Fernando Alfonso, MD, PhD Imad A. Alhaddad, MBBS, FACC Sana M. Al-Khatib, MD, FACC Suhail Q. Allaqaband, MBBS, FACC Larry A. Allen, MD, FACC Mouaz H. Al-Mallah, MD, FACC Carolyn A. Altman, MD, FACC Aman M. Amanullah, MD, PhD, FACC Zahid Amin, MBBS Ezra A. Amsterdam, MD, FACC Karthikeyan Ananthasubramaniam, MBBS, FACC H. Vernon Anderson, MD, FACC Jeffrey L. Anderson, MD, FACC Dominick J. Angiolillo, MD, PhD, FACC Christopher P. Appleton, MD, FACC Joseph R. Aragon, MD, FACC Andrew E. Arai, MD Juan M. Aranda, Jr., MD, FACC Paul Wayne Armstrong, MD, FACC William F. Armstrong, MD, FACC Herbert D. Aronow, MD, FACC
6 GO for ACC.12!

James A. Arrighi, MD, FACC Gerard P. Aurigemma, MD, FACC Richard G. Bach, MD, FACC Jayant Bagai, MBBS, FACC Aaron L. Baggish, MD Alison Bailey, MD, FACC C. Noel Bairey Merz, MD, FACC Christie M. Ballantyne, MD, FACC Gerald Barbeau, MD, FACC Gregory W. Barsness, MD, FACC John R. Bartholomew, III, MD, FACC Riyaz Bashir, MBBS, FACC Jean-Pierre L. Bassand, MD, FACC Eric R. Bates, MD, FACC Timothy A. Beaver, MD, FACC Jeffrey S. Berger, MD, FACC Lisa Bergersen, MD, MPH, FACC Daniel S. Berman, MD, FACC Colin Berry, MB, ChB, FACC John F. Beshai, MD, FACC Patricia J. M. Best, MD, FACC Deepak L. Bhatt, MD, MPH, FACC Tandeep Bhatti, MD, FACC Vera Bittner, MD, FACC Ron Blankstein, MD, FACC David A. Bluemke, MD, PhD Kay Blum, NP, PhD Elizabeth D. Blume, MD, FACC Xu Bo William E. Boden, MD, FACC John P. Boehmer, MD, FACC Eric Boersma, PhD Raoul Bonan, MD, FACC Robert O. Bonow, MD, MACC Jeffrey S. Borer, MD, FACC

Barry Borlaug, MD, FACC Robert C. Bourge, MD, FACC Biykem Bozkurt, MD, PhD, FACC Peter A. Brady, FACC Somjot Singh Brar, MD, FACC Sorin J. Brener, MD, FACC Emmanouil S. Brilakis, MD, PhD, FACC Ralph G. Brindis, MD, MPH, MACC Jeffrey A. Brinker, MD, FACC David L. Brown, MD, FACC John E. Brush, Jr., MD, FACC Randall M. Bryant, MD Matthew J. Budoff, MD, FACC Hector Bueno, MD, PhD James A. Burke, MD, FACC Javed Butler, MBBS, FACC David Calhoun, MD Hugh Calkins, MD, FACC David S. Cannom, MD, FACC Christopher P. Cannon, MD, FACC Warren J. Cantor, MD Davide Capodanno, MD Joseph Patrick Carrozza, Jr., MD, FACC Ivan P. Casserly, MD, FACC Ricardo Castillo, MD, FACC Bojan Cercek, MD, FACC Paul Chan, MD, MSc Panithaya Chareonthaitawee, MD, FACC Sandra L. Chase, PharmD Farooq A. Chaudhry, MD, FACC Jersey Chen, MD Jie Cheng, FACC Stanley J. Chetcuti, MD, FACC Alaide Chieffo, MD

ACC.12 Acknowledgments
Kenneth Chin, MBBS, FACC Aram V. Chobanian, MD, FACC George S. Chrysant, MD, FACC Sumeet S. Chugh, MD, FACC Joaquin E. Cigarroa, MD, FACC Mehmet Cilingiroglu, MD, FACC John G. F. Cleland, MD, FACC David J. Cohen, MD Mauricio G. Cohen, MD, FACC Meryl S. Cohen, MD, FACC Tyrone J. Collins, MD, FACC John P. Cooke, MD, PhD Joshua M. Cooper, MD, FACC Leslie T. Cooper, MD, FACC Salvatore P. Costa, MD, FACC David Alan Cox, MD, FACC Jesse W. Currier, MD, FACC Jeptha P. Curtis, MD, FACC Tillmann Cyrus, MD, FACC George D. Dangas, MD, PhD, FACC James P. Daubert, MD, FACC Harold L. Dauerman, MD, FACC Ravin Davidoff, MD, FACC Charles J. Davidson, MD, FACC Michael H. Davidson, MD, FACC Mark G. Davies, MB, BCh, PhD, FACC Robbert de Winter Larry S. Dean, MD, FACC G. William Dec, Jr., MD, FACC Carole J. Decker, RN Gregory J. Dehmer, MD, FACC Ali E. Denktas, MD, FACC David DeNofrio, MD, FACC Akshay S. Desai, MD, FACC Marcelo F. Di Carli, MD, FACC Robert S. Dieter, MD, FACC John P. DiMarco, MD, FACC Alexios P. Dimas, MD, FACC Germano DiSciascio, MD, FACC Sanjay Dixit, MBBS, FACC Caroline Lloyd Doherty, MSN, CRNP, AACC Hisham Dokainish, MD, FACC James Douketis, MD Douglas E. Drachman, MD, FACC Mark H. Drazner, MD, FACC Andre J. Duerinckx, FACC Stephanie H. Dunlap, DO Kim A. Eagle, MD, MACC Robert T. Eberhardt, MD, FACC Ramin Ebrahimi, MD, FACC Andrew Jeffrey Einstein, MD, PhD, FACC Kenneth A. Ellenbogen, MD, FACC Stephen G. Ellis, MD, FACC Sammy Elmariah, MD Andrew E. Epstein, MD, FACC Raimund A Erbel, MD, FACC N. A. Mark Estes, III, MD, FACC Gregory A. Ewald, MD, FACC Derek V. Exner, MD, FACC Mitchell N. Faddis, MD, PhD, FACC Thomas E. Fagan, MD, FACC Peter S. Fail, MD, FACC Bruno Farah, MD Andrew Farb, MD, FACC David P. Faxon, MD, FACC William Fuller Fearon, MD, FACC Frederick Feit, MD, FACC Dmitriy N. Feldman, MD, FACC Marc D. Feldman, MD, FACC G. Michael Felker, MD, FACC Keith C. Ferdinand, MD, FACC Victor A. Ferrari, MD, FACC Stephan D. Fihn, MD, MPH Tim A. Fischell, MD, FACC Scott D. Flamm, MD, FACC Mark A. Fogel, MD, FACC Gregg C. Fonarow, MD, FACC Joanne M. Foody, MD, FACC Paul Forfia, MD Elyse Foster, MD, FACC Wayne J. Franklin, MD, FACC Robert P. Frantz, MD, FACC James B. Froehlich, MD, MPH, FACC Edward D. Frohlich, MD, FACC Krishna K Gaddam, MD Runlin Gao, MD, FACC Lawrence A. Garcia, MD, FACC Julius M. Gardin, MD, FACC Marie D. Gerhard-Herman, MD, FACC Anthony Gershlick, MD Jalal K. Ghali, MD, FACC Raymond J. Gibbons, MD, FACC C. Michael Gibson, MD, FACC Ian C. Gilchrist, MD, FACC Anne M. Gillis, MD Michael M. Givertz, MD, FACC Michael Robert Gold, MD, PhD, FACC Lee R. Goldberg, MD, MPH, FACC Samuel Z. Goldhaber, MD, FACC James A. Goldstein, MD, FACC Sarah J. Goodlin, MD, FACC Shaun G. Goodman, MD, FACC Stephen S. Gottlieb, MD, FACC Christopher B. Granger, MD, FACC James Aaron Grantham, MD, FACC Liliana R. Grinfeld, MD, FACC Paul Michael Grossman, MD, FACC Maya E. Guglin, MD, FACC Rajiv Gulati, MD, FACC Anuj Gupta, MD, FACC Paul A. Gurbel, MD, FACC Rory Hachamovitch, MD, FACC David E. Haines, MD, FACC Jonathan L. Halperin, MD, FACC Kishore J. Harjai, MD, FACC Robert A. Harrington, MD, FACC Thomas H. Hauser, MD, FACC Edward P. Havranek, MD, FACC David L. Hayes, MD, FACC Harvey S. Hecht, MD, FACC
ACC.12 Final Program 7

Acknowledgments ACC.12
Paul A. Heidenreich, MD, FACC Gary V. Heller, MD, PhD, FACC Robert C. Hendel, MD, FACC Timothy D. Henry, MD, FACC James Bernard Hermiller, Jr., MD, FACC Adrian F. Hernandez, MD Howard C. Herrmann, MD, FACC William R. Hiatt, MD Ziyad M. Hijazi, MBBS, MPH, FACC Alan T. Hirsch, MD, FACC Glenn A. Hirsch, MD, MHS, FACC Kalon K. L. Ho, MD, FACC Katherine J. Hoercher, RN Udo Hoffmann, MD, MPH Stefan H. Hohnloser, MD, FACC Brian D. Hoit, MD, FACC Thomas A. Holly, MD, FACC David R. Holmes, Jr., MD, FACC Ralf Holzer, MD Shunichi Homma, MD, FACC Susan D. Housholder-Hughes, NP, AACC Henry H. Hsia, MD, FACC Eileen M. Hsich, MD, FACC W. Gregory Hundley, MD, FACC Judy W. Hung, MD Mathew D. Hutchinson, MD, FACC Adolph M. Hutter, Jr., MD, MACC Julia H. Indik, MD, PhD, FACC David Dunbar Ivy, MD, FACC Warren M. Jackman, MD, FACC Elizabeth A. Jackson, MD, FACC Alice K. Jacobs, MD, FACC Jeffrey P. Jacobs, MD, FACC Farouc A. Jaffer, MD, PhD, FACC Diwakar Jain, MD, FACC Kenneth A. Jamerson, MD Stefan K. James Ik-Kyung Jang, MD, PhD, FACC Allen Jeremias, MD, FACC
8 GO for ACC.12!

Robert H. Jones, MD, MACC Ion S. Jovin, MD, FACC Henri Justino, MD, CM, FACC Jens J. Kaden, MD Alan H. Kadish, MD, FACC Mathew Samuel Kalarickal, MD David E. Kandzari, MD, FACC Samir R. Kapadia, MBBS, FACC Aaron V. Kaplan, MD, FACC Norman M. Kaplan, MD Saibal Kar, MD, FACC Ronald P. Karlsberg, MD, FACC Andrew M. Kates, MD, FACC Sanjay Kaul, MBBS, FACC Dean J. Kereiakes, MD, FACC Steven J. Keteyian, PhD Amit Khera, MD, MSc, FACC Henry E. Kim, MD, MPH, FACC Carey D. Kimmelstiel, MD, FACC Ajay J. Kirtane, MD, FACC Kyle W. Klarich, MD, FACC Neal S. Kleiman, MD, FACC Lloyd W. Klein, MD, FACC George J. Klein, MD Paul Kligfield, MD, FACC Eva M. Kline-Rogers, RN Bradley P. Knight, MD, FACC Todd M. Koelling, MD, FACC Michael C. Kontos, MD, FACC Smadar Kort, MD, FACC Mikhail Kosiborod, MD, FACC Jan Kovac, II, MD, FACC Jason Ciril Kovacic, MBBS, PhD, FACC Sandor J. Kovacs, Jr., MD, PhD, FACC Christopher M. Kramer, MD, FACC Richard A. Krasuski, MD, FACC Jacqueline Kreutzer, MD, FACC Eric V. Krieger, MD Harlan M. Krumholz, MD, SM, FACC Aaron D. Kugelmass, MD, FACC Sudhir S. Kushwaha, MD, FACC

Fred M. Kusumoto, MD, FACC Michael A. Kutcher, MD, FACC Jeffrey T. Kuvin, MD, FACC Raymond Y. K. Kwong, MD, FACC Nasser M. Lakkis, MD, FACC Omosalewa O. Lalude, MBBS, FACC Rachel J. Lampert, MD, FACC Roberto M. Lang, MD, FACC Richard A. Lange, MD, FACC Alexandra J. Lansky, MD, FACC Gregory M. Lanza, MD, PhD, FACC Warren K. Laskey, MD, FACC Steven B. Laster, MD, FACC Christine E. Lawless, MD, FACC Martin B. Leon, MD, FACC Amir Lerman, MD, FACC John R. Lesser, MD, FACC Wayne C. Levy, MD, FACC Gregory D. Lewis, MD Joao A. C. Lima, MD, FACC David Lin, MD, FACC A. Michael Lincoff, MD, FACC Bruce D. Lindsay, MD, FACC Mark S. Link, MD, FACC Christopher F. Liu, MD, FACC Margaret A. Lloyd, MD Thomas M. Maddox, MD, MSc, FACC Akiko Maehara, MD Francesco Maisano, MD David J. Malenka, MD, FACC Calin V. Maniu, MD, FACC Francis E. Marchlinski, MD, FACC Frank I. Marcus, MD, FACC David W. Markham, MD Larry Markham, MD David Joel Maron, MD, FACC Randolph P. Martin, MD, FACC Alice M. Mascette, MD, FACC Frederick A. Masoudi, MD, MSPH, FACC Barry M. Massie, MD, FACC

ACC.12 Acknowledgments
Paul J. Mather, MD, FACC Verghese Mathew, MD, FACC Mathew S. Maurer, MD Robert D. McBane, II, MD, FACC James K. McCord, MD Doff B. McElhinney, MD Dana P. McGlothlin, MD Darren K. McGuire, MD, MHSc, FACC Vallerie V. McLaughlin, MD, FACC Dennis M. McNamara, MD, FACC Robert L. McNamara, MD, MHS, FACC David D. McPherson, MD, FACC Jessica L Mega, MD Julinda Mehilli Roxana Mehran, MD, FACC Shamir R. Mehta, MD, FACC Bernhard Meier, MD, FACC John C. Messenger, MD, FACC David C. Metzger, MD, FACC Alan B. Miller, MD, FACC Fletcher A. Miller, Jr., MD, FACC John M. Miller, MD, FACC Gary S. Mintz, MD, FACC Gregory J. Mishkel, MD, FACC Suneet Mittal, MD, FACC Emile R. Mohler, III, MD, FACC David J. Moliterno, MD, FACC Stephanie A. Moore, MD, FACC David A. Morrow, MD, MPH, FACC William R. Morrow, MD, FACC Mauro Moscucci, MD, FACC Jeffrey W. Moses, MD, FACC Arthur J. Moss, MD, FACC Joshua D. Moss, MD, FACC Luis M. B. Moura, MD, PhD, FACC Issam D. Moussa, MD, FACC Debabrata Mukherjee, MD, FACC David W. M. Muller, MBBS, FACC Srinivas Murali, MBBS, FACC Robert J. Myerburg, MD, FACC Gerald V. Naccarelli, MD, FACC Sherif F. Nagueh, MD, FACC Srihari S. Naidu, MD, FACC Vijay Nambi, MBBS, FACC Navin C. Nanda, MD, FACC Shawna D. Nesbitt, MD David E. Newby, MD, PhD, FACC Eugenia Nikolsky, MD, PhD, FACC Steven E. Nissen, MD, MACC Rick A. Nishimura, MD, FACC Kevin D. OBrien, MD Patrick T. OGara, MD, FACC Masahiko Ochiai, MD, PhD, FACC Jae K. Oh, MD, FACC Erik Magnus Ohman, MD, FACC Jeffrey W. Olin, DO, FACC Brian Olshansky, MD, FACC Suzanne Oparil, MD, FACC Catherine M. Otto, MD, FACC Ronald J. Oudiz, MD, FACC Ramdas G. Pai, MBBS, FACC Tullio Palmerini, MD Salpy V. Pamboukian, MD, FACC Julio A. Panza, MD, FACC Seung-Jung Park, MD, PhD Myung H. Park, MD, FACC Alan S. Pearlman, MD, FACC Patricia A. Pellikka, MD, FACC Carl J. Pepine, MD, MACC Eduardo Perna, MD Eric D. Peterson, MD, MPH, FACC Harry R. Phillips, MD, FACC Gregory Piazza, MD, FACC Philippe Pibarot, DVM, PhD, FACC Michael H. Picard, MD, FACC Augusto Pichard, MD, FACC Ileana L. Pina, MD, FACC Edward Plow, PhD Donna M. Polk, MD, MPH, FACC Michael Poon, MD, FACC Brian D. Powell, MD, FACC Abhiram Prasad, MD, FRCP, FACC Matthew J. Price, MD, FACC Miguel A. Quinones, MD, FACC Gilbert Raff, MD, FACC Paolo Raggi, MD, FACC Michael Ragosta, MD, FACC Shahbudin H. Rahimtoola, MD, MACC Navin Rajagopalan, MD, FACC Sanjay Rajagopalan, MD, FACC Nalini Marie Rajamannan, MD, FACC C. Venkata S. Ram, MBBS, FACC Ravi N. Ramani, MD Jesus Eduardo Rame, MD Sunil V. Rao, MD, FACC Saif S. Rathore, MPH Rita F. Redberg, MD, MSc, FACC Bernhard Reimers John F. Rhodes, Jr., MD, FACC Vera H. Rigolin, MD, FACC Michael P. Riley, MD, PhD Michael J. Rinaldi, MD, FACC Melissa R. Robinson, MD Matthew T. Roe, MD, FACC Joseph G. Rogers, MD, FACC Anand Rohatgi, MD, FACC Ivan Rokos, MD, FACC Kerry L. Rosen, MD, FACC Raphael Rosenhek, MD Robert S. Rosenson, MD, FACC Carlos E. Ruiz, MD, PhD, FACC John S. Rumsfeld, MD, PhD, FACC Jeremy N. Ruskin, MD, FACC Stuart D. Russell, MD, FACC Arwa Saidi, MB, BCh, FACC Ernesto E. Salcedo, MD, FACC Margaret M. Samyn, MD, FACC Raul D. Santos, MD, DPhil Lowell F. Satler, MD, FACC William H. Sauer, MD, FACC Sherry J. Saxonhouse, MD, FACC Prof. Bruno Scheller Nelson B. Schiller, MD, FACC
ACC.12 Final Program 9

Acknowledgments ACC.12
Paul Schoenhagen, MD Joachim Schofer Benjamin M. Scirica, MD, MPH, FACC Robert L. Scott, MD, PhD, FACC Victor Serebruany, MD, PhD Bindi K. Shah, MD, FACC Pravin M. Shah, MD, MACC Prediman K. Shah, MD, FACC Esther Shao, MD, PhD Samin K. Sharma, MBBS, FACC Leslee J. Shaw, PhD, FACC Mobeen Sheikh, MD, FACC Richard J. Sheppard, MD, CM Jerold S. Shinbane, MD, FACC Mehdi H. Shishehbor, DO, MPH Robert J. Siegel, MD, FACC Horst Sievert, MD, FACC Marc A. Silver, MD, FACC Candice K. Silversides, MD Daniel I. Simon, MD, FACC Michael Hugh Sketch, Jr., MD, FACC James N. Slater, MD, FACC Christopher S. Snyder, MD Scott D. Solomon, MD, FACC Prem Soman, MBBS, FACC Paul Sorajja, MD, FACC David E. Sosnovik, MB, BCh, FACC Laurence S. Sperling, MD, FACC John A. Spertus, MD, MPH, FACC Komandoor S. Srivathsan, MBBS, FACC Bruce Sheldon Stambler, MD, FACC Randall C. Starling, MD, MPH, FACC Philippe Gabriel Steg, MD, FACC James H. Stein, MD, FACC Paul D. Stein, MD, FACC Daniel Howard Steinberg, MD, FACC Steven R. Steinhubl, MD, FACC William J. Stewart, MD, FACC Gregg W. Stone, MD, FACC Neil J. Stone, MD, FACC George A. Stouffer, MD, FACC Karen K. Stout, MD, FACC
10 GO for ACC.12!

Takahiko Suzuki Corrado Tamburino Allen J. Taylor, MD, FACC James E. Tcheng, MD, FACC John R. Teerlink, MD, FACC Jeffrey J. Teuteberg, MD Paul D. Thompson, MD, FACC Henry H. Ting, MD, FACC Peter P. Toth, MD, PhD, FACC Mark I. Travin, MD, FACC Jennifer Tremmel, MD, FACC Jeffrey C. Trost, MD, FACC Robin J. Trupp, MSN, RN, ACNP Etsuo Tsuchikane Alexander G. Turpie, FACC E. Murat Tuzcu, MD, FACC Patricia A. Uber, PharmD James E. Udelson, MD, FACC Philip M. Urban, MD, FACC Viola Vaccarino, MD, PhD Alex S. Vahanian, MD Anne Marie Valente, MD, FACC Paul D. Varosy, MD, FACC Hector O. Ventura, MD, FACC Ralph J. Verdino, MD, FACC Anil Verma, MD Mladen I. Vidovich, MD, FACC Todd C. Villines, MD, FACC Salim S. Virani, MD Renu Virmani, MD, FACC Joseph A. Vita, MD, FACC Pieter-Jan J. Vlaar Szilard Voros, FACC Ron Waksman, MD, FACC Lars Wallentin, MD Paul J. Wang, MD, FACC Tracy Wang, MD, FACC R. Parker Ward, MD, FACC Michael A. Weber, MD, FACC Mark W. I. Webster, MD Bonnie H. Weiner, MD, FACC

Andrew R. Weintraub, MD, FACC William S. Weintraub, MD, FACC Raul Weiss, MD, FACC Robert Matthew Weiss, MD Neil J. Weissman, MD, FACC Giora Weisz, MD Francine K. Welty, MD, PhD, FACC J. Marcus Wharton, MD Grayson Wheatley, III, MD Harvey D. White, DSc, FACC Christopher J. White, MD, FACC Harvey D. White, DSc, FACC Susan E. Wiegers, MD, FACC David J. Wilber, MD, FACC Kim Allan Williams, Sr., MD, FACC Peter Wilmshurst Stephan Windecker, MD Suzanne J. Wingate, PhD, CRNP Michael D. Winniford, MD, FACC Bernhard Witzenbichler, MD Stephen D. Wiviott, MD, FACC Wojciech Wojakowski Shing-Chiu Wong, MD, FACC Malissa Jane Wood, MD, FACC Scott A. Wright, MD, FACC Nina Wunderlich Janet Fredal Wyman, MSN, NP, ACNS-BC, AACC Masahisa Yamane, MD, FACC Phillip C. Yang, MD, FACC Xiaoming Yang, MD, PhD Robert W. Yeh, MD, FACC Doron Zahger, MD Alan Zajarias, MD, MSc, FACC David Xiao-Ming Zhao, MD, FACC Khaled M. Ziada, MD, FACC Michael R. Zile, MD, FACC Gilbert J. Zoghbi, MD, FACC William A. Zoghbi, MD, FACC ACC-i2 with TCT Affiliate Recognition: VIVA 12: Vascular InterVentional Advances

ACC.12

Elite FIT Rising Star Acknowledgments

Please join us in acknowledging the work of your peers. The following Fellows in Training have been selected as part of an elite group of FIT rising stars, based upon their top scoring abstract or case submission for ACC.12.
Ahmad Jeroudi Ali Alizadehsovari Amit Amin Amit Noheria Andrew Choi Anita Radhakrishnan Benjamin Galper Brian Davidson Christopher Statile Dan Sorajja Danny Eapen Dawn Scantlebury Dharam Kumbhani Dongngan Truong Eric Rome Evan Brittain Farbod Raiszadeh Haseeb Jafri Jeffrey Testani JoEllyn Abraham John Dodson John Lee Jose Vargas Karim Sallam Khurram Nasir Kumar Dharmarajan Kyle Ulveling Louai Razzouk Manoj Kesarwani Marnie Taylor Matthew Solomon Max Liebo Megan Coylewright Meredith Brisco Michael Blaha Michael Burke Morteza Farasat Mosi Bennett Murali Senapathi Nada Shaban Neha Yadav Nitesh Sood Nitin Mahajan Omar Khalique Paaladinesh Thavendiranathan Philip Green Poulina Uddin Quinn Pack Raymond Chan Raymond Chan Robert Mentz Robert Tunks Sameer Jamal Samir Thadani Sandeep Goyal Seshu Rao Sharath Subramanian Shikhar Agarwal Siddharth Wayangankar Sreedevi Gondi Stacey Clegg Tarek Mousa Tomas Neilan Yasmin Hamirani Zubin Eapen
ACC.12 Final Program 11

ACC.12 GRANTOR ACKNOWLEDGMENTS*

ACUTE CORONARY SYNDROMES PATHWAY PREVENTION/GENERAL CARDIOLOGY PATHWAY

ARRHYTHMIAS PATHWAY

PULMONARY HYPERTENSION PATHWAY

DIAGNOSTIC TESTING AND IMAGING PATHWAY

VALVULAR PATHWAY

HEART FAILURE PATHWAY

*Grantors as of February 27, 2012 2012 American College of Cardiology. A12269

ACC-i2 with TCT GRANTOR ACKNOWLEDGMENTS*

*Grantors as of February 27, 2012 2012 American College of Cardiology. A12270

ACC.12 CLINICAL FOCUS SESSIONS GRANTOR ACKNOWLEDGMENTS*

CHAMPIONING CARE FOR THE PATIENT WITH AORTIC STENOSIS

FIRST LINE OF DEFENSE: RISK FACTORS AND PREVENTION IN THE CARDIOLOGY PRACTICE

INNOVATIONS IN TRANSLATION: ACS

INNOVATIONS IN TRANSLATION: ATRIAL FIBRILLATION JOINT SESSION OF THE HEART RHYTHM SOCIETY AND ACC

MULTIDISCIPLINARY APPROACH TO THE HIGH RISK AORTIC STENOSIS PATIENT JOINT SESSION OF AATS, STS AND ACC

*Grantors as of February 27, 2012 2012 American College of Cardiology. A12271

ACC.12 SESSION GRANTOR ACKNOWLEDMENTS*

THE ROLE OF THERAPEUTIC HYPOTHERMIA IN THE TREATMENT OF CARDIAC ARREST SESSION #263 - SUNDAY, MARCH 25, 4:30 P.M. 6:00 P.M. SUPPORTED BY EDUCATIONAL GRANTS FROM:

ANTITHROMBOTIC THERAPIES FOR ATRIAL FIBRILLATION: THE CURRENT STATE OF THE ART SESSION #747 - TUESDAY, MARCH 27, 8:00 A.M. 9:30 A.M. IN PARTNERSHIP WITH THE TEAM-A INITIATIVE

SUPPORTED BY AN EDUCATIONAL GRANT FROM:

BRISTOL-MYERS SQUIBB AND PFIZER, INC.

*Grantors as of February 27, 2012 2012 American College of Cardiology. A12294

ACCF Charitable Benefactors

The American College of Cardiology Foundation proudly recognizes our 2011 donors whose generosity demonstrates the spirit of giving that enables the College to foster optimal cardiovascular care. The following donors are recognized for their gifts to ACCF initiatives between January 1, 2011 and December 31, 2011.
Margarita Abbey, NP Arnold Abrams, MD Arnold Adicoff, MD, FACC Ashok Agarwal, MD, FACC Anwar Ahmad, MBBS, FACC Walter Allison III, MD Joseph Alpert, MD, FACC & Helle Mathiasen, PhD Arthur Anderson, MD, FACC Paul Anderson, MD, FACC Lewis Anthony, MD, FACC Emanuel Arbel, MD, FACC Surya Artham, MD, MPH James Asaph, MD, FACC Manisha Ashar, MD, FACC John Auseon, DO, FACC Catherine Avgeropoulou, MD Darla Bakersmith-Hess, MD, FACC Ajay Bali, MBBS, FACC Scott Baron, MD, FACC Habib Bassil, MD, FACC Asish Basu, MBBS, FACC Jennifer Ray Beckman & Jon Beckman John Beeble, MD Linda Bell & Douglas Bell George Beller, MD, MACC & Emily Couric Pachalla Bhat, MD, FACC Kathleen Blake, MD, FACC Boris Bogomilov, MD, FACC Marc Bois, MD, FACC Michael Boland, MD, FACC John Bowers, MD, FACC Ahmet Bozer, MD, FACC Joseph Branconi, MD, FACC
16 GO for ACC.12!

Alan Brenner, MD, FACC Craig Brenner Drs. Ralph and Claire Brindis Allison Brooks, NP, AACC Carman Brooks, MD, FACC Nathan Brown, MD, FACC Christine Browning, MD Peter Bruno, MD, FACC John Brush, Jr., MD, FACC Howard Buckley, MD, FACC Marcia Buckley Bull, MD, FACC Calvert Busch, MD, FACC Homobono Calleja, MD, FACC & Cecilia Calleja Taufique James Calvin, MD, FACC Joanne Ceimo, MD, FACC Bernard R. Chaitman, MD, FACC Sandra Chase, PharmD Leonid Chernov, MD, FACC Devyani Chowdhury, MBBS, FACC Lalji Chudasama, MD, FACC Carolyn Clark Lianna Collinge Peter Correnti, Jr., DO Thelma Cote Peper Daniel Courtade, MD, FACC William Crafford, Jr., MD, FACC L. Bruce Cronk, MD, FACC Deborah Croy, NP, AACC Ira Dauber, MD, FACC G. William Dec, Jr., MD, FACC Anand Deshmukh, MD Robert Deutscher, MD, FACC Michael DeVita, DO, FACC Quinton Dickerson, Jr., MD, FACC

Vincent Donlon, MHA W. Daniel Doty, MD, FACC Pamela Douglas, MD, MACC & Geoffrey Ginsburg, MD, PhD, FACC Andrew Drakonakis, MD, FACC Denis Drew, MD, FACC Joseph Drozda, Jr., MD, FACC Eric Drummer, MD, FACC Angelos Economou, MD, FACC Haskell Ellison, MD, FACC Georg Emlein, MD, FACC Raimund Erbel, MD, FACC John Erwin III, MD, FACC Steven Ettinger, MD, FACC Kameel Farag, MD, FACC James Fasules, MD, FACC Meredith Filson-Perry, RN Jeffrey Fisher, MD, FACC Michael Flynn, MD, FACC Kenneth Forman, MD Robert Francis, MD, FACC Milton Frank III, MD William Frankl, MD, FACC Roberto Fred Santana, MD, FACC Leon Friedman, MD, FACC Eugene Fu, MD, FACC Juan Fuselli, MD Joseph Gaeta, MD, FACC Julius Gardin, MD, FACC & Susan Gardin Richard Gerber, MD, FACC Michael Gewitz, MD, FACC Michael Girolami, MD, FACC Julian Gladstone, MD, FACC Tyler Gluckman, MD, FACC

ACCF Charitable Benefactors

Harry Goldberg, MD, FACC Alfredo Gonzalez, MD, FACC David Gooray, MD, FACC Gabriel Gregoratos, MD, FACC Jan Griffin, NP Bhavdeep Gupta, MD, FACC & Dolly Gupta Eileen Handberg, PhD, ARNP, FACC Bruce Handler, MD, FACC Syed Haq, MBBS, FACC Masood Haque, MD, FACC Kishore Harjai, MD, FACC Lawrence Harris, MD, FACC Erhard Helmling, MD Thomas Hennebry, MB, BCh, FACC Shigeaki Hinohara, MD, FACC Tetsuya Hirano, MD, PhD, FACC Murray Hoffman, MD, FACC David Holmes, Jr., MD, FACC Mun Hong, MD, FACC Deepak Hooda, MD Susan Housholder-Hughes, NP, AACC Victor Howard, MD, FACC Larry Hurwitz, MD, FACC Saleem Husain, MD, FACC John Hutcherson, MD, FACC Elisabeth Immanuel-Alexis, MBBS, FACC David Jackson, MD, FACC Lester Jacobson, MD, FACC Mansoor Jelveh, MD, FACC Thomas Johnson, MD, FACC Zoe Jones, MD, FACC Edmundo Jordan-Morey, MD, FACC Robert Kalman Anna Kalynych, MD, FACC Murat Karatepe, MD, FACC Someswarareddy Karri, MBBS, FACC John Kassotis, MD, FACC Maximiliaan Kaulbach, MD, FACC Julian Keil, PhD, FACC Dennis Kelly, MD, FACC Gabriel Khan, MD, FACC Stephen Kiefer, MD, FACC William Kimber, MD, FACC Marvin Kirsh, MD, FACC Jay Kleiman, MD, FACC Colette Kohler, MD, FACC Richard Kovacs, MD, FACC & Roxanne Kovacs Fred Krainin, MD, FACC Gerald Lackey, DO, PhD, FACC Lawrence Laslett, MD, FACC Francis Lau, MD, FACC Ronald Lech, MD, PhD, FACC Sidney Levitsky, MD, FACC Richard Lewis, MD, FACC Shoa-Lin Lin, MD, FACC William Lista, MD, FACC Steven Lloyd, MD, FACC Jose Eugenio Lopez, MD, FACC Lawrence Lubow, MD, FACC Walter Lucia, MD Eugene Magnier, MD, PhD, FACC George Maha, MD Sabyasachi Mahapatra, MBBS, FACC Tariq Malik, MBBS, FACC Amalendu Mandal, MD, FACC Andre Marquand, MD, FACC Raymond Massay, MBBS, DM, FACC Allan Mattern, MD, FACC Manuel Mayor, MD, FACC Gloria Mays, MD, FACC John McBride, MD, FACC James McClurken, MD, FACC Herbert McDonald, MD, FACC Martin McGough, MD, FACC Charles McKay, MD, FACC & Maleah Groover-McKay Daniel McMartin, MD, FACC Joseph Messer, MD, MACC & Nancy L. Koch David Messinger, MD, FACC Keith Miller, MD, PhD, FACC Ronald Miller, MD, FACC Margo Minissian, ACNP-BC, MSN, CNS Stephanie Mitchell Vijay Mittal, MD, FACC Chitta Mohapatra, MD, FACC Christos Moschos, MD, FACC Ashish Mukherjee Narayan Mulamalla, MD, FACC Pramod Multani, MBBS, FACC Stans Murad-Netto, MD, FACC Maheswari Murugesan, NP Munir Nassar, MD Rudolph Nisi, MD, FACC Steven Nissen, MD, MACC Michael Nocero, Jr., MD, MACC Jacqueline Noonan, MD, FACC Lester Nunnally, MD, FACC John Nwogu, MBBS, FACC Patrick OGara, MD, FACC Peter Odhiambo, MD, FACC William Oetgen, MD, MBA, FACC Larry Osborn, MD, FACC Yukio Ozawa, MD, FACC John Packard, MD, FACC Vachaspathi Palakodeti, MBBS, FACC Madhava Pally, MBBS, FACC Bipin Patadia, MBBS, FACC Mrugesh B. Patel Timir Paul, MD Paul Piccini, MD, FACC Donna Polk, MD, MPH, FACC Richard Popp, MD, MACC & Janis Popp Herman Price, MD, FACC David Propert, MD, FACC William Pryor, MD, FACC Satyavardhan Pulukurthy, MD Jerome Radding, MD, FACC Martha Radford, MD, FACC Atul Ramachandran, MD, FACC Nathaniel Reichek, MD, FACC Joseph Restivo, MD, FACC James Reynolds, MD, FACC Larry Riedel, MD Gaetan Ringuette, MD, FACC Janet Rippy, MD, FACC & Fredrick Hohlt Jose Rivera Del Rio, MD, FACC Abel Robertson, Jr., MD, PhD, FACC Jerome Robinson, MD, FACC George Rodgers, MD, FACC & Leslie Rodgers Joseph Romeo, MD, FACC Fred Rose, MD, FACC James Ross, MD, FACC Dennis Rowe, MD, FACC John Rumsfeld, MD, PhD, FACC Elayne Russek
ACC.12 Final Program 17

ACCF Charitable Benefactors

Shelley Russek, PhD & David Farb Sharon S. Sadeghinia Jonathan Safren, MD, FACC Bal Sahay, MBBS, FACC Rosemarie Salerni, MD, FACC George Sanders, MD, FACC Jack Sanders, MD, FACC Joseph Saporito, MD, FACC Barry Saul II, MD, FACC Wade Saunders III, MD, FACC John Schaeffer, MD, FACC Gerold Schiebler, MD, FACC Carsten Schmalfuss, MD, FACC Mark Schoenfeld, MD, FACC Douglas Schreck, MD, FACC Jackie See, MD, FACC Marvin Segal, MD, FACC Samir Shah, MD, FACC Jami Shakibi, MD, FACC Abdolhamid Sheikhzadeh, MD, FACC TianChu Shih, DO, FACC Leonard Silverman, MD, FACC Sidney Smith, Jr., MD, FACC & Lucy Smith Samuel Sobol, MD, FACC James Spann, Jr., MD, FACC Kurt Spriggs, DO, FACC Jasbir Sra, MD, FACC Bhaskaran Sreekumar, MD, FACC Lawrence Staples, MD, FACC & Marilyn Staples Eric Stern, MD, FACC W. Theodore Steudel, MD, FACC James Stone, MD, PhD, FACC Siegfried Storz, MD, FACC Ruth Strang, MD, FACC Samuel Suede, MD, FACC W. David Sullivan, MD, FACC Maria Arlene Sumido, RN James Swan, MD, FACC Alexander Sytman, MD, FACC Burton Tabakin, MD, FACC Kan Takayanagi, MD, PhD, FACC Linda Tavares, MS, RN, ACNP-BC, AACC Richard Taylor
18 GO for ACC.12!

Madhusudan Thakur, MBBS, FACC Gerasim Tikoff, MD, FACC Peter Tilkemeier, MD, FACC Alain Tocatjian, MD, FACC Dorothy Tripodi, RN Deborah Tsunoda, NP E. Tuzcu, MD, FACC David Unterman, MD, FACC Mucio Valenca, MD, FACC Romeo Vecht, MB, ChB, FACC Renu Virmani, MD, FACC Robert Vranian, MD, FACC Edwin Vyhmeister, MD, FACC Stanley Wagner, MD, FACC Stephen Wallenhaupt, MD Howard Walpole, Jr., MD, FACC John Wanamaker, MD, FACC Howard Warner, MD, FACC James Warnock, Jr., MD, FACC Ichiro Watanabe, MD, FACC Suzanne Waters, NP W. Douglas Weaver, MD, MACC Jan Weber, MD, FACC Harry Weinrauch, MD, FACC Myron Weisfeldt, MD, FACC & Linda Weisfeldt Harlan Weisman, MD, FACC Armisted L. Wellford Edward Westmark David Wilber, MD, FACC John Williams, Jr., MD, MACC & Jan Williams Patrick Williams, MD, FACC John Wilson, MD Michael Wolk, MD, MACC Maylene Wong, MD, FACC Harry Woske, MD, FACC Milford Wyman, MD, FACC Vidya Yalamanchi, MBBS, FACC Noriaki Yamamoto, MD Takashi Yanaga, MD, FACC James Yates, MD, FACC Albert Zager, MD, FACC & Marilouise Zager Izhar Zahavi, MD, FACC Alex Zakharia, MD, FACC

Syamasundera Zampani, MD, FACC Bujung Zen, MD, FACC Douglas Zipes, MD, MACC & Joan Zipes Nazih Zuhdi, MD, FACC Alan Zunamon, MD, FACC Association of Black Cardiologists, Inc. Baptist Memorial Medical Group Blount Memorial Physician Group, Inc. California Cardiovascular Specialists Inc. California Pacific Medical Center Cardiology Consultants of NY, PC Cardiology Services PSC Cardiovascular Associates of North Jersey, PC Cardiovascular Care Associates Central Coast Cardiology A Medical Corporation DeTar Healthcare System Dr. Jordan Cardiology Center, PSC East Tennessee State University East Texas Cardiology, P.A. Easton Cardiovascular Associates, P.C. Fidelity Charitable Gift Fund Heart Care Associates, P.S.C. Heart Center of Charlotte, PA Heartcare Associates of Bucks County, P.C. Imperial Valley Family Care Medical Group A.P.C. Jefferson Medical Associates Kitsap Cardiology Consultants, PLLC Learners Digest International Midsouth Cardiovascular Center, PLLC MK & A Corporation Nevada Heart & Vascular, LLP Ocala Heart Clinic II LLC Ocean Cardiovascular, LLC Partners HealthCare Pittsburgh North Cardiovascular See Family Trust of Missouri Semma Medical PLLC Sherman Heart Group, LLC The Michael Wolk Heart Foundation, Inc. The Russek Foundation Inc. Virginia Cardiovascular Consultants PC Western Slope Cardiology, P.C.

Eugene Braunwald Clinical Investigator Award Endowment

The following donors are recognized for their gifts to the ACCFs Eugene Braunwald Clinical Investigator Award.
Hafil Abdulgani, MD, FACC Joseph Alpert, MD, FACC William H. Barry George Beller, MD, MACC Roger Blumenthal, MD, FACC Christoph Bode, MD, PhD, FACC Alfred Bove, MD, PhD, MACC Lawrence Boxt, MD, FACC Craig Brenner Ralph Brindis, MD, MPH, FACC Marcia Buckley Bull, MD, FACC Hugh Calkins, MD, FACC Joanne Ceimo, MD, FACC Bernard R. Chaitman, MD, FACC Craig Clark, MD, DO, FACC Gary Francis, MD, FACC Julius Gardin, MD, FACC Joan Gnadt, MD, FACC Lester Jacobson, MD, FACC Robert Jones, MD, MACC Fred Krainin, MD, FACC Peter Libby, MD, FACC Sabyasachi Mahapatra, MBBS, FACC Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Chitta Mohapatra, MD, FACC Jacqueline Noonan, MD, FACC Martha Radford, MD, FACC Tsuguya Sakamoto, MD, FACC Jasvinder Sidhu, MD, FACC Renu Virmani, MD, FACC Myron Weisfeldt, MD, FACC Harlan Weisman, MD, FACC John Williams, Jr, MD, MACC James Young, MD, FACC Douglas Zipes, MD, MACC Learners Digest International Partners HealthCare Anonymous Donor

Cardiovascular Leadership Institute

The following donors have honored a mentor or leader who has helped paved the way for the next generation of cardiovascular professionals. Donations were made to the ACCFs Cardiovascular Leadership Institute.
Donor Surya Artham, MD, MPH Allison Brooks, NP, AACC Christine Browning, MD Deborah Croy, NP, AACC Pamela Douglas, MD, MACC John Erwin III, MD, FACC Honoree In honor of Carl J. Lavie, MD, FACC In honor of John Dent, MD, FACC In honor of Anthony J. Minisi, MD, FACC In honor of John Dent, MD, FACC In honor of Richard L. Popp, MD, MACC In honor of Rick A. Nishimura, MD, FACC
ACC.12 Final Program 19

Cardiovascular Leadership Institute

Donor Steven Ettinger, MD, FACC Kameel Farag, MD, FACC Eugene Fu, MD, FACC Jan Griffin, NP Bhavdeep Gupta, MD, FACC Kishore Harjai, MD, FACC Kishore Harjai, MD, FACC Mun Hong, MD, FACC Mun Hong, MD, FACC Lester Jacobson, MD, FACC Robert Kalman James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC James McClurken, MD, FACC Margo Minissian, ACNP-BC, MSN, CNS Vijay Mittal, MD, FACC Maheswari Murugesan, NP Michael Nocero, Jr., MD, MACC Timir Paul, MD Donna Polk, MD, MPH, FACC David Propert, MD, FACC Nathaniel Reichek, MD, FACC Janet Rippy Hohlt, MD, FACC TianChu Shih, DO, FACC Linda Tavares, MS, RN, ACNP-BC, AACC Richard Taylor Peter Tilkemeier, MD, FACC Howard Walpole, Jr., MD, FACC Suzanne Waters, NP John Wilson, MD John Wilson, MD John Wilson, MD John Wilson, MD Alex Zakharia, MD, FACC Alan Zunamon, MD, FACC Ocala Heart Clinic II LLC Pittsburgh North Cardiovascular Honoree In honor of Charles E. Chambers, MD, FACC In honor of Kennenth A. Ellenbogen, MD, FACC In honor of John Dent, MD, FACC In honor of Michael P. Savage, MD, FACC In honor of Cynthia L. Grines, MD, FACC In honor of Gregg W. Stone, MD, FACC In honor of Kenneth M. Kent, MD, PhD, FACC In honor of Martin B. Leon, MD, FACC In honor of Monte Malach, MD, FACC In honor of Anthony J. Atala, MD In honor of Randolph Chitwood, Jr., MD, FACC In honor of Daniel E. Forman, MD, FACC In honor of John G. Harold, MD, MACC In honor of Robert H. Jones, MD, MACC In honor of Aaron D. Kugelmass, MD, FACC In honor of Scott Millikan, MD, FACC In honor of Marc E. Shelton, MD, FACC In memory of James T. Dove, MD, MACC In honor of Ajay Acharya, MD, FACC In honor of John Dent, MD, FACC In honor of Leonard S. Dreifus, MD, MACC In honor of Paul W. McMullan, Jr., MD, FACC In honor of C. Noel Bairey Merz In honor of Joseph K. Perloff, MD, FACC In honor of Felix J. Rogers, DO, FACC In honor of John Dent, MD, FACC In honor of Paula J. Schrank In honor of Alfred F. Parisi, MD, FACC In honor of Douglas C. Morris, MD, FACC In honor of John Dent, MD, FACC In honor of Alan H. Gradman In honor of Jerome E. Granato In honor of Indu G. Poornima In honor of Venkatraman Srinivasan In honor of Hadi Dizadji, MD, FACC In honor of Ajay Acharya, MD, FACC In honor of Ram L. Dhawan, MD, FACC

If you would like to participate in any of the American College of Cardiology Foundations giving programs, please email gift@acc.org.
20 GO for ACC.12!

Get Your DailY Dose of Quality at aCC.12

Learn more about ACCs quality improvement programs and how you can get involved during ACC.12

aCC Central (Booth #10027)

2012 American College of Cardiology. E1204

ExpEriEncE

Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!
iScience is a comprehensive digital library of presentations from ACC.12 and includes over 400 hours of educational content. It is the most convenient way to experience all the education from ACC.12 and allows you to watch presenters slides while listening to fully-synchronized audio as if you were actually attending each session. Features of iScience include:
Online access to content within 24 hours Convenient USB drive with access to the entire iScience library for offline viewing Streaming content for viewing on iPad and iPhone devices. Downloadable PDFs of presenter slides for convenient reference and note taking Downloadable MP3 files for convenient on-the-go audio Plus, you can earn additional CME credit with iScience
Order iScience today at the following locations: South Building, Grand Concourse Lobby, Level 3 ACC Central, Booth #10027, in the Exhibit Hall Or order online at www.CMEonCall.com/acc Enter your badge number to receive the attendee discount.
Special attendee pricing expires March 27, 2012. *Savings vary with registration category

A12199 2012 American College of Cardiology

Stay up-to-date with NEW official magazines of the American College of Cardiology CardioSource WorldNews and CardioSource InterventionalNews!
These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with: Perspectives from thought leaders Debates on the key controversies in medicine Practical insights into complex clinical data implications for your practice
What ACOs Mean
istance page 36 Clopidogrel Res

The Issue of

age 18 in the Elderlyp

Stents

p for Intervention

age 23

on Home Monito ringpage 13

Gregg C. Fonaro w,

MD

Suzanne Oparil, MD
on JNC 8page
31

CardioSource lNews Inter ventiona

PREMIER ISSUE
MARCH 2012

ISSUE 1 VOLUME 1 | www.cswnews.org

You

ws and Views r Source for Ne

from the World

of Cardiology

Your Source for

C ar di o S o ur c e WorldNews
News and Vie ws from the Wo rld of Cardiolo gy

on Politics vs.

Steven E. Nissen , MD

Sciencepage 46

VOLUME 1 | ISSUE 1 ww w.cswnews.o rg

JANUARY 201 2

PREMIER ISS UE

The New Frontier:

How the Development of TAVI

Will Change Everyt hing
CLINICAL NEWS IN THIS ISSUE:
Georges Take
Life after COURAGE
PAGE 2

T HE

NOW
JACC in a Flash 8

F U T U RE
Chriss Corner

IS

How new anticoagu lants will impact stroke prevention in AF PAGE 20

IN THIS ISSUE:
Welcome to CardioSource World News
PAGE 2

k Jack In The Bac

Number Check

es: Novel Techniqu

radial Grasping trans access
PAGE 42

9 Journal Scan tdown 12 Cardiology Coun 14 ion ACCEL Intervent 15 Hot Topic

Reduction in Incidence of MI

46% 50%
How you can help your patie nts with obesity
PAGE 42

CLINICAL NEWS
Cardiology Cou ntdown 3 JACC in a Flas h 8 Journal Scan 9 ACCEL Summar ies 10 Hot Topic 13 Special Meeting Coverage 14

Problems with nt PCI reimburseme

PAGE 48

ts from New data poin s NCDR database

PAGE 36

Creating the future

PAGE 48

Jack In The Bac

Reduction in Sudden Cardiac Deaths

Interesting stats and tidbits to ponder

PAGE 36

Number Che

ck

Patient Focus

Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.

Stop by ACC CentrAl, booth #10027 to leArn more!

2012 American College of Cardiology. G1212

Save 15% off select educational products and courses purchased on site!

Visit ACC Central, Booth #10027!

2012 American College of Cardiology. J1204

Make MULTAQ your rst-choice AAD

General Information

Keeps patients in sinus rhythm longer and reduces symptomatic AFib recurrence 1

25%
RRR

of rst AFib recurrence (symptomatic or asymptomatic)1 Absolute difference in recurrence rate of about 11% at 1 year (P<0.001; primary endpoint) Majority of rst recurrences were symptomatic

62.3%

of patients treated with MULTAQ were free of symptomatic AFib recurrence vs 54% of patients on placebo at 1 year (P<0.001; secondary endpoint)1

Decreases risk of patients being hospitalized for AFib events 2

24%
RRR*

in CV hospitalization or mortality, the combined primary endpoint (P<0.0001, entirely attributable to reduced CV hospitalizations, principally hospitalizations related to AFib) 2
*Relative risk reduction (RRR) observed over the study period (median 22-month treatment and follow-up; minimum 12 months, maximum 30 months).2,3

400-mg tablet bid, with morning and evening meals

The absolute bioavailability of MULTAQ increases when administered with a full meal

NO hospital initiation required 2 NO loading dose 2 NO titration 2

Tune in at Booth

#14000

Indication MULTAQ is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial brillation (AFib) in patients in sinus rhythm with a history of paroxysmal or persistent AFib. Important Update: Boxed WARNING, contraindications, and warnings have been revised due to label change. Important Safety Information for MULTAQBoxed WARNING WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients. MULTAQ is contraindicated in patients in atrial brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure. Please see additional Important Safety Information and brief summary of full Prescribing Information, including boxed WARNING, on following pages.

In tune with your patients needs

Visit MULTAQ.com/hcp for more information.

Important Safety Information for MULTAQ WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION

General Information

MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients. MULTAQ is contraindicated in patients in atrial brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure. MULTAQ is also contraindicated in patients: With second- or third-degree atrioventricular (AV) block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker), bradycardia <50 bpm, QTc Bazett interval 500 ms or PR interval >280 ms Who are or may become pregnant (Category X) or nursing. MULTAQ may cause fetal harm when administered to a pregnant woman With concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, ritonavir, or drugs or herbal products that prolong the QT interval and might increase the risk of Torsade de Pointes, such as phenothiazine antipsychotics, tricyclic antidepressants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics With liver toxicity related to the previous use of amiodarone With severe hepatic impairment Cardiovascular Death in NYHA Class IV or Decompensated Heart Failure MULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heart failure with recent decompensation requiring hospitalization because it doubles the risk of death. Cardiovascular Death and Heart Failure in Permanent AFib MULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events in patients with permanent AFib. Patients treated with MULTAQ should undergo monitoring of cardiac rhythm no less often than every 3 months. Cardiovert patients who are in AFib (if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benet in subjects in permanent AFib. Increased Risk of Stroke in Permanent AFib In a placebo-controlled study in patients with permanent atrial brillation, dronedarone was associated with an increased risk of stroke, particularly in the rst two weeks of therapy. MULTAQ should only be initiated in patients in sinus rhythm who are receiving appropriate antithrombotic therapy. New Onset or Worsening Heart Failure New onset or worsening of heart failure has been reported during treatment with MULTAQ in the postmarketing setting. In a placebo-controlled study in patients with permanent AFib, increased rates of heart failure were observed in patients with normal left ventricular function and no history of symptomatic heart failure, as well as those with a history of heart failure or left ventricular dysfunction. Advise patients to consult a physician if they develop signs or symptoms of heart failure, such as weight gain, dependent edema, or increasing shortness of breath. If heart failure develops or worsens and requires hospitalization, discontinue MULTAQ. Liver Injury Hepatocellular liver injury, including acute liver failure requiring transplant, has been reported in patients treated with MULTAQ in the postmarketing setting. Advise patients treated with MULTAQ to report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Consider obtaining periodic hepatic serum enzymes, especially during the rst 6 months of treatment. It is not known whether routine periodic monitoring of serum enzymes will prevent the development of severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serum enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found, institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ in patients without another explanation for the observed liver injury. Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics Hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ. QT Interval Prolongation MULTAQ induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation. If the QTc Bazett interval is 500 ms, discontinue MULTAQ. Increase in Creatinine Small increases in creatinine levels (about 0.1 mg/dL) following MULTAQ treatment initiation have been shown to be a result of inhibition of creatinines tubular secretion. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Larger increases in creatinine after MULTAQ initiation have been reported in the postmarketing setting. Some cases also reported increases in blood urea nitrogen. In most cases, these effects appear to be reversible upon drug discontinuation. Monitor renal function periodically. Women of Childbearing Potential Premenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. Counsel women of childbearing potential regarding appropriate contraceptive choices. Drug-Drug Interactions Treatment with Class I or III antiarrhythmics or drugs that are strong inhibitors of CYP 3A must be stopped before starting MULTAQ (see Contraindications) Patients should be instructed to avoid grapefruit juice beverages while taking MULTAQ Calcium channel blockers with depressant effects and beta-blockers could increase the bradycardia effects of MULTAQ on conduction Increased digoxin levels and gastrointestinal disorders have been observed when MULTAQ was coadministered with digoxin. Digoxin can also potentiate the electrophysiologic effects of MULTAQ (such as decreased AV-node conduction); consider the need for continued digoxin therapy when prescribing MULTAQ. If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated with MULTAQ. Monitor INR after initiating MULTAQ in patients taking warfarin Statins: Follow statin label recommendations for use with CYP 3A and P-gP inhibitors such as MULTAQ Adverse Reactions In studies, the most common adverse reactions observed with MULTAQ were diarrhea, nausea, abdominal pain, vomiting, and asthenia. Please see brief summary of Prescribing Information, including boxed WARNING, on following pages. References: 1. Singh BN, Connolly SJ, Crijns HJGM, et al; for the EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial brillation or utter. N Engl J Med. 2007;357:987-999. 2. MULTAQ (dronedarone) Prescribing Information. Sano-aventis U.S. LLC; 2011, Bridgewater, NJ. 3. Hohnloser SH, Crijns HJGM, van Eickels M, et al; for the ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial brillation. N Engl J Med. 2009;360:668-678.

US.DRO.11.12.032 December 2011 2011 sano-aventis U.S. LLC, A SANOFI COMPANY

MULTAQ (dronedarone) Tablets

Rx Only

Brief Summary of Prescribing Information WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION In patients with symptomatic heart failure and recent decompensation requiring hospitalization or NYHA Class IV heart failure; MULTAQ doubles the risk of death. (14.3 in the full prescribing information) MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. (4, 5.1) In patients with permanent atrial brillation, MULTAQ doubles the risk of death, stroke and hospitalization for heart failure. (14.4 in the full prescribing information). MULTAQ is contraindicated in patients in atrial brillation (AF) who will not or cannot be cardioverted into normal sinus rhythm. (4, 5.2)

1 INDICATIONS AND USAGE MULTAQ is indicated to reduce the risk of hospitalization for atrial brillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial brillation (AF) [see Clinical Studies (14) in the full prescribing information]. 2 DOSAGE AND ADMINISTRATION The recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be taken as one tablet with the morning meal and one tablet with the evening meal. Treatment with Class I or III antiarrhythmics (e.g., amiodarone, ecainide, propafenone, quinidine, disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole) must be stopped before starting MULTAQ [see Contraindications (4)]. 4 CONTRAINDICATIONS MULTAQ is contraindicated in patients with: Permanent atrial brillation (patients in whom normal sinus rhythm will not or cannot be restored) [see Boxed Warning and Warnings and Precautions (5.2)] Symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV symptoms [see Boxed Warning and Warnings and Precautions (5.1)] Second- or third-degree atrioventricular (AV) block, or sick sinus syndrome (except when used in conjunction with a functioning pacemaker) Bradycardia <50 bpm Concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see Drug Interactions (7.2)] Concomitant use of drugs or herbal products that prolong the QT interval and might increase the risk of Torsade de Pointes, such as phenothiazine anti-psychotics, tricyclic antidepressants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics Liver toxicity related to the previous use of amiodarone QTc Bazett interval 500 ms or PR interval >280 ms Severe hepatic impairment Pregnancy (Category X): MULTAQ may cause fetal harm when administered to a pregnant woman. MULTAQ is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus [see Use in Specic Populations (8.1)]. Nursing mothers [see Use in Specic Populations (8.3)] 5 WARNINGS AND PRECAUTIONS 5.1 Cardiovascular Death in NYHA Class IV or Decompensated Heart Failure MULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heart failure with recent decompensation requiring hospitalization because it doubles the risk of death. 5.2 Cardiovascular Death and Heart Failure in Permanent AF MULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events in patients with permanent AF. Patients treated with dronedarone should undergo monitoring of cardiac rhythm no less often than every 3 months. Cardiovert patients who are in atrial brillation (if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benet in subjects in permanent AF. 5.3 Increased Risk of Stroke in Permanent AF In a placebo-controlled study in patients with permanent atrial brillation, dronedarone was associated with an increased risk of stroke, particularly in the rst two weeks of therapy [see Clinical Studies (14.4) in the full prescribing information]. MULTAQ should only be initiated in patients in sinus rhythm who are receiving appropriate antithrombotic therapy [see Drug interactions (7.3)]. 5.4 New Onset or Worsening Heart Failure New onset or worsening of heart failure has been reported during treatment with MULTAQ in the postmarketing setting. In a placebo controlled study in patients with permanent AF increased rates of heart failure were observed in patients with normal left ventricular function and no history of symptomatic heart failure, as well as those with a history of heart failure or left ventricular dysfunction. Advise patients to consult a physician if they develop signs or symptoms of heart failure, such as weight gain, dependent edema, or increasing shortness of breath. If heart failure develops or worsens and requires hospitalization, discontinue MULTAQ. 5.5 Liver Injury Hepatocellular liver injury, including acute liver failure requiring transplant, has been reported in patients treated with MULTAQ in the post-marketing setting. Advise patients treated with MULTAQ to report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Consider obtaining periodic hepatic serum enzymes, especially during the rst 6 months of treatment, but it is not known whether routine periodic monitoring of serum enzymes will prevent the development of severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serum enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found,

institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ in patients without another explanation for the observed liver injury. 5.6 Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics Hypokalemia or hypomagnesemia may occur with concomitant administration of potassiumdepleting diuretics. Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ. 5.7 QT Interval Prolongation Dronedarone induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation [see Clinical Pharmacology (12.2) in the full prescribing information and Clinical Studies (14.1) in the full prescribing information]. If the QTc Bazett interval is 500 ms, discontinue MULTAQ [see Contraindications (4)]. 5.8 Increase in Creatinine after Treatment Initiation Small increases in creatinine levels (about 0.1 mg/dL) following dronedarone treatment initiation have been shown to be a result of inhibition of creatinines tubular secretion. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Larger increases in creatinine after dronedarone initiation have been reported in the postmarketing setting. Some cases also reported increases in blood urea nitrogen. In most cases, these effects appear to be reversible upon drug discontinuation. Monitor renal function periodically. 5.9 Women of Childbearing Potential Premenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. Counsel women of childbearing potential regarding appropriate contraceptive choices. [see Use in Specic Populations (8.1)]. 6 ADVERSE REACTIONS The following safety concerns are described elsewhere in the label: New or worsening heart failure [see Warnings and Precautions (5.4)] Liver Injury [see Warnings and Precautions (5.5)] Hypokalemia and hypomagnesemia with potassium-depleting diuretics [see Warnings and Precautions (5.6)] QT prolongation [see Warnings and Precautions (5.7)] 6.1 Clinical Trials Experience The safety evaluation of dronedarone 400 mg twice daily in patients with AF or AFL is based on 5 placebo controlled studies, ATHENA, EURIDIS, ADONIS, ERATO and DAFNE. In these studies, a total of 6285 patients were randomized and treated, 3282 patients with MULTAQ 400 mg twice daily, and 2875 with placebo. The mean exposure across studies was 12 months. In ATHENA, the maximum follow-up was 30 months. In clinical trials, premature discontinuation because of adverse reactions occurred in 11.8% of the dronedarone-treated patients and in 7.7% of the placebo-treated group. The most common reasons for discontinuation of therapy with MULTAQ were gastrointestinal disorders (3.2 % versus 1.8% in the placebo group) and QT prolongation (1.5% versus 0.5% in the placebo group). The most frequent adverse reactions observed with MULTAQ 400 mg twice daily in the 5 studies were diarrhea, nausea, abdominal pain, vomiting, and asthenia. Table 1 displays adverse reactions more common with dronedarone 400 mg twice daily than with placebo in AF or AFL patients, presented by system organ class and by decreasing order of frequency. Adverse laboratory and ECG effects are presented separately in Table 2. Table 1: Adverse Drug Reactions that Occurred in at Least 1% of Patients and Were More Frequent than Placebo Placebo (N=2875) Gastrointestinal Diarrhea Nausea Abdominal pain Vomiting Dyspeptic signs and symptoms General Asthenic conditions Cardiac Bradycardia Skin and subcutaneous tissue Including rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic 3% 5% 1% 3% 5% 7% 6% 3% 3% 1% 1% 9% 5% 4% 2% 2% Dronedarone 400 mg twice daily (N=3282)

Photosensitivity reaction and dysgeusia have also been reported at an incidence less than 1% in patients treated with MULTAQ. The following laboratory data/ECG parameters were reported with MULTAQ 400 mg twice daily. Table 2: Laboratory data/ECG parameters not necessarily reported as adverse events Placebo (N=2875) Early increases in creatinine 10% QTc prolonged 21% (N=2237) 19% MULTAQ 400 mg twice daily (N=3282) 51% (N=2701) 28%

Assessment of demographic factors such as gender or age on the incidence of treatment-emergent adverse events did not suggest an excess of adverse events in any particular sub-group. 6.2 Postmarketing Experience The following adverse reactions have been identied during post-approval use of MULTAQ. Because these reactions are reported voluntarily from a population of an unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Cardiac: New or worsening heart failure [see Warnings and Precautions (5.3)] Hepatic: Liver Injury [see Warnings and Precautions (5.5)] Respiratory: Postmarketing cases of interstitial lung disease including pneumonitis and pulmonary brosis have been reported. 7 DRUG INTERACTIONS Dronedarone is metabolized primarily by CYP 3A and is a moderate inhibitor of CYP 3A and CYP 2D6 [see Clinical Pharmacology (12.3) in the full prescribing information]. Dronedarones blood levels can therefore be affected by inhibitors and inducers of CYP 3A, and dronedarone can interact with drugs that are substrates of CYP 3A and CYP 2D6. Dronedarone has no signicant potential to inhibit CYP 1A2, CYP 2C9, CYP 2C19, CYP 2C8 and CYP 2B6. It has the potential to inhibit P-glycoprotein (P-gP) transport. Pharmacodynamic interactions can be expected with beta-blockers; calcium antagonists and digoxin [see Drug Interactions (7.1)]. In clinical trials, patients treated with dronedarone received concomitant medications including beta-blockers, digoxin, calcium antagonists (including those with heart rate-lowering effects), statins and oral anticoagulants. 7.1 Pharmacodynamic Interactions Drugs prolonging the QT interval (inducing Torsade de Pointes) Co-administration of drugs prolonging the QT interval (such as certain phenothiazines, tricyclic antidepressants, certain macrolide antibiotics, and Class I and III antiarrhythmics) is contraindicated because of the potential risk of Torsade de Pointes-type ventricular tachycardia [see Contraindications (4)]. Digoxin Digoxin can potentiate the electrophysiologic effects of dronedarone (such as decreased AV-node conduction). In clinical trials, increased levels of digoxin were observed when dronedarone was co-administered with digoxin. Gastrointestinal disorders were also increased. Because of the pharmacokinetic interaction [see Drug Interaction (7.3)] and possible pharmacodynamic interaction, consider the need for continued digoxin therapy. If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity. Calcium channel blockers Calcium channel blockers with depressant effects on the sinus and AV nodes could potentiate dronedarones effects on conduction. Give low doses of calcium channel blockers initially and increase only after ECG verication of good tolerability [see Drug Interactions (7.3)]. Beta-blockers In clinical trials, bradycardia was more frequently observed when dronedarone was given in combination with beta-blockers. Give low dose of beta-blockers initially, and increase only after ECG verication of good tolerability [see Drug Interactions (7.3)]. 7.2 Effects of Other Drugs on Dronedarone Ketoconazole and other potent CYP 3A inhibitors Repeated doses of ketoconazole, a strong CYP 3A inhibitor, resulted in a 17-fold increase in dronedarone exposure and a 9-fold increase in Cmax. Concomitant use of ketoconazole as well as other potent CYP 3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated [see Contraindications (4)]. Grapefruit juice Grapefruit juice, a moderate inhibitor of CYP 3A, resulted in a 3-fold increase in dronedarone exposure and a 2.5-fold increase in Cmax. Therefore, patients should avoid grapefruit juice beverages while taking MULTAQ. Rifampin and other CYP 3A inducers Rifampin decreased dronedarone exposure by 80%. Avoid rifampin or other CYP 3A inducers such as phenobarbital, carbamazepine, phenytoin, and St Johns wort with dronedarone because they decrease its exposure signicantly. Calcium channel blockers Verapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure by approximately 1.4-to 1.7-fold [see Drug Interactions (7.1, 7.3)]. Pantoprazole Pantoprazole, a drug that increases gastric pH, did not have a signicant effect on dronedarone pharmacokinetics. 7.3 Effects of Dronedarone on Other Drugs Statins Dronedarone increased simvastatin/simvastatin acid exposure by 4- and 2-fold, respectively. Because of multiple mechanisms of interaction with statins (CYPs and transporters), follow statin label recommendations for use with CYP 3A and P-gP inhibitors such as dronedarone. Calcium channel blockers Dronedarone increases calcium channel blocker (verapamil, diltiazem or nifedipine) exposure by 1.4- to 1.5-fold [see Drug Interactions (7.1)]. Sirolimus, tacrolimus, and other CYP3A substrates with narrow therapeutic range Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. Monitor plasma concentrations and adjust dosage appropriately. Beta-blockers and other CYP 2D6 substrates Dronedarone increased propranolol exposure by approximately 1.3-fold following single dose administration. Dronedarone increased metoprolol exposure by 1.6-fold following multiple dose administration [see Drug Interaction (7.1)]. Other CYP 2D6 substrates, including other betablockers, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs) may have increased exposure upon co-administration with dronedarone. P-glycoprotein substrates Digoxin Dronedarone increased digoxin exposure by 2.5-fold by inhibiting the P-gP transporter [see Drug Interactions (7.1)].

MULTAQ (dronedarone) Tablets

Dabigatran Exposure to dabigatran is higher when it is administered with dronedarone than when it is administered alone (1.7- to 2-fold). Other P-gP substrates are expected to have increased exposure when co-administered with dronedarone. Warfarin and losartan (CYP 2C9 substrates) Losartan No interaction was observed between dronedarone and losartan. Warfarin When healthy subjects were administered dronedarone 600 mg twice daily, exposure to S-warfarin was higher than when warfarin was administered alone (1.2-fold). Exposure to R-warfarin was unchanged and there were no clinically signicant increases in INR. More patients experienced clinically signicant INR elevations ( 5) usually within 1 week after starting dronedarone vs. placebo in patients taking oral anticoagulants in ATHENA. However, no excess risk of bleeding was observed in the dronedarone group. Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated on dronedarone. Monitor INR after initiating dronedarone in patients taking warfarin. Theophylline (CYP 1A2 substrate) Dronedarone does not increase steady state theophylline exposure. Oral contraceptives No decreases in ethinylestradiol and levonorgestrel concentrations were observed in healthy subjects receiving dronedarone concomitantly with oral contraceptives. 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Pregnancy Category X [see Contraindications (4)] MULTAQ may cause fetal harm when administered to a pregnant woman. In animal studies, dronedarone was teratogenic in rats at the maximum recommended human dose (MRHD), and in rabbits at half the MRHD. If this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. When pregnant rats received dronedarone at oral doses greater than or equal to the MRHD (on a mg/m2 basis), fetuses had increased rates of external, visceral and skeletal malformations (cranioschisis, cleft palate, incomplete evagination of pineal body, brachygnathia, partially fused carotid arteries, truncus arteriosus, abnormal lobation of the liver, partially duplicated inferior vena cava, brachydactyly, ectrodactylia, syndactylia, and anterior and/or posterior club feet). When pregnant rabbits received dronedarone, at a dose approximately half the MRHD (on a mg/m2 basis), fetuses had an increased rate of skeletal abnormalities (anomalous ribcage and vertebrae, pelvic asymmetry) at doses 20 mg/kg (the lowest dose tested and approximately half the MRHD on a mg/m2 basis). Actual animal doses: rat (80 mg/kg/day); rabbit (20 mg/kg) 8.3 Nursing Mothers It is not known whether MULTAQ is excreted in human milk. Dronedarone and its metabolites are excreted in rat milk. During a pre- and post-natal study in rats, maternal dronedarone administration was associated with minor reduced body-weight gain in the offspring. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from MULTAQ, discontinue nursing or discontinue the drug [see Contraindications (4)]. 8.4 Pediatric Use Safety and efficacy in children below the age of 18 years have not been established. 8.5 Geriatric Use More than 4500 patients with AF or AFL aged 65 years or above were included in the MULTAQ clinical program (of whom more than 2000 patients were 75 years or older). Efficacy and safety were similar in elderly and younger patients. 8.6 Renal Impairment Patients with renal impairment were included in clinical studies. Because renal excretion of dronedarone is minimal [see Clinical Pharmacology (12.3) in the full prescribing information], no dosing alteration is needed. 8.7 Hepatic Impairment Dronedarone is extensively metabolized by the liver. There is little clinical experience with moderate hepatic impairment and none with severe impairment. No dosage adjustment is recommended for moderate hepatic impairment [see Contraindications (4) and Clinical Pharmacology (12.3) in the full prescribing information]. 10 OVERDOSAGE In the event of overdosage, monitor the patients cardiac rhythm and blood pressure. Treatment should be supportive and based on symptoms. It is not known whether dronedarone or its metabolites can be removed by dialysis (hemodialysis, peritoneal dialysis or hemoltration). There is no specic antidote available. Issued December 2011 Manufactured by Sano Winthrop Industrie 1, rue de la Vierge 33440 Ambares, France Issue date: December 26, 2011 sano-aventis, 2011 All rights reserved. MULTAQ is a trademark of sano-aventis. The brands listed are the registered trademarks of their respective owners and are not trademarks of sano-aventis U.S. LLC. sano-aventis U.S. LLC Bridgewater, NJ 08807 DRO-BPLR-ACC-DEC11

ACC.12

Directory
All activities are located in McCormick Place unless otherwise noted.

ABIM Information Desk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b ACC .12 Main Tent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027 ACC Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a ACCEL Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a Business Center (FedEx Office) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5 CardioSmart Fun Run/Walk Kiosk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5 Career Placement Center . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N137 Coat Check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B South, West Transportation Lobby Grand Concourse Level 1 near Hyatt Convocation Convocation Ceremony . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B Convocation Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B Convocation Hoods, Gowns & Photography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B Education Sessions & Information E-Abstracts Self-Study Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hall A1 near Posters General Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5 North, Levels 2, 4 Heart Songs Learning Lab . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S406 Lobby Meet the Experts/Lunchtime/International Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5 North, Levels 2, 4 Maintenance of Certification MOC Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .South, Rooms S105a, S105d MOC Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b MOC Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104a Poster Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2 Exhibitor Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C Expo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2 ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027 CardioSmart Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1 ExpoSuites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2 Health IT Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1

ACC.12 Final Program

27

Directory ACC.12
Interventional Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1 Public Service Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2 Publishers Showcase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1 First Aid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5 Heart Hubs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B South, West Transportation Lobby Housing Assistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3 Information Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3 West Transportation Lobby Interfaith Prayer Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N136 iScience Sales Counters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3 Learning Destinations CardioSmart Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097 CV Innovations Educational Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097 Heart of Innovation Featured Learning Destination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #1076 Industry-Expert Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22042 Interactive Learning Labs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22027, #22035, #23027 Lounges ACC Member Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22063 CCA Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N138 Faculty Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a FIT Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N139 International Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #15097 Lost and Found . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N128 Medical Meetings Information Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5 Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C Portfolio Pick-Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3 West Transportation Lobby Press Conference Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lakeside, Level 3 Restaurants Bistro ACC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #1100 Windy City Caf & Tech Hub . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #22111 Restaurant Reservations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3 Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b Speaker Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b

28

GO for ACC.12!

ACC.12

General Meeting Information

About McCormick Place ACC .12 takes place in McCormick Place Convention Center . The street address is 2301 S . Lake Shore Drive, Chicago, IL 60616 . Be sure to allow enough time to get where you want to be . It can take up to 15 minutes to walk between some locations within the center . Apple Android

ABIM Information Desk McCormick Place South, Room S104b Telephone: 312-791-6740 Saturday, March 24 Sunday, March 25 Monday, March 26 7:30 a .m . 6:00 p .m . 7:30 a .m . 6:00 p .m . 8:00 a .m . 5:30 p .m .

Search ACC.12 in your app store or browse to: http://ativ.me/acc ACC.12 Online ACC .12 Online features live webcasts of 60 sessions and on demand webcasts of an additional 18 sessions from the Legends of Cardiovascular Medicine and Core Curriculum series available to all ACC .12 attendees for free for the duration of the meeting . Sessions marked with the ACC .12 Online icon within the Program-At-A-Glance (starting on page 72) are available on ACC .12 Online . To access ACC .12 Online and see a complete schedule of webcasts, go to: http://acc12online.cardiosource. org, and login with your email address and passcode: ACCONLINE ACC Central McCormick Place South, Hall A1, #10027 At ACC Central youll find comprehensive information on ACCs quality initiatives; NCDR registries and research; selfassessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, dont miss the exciting new products and services designed to help you translate science into practice . ACC Office McCormick Place South, Room S100a Telephone: 312-791-6720 Fax: 312-791-6722 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 6:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . 5:30 p .m . 7:00 a .m . 9:30 a .m .
ACC.12 Final Program 29

ABIM staff will be available on site in Room S104b to answer your questions regarding the ABIMs Maintenance of Certification program and process . You must be enrolled in ABIMs MOC program in order to attend the ACCF Study Sessions . If you are not a current enrollee, please go to the Physician Login at ABIMs website, www.abim.org, and follow the instructions to enroll . You may also enroll in the ABIM MOC program on site by visiting staff in room S104b, but please allow sufficient time to do this prior to the start of the session . For your convenience, there will be computer terminals in the ACC MOC Center, Room S104b, for you to take the ABIM MOC test after the study session, if desired . Regarding the study sessions, you must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis . ACC.12 eMeeting Planner Make the most out of ACC .12 with instant access to sessions, abstracts, exhibitors, maps and more! Plus, get access to the ACC .12 twitter feed, download eBooks of the Final Program, Program-At-A-Glance and the JACC Abstract Supplement, and read the daily newspaper CardioSourceNews from ACC.12 . Download the app on your mobile device (available for Apple, Android and Kindle Fire devices) .

General Meeting Information ACC.12

ACCEL Office McCormick Place South, Room S100a Telephone: 312-791-6726 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 1:00 p .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 3:00 p .m . record of the session numbers you attended and know your badge number . You may enter your information at the conclusion of a session from any internet-enabled computer by visiting www.accscientificsession.org. Please allow time for the system to update if you registered the same day you are accessing the CME/CNE system . Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit cannot be doubly awarded for sessions taking place concurrently . Children During Expo hours, children (defined as anyone under 18 years of age) will be permitted in the Expo Hall only if accompanied by an adult at all times . Children between 12 and 18 years of age are required to register for admission to the Exposition in the Family Member category at the posted rate . Under no circumstances will children be allowed in the Expo Hall during installation or dismantle periods . For reasons of insurance liability and safety, strollers and infant carriers are not permitted in the Expo Hall at any time . Infants must be held at all times . Because of limited seating capacity and the highly technical nature of the education program, children are not invited to attend presentations . Coat Check McCormick Place North, Hall B; South, West Transportation Lobby; Grand Concourse Level 1 near Hyatt Friday, March 23 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 6:30 p .m . 7:00 a .m . 7:00 p .m . 7:00 a .m . 7:00 p .m . 7:00 a .m . 10:00 p .m . 7:00 a .m . 12:30 p .m .

Business Center McCormick Place South, Grand Concourse Level 2.5 Telephone: 312-949-2100 The FedEx Office Print & Ship Center in McCormick Place offers you virtually everything you need to meet your convention exhibiting needs from packing and shipping to signage, copying and last-minute office supplies . Hours: Friday Monday Car Rental Telephone: 1-800-654-2240 The ACC has arranged rental car discounts through Hertz . You can call the above number or go to www.hertz.com to make your reservation . Conference ID is CV#044W0006 . The closest Hertz office is at the Hyatt Regency McCormick Place, office number 312-567-0380 . Career Placement Center McCormick Place North, Room N137 Telephone: 312-808-2970 Saturday, March 24 Sunday, March 25 Monday, March 26 9:00 a .m . 5:00 p .m . 9:00 a .m . 5:00 p .m . 9:00 a .m . 5:00 p .m .

8:30 a .m . 5:00 p .m .

Attendees can check coats and/or luggage for $3 .00 per coat and $4 .00 per bag .

The ACC Cardiology Career Resource Center is the perfect venue for setting up interviews, posting jobs or rsums/CVs, and reviewing more than 300 positions listed on the Colleges online job bank . The service is free to candidates and very economical for employers . Certificate of Attendance and Claiming CME/CNE Credit The online ACC .12/ACC-i2 with TCT CME/CNE Credit site will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a
30 GO for ACC.12!

Convocation
Convocation Ceremony McCormick Place North, Hall B Monday, March 26, 2012, 6:30 p.m. The Convocation Ceremony, presided over by David R . Holmes, Jr ., President, MD, FACC, is one of the most exciting and prestigious events to take place during the Annual Scientific Session, honoring new Fellows (FACC), recognizing

ACC.12 General Meeting Information

Associates of the American College of Cardiology (AACC), distinguished guests, and the induction of William A . Zoghbi, MD, FACC, as president of the College . Convocation Office McCormick Place North, Hall B Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 Convocation Hoods and Gowns McCormick Place North, Hall B Saturday, March 24 Sunday, March 25 Monday, March 26 combines 3D echo images with the auscultation findings on 4 common valvular abnormalities . In addition, youre able to test your knowledge with pre- and post-tests . MOC Education Room McCormick Place South, Rooms S105a, S105d 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 3:00 p .m . 9:00 a .m . 11:00 a .m . For the Maintenance of Certification (MOC) study sessions, preregistered attendees must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis . MOC Lounge McCormick Place South, Room S104b See also ABIM Information Desk above for additional information . Attendees may use the computer terminals in the Lounge to take the ABIM, ACCSAP or ABP tests after the conclusion of the sessions . MOC Simulation Room McCormick Place South, Room S104a 11:00 a .m . 4:00 p .m . 10:00 a .m . Noon ABIM offers an option for interventional cardiology diplomats to earn credit toward completion of the Self-Evaluation of Medical Knowledge requirement for Maintenance of Certification . Interventional Cardiology Simulations is the first-ever ABIM-developed lab-based simulation that provides an opportunity to perform cases that mirror what an interventional cardiologist would typically face in daily practice . Medical Simulation Corporations SimSuite technology replicates a real-life catheterization lab suit . Physicians complete the Interventional Cardiology Simulations on-site in room S104a . Poster Sessions McCormick Place South, Hall A Telephone: 312-791-6768 Posters will be displayed from 9:30 a .m . 4:30 p .m . on Saturday and Sunday; 9:30 a .m . 2:00 p .m . on Monday . Presenters will be available Saturday through Monday from 9:30 a .m . 10:30 a .m . and 11:00 a .m . noon . Come during the presenter hours, meet the presenters and view the poster boards facilitated by poster discussants . Best poster awards will be awarded to one winner in each of the clinical pathways .
ACC.12 Final Program 31

8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 9:00 p .m .

Collect academic attire and sign the Convocation Register . Convocation Portrait Photography McCormick Place North, Hall B To schedule an appointment: Friday, March 23 Saturday, March 24

Portraits may be posted and photographed on: Saturday, March 24 1:00 p .m . 5:00 p .m . Sunday, March 25 10:00 a .m . 5:00 p .m . Monday, March 26 10:00 a .m . 6:00 p .m .

Education Sessions and Information

E-Abstracts Learning Station Accepted abstracts are also available as e-abstracts online and may be viewed from the dedicated terminals in the Poster Sessions area, Hall A1 . For 24/7 perusal of the e-abstracts, visit www.accscientificsession.org . Heart Songs Learning Lab McCormick Place South, Room S406 Lobby A unique audio-visual program to refresh cardiac auscultation skills by listening to heart sounds while viewing phonocardiograms, echoes and more on an iPod Touch, iPad or laptop computer . This clinical skills workshop provides attendees with a choice of three sessions basic, advanced and expert levels . Plus, a video program that

General Meeting Information ACC.12

Exhibitor Newsroom McCormick Place North, Hall C Telephone: 312-808-2015 Fax: 312-808-2016 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . Inside the Session Room: Find seats as far forward as possible Move to the center of the row and fill all seats so chairs are available for additional attendees Store materials under chairs to maximize seating Take all personal effects when exiting; re-entry to an overcrowded session room may not be allowed Outside the Session Room: Step back from the entrance Form a line; the next attendee in line will be admitted into the session and escorted to an available seat If space does not permit you to attend a session, a recording of the session may be available for purchase at the iScience sales desk . Orderly conduct is appreciated. Thank you for your cooperation! First Aid McCormick Place South, First Aid Room, Level 2.5 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 8:00 p .m . 8:00 a .m . 5:00 p .m .

The Exhibitor Newsroom provides members of the media with access to information from exhibiting companies and their representatives . The fee is $350 on site . An ACC .12 exhibitor may register a maximum of four individuals to the Exhibitor Newsroom . Use of the Exhibitor Newsroom is limited to ACC .12 exhibiting companies . Persons who wish to substitute for an advance registrant must present a letter of authorization from the exhibiting companys primary contact .

Expo
McCormick Place South, Halls A1 & A2 A vital part of your ACC education can be found in the ACC .12 Expo, where more than 300 exhibiting companies and organizations showcase the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care . Dont miss these key specialty areas in the Expo: ACC Central: South, Hall A1, #10027 CardioSmart Pavilion: South, Hall A1 ExpoSuites: South, Halls A1 & A2 Health IT Pavilion: South, Hall A1 Interventional Pavilion: South, Hall A1 Public Service Area: South, Hall A2 Publishers Showcase: South, Hall A1 Fire Safety Information Seating capacity has been maximized in all session rooms according to local fire regulations . Standing in the aisles or against the walls is not permitted . If overcrowding occurs, staff/security personnel will close the session . Further admittance will not be allowed until the next speaker change . Noncompliance may subject the session to be shut down by the Fire Marshal .

The first aid room in McCormick Place Convention Center will be operated and staffed by licensed medical professionals . The station will carry basic first aid supplies as well as overthe-counter medications available for distribution, oxygen and an AED . Heart Hubs McCormick Place North, Hall B McCormick Place South, West Transportation Lobby Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:30 a .m . 6:00 p .m . 7:30 a .m . 6:00 p .m . 7:30 a .m . 5:30 p .m . 7:30 a .m . 11:45 a .m .

Relax with refreshments in a lounge setting while sessions from ACC .12 come to you on plasma screens . With two convenient locations in McCormick Place, this is the place to be for networking and news watching .

32

GO for ACC.12!

ACC.12 General Meeting Information

Housing Assistance McCormick Place, Lakeside, Level 3 Telephone: 312-949-3207 J . Spargo & Associates, Inc . staff is available to assist with hotel reservations at official ACC .12 hotels . Information Stations McCormick Place South, Grand Concourse Lobby, Level 2.5; Level 3, West Transportation Lobby At locations throughout the convention center you will find Information Stations where you can Access the internet Browse the education sessions Plan, save and print your itinerary Locate attendees, exhibitors and products View the Exposition floor plan ACC.12 Information Stations compliments of Forest Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. and Merck & Co., Inc. iScience Sales Desk McCormick Place South, Grand Concourse Lobby, Level 3 and ACC Central, Hall A1, #10027 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 6:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . Noon Learning Destinations McCormick Place South, Halls A1 and A2 Learning Destinations are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience . We invite you to visit these dynamic learning environments, located in the Expo Hall . CardioSmart Forum: South, Hall A2, CV Theater, #22097 CV Innovations Educational Forum: South, Hall A2, CV Theater, #22097 Heart of Innovation Featured Learning Destination: South, Hall A1, #1076 Interactive Learning Labs: South, Hall A1, #22027, #22035, #23027 Industry-Expert Theater: South, Hall A1, #22042 Please see the Learning Destinations section on page 57 for additional information . Lost and Found

McCormick Place North, Room 128

Telephone: 312-670-5312 If you lose or find an item, please contact the ACC Office .

Lounges
ACC Member Lounge McCormick Place South, Hall A1, #22063 The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere . CCA Community Lounge McCormick Place North, Room N138 Friday, March 23 Informal Session Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 Informal Session Noon 5:00 p .m . Noon 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 2:00 p .m . 5:00 p .m .

iScience, the ACC .12 Meeting on Demand, is a comprehensive digital library of presentations from ACC .12 and includes over 400 hours of educational content . It is the most convenient way to experience all the education from ACC .12 and allows you to watch presenters slides while listening to fullysynchronized audio as if you were actually attending each session . Purchase on site in Chicago and save $1,000 or more!

The ideal place to relax, check your email and touch base with your CCA peers .
ACC.12 Final Program 33

General Meeting Information ACC.12

Faculty Lounge McCormick Place South, Room S100a Telephone: 312-791-6715 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 6:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . 5:30 p .m . 7:00 a .m . 9:30 a .m . Rush-Presbyterian St. Lukes Medical Center 1653 W . Congress Pkwy . Chicago, IL 60612 312-942-5000 www.rush.edu Consult your hotel concierge for additional services and locations . Medical Meetings Information McCormick Place, Grand Concourse Lobby, Level 2.5 Information about other national and international medical meetings is available . Distribution of literature is confined to the publication bins provided; posters are not permitted . For news and updates about ACC .12 look for the daily editions of the CardioSource News from ACC.12 displayed on racks throughout McCormick Place . Name Badges Your badge serves as your passport to education sessions, the Exposition and to complimentary shuttle service . You must wear your name badge at all times . For security reasons, persons without badges will not be permitted access to attend events . Badge Colors: Dark Blue Stripe Grey Stripe Purple Stripe

Invited faculty for ACC .12 will receive a white Faculty ribbon that will give them access to the Faculty Lounge . Services in the Lounge include computer/internet and printer access, work and meeting space, food service and a comfortable lounge atmosphere for private faculty networking . FIT Community Lounge McCormick Place North, Room N139 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 5:00 p .m . 8:00 a .m . 2:00 p .m .

The ideal place to relax, check your email and touch base with your FIT peers . International Lounge McCormick Place, Hall A1, #15097 Saturday, March 24 Sunday, March 25 Monday, March 26 9:30 a .m . 4:30 p .m . 9:30 a .m . 4:30 p .m . 9:30 a .m . 2:00 p .m .

ACC .12 Professional Registrants One Day Only Registrants Exhibitor Full Access (Expo Hall and all official ACC .12 Education sessions), Consultant Exhibitor (Expo Hall only), Exhibitor Newsroom ACC Staff and Official Contractors Exhibits Only, Family Member Media

The lounge is open to all attendees practicing outside the United States, offering the opportunity to network with colleagues, learn about the multitude of international ACC initiatives and partnerships, and find information regarding international membership in the ACC .

Yellow Stripe Green Stripe Orange Stripe Red Stripe

Medical Information
Dentist 800-DENTIST or www.1800DENTIST.COM Hospitals Mercy Hospital 2525 South Michigan Avenue Chicago, IL 60616 312-567-2000 www.mercy-chicago.org
34 GO for ACC.12!

We recommend for your safety that you do not wear your name badge in public .

ACC.12 General Meeting Information

Newsroom McCormick Place North, Hall C Telephone: 312-808-2000 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . 7:30 a .m . 5:00 p .m . ribbons and instructions . Staff are available to assist presenters with disclosure compliance information and materials . Public Transportation CTA & METRA Telephone: 312-836-7000 The Chicago Transit Authority (CTA) offers fast, direct train service from both airports to downtown Chicago, convenient bus and train lines to major attractions, simple fare cards and easy-to-use maps and brochures . For route, fare and schedule information, call any day from 5:00 a .m . 1:00 a .m . (CT) . The CTA system map and Downtown Sightseeing Guide are available at all train stations, both airports, visitor information centers and hotels . You can also plan your trip online by visiting http://www.transitchicago.com. Registration McCormick Place Lakeside, Level 3 Telephone: 312-949-3205 Friday, March 23 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 5:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . 6:00 p .m . 7:00 a .m . 5:00 p .m . 7:00 a .m . Noon

Arrangements for interview and inquiries concerning news releases and news conferences should be directed to Beth Casteel in the Newsroom . Parking McCormick Place parking rate is $19 for up to 16 hours and $30 from 16 to 24 hours . There are no in-and-out privileges . Overnight parking is available in Lot A only . Lost tickets will pay the $30 fee per day . Parking fees can be paid by cash or credit card; Visa, MasterCard and American Express are accepted . Places of Worship Chicago has an extremely diverse population and visitors can find any number of religious institutions throughout the city for just about any faith . For a brief listing of places of worship, visit the Chicago Convention and Tourism Bureau website at www.choosechicago.com and search for places for worship on their home page . Portfolio Pick-Up McCormick Place, Lakeside, Level 3 McCormick Place South, West Transportation Lobby Once at the convention center, proceed to Registration or to the Portfolio Pickup Station located in the West Transportation Lobby to receive your portfolio bag and JACC ACC.12 Abstract Supple- ment . The Final Program will be included in the portfolio bag . Poster Info Booth McCormick Place South, Hall A Telephone: 312-791-6767 Poster presenters may check the U-Search computer kiosks throughout the poster hall to reconfirm poster board information and session presentation times . Poster Discussants and Best Poster Judges may check-in with staff to receive

Registration Cancellations, Substitutions and Refunds As printed in the Registration Instructions, registration fees are non-refundable after Feb . 15, 2012 . Cancelled registrations are non-transferable . Restaurant Reservations Service McCormick Place, Grand Concourse Lobby, Level 3 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 10:30 a .m . 6:30 p .m . 10:30 a .m . 6:30 p .m . 10:30 a .m . 6:30 p .m . 10:00 a .m . 1:00 p .m .

Representatives are available to recommend and to confirm reservations at any of the areas restaurants .

ACC.12 Final Program

35

General Meeting Information ACC.12

Restaurants McCormick Place South, Hall A2 Two restaurants satisfying a range of culinary tastes will be located in the Expo Hall . The restaurants each offer a large seating area where you can eat, network with colleagues and plan your schedule . Bistro ACC: An innovative dining option that is conveniently located at the back of the 4000 aisle . Assorted menu options include several fresh and healthy options, international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets in advance by going to www.bistroacc.com or visit the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall . Windy City Caf & Tech Hub: Join colleagues for a more upscale buffet-style dining experience at the Windy City Caf & Tech Hub, located at the back of the 22000 aisle . The Windy City Caf offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices recharge your batteries and your phones batteries all in one location! Monday, March 26, 2012 Between hotels and McCormick Place 6:00 a .m . 10:00 p .m .* Tuesday, March 27, 2012 Between hotels and McCormick Place 6:00 a .m . 1:00 p .m .* *Last motorcoach departs McCormick Place at this time . Last motorcoach departs the hotels approximately 90 minutes prior to this time . McCormick Place is the transfer point for all routes . To make arrangements for a wheelchair-accessible shuttle, contact the shuttle supervisor at McCormick Place during shuttle hours . Shuttle service information is current as of time of printing . Please check the route signs at McCormick Place and posted in the lobby of each hotel for updated information . Smoking The American College of Cardiology promotes a No Smoking policy . The use of tobacco products is strictly prohibited in the Convention Center and all hotel meeting rooms hosting ACC .12 events . Thank you for your compliance . Speaker Ready Room McCormick Place South, Room S100b Telephone: 312-791-6728 Friday, March 23 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 5:00 p .m . 6:00 a .m . 6:00 p .m . 6:00 a .m . 6:00 p .m . 6:00 a .m . 5:30 p .m . 6:00 a .m . 10:00 a .m .

Shuttle Bus Service

Shuttle service will operate daily from McCormick Place and the official hotels on a daily basis (except the Hyatt Regency McCormick Place, which is considered within walking distance) . Check the shuttle sign posted in the lobby of each hotel for additional information, changes, frequency of service and boarding locations . Hours of Operation Friday, March 23 Sunday, March 25 Between hotels and McCormick Place 6:00 a .m . 6:45 p .m .* Please note, on Sunday, March 25, there will be intermittent suspension of service and delays due to the Shamrock Shuffle 8K Race between the hours of 8 a.m. noon. Please plan accordingly.

New this year: All invited faculty, including speakers, cochairs and panelists, must check in at the Speaker Ready Room to confirm presentation times and review electronic files, even if they have uploaded their files in advance . There will be one Speaker Ready Room to assist all presenters for both ACC .12 and ACC-i2 with TCT . We recommend presenters visit the Speaker Ready Room 24 hours before their presentation begins . However, presenters must go to the Speaker Ready Room at least 4 hours in advance to review and approve their presentations . Presenters who do not

36

GO for ACC.12!

ACC.12 General Meeting Information

check-in sufficiently in advance of their presentation may give the scheduled talk, but may not have visuals . Speaker Registration McCormick Place South, Room S100b Friday, March 23 Saturday, March 24 Sunday, March 25 Monday, March 26 Tuesday, March 27 7:00 a .m . 5:00 p .m . 6:00 a .m . 6:00 p .m . 6:00 a .m . 6:00 p .m . 6:00 a .m . 5:30 p .m . 6:00 a .m . 10:00 a .m .

This is the location for all faculty registration . All advanceregistered faculty should have received a white faculty ribbon with the badge in the mail; otherwise they may be picked up in this office . Transportation Hertz: 800-654-2240 Airport Shuttle: 888-284-3826 Taxis American-United Taxi: 773-248-7600 Checker Cab: 312-243-2537 Yellow Cab: 312-829-4222 Flash Cab: 773-561-1444 Taxis are plentiful and easy-to-hail in downtown, and offer a convenient way to get around the city . Taxis charge a base rate of $2 .25 for the first 1/9 mile, plus, 20 for each additional 1/9 mile . If a gas surcharge is in effect, a sign will be displayed inside the taxicab and a surcharge may apply . Tolls are an extra charge; taxis charge $1 for the first additional passenger over age 12 and under age 65 . Each additional passenger after first passenger, over 12 and under 65 is $ .50 . It is standard to tip the driver about 15 20% of the fare, plus $1 2 per bag if the driver helps you with luggage .

ACC.12 Final Program

37

ACC.12

McCormick Place Convention Center

38

GO for ACC.12!

ACC.12

Poster Hall Map

Saturday, March 24, 2012

ACC.12 Final Program

39

ACC.12

Poster Hall Map

Sunday, March 25, 2012

40

GO for ACC.12!

ACC.12

Poster Hall Map

Monday, March 26, 2012

ACC.12 Final Program

41

ACC.12

Hotels
Map Hotel Address Phone Fax

17 1 18 2 3 5 4 6 7 9 10 11 13 14 15 16 19 23 24 25 26 28 20 29 30 21 32 33 34 35 36 22 37 38 39 40 41 8 12 27 31 42 43 44 45

Allegro Chicago, A Kimpton Hotel Amalfi Hotel Chicago Burnham, A Kimpton Hotel Chicago Marriott Downtown Magnificent Mile Conrad Chicago Courtyard by Marriott Magnificent Mile Courtyard Chicago Downtown River North Dana Hotel and Spa Doubletree Chicago Magnificent Mile Embassy Suites Chicago Downtown Embassy Suites Chicago Downtown Lakefront Fairfield Inn and Suites Four Seasons Hard Rock Hotel Hilton Chicago Holiday Inn Chicago Mart Plaza Hotel Cass, A Holiday Inn Express Hyatt Regency Chicago Hyatt Regency McCormick Place Inn of Chicago InterContinental Chicago JW Marriott Monaco Chicago, A Kimpton Hotel Omni Chicago Palmer House Hilton Palomar Chicago, A Kimpton Hotel Renaissance Blackstone Renaissance Chicago Hotel Residence Inn by Marriott Chicago Downtown River North Residence Inn by Marriott Magnificent Mile Ritz Carlton Sax Chicago- A Thompson Hotel Sheraton Chicago Hotel and Towers Silversmith Hotel Sofitel Chicago Water Tower Springhill Suites by Marriott Chicago Downtown River North Swissotel Chicago The Drake Hotel The Fairmont Chicago The James Hotel The Peninsula Hotel theWit Hotel Westin Chicago River North Westin Michigan Avenue Wyndham Chicago

171 West Randolph Street Chicago, IL 60601 20 W Kinzie Street Chicago, IL 60654 1 West Washington Street Chicago, IL 60601 540 North Michigan Avenue Chicago, IL 60611 520 North Rush Street at Michigan Avenue Chicago, IL 60611 165 East Ontario Street Chicago, IL 60611 30 East Hubbard Street Chicago, IL 60611 660 North State Street Chicago, IL 60654 300 East Ohio Street Chicago, IL 60611 600 North State Street Chicago, IL 60654 511 North Columbus Drive Chicago, IL 60611 216 East Ontario Street Chicago, IL 60611 120 East Delaware Place Chicago, IL 60611 230 North Michigan Avenue Chicago, IL 60601 720 South Michigan Avenue Chicago, IL 60605 350 West Mart Center Drive Chicago, IL 60654 640 North Wabash Chicago, IL 60611 151 East Wacker Drive Chicago, IL 60601 2233 South Martin Luther King Drive Chicago, IL 60616 162 East Ohio Street Chicago, IL 60611 505 North Michigan Avenue Chicago, IL 60611 151 West Adams Street Chicago, IL 60604 225 North Wabash Avenue Chicago, IL 60601 676 North Michigan Avenue Chicago, IL 60611 17 East Monroe Street Chicago, IL 60603 505 North State Street Chicago, IL 60654 636 South Michigan Avenue Chicago, IL 60605 1 West Wacker Drive Chicago, IL 60601 410 North Dearborn Street Chicago, IL 60610 201 East Walton Place Chicago, IL 60611 160 East Pearson Street Chicago, IL 60611 333 North Dearborn Street Chicago, IL 60654 301 East North Water Street Chicago, IL 60611 10 South Wabash Avenue Chicago, IL 60603 20 East Chestnut Street Chicago, IL 60611 410 North Dearborn Street Chicago, IL 60654 323 East Wacker Drive Chicago, IL 60601 140 East Walton Place Chicago, IL 60611 200 North Columbia Drive Chicago, IL 60601 55 East Ontario Chicago, IL 60611 108 East Superior Street Chicago, IL 60611 201 North State Street Chicago, IL 60601 320 North Dearborn Street Chicago, IL 60654 909 North Michigan Avenue Chicago, IL 60611 633 North St . Clair Street Chicago, IL 60611

312-236-0123 312-395-9000 312-782-1111 312-836-0100 312-645-1500 312-573-0800 312-329-2500 312-202-6000 312-787-6100 312-943-3800 312-836-5900 312-787-3777 312-280-8800 312-345-1000 312-922-4400 312-836-5000 312-787-4030 312-565-1234 312-567-1234 312-787-3100 312-944-4100 312-660-8200 312-960-8522 312-944-6664 312-726-7500 312-755-9703 312-447-0955 312-372-7200 312-494-9301 312-943-9800 312-266-1000 312-245-0333 312-464-1000 312-795-6500 312-324-4000 312-644-4071 312-565-0565 312-787-2200 312-565-8000 312-337-1000 312-337-2888 312-467-0200 312-744-1900 312-943-7200 312-573-0300

312-236-0917 312-395-9001 312-762-3554 312-836-0100 312-645-1550 312-573-0573 312-329-0293 312-202-6033 312-787-6259 312-943-7629 312-839-5901 312-787-8714 312 280-1748 312-345-1012 312-922-5240 312-222-9508 312-787-1381 312-239-4414 312-528-4000 312-573-3136 312-944-3050 312-660-8201 312-960-1883 312-266-3017 312-917-1707 312-755-9713 312-765-0545 312-372-0093 312-494-9302 312-943-8597 312-266-9498 312-923-2444 312-464-9140 312-372-7320 312-324-4025 312-644-9302 312-268-8252 312-787-1431 312-856-1032 312-337-7217 312-751-2888 312-673-8617 312-527-2650 312-397-5580 312-274-0164

42

GO for ACC.12!

ACC.12

Hotel Map

ACC.12 Final Program

43

ACC.12

General Education Information

Accreditation Information
Statement of Need Cardiovascular disease (CVD) is the leading cause of death in the United States . It is estimated that 83 million Americans have one or more forms of CVD and on average, more than 2,200 Americans die of this disease each day . Members of the health care team provide care for patients with cardiovascular health needs in a wide variety of environments affecting the lives of countless patients and families . As the overall care of the patient with CVD becomes more complex, it is imperative that the cardiovascular professional remain current on the diagnosis, treatment and management of these diseases . As in the past, this program will offer needs-based educational programming, including the comprehensive review of current established practice patterns as well as state-of-the-art updates, techniques and translational research in the diagnosis and treatment of cardiovascular disease in areas such as womens health, vascular and valvular disease, imaging modalities, interventional cardiology, congenital cardiology, electrophysiology, pulmonary hypertension, STEMI, and addressing comorbidities . Additionally, to address the ongoing needs of our members, emphasis on performance in practice, as related to Maintenance of Certification (MOC) and Maintenance of Licensure (MOL), will be a focus for those requiring this educational emphasis . 1 . KNOWLEDGE To disseminate knowledge of optimal cardiovascular care, disease prevention and improvements in overall patient outcomes . Educational strategies for attaining this goal within specific learning pathways are to: Offer a core curriculum of cardiovascular and interventional education, including comprehensive reviews of established practice patterns as well as state-of-the-art techniques in the diagnosis and treatment of CVD Provide updates of available pharmaceuticals, medical devices and management strategies for cardiovascular patients Present basic and clinical research findings, independent of commercial interests, to increase the evidence base related to the care of patients with cardiovascular disease Disseminate information related to practice management, quality of care, ethical practices and non-clinical topics that contribute to desired patient outcomes Provide a forum for analyzing and critiquing new approaches to non-surgical management of patients with cardiovascular disease Create opportunities for knowledge exchange between general cardiologists and interventionalists, as well as cross-discipline areas of cardiology (e .g ., cardiovascular surgery) 2 . COMPETENCE To foster the translation of evidencebased cardiovascular science and interventional concepts and techniques into daily clinical practice . Educational strategies for attaining this goal within specific learning pathways are to: Offer education to satisfy, in part, requirements for MOC in cardiovascular and interventional medicine

Program Goals
Two global goals for the Annual Scientific Session communicate a commitment by the College to provide needsbased education that is independent of commercial interests and fosters change in learners knowledge, competence and performance to ultimately improve patient outcomes .

44

GO for ACC.12!

General Education Information ACC.12

Provide individualized training in clinical diagnostics and procedures, presented in self- paced and handson formats Promote professional exchanges between and within groups of cardiovascular care providers with similar clinical, geographic and/or educational interests Present best practices of cardiovascular specialists and related health care professionals working in multidisciplinary teams Create a forum for global collaboration and cooperation on issues in cardiovascular medicine to improve professional practices worldwide ACC .12 program level objectives can be found on our website, www.accscientificsession.org, select Education, then Accreditation. Continuing Nurse Education Credit The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centers Commission on Accreditation . The ACCF designates the Annual Scientific Session (ACC .12) educational activity for a maximum of 43 .25 continuing education hours . Continuing Pharmacy Education Credit The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education . The ACPE Universal Program Numbers for ACC .12 can be found within the daily session listings starting on page 105 . This program has been designated as a Knowledge-Based Program and provides a maximum of 24 .75 contact hours of continuing education credit . Continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 6 weeks to participants who have attended the program and completed an activity evaluation form .

Target Audience
The Annual Scientific Session is intended for all professionals involved in delivering cardiovascular care, with particular emphasis on physicians, scientists, nurse practitioners, clinical nurse specialists, physicians assistants, nurses, pharmacists and practice administrators . Medical students and trainees, technicians, dietitians and other health care professionals will also benefit .

CME/CNE Credit System

The online ACC .12 CME/CNE Credit System will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a record of the session numbers you attended and know your badge number. You may enter your information at the conclusion of a session through the ACC .12 eMeeting Planner or by visiting www.accscientificsession.org. Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit can not be doubly awarded for sessions taking place concurrently . ACC .12 registrants in the following categories have access to the system: ACC Member, ACC International Associate, ACC Cardiac Care Team Member, ACC Cardiovascular Service Administrator Member, ACC FIT Member, ACC Emeritus Member, Nonmember Physician, Nonmember Trainee/ Resident, Nonmember Nonphysician, Nonmember Government and One-Day . Those categories not eligible are Nonmember Administrator, Nonmedical, Exhibits, Exhibits Only and Family Member .

Accreditation
Requirements for successful completion and awarding of credit is attendance in sessions offering credit in their entirety and completion of the evaluation tool . Each participant should only claim the credit commensurate with the extent of their participation in each completed session . While offering credits noted below, the program is not intended to provide extensive training or certification in the field . Continuing Medical Education Credit The American College of Cardiology Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians . The ACCF designates the Annual Scientific Session (ACC .12) live educational activity for a maximum of 45 .75 AMA PRA Category 1 Credits .

ACC.12 Final Program

45

General Education Information ACC.12

ACPE Credit Claiming

This year for ACC .12, a maximum of 24 .75 contact hours of continuing education credit are available for pharmacists . In order to claim this credit, please complete the following steps: Log-in to the ACC .12 evaluation at www. accscientificsession.org and complete the overall evaluation After completing the overall evaluation, select the choice stating you are interested in claiming ACPE credits Open the link to claim credit in a separate window and fill in the appropriate information Continue with the ACC .12 evaluation to select your sessions and claim your certificate of attendance The ACPE credit claiming site will close in early May and continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 6 weeks to participants who have attended the program and completed an activity evaluation form If you have any questions regarding this process, please contact Christina Chadwick at cchadwic@acc.org .

eMeeting Planner App . See additional information regarding download instructions, how to access these sites and online program planning at www.accscientificsession.org .

Learner Bill of Rights

The American College of Cardiology Foundation (ACCF) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge or skill; and to attain or enhance a desired competency . As part of ACCFs duty to you as a learner, you have the right to expect that your continuing medical education experience with ACCF includes the following: Content that: Promotes improvements or quality in healthcare Is current, valid, reliable, accurate and evidence-based Addresses the stated objectives or purpose Is driven and based on independent survey and analysis of learner needs, not commercial interests Has been reviewed for bias and scientific rigor Offers balanced presentations that are free of commercial bias Is vetted through a process that resolves any conflicts of interest of planners and faculty Is evaluated for its effectiveness in meeting the identified educational need A learning environment that: Is based on adult learning principles that support the use of various modalities Supports learners abilities to meet their individual needs Respects and attends to any special needs of the learners Respects the diversity of groups of learners Is free of promotional, commercial and/or sales activities Disclosure of: Relevant financial relationships that planners, teachers and authors have with commercial interests related to the content of the activity Commercial support (funding or in-kind resources) of this activity

Disclaimers
The American College of Cardiology Foundation does not warrant the completeness, accuracy or usefulness of any opinions, advices or other information provided through this activity . In no event will ACCF be liable for any decision made, or action take, in reliance upon the information provided through this activity . Accredited status does not imply endorsement by the ACCF of any commercial products displayed in conjunction with the activity . ACCF reserves the right to modify faculty and program without notice .

Abstracts of Original Contributions

More than 2,100 oral and poster abstracts are scheduled to be presented at ACC .12 and ACC-i2 with TCT . The full text of the abstracts is contained in the supplement to the March 27, 2012 issue of JACC, which is distributed in print and CD format onsite in Chicago, and will be posted at onlinejacc.org, on Monday, March 26, 2012 . The abstracts will also be available as an e-book download and via the ACC .12
46 GO for ACC.12!

ACC.12

Disclosure of Financial Relationships

Joint Conflict of Interest (COI) and Relationship with Industry (RWI) Policies of the American College of Cardiology Foundation (ACCF) and the Cardiovascular Research Foundation (CRF) ACCF/CRF require and collect disclosure of relationships with industry (RWI) from all individuals who are in a position to control or influence educational content . This is done annually in conjunction with all of ACCs meetings and educational offerings for which CME/CNE/CPE is offered (including the annual ACC Scientific Session) and all of CRFs meetings and educational offerings for which CME is offered (including TCT, CRFs major annual educational event) . All individuals involved in directing, planning, and delivering educational content for ACCF and CRF (course directors, planning committee members, faculty, staff, etc) are required to submit RWI disclosures prior to participation; otherwise their participation in the event is precluded . If disclosure of RWI information is not already on file at the inception of a new activity, that information is collected at confirmation of individual participation . This information is also confirmed and updated prior to the development of each CME/CNE/CPE activity to ensure that the most up-to-date information is collected and available . Likewise, nonphysician staff are required to complete RWI Disclosure Declaration forms . ACCF requires that all faculty disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations . COI (RWI) Declaration The online Required Faculty Disclosure Declaration form requires each individual to identify financial relationships that he or she and/or his or her spouse or partner have had with any organization within the preceding 12 months or that is anticipated in the next 12 months that could be perceived as a relevant conflict of interest . Any individual who does not complete the form is not permitted to participate; this includes course director(s) and planners (who are then excluded from planning the activity) as well as faculty . For a live activity, each faculty is required to check in upon arrival; and faculty who have not completed their RWI declarations are not allowed to enter the CME/CNE/CPE activity . For enduring activities, the CME/CNE/CPE product is not published, either online or in print, until all declarations are completed . COI Resolution Director(s) and planning committee members are required to complete the COI Resolution form prior to content development . In the event that a conflict of interest exists, the activity content is reviewed by course director(s), planning committee members, CME/CNE/CPE committee members, or designees who do not have conflicts of interest . Speakers, Presenters, Moderators, Panelists and Live Case Operators who have declared a COI or RWI are required to complete a COI Resolution form online to agree that their conflict(s) will be resolved by any mechanisms recommended by ACCF/CRF including one or more of the following: 1 . Confirming that no patient care recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship 2 . Confirming that if patient recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship, the conflict will need to be resolved (see next paragraph) 3 . Submitting an alternate resolution of the conflict that is then reviewed by the CME/CNE/CPE Committee, course director(s) and/or planning committee, and if acceptable, approved 4 . Recommending an alternate speaker 5 . Agreeing to divest themselves of the financial relationship Upon receipt of the COI Resolution form, the course director(s), planning committee members, or CME/CNE/CPE committee members or their designees review each COI Resolution form to determine the course of action, if any, necessary to resolve the conflict . Possible conflict resolution mechanisms, based on the educational design of the program, include using a variety of approaches including, but not limited to:

ACC.12 Final Program

47

Disclosure of Financial Relationships ACC.12

1 . Prior knowledge of speakers presentation history (for example, in the past has the individual participated in unbiased presentations, discussions, published literature, etc .) 2 . Knowledge of content and its relevance to the financial relationships 3 . Interview with speakers 4 . Slide peer review 5 . Abstract peer review 6 . Replacing the presenter For ACCF and TCT annual scientific sessions where presentations number in the thousands, a committee is formed to review all faculty financial relationships to determine whether slide review is necessary; if so, slides are reviewed prior to presentation and, when necessary, changes are recommended and implemented up to and including presenter replacement . Effective July 2010, in response to an ACCME/ANCC update, sessions with industry employee speakers are allowed to be certified under the following circumstances: 1 . If the content of the session DOES NOT relate to the business lines and products of the industry employer 2 . The presentation is about the scientific or discovery process itself 3 . The presentation is about products that have not yet entered the clinical arena (including products that are under investigation) at the level of biology or physics but not about products 4 . Presentation slides are submitted at least 2 weeks before the start of the CME/CNE/CPE activity, and the presenter agrees in advance to any and all modifications requested by the CME/CNE/CPE committee To view the ACC .12 Disclosure Digest which contains disclosure information for all ACC .12 and ACC-i2 with TCT speakers, please visit www.accscientificsession.org, and select Education, then Presenter Disclosures. Or, if your smart phone is enabled with a QR code reader, scan the code below:

48

GO for ACC.12!

ACC.12

Scientific Session Descriptions

ACC.12 has something for everyone, including 16 learning pathways designed to address the specific needs of our learners. Plus, ACC.12 features an integrated ACC-i2 with TCT Interventional Learning Pathway, promoting the continued collaboration between the general and interventional cardiology communities.
Please Note: Admission to all sessions is by permissible badge type only on a first-come, first-served basis.

Session Formats
Symposia This classic educational format offers detailed discussions of interest to both general cardiologists and subspecialists in various aspects of scientific, clinical and procedural cardiology . Sessions run for 90 minutes, and topics may include novel approaches to clinical issues as well as evidence-based data and/or clinical trial results . Individuals who have directly contributed information to the subject being discussed typically present these sessions . Oral Contributions Each year, the meetings feature oral contributions by the original author of some of the best abstracts accepted to the meeting . Groups of several oral abstracts focusing on a similar topic are offered in 90-minute sessions . The allotted time for each abstract is no more than 15 minutes . Many sessions feature a Year in Review talk that provides an overview of what has been accomplished in the past year . Moderated Poster Sessions This years poster abstract sessions feature over a thousand posters in the classic flat board format . Poster abstract sessions feature dedicated viewing hours, poster discussant faculty to facilitate questions/interaction, Best Poster Award judging, and an e-abstract self-directed learning/archival system . All poster sessions will be moderated; and poster boards will group like subject matter together, fostering interaction between poster discussants and presenters/poster audience . There will be two daily dedicated poster presentation/attendee viewing hours: 9:30 a .m . 10:30 a .m . and 11:00 a .m . noon . Limited educational programming will

be scheduled during these times to encourage attendees to visit the poster sessions and interact with the presenters . Poster sessions for ACC-i2 with TCT will be held from 9:30 a .m . to noon on Saturday, March 24 . New this year, all posters within a given pathway will be presented on the same day and will remain on display for the entire time that the Expo Hall is open . New this year, one poster presentation from each pathway will be selected as a Best Poster Award winner . The presenter will receive a gift certificate good towards an ACCF educational product or program . ACC.12 Online New this year, attendees will experience ACC .12 Online for free! ACC .12 Online features some of the most critical, cutting-edge presentations from ACC .12 with live webcasts of 60 sessions and 18 on-demand programs from the Legends of CV Medicine Series and Core Curriculum sessions available to attendees for free during the meeting . Choose to watch them from a Heart Hub or from your own mobile device multi-tasking among the simultaneous presentations . To access ACC .12 Online and see a complete schedule of live broadcasts, go to: http://acc12online.cardiosource.org and login with your e-mail address and passcode: ACCONLINE ACC-i2 with TCT Live and Taped Cases Three live and taped case sessions (one session each on Saturday, Sunday and Monday afternoons) allow attendees to watch an actual invasive cardiovascular procedure in progress via satellite feed from a clinical setting . Some pretaped cases will also be presented .

ACC.12 Final Program

49

Scientific Session Descriptions ACC.12

International Lunch Symposia ACC is co-hosting a series of symposia held over lunchtime with 18 non-U .S .-based cardiovascular societies . These sessions focus on global clinical and patient management issues that can be presented from the perspective of U .S .based physicians and non-U .S .-based physicians . Attendees are encouraged to bring their own lunch to the sessions . Food for purchase is available at nearby concessions outside of the symposia rooms . Legends of Cardiovascular Medicine Expand your horizons with the Legends of Cardiovascular Medicine Lecture Series . Each Legend is an individual that is recognized by all cardiologists as a true leader and innovator and has been selected based on their outstanding contributions to the field of cardiovascular medicine . The Legends will share with the audience their unique professional history of accomplishments and contributions to the cardiovascular field; key milestones that changed practice in their area of expertise; and insights into the future of cardiovascular care . During the Q&A segment, the Legends will share biographical information, impressionable moments from mentors, guiding principles, lessons learned and other introspective thoughts from their own life stories . Meet the Experts Meet the Experts are energizing, case-based, interactive sessions that emphasize scholarly discussion and debate in a lively, but informal small-group setting (maximum capacity of 150) . A specific topic is selected for each session and audience participation is encouraged . Provocative clinical case vignettes or organizational scenarios are typically presented with the case presenter and panelists each making their brief remarks and encouraging participant interaction . Audience response systems are available in each of the Meet the Experts rooms bring your own personal mobile device to participate . Special Sessions Special sessions are unique events that focus on activities of broad interest to many attendees . The Special Topics Learning Pathway highlights these offerings, which include the Opening Showcase, late-breaking clinical trials, the Young Investigators Awards, sessions designed expressly for fellows in training, the new and exciting Legends of Cardiovascular Medicine Lecture Series, the College business meeting, the
50 GO for ACC.12!

61st Annual Convocation, and the closing session, preceded by Innovators in Cardiology, featuring top leaders in the field . Heart Songs Learning Lab Back by popular demand is the highly rated Heart Songs SelfPaced Learning Lab a unique audio-visual program to refresh cardiac auscultation skills . After a pre-test, attendees will then listen to Heart Sounds while viewing phonocardiograms, echoes, etc . on an iPod Touch, an iPad or laptop computer . Attendees can view the sessions and take both the pre-test and post-test on their own device or use devices provided in the room to document improvement in their auscultation skills . Each session takes approximately 30 minutes to complete . Sessions are self-paced and can start anytime from 9 a .m . to 5 p .m .

Lifelong Learning
Again this year, you can obtain Maintenance of Certification (MOC) points at ACC .12 by participating in daily study sessions approved by the American Board of Internal Medicine (ABIM) . Youll find presentations geared to general cardiology, interventional cardiology and new this year electrophysiology . In addition, pediatric cardiologists will have the opportunity to participate in an interactive MOC study session with questions from the American Board of Pediatrics (ABP) . There is no cost for MOC sessions . They are included in your registration fee! Also back by popular demand is the Cardiology Core Curriculum, offering a review of every major area of cardiology and helping you to prepare for board exams or refresh clinical knowledge and skills at any stage of your career . Maintenance of Certification Start with a new self-assessment session featuring clinically relevant guidelines and trials . Then look for 12 additional Recertification Made Easy review sessions, 2 in interventional cardiology, 2 in electrophysiology, and 8 in general cardiology (half based on ABIM home-study modules and half based on new ACC general cardiology modules) . After the study session, nearby computer workstations allow you to immediately take a post-test, each worth 10 MOC points . Earn up to 70 ABIM MOC points .

ACC.12 Scientific Session Descriptions

All ABIM workshop participants must be registered for the session and enrolled in the ABIM MOC program to attend . ABIM staff will be available to assist with on-site enrollment and to answer MOC questions, but please arrive at the session 15 minutes prior to the start . Registrants who sign up for the new ACC general cardiology modules will be able to access them online through their CardioSource account . Pediatric Cardiology MOC This interactive session is based on a group of home study modules approved by the American Board of Pediatrics (ABP) . Youll review with the experts, learn alongside your peers, challenge your medical knowledge with test questions, and get instant feedback with an audience response system . Remember to bring your laptop to the MOC review session . Configure it in advance to receive the convention centers WiFi signal, and make sure you can access your ABP portfolio . During the program, youll submit ABP MOC module answers electronically through the portfolio on the ABP website . The study session prepares you to earn 10 ABP MOC points . The credit approval period for this module is January 1, 2012 December 31, 2012 . Participants must be an ABP diplomate and enrolled in the ABP MOC process at the time of the session . For information about enrolling in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio . Cardiology Core Curriculum With the constant growth in cardiovascular knowledge and technology, the need to learn doesnt end once you enter practice . Update your knowledge, refresh your skills, or simply prepare for the board certification examination with ACCs highly respected Lifelong Learning Cardiology Core Curriculum . Using the Competency-Based Learning System, you begin with an online pre-test that highlights your areas of educational need . Next, select the Core Curriculum sessions that fill your knowledge gaps . After passing an online posttest, youll receive 10 ABIM Part 2 MOC credits

ACC.12 Final Program

51

ACC.12

Expo
Continue Your Education at the ACC.12 Expo
South Building, Level 3, Halls A1 and A2 A vital part of your ACC education can be found in the ACC .12 Expo . Gain an understanding of the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care . The ACC .12 Expo features the largest gathering of innovative cardiovascular products and services being shown under one roof . More than 300 exhibiting companies and organizations showcase their products, technologies and services in these categories: Associations Education Food Service, Nutrition and Lifestyle Hospital/Institution/Practice Imaging Information Technology Medical Devices Medical Equipment Pharmaceuticals Publishing Research You dont have to miss a minute of education to explore the Expo Hall, located in the South Building, Level 3, Halls A1 and A2 . ACC .12 offers more than six hours of dedicated Expo time unopposed by education sessions to meet with industry and learn more about their offerings . Round out your day by discovering cutting-edge innovations as you enjoy morning and afternoon coffee breaks, sponsored by Sanofi US, in the Expo Hall . NEW for ACC.12! Join your colleagues for lunch in the Expo Hall on Monday, March 26, from noon to 2:00 p .m .

Expo Hours
Saturday, March 24 Dedicated Expo Hours Expo Coffee Break Expo Mid-Day Break* Expo Coffee Break Sunday, March 25 Dedicated Expo Hours Expo Coffee Break Expo Mid-Day Break* Expo Coffee Break Monday, March 26 Dedicated Expo Hours Expo Coffee Break Expo Mid-Day Break* and NEW for ACC .12! Lunch Hospitality Event 9:30 a.m. 4:30 p.m. 9:30 a .m . 11:30 a .m . 11:30 a .m . 2:00 p .m . 3:30 p .m . 4:30 p .m . 9:30 a.m. 4:30 p.m. 9:30 a .m . 10:45 a .m . 12:15 p .m . 2:00 p .m . 3:30 p .m . 4:30 p .m . 9:30 a.m. 2:00 p.m. 9:30 a .m . 10:30 a .m .

Noon 2:00 p .m .

ACC thanks Sanofi US for its sponsorship of the morning and afternoon coffee breaks . *Limited ACC.12 lunchtime sessions run concurrently during these time periods

Specialty Areas
We help you maximize your time in the Expo Hall by gathering the vendors you want to see into specialty areas . American College of Cardiology ACC Central McCormick Place South, Hall A1, #10027 At ACC Central youll find comprehensive information on ACCs quality initiatives; NCDR registries and research; selfassessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, dont miss the exciting new products and services designed to help you translate science into practice .

52

GO for ACC.12!

Expo ACC.12
CardioSmart Pavilion

McCormick Place South, Hall A1

As society moves toward more heart-healthy products, ACC has teamed up with consumer companies to help guide physicians and patients to make healthier dietary and lifestyle choices . Visit the CardioSmart Pavilion and sample new heart-healthy options being offered by a variety of consumer companies . Health IT Pavilion McCormick Place South, Hall A1 ACC is highly committed to assisting its members in the adoption and implementation of health IT to promote quality in cardiovascular care . The Health IT Pavilion is dedicated to showcasing health IT companies and consulting firms; their products, services and technologies; and the benefits to health care providers . Interventional Pavilion McCormick Place South, Hall A1 Learn about groundbreaking products, services and technologies for interventional cardiology in the Interventional Pavilion . With many new devices and technologies coming into the marketplace, interventional and general cardiologists will want to ensure a visit to this pavilion is on their ACC meeting agendas . Public Service Area McCormick Place South, Hall A2 The Public Service Area gathers cardiovascular societies and non-profit organizations into one location . Visit with these organizations for educational materials, market research and information about advocacy efforts in the U .S . and around the world . Publishers Showcase McCormick Place South, Hall A1 The very popular Publishers Showcase features publishers of medical texts, journals and other relevant materials . Books and subscriptions are also available for purchase in this area .

Networking Areas
Relax and recharge as you network with your colleagues in these areas of the Expo Hall . ACC Member Lounge McCormick Place South, Hall A1, #22063 The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere . Bistro ACC McCormick Place South, Hall A2, #1100 Bistro ACC is an innovative dining option offering several fresh and healthy menu choices, including international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets by visiting the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall . International Lounge McCormick Place South, Hall A2, #15097 As a service to our international attendees, we offer a designated International Lounge, where you can join colleagues from around the world to discuss and share the latest science, research and treatment modalities in the field of cardiology . ACC membership materials are available in several languages . Windy City Caf & Tech Hub McCormick Place South, Hall A2, #22111 Join colleagues for a more upscale buffet-style dining experience at the Windy City Caf & Tech Hub . The Windy City Caf offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices recharge your batteries and your phones batteries all in one location!

ACC.12 Final Program

53

ACC.12

Exhibitors
Exhibitors as of February 28, 2012. Please refer to the ACC .12 ExpoGuide and the ExpoGuide Addendum, available at the Expo Hall entrances and in your meeting bag, for the most updated list of exhibitors.

Company Name

Booth Number

Company Name

Booth Number

Company Name

Booth Number

Abbott . . . . . . . . . . . . . . . . . . . . . . 4040 Abbott Vascular . . . . . . . . . . . . . . . 6048 Abiomed, Inc . . . . . . . . . . . . . . . . . 9063 ACC China Chapter . . . . . . . . . . . .17101 ACC Egypt . . . . . . . . . . . . . . . . . . .18100 ACC Pakistan Chapter . . . . . . . . . .18104 ACC-Caribbean Chapter c/o Caribbean Cardiac Society . . . .17102 Access Closure, Inc . . . . . . . . . . . .10079 Accreditation for Cardiovascular Excellence . . . . . . . . . . . . . . . .19100 Accumetrics, Inc . . . . . . . . . . . . . . .19007 ACIST Medical Systems/Bracco Diagnostics . . . . . . . . . . . . . . . 9048 Actelion Pharmaceuticals US, Inc . . . . . . . . . . . . . 8038, 10038 Advanced Cardiac Diagnostics LLC . . . . . . . . . . . .11085 Agfa HealthCare . . . . . . . . . . . . . .12055 AirStrip Technologies . . . . . . . . . . .13101 Alere Home Monitoring . . . . . . . . .19085 Amarin Corp . . . . . . . . . . . . . . . . .20015 Amazing Charts . . . . . . . . . . . . . . 23020 AME Publishing Company . . . . . . . .1005 American College of Cardiology Mexico Chapter . . . . . . . . . . . .17100 American College of Cardiology ACC Central . . . . . . . . . . . . . 10027 American College of Physicians/ Annals of Internal Medicine . . . .1038 American College of Radiology . . . . .6101 American Express OPEN . . . . . . . 20075 American Heart Association . . . . . . 2040 American Physician Institute . . . . . 12074 American Society of Echocardiography . . . . . . . . . . 19096 American Society of Nuclear Cardiology . . . . . . . . . . . . . . . 20096 Amgen . . . . . . . . . . . . . . . . . . . . . .14036

Amyloidosis Foundation, Inc . . . . . .20102 Angelini Pharmaceuticals . . . . . . . .15090 AngioScore, Inc . . . . . . . . . . . . . . . 9077 ANSAR Medical Technologies, Inc . 23021 Aprima Medical Software . . . . . . .18032 Arbor Pharmaceuticals, Inc . . . . . . .15089 Arstasis Inc . . . . . . . . . . . . . . . . . . 10090 Ascendian Healthcare Consulting . .18041 Astellas Pharma US, Inc . . . . . . . . .10001 AstraZeneca Pharmaceuticals . . . . .6012 AtCor Medical, Inc . (USA) . . . . . . . .11089 athenahealth, Inc . . . . . . . . . . . . . .17031 Atherotech Diagnostics Lab . . . . . .19089 Bard Medical Division . . . . . . . . . .18002 Bard Peripheral Vascular . . . . . . . . 4048 Baxter Healthcare . . . . . . . . . . . . .14082 Berkeley HeartLab, Inc . . . . . . . . . .10042 Best Vascular . . . . . . . . . . . . . . . . . .7073 BG Medicine, Inc . . . . . . . . . . . . . . 19006 BioMed Central . . . . . . . . . . . . . . .19049 BMS/Pfizer . . . . . . . . . . . . . . . . . . 2001 BodyPartChart LLC . . . . . . . . . . . .11087 Boehringer Ingelheim . . . . . . . . . . . 6000 Borgess Health . . . . . . . . . . . . . . .19078 Boston Scientific . . . . . . . . . . . . . . 3063 Brazilian Society of Cardiology . . . .18096 British Cardiovascular Society . . . .17096 Cambridge Heart, Inc . . . . . . . . . . .12081 Cameron Health, Inc . . . . . . . . . . . . 2063 Canadian Cardiovascular Society . . 21107 Cardiac CT Angiography Training . .19106 CardiacAssist, Inc . . . . . . . . . . . . . . 9088 Cardiology News . . . . . . . . . . . . . .17005 Cardiology Today/SLACK Incorporated . . . . . . . . . . . . . . . .1024 Cardiomedix/Commwell . . . . . . . . .18000 CardioMEMS, Inc . . . . . . . . . . . . . .15088 CardioNet, Inc . . . . . . . . . . . . . . . . .11097 Cardionics . . . . . . . . . . . . . . . . . . 20091

CardioPulse (formerly CAOS) . . . . 20049 Cardiostim 2012/Reed Expositions France . . . . . . . . . .18105 Cardiovascular Business . . . . . . . .12096 Cardiovascular Credentialing International (CCI) . . . . . . . . . . .19105 Cardiovascular Research Foundation . . . . . . . . . . . . . . . . 2048 Cardiovascular Systems, Inc . . . . . . 9078 CardioVillage/University of Virginia . . . . . . . . . . . . . . . . . . .15044 Carle Physician Group . . . . . . . . . 20080 CellAegis Devices Inc . . . . . . . . . . .10087 Centers for Medicare & Medicaid Services . . . . . . . . . .19076 Centra . . . . . . . . . . . . . . . . . . . . . .21079 Cerner Corporation . . . . . . . . . . . .18049 CFI Medical Solutions . . . . . . . . . . 4097 Cleveland Clinic . . . . . . . . . . . . . . .23019 Cleveland Clinic Abu Dhabi . . . . . .13086 Cleveland Clinic C5 Research . . . . .23016 The Coca-Cola Company . . . . . . . .19063 Community Health Systems . . . . . .10083 Compulink Business Systems, Inc . . . . . . . . . . . . . . .12087 Contec Medical Systems Co ., LTD . . . . . . . . . . 20048 Cook Medical . . . . . . . . . . . . . . . . . 9057 Corindus Vascular Robotics . . . . . . 3097 Crescendo Systems Corp . . . . . . . .18030 Cryolife . . . . . . . . . . . . . . . . . . . . 20009 CVRx, Inc . . . . . . . . . . . . . . . . . . . 10063 Cytokinetics, Inc . . . . . . . . . . . . . . .17083 Daiichi Sankyo, Inc . . . . . . . . . . . . .14026 Daiichi Sankyo, Inc . & Lilly USA LLC . . . . . . . . . . . . . .18013 DailyCare BioMedical Inc . . . . . . . . .1004 Data Strategies, Inc . . . . . . . . . . . 20034 Demos Medical Publishing . . . . . . . .1040

54

GO for ACC.12!

ACC.12 Exhibitors
Company Name Booth Number Company Name Booth Number Company Name Booth Number

DesAcc, Inc . . . . . . . . . . . . . . . . . .19081 Diagnosoft, Inc . . . . . . . . . . . . . . . .18026 Diagnostic & Interventional Cardiology . . . . . . . . . . . . . . . 10004 DiaPharma Group, Inc . . . . . . . . . . . 11075 Digisonics . . . . . . . . . . . . . . . . . . .10073 The Doctors Company . . . . . . . . . 10043 Dornier MedTech America, Inc . . . .10088 DR Systems, Inc . . . . . . . . . . . . . . .18035 DrFirst, Inc . . . . . . . . . . . . . . . . . . .19087 Duke Clinical Research Institute . . .11063 eCardio . . . . . . . . . . . . . . . . . . . . . 7097 eClinicalWorks . . . . . . . . . . . . . . . .19039 Edan Instruments, Inc . . . . . . . . . . . .6100 Edwards Lifesciences . . . . . . . . . . 3048 Ekos Corporation . . . . . . . . . . . . . . 9083 Elsevier-ClinicalKey . . . . . . . . . . . . . 1011 Emerge Clinical Solutions . . . . . . . 2054 Endothelix, Inc . . . . . . . . . . . . . . . . .1055 Endovascular Today . . . . . . . . . . . . 8072 Epiphany Cardiography Products . .17037 Epsilon Imaging, Inc . . . . . . . . . . . .20074 ES Physician Agent . . . . . . . . . . . .18004 Esaote North America . . . . . . . . . . .2019 European Society of Cardiology . . .11080 Fibromuscular Dysplasia Society of America (FMDSA) . . . . . . . . .21105 Flexible Informatics . . . . . . . . . . . . 6072 Forest Pharmaceuticals . . . . . . . . .18063 FUJIFILM Medical Systems USA, Inc . . . . . . . . . . . . . . . . . .19053 Gambro UF Solutions, Inc . . . . . . . .19088 GE Healthcare . . . . . . . . . . . . . . . . .8013 GEMMS . . . . . . . . . . . . . . . . . . . . 20027 GeneDx . . . . . . . . . . . . . . . . . . . . . 6073 Genentech and Roche . . . . . . . . . .15027 Genway Biotech . . . . . . . . . . . . . . .15084 Genzyme . . . . . . . . . . . . . . . . . . . .13083 Gilead Sciences . . . . . . . . . 8000, 10006 Glenmark Pharmaceuticals . . . . . .10041 Guerbet . . . . . . . . . . . . . . . . . . . . . .8071 Harvard Clinical Research Institute . . . . . . . . . . . . . . . . . .16083 The Healthcare Network . . . . . . . 20033 Health Management Associates . . .21077

Health Outcomes Sciences . . . . . . 4096 Heart Institute Diagnostic Lab . . . .20101 The Heart Institute for Children, Hope Childrens Hospital, Advocate Christ Medical Center . 20097 Heart Rhythm Society . . . . . . . . . .20105 Heart Test Laboratories, Inc . . . . . .18085 Heartbeat International . . . . . . . . 20098 HeartSine Technologies, Inc . . . . . .15082 HeartWare Inc . . . . . . . . . . . . . . . .11079 Henry Schein MicroMD . . . . . . . . 20035 Hershey Center for Health & Nutrition . . . . . . . . . . . . . . . . 20063 Hitachi Aloka Medical . . . . . . . . . .12063 HMP Communications, LLC . . . . . . 8049 Hokanson . . . . . . . . . . . . . . . . . . 16004 Hospital Corporation of America (HCA) . . . . . . . . . . . . . . . . . . . 10096 HRA Healthcare Research & Analytics . . . . . . . . . . . . . . . . .11086 Hypertrophic Cardiomyopathy Association . . . . . . . . . . . . . . . .21100 IEM . . . . . . . . . . . . . . . . . . . . . . . .10089 INC Research . . . . . . . . . . . . . . . . .24018 INDEC Systems Inc . . . . . . . . . . . . . 9056 INFINITT North America . . . . . . . . .12088 InfraReDx, Inc . . . . . . . . . . . . . . . . . 3054 InspireMD . . . . . . . . . . . . . . . . . . . 2067 Intelemage, LLC . . . . . . . . . . . . . . .14084 International Society for Cardiovascular Translational Research . . . . . . . . . . . . . . . . . 21101 Intersocietal Accreditation Commission (IAC) . . . . . . . . . . .20104 Intuitive Solutions . . . . . . . . . . . . 20038 Israel Heart Society . . . . . . . . . . . .17104 Itamar Medical . . . . . . . . . . . . . . .18016 JAMA & Archives Journals . . . . . . . .1030 Janssen Pharmaceuticals, Inc . . . . .10007 Jaypee Highlights Medical Pub . . . . .1044 John Welsh Cardiovascular Diagnostic Laboratory . . . . . . .19104 Jones & Bartlett Learning . . . . . . . .1034 JTE Multimedia . . . . . . . . . . . . . . . .1006 Kaneka . . . . . . . . . . . . . . . . . . . . 20087

Koven Technology, Inc . . . . . . . . . .11081 Lantheus Medical Imaging, Inc . . . . 6099 Laurel Bridge Software, Inc . . . . . . 6098 Le Cardiologue . . . . . . . . . . . . . . . .1042 LifeWatch Services, Inc . . . . . . . . .15083 LipoScience . . . . . . . . . . . . . . . . . .18069 Lippincott Williams & Wilkins/ Wolters Kluwer Health . . . . . . . .1017 Littmann Stethoscopes . . . . . . . . .16001 LUMEDX . . . . . . . . . . . . . . . . . . . .17007 MAQUET Medical Systems . . . . . . 3096 Mars Botanical . . . . . . . . . . . . . . .21063 Mayo Clinic . . . . . . . . . . . . . . . . . .19001 McGraw-Hill . . . . . . . . . . . . . . . . . .1010 McKesson . . . . . . . . . . . . . . . . . . .18027 MedActivus . . . . . . . . . . . . . . . . . .19079 MedAxiom . . . . . . . . . . . . . . . . . . .12049 MedCo Data LLC . . . . . . . . . . . . . 20045 The Medical Roundtable c/o FoxP2 Media LLC . . . . . . . . .1032 Medical Simulation Corporation . . . .1051 The Medicines Company . . . . . . . . 4054 Mednet Healthcare Technologies . . 6097 MEDRAD Interventional . . . . . . . . . 6062 Medstreaming LLC . . . . . . . . . . . .18007 Medtronic, Inc . . . . . . . . . . . . . . . . 6038 The Mended Hearts, Inc . . . . . . . . .21069 Merck . . . . . . . . . . . . . . . . . . . . . .14008 Merge Healthcare . . . . . . . . . . . . .17043 Methodist DeBakey Heart & Vascular Center . . . . . . . . . . . .17082 Met-Test, LLC . . . . . . . . . . . . . . . .17089 Midmark Corporation . . . . . . . . . . .12080 MiE America-Medical Imaging Electronics . . . . . . . . . . . . . . . .10081 Millar Instruments . . . . . . . . . . . . 10000 Miller Pharmacal Group, Inc . . . . . . 7096 Million Hearts . . . . . . . . . . . . . .21067 Mortara Instrument . . . . . . . . . . . . 9026 Mountain States Health Alliance . .19084 National Death Index . . . . . . . . . . .21080 National Heart, Lung and Blood Institute (NHLBI) . . . . . . .16089 Navigant, formerly Paragon Health . . . . . 20051
ACC.12 Final Program 55

Exhibitors ACC.12
Company Name Booth Number Company Name Booth Number Company Name Booth Number

ndd Medical Technologies . . . . . . .17003 New England Journal of Medicine . 16000 NextGen Healthcare . . . . . . . . . . . 19043 NextServices Inc . . . . . . . . . . . . . . .19035 Norav Medical . . . . . . . . . . . . . . . .18001 NorthEast Monitoring, Inc . . . . . . . 20081 Northwestern Medicine . . . . . . . . .14083 Novartis Pharmaceuticals Corporation . . . . . . . . . 16017, 18020 Oklahoma Heart Hospital . . . . . . . .18099 Oxford University Press . . . . . . . . . .1012 Panasonic . . . . . . . . . . . . . . . . . . .18075 PCNA Preventive Cardiovascular Nurses Association . . . . . . . . . .21104 Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) . . . . . . . . . . . . . . 10084 Perkins Healthcare Technologies . .21091 Philips . . . . . . . . . . . . . . . . . . . . . . .6076 PhoneTree . . . . . . . . . . . . . . . . . . .21090 PhysBiz Tech . . . . . . . . . . . . . . . . 20043 Pie Medical Imaging . . . . . . . . . . . 9090 Pikeville Medical Center . . . . . . . . .12086 Pivotal Therapeutics Inc . . . . . . . . 24020 PracticeLink .com . . . . . . . . . . . . . . 2004 PracticeMax . . . . . . . . . . . . . . . . .17029 Provation Medical-Wolters Kluwer Health . . . . . . . . . . . . . 20053 Pulmonary Hypertension Association . . . . . . . . . . . . . . . .21082 Pulse Biomedical, Inc . . . . . . . . . . .19082 Pulse Medical Inc . . . . . . . . . . . . . .12072 QGenda .com . . . . . . . . . . . . . . . . 20039 Quaker Oats . . . . . . . . . . . . . . . . .21071 Roche Diagnostics . . . . . . . . . . . . 16009 Rush University Medical Center . . .10082 Saint Alphonsus Health System . . 20076 Sanofi . . . . . . . . . . . . . . . .12001, 14000

Saudi Heart Association . . . . . . . . .18102 SCHILLER . . . . . . . . . . . . . . . . . . .11054 ScImage . . . . . . . . . . . . . . . . . . . . 7063 ScottCare Corporation . . . . . . . . . . .2013 seca . . . . . . . . . . . . . . . . . . . . . . 20090 Shape Medical Systems, Inc . . . . . .14089 Shiel Medical Laboratory . . . . . . . .19075 Shimadzu Medical Systems USA . . 8048 Siemens Healthcare . . . . . . . . . . . . 2026 Sim-e-Child . . . . . . . . . . . . . . . . . .18101 Singulex, Inc . . . . . . . . . . . . . . . . . .18089 Sociedad Latinoamericana de Cardiologia Intervencionista (SOLACI) . . . . . . . . . . . . . . . . .18097 Sociedad Venezolana de Cardiologia . . . . . . . . . . . . .17105 Society for Cardiovascular Angiography and Interventions (SCAI) . . . . . . . . . 9082 Society for Heart Attack Prevention and Eradication (SHAPE) . . . . .21106 Society of Cardiovascular Computed Tomography . . . . . .19103 Society of Chest Pain Centers . . . 16044 Spacelabs Healthcare . . . . . . . . . .11001 Spanish Society of Cardiology . . . .21096 Spartan Bioscience . . . . . . . . . . . . 9089 Springer . . . . . . . . . . . . . . . . . . . . . .1026 St . Jude Medical . . . . . . . . . . . . . . .3013 St . Lukes Health System . . . . . . . .19074 StopAfib .org . . . . . . . . . . . . . . . . .21098 SUBWAY . . . . . . . . . . . . . . . . . . . .21062 Summit Doppler Systems . . . . . . . . 11073 Takeda Pharmaceuticals North America . . . . . . . . . . . . .15037 TeraRecon . . . . . . . . . . . . . . . . . . .18055 Terumo Interventional Systems . . .21015 Texas Childrens Hospital . . . . . . . .12078

theheart .org . . . . . . . . . . . . . . . . . .12073 Thoratec Corporation . . . . . . . . . . .12097 TIMI Study Group . . . . . . . . . . . . . .10050 TomTec Imaging Systems GmbH . .10097 Toshiba America Medical Systems, Inc . . . . . . . . . . . . . . . 6026 Total Vein Systems . . . . . . . . . . . .15045 TransAmerican Medical Imaging . . 7098 Transgenomic, Inc . . . . . . . . . . . . . 11078 Trinity Mother Frances Hospitals & Clinics . . . . . . . . . . . . . . . . . 20084 Turkish Society of Cardiology ACC Istanbul Chapter Consortium . .17103 TYRX Inc . . . . . . . . . . . . . . . . . . . . 9085 Unfors RaySafe, Inc . . . . . . . . . . . . .1057 Universal Medical Resources, Inc . .10039 UpToDate . . . . . . . . . . . . . . . . . . . 20057 Vascular Solutions . . . . . . . . . . . . . .1053 Vasomedical, Inc . . . . . . . . . . . . . . .14097 VectraCor . . . . . . . . . . . . . . . . . . .13090 The VEINS Chicago 2012 . . . . . . . . 9076 Velos, Inc . . . . . . . . . . . . . . . . . . . .12084 Verathon Medical . . . . . . . . . . . . . .13089 Vital Images . . . . . . . . . . . . . . . . . .11088 Volcano Corporation . . . . . . . . . . . 8054 W .A . Baum Co ., Inc . . . . . . . . . . . . 10045 Weaver and Company . . . . . . . . . .18083 Welch Allyn, Inc . . . . . . . . .16037, 16045 Western Systems Research, Inc . . .13088 Wiley-Blackwell . . . . . . . . . . . . . . . .1016 WomenHeart: The National Coalition for Women with Heart Disease . . . . . . . . . . . . . .21103 World Heart Federation . . . . . . . . .19097 Yuma Regional Medical Center . . .19077 ZHealth Publishing . . . . . . . . . . . . . .7072 Z-Medica Corporation . . . . . . . . . . 8097 ZOLL Medical Corporation . . . . . . . 8063

ACC has advised all exhibiting companies that it is each companys responsibility to ensure adherence to FDA regulations, policies, practices and guidelines, and all other applicable industry guidelines, concerning the demonstration, discussion, use and/or display of products, technologies and/or services the ACC.12 Annual Scientific Session Exposition. Exhibiting companies have also been reminded of the FDA restrictions on the promotion of investigational and pre-approved drugs, devices and procedures. Information regarding FDA regulations should be obtained directly from the FDA.
56 GO for ACC.12!

ACC.12

Learning Destinations
Learning Destinations are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience. We invite you to visit these dynamic learning environments, located in the Expo Hall (South Building, Level 3, Halls A1 and A2).

NEW for ACC.12! CardioSmart Forum

McCormick Place South, Hall A2, CV Theater, #22097 You know that behavioral change is one of the most important factors in your patients living a heart-healthy lifestyle . (They know that, too .) So how can you help your patients overcome their resistance to changing their eating behaviors for the better? And for the long term? Visit the CardioSmart Forum* on Saturday, March 24, from 11:15 a .m . to 12:15 p .m . for the presentation Eat What You Love, Love What You Eat: How to Break Your Eat-Repent-Repeat Cycle . Dr . Michelle May, author of the award-winning book of the same name, will deconstruct the Mindful Eating Cycle and explore the biopsycho-social drivers of each decision point . Youll learn a powerful and universal approach to the complex issues contributing to problematic eating behaviors and walk away with six unconventional strategies that promote heart-healthy lifestyles, which could help improve your patients outcomes . This presentation is part of the CardioSmart: Hot Topics for Better Patient Outcomes series .

Topics include: Device Development and Innovation Current Approaches for Treating Calcified Peripheral Arterial Disease Challenges Associated with Treating Calcified Coronary Artery Disease The Role of Innovative Technologies in a Novel Strategy to Prevent First Coronary Event The Role of Nanotechnology in Cardiovascular Diseases Cellular Therapy Tissue Engineering Personalized Medicine

NEW for ACC.12! The Heart of Innovation Featured Learning Destination

McCormick Place South, Hall A1, #1076

CV Innovations Educational Forum

McCormick Place South, Hall A2, CV Theater, #22097 The ACC, in partnership with Elsevier Business Intelligence and the International Society for Cardiovascular Translational Research, will once again offer the CV Innovations Educational Forum*, featuring cutting-edge cardiovascular research and cardiovascular product development . Catch a glimpse of the future on Sunday, March 25, and Monday, March 26, as physicians, researchers, venture capitalists and investment bankers gather for presentations and panel discussions, and explore cardiovascular technologies in development . Refer to the ACC .12 Learning Destination Presentations pages at the end of each daily section for the scheduled presentations, speakers and descriptions . In the spectrum of chronic cardiovascular diseases, two of the most significant challenges faced by cardiology professionals today are coronary artery disease and heart failure caused by valvular disease . In the Heart of Innovation Learning Destination*, you will explore the evolution of the standard of care for these two diseases through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement . The Heart of Innovation will allow you to closely examine the protocols, approaches and advances that are driving better clinical outcomes today . To help you see the continuum of progress, you will revisit the innovators and innovations of the past, while exploring the exciting possibilities for the future and weighing in with your own opinions about how new
ACC.12 Final Program 57

Learning Destinations ACC.12

techniques and technologies will impact your practice in years to come . The adjoining Thought Leader Theater will feature clinically based presentations, as well as discussions with physicians and healthcare providers who are at the forefront of cardiovascular innovation . Refer to the ACC .12 Learning Destination Presentations pages at the end of each daily section for the scheduled presentations, speakers and descriptions . ACC is grateful for the support of the Marquee Heart of Innovation Partner: Antiplatelet Therapy Choices for High-Risk PCI Patients in the Era of Generic Clopidogrel: The Role of Platelet Reactivity Testing Accumetrics Considerations for Radionuclide Myocardial Perfusion Imaging in Patients with COPD/Asthma Astellas Pharma US, Inc. Pradaxa (Dabigatran Etexilate Mesylate) Capsules Boehringer Ingelheim Pharmaceuticals, Inc. A Stroke Prevention Option in Nonvalvular Atrial Fibrillation Janssen Pharmaceuticals Inc. Managing Atherosclerotic Risk with a Particle Focus New Recommendations and Emerging Data LipoScience Next Generation DES: Evolving the Treatment Paradigm Medtronic, Inc. Emerging Procedures Today, Future Standard of Care Toshiba Medical Systems Treating a Patient at Risk for SCD after PCI Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator ZOLL

Helping you transform patient care through innovations and partnerships ACC also thanks the following supporting companies: bioMrieux CFI Medical Solutions Corindus Vascular Robotics Edwards Lifesciences International Society for Cardiovascular Translational Research ACC also thanks the following participating companies: Health Outcomes Sciences MAQUET Medical Systems USA Medtronic, Inc . Terumo Interventional Systems

Interactive Learning Labs

McCormick Place South, Hall A1, #22027, #22035 & #23027 Experience hands-on training and interactive didactic presentations in the Interactive Learning Labs*. This unique educational opportunity puts new technology in your hands and new information in your arsenal . Refer to the ACC .12 Learning Destination Presentations pages at the end of each daily section for the scheduled presentations, speakers and descriptions . Actelion Pharmaceuticals US, Inc. (#23027) Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program PAH: A Case-Based Exploration of Management Strategies Philips Healthcare (#22035) Speckle Tracking Today for Myocardial Deformation A Hands-On Guided Workshop How Can Cardiology Informatics Enrich My Electronic Health Records Strategy? Clinical Application of Real-Time 3D TEE for Percutaneous Structural Heart Interventions

Industry-Expert Theater
McCormick Place South, Hall A1, #22042 Connect with the experts in the Industry-Expert Theater* as presenters share the latest in cardiovascular practices, products, services and technologies while you enjoy refreshments or lunch presentations are conveniently scheduled during the daily coffee and mid-day breaks . Refer to the ACC .12 Learning Destination Presentations pages at the end of each daily section for the scheduled presentations, speakers and descriptions .
58 GO for ACC.12!

ACC.12 Learning Destinations

Hypothermia for Cardiac Protection in Acute Myocardial Infarction Cardiac CT The Journey from Plaque Recognition to Prognosis Benefit of Cardiac Troponin Point-of-Care Testing in the Emergency Department Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing Innovations in Cardiovascular Interventions Terumo Interventional Systems/The Medicines Company (#22027) Educating to Help Improve Outcomes: Hands-On Radial Access Simulations Optimizing Your Outpatient PCI: What You Need to Know and Consider * Presentations in the ACC.12 Learning Destinations are not part of the official ACC Annual Scientific Session & Expo and/ or ACC-i2 with TCT, as planned by their Program Committees. Presentations in the ACC.12 Learning Destinations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

ACC.12 Final Program

59

ACC.12

Non-Accredited Educational Events

These events are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. These events do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit. Presentation schedules are current as of Feb. 28, 2012, and are subject to change. Please check the ACC .12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your Official Meeting Bag, for updated information. More information is also available at www .expo .acc .org .

Friday, March 23, 5:30 p.m. 9:30 p.m.

Swisstel Chicago 323 East Wacker Drive Optimizing PCI Outcomes: A Vision for 2012 Sponsored by Cardiovascular Research Foundation Course Directors: Martin B . Leon, MD NewYork-Presbyterian Hospital/ Columbia University Medical Center; New York, NY Gregg W . Stone, MD NewYork-Presbyterian Hospital/ Columbia University Medical Center; New York, NY Faculty: Antonio Colombo, MD Columbus Hospital/San Raffaele Hospital; Milan, Italy George D . Dangas, MD, PhD Mount Sinai Medical Center; New York, NY William F . Fearon, MD Stanford University Medical Center; Stanford, CA C . Michael Gibson, MD Beth Israel Deaconess Medical Center; Boston, MA Eberhard Grube, MD University Hospital Bonn; Bonn, Germany Ajay J . Kirtane, MD, SM NewYork-Presbyterian Hospital/ Columbia University Medical Center; New York, NY Yves Louvard, MD Institut Hospitalier Jacques Cartier; Massy, France Akiko Maehara, MD Cardiovascular Research Foundation; New York, NY Brij Maini, MD Pinnacle Health System; Harrisburg, PA Roxana Mehran, MD Mount Sinai Medical Center; New York, NY Gary S . Mintz, MD Cardiovascular Research Foundation; Washington, DC E . Magnus Ohman, MD Duke University Medical Center; Durham, NC Seung-Jung Park, MD, PhD Asan Medical Center; Seoul, South Korea
60 GO for ACC.12!

Manesh R . Patel, MD Duke University Medical Center; Durham, NC Jeffrey J . Popma, MD Beth Israel Deaconess Medical Center; Boston, MA Erick Schampaert, MD Hopital du Sacre-Coeur de Montreal; Montreal, Canada Patrick W . Serruys, MD, PhD Thoraxcenter; Rotterdam, The Netherlands Paul S . Teirstein, MD Scripps Clinic and Research Foundation; La Jolla, CA Giora Weisz, MD NewYork-Presbyterian Hospital/Columbia University Medical Center; New York, NY Mathew Williams, MD NewYork-Presbyterian Hospital/ Columbia University Medical Center; New York, NY

Saturday, March 24, 6:30 p.m. 9:00 p.m.

Hyatt Regency McCormick Place (Grand Ballroom) 2233 South Martin Luther King Drive Evaluating Recent Clinical Trial Data in the Secondary Prevention of Acute Coronary Syndrome (ACS) Sponsored by theheart.org Chair: C . Michael Gibson, MD Chairman, PERFUSE Study Group; Chairman, WikiDoc Foundation; Chief of Clinical Research CV Division, Beth Israel Deaconess Medical Center; Associate Professor of Medicine, Harvard Medical School; Consulting Professor in Medicine, Duke University School of Medicine; Durham, NC Faculty: John H . Alexander, MD, MHS Associate Professor of Medicine, Division of Cardiovascular Medicine, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC Freek W . A . Verheugt, MD Professor of Cardiology, Chairman, Department of Cardiology, Onze Lieve Vrouwe Gasthuis; Amsterdam, The Netherlands

ACC.12 Non-Accredited Educational Events

E . Magnus Ohman, MD Professor of Medicine, Associate Director, Duke Heart Center - Cardiology Clinics; Director, Program for Advanced Coronary Disease, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC Medicine; Director, Cardiovascular Imaging Program, Zena and Michael A. Wiener Cardiovascular Institute and Marie-Jose and Henry R. Kravis Center for Cardiovascular Health; New York, NY Speakers: Marco A . Costa, MD, PhD, FACC, FSCAI Professor of Medicine; Director, Interventional Cardiovascular Center, Director, Center for Research and Innovation; HarringtonMcLaughlin Heart and Vascular Institute; University Hospitals, Case Western Reserve University; Cleveland, OH Koji Kato, MD, PhD Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA Soo Joong Kim, MD, PhD Associate Professor of Medicine, Kyung Hee University Hospital; Seoul, Korea; Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA Francesco Prati, MD Interventional Cardiology, San Giovanni Hospital, CLI Foundation; Rome, Italy Abhiram Prasad, MD Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic; Rochester, MN Taishi Yonetsu, MD Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA

Sunday, March 25, 5:30 a.m. 7:30 a.m.

Hyatt Regency McCormick Place 2233 South Martin Luther King Drive Pathways of Disease Progression in Heart Failure What Can Galectin-3 Tell Us? Sponsored by BG Medicine, Inc. Chair: Professor John G .F . Cleland University of Hull; United Kingdom Faculty: Inder Anand, MD, DPhil, FACC, FRCP University of Minnesota and Minneapolis VA Medical Center; Minneapolis, MN Rudolf A . de Boer, MD, PhD University of Groningen; The Netherlands Jennifer E . Ho, MD National Heart, Lung, and Blood Institutes Framingham Heart Study; Framingham, MA Kenneth Stein, MD, FACC Senior Vice President and Chief Medical Officer, Cardiac Rhythm Management at Boston Scientific; Minneapolis, MN

Sunday, March 25, 6:30 p.m. 8:15 p.m.

Four Seasons Hotel Chicago 120 East Delaware Place Baroreflex Activation Therapy (BAT) for Resistant Hypertension & Heart Failure: A Novel Approach to Cardiovascular Treatment Sponsored by CVRx, Inc. Chairmen: Eugene Braunwald, MD Distinguished Hersey Professor, Harvard Medical School; Founding Chairman, TIMI Study Group, Brigham and Womens Hospital Alberto Zanchetti, MD Scientific Director, Istituto Auxologico of Milan; Emeritus Professor of Internal Medicine, University of Milan Speakers: Prof . John D . Bisognano, MD Director of Outpatient Cardiology, University of Rochester Medical Center Prof . George Bakris, MD Director, Hypertension Center, The University of Chicago Hospitals
ACC.12 Final Program 61

Sunday, March 25, 5:30 a.m. 7:30 a.m.

Chicago Marriott Magnificent Mile 540 North Michigan Avenue 3rd Annual Massachusetts General Hospital Optical Coherence Tomography (OCT) Symposium: A Comprehensive Review of OCT in Todays Cath Lab Environment Sponsored by St. Jude Medical Moderators: Ik Kyung Jang, MD, PhD, FACC Professor of Medicine, Harvard Medical School; Interventional Cardiology, Massachusetts General Hospital; Director, Cardiology Laboratory for Integrative Physiology & Imaging (CLIPI); Boston, MA Jagat Narula, MD, PhD, FACC Philip J. and Harriet L. Goodhart Chair in Cardiology, Professor of Medicine, Associate Dean for Global Health, Mount Sinai School of

Non-Accredited Educational Events ACC.12

Prof . Hermann Haller, MD Director, Department of Nephrology at Hannover Medical School in Germany Prof . Hani N . Sabbah, MD Professor of Medicine, Wayne State University; Director of Cardiovascular Research, Henry Ford Health System Prof . Uta Hoppe, MD Director, Department of Internal Medicine II, Paracelsus University Salzburg, Austria Prof . William T . Abraham, MD Director, Division of Cardiovascular Medicine, The Ohio State University

Sunday, March 25, 6:30 p.m. 9:00 p.m.

InterContinental Chicago (Grand Ballroom, 7th Floor) 505 North Michigan Avenue SYMPLICITY HTN-3 Trial: Evaluating Renal Denervation for Resistant Hypertension Sponsored by Medtronic, Inc. Physician Panel: Henry Krum SYMPLICITY HTN-1 Lead Author Murray Esler SYMPLICITY HTN-2 Lead Author Suzanne Oparil SYMPLICITY HTN-3 Steering Committee David Kandzari SYMPLICITY HTN-3 Steering Committee

62

GO for ACC.12!

Independent CME/CE-Certified Pre Conference & Evening Programs

Independent CME/CE-Certified Pre Conference or Evening Programs are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Titles, times and/or locations are subject to change.

Friday, March 23, 11:00 a.m. 1:00 p.m.

McCormick Place, Room S501 ECMO 2012: New Technologies and New Indications Sponsored by Methodist DeBakey Heart and Vascular Center 11:00 11:25 11:30 11:50 12:10 12:30 12:50 1:00 Registration and Lunch Welcome and Introductions Wade L . Fischer, MD ECMO: History, Trials, and Utilization Faisal Masud, MD Use of ECMO in the Acute MI and ARDS Patient Wade L . Fischer, MD ECMO as the Bridge-to-Transplant Christian Bermudez, MD Future Considerations Matthias Loebe, MD, PhD Question and Answer Adjourn

2:35 2:50

From small-molecules to cardio-regenerative drugsfor heart repair Jay Schneider, MD, PhD Adjourn

Friday, March 23, 8:00 a.m. 4:30 p.m.

McCormick Place, Room N229 28th International Conference on Recent Advances in Echocardiography and Allied Techniques Sponsored by University of Alabama at Birmingham Case Studies In Echocardiography 7:30 Registration, Coffee/Tea 7:55 Welcome and Course Orientation Dr . Navin Nanda 8:00 Session I . Cardiomyopathy, Congenital Heart Disease, CT/MRI, Intracardiac Echo, LV, Masses, Myocardial Infarction, Percutaneous Devices, Tissue Doppler Imaging, Valvar Heart Disease, Velocity Vector Imaging, 3D Echo, Miscellaneous Case Presentations and Discussion, Cases 1-15 10:00 Refreshment break 10:15 Session II . Biventricular Pacing, Cardiomyopathy/ Myocarditis, Coronary Artery Disease, CT/MRI, Echo Quantification, Embolism, LV Diastolic Function, Masses, Post Intervention, Prosthetic Valves, Shunt Lesions, Valvar Heart Disease, 3D Echo . Case Presentations and Discussion, Cases 16-23 11:30 Session III . Aortic Pathologies, Cardiac Dyssynchrony, Congenital Heart Disease, Critical Care, CT/MRI, Masses, Pericarditis, Stress Echo, Valvar Heart Disease, Valve Repair, 3D Echo . 1:00 Lunch on your own 2:00 Session IV . Cardiomyopathy/Myocarditis, CT/MRI, Congenital Heart Disease, Endocarditis, Heart Failure, Post Intervention, Prosthetic Valves, Pulmonary Hypertension, RV Function, Strain and Strain Rate, Valve Repair and Surgery, 3D Echo .

Friday, March 23, Noon 3:00 p.m.

McCormick Place, Room S502 Future Direction of Stem Cells in Cardiovascular Disease Sponsored by Texas Heart Institute 12:00 12:15 12:20 12:40 1:00 1:20 1:35 1:55 2:15 Luncheon Buffet Welcome and Introductions Stem Cells in Cardiovascular Disease: Where Are We Today? James T . Willerson, MD Peripheral Vascular Disease and Stem Cell Therapy Emerson C . Perin, MD, PhD Cell Therapy of Acute ST Elevation Myocardial Infarction Andreas M . Zeiher, MD Break Case from Texas Heart Institute Emerson C . Perin, MD, PhD Stem Cell Transplantation for Ischemic Cardiomyopathy James T . Willerson, MD cKit Stem Cell Therapy of Ischemic Cardiomyopathy Piero Anversa, MD

ACC.12 Final Program

63

Independent CME/CE-Certified Pre Conference & Evening Programs ACC.12

3:30 Session V . Cardiomyopathy/Myocarditis, Coronary Aneurysm, Embolism, Endocarditis, Heart Failure, Masses, Myocardial Infarction, Pericardial Disease, Peripheral Arterial Disease, Prosthetic Valves, RV Volume, Systemic Diseases, Trauma, Valvar Heart Disease, Valve Repair, 3D Echo, Miscellaneous . Adjournment

Sunday, March 25, 6:30 p.m. 9:15 p.m.

Chicago Marriott Downtown 540 North Michigan Avenue Hemodynamic Catheterization- HFpEF and Beyond Sponsored by Mayo Clinic 6:00 6:30 Registration Heart Failure with Preserved EF - When and Why Do You Need Invasive Hemodynamic Evaluation Margaret M . Redfield, MD Hemodynamic Evaluation of Dyspnea with Normal Ejection Fraction Barry A . Borlaug, MD Invasive Evaluation of Pulmonary Hypertension: Is it The Left Heart, Vasculature or Both Robert P . Frantz, MD Hemodynamic Assessment Pre and Post TAVR Charanjit S . Rihal, MD Jugular Distention and Edema: Myocardium, Pericardium, or Something Else Barry A . Borlaug, MD Hypertrophic Cardiomyopathy: What Cath Will Tell You That Echo Cannot Paul Sorajja, MD Adjourn

4:30

Saturday, March 24, 6:30 p.m. 8:45 p.m.

Chicago Marriott Downtown 540 North Michigan Avenue 6:45 7:15 Clinical Challenges in the Secondary Prevention of CAD Sponsored by Mayo Clinic 6:00 6:30 6:45 Registration Introduction Great Expectations: How to Meet Quality Indicators for Secondary Prevention in CAD Randal J . Thomas, MD Early Onset CAD: Tests, Treatments, and Family Screening Iftikhar J . Kullo, MD LDL and Beyond: Challenges in Lipid Management for Secondary CAD Prevention Thomas G . Allison, PhD The Obesity Paradox in CAD: How to Assess and Reduce Obesity-Related CAD Risk Jorge F . Trejo-Gutierrez, MD Panel Discussion Adjourn

7:45 8:15

7:10 7:35

8:45 9:15

8:00

8:25 8:45

64

GO for ACC.12!

Your Roadmap to ACC.12

Your Roadmap to ACC.12

ExpEriEncE

Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!
iScience is a comprehensive digital library of presentations from ACC.12 and includes over 400 hours of educational content. It is the most convenient way to experience all the education from ACC.12 and allows you to watch presenters slides while listening to fully-synchronized audio as if you were actually attending each session.

Your Roadmap to ACC.12

Features of iScience include:

Online access to content within 24 hours Convenient USB drive with access to the entire iScience library for offline viewing Streaming content for viewing on iPad and iPhone devices. Downloadable PDFs of presenter slides for convenient reference and note taking Downloadable MP3 files for convenient on-the-go audio Plus, you can earn additional CME credit with iScience
Order iScience today at the following locations: South Building, Grand Concourse Lobby, Level 3 ACC Central, Booth #10027, in the Exhibit Hall Or order online at www.CMEonCall.com/acc Enter your badge number to receive the attendee discount.
Special attendee pricing expires March 27, 2012. *Savings vary with registration category

A12199 2012 American College of Cardiology

Your Road Map to ACC.12

How to navigate and stay connected!

Planning Tools: Your most important e-navigation tools!

NEW! ACC.12 eMeeting Planner App
Get instant access to information about sessions, abstracts, exhibitors, maps , the ACC.12 twitter feed, and more Download eBooks of the Final Program, Program-At-AGlance and the JACC Abstract Supplement Read the daily newspaper CardioSourceNews from ACC.12 Search ACC.12 in your app marketplace or browse to http://ativ.me/acc to download the app on your mobile device (available for Apple, Android and Kindle Fire devices). Apple Android

Connect with Your Colleagues

ACC.12 Community
Go to www.accscientificsession.org/CommunityACC12 to join in discussions with your colleagues and fellow attendees.

Twitter at @ACC_2012
Follow us for the latest news, plus, search for and use the hashtag #ACC12 for everything ACC.12.

ACC in Touch Blog

At blog.cardiosource.org for coverage of the meeting from ACC leaders

ACC.12 Heart Hubs

Stop by North, Hall B, or South, West Transportation Lobby and relax with refreshments in a lounge setting while sessions from ACC.12 come to you on plasma screens.

Web-Based Program Planner

Go to www.accscientificsession.org, and select Plan Your ACC.12 to search for sessions and build a personalized itinerary.

ACC.12 Session Highlights: Science in the Morning; Practical Clinical Application in the Afternoon!
ACC.12 Opening Showcase and Late-Breakers
Saturday, March 24, 8:00 a.m. 10:00 a.m., Hall B, ACC.12 Main Tent.

NEW! ACC.12 Online

Live webcasts of 60 sessions and 18 on demand webcasts (Legends and Core Curriculum sessions) from anywhere in Chicago available to attendees for free during the meeting. Look for the ACC.12 Online icon in the Program-At-A-Glance (page 72). Go to http://acc12online.cardiosource.org and login with your e-mail and passcode: ACCONLINE.

Legends of Cardiovascular Medicine Lecture Series

Friday, March 23 Legends of Cardiovascular Medicine Roundtable Forum and Reception (By Invitation Only) 1:30 p.m. 5:30 p.m., Room S100c Saturday, March 24 2012 Simon Dack Lecture (during the ACC.12 Opening Showcase): Eugene Braunwald, MD, MACC 8:00 a.m. 10:00 a.m., Hall B, ACC.12 Main Tent
ACC.12 Final Program 65

Road Map ACC.12

43rd Annual Bishop Lecture: Magdi H. Yacoub, MB, BCh, FACC 2:00 p.m. 3:00 p.m., Room N426 Sunday, March 25 2012 Dan G. McNamara Lecture: Jane Somerville, MD, FACC 2:00 p.m. 3:30 p.m., Room N228 James T. Dove Lecture: Valentin Fuster, MD, PhD, MACC 4:30 p.m. 5:30 p.m., Room N427 Monday, March 26 2012 Maseri-Florio International Lecture: Antonio Colombo, MD, FACC 2:00 p.m. 3:00 p.m., Room N231

Maintenance of Certification
Get all the MOC points you need with Lifelong Learning Sessions! Attend ABIM MOC sessions worth 10 ABIM MOC points and ABP MOC session worth 10 ABP MOC points visit the MOC Lounge in Room S104b to learn more and signup. Refer to the full listing on page 96. Cardiology Core Curriculum sessions offer a review of every major area of cardiology. Take an online post-test, and receive 10 ABIM Part 2 MOC credits. Refer to the full listing on page 96.

ACC.12 Closing Session: Innovators in Cardiology

Featuring Robert M. Califf, MD, MACC, Kenneth Chien, MD, PhD, Martin B. Leon, MD, FACC, Michael J. Mack, MD, FACC and A. Jamil Tajik, MD, FACC Tuesday, March 27, 9:45 a.m. 11:45 a.m., Hall B, ACC.12 Main Tent

Joint Society Partner Sessions

Cardiovascular Research Foundation (CRF): The ACC-i2 with TCT pathway has been planned and developed in collaboration with CRF refer to the full listing on page 87 American Association for Clinical Chemistry How to Use Cardiac Biomarkers: Tuesday, March 27, 8:00 a.m. 9:30 a.m., Room N230 American Association of Thoracic Surgeons and Society for Thoracic Surgeons Multidisciplinary Approach to the High-risk Aortic Stenosis Patient Monday, March 26, 5:45 p.m. 9:05 p.m., Room S401a American Society of Echocardiography: A full-day of sessions on Sunday, March 25 in Room S406a refer to the full listing on page 94 Association of Black Cardiologists: Ethnic and Racial Disparities in Cardiovascular Disease A Call to Action Sunday, March 25, 2:00 p.m. 3:30 p.m., Room N230 Healthcare Information Management Systems Society (HIMMS): A two-part session on Sunday, March 25 in Room N227b refer to the full listing on page 98 Heart Failure Society of America: A full-day of sessions on Sunday, March 25 in Room S406b refer to the full listing on page 94 Heart Rhythm Society: A full-day of programming on Sunday, March 25 refer to the full listing on page 91

Late-Breaking Clinical Trial Sessions

Hall B, ACC.12 Main Tent Saturday, March 24 ACC.12 Opening Showcase and Late-Breakers 8:00 a.m. 10:00 a.m. Sunday, March 25 Late-Breaking Clinical Trials II 8:00 a.m. 9:30 a.m. Monday, March 26 NEW! Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials 8:00 a.m. 9:30 a.m. Late-Breaking Clinical Trials IV 10:30 a.m. Noon Tuesday, March 27 NEW! Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials 8:00 a.m. 9:30 a.m.

66

GO for ACC.12!

ACC.12 Road Map

International Society for Cardiovascular Translational Research (ISCTR): Translational Research Symposium A full-day of programming on Saturday, March 24 in Room N228 Preventive Cardiovascular Nurses Association Monday, March 26, 10:30 a.m. Noon, Room S105 Society for Vascular Surgery Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease Saturday, March 24, 4:30 p.m. 6:00 p.m., Room S103c

ACC-i2 with TCT Live Cases

Hall B, ACC.12 Main Tent Live and Taped Case Session I: Multivessel PCI Physiology and Imaging Saturday, March 24, 2:00 p.m. 5:00 p.m. Live and Taped Case Session II: Left Main and Bifurcation Complex PCI Sunday, March 25, 2:00 p.m. 5:00 p.m. Live and Taped Case Session III: Valvular Heart Disease Monday, March 26, 12:30 p.m. 2:30 p.m.

ACC.12 International Sessions

Friday, March 23 4th Annual International Cardiovascular Conference: Focus on the Middle East 8:00 a.m. Noon, Room S101a Monday, March 26 Cardiovascular Clinical Research and Practice in China 8:00 a.m. 9:30 a.m., Room N229 Joint Session with the European Society of Cardiology Management of Heart Disease in Pregnancy 8:00 a.m. 9:30 a.m., Room N426 18 international lunchtime symposia, jointly sponsored with cardiology societies from across the globe Monday, March 26 from 12:15 p.m. 1:45 p.m. refer to the full listing on page 83 Joint Symposium of the Italian Federation of Cardiology and the Pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial Fibrillation 2:00 p.m. 3:30 p.m., Room N230 Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of Cardiology 3:45 p.m. 5:15 p.m., Room N230 Mediterranean Diet and Its Protective Effect on Cardiovascular Disease 3:45 p.m. 5:15 p.m., Room S405 Tuesday, March 27 Joint Session with the European Society of Cardiology Pros and Cons of New Approaches for Antiplatelet and Anticoagulant Therapy 8:00 a.m. 9:30 a.m., Room N426

Heart Songs Learning Lab

Listen to heart sounds on your mobile device to improve your cardiac auscultation skills Vista Room Lobby, Saturday, March 24 Monday, March 26, 9:00 a.m. 5:00 p.m.

ACC.12 Specialty Sessions

Educating the Educators A bootcamp for Cardiology Fellowship Program Directors and Coordinators Saturday, March 24, Room S405a refer to the full listing on page 100. Pharmacology Program A full-day of programming Saturday, March 24, Room N427 Master Clinician Sessions Discuss complex real-world cases Sunday, March 25, Room S401a refer to the full listing on page 96 Congenital Cardiology Solutions Sessions spanning all four days focused on patient care across the continuum of CHD including cutting-edge live cases refer to the full listing on page 92 The FIT Forum Sessions spanning three days and packed with tips on launching and maintaining a successful career, plus, a special Mix n Mingle just for FITs with top ACC leaders refer to the full listing on page 100

ACC.12 Final Program

67

Road Map ACC.12

ACC-i2 with TCT Fellows Bootcamp A full-day of programming focusing on interventional treatment of coronary and structural heart disease Monday, March 26, Room S103b refer to the full listing on page 88

Networking Opportunities
Friday, March 23 CVT Section Meeting: 6:30 p.m., Hilton Chicago, Waldorf Room Sports & Exercise Cardiology Section Meeting: 7:00 p.m., Hilton Chicago, Marquette Room

Clinical Focus Sessions

Certified evening sessions held at the Fairmont Hotel (unless otherwise indicated) will address additional gaps in knowledge limited seating available. Saturday, March 24, 6:30 p.m. 9:30 p.m. First Line of Defense: Risk Factors & Prevention in the Cardiology Practice Championing Care for Patients with Aortic Stenosis: The Role of Cardiologists and Primary Care from Recognition to Recovery Sunday, March 25, 6:30 p.m. 9:30 p.m. Innovations in Translation: Atrial Fibrillation Innovations in Translation: ACS Monday, March 26, 5:45 p.m. 9:05 p.m. Multidisciplinary Approach to the High Risk Aortic Stenosis Patient Convention Center, Room S401a

CVT Section Reception: 8:00 p.m., Hilton Chicago, Williford C Saturday, March 24 Practice Administrators Work Group Meeting: 7:00 a.m., Hyatt McCormick Place, Field Room A Geriatric Cardiology Section Meeting: 6:00 p.m., Hilton Chicago, Marquette Room ACPC Section Meeting: 6:30 p.m., Hilton Chicago, Continental A/B Geriatric Cardiology Reception: 7:00 p.m., Hilton Chicago Joliet Sunday, March 25 WIC Section Meeting: 6:00 p.m., Hilton Chicago, Williford A Imaging Section Meeting: 6:00 p.m., Hyatt McCormick Place, CC 24 A/B/C Interventional Section Meeting: 6:00 p.m., Hyatt McCormick Place, CC 23 Academic Section Meeting: 6:00 p.m., Hyatt McCormick Place, Regency A WIC Reception: 7:00 p.m., Hilton Chicago Astoria Monday, March 26 Early Career Section Meeting: 6:30 a.m., Hyatt McCormick Place, CC 12 A/B 61st Annual Convocation: 6:30 p.m., Hall B, ACC.12 Main Tent Room ACC.12 Presidents, All Chapter, New Fellows and Associates Reception: Immediately following Convocation

68

GO for ACC.12!

ACC.12 Road Map

ACC.12 Expo and Learning Destinations

Gain an understanding of the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care. Learn more on page 52. Expand upon your education in new and creative ways in the ACC.12 Learning Destinations diverse, non-accredited, educationally focused areas that offer new and creative venues for learning. Learn more on page 57.

iScience, ACC.12 Meeting on Demand

Cant make it to all the sessions you want to attend? Purchase iScience, a comprehensive digital library of presentations from ACC.12 Stop by Grand Concourse Lobby, Level 3 or ACC Central, Booth #10027, and save $1,000 or more!

ACC.12 Final Program

69

ACC.12

Schedule-At-A-Glance
As of 1/3/2012 subject to change

Attendees will be arriving on Friday, March 23, to attend ACC.12, which opens on Saturday, March 24, at 8 a.m.

8 a.m.

9 a.m.

10 a.m.

11 a.m.

12 p.m.

1 p.m.
Expo Open

2 p.m.

Saturday March 24
ACC.12 Opening Showcase & Late-Breakers Scienti c Sessions Oral Abstracts Maintenance of Certi cation (MOC) Study Sessions

Expo Coffee Break

Expo Mid-Day Break

Lunchtime Sessions

Scienti c Sessions

Maintenance of Certi cation (MOC) Study Sessions Poster Sessions Poster Presentations Expo Open

Poster Presentations

Sunday March 25
Scienti c Sessions Oral Abstracts

Expo Coffee Break Scienti c Sessions Oral Abstracts

Expo Mid-Day Break

Lunchtime Sessions

Scienti c Sessions

Maintenance of Certi cation (MOC) Study Sessions

Maintenance of Certi cation (MOC) Study Sessions Poster Sessions

Poster Presentations

Poster Presentations Expo Open

Monday March 26
Scienti c Sessions

Expo Coffee Break Scienti c Sessions

Expo Mid-Day Break Lunch Hospitality Event Joint International Lunchtime Sessions Maintenance of Certi cation (MOC) Study Sessions Poster Sessions Scienti c Sessions

Poster Presentations

Poster Presentations

Tuesday March 27
70 GO for ACC.12!

Scienti c Sessions

ACC.12 Closing Session: Innovators in Cardiology

3 p.m.

4 p.m.

5 p.m.

6 p.m.

7 p.m.

8 p.m.

9 p.m.

10 p.m.

Expo Coffee Break Scienti c Sessions Maintenance of Certi cation (MOC) Study Sessions ACC Clinical Focus Session

Expo Coffee Break Scienti c Sessions Maintenance of Certi cation (MOC) Study Sessions ACC Clinical Focus Session

Scienti c Sessions Maintenance of Certi cation (MOC) Study Sessions Convocation

ACC Clinical Focus Session Reception

ACC.12 Final Program

71

ACC.12 Program-At-A-Glance

Daily Schedule
Sessions are listed alphabetically by learning pathway based on time block. The ACC.12 Online icon indicates sessions are available as live or on-demand webcasts. Please refer to page 65 for additional information on accessing these free sessions.

Friday, March 23 & Saturday, March 24, 2012

iScience icon indicates sessions are included as part of iScience 2012: ACC.12 Meeting on Demand

Friday, March 23, 2012

PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

Morning Sessions
LIFELONG SPECIAL MOC Symposium 801 746 ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC Self Assessment Session: Update in Clinically Relevant Guidelines and Trials 4th Annual Cardiovascular Conference: Focus on the Middle East 7:30 a.m. 8:00 a.m. 10:00 a.m. Noon S105a S101a 105 105

Mid-day Sessions
SPECIAL Legends 400 Legends of Cardiovascular Medicine Roundtable Forum and Reception (By Invitation Only) 1:30 p.m. 5:30 p.m. S100c 106

Saturday, March 24, 2012

PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

8:00 a.m. 9:30 a.m. (exceptions noted in bold)

ACC-i2/TCT ACS ACS ACS ARR CCS CCS HF HF HF HF IMAG IMAG IMAG ISCHEM LIFELONG PRACTICE QUAL QUAL SPECIAL TEST Symposium Experts Oral Oral Experts Symposium MOC Experts Symposium Oral Oral Experts Oral Oral Oral MOC Symposium Experts Symposium Special Symposium 2644 200 902 903 201 202 802 203 732 905 906 204 908 909 910 802 600 205 601 300 602 Interventional Featured Clinical Studies I Contemporary Management of UA/NSTEMI P2Y12 Antagonists: Unraveling the Mechanisms and Optimizing Benefit-Risk New Therapeutic Options in ACS: From Antiplatelets to Antibiotics How to Manage a Device/Lead Advisory Complex Issues Facing ACHD Patients: Obstructive Lesions ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment The Latest in Heart Failure with Preserved Ejection Fraction Pharmacology Program: Pharmacotherapy of Chronic Heart Failure Predicting Outcomes in Heart Failure: Biomarkers and Beyond Pathogenic and Therapeutic Insights from Experimental Heart Failure Models Multimodality Imaging in Evaluation of Prosthetic Valve Function A Better Understanding of Ischemia and Function: Insights from Cardiac MRI New Imaging Approaches to Atherosclerosis and the Microcirculation Sex, Scoring, Sadness, Statins, Stents and Surgery ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment Cardiology Procedures 2012: How to Code and Get Reimbursed Am I Placing Inappropriate ICDs and Stents?: Recent Registry Surprises Patient-Centered Care: The New Imperative ACC.12 Opening Showcase and Late-Breaking Clinical Trials: Featuring the Legends of Cardiovascular Medicine Lecture Series Simon Dack Lecture Translational Research Symposium with the International Society for Cardiovascular Translational Research: New Breakthroughs in Cardiovascular Genomics Approaching the Clinic Challenging Sports Cardiology Cases in Younger Athletes 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:00 a.m. 9:30 a.m. S102b S504a S406b S402 S503 S105a S105d S502 N427 S405 S404 S505 S403 N426 N227b S105d N231 S501a N226 Hall B, ACC.12 Main Tent N228 107 107 107 108 108 108 109 109 109 109 109 110 110 110 111 111 112 112 112 112 113

TEST

Symposium

603

8:00 a.m.

9:30 a.m.

N230

113

72

GO for ACC.12!

ACC.12 Daily Schedule Saturday, March 24, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

8:00 a.m. 9:30 a.m. (continued exceptions noted in bold)

VALV VASC SelfDirected Oral 1501 931 Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience New Insights in Peripheral Vascular Disease 9:00 a.m. 8:00 a.m. 5:00 p.m. 9:30 a.m. Vista Room Lobby N229 113 113

9:30 a.m. 10:30 a.m. (exceptions noted in bold)

ACC-i2/TCT IMAG VASC Poster Poster Poster Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. Hall A Hall A Hall A

10:30 a.m. Noon (exceptions noted in bold)

ACC-i2/TCT CCS IMAG PREV VASC Poster Oral Poster Symposium Poster 733 901 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. From Targeting Errors to UNOS: How Quality and Databases Can Impact Clinical Care Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Pharmacology Program: Cardiovascular Implications of Dietary Supplements Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 11:00 a.m. 10:30 a.m. 11:00 a.m. 10:30 a.m. 11:00 a.m. Noon Noon Noon Noon Noon Hall A S105a Hall A N427 Hall A 114 114

12:15 p.m. 1:45 p.m (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR HF IMAG IMAG ISCHEM ISCHEM LIFELONG LIFELONG LIFELONG PRACTICE PRACTICE PREV QUAL QUAL SPECIAL SPECIAL Experts Experts Experts Symposium Symposium Symposium Experts Experts Experts Symposium Symposium Symposium Symposium MOC MOC Symposium Symposium Symposium Experts Symposium Special Special 2301 2302 2303 2606 2607 604 206 207 208 605 606 734 607 803 804 608 609 611 209 610 103 104 Atypical Thrombotic ACS Case Reviews Chronic Total Occlusions and Left Main Case Reviews Coronary Imaging Case Reviews TAVR: Procedural Aspects and Best Practices Acute Venous Thromboembolic Disease Controversies in ACS Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation: How to Decide? Atrial Fibrillation and Heart Failure: A Dynamic Duo Imaging Patients with Pericardial Disease Cardiovascular Magnetic Resonance in Myocarditis Revascularization in SIHD: Integrating New Evidence Pharmacology Program: Pharmacologic Considerations in the Setting of PCI Everything You Wanted to Know about ABIM Recertification (and more...) ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2010 Update (A1-K) ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2011 Update (A1-L) Women in Cardiology The Challenges in Daily Practice Is There a Role for HDL Therapy: Are We AIMing Too HIGH? Getting Access to Data: Successful Examples from the NCDR Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational Research Educating the Educators: Bootcamp for Cardiology Fellowship Program Directors and Coordinators Fit Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 1: Finding the Right Job 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:30 p.m. 12:30 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 3:00 p.m. 3:00 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. S101a S102b S103b S102b S103c S404 S503 S502 S505 S402 S401a N427 N226 S105a S105d N229 N230 S100c S501a N228 S405a N227b 114 114 115 115 115 115 116 116 116 116 116 116 116 118 118 116 117 117 117 117 117 117

ACC.12 Final Program

73

Saturday, March 24, 2012 Daily Schedule ACC.12

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

12:15 p.m. 1:45 p.m (continued exceptions noted in bold)

VALV VALV Experts Symposium 210 612 Organic Mitral Regurgitation Case-Management The Spectrum of Degenerative Mitral Valve: From Imaging to Treatment 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:45 p.m. S504a N426 118 118

2:00 p.m. 3:30 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ACS ACS ARR ARR ARR ARR CCS HF HF IMAG IMAG ISCHEM LIFELONG LIFELONG PRACTICE PREV QUAL SPECIAL SPECIAL SPECIAL Live/Taped Cases Oral Symposium Symposium Symposium Symposium Experts Symposium Symposium Experts Symposium Symposium Symposium Symposium Experts Symposium Experts Symposium Symposium Core Core Symposium Symposium Experts Special Special Legends 2201 2502 2608 2609 2610 2645 211 613 618 212 614 615 735 616 213 617 214 619 620 805 806 621 622 215 106 107 401 Live and Taped Case Session I: Multivessel PCI Physiology and Imaging Acute Myocardial Infarction Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early Thrombosis Hemodynamics and Angiography I: Basic Issues Renal Interventions for Hypertension and Renal Function Preservation Interventional Featured Clinical Studies II Optimal STEMI Management from Presentation to Post-Discharge Care State-of-the-Art in STEMI Care Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular Therapies Management of Difficult AF: When to Change Drugs, When to Give Up Can Remote Disease Management Improve Clinical Outcomes? Challenges in the Management of Supraventricular Tachycardia Pharmacology Program: Pharmacotherapy of New Antithrombotics Quality, Safety and Resources Enhancing Pediatric Cardiovascular Care From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support Devices Cardiorenal Syndrome in Heart Failure: From Definition to Management Current Topics in Cardiac CT Multimodality Imaging of Hypertrophic Cardiomyopathy Stable Ischemic Heart Disease in Women: Are They Really from Venus? Core Curriculum: Congenital Heart Disease Core Curriculum: Congestive Heart Failure ACC/MedAxiom/ACCA: Physician/Hospital Integration 101 Emerging Trends in Atherosclerosis When Should a Medicine or Device Stop Being Used in Practice? Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and Coordinators FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 2 Launching a Successful Career Legends of Cardiovascular Medicine Lecture Series 43rd Annual Louis F. Bishop Lecture 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 5:00 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:15 p.m. 3:00 p.m. Hall B, ACC.12 Main Tent S103b S101a S102b S103c S102c S504a S404 N228 S503 S406a S403 N427 N231 S502 S406b S505 S402 S401a N226 N229 N230 S100c S501a S405a N227b N426 119 119 119 120 120 120 121 121 121 121 121 121 122 122 122 122 122 122 123 123 123 123 123 123 123 124 124

3:30 p.m. 6:00 p.m. (exceptions noted in bold)

LIFELONG LIFELONG SPECIAL MOC MOC Special 807 808 107A ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2011 Update (A1-L) ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2010 Update (A1-K) FIT Forum I: Mix n Mingle 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 4:30 p.m. S105a S105d Hall A, Bistro ACC 124 124 125

74

GO for ACC.12!

ACC.12 Daily Schedule Saturday, March 24, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

4:30 p.m. 6:00 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR ARR ARR ARR Experts Experts Symposium Symposium Symposium Symposium Experts Symposium Symposium Symposium 2305 2306 2611 2612 2613 623 216 624 627 736 Vascular Access Challenges and Complications Case Reviews Unusual Cases of ACS Case Reviews Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up II: Very Late Stent Thrombosis and Late Catch-up Hemodynamics II (HOCM) Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease: In Collaboration with the Society of Vascular Surgery Adjunctive Pharmacology in ACS: Anticoagulants and Antiplatelet Agents The Risk versus Benefit of DFT Testing Management of Complications of Pacemakers and Leads Translational Research Symposium with the International Society for Cardiovascular Translational Research: Tissue Engineering Pharmacology Program: Pharmacologic Considerations with Antiarrhythmic Drugs, and Dyslipidemia and Residual Risk: When and How Do You Add to Statin Therapy? Updates on Care in the Congenital Heart Disease Patients Heart Failure Disease Management: Issues for 2012 Management of Acute Decompensated Heart Failure: From Hemodynamic Subsets to Appropriate Treatment Strategies Myocardial Perfusion Imaging: Picking the Right Test Multi-Modality Imaging: Chest Pain in the Emergency Department Stable Ischemic Heart Disease: Whats New in the Guidelines (And What Should Be)? Core Curriculum: Echocardiography Core Curriculum: Cardiac Electrophysiology Information Technology, Medicine and the Future Hypertension Guidelines 2012 Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE Registry Educating the Educators: Symposium for Cardiology Fellowship Program Directors and Coordinators FIT Forum II: Jeopardy Ischemic Mitral Regurgitation Valve Repair: How to Achieve Success Translational Research Symposium with the International Society for Cardiovascular Translational Research: Devices Carotid Artery Disease: Is the Picture Clarifying? 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 5:30 p.m. 6:00 p.m. S102c S103b S101a S102b S103c S404 S503 S403 N228 N427 125 125 125 125 126 126 126 126 127 125

CCS HF HF IMAG IMAG ISCHEM LIFELONG LIFELONG PRACTICE PREV QUAL SPECIAL SPECIAL VALV VALV VALV VASC

Symposium Experts Symposium Experts Symposium Symposium Core Core Symposium Symposium Experts Special Special Experts Symposium Symposium Symposium

625 217 626 218 628 629 809 810 630 631 219 109 110 220 632 633 743

4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 5:30 p.m. 4:30 p.m.

6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:50 p.m. 6:00 p.m.

N231 S502 S406b S505 S402 S401a N226 N229 N230 S100c S501a S405a N227b S504a N426 N228 S406a

127 127 127 127 127 128 128 128 128 128 128 128 129 129 129 129 129

6:30 p.m. 9:30 p.m. (exceptions noted in bold)

ARR Symposium 1601 Critical Links in Atrial Fibrillation: Priorities in Risk Assessment, Treatment and Patient Education First Line of Defense: Risk Factors and Prevention in the Cardiology Practice A Master Class for the Community Cardiologist 6:30 p.m. 9:00 p.m. Fairmont Hotel, 129 International Ballroom Fairmont Hotel, 130 Gold Room Fairmont Hotel, 130 Imperial Ballroom

PREV VALV

Clinical Focus Clinical Focus

1602 1604

6:30 p.m.

9:30 p.m. 9:30 p.m.

Championing Care for the Patient with Aortic Stenosis: The Role of Cardiologists and Primary 6:30 p.m. Care from Recognition to Recovery

ACC.12 Final Program

75

ACC.12 Program-At-A-Glance

Daily Schedule
Sessions are listed alphabetically by learning pathway based on time block.
PATHWAY SESSION TYPE SESS. # TITLE

Sunday, March 25, 2012

The ACC.12 Online icon indicates sessions are available as live or on-demand webcasts. Please refer to page 65 for additional information on accessing these free sessions. iScience icon indicates sessions are included as part of iScience 2012: ACC.12 Meeting on Demand

START

END

ROOM

PAGE

8:00 a.m. 9:30 a.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ACS ARR ARR Oral Oral Oral Oral Oral Oral Symposium Experts Oral Experts Oral 2500 2501 2504 2505 2508 2510 2614 221 916 222 904 Outcomes in Patients Treated with TAVR Adjunct Pharmacology PCI in Complex Lesions PCI in Complex Patients Intravascular Diagnostics Vascular Access Abnormalities of the Atrium Complications of AMI 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. N227b S101a S103c S102c S106b S103b S102b S504a S401a S503 N426 137 137 138 138 139 139 140 140 140 141 141

What Impacts Outcomes in ACS? From Genes to Plaque Morphology to Environment Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Genetic Syndromes for the Clinician (HCM, Brugada, Long QT) Joint Oral Arrhythmias Session of the Heart Rhythm Society and the American College of Cardiology: Management of the Patient with Atrial Fibrillation Anticoagulation and Prevention of Stroke Preoperative Assessment of Patients on the Single Ventricle Pathway: Special Problems Creative Solutions Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Pharmacological Treatment of Systolic and Diastolic Heart Failure Cardiac PET: Incorporation into Daily Practice Joint Oral Session of the American Society of Echocardiography and the American College of Cardiology: Newest Applications of Echo to Clinical Practice CCA Team-Based Maintenance of Certification Whats New in Pulmonary Hypertension Prevention: Focus on Lipids Tools to Improve Care Transition: The Hospital to Home (H2H) Experience Insights and Innovations to Improve Cardiac Risk Late-Breaking Clinical Trials II

CCS HF

Symposium Symposium

634 635

8:00 a.m. 8:00 a.m.

9:30 a.m. 9:30 a.m.

N231 S406b

141 141

IMAG IMAG LIFELONG PHTN PREV QUAL QUAL SPECIAL SPECIAL TEST VALV VALV

Experts Oral Symposium Oral Oral Experts Oral Special Special Oral Oral SelfDirected

223 907 731 912 911 224 913 304 405 914 915 1502

8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:00 a.m.

9:30 a.m. 9:30 a.m. 10:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 5:00 p.m.

S505 S406a S105d N226 S100c S501a N229 Hall B, ACC.12 Main Tent S105a S402 N427 Vista Room Lobby

142 142 142 142 142 143 143 143 144 144 145 145

Young Investigators Award Competition: ACCF/Herman K. Gold Young Investigators Award in Molecular and Cellular Cardiology Diagnostic Testing: Sports Cardiology Valvular Oral Abstracts Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience

9:30 a.m. 10:30 a.m. (exceptions noted in bold)

ACS CCS PERI PHTN Poster Poster Poster Poster Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. Hall A Hall A Hall A Hall A

76

GO for ACC.12!

ACC.12 Daily Schedule Sunday, March 25, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

9:30 a.m. 10:30 a.m. (continued exceptions noted in bold)

PREV TEST VALV Poster Poster Poster Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. Hall A Hall A Hall A

10:45 a.m. 12:15 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ACS ARR ARR CCS CCS CCS HF HF HF IMAG Oral Oral Oral Oral Oral Symposium Oral Poster Oral Oral Symposium Oral Poster Experts Oral Oral Symposium 225 921 922 638 918 919 637 920 2503 2506 2507 2509 2511 2615 917 Bioresorbable Vascular Scaffolds Drug-eluting Stents Imaging in TAVR Prevention and Treatement of Restenosis Outcomes in Patients Treated with PCI Congenital/Pediatric Improving Outcomes in ACS. Insights from Basic Science and Preclinical Research. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Cardiac MRI for the Treatment and Evaluation of Arrhythmias Joint Oral Session of the Heart Rhythm Society and the American College of Cardiology: Cardiac Arrest and the Care of the ICD Patient Post-Operative Glenns and Fontans: Navigating Turbulent Waters Adults with Congenital Heart Disease: Imaging Predictors, Evolving Therapies and Outcomes Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Heart Failure Care for the Very Old: What Are the Key Issues for Success? Joint Oral Session of the Heart Failure Society of America and the American College of Cardiology: Individualizing Pharmacological Therapy in Heart Failure Improving Patient Selection for Device-Based Therapies Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Cardiomyopathy A Comprehensive Echocardiographic Approach Cardiac CT: Toward a Better Understanding of CAD Who Said Theres Nothing New? All That Glitters in Myocardial and Pericardial Disease Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 226 227 926 927 ACC/MedAxiom/ACCA: Physician/Hospital Integration: Making It Work Update on the ATP IV Guidelines Prevention: Renal Sympathetic Denervation A Novel Therapy for Hypertension? Prevention: Cardiovascular Risk Assessment and Rehabilitation Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 650 928 406 929 U.S. Health System Reform: Whats Missing? Improving PCI Outcomes Young Investigators Award Competition: Physiology, Pharmacology, and Pathology Diagnostic Testing: ECG and Cardiopulmonary Exercise Testing Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 930 Valvular Oral Abstracts 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. Noon 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. Noon 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. S106b S101a S102c S103c S103b S102b N227b Hall A S404 N426 N231 S402 Hall A S502 S406b S405 S406a 150 150 150 151 148 149 149 149 145 146 146 147 147 148 148

IMAG ISCHEM PERI PERI PHTN PRACTICE PREV PREV PREV PREV QUAL QUAL SPECIAL TEST TEST VALV

Oral Oral Oral Poster Poster Experts Experts Oral Oral Poster Symposium Oral Special Oral Poster Oral

924 923 925

10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 11:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 10:45 a.m.

12:15 p.m. 12:15 p.m. 12:15 p.m. Noon Noon 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. Noon 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. Noon 12:15 p.m.

S403 N230 N226 Hall A Hall A S505 S501a N228 S401a Hall A S100c N229 S105a S503 Hall A N427

151 151 152

152 152 153 153

153 153 154 154

155

ACC.12 Final Program

77

Sunday, March 25, 2012 Daily Schedule ACC.12

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

10:45 a.m. 12:15 p.m. (continued exceptions noted in bold)

VALV VASC Poster Oral 932 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. New Insights in Perpheral Vascular Disease and Year in Review 11:00 a.m. 10:45 a.m. Noon 12:15 p.m. Hall A S504a 155

12:30 p.m. 1:45 p.m. (exceptions noted in bold)

ACC-i2/TCT Symposium 646 Interventional Cardiovascular Medicine in 2012: An Update for the Non-Interventionalist and the Douglas P. Zipes, M.D., Distinguished Young Scientist Awardee Lecture Cardiac Care Team Session I: Keynote Address Cardiac Care Team Session II: Cath Lab of Tomorrow Pathway to a High-risk Aortic Valve Program Aortic Valve Case Reviews Coronary Complications Case Reviews Multivessel and Hemodynamic Support Case Reviews Endovascular Intervention for Venous Disease Platelet Inhibition in 2012: What You Need To Know The Future of ACS Clinical Trials Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Investigation and Management of Syncope Career & Mentoring Session for Pediatric and Congenital Cardiologists Cardiac MR for the Evaluation of the Heart Failure Patient Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Issues in the Diagnosis and Treatment of Chronic Ambulatory Heart Failure Cardiotoxicity of Cancer Chemotherapy: Molecular Basis and Strategies for Early Detection and Prevention Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Interventional Echocardiography Evolving Role in Patient Management Cost-Effective Imaging in Patients with Chronic CAD Managing High-risk Patients with Stable Ischemic Heart Disease ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part A ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part B Grasping the Complexity of Myocardial and Pericardial Diseases The New Hypertrophic Cardiomyopathy Practice Guidelines Emerging Approaches to Pulmonary Hypertension with Left Ventricular Dysfunction Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part I: Making the Electronic Health Record Meaningful and Useful A Washington Perspective Management of Hypertension in the Elderly FIT Forum III: How to Write and Evaluate Medical Journal Articles Role of Exercise Treadmill Testing in 2012 Controversies in Valve Disease I 12:15 p.m. 1:45 p.m. N228 155

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR CCS HF HF

Special Special Experts Experts Experts Symposium Symposium Symposium Symposium Special Experts Symposium

2101 2102 2308 2309 2310 2616 2617 639 640 301 228 641

12:30 p.m. 1:00 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m.

1:00 p.m. 2:30 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m.

S103b S103b S101a S102b S102c S103c S106b S404 N426 N231 S502 S406b

156 160 156 156 156 156 156 156 157 157 157 157

HF IMAG

Symposium Symposium

642 643

12:30 p.m. 12:30 p.m.

1:45 p.m. 1:45 p.m.

S405 S406a

157 158

IMAG ISCHEM LIFELONG LIFELONG PERI PERI PHTN PRACTICE

Symposium Symposium MOC MOC Experts Symposium Symposium Symposium

644 645 811 812 229 648 649 647

12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m.

1:45 p.m. 1:45 p.m. 3:00 p.m. 3:00 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m.

S403 S401a S105a S105d S505 N226 S402 N227b

158 158 158 158 159 159 159 159

PREV SPECIAL TEST VALV

Experts Special Symposium Symposium

230 111 651 652

12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m.

1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m.

S501a N229 N230 N427

159 159 160 160

78

GO for ACC.12!

ACC.12 Daily Schedule Sunday, March 25, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

2:00 p.m. 3:30 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ACS ARR ARR CCS HF Special Live/Taped Cases Symposium Symposium Symposium Symposium Special Experts Symposium Experts Symposium Legends Symposium 2131 2202 2618 2619 2620 2621 2103 231 653 232 654 402 655 2:00 p.m. Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist I: Mitral and Aortic Valve (with Remote Demonstrations from the Seattle Science Foundation) Live and Taped Case Session II: Left Main and Birfucation Complex PCI Imaging Transcatheter Aortic Valve Procedures I: Intra- and Post-Procedural Imaging Emerging Technologies Peripheral Artery Disease: Superficial Femoral Artery Chronic Total Occlusions Cardiac Care Team Session III: Medications and Other Techniques to Manage the Patient in the Cath Lab Management of Chest Pain in the Emergency Department State-of-the-Art in Non ST Elevation Acute Coronary Syndromes Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Optimizing the Management of the Patient with Implantable Devices Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Atrial Fibrillation Prevention of Stroke 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:30 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 3:30 p.m. 5:00 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. S102c Hall B, ACC.12 Main Tent S101a S102b S103c S106b S103b S504a S404 S503 N426 N228 S406b 160 161 161 161 161 162 165 162 162 162 162 162 163

Legends in Cardiovascular Medicine Lecture Series 2012 Dan G. McNamara Lecture Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: The Growing Role of Devices in Heart Failure Management ICD, CRT, Hemodynamic Monitoring and Ultrafiltration The NHLBI Heart Failure Clinical Trials Network: A New Paradigm for Investigation and Training Role of CMR in Valvular Heart Disease Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Healthcare Reform Impact on Imaging Radionuclide Imaging in the Heart Failure Patient Heart Failure In Stable Ischemic Heart Disease: Not for the Weak of Heart Master Clinician I: Discussion of Three Complex Real World Cases Core Curriculum: General Cardiology Core Curriculum: Valvular Heart Disease Controversies in Hypertrophic Cardiomyopathy Pulmonary Hypertension Management in Special Populations Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part II: EHR Implementation Lessons from the Trenches Dietary Approaches for CVD Prevention: Matching the Diet to the Patient Resistant Hypertension

HF IMAG IMAG IMAG ISCHEM LIFELONG LIFELONG LIFELONG PERI PHTN PRACTICE

Symposium Experts Symposium Symposium Experts Symposium Core Core Symposium Symposium Symposium

656 233 657 658 234 659 813 814 661 662 660

2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m.

3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m.

S405 S505 S406a S403 S502 S401a N226 N229 N427 S402 N227b

163 163 163 163 163 163 164 164 164 164 164

PREV PREV QUAL SPECIAL

Experts Symposium Symposium Special

235 663 664 302

2:00 p.m. 2:00 p.m. 2:00 p.m. 3:00 p.m.

3:30 p.m. 3:30 p.m. 3:30 p.m. 3:15 p.m.

S501a S100c N230 ACC Member Lounge

164 165 165 165

Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology: Ethnic and Racial Disparities in Cardiovascular Disease A Call to Action Business Meeting of the College

4:30 p.m. 6:00 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS Special Special Experts Symposium Symposium Symposium Symposium 2104 2105 2311 2622 2623 2624 665 Cardiac Care Team Session IV: Same Day Discharge for PCI Cardiac Care Team V: Structural Heart Disease Mitral Valve Endovascular Case Reviews Imaging Transcatheter Mitral Valve Procedures Peripheral Artery Disease: Critical Limb Ischemia Vascular Access and Outcomes following PCI for ACS: What You Should Know Literature Interpretation and Statistical Pitfalls in ACS Trials 3:30 p.m. 5:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 5:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S103b S103b S102b S101a S103c S106b S402 165 171 166 166 166 167 167

ACC.12 Final Program

79

Sunday, March 25, 2012 Daily Schedule ACC.12

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

4:30 p.m. 6:00 p.m. (continued exceptions noted in bold)

ARR CCS CCS HF HF HF IMAG LIFELONG LIFELONG LIFELONG LIFELONG LIFELONG PERI PRACTICE PREV PREV PREV SPECIAL SPECIAL SPECIAL SPECIAL TEST VALV Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium MOC MOC Core Core Experts Symposium Experts Symposium Symposium Experts Legends Symposium Symposium Experts Experts 666 667 668 669 670 671 672 737 815 816 817 818 236 673 237 675 730 263 403 744a 744b 261 238 Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Atrial Fibrillation Management of the Arrhythmia The Great Debates ACHD for the General Cardiologist Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Management of Advanced Heart Failure and Transplantation Heart Transplantation: Challenges in 2012 Personalized Medicine and the Future of Medical Care Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Echo in 2012 What You Need to Know to Keep Up Master Clinician: Clinical Cases II ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part B ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part A Core Curriculum: Coronary Artery Disease Core Curriculum: Nuclear Cardiology Genetic Evaluation of Cardiomyopathy Future Compensation Under Health Care Reform Reducing Disparities in Cardiovascular Preventive Care Whats New in the ACCF/AHA Guidelines The Difficult-to-Manage Lipid Patient The Role of Therapeutic Hypothermia in the Treatment of Cardiac Arrest Legends of Cardiovascular Medicine Lecture Series 3rd Annual James T. Dove Lecture Clinical Decision-Making for Fellows in Training: Part A Clinical Decision-Making for Fellows in Training: Part B Cardiac Dilemmas in Athletes Aortic Stenosis Case Management 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 3:30 p.m. 3:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 5:30 p.m. 5:50 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. N426 N231 N230 S406b S405 S404 S406a S401a S105a S105d N226 N229 S505 N227b S501a N228 S100c S502 N427 S403 S403 S503 S504a 167 167 168 168 168 168 168 169 165 166 169 169 169 169 169 169 170 170 170 170 170 171 171

6:30 p.m. 9:30 p.m. (exceptions noted in bold)

ACS Clinical Focus 1605 Innovations in Translation: ACS 6:30 p.m. 9:30 p.m. Fairmont Hotel, Imperial Ballroom Fairmont Hotel, International Ballroom 171

ARR

Clinical Focus

1603

Joint Session of the Heart Rhythm Society of America and the American College of Cardiology Innovations in Translation: Atrial Fibrillation

6:30 p.m.

9:30 p.m.

172

80

GO for ACC.12!

ACC.12 Program-At-A-Glance

Daily Schedule
Sessions are listed alphabetically by learning pathway based on time block.

Monday, March 26, 2012

The ACC.12 Online icon indicates sessions are available as live or on-demand webcasts. Please refer to page 65 for additional information on accessing these free sessions. iScience icon indicates sessions are included as part of iScience 2012: ACC.12 Meeting on Demand

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

8:00 a.m. 9:30 a.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR ARR CCS CCS HF HF HF IMAG IMAG IMAG LIFELONG PRACTICE PREV PREV QUAL SPECIAL SPECIAL SPECIAL TEST VALV VALV VALV Special Special Symposium Symposium Symposium Symposium Symposium Experts Symposium Symposium Symposium Experts Symposium Symposium Experts Symposium Symposium Boot Camp Symposium Symposium Symposium Symposium Special Special Symposium Symposium Experts Symposium Self-Directed 2111 2121 2625 2626 2627 2628 676 239 677 678 679 240 680 681 241 682 683 112 684 685 686 687 305 407 738 688 242 674 1503 Fellows Bootcamp: Coronary I Multi-Disciplinary Management of the Failing Heart: Team Based Evaluation and Therapy of Advanced Heart Disease I Left Main Disease: Role of Imaging for Assessment, Treatment and Follow-Up TAVR Complications: Incidence, Management and Avoidance Management of Renovascular Hypertension Left Main Coronary Intervention: State-of-the-Art Shock in ACS Case-Oriented Gaps in the Guidelines: Who Should Get an ICD? Clinical Management of the AF Patient: Treating the Patient and the Health Care Provider Pulmonary Artery Stenosis Current Therapy and Future Directions: Live Case Women with Congenital Heart Disease: Fertility, Pregnancy and Menopause Myocarditis: When to Biopsy, Who to Treat, Which Therapy? Controversies in the Management of Heart Failure Surgical Therapy of Heart Failure Imaging the Right Ventricle Advanced LV Dysfunction: A Multimodality Approach Future Directions for Cardiac CT CCA Research Bootcamp Session I: Methods for Engaging in Research ACC/MedAxiom/ACCA: Cardiovascular Service Lines ACC China Chapter Session: Cardiovascular Clinical Research and Practice in China Global CVD Prevention: Heart Disease and Risk Factors in Specific Populations Where Will Cardiology Be in 2015? Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials Young Investigators Award Competition: Clinical Investigations, Congenital Heart Disease and Cardiovascular Surgery Joint Session of the European Society of Cardiology and the American College of Cardiology I: Management of Heart Disease in Pregnancy Challenging Sports Cardiology Cases in Older Athletes Tricuspid Valve Disease Case Management Valvular Heart Disease in the Older Adult (with Many DRG Codes): Navigating the Options Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 5:00 p.m. S103b S102c S101a S102b S103c S106b S401a S504a N226 N231 S501a S502 S406b S404 S505 S405 S403 S105d S105a N229 S100c N427 Hall B, ACC.12 Main Tent N230 N426 N227b S503 S402 Vista Room Lobby 177 177 177 177 177 178 178 178 178 178 179 179 179 179 179 179 180 180 180 180 180 180 181 181 181 182 182 182 182

ACC.12 Final Program

81

Monday, March 26, 2012 Daily Schedule ACC.12

PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

9:30 a.m. 10:30 a.m. (exceptions noted in bold)

ARR HF ISCHEM QUAL Poster Poster Poster Poster Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. Hall A Hall A Hall A Hall A

10:30 a.m. Noon (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR ARR ARR ARR CCS CCS HF HF HF IMAG IMAG ISCHEM PRACTICE PREV PREV PREV QUAL QUAL QUAL SPECIAL SPECIAL SPECIAL TEST VALV VASC Special Special Symposium Symposium Symposium Symposium Symposium Experts Symposium Symposium Poster Symposium Symposium Symposium Symposium Poster Symposium Symposium Poster Experts Experts Symposium Symposium Symposium Symposium Poster Special Special Symposium Experts Experts Experts 306 408 741 262 246 264 244 245 698 699 700 742 696 697 692 693 694 695 2112 2122 2629 2630 2631 2632 689 243 690 691 Fellows Bootcamp: Coronary II Multi-Disciplinary Management of the Failing Heart: Team-based Evaluation and Therapy of Advanced Heart Disease II Establishing a Cardiac Catheterization Imaging/Physiology Program Hemodynamics III (PVL and ASD Closure) All You Need to Know about Carotid Artery Stenting DES: Future Directions Improving STEMI Outcomes: Saving Myocardium and Attenuating Remodeling Perioperative Management of Patients with Cardiac Implantable Electronic Device Controversies in Device Therapy The Genetics of Sudden Cardiac Death: What Do We Know and How Best to Evaluate and Manage Such Patients Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Pulmonary Vein Stenosis: What Are Realistic Expectations? Challenging Imaging Issues in Congenital Heart Disease LVAD as Destination Therapy for Advanced Heart Failure Management of Peripartum Cardiomyopathy: Update 2012 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Cardiac CT in 2012: State-of-the-Art Role of Echo in the Evaluation and Management of Patients with Mitral Regurgitation Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Leadership and Governance Womens Cardiovascular Health Vitamins and Supplements in Cardiovascular Disease Prevention Joint Symposium of the Preventive Cardiovascular Nurses Association and the American College of Cardiology Lies, Damned Lies and Statistics: Pitfalls in Literature Interpretation The Future of Cardiovascular Diseases: Where Are We Going (and Where Do We Want to Go) Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Late-Breaking Clinical Trials IV Young Investigators Award Competition: Cardiovascular Health Outcomes and Population Genetics Integrative Medicine ECGs in Athletes: The Great ECG Screening Debate and Challenging Cases Complications of Interventions for Valvular Heart Disease Challenging Cases in Anticoagulation Management: Spotlight on the Novel Anticoagulants 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon Noon S103b S102c S101a S102b S103c S106b S401a S504a S406a N226 Hall A N229 N231 S406b S404 Hall A S405 S403 Hall A S503 S501a S100c S105d N427 N426 Hall A Hall B, ACC.12 Main Tent N230 N227b S502 S505 S105a 186 187 187 187 187 187 185 185 186 186 186 186 185 185 184 185 185 185 182 183 183 183 183 184 184 184 184 184

82

GO for ACC.12!

ACC.12 Daily Schedule Monday, March 26, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

12:15 p.m. 1:45 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACS ARR ARR CCS HF IMAG ISCHEM LIFELONG LIFELONG PREV PREV PREV QUAL QUAL SPECIAL VALV VASC Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch MOC Special Live/Taped Cases Experts Experts Experts Symposium Symposium Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch Intl. Lunch MOC MOC Intl. Lunch Intl. Lunch Symposium Intl. Lunch Intl. Lunch Special Intl. Lunch Intl. Lunch 502 503 505 511 518 819 2113 2203 2313 2314 2315 2633 2634 513 501 509 506 517 507 508 819 820 512 516 701 510 515 113 504 514 Joint Session of the Argentine Society of Cardiology and the American College of Cardiology: Carotids Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Drug-eluting Stents From the Early Beginning to New Stent Platforms Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Coronary Total Occlusions Joint Session of the Korean Society of Cardiology and the American College of Cardiology: Treating Complex Lesions Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: Devices ASDs, VSDs, Perivalvular Leaks ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2010 Update (B2-K) Fellows Bootcamp: Case Reviews Live and Taped Case Sesion III: Valvular Heart Disease Non-coronary Complications Case Reviews Structural Case Reviews Shock and Hemodynamic Support Case Reviews Controversies in Vascular and Endovascular Medicine Non-ST-Elevation ACS in 2012: What You Need To Know Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: Improving Outcomes Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Risk Stratification for Sudden Cardiac Death Joint Session of the Cardiological Society of India and the American College of Cardiology: AF Medical, EP, Surgical Options 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:30 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 2:45 p.m. 1:45 p.m. 2:30 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 2:45 p.m. 2:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. N226 N426 N228 N229 S505 S105a S103b Hall B, ACC.12 Main Tent S101a S102b S102c S103c S106b S404 S403 S401a N231 S501a S406b N427 S105a S105d S504a S502 S100c N230 N227b S402 S405 S503 188 188 188 188 189 189 194 194 189 189 189 189 190 190 190 190 191 191 191 191 192 192 192 192 193 193 193 193 193 194

Joint Session of the Egyptian Society of Cardiology and the American College 12:15 p.m. of Cardiology: Adult Congenital Heart Disease Where We Came From and Where We Are Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Heart Failure Devices to Transplantation Joint Session of the German Cardiac Society and the American College of Cardiology: Imaging Evolving Strategies Joint Session of the British Cardiovascular Society and the American College of Cardiology: NICE Guidelines ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2010 Update (B2-K) ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Clinical Cardiac Electrophysiology 2010 Update (B3-K) Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant Hypertension Joint Session of the South American Society of Cardiology and the American College of Cardiology: Prevention Assessing and Educating Across Regions Role of Physical Activity in CVD Prevention Joint Session of the Israel Heart Society and the American College of Cardiology: PCI Joint Session of the Saudi Heart Association and the American College of Cardiology: Quality Registries FIT Forum IV: Guidance for the First Steps of Your Cardiology Career Joint Session of the Canadian Cardiovascular Society and the American College of Cardiology: Repairs/Replacement: Catheter-based or (Minimally Invasive) Surgery Joint Session of the Pakistan Cardiac Society and the American College of Cardiology: Vascular VTE, PHTN 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m.

ACC.12 Final Program

83

Monday, March 26, 2012 Daily Schedule ACC.12

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

2:00 p.m. 3:30 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT MOC Special Special 823 2114 2132 ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2011 Update (B2-L) Fellows Bootcamp: Structural Heart Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist II: Left Atrial Appendage Closure, PFO, ASD and Transseptal Puncture (with Remote Demonstrations from the Seattle Science Foundation) Imaging Transcatheter Aortic Valve Procedures II: Selecting the Best Patient, Valve and Vascular Approach Spotlight Session on TAVR Management of Symptomatic Severe Carotid Artery Disease State-of-the-Art STEMI: All You Need to Know Sudden Cardiac Death Risk Stratification in Heart Failure: Past, Present and Future Directions Syncope in Special Populations Acquired Heart Disease in Childhood Epidemiology: Current and Future Management Cardiac Resynchronization Therapy: Whom to Refer for Implantation? Understanding the Complexity of the Right Ventricle: Challenges and Progress 3:00 p.m. 2:00 p.m. 2:00 p.m. 5:30 p.m. 3:30 p.m. 3:30 p.m. S105a S103b S102c 200 194 195

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ARR ARR CCS HF HF HF IMAG IMAG ISCHEM LIFELONG LIFELONG LIFELONG LIFELONG PHTN PRACTICE PRACTICE PREV PREV

Symposium Symposium Symposium Symposium Symposium Symposium Experts Symposium Symposium Symposium Symposium Symposium Symposium Core Core MOC MOC Experts Experts Symposium Experts Symposium

2635 2636 2637 2638 702 703 247 704 705 706 707 708 709 821 822 823 824 249 248 710 250 711

2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m.

3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 5:30 p.m. 5:30 p.m. 3:30 p.m. 3:30 p.m. 5:30 p.m. 3:30 p.m. 3:30 p.m.

S101a S102b S103c S106b S406a N227b S501a S406b S404 N230 S405 S403 S401a N226 N229 S105a S105d S505 S504a S402 S502 S100c

195 195 195 196 196 196 196 196 196 197 197 197 197 197 198 200 200 198 198 198 198 199

2:00 p.m. Joint Symposium of the Italian Federation of Cardiology and the Pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial Fibrillation Management of the Patient with Valvular Heart Disease: Role of Echo Advances in Nuclear Cardiology: Current and Future Applications Transitioning from ACS to Stable Ischemic Heart Disease Core Curriculum: Cardiac Catheterization Core Curriculum: Preventive Cardiology ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2011 Update (B2-L) ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Clinical Cardiac Electrophysiology 2011 Update (B3-L) Pearls and Caveats in Managing Patients with Pulmonary Hypertension Issues That Have Caused Medical Professional Liability Claims: Are You at Risk? A Special Presentation from The Doctors Company Impact of Healthcare Policy on the Academic Cardiovascular Mission Labile Hypertension: Evaluation and Management Joint Symposium of the American Association of Clinical Endocrinologists and the American College of Cardiology: Cardiologists as Endocrinologists Emerging Management of the Diabetic Patient 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 3:00 p.m. 3:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m.

QUAL QUAL SPECIAL VALV VALV

Symposium Symposium Legends Experts Symposium

712 713 404 251 714

Bringing Evidence to the Bedside: Making Guidelines More Accessible to Clinicians Making a Difference: Cardiology Leadership in the Community and the World Legends of Cardiovascular Medicine Lecture Series 11th Annual Maseri-Florio International Lecture Complex Valvular Heart Disease Calcific Aortic Stenosis: Diagnosis and Treatment in the 21st Century

2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m.

3:30 p.m. 3:35 p.m. 3:00 p.m. 3:30 p.m. 3:30 p.m.

N427 N228 N231 S503 N426

199 199 199 199 199

3:45 p.m. 5:15 p.m. (exceptions noted in bold)

ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ACC-i2/TCT ARR Symposium Symposium Symposium Symposium Symposium Symposium 2639 2640 2641 2642 2643 715 Controversies in Intravascular Imaging Mitral Interventions Importance of Bleeding in Patients with CV Disease: A Personalized Approach for Treatment Strategies Endovascular Management of Erectile Dysfunction ACS: New Insights and Novel Therapies Challenges in the Management of Ventricular Arrhythmias 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. S101a S102b S103b S103c S106b S406a 202 200 200 201 201 201

84

GO for ACC.12!

ACC.12 Daily Schedule Monday, March 26, 2012

PATHWAY

SESSION TYPE SESS. # TITLE

START

END

ROOM

PAGE

3:45 p.m. 5:15 p.m. (continued exceptions noted in bold)

ARR CCS HF HF IMAG LIFELONG LIFELONG PERI PERI PHTN PREV PREV Symposium Experts Symposium Symposium Symposium Core Core Experts Symposium Experts Symposium Symposium 716 252 717 718 719 825 826 253 720 254 729 745 Issues in Cardiac Resynchronization Therapy Golden Moments: When Is the Right Time to Intervene in Congenital Heart Disease? Improving Outcomes and Reducing Heart Failure Readmissions Controversies in Treatment of Comorbidities in Heart Failure: Paradoxes and Challenges in Treatment Emerging Applications of CMR Core Curriculum: Vascular Disease Core Curriculum: Landmark Trials Challenges in Hypertrophic Cardiomyopathy: Case Studies New Directions in the Evaluation and Management of the Cardiomyopathies Pulmonary Hypertension Tools for the Cardiologist Beyond Statins: LDL Management in the Challenging Patient World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and Its Protective Effect on Cardiovascular Disease Transforming Health Care Delivery through CV Registries Applying Newer Cardiovascular Agents to Older Adults Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of Cardiology Stress Testing in Women Advanced Hemodynamics for Valvular Heart Disease Importance of Registries for Valve Disease: A Glimpse into the ACC Future 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. N227b S501a S406b S404 S403 N226 N229 S505 N231 S504a S100c S405 201 201 202 202 202 202 203 203 203 203 203 203

QUAL QUAL SPECIAL TEST VALV VALV

Symposium Symposium Symposium Experts Experts Symposium

721 722 740 255 256 723

3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m.

5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m.

N427 N228 N230 S502 S503 N426

204 204 204 204 204 204

5:45 p.m. 9:05 p.m. (exceptions noted in bold)

ACC-i2/TCT Clinical Focus 1607 Joint Session of the American Association for Thoracic Surgery, the Society of Thoracic Surgeons and the American College of Cardiology: Multidisciplinary Approach to the High-risk Aortic Stenosis Patient 61st Annual Convocation 5:45 p.m. 9:05 p.m. S401a 205

SPECIAL

Special

307

6:30 p.m.

8:00 p.m.

Hall B, ACC.12 Main Tent

205

ACC.12 Final Program

85

ACC.12 Program-At-A-Glance

Daily Schedule
Sessions are listed alphabetically by learning pathway based on time block.
PATHWAY SESSION TYPE SESS. # TITLE

Tuesday, March 27, 2012

The ACC.12 Online icon indicates sessions are available as live or on-demand webcasts. Please refer to page 65 for additional information on accessing these free sessions. iScience icon indicates sessions are included as part of iScience 2012: ACC.12 Meeting on Demand

START

END

ROOM

PAGE

8:00 a.m. 9:30 a.m. (exceptions noted in bold)

ACS ARR CCS CCS HF IMAG ISCHEM LIFELONG PHTN Symposium Symposium Symposium Symposium Experts Experts Experts Boot Camp Symposium 728 747 724 725 257 258 259 114 726 Joint Symposium of the American Association for Clinical Chemistry and the American College of Cardiology: How to Use Cardiac Biomarkers Antithrombotic Therapies for Atrial Fibrillation: Current State of the Art Complex Conotruncal Malformations: What the Surgeon Needs to Know and How to Get the Information Coming of Age: The HLHS Turns 21 Cardiac Amyloidosis Echo in Assessment of Low Gradient Aortic Stenosis Innovations in Noninvasive Evaluation of Stable Ischemic Heart Disease CCA Research Bootcamp Session II: Successful Research Execution and Dissemination Sesion Conjunta Con La Sociedad Espanola de Cardiologa Sociedad Interamerica de Cardiologa/American College of Cardiology: Problemas Relevantes en Cardiologa 2012 Joint Symposium of the American Society of Hypertension and the American College of Cardiology: Hypertension in the Critically Ill Patient Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials Joint Session of the European Society of Cardiology and the American College of Cardiology II: Pros and Cons of New Approaches for Antiplatelet and Anticoagulant Therapy Aortic Regurgitation/BAV 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. N230 S404 N229 N231 S502 S505 S503 S105d S403 209 209 209 209 209 210 210 210 210

PREV SPECIAL SPECIAL

Symposium Special Symposium

727 308 739

8:00 a.m. 8:00 a.m. 8:00 a.m.

9:30 a.m. 9:30 a.m. 9:30 a.m.

S406a Hall B, ACC.12 Main Tent N426

210 210 211

VALV

Experts

260

8:00 a.m.

9:30 a.m.

S504a

211

9:45 a.m. 11:45 a.m. (exceptions noted in bold)

SPECIAL Special 309 ACC.12 Closing Session: Innovators in Cardiology 9:45 a.m. 11:45 a.m. Hall B, ACC.12 Main Tent 211

86

GO for ACC.12!

ACC.12 Program-At-A-Glance

Topic Schedule
Sessions are listed alphabetically by learning pathway based on time block. The ACC.12 Online icon indicates sessions are available as live or on-demand webcasts. Please refer to page 65 for additional information on accessing these free sessions. iScience icon indicates sessions are included as part of iScience 2012: ACC.12 Meeting on Demand

ACC-i2 wITh TCT

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Symposium Poster Poster Symposium Experts Experts Experts Symposium Symposium Live/Taped Cases Oral Symposium Symposium Symposium Symposium Experts Experts Symposium Symposium Symposium 734 2301 2302 2303 2606 2607 2201 2502 2608 2609 2610 2645 2305 2306 2611 2612 2613 2644 Interventional Featured Clinical Studies I Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Pharmacology Program: Pharmacologic Considerations in the Setting of PCI Atypical Thrombotic ACS Case Reviews Chronic Total Occlusions and Left Main Case Reviews Coronary Imaging Case Reviews TAVR: Procedural Aspects and Best Practices Acute Venous Thromboembolic Disease Live and Taped Case Session I: Multivessel PCI Physiology and Imaging Acute Myocardial Infarction Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early Thrombosis Hemodynamics and Angiography I: Basic Issues Renal Interventions for Hypertension and Renal Function Preservation Interventional Featured Clinical Studies II Vascular Access Challenges and Complications Case Reviews Unusual Cases of ACS Case Reviews Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up II: Very Late Stent Thrombosis and Late Catch-up Hemodynamics II (HOCM) Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease: In Collaboration with the Society of Vascular Surgery 8:00 a.m. 9:30 a.m. 11:00 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 9:30 a.m. 10:30 a.m. Noon 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 5:00 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S102b hall A hall A N427 S101a S102c S103b S102b S103c hall B, ACC.12 Main Tent S103b S101a S102b S103c S102c S102c S103b S101a S102b S103c 116 114 114 115 115 115 119 119 119 120 120 120 125 125 125 125 126 107

SuNDAy, MARCh 25, 2012

Oral Oral Oral Oral Oral Oral Symposium Oral Oral Oral Oral 2500 2501 2504 2505 2508 2510 2614 2503 2506 2507 2509 Outcomes in Patients Treated with TAVR Adjunct Pharmacology PCI in Complex Lesions PCI in Complex Patients Intravascular Diagnostics Vascular Access Abnormalities of the Atrium Bioresorbable Vascular Scaffolds Drug-eluting Stents Imaging in TAVR Prevention and Treatement of Restenosis 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. N227b S101a S103c S102c S106b S103b S102b S106b S101a S102c S103c 137 137 138 138 139 139 140 145 146 146 147

ACC.12 Final Program

87

Topic Schedule Program-At-A-Glance ACC.12

ACC-i2 wITh TCT

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012 (continued)

Oral Symposium Symposium Special Experts Experts Experts Symposium Symposium Special Special Live/Taped Cases Symposium Symposium Symposium Symposium Special Special Experts Symposium Symposium Symposium Special 2511 2615 646 2101 2308 2309 2310 2616 2617 2102 2131 2202 2618 2619 2620 2621 2103 2104 2311 2622 2623 2624 2105 Outcomes in Patients Treated with PCI Congenital/Pediatric Interventional Cardiovascular Medicine in 2012: An Update for the Non-Interventionalist and the Douglas P. Zipes, M.D., Distinguished Young Scientist Awardee Lecture Cardiac Care Team Session I: Keynote Address Aortic Valve Case Reviews Coronary Complications Case Reviews Multivessel and Hemodynamic Support Case Reviews Endovascular Intervention for Venous Disease Platelet Inhibition in 2012: What You Need to Know Cardiac Care Team Session II: Cath Lab of Tomorrow Pathway to a High-risk Aortic Valve Program Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist I: Mitral and Aortic Valve (with Remote Demonstrations from the Seattle Science Foundation) Live and Taped Case Session II: Left Main and Birfucation Complex PCI Imaging Transcatheter Aortic Valve Procedures I: Intra- and Post-Procedural Imaging Emerging Technologies Peripheral Artery Disease: Superficial Femoral Artery Chronic Total Occlusions Cardiac Care Team Session III: Medications and Other Techniques to Manage the Patient in the Cath Lab Cardiac Care Team Session IV: Same Day Discharge for PCI Endovascular Case Reviews Imaging Transcatheter Mitral Valve Procedures Peripheral Artery Disease: Critical Limb Ischemia Vascular Access and Outcomes following PCI for ACS: What You Should Know Cardiac Care Team V: Structural Heart Disease Mitral Valve 10:45 a.m. 10:45 a.m. 12:15 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 12:30 p.m. 1:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:30 p.m. 3:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 5:00 p.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:00 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 2:30 p.m. 3:30 p.m. 5:00 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 5:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S103b S102b N228 S103b S101a S102b S102c S103c S106b S103b S102c hall B, ACC.12 Main Tent S101a S102b S103c S106b S103b S103b S102b S101a S103c S106b S103b 147 148 155 156 156 156 156 156 156 160 160 161 161 161 161 162 165 165 166 166 166 167 171

MONDAy, MARCh 26, 2012

Special Special Symposium Symposium Symposium Symposium Special Special Symposium Symposium Symposium Symposium Intl. Lunch Intl. Lunch 2111 2121 2625 2626 2627 2628 2112 2122 2629 2630 2631 2632 502 503 Fellows Bootcamp: Coronary I Multi-Disciplinary Management of the Failing Heart: Team Based Evaluation and Therapy of Advanced Heart Disease I Left Main Disease: Role of Imaging for Assessment, Treatment, and Follow-up TAVR Complications: Incidence, Management and Avoidance Management of Renovascular Hypertension Left Main Coronary Intervention: State-of-the-Art Fellows Bootcamp: Coronary II Multi-Disciplinary Management of the Failing Heart: Team Based Evaluation and Therapy of Advanced Heart Disease II Establishing a Cardiac Catheterization Imaging/Physiology Program Hemodynamics III (PVL and ASD Closure) All You Need to Know about Carotid Artery Stenting DES: Future Directions Joint Session of the Argentine Society of Cardiology and the American College of Cardiology: Carotids Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Drug-eluting Stents From the Early Beginning to New Stent Platforms 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 12:15 p.m. 12:15 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. Noon Noon Noon Noon Noon Noon 1:45 p.m. 1:45 p.m. S103b S102c S101a S102b S103c S106b S103b S102c S101a S102b S103c S106b N226 N426 177 177 177 177 177 178 182 183 183 183 183 184 188 188

88

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

ACC-i2 wITh TCT

SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012 (continued)

Intl. Lunch Intl. Lunch Intl. Lunch MOC Special Experts Experts Experts Symposium Symposium Live/Taped Cases Special Special 505 511 518 819 2113 2313 2314 2315 2633 2634 2203 2114 2132 Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Coronary Total Occlusions Joint Session of the Korean Society of Cardiology and the American College of Cardiology: Treating Complex Lesions Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: Devices ASDs, VSDs, Perivalvular Leaks ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2010 Update (B2-K) Fellows Bootcamp: Case Reviews Non-coronary Complications Case Reviews Structural Case Reviews Shock and Hemodynamic Support Case Reviews Controversies in Vascular and Endovascular Medicine Non-ST-Elevation ACS in 2012: What You Need to Know Live and Taped Case Session III: Valvular Heart Disease Fellows Bootcamp: Structural Heart Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist II: Left Atrial Appendage Closure, PFO, ASD and Transseptal Puncture (with Remote Demonstrations from the Seattle Science Foundation) Imaging Transcatheter Aortic Valve Procedures II: Selecting the Best Patient, Valve and Vascular Approach Spotlight Session on TAVR Management of Symptomatic Severe Carotid Artery Disease State-of-the-Art STEMI: All You Need to Know 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 12:30 p.m. 2:00 p.m. 2:00 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 2:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 1:45 p.m. 2:30 p.m. 3:30 p.m. 3:30 p.m. N228 N229 S505 S105a S103b S101a S102b S102c S103c S106b hall B, ACC.12 Main Tent S103b S102c 188 188 189 189 194 189 189 189 189 190 194 194 195

Symposium Symposium Symposium Symposium MOC Symposium Symposium Symposium Symposium Symposium Clinical Focus

2635 2636 2637 2638 823 2639 2640 2641 2642 2643 1607

2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 3:00 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 3:45 p.m. 5:45 p.m.

3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 5:30 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 5:15 p.m. 9:05 p.m.

S101a S102b S103c S106b S105a S101a S102b S103b S103c S106b S401a

195 195 195 196 200 202 200 200 200 201 205

ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2011 Update (B2-L) Controversies in Intravascular Imaging Mitral Interventions Importance of Bleeding in Patients with CV Disease: A Personalized Approach for Treatment Strategies Endovascular Management of Erectile Dysfunction ACS: New Insights and Novel Therapies Joint Session of the American Association for Thoracic Surgery, the Society of Thoracic Surgery and the American College of Cardiology: Multidisciplinary Approach to the High Risk Aortic Stenosis Patient

ACC.12 Final Program

89

Topic Schedule Program-At-A-Glance ACC.12

ACuTE CORONARy SyNDROMES

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Experts Oral Oral Symposium Experts Symposium Symposium Symposium 200 902 903 604 211 613 618 623 Contemporary Management of UA/NSTEMI P2Y12 Antagonists: Unraveling the Mechanisms and Optimizing Benefit-Risk New Therapeutic Options in ACS: From Antiplatelets to Antibiotics Controversies in ACS Optimal STEMI Management from Presentation to Post-Discharge Care State-of-the-Art in STEMI Care Translational Research Symposium with the International Society for Cardiovascular Research: Cellular Therapies Adjunctive Pharmacology in ACS: Anticoagulants and Antiplatelet Agents 8:00 a.m. 8:00 a.m. 8:00 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. S504a S406b S402 S404 S504a S404 N228 S404 107 107 108 115 121 121 121 126

Translational 2:00 p.m. 4:30 p.m.

SuNDAy, MARCh 25, 2012

Experts Oral Poster Oral Poster Symposium Experts Symposium Symposium Clinical Focus 639 231 653 665 1605 917 221 916 Complications of AMI What Impacts Outcomes in ACS? From Genes to Plaque Morphology to Environment Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Improving Outcomes in ACS: Insights from Basic Science and Preclinical Research Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. The Future of ACS Clinical Trials Management of Chest Pain in the Emergency Department State-of-the-Art in Non ST Elevation Acute Coronary Syndromes Literature Interpretation and Statistical Pitfalls in ACS Trials Innovations in Translation: ACS 8:00 a.m. 8:00 a.m. 9:30 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 6:30 p.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. 12:15 p.m. Noon 1:45 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 9:30 p.m. S504a S401a hall A N227b hall A S404 S504a S404 S402 Fairmont hotel, Imperial Ballroom 156 162 162 167 171 148 140 140

MONDAy, MARCh 26, 2012

Symposium Symposium Intl. Lunch 676 689 513 Shock in ACS Improving STEMI Outcomes: Saving Myocardium and Attenuating Remodeling Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: Acute Coronary Syndromes Improving Outcomes 8:00 a.m. 10:30 a.m. 12:15 p.m. 9:30 a.m. Noon 1:45 p.m. S401a S401a S404 178 184 190

TuESDAy, MARCh 27, 2012

Symposium 728 Joint Symposium of the American Association for Clinical Chemistry and the American College of Cardiology: How to Use Cardiac Biomarkers 8:00 a.m. 9:30 a.m. N230 209

90

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

ARRhyThMIAS
SESSION TYPE SESS. # TITLE START END ROOM PAGE

Saturday, March 24, 2012

Experts Experts Experts Symposium Symposium Symposium Symposium Experts Symposium Symposium Symposium 201 206 212 614 615 735 736 216 624 627 1601 How to Manage a Device/Lead Advisory Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation: How to Decide? Management of Difficult AF: When to Change Drugs, When to Give Up Can Remote Disease Management Improve Clinical Outcomes? Challenges in the Management of Supraventricular Tachycardia Pharmacology Program: Pharmacotherapy of New Antithrombotics Pharmacology Program: Pharmacologic Considerations with Antiarrhythmic Drugs, and Dyslipidemia and Residual Risk: When and How Do You Add to Statin Therapy? The Risk versus Benefit of DFT Testing Management of Complications of Pacemakers and Leads Translational Research Symposium with the International Society for Cardiovascular Translational Research: Tissue Engineering A New ERA in Atrial Fibrillation: Strategies for Implementing New Therapies 8:00 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 4:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 6:30 p.m. 9:30 a.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 5:30 p.m. 10:00 p.m. S503 S503 S503 S406a S403 N427 N427 S503 S403 N228 108 116 121 121 121 122 125 126 126 127

Fairmont Hotel, 129 International Ballroom

SuNDAy, MARCh 25, 2012

Experts Oral Oral Oral Symposium Experts Symposium Symposium Clinical Focus 222 904 918 919 640 232 654 666 1603 Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Genetic Syndromes for the Clinician (HCM, Brugada, Long QT) Joint Oral Arrhythmias Session of the Heart Rhythm Society and the American College of Cardiology: Management of the Patient with Atrial Fibrillation Anticoagulation and Prevention of Stroke Cardiac MRI for the Treatment and Evaluation of Arrhythmias Joint Oral Session of the Heart Rhythm Society and the American College of Cardiology: Cardiac Arrest and the Care of the ICD Patient Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Investigation and Management of Syncope Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Optimizing the Management of the Patient with Implantable Devices Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Atrial Fibrillation Prevention of Stroke Joint Symposium of the Heart Rhythm Society and the American College of Cardiology: Atrial Fibrillation Management of the Arrhythmia Joint Session of the Heart Rhythm Society of America and the American College of Cardiology: Innovations in Translation Atrial Fibrillation 8:00 a.m. 8:00 a.m. 10:45 a.m. 10:45 a.m. 12:30 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 6:30 p.m. 9:30 a.m. 9:30 a.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 9:30 p.m. S503 N426 S404 N426 N426 S503 N426 N426 Fairmont hotel, International Ballroom 141 141 148 149 157 162 162 167 172

MONDAy, MARCh 26, 2012

Experts Symposium Poster Experts Symposium Symposium Poster Intl. Lunch Intl. Lunch Symposium 501 509 702 243 690 691 239 677 Case-Oriented Gaps in the Guidelines: Who Should Get an ICD? Clinical Management of the AF Patient: Treating the Patient and the Health Care Provider Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Perioperative Management of Patients with Cardiac Implantable Electronic Device Controversies in Device Therapy The Genetics of Sudden Cardiac Death: What Do We Know and How Best to Evaluate and Manage Such Patients Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Risk Stratification for Sudden Cardiac Death Joint Session of the Cardiological Society of India and the American College of Cardiology: AF Medical, EP, Surgical Options Sudden Cardiac Death Risk Stratification in Heart Failure: Past, Present and Future Directions 8:00 a.m. 8:00 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. Noon Noon Noon Noon 1:45 p.m. 1:45 p.m. 3:30 p.m. S504a N226 hall A S504a S406a N226 hall A S403 S401a S406a 190 190 196 184 184 184 178 178

ACC.12 Final Program

91

Topic Schedule Program-At-A-Glance ACC.12

ARRhyThMIAS
SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012 (continued)

Symposium Symposium Symposium 703 715 716 Syncope in Special Populations Challenges in the Management of Ventricular Arrhythmias Issues in Cardiac Resynchronization Therapy 2:00 p.m. 3:45 p.m. 3:45 p.m. 3:30 p.m. 5:15 p.m. 5:15 p.m. N227b S406a N227b 196 201 201

TuESDAy, MARCh 27, 2012

Symposium 747 Antithrombotic Therapies for Atrial Fibrillation: Current State of the Art 8:00 a.m. 9:30 a.m. S404 209

CONGENITAL CARDIOLOGy SOLuTIONS

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Symposium Oral Symposium Symposium 202 901 616 625 Complex Issues Facing ACHD Patients: Obstructive Lesions From Targeting Errors to UNOS: How Quality and Databases Can Impact Clinical Care Quality, Safety and Resources Enhancing Pediatric Cardiovascular Care Updates on Care in the Congenital Heart Disease Patients 8:00 a.m. 10:30 a.m. 2:00 p.m. 4:30 p.m. 9:30 a.m. Noon 3:30 p.m. 6:00 p.m. S105a S105a N231 N231 108 114 122 127

SuNDAy, MARCh 25, 2012

Symposium MOC Poster Symposium Oral Poster Special Legends Symposium Symposium 301 402 667 668 637 920 634 802 Preoperative Assessment of Patients on the Single Ventricle Pathway: Special Problems Creative Solutions ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Post-Operative Glenns and Fontans: Navigating Turbulent Waters Adults with Congenital Heart Disease: Imaging Predictors, Evolving Therapies and Outcomes Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Career & Mentoring Session for Pediatric and Congenital Cardiologists Legends in Cardiovascular Medicine Lecture Series 2012 Dan G. McNamara Lecture The Great Debates ACHD for the General Cardiologist 8:00 a.m. 8:00 a.m. 9:30 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 2:00 p.m. 4:30 p.m. 4:30 p.m. 9:30 a.m. 10:00 a.m. 10:30 a.m. 12:15 p.m. 12:15 p.m. Noon 1:45 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. N231 S105d hall A N231 S402 hall A N231 N228 N231 N230 157 162 167 168 149 149 141 109

MONDAy, MARCh 26, 2012

Symposium Symposium Symposium Symposium Intl. Lunch Experts Experts 678 679 692 693 506 247 252 Pulmonary Artery Stenosis Current Therapy and Future Directions: Live Case Women with Congenital Heart Disease: Fertility, Pregnancy and Menopause Pulmonary Vein Stenosis: What Are Realistic Expectations? Challenging Imaging Issues in Congenital Heart Disease Joint Session of the Egyptian Society of Cardiology and the American College of Cardiology: Adult Congenital Heart Disease: Where We Came From and Where We Are Acquired Heart Disease in Childhood Epidemiology: Current and Future Management Golden Moments: When Is the Right Time to Intervene in Congenital Heart Disease? 8:00 a.m. 8:00 a.m. 10:30 a.m. 10:30 a.m. 12:15 p.m. 2:00 p.m. 3:45 p.m. 9:30 a.m. 9:30 a.m. Noon Noon 1:45 p.m. 3:30 p.m. 5:15 p.m. N231 S501a N229 N231 N231 S501a S501a 178 179 184 185 191 196 201

TuESDAy, MARCh 27, 2012

Symposium Symposium 724 725 Complex Conotruncal Malformations: What the Surgeon Needs to Know and How to Get the Information Coming of Age: The HLHS Turns 21 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. N229 N231 209 209

92

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

hEART FAILuRE
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Experts Symposium Oral Oral Experts Experts Symposium Experts Symposium 203 732 905 906 207 213 617 217 626 The Latest in Heart Failure with Preserved Ejection Fraction Pharmacology Program: Pharmacotherapy of Chronic Heart Failure Predicting Outcomes in Heart Failure: Biomarkers and Beyond Pathogenic and Therapeutic Insights from Experimental Heart Failure Models Atrial Fibrillation and Heart Failure: A Dynamic Duo From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support Devices Cardiorenal Syndrome in Heart Failure: From Definition to Management Heart Failure Disease Management: Issues for 2012 Management of Acute Decompensated Heart Failure: From Hemodynamic Subsets to Appropriate Treatment Strategies 8:00 a.m. 8:00 a.m. 8:00 a.m. 8:00 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 4:30 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. S502 N427 S405 S404 S502 S502 S406b S502 S406b 109 109 109 109 116 122 122 127 127

SuNDAy, MARCh 25, 2012

Symposium Experts Oral Oral Experts Symposium 635 225 921 922 228 641 Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Pharmacological Treatment of Systolic and Diastolic Heart Failure Heart Failure Care for the Very Old: What Are the Key Issues for Success? Joint Oral Session of the Heart Failure Society of America and the American College of Cardiology: Individualizing Pharmacological Therapy in Heart Failure Improving Patient Selection for Device-Based Therapies Cardiac MR for the Evaluation of the Heart Failure Patient Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Issues in the Diagnosis and Treatment of Chronic Ambulatory Heart Failure Cardiotoxicity of Cancer Chemotherapy: Molecular Basis and Strategies for Early Detection and Prevention Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: The Growing Role of Devices in Heart Failure Management ICD, CRT, Hemodynamic Monitoring and Ultrafiltration The NHLBI Heart Failure Clinical Trials Network: A New Paradigm for Investigation and Training Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Management of Advanced Heart Failure and Transplantation Heart Transplantation: Challenges in 2012 Personalized Medicine and the Future of Medical Care 8:00 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 12:30 p.m. 12:30 p.m. 9:30 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:45 p.m. S406b S502 S406b S405 S502 S406b 141 150 150 150 157 157

Symposium Symposium

642 655

12:30 p.m. 2:00 p.m.

1:45 p.m. 3:30 p.m.

S405 S406b

157 163

Symposium Symposium Symposium Symposium

656 669 670 671

2:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m.

3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m.

S405 S406b S405 S404

163 168 168 168

MONDAy, MARCh 26, 2012

Experts Symposium Symposium Poster Symposium Symposium Poster Intl. Lunch Symposium Symposium Symposium 517 704 705 706 694 695 240 680 681 Myocarditis: When to Biopsy, Who to Treat, Which Therapy? Controversies in the Management of Heart Failure Surgical Therapy of Heart Failure Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. LVAD as Destination Therapy for Advanced Heart Failure Management of Peripartum Cardiomyopathy: Update 2012 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Heart Failure Devices to Transplantation Cardiac Resynchronization Therapy: Whom to Refer for Implantation? Understanding the Complexity of the Right Ventricle: Challenges and Progress Joint Symposium of the Italian Federation of Cardiology and the Pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial Fibrillation 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. Noon Noon Noon 1:45 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. S502 S406b S404 hall A S406b S404 hall A S501a S406b S404 N230 191 196 196 197 185 185 179 179 179

ACC.12 Final Program

93

Topic Schedule Program-At-A-Glance ACC.12

hEART FAILuRE
SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012 (continued)

Symposium Symposium 717 718 Improving Outcomes and Reducing Heart Failure Readmissions Controversies in Treatment of Comorbidities in Heart Failure: Paradoxes and Challenges in Treatment 3:45 p.m. 3:45 p.m. 5:15 p.m. 5:15 p.m. S406b S404 202 202

TuESDAy, MARCh 27, 2012

Experts 257 Cardiac Amyloidosis 8:00 a.m. 9:30 a.m. S502 209

IMAGING
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Experts Oral Oral Poster Poster Experts Symposium Experts Symposium Experts Symposium 208 605 214 619 218 628 204 908 909 Multimodality Imaging in Evaluation of Prosthetic Valve Function A Better Understanding of Ischemia and Function: Insights from Cardiac MRI New Imaging Approaches to Atherosclerosis and the Microcirculation Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Imaging Patients with Pericardial Disease Cardiovascular Magnetic Resonance in Myocarditis Current Topics in Cardiac CT Multimodality Imaging of Hypertrophic Cardiomyopathy Myocardial Perfusion Imaging: Picking the Right Test Multi-Modality Imaging: Chest Pain in the Emergency Department 8:00 a.m. 8:00 a.m. 8:00 a.m. 9:30 a.m. 11:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 4:30 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. 10:30 a.m. Noon 1:45 p.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. S505 S403 N426 hall A hall A S505 S402 S505 S402 S505 S402 116 116 122 122 127 127 110 110 110

SuNDAy, MARCh 25, 2012

Experts Oral Symposium Oral Symposium Symposium Experts Symposium Symposium Symposium 223 907 638 924 643 644 233 657 658 672 Cardiac PET: Incorporation into Daily Practice Joint Oral Session of the American Society of Echocardiography and the American College of Cardiology: Newest Applications of Echo to Clinical Practice Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Cardiomyopathy A Comprehensive Echocardiographic Approach Cardiac CT: Toward a Better Understanding of CAD Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Interventional Echocardiography Evolving Role in Patient Management Cost-Effective Imaging in Patients with Chronic CAD Role of CMR in Valvular Heart Disease Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Healthcare Reform Impact on Imaging Radionuclide Imaging in the Heart Failure Patient Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Echo in 2012 What You Need to Know to Keep Up 8:00 a.m. 8:00 a.m. 10:45 a.m. 10:45 a.m. 12:30 p.m. 12:30 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 4:30 p.m. 9:30 a.m. 9:30 a.m. 12:15 p.m. 12:15 p.m. 1:45 p.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. S505 S406a S406a S403 S406a S403 S505 S406a S403 S406a 142 142 151 151 158 158 163 163 163 168

94

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

IMAGING
SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012

Experts Symposium Symposium Symposium Symposium Intl. Lunch Symposium Symposium Symposium 241 682 683 696 697 507 707 708 719 Imaging the Right Ventricle Advanced LV Dysfunction: A Multimodality Approach Future Directions for Cardiac CT Cardiac CT in 2012: State-of-the-Art Role of Echo in the Evaluation and Management of Patients with Mitral Regurgitation Joint Session of the German Cardiac Society and the American College of Cardiology: Imaging Evolving Strategies Management of the Patient with Valvular Heart Disease: Role of Echo Advances in Nuclear Cardiology: Current and Future Applications Emerging Applications of CMR 8:00 a.m. 8:00 a.m. 8:00 a.m. 10:30 a.m. 10:30 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 3:45 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. Noon Noon 1:45 p.m. 3:30 p.m. 3:30 p.m. 5:15 p.m. S505 S405 S403 S405 S403 S406b S405 S403 S403 179 179 180 185 185 191 197 197 202

TuESDAy, MARCh 27, 2012

Experts 258 Echo in Assessment of Low Gradient Aortic Stenosis 8:00 a.m. 9:30 a.m. S505 210

ChRONIC CAD/STABLE ISChEMIC hEART DISEASE

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Oral Symposium Symposium Symposium 910 606 620 629 Sex, Scoring, Sadness, Statins, Stents and Surgery Revascularization In SIHD: Integrating New Evidence Stable Ischemic Heart Disease in Women: Are They Really from Venus? Stable Ischemic Heart Disease: Whats New in the Guidelines (And What Should Be)? 8:00 a.m. 12:15 p.m. 2:00 p.m. 4:30 p.m. 9:30 a.m. 1:45 p.m. 3:30 p.m. 6:00 p.m. N227b S401a S401a S401a 111 116 123 128

SuNDAy, MARCh 25, 2012

Oral Symposium Experts 923 645 234 Who Said Theres Nothing New? Managing High-risk Patients with Stable Ischemic Heart Disease Heart Failure in Stable Ischemic Heart Disease: Not for the Weak of Heart 10:45 a.m. 12:30 p.m. 2:00 p.m. 12:15 p.m. 1:45 p.m. 3:30 p.m. N230 S401a S502 151 158 163

MONDAy, MARCh 26, 2012

Poster Poster Intl. Lunch Symposium 508 709 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Joint Session of the British Cardiovascular Society and the American College of Cardiology: NICE Guidelines Transitioning from ACS to Stable Ischemic Heart Disease 9:30 a.m. 11:00 a.m. 12:15 p.m. 2:00 p.m. 10:30 a.m. Noon 1:45 p.m. 3:30 p.m. hall A hall A N427 S401a 191 197

TuESDAy, MARCh 27, 2012

Experts 259 Innovations in Noninvasive Evaluation of Stable Ischemic Heart Disease 8:00 a.m. 9:30 a.m. S503 210

ACC.12 Final Program

95

Topic Schedule Program-At-A-Glance ACC.12

LIFELONG LEARNING
SESSION TYPE SESS. # TITLE START END ROOM PAGE

FRIDAy, MARCh 23, 2012

MOC 801 ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC Self Assessment Session: Update in Clinically Relevant Guidelines and Trials 7:30 a.m. 10:00 a.m. S105a 105

SATuRDAy, MARCh 24, 2012

MOC Symposium MOC MOC Core Core MOC MOC Core Core 802 607 803 804 805 806 807 808 809 810 ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment Everything You Wanted to Know about ABIM Recertification (and more...) 8:00 a.m. 12:15 p.m. 10:00 a.m. 1:45 p.m. 3:00 p.m. 3:00 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S105d N226 S105a S105d N226 N229 S105a S105d N226 N229 111 116 118 118 123 123 124 127 128 128

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular 12:30 p.m. Disease 2010 Update (A1-K) ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular 12:30 p.m. Disease 2011 Update (A1-L) Core Curriculum: Congenital Heart Disease Core Curriculum: Congestive Heart Failure 2:00 p.m. 2:00 p.m.

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular 3:30 p.m. Disease 2011 Update (A1-L) ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular 3:30 p.m. Disease 2010 Update (A1-K) Core Curriculum: Echocardiography Core Curriculum: Cardiac Electrophysiology 4:30 p.m. 4:30 p.m.

SuNDAy, MARCh 25, 2012

Symposium MOC MOC Symposium Core Core MOC MOC Symposium Core Core 731 811 812 659 813 814 815 816 737 817 818 CCA Team-Based Maintenance of Certification ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part A ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part B Master Clinician I: Discussion of Three Complex Real World Cases Core Curriculum: General Cardiology Core Curriculum: Valvular Heart Disease ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part B ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC General Cardiology Module Part A Master Clinician: Clinical Cases II Core Curriculum: Coronary Artery Disease Core Curriculum: Nuclear Cardiology 8:00 a.m. 12:30 p.m. 12:30 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 3:30 p.m. 3:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 10:30 a.m. 3:00 p.m. 3:00 p.m. 3:30 p.m. 3:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S105d S105a S105d S401a N226 N229 S105a S105d S401a N226 N229 142 158 158 163 164 164 165 166 169 169 169

MONDAy, MARCh 26, 2012

Boot Camp MOC MOC Core Core MOC MOC 112 819 820 821 822 823 824 CCA Research Bootcamp Session I: Methods for Engaging in Research ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2010 Update (B2-K) ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Clinical Cardiac Electrophysiology 2010 Update (B3-K) Core Curriculum: Cardiac Catheterization Core Curriculum: Preventive Cardiology ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Interventional Cardiology 2011 Update (B2-L) ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy Clinical Cardiac Electrophysiology 2011 Update (B3-L) 8:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 3:00 p.m. 3:00 p.m. 9:30 a.m. 2:45 p.m. 2:45 p.m. 3:30 p.m. 3:30 p.m. 5:30 p.m. 5:30 p.m. S105d S105a S105d N226 N229 S105a S105d 180 192 192 197 198 200 200

96

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

LIFELONG LEARNING
SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012 (continued)

Core Core 825 826 Core Curriculum: Vascular Disease Core Curriculum: Landmark Trials 3:45 p.m. 3:45 p.m. 5:15 p.m. 5:15 p.m. N226 N229 202 203

TuESDAy, MARCh 27, 2012

Boot Camp 114 CCA Research Bootcamp Session II: Successful Research Execution and Dissemination 8:00 a.m. 9:30 a.m. S105d 210

PERICARDIAL/MyOCARDIAL DISEASE
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012

Poster Oral Poster Experts Symposium Symposium Experts 229 648 661 236 925 Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. All That Glitters in Myocardial and Pericardial Disease Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Grasping the Complexity of Myocardial and Pericardial Diseases The New Hypertrophic Cardiomyopathy Practice Guidelines Controversies in Hypertrophic Cardiomyopathy Genetic Evaluation of Cardiomyopathy 9:30 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 12:30 p.m. 2:00 p.m. 4:30 p.m. 10:30 a.m. 12:15 p.m. Noon 1:45 p.m. 1:45 p.m. 3:30 p.m. 6:00 p.m. hall A N226 hall A S505 N226 N427 S505 159 159 164 169 152

MONDAy, MARCh 26, 2012

Experts Symposium 253 720 Challenges in Hypertrophic Cardiomyopathy: Case Studies New Directions in the Evaluation and Management of the Cardiomyopathies 3:45 p.m. 3:45 p.m. 5:15 p.m. 5:15 p.m. S505 N231 203 203

PuLMONARy hyPERTENSION
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012

Oral Poster Poster Symposium Symposium 649 662 912 Whats New in Pulmonary Hypertension Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Emerging Approaches to Pulmonary Hypertension with Left Ventricular Dysfunction Pulmonary Hypertension Management in Special Populations 8:00 a.m. 9:30 a.m. 11:00 a.m. 12:30 p.m. 2:00 p.m. 9:30 a.m. 10:30 a.m. Noon 1:45 p.m. 3:30 p.m. N226 hall A hall A S402 S402 159 164 142

MONDAy, MARCh 26, 2012

Experts Experts 249 254 Pearls and Caveats in Managing Patients with Pulmonary Hypertension Pulmonary Hypertension Tools for the Cardiologist 2:00 p.m. 3:45 p.m. 3:30 p.m. 5:15 p.m. S505 S504a 198 203

TuESDAy, MARCh 27, 2012

Symposium 726 Sesion Conjunta Con La Sociedad Espanola de Cardiologa Sociedad Interamerica de Cardiologa/American College of Cardiology: Problemas Relevantes en Cardiologa 2012 8:00 a.m. 9:30 a.m. S403 210

ACC.12 Final Program

97

Topic Schedule Program-At-A-Glance ACC.12

PRACTICE PERFORMANCE, IMPROvEMENT AND ADMINISTRATION

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Symposium Symposium Symposium Symposium Symposium 600 608 609 621 630 Cardiology Procedures 2012: How to Code and Get Reimbursed Women in Cardiology The Challenges in Daily Practice ACC/MedAxiom/ACCA: Physician/Hospital Integration 101 Information Technology, Medicine and the Future 8:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 4:30 p.m. 9:30 a.m. 1:45 p.m. 1:45 p.m. 3:30 p.m. 6:00 p.m. N231 N229 N230 N230 N230 112 116 117 123 128

SuNDAy, MARCh 25, 2012

Experts Symposium 226 647 ACC/MedAxiom/ACCA: Physician/Hospital Integration: Making it Work Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part I: Making the Electronic Health Record Meaningful and Useful A Washington Perspective Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part II: EHR Implementation Lessons from the Trenches Future Compensation under Health Care Reform 10:45 a.m. 12:30 p.m. 12:15 p.m. 1:45 p.m. S505 N227b 152 159

Symposium

660

2:00 p.m.

3:30 p.m.

N227b

164

Symposium

673

4:30 p.m.

6:00 p.m.

N227b

169

MONDAy, MARCh 26, 2012

Symposium Experts Experts Symposium 684 244 248 710 ACC/MedAxiom/ACCA: Cardiovascular Service Lines Leadership and Governance Issues that Have Caused Medical Professional Liability Claims: Are You at Risk? A Special Presentation from The Doctors Company Impact of Healthcare Policy on the Academic Cardiovascular Mission 8:00 a.m. 10:30 a.m. 2:00 p.m. 2:00 p.m. 9:30 a.m. Noon 3:30 p.m. 5:30 p.m. S105a S503 S504a S402 180 185 198 198

PREvENTION
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Symposium Symposium Symposium Symposium Clinical Focus 733 611 622 631 1602 Pharmacology Program: Cardiovascular Implications of Dietary Supplements Is There a Role for HDL Therapy: Are We AIMing Too HIGH? Emerging Trends in Atherosclerosis Hypertension Guidelines 2012 First Line of Defense: Risk Factors and Prevention in the Cardiology Practice A Master Class for the Community Cardiologist 10:30 a.m. 12:15 p.m. 2:00 p.m. 4:30 p.m. 6:30 p.m. Noon 1:45 p.m. 3:30 p.m. 6:00 p.m. 9:30 p.m. N427 S100c S100c S100c Fairmont hotel, Gold Room 114 117 123 128 130

SuNDAy, MARCh 25, 2012

Oral Poster Experts Oral Oral Poster Experts Experts 230 235 227 926 927 911 Prevention: Focus on Lipids Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Update on the ATP IV Guidelines Prevention: Renal Sympathetic Denervation A Novel Therapy for Hypertension? Prevention: Cardiovascular Risk Assessment and Rehabilitation Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Management of Hypertension in the Elderly Dietary Approaches for CVD Prevention: Matching the Diet to the Patient 8:00 a.m. 9:30 a.m. 10:45 a.m. 10:45 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 2:00 p.m. 9:30 a.m. 10:30 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. Noon 1:45 p.m. 3:30 p.m. S100c hall A S501a N228 S401a hall A S501a S501a 159 164 157 153 153 142

98

GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

Prevention
SESSION TYPE SESS. # TITLE START END rooM PAGE

SUnDAY, MArCH 25, 2012 (continued)

Symposium Experts Symposium Symposium 663 237 675 730 Resistant Hypertension Reducing Disparities in Cardiovascular Preventive Care Whats New in the ACCF/AHA Guidelines The Difficult-to-Manage Lipid Patient 2:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 3:30 p.m. 6:00 p.m. 6:00 p.m. 6:00 p.m. S100c S501a n228 S100c 165 169 169 170

MonDAY, MArCH 26, 2012

Symposium Symposium Experts Symposium Symposium Intl. Lunch Intl. Lunch Symposium Experts Symposium 685 686 245 698 699 512 516 701 250 711 ACC China Chapter Session: Cardiovascular Clinical Research and Practice in China Global CVD Prevention: Heart Disease and Risk Factors in Specific Populations Womens Cardiovascular Health Vitamins and Supplements in Cardiovascular Disease Prevention Joint Symposium of the Preventive Cardiovascular Nurses Association and the American College of Cardiology Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant Hypertension Joint Session of the South American Society of Cardiology and the American College of Cardiology: Prevention Assessing and Educating Across Regions Role of Physical Activity in CVD Prevention Labile Hypertension: Evaluation and Management Joint Symposium of the American Association of Clinical Endocrinologists and the American College of Cardiology: Cardiologists as Endocrinologists Emerging Management of the Diabetic Patient Beyond Statins: LDL Management in the Challenging Patient World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and Its Protective Effect on Cardiovascular Disease 8:00 a.m. 8:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 12:15 p.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 9:30 a.m. 9:30 a.m. Noon Noon Noon 1:45 p.m. 1:45 p.m. 1:45 p.m. 3:30 p.m. 3:30 p.m. n229 S100c S501a S100c S105d S504a S502 S100c S502 S100c 180 180 185 186 186 192 192 193 198 199

Symposium Symposium

729 745

3:45 p.m. 3:45 p.m.

5:15 p.m. 5:15 p.m.

S100c S405

203 203

tUeSDAY, MArCH 27, 2012

Symposium 727 Joint Symposium of the American Society of Hypertension and the American College of Cardiology: Hypertension in the Critically Ill Patient 8:00 a.m. 9:30 a.m. S406a 210

QUAlitY of CAre AnD oUtCoMeS

SESSION TYPE SESS. # TITLE START END rooM PAGE

SAtUrDAY, MArCH 24, 2012

Experts Symposium Experts Symposium Experts Experts 205 601 209 610 215 219 Am I Placing Inappropriate ICDs and Stents? Recent Registry Surprises Patient-Centered Care: The New Imperative Getting Access to Data: Successful Examples from the NCDR Translational Research Symposium with the International Society for Cardiovascular Research: Mission and Strategy in Translational Research When Should a Medicine or Device Stop Being Used in Practice? Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE Registry Translational 8:00 a.m. 8:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 4:30 p.m. 9:30 a.m. 9:30 a.m. 1:45 p.m. 1:45 p.m. 3:30 p.m. 6:00 p.m. S501a n226 S501a n228 S501a S501a 112 112 117 117 123 128

SUnDAY, MArCH 25, 2012

Experts Oral 224 913 Tools to Improve Care Transition: The Hospital to Home (H2H) Experience Insights and Innovations to Improve Cardiac Risk 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. S501a n229 143 143

ACC.12 Final Program

99

Topic Schedule Program-At-A-Glance ACC.12

QuALITy OF CARE AND OuTCOMES

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012 (continued)

Symposium Oral Symposium 650 928 664 U.S. Health System Reform: Whats Missing? Improving PCI Outcomes Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology: Ethnic and Racial Disparities in Cardiovascular Disease A Call to Action 10:45 a.m. 10:45 a.m. 2:00 p.m. 12:15 p.m. 12:15 p.m. 3:30 p.m. S100c N229 N230 153 153 165

MONDAy, MARCh 26, 2012

Symposium Poster Symposium Symposium Poster Intl. Lunch Intl. Lunch Symposium Symposium Symposium Symposium 510 515 712 713 721 722 700 742 687 Where Will Cardiology Be in 2015? Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Lies, Damned Lies and Statistics: Pitfalls in Literature Interpretation The Future of Cardiovascular Diseases: Where Are We Going (and Where Do We Want to Go) Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Joint Session of the Israel Heart Society and the American College of Cardiology: PCI Joint Session of the Saudi Heart Association and the American College of Cardiology: Quality Registries Bringing Evidence to the Bedside: Making Guidelines More Accessible to Clinicians Making a Difference: Cardiology Leadership in the Community and the World Transforming Health Care Delivery through CV Registries Applying Newer Cardiovascular Agents to Older Adults 8:00 a.m. 9:30 a.m. 10:30 a.m. 10:30 a.m. 11:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 3:45 p.m. 3:45 p.m. 9:30 a.m. 10:30 a.m. Noon Noon Noon 1:45 p.m. 1:45 p.m. 3:30 p.m. 3:35 p.m. 5:15 p.m. 5:15 p.m. N427 hall A N427 N426 hall A N230 N227b N427 N228 N427 N228 193 193 199 199 204 204 186 186 180

SPECIAL TOPICS
SESSION TYPE SESS. # TITLE START END ROOM PAGE

FRIDAy, MARCh 23, 2012

Symposium Legends 746 400 4th Annual Cardiovascular Conference: Focus on the Middle East Legends of Cardiovascular Medicine Roundtable Forum and Reception (By Invitation Only) 8:00 a.m. 1:30 p.m. Noon 5:30 p.m. S101a S100c 105 106

SATuRDAy, MARCh 24, 2012

Special Special Special Special Special Legends Special Special Special 300 103 104 106 107 401 107A 109 110 ACC.12 Opening Showcase and Late-Breaking Clinical Trials: Featuring the Legends of Cardiovascular Medicine Lecture Series Simon Dack Lecture Educating the Educators: Bootcamp for Cardiology Fellowship Program Directors and Coordinators Fit Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 1: Finding the Right Job Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and Coordinators FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 2: Launching a Successful Career Legends of Cardiovascular Medicine Lecture Series 43rd Annual Louis F. Bishop Lecture FIT Forum I: Mix n Mingle Educating the Educators: Symposium for Cardiology Fellowship Program Directors and Coordinators FIT Forum II: Jeopardy 8:00 a.m. 12:15 p.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 2:00 p.m. 3:30 p.m. 4:30 p.m. 4:30 p.m. 10:00 a.m. 1:45 p.m. 1:45 p.m. 3:30 p.m. 3:15 p.m. 3:00 p.m. 4:30 p.m. 6:30 p.m. 6:00 p.m. hall B, ACC.12 Main Tent S405a N227b S405a N227b N426 hall A, Bistro ACC S405a N227b 112 117 117 123 124 124 125 128 129

100 GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

SPECIAL TOPICS
SESSION TYPE SESS. # TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012

Special Special Special Special Special Experts Legends Symposium Symposium 304 405 406 111 302 263 403 744a 744b Late-Breaking Clinical Trials II 8:00 a.m. 8:00 a.m. 10:45 a.m. 12:30 p.m. 3:00 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 4:30 p.m. 9:30 a.m. 9:30 a.m. 12:15 p.m. 1:45 p.m. 3:15 p.m. 6:00 p.m. 5:30 p.m. 5:50 p.m. 6:00 p.m. hall B, ACC.12 Main Tent S105a S105a N229 ACC Member Lounge S502 N427 S403 S403 143 144 154 159 165 170 170 170 170 Young Investigators Award Competition: ACCF/Herman K. Gold Young Investigators Award in Molecular and Cellular Cardiology Young Investigators Award Competition: Physiology, Pharmacology, and Pathology FIT Forum III: How to Write and Evaluate Medical Journal Articles Business Meeting of the College The Role of Therapeutic Hypothermia in the Treatment of Cardiac Arrest Legends of Cardiovascular Medicine Lecture Series Third Annual James T. Dove Lecture Clinical Decision Making for Fellows in Training: Part A Clinical Decision Making for Fellows in Training: Part B

MONDAy, MARCh 26, 2012

Special Special Symposium Special Special Symposium Special Legends Symposium Special 305 407 738 306 408 741 113 404 740 307 Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials Young Investigators Award Competition: Clinical Investigations, Congenital Heart Disease and Cardiovascular Surgery Joint Session of the European Society of Cardiology and the American College of Cardiology I: Management of Heart Disease in Pregnancy Late-Breaking Clinical Trials IV 8:00 a.m. 8:00 a.m. 8:00 a.m. 10:30 a.m. 10:30 a.m. 10:30 a.m. 12:15 p.m. 2:00 p.m. 3:45 p.m. 6:30 p.m. 9:30 a.m. 9:30 a.m. 9:30 a.m. Noon Noon Noon 1:45 p.m. 3:00 p.m. 5:15 p.m. 8:00 p.m. hall B, ACC.12 Main Tent N230 N426 hall B, ACC.12 Main Tent N230 N227b S402 N231 N230 hall B, ACC.12 Main Tent 181 181 181 186 187 187 193 199 204 205

Young Investigators Award Competition: Cardiovascular Health Outcomes and Population Genetics Integrative Medicine FIT Forum IV: Guidance for the First Steps of Your Cardiology Career Legends of Cardiovascular Medicine Lecture Series 11th Annual Maseri-Florio International Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of Cardiology 61st Annual Convocation

TuESDAy, MARCh 27, 2012

Special Symposium Special 308 739 309 Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials Joint Session of the European Society of Cardiology and the American College of Cardiology II: Pros and Cons of New Approaches for Antiplatelet and Anticoagulant Therapy ACC.12 Closing Session: Innovators in Cardiology 8:00 a.m. 8:00 a.m. 9:45 a.m. 9:30 a.m. 9:30 a.m. 11:45 a.m. hall B, ACC.12 Main Tent N426 hall B, ACC.12 Main Tent 210 211 211

ACC.12 Final Program 101

Topic Schedule Program-At-A-Glance ACC.12

DIAGNOSTIC TESTING: ECG ExERCISE AND SPORTS

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Symposium Symposium 602 603 Translational Research Symposium with the International Society for Cardiovascular Translational Research: New Breakthroughs in Cardiovascular Genomics Approaching the Clinic Challenging Sports Cardiology Cases in Younger Athletes 8:00 a.m. 8:00 a.m. 9:30 a.m. 9:30 a.m. N228 N230 113 113

SuNDAy, MARCh 25, 2012

Oral Poster Oral Poster Symposium Experts 651 261 929 914 Diagnostic Testing: Sports Cardiology Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Diagnostic Testing: ECG and Cardiopulmonary Exercise Testing Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Role of Exercise Treadmill Testing in 2012 Cardiac Dilemmas in Athletes 8:00 a.m. 9:30 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 4:30 p.m. 9:30 a.m. 10:30 a.m. 12:15 p.m. Noon 1:45 p.m. 6:00 p.m. S402 hall A S503 hall A N230 S503 160 171 154 144

MONDAy, MARCh 26, 2012

Symposium Experts Experts 688 262 255 Challenging Sports Cardiology Cases in Older Athletes ECGs in Athletes: The Great ECG Screening Debate and Challenging Cases Stress Testing in Women 8:00 a.m. 10:30 a.m. 3:45 p.m. 9:30 a.m. Noon 5:15 p.m. N227b S502 S502 182 187 204

vALvuLAR hEART DISEASE

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Self-Directed Experts Symposium Experts Symposium Symposium Clinical Focus 1501 210 612 220 632 633 1604 Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience Organic Mitral Regurgitation Case-Management The Spectrum of Degenerative Mitral Valve: From Imaging to Treatment Ischemic Mitral Regurgitation Valve Repair: How to Achieve Success Translational Research Symposium with the International Society for Cardiovascular Translational Research: Devices Championing Care for the Patient with Aortic Stenosis: The Role of Cardiologists and Primary Care from Recognition to Recovery 9:00 a.m. 12:15 p.m. 12:15 p.m. 4:30 p.m. 4:30 p.m. 5:30 p.m. 6:30 p.m. 5:00 p.m. 1:45 p.m. 1:45 p.m. 6:00 p.m. 6:00 p.m. 6:50 p.m. 9:30 p.m. vista Room Lobby S504a N426 S504a N426 N228 113 118 118 129 129 129

Fairmont hotel, 130 Imperial Ballroom

SuNDAy, MARCh 25, 2012

Oral Self-Directed Poster Oral Poster Symposium Experts 652 238 930 915 1502 Valvular Oral Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Valvular Oral Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Controversies in Valve Disease I Aortic Stenosis Case Management 8:00 a.m. 9:00 a.m. 9:30 a.m. 10:45 a.m. 11:00 a.m. 12:30 p.m. 4:30 p.m. 9:30 a.m. 5:00 p.m. 10:30 a.m. 12:15 p.m. Noon 1:45 p.m. 6:00 p.m. N427 vista Room Lobby hall A N427 hall A N427 S504a 160 171 155 145 145

102 GO for ACC.12!

ACC.12 Program-At-A-Glance Topic Schedule

vALvuLAR hEART DISEASE

SESSION TYPE SESS. # TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012

Experts Symposium Self-Directed Experts Intl. Lunch Experts Symposium Experts Symposium 242 674 1503 246 504 251 714 256 723 Tricuspid Valve Disease Case Management Valvular Heart Disease in the Older Adult (with Many DRG Codes): Navigating the Options Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience Complications of Interventions for Valvular Heart Disease Joint Session of the Canadian Cardiovascular Society and the American College of Cardiology: Repairs/Replacement Catheter Based or (Minimally Invasive) Surgery Complex Valvular Heart Disease Calcific Aortic Stenosis: Diagnosis and Treatment in the 21st Century Advanced Hemodynamics for Valvular Heart Disease Importance of Registries for Valve Disease: A Glimpse into the ACC Future 8:00 a.m. 8:00 a.m. 9:00 a.m. 10:30 a.m. 12:15 p.m. 2:00 p.m. 2:00 p.m. 3:45 p.m. 3:45 p.m. 9:30 a.m. 9:30 a.m. 5:00 p.m. Noon 1:45 p.m. 3:30 p.m. 3:30 p.m. 5:15 p.m. 5:15 p.m. S503 S402 vista Room Lobby S505 S405 S503 N426 S503 N426 182 182 182 187 193 199 199 204 204

TuESDAy, MARCh 27, 2012

Experts 260 Aortic Regurgitation/BAV 8:00 a.m. 9:30 a.m. S504a 211

PERIPhERAL vASCuLAR, AORTIC AND CAROTID DISEASE

SESSION TYPE SESS. # TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012

Oral Poster Poster Symposium 743 931 New Insights in Peripheral Vascular Disease Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Poster presentations will be featured in this learning pathway. Refer to the Supplement to JACC: Abstracts of Original Contributions for a complete listing. Carotid Artery Disease: Is the Picture Clarifying? 8:00 a.m. 9:30 a.m. 11:00 a.m. 4:30 p.m. 9:30 a.m. 10:30 a.m. Noon 6:00 p.m. N229 hall A hall A S406a 129 113

SuNDAy, MARCh 25, 2012

Oral 932 New Insights in Perpheral Vascular Disease and Year in Review 10:45 a.m. 12:15 p.m. S504a 155

MONDAy, MARCh 26, 2012

Experts Intl. Lunch 264 514 Challenging Cases in Anticoagulation Management: Spotlight on the Novel Anticoagulants Joint Session of the Pakistan Cardiac Society and the American College of Cardiology: Vascular VTE, PHTN 10:30 a.m. 12:15 p.m. Noon 1:45 p.m. S105a S503 187 194

ACC.12 Final Program 103

Visit us at ACC Central Booth 10027

WHAT
quality chasm?
With guidelines-focused clinical registries from the NCDR, youll always know which quality improvement steps to take and when to take them.

Achieving quality care is your challenge. Take it on with NCDR.

www.ncdr.com/takeiton

NCDR is an initiative of the American College of Cardiology Foundation, with partnering support from the following organizations: CARE RegistryThe Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/ Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI RegistryThe Society for Cardiovascular Angiography and Interventions; ICD RegistryHeart Rhythm Society; IMPACT RegistryThe Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE RegistryMedAxiom; STS/ACC TVT RegistryAn initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION RegistryGWTGAn initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine. 2012 American College of Cardiology Foundation. All rights reserved. B12016

Friday, March 23 & Saturday, March 24

ACC.12

Fri., March 23 & Sat., March 24

ACC.12 Scientific Session

Friday, March 23, 2012

Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning SeSSionS
LIFELONG MOC

Session I: Global Challenge and Success in CHF Co-Chairs: Panelists: William A. Zoghbi, Houston, TX Hani Najm, Riyadh, Saudi Arabia Farida Al Habib, Sharq, Kuwait, Mohamad B. Bdeir, Riyadh, Saudi Arabia, Mahmoud Hassanein, Cairo, Egypt, Douglas L. Mann, Saint Louis, MO Myocardial Regeneration and Repair Jonathan Leor, Tel Hashomer, Israel Whats on the Horizon for Decompensated CHF Hani N. Sabbah, Detroit, MI Middle Eastern Models for Heart Failure Clinics and Centers Alessandro Salustri, Abu Dhabi, United Arab Emirates Community Wide Management of Heart Failure the Dangers of Siloed Metrics Focused on Hospitals Robert M. Califf, Durham, NC Panel Discussion: Global Challenge and Success in CHF Break Session II: Cardiometabolic Syndrome: An Epidemic that Ignores Borders, Time Zones, and Religion Co-Chairs: Panelists: Nanette Kass Wenger, Atlanta, GA Chaim Lotan, Jerusalem, Israel Ziyad Ghazzal, Atlanta, GA, Feridoun Noohi Bezanjani, Tehran, Islamic Republic of Iran, Adel El Etriby, Cairo, Egypt, Paul D. Thompson, Hartford, CT Cardiometabolic Syndrome in the Middle East: A Growing Import from the West Incidence, Trends, and Regional Challenges Jassim M. S. Al Suwaidi, Doha, Qatar Lifestyle Modification in Cardiometabolic Syndrome Alison Bailey, Lexington, KY The Crucial Role of Women in Addressing This Challenge Azin Alizadehasl, Tabriz, Islamic Republic of Iran Children Should be the Target to Reverse This Challenge Michele Mietus-Snyder, Washington, DC Panel Discussion: Cardiometabolic Syndrome An Epidemic That Ignores Borders, Time Zones and Religion Introduction to Collaborative Research Project Omar Mahmoud Lattouf, Atlanta, GA Wrap Up Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt, William A. Zoghbi, Houston, TX, Hani Najm, Riyadh, Saudi Arabia, Nanette Kass Wenger, Atlanta, GA, Chaim Lotan, Jerusalem, Israel

801

ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy ACC Self Assessment Session: Update in Clinically Relevant Guidelines and Trials Friday, March 23, 2012, 7:30 a.m. 10:00 a.m. McCormick Place South, S105a CME/CNE Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module.

Morning

8:45 9:00 9:15

9:30

9:45 10:00

10:15

10:30 10:45

Co-Chairs: Question Moderators:

SPECIAL SyMPOSIUM

Patrick T. OGara, Boston, MA Rick A. Nishimura, Rochester, MN James Fang, Cleveland, OH Steve R. Ommen, Rochester, MN 4th Annual Cardiovascular Conference Focus on the Middle East Friday, March 23, 2012, 8:00 a.m. Noon McCormick Place South, S101a CME/CNE Hours: 3.75 Aaron D. Kugelmass, Springfield, MA Mohamed Sobhy Aly, Alexandria, Egypt Introduction, Overview, Reflection on Program Huon Gray, Southampton, United Kingdom, David R. Holmes, Jr., Rochester, MN, Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt Plenary Lecture: Sudden Death: What Do We Know? Douglas P. Zipes, Indianapolis, IN

11:00 11:15

746

11:30 11:45

Co-Chairs: 8:00

8:15

ACC.12 Final Program 105

Friday, March 23, 2012 ACC.12

Afternoon SeSSionS
SPECIAL LEGENDS

400

Legends of Cardiovascular Medicine: Roundtable Forum and Reception (By Invitation Only) Friday, March 23, 2012, 1:30 p.m. 5:30 p.m. McCormick Place South, S100c CME/CNE Hours: 3 Anthony N. DeMaria, San Diego, CA Introduction of Eugene Braunwald, MD, MACC Presentation by Eugene Braunwald, MD, MACC Eugene Braunwald, Boston, MA Introduction of Antonio Colombo, MD, FACC Presentation by Antonio Colombo, MD, FACC Antonio Colombo, Milan, Italy Introduction of Valentin Fuster, MD, PhD, MACC Presentation by Valentin Fuster, MD, PhD, MACC Valentin Fuster, New York, NY Introduction of Jane Somerville, MD, FACC Presentation by Jane Somerville, MD, FACC Jane Somerville, London, United Kingdom Introduction of Magdi H. yacoub, MB, BCh, FACC Presentation by Magdi H. yacoub, MB, BCh, FACC Magdi H. Yacoub, Harefield, Middlesex, United Kingdom Panel Discussion and Audience Question and Answer Private Reception Immediately Follows in Faculty Lounge S100a

Chair: 1:30 1:35 1:55 2:00 2:20 2:25 2:45 2:50 3:10 3:15

3:35 4:30

AFTERNOON

106 GO for ACC.12!

ACC.12 Scientific Session

Saturday, March 24, 2012

Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning SeSSionS
ACC-i2/TCT SyMPOSIUM

2644

Interventional Featured Clinical Studies I Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S102b CME/CNE Hours: 1.5 George D. Dangas, New York, NY Ted Feldman, Evanston, IL Matthew J. Price, La Jolla, CA, Jan Kovac, Leicestershire, UK Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel (RESET Trial) GENNARO SARDELLA, Simone Calcagno, Carlotta De Carlo, Mauro Pennacchi, Filippo Placentino, Rocco Stio, Massimo Mancone, Luigi Lucisano, Emanuele Canali, Francesco Fedele, Dept.Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy Panel Discussion A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-months Dual Antiplatelet Therapy following Endeavor Zotarolimus-eluting Stent Implantation Myeong-Ki Hong, Byeong-Keuk Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Jung-Han Yoon, Hyuck-Moon Kwon, Yangsoo Jang, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea Panel Discussion Treatment of High Risk Aortic Stenosis Patients with Transcatheter Medtronic CoreValve Implantation: Results from the International Multi-center ADVANCE Study Axel Linke, Ulrich Gerckens, Peter Wenaweser, Corrado Tamburino, Johan Bosmans, Stephen Brecker, Robert Bauernschmitt, University of Leipzig Heart Center, Leipzig, Germany Panel Discussion First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel Response Variability: Results of the Genotype Information and Functional Testing (GIFT) EXOME Study Matthew J. Price, Andrew R. Carson, Sarah S. Murray, Tierney Phillips, Lee Janel, Rebecca Tisch, Eric Topol, Samuel Levy, Scripps Translational Science Institute, La Jolla, CA, Scripps Clinic, La Jolla, CA Panel Discussion Long-term Outcomes following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience Josep Rodes-Cabau, John Webb,
ACS ORAL

Co-Chairs: Panelists: 8:00

Anson Cheung, Jian Ye, Eric Dumont, Feindel Chris, mark osten, Madhu Natarajan, James L. Velianou, Giussepe Martucci, Benoit DeVarennes, Chris R. Thompson, Robert Chisholm, Mark Peterson, Samuel Lichtenstein, Stefan Toggweiler, Daniel Doyle, Robert DeLarochellire, Jean Dumesnil, Kevin Teoh, Victor Chu, Asim Cheema, David Wood, Philippe Pibarot, Eric Horlick, Quebec Heart and Lung Institute, Quebec, Canada, St. Pauls Hospital, Vancouver, Canada 9:10 9:15 Panel Discussion A Double-blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis Antonio Colombo, Ugo Limbruno, corrado lettieri, Ernesto Lioy, Angelo Guglielmotti, Marco Calabresi, Marco Valgimigli, Daniela Pierucci, San Raffaele Hospital, Milan, Italy Panel Discussion
ACS EXPERTS

Morning

9:25

8:10 8:15

200

Contemporary Management of UA/NSTEMI Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S504a CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-065-L01-P Keith A. A. Fox, Edinburgh, Scotland, United Kingdom Eric R. Bates, Ann Arbor, MI, James M. Brophy, Montreal, Canada, Roxana Mehran, New York, NY, Charanjit S. Rihal, Rochester, MN P2y12 Antagonists: Unraveling the Mechanisms and Optimizing Benefit-Risk Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S406b CME/CNE Hours: 1.5 Anthony Gershlick, Leicester LE3 9QP, United Kingdom, Glenn A. Hirsch, Baltimore, MD 9023 Timing and Clinical Setting of Cardiovascular Death or Myocardial Infarction following PCI for ACS: Observations from the TRITON-TIMI 38 Trial Benjamin Scirica, David Morrow, Elliott Antman, Marc Bonaca, Sabina Murphy, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham and Womens Hospital, Boston, MA 9024 Prasugrel 5 Mg in Low Body Weight Patients Reduces Platelet Reactivity to a Similar Extent as Prasugrel 10 Mg in Higher Body Weight Patients: Results from the FEATHER Trial David Erlinge, Jurrien Ten Berg, David Foley, Dominick Angiolillo, Patricia Brown, Henrik Wagner, Chunmei Zhou, Joe Jakubowski, Thomas Bergmeijer, Stefan James, Kenneth Winters, Department of Cardiology, Lund, Sweden

Chair: Panelists:

Case Presenter: Vamsi Krishna, Los Angeles, CA

8:25 8:30

902

Co-Chairs: 8:00

8:40 8:45

8:13

8:55 9:00

ACC.12 Final Program 107

Saturday, March 24, 2012 ACC.12

8:26 9025 Discharge Aspirin Dose and Clinical Outcomes in Patients with ACS: An Analysis from the TRITON-TIMI 38 Study Payal Kohli, Jacob Udell, Sabina Murphy, Elliott Antman, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham & Womens Hospital, Boston, MA 9026 Restoring Platelet Function Ex Vivo by Adding Fresh Platelets within 24-hours of a Prasugrel 60 mg Loading Dose M. Urooj Zafar, Carlos Santos-Gallego, David Vorchheimer, Juan Viles-Gonzalez, Sammy Elmariah, Chiara Giannarelli, David Small, Joseph Jakubowski, Valentin Fuster, Juan Badimon, Mount Sinai School of Medicine, New York, NY, Eli Lilly and Company, Indianapolis, IN 9027 Adenosine May Mediate Ticagrelor-Induced Dyspnea Li-ming Gan, Ann Wittfeldt, Hakan Emanuelsson, Sven Nylander, Jenny Jonasson, Institute of Clinical and Molecular Medicine, Sahlgrenska Academy at Gteborg University, Gteborg, Sweden 9028 Effect of Upstream Clopidogrel Treatment on Infarct Size and Microvascular Obstruction Assessed by CMR in Patients with STEMI Undergoing Primary PCI Suzanne de Waha, Ingo Eitel, Steffen Desch, Georg Fuernau, Philipp Lurz, Gerhard Schuler, Holger Thiele, University of Leipzig Heart Center, Department of Internal Medicine Cardiology, Leipzig, Germany
ACS ORAL

8:45

8:39

9036 Early Short-term Doxycycline Therapy in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction and the Ominous Progression to Adverse Remodeling (TIPTOP): A Randomized Controlled Trial Giampaolo Cerisano, Piergiovanni Buonamici, Renato Valenti, Roberto Sciagr, Silvia Raspanti, Nazario Carrabba, Alberto Santini, Emilio Vincenzo Dovellini, David Antoniucci, Careggi Hospital, Florence, Italy 9037 Ticagrelor versus Prasugrel in Acute Coronary Syndrome Patients with High on Clopidogrel Treatment Platelet Reactivity Post PCI: A Pharmacodynamic Study Dimitrios Alexopoulos, Ioanna Xanthopoulou, Eleni Mavronasiou, Anastasia Galati, George Kassimis, Konstantinos C. Theodoropoulos, George Makris, Anastasia Damelou, Grigorios Tsigkas, Periklis Davlouros, George Hahalis, Patras University Hospital, Patras, Greece 9038 Pharmacodynamics of Vorapaxar, a Platelet PAR-1 Antagonist, and Its Interaction with P2y12 Receptor Pathway in the TRACER Trial Lisa K. Jennings, David Moliterno, Robert Storey, Edward Hord, Jayaprakash Kotha, Richard Becker, Susan Smyth, Luis Providencia, Tiziano Moccetti, Marco Valgimigli, Jean-Pierre Dery, J.H. Cornel, Gregory Thomas, Kurt Huber, Edmond Chen, John Strony, Tyrus Rorick, Pierluigi Tricoci, Kenneth Mahaffey, CirQuest Labs and the Department of Medicine, University of Tennessee Health Science Center, Memphis, TN
ARR

9:00

Morning

8:52

9:15

9:05

903

New Therapeutic Options in ACS: From Antiplatelets to Antibiotics Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S402 CME/CNE Hours: 1.5 David P. Faxon, Boston, MA Shamir R. Mehta, Hamilton, Canada 9033 Intracoronary Stem Cell Therapy in Patients with Acute Myocardial Infarction: 36-month Results of a Randomized, Double-blind, Placebo Controlled Trial with Serial MRI Follow-ups Jochen Woehrle, Fabian von Scheidt, Sinisa Markovic, Peter Schauwecker, Klaus Schwarz, Markus Wiesneth, Hubert Schrezenmeier, Vinzenz Hombach, Wolfgang Rottbauer, Peter Bernhardt, University of Ulm, Ulm, Germany 9034 Transradial versus Transulnar Artery Coronary Interventions: A Randomized Study George Hahalis, Ioanna Xanthopoulou, Grigorios Tsigkas, Theodora E. Plakomyti, Anastasia Galati, Periklis Davlouros, Christos Pappas, Nikolaos Grapsas, Dimitrios Alexopoulos, Patras University Hospital, Patras, Greece 9035 Panacea or Personalized Medicine? Optimizing Antiplatelet Therapy in Acute Coronary Syndrome: A Cost-effectiveness Analysis Dhruv Kazi, Alan M. Garber, Rashmee Shah, Ceron Rhee, Solomon Moshkevich, Matthew W. Mell, MD, Derek Boothroyd, Douglas K. Owens, Mark Hlatky, Stanford University, Stanford, CA, Veterans Affairs Medical Center, Palo Alto, CA

EXPERTS

201

How to Manage a Device/Lead Advisory Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Robert G. Hauser, Minneapolis, MN Andrew E. Epstein, Philadelphia, PA, David L. Hayes, Rochester, MN, Randall J. Lee, San Francisco, CA Complex Issues Facing ACHD Patients: Obstructive Lesions Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S105a CME/CNE Hours: 1.5 Curtis J. Daniels, Columbus, OH Gary D. Webb, Cincinnati, OH, Eric V. Krieger, Boston, MA Michael Earing, Milwaukee, WI, Wayne J. Franklin, Houston, TX, Michelle Gurvitz, Boston, MA, Craig S. Broberg, Portland, OR, Angela T. Yetman, Salt Lake City, UT

Co-Chairs: 8:00

Chair: Panelists:

Case Presenter: Kenneth A. Ellenbogen, Richmond, VA

CCS SyMPOSIUM

202

8:15

Co-Chairs:

Case Presenter: Eric V. Krieger, Boston, MA Panelists:

8:30

108 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

CCS MOC

802

ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment Saturday, March 24, 2012, 8:00 a.m. 10:00 a.m. McCormick Place South, S105d CME Hours: 2 Please refer to the full session listing, listed on page 111, for additional session information.

8:30

9055 Association of Total and High-MolecularWeight Adiponectin with New-Onset Heart Failure in Older Adults: The Cardiovascular Health Study Maria G. Karas, David Benkeser, Alice M. Arnold, Luc Djousse, Susan Zieman, Kenneth J. Mukamal, Russell Tracy, Christos S. Mantzoros, David Siscovick, John Gottdiener, Joachim Ix, Jorge Kizer, Weill Cornell Medical College, New York, NY 9056 Echocardiographic and Biomarker Phenotype of Heart Failure with Preserved Ejection Fraction (HFPEF) in Older Individuals in Comparison to Hypertension without Heart Failure (HTN), Elderly with Risk Factors and Healthy Aging: Importance of Myocyte Injury, Fibrosis, LV Hypertrophy and Diastolic Load John S. Gottdiener, Traci Bartz, Christopher DeFilippi, Willem Kop, Dalane Kitzman, Eddy Barasch, Stephen Seliger, Donald Lloyd-Jones, University of Maryland School of Medicine, Baltimore, MD 9057 Post-Exercise Levels of Biomarkers of Cardiomyocyte Stress Improve Prediction of Adverse Outcomes in Patients with Advanced Heart Failure Petr Jarolim, Michael J. Conrad, David Morrow, John Rozehnal, Martin Kotrc, Josef Kautzner, Vojtech Melenovsky, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, Institute of Clinical and Experimental Medicine, Prague, Czech Republic 9058 Concentric Left Ventricular Hypertrophy as Independent Predictor of 1-year Rehospitalization and Mortality in Patients Hospitalized for Acute Heart Failure and Preserved Ejection Fraction Liang Zhong, Yee How Lau, Ling Ling Sim, David Sim, Bernard Kwok, Terrance Chua, Raymond Lee, Ru-San Tan, National Heart Centre Singapore, Singapore, Singapore, Novena Heart Centre Singapore, Singapore
HF ORAL

8:45

Morning

HF EXPERTS

203

The Latest in Heart Failure with Preserved Ejection Fraction Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S502 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-067-L01-P James C. Fang, Cleveland, OH 9:00 Barry Borlaug, Rochester, MN, Anita Deswal, Houston, TX, William Little, Winston Salem, NC, Margaret M. Redfield, Rochester, MN, Patricia Uber, Baltimore, MD Pharmacology Program: Pharmacotherapy of Chronic Heart Failure Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N427 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-148-L04-P Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL Jesus Almendral, New Brunswick, NJ, Akshay S. Desai, Boston, MA, Narith Ou, Rochester, MN, Jo E. Rodgers, Chapel Hill, NC Pharmacotherapy of Chronic Heart Failure David Parra, West Palm Beach, FL Panel Discussion

Chair: Panelists:

Case Presenter: David Aguilar, Houston, TX

HF SyMPOSIUM

732

9:15

Co-Chairs: Panelists:

8:00 9:00
HF ORAL

906

905

Predicting Outcomes in Heart Failure: Biomarkers and Beyond Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S405 CME/CNE Hours: 1.5 Maya E. Guglin, Tampa, FL 9053 Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community Jennifer Ho, Chunyu Liu, Asya Lyass, Paul Courchesne, Michael Pencina, Vasan Ramachandran, martin larson, Daniel Levy, Framingham Heart Study, Framingham, MA 9054 Long-term Trajectory of Two Unique Cardiac Biomarkers and Subsequent Left Ventricular Structural Pathology and Risk of Incident Heart Failure in Community Dwelling Older Adults Christopher R. DeFilippi, Danielle Glick, Robert Christenson, John Gottdiener, Stephen Seliger, University of Maryland School of Medicine, Baltimore, MD

Pathogenic and Therapeutic Insights from Experimental Heart Failure Models Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S404 CME/CNE Hours: 1.5 Biykem Bozkurt, Houston, TX Javed Butler, Atlanta, GA 9063 Connexin43 Expression Is Essential for Functional Cardiomyogenic Differentiation of Human Fetal Mesenchymal Stem Cells Arti Ramkisoensing, Danil Pijnappels, Martin Schalij, Antoine de Vries, Douwe Atsma, Leiden University Medical Center, Leiden, The Netherlands 9064 An Injectable Acellular Capillary Hydrogel Improves Left Ventricular Function after Myocardial Infarction Domenico G. Della Rocca, Bradley J. Willenberg, Leonardo F. Franklin, Stacy L. Porvasnik, John W. Petersen, Prateek S. Wate, Eileen M. Handberg, Gregory Schultz, Francesco Romeo, Christopher D. Batich, Barry J. Byrne, Carl J. Pepine, University of Florida, Gainesville, FL

Co-Chairs: 8:00

Chair: 8:00

8:15

8:15

ACC.12 Final Program 109

Saturday, March 24, 2012 ACC.12

8:30 9065 Characterization and Biocompatibility of Perfusion-Decellularized Human Heart Matrix: Toward Bioengineering Perfusable Human Heart Grafts Pedro L Sanchez, M Eugenia FernandezSantos, Salvatore Costanza, Hugo Rodrguez-Abella, Stefan Kren, Gregorio Garrido, Jose Luis Escalante, Rafael Matesanz, Doris Taylor, Fernandez-Aviles Francisco, Hospital General Universitario Gregorio Maraon, Madrid, Spain, University of Minnesota, Minneapolis, MN 9066 Mechanical Unloading with Left Ventricular Assist Device after Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling Xufeng Wei, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 9067 Calcium Cycling Protein S100A1 Does not Recover Following Continuous-flow Left Ventricular Assist Device Support of the Failing Human Heart Mosi Kadin Bennett, Wendy Sweet, Wai Hong Tang, Maria Mountis, Randall Starling, Christine Moravec, Cleveland Clinic, Cleveland, OH 9068 Lack of Cardiac Myosin Binding Protein-C Phosphorylation Is a Model of Heart Failure with Preserved Ejection Fraction Carl Wei-Chan Tong, Mohamed I. Abdalla, Xin Wu, yang liu, Mariappan Muthuchamy, Richard Moss, Texas A&M Health Science Center College of Medicine, Temple, TX, University of Wisconsin School of Medicine and Public Health, Madison, WI
IMAG EXPERTS

Resonance Study Tevfik Fehmi Ismail, Andrew Jabbour, Francisco D. Alpendurada, Niraj Mistry, Benjamin Hewins, Amy Mallorie, Natasha Davendralingam, Ankur Gulati, Ricardo Wage, Dudley Pennell, Sanjay Prasad, Royal Brompton Hospital, London, United Kingdom 8:30 9085 Infarct Heterogeneity Is an Independent and Incremental Predictor of Mortality in Patients with Severe Ischemic Cardiomyopathy Lisa Asamoto, Rory Hachamovitch, Zoran Popovic, Randall Starling, Scott Flamm, Thomas Marwick, Deborah Kwon, Cleveland Clinic, Cleveland, OH 9086 Necrosis and Ischemia for Risk Stratification in Patients with Known or Suspected Ischemic Cardiomyopathy: Study with Stress Cardiac Magnetic Resonance Clara Bonanad, Vicente Bodi, M Pilar Lpez, JVicente Monmeneu, Juan Sanchis, Julio Nunez, Fabian Chaustre, Angel Llacer, Clara Bonanad, Valencia, Spain 9087 Fractional Flow Reserve Correlates with Blood Oxygen Level-Dependent (BOLD) Magnetic Resonance Imaging in Coronary Artery Disease Peter Bernhardt, Wolfgang Rottbauer, Jochen Woehrle, University of Ulm, Ulm, Germany 9088 Aortic Biomechanics by MRI: Relation with Age, Gender and Traditional Cardiovascular Risk Factors A Cross-sectional and Longitudinal Study: The Multi-Ethnic Study of Atherosclerosis (MESA) Gisela Teixido, Atul Chugh, Alban Redheuil, Chia Ying Liu, Richard Stacey, Colin Wu, Harry Dietz, Antoinette Gomes, Martin Prince, Artur Evangelista, Greg Hundley, David Bluemke, Joao Lima, Hospital Universitari vall dHebron, Barcelona, Spain, Johns Hopkins Hospital, Baltimore, MD
IMAG ORAL

Morning

8:45

8:45

9:00

9:00

9:15

9:15

204

Multimodality Imaging in Evaluation of Prosthetic Valve Function Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S505 CME/CNE Hours: 1.5 James G. Jollis, Durham, NC
909

Chair:

Case Presenters: Julie Damp, Nashville, TN, Jennifer Dickerson, Columbus, OH Panelists: Paul A. Grayburn, Dallas, TX, Fletcher A. Miller, Rochester, MN, David Orsinelli, Columbus, OH A Better Understanding of Ischemia and Function: Insights from Cardiac MRI Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S403 CME/CNE Hours: 1.5 Rosario Freeman, Seattle, WA Issam A. Mikati, Chicago, IL 9083 Quantification of Absolute Myocardial Perfusion in Patients with Coronary Artery Disease: Comparison between Cardiac Magnetic Resonance and Positron Emission Tomography Geraint Morton, Amedeo Chiribiri, Masaki Ishida, Shazia Hussain, Andreas Schuster, Andreas Indermuehle, Divaka Perera, Erik Hedstrom, Sally Barrington, Eike Nagel, Kings College London, London, United Kingdom 9084 Prevalence and Significance of Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic 8:15

New Imaging Approaches to Atherosclerosis and the Microcirculation Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Robert W.W. Biederman, Pittsburgh, PA Prem Soman, Pittsburgh, PA 9093 Assessing Mild Coronary Atherosclerosis by Means of Transthoracic Enhanced Doppler Echocardiography in Convergent Color Doppler Mode: A Validation Study versus Intravascular Ultrasound Carlo Caiati, Mario Lepera, Daniela Santoro, Marco Marzullo, Stefano Giuseppe Primitivo, Paolo Pollice, Caterina Rizzo, Filippo Masi, Donato Guagliara, Stefano Favale, Bari, Italy 9094 Arrest of Atherosclerotic Progression and Reduction in Inflammatory Burden by Long-term Apocynin Treatment: Molecular and Ultrasound Imaging of Vascular Phenotype Ya Ni Liu, Brian Davidson, Qi Yue, Yan Zhao, Todd Belcik, Aris Xie, Yoichi Inaba, Ruggeri M. Zaverio, Beat Kaufmann, Jonathan Lindner, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Peoples Republic of China, Oregon Health and Science University, Portland, OR

Co-Chairs: 8:00

IMAG ORAL

908

Co-Chairs: 8:00

8:15

110 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

8:30 9095 Correlation of Vasa Vasorum and Plaque Progression and Response to Atorvastatin Therapy an a Rabbit Model of Atherosclerosis: In Vivo Intravascular Ultrasound and Contrast-Enhanced Ultrasound Imaging Study JinWei Tian, Sining Hu, Haibo Jia, Jingbo Hou, Shaosong Zhang, Bo Yu, Ik-Kyung Jang, The Second Affiliated Hospital of Harbin Medical University, Haerbin, Peoples Republic of China, Massachusetts General Hospital, Harvard Medical School, Boston, MA 9096 Incremental Diagnostic Value of Dynamic CT-based Myocardial Perfusion Imaging for the Detection of Hemodynamic Relevant Coronary Artery Stenosis as Determined by Fractional Flow Reserve Alexander Becker, Fabian Bamberg, Martin Greif, Franz von Ziegler, Christoph Becker, University of Munich, Munich, Germany 9097 Early Detection of Severe Microvascular Dysfunction with Multidetector Computed Tomography Immediately after Primary Angioplasty in Patients with Acute Myocardial Infarction Koichi Tamita, Shuichiro Kaji, Toshiharu Iwamura, Mika Maeda, Toshiki Fujiwara, Junichi Yoshikawa, Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan, Kobe City Medical Center General Hospital, Kobe, Japan 9098 Computed Tomography Angiography-Derived Coronary Plaque Arc Calcification is Associated with Culprit Lesion Status in Acute Coronary Syndromes Rani K. Hasan, Andrea Vavere, Carlos Rochitte, Armin Arbab-Zadeh, Ilan Gottlieb, John Texter, Marc Dewey, Hiroyuki Niinuma, Melvin Clouse, Joao Lima, Jeffrey Brinker, Julie Miller, Johns Hopkins University, Baltimore, MD Sex, Scoring, Sadness, Statins, Stents and Surgery Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N227b CME/CNE Hours: 1.5 Joaquin Cigarroa, Portland, OR Adolph M. Hutter, Boston, MA 9103 Gender Effects on Coronary Microvascular Dysfunction in Patients with Suspected Coronary Artery Disease Venkatesh Murthy, Masanao Naya, Sharmila Dorbala, Ron Blankstein, Marcelo Di Carli, Brigham & Womens Hospital, Boston, MA 9104 Combined Anatomical and Clinical Factors for the Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention: The Logistic Clinical SyNTAX Score Vasim Farooq, Yvonne Vergouwe, Lorenz Raber, Pascal Vrancx, Hector Garcia, Salvatore Brugaletta, A. Kappetein, Marie-angle Morel, Ton de Vries, Michael Swart, Keith Dawkins, Marco Valgimigli, Stephan Windecker, Ewout W. Steyerberg, Patrick Serruys, Thorax Center, Rotterdam, The Netherlands 9105 Do Behavioral Risk Factors Explain the Association Between Depressive Symptoms and Cardiovascular Risk In Individuals with Coronary Heart Disease? Report from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Siqin Ye, Paul Muntner, Daichi Shimbo, Joshua Richman, Suzanne Judd, Karina Davidson, Monika Safford, Columbia University Medical Center, New York, NY, University of Alabama at Birmingham, Birmingham, AL 8:45 9106 The Clinical Benefit of Therapies That Raise High-density Lipoprotein Cholesterol Added to Treatment with a Statin Brian Anthony Ference, Nitin Mahajan, Wonsuk Yoo, Luis Afonso, John Flack, Wayne State University School of Medicine, Detroit, MI 9107 Long-term Mortality following Coronary Artery Bypass Graft Surgery and Stenting with Drug-eluting Stents Chuntao Wu, Songyang Zhao, Fabian T. Camacho, Edward Hannan, Penn State Hershey College of Medicine, Hershey, PA, University at Albany School of Public Health, State University of New York, Rensselar, NY 9108 Impact of Interventional versus Conservative Approach on 5-year Mortality of Patients with Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry Anselm K. Gitt, Uwe Zeymer, Andrea Papp, Ralf Zahn, Jochen Senges, STARStudy-Group, Herzzentrum Ludwigshafen, Ludwigshafen, Germany, Institut f. Herzinfarktforschung Ludwigshafen an der Universitaet Heidelberg, Ludwigshafen, Germany ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy 2011 Pediatric Cardiology Subspecialty Self-Assessment Saturday, March 24, 2012, 8:00 a.m. 10:00 a.m. McCormick Place South, S105d CME/CNE Hours: 2 The American College of Cardiology Foundation (ACCF) and the American Board of Pediatrics have joined forces to help pediatric cardiologists attending ACC.12 earn Maintenance of Certification (MOC) credit. Tickets are required for entrance to the session and attendance is limited. If you have not registered in advance, please visit the session in advance of the session to check to availability. Participants must be registered as an ABP diplomate and enrolled at the time of the session in the ABP MOC process. For information about enrolling as an ABP diplomate in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio. Each session registrant must bring his/her own laptop, set up to receive Wi-Fi access. All attendees should program and test the laptop prior to the ABP MOC session to ensure 1) the laptop will receive the convention centers wireless signal 2) the attendees ABP portfolio can be accessed. During the program, each attendee will submit ABP MOC module answers electronically through the ABP website. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. No ACC.12 Final Program 111

8:45

Morning

9:00

9:00

9:15

9:15

LIFELONG MOC

802

ISCHEM ORAL

910

Co-Chairs: 8:00

8:15

8:30

Saturday, March 24, 2012 ACC.12

paper copies of the module will be provided. Attendees will not be able to leave the room with notes, answers or other relevant session discussion. 10 MOC credits are available for this activity. Chair: Steven R. Neish, San Antonio, TX MOC Faculty: Mark B. Lewin, Seattle, WA, Karen K. Stout, Seattle, WA
PRACTICE SyMPOSIUM SPECIAL SPECIAL

300

ACC.12 Opening Showcase and Late-Breaking Clinical Trials Saturday, March 24, 2012, 8:00 a.m. 10:00 a.m. McCormick Place North, Hall B, ACC.12 Main Tent CME/CNE/CPE Hours: 2 ACPE No. 0012-9999-12-132-L04-P Join us for the ACC.12 Opening Showcase session, which welcomes attendees to Chicago! The session will feature the Presidential Address from David R. Holmes, Jr., MD, FACC. The 2012 Simon Dack Lecture will be presented, as part of our Legends of Cardiovascular Medicine Series, by Eugene Braunwald, MD, MACC. In addition, you wont want to miss the groundbreaking late-breaking clinical trials presented as part of this exciting showcase session.

Morning

600

Cardiology Procedures 2012: How to Code and Get Reimbursed Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N231 CME/CNE Hours: 1.5 James C. Blankenship, Danville, PA Kenneth P. Brin, Loves Park, IL Whats New in Coding? CPT Codes for 2012 Robert N. Piana, Nashville, TN Questions and Answers Getting Paid in 2012: Upcoming Changes in Reimbursement James C. Blankenship, Danville, PA Questions and Answers Breaking the Code: Tips and Tricks on Coding and Reimbursement Linda Gates-Striby, Indianapolis, IN Questions and Answers Peek into the Future: Coding and Reimbursement Initiatives in 2013 Kenneth P. Brin, Loves Park, IL 8:12 8:00 8:04 8:10

Co-Chairs: 8:00 8:20 8:25 8:45 8:50 9:10 9:15

Opening Video and National Anthem Welcome, Introductions and Acknowledgements David R. Holmes, Jr., Rochester, MN Introduction of Keynote Lecturer David R. Holmes, Jr., Rochester, MN Simon Dack Lecture: The Treatment of Acute Myocardial Infarction Into the Second Century Eugene Braunwald, Boston, MA ACC Presidential Address David R. Holmes, Jr., Rochester, MN Late-Breaking Clinical Trial Presentations David R. Holmes, Jr., Rochester, MN Roberto Bolli, Louisville, KY, Robert M. Califf, Durham, NC, Eduardo Marban, Los Angeles, CA, Andreas M. Zeiher, Frankfurt, Germany Opening Remarks David R. Holmes, Jr., Rochester, MN Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial Emerson C. Perin, James Willerson, Stephen Ellis, Timothy Henry, Carl Pepine, David Zhao, Dejian Lai, Barry Byrne, Antonis Hatzopoulos, Marc Penn, Jay Traverse, Adrian Gee, Marvin Kronenberg, Daniel Martin, James Thomas, Doris Taylor, Christopher Cogle, Sonia Skarlatos, Lem Moye, Robert Simari, Cardiovascular Cell Therapy Research Network (CCTRN), Houston, TX Panel Discussion Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2P) TIMI 50 Trial David A. Morrow, Brigham & Womens Hospital, Boston, MA Panel Discussion Closing Remarks David R. Holmes, Jr., Rochester, MN

8:37 9:00 Chair: Panelists:

QUAL EXPERTS

205

Am I Placing Inappropriate ICDs and Stents?: Recent Registry Surprises Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Frederick A. Masoudi, Denver, CO Paul Chan, Kansas City, MO, Manesh R. Patel, Durham, NC, Khether E. Raby, Stoneham, MA, Bruce L. Wilkoff, Cleveland, OH Patient-Centered Care: The New Imperative Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Blair D. Erb, Bozeman, MT Mary Norine Walsh, Indianapolis, IN Patients are More than a P-value Bray Patrick-Lake, Boulder, CO CardioSmart: An Extension of your Practice Joanne M. Foody, Boston, MA Engaging Patients through the Community Andrew M. Freeman, Denver, CO Partnering with your Patient Suzanne Hughes, Hudson, OH Shared Decision Making for Patients William R. Lewis, Cleveland, OH Question and Answer

Chair: Panelists:

9:05 9:08

Case Presenter: Paul D. Varosy, Denver, CO

QUAL SyMPOSIUM

601

Co-Chairs: 8:00 8:16 8:32 8:48 9:04 9:20

9:23 9:30

9:46 9:53

112 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

TEST SyMPOSIUM

602

Translational Research Symposium with the International Society for Cardiovascular Translational Research: New Breakthroughs in Cardiovascular Genomics: Approaching the Clinic Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Jennifer L. Hall, Minneapolis, MN 9p21: A Major Genetic Predictor of Cardiovascular Disease Function and Application Robert Roberts, Ottawa, Canada Genetic Testing: How it All Fits Robert Superko, Alameda, CA, Geoffrey S. Ginsburg, Durham, NC Advances in Genomic Biomarkers and Diagnostics Geoffrey S. Ginsburg, Durham, NC Proteomics Role in Personalized Medicine Jennifer Van Eyk, Baltimore, MD Panel Discussion

8:15

9314 Long-term Efficacy of Endovascular Treatment for Patients with Critical Limb Ischemia Due to Isolated below the Knee Lesions Kiyonori Nanto, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Kansai Rosai Hospital, Amagasaki, Japan 9315 Dual Antiplatelet Therapy Responsiveness in Patients Undergoing Percutaneous Revascularization for Peripheral Arterial Occlusive Disease Chad Kliger, Anvar Babaev, Binita Shah, Frederick Feit, James Slater, Michael Attubato, Lenox Hill Heart and Vascular Institute, New York, NY, New York University School of Medicine, New York, NY 9316 Impact of Perioperative Complication after Aortoiliac Stenting for Patients with Peripheral Artery Disease Kei Sato, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Masaaki Uematsu, Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan 9317 The S Curve: A Novel Morphological Finding in the Internal Carotid Artery in Patients with Fibromuscular Dysplasia Sanjum S. Sethi, Joe Lau, Phillip Erwin, Susan Gustavson, Jeffrey Olin, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 9318 Peripheral Artery Dissection in Patients with Fibromuscular Dysplasia: A Report from the United States Fibromuscular Dysplasia Patient Registry Jeffrey W. Olin, Xiaokui Gu, James Froehlich, J. Michael Bacharach, Kim Eagle, Bruce Gray, Mark Grise, Michael Jaff, Soo Hyun Kim, Eva Kline-Rogers, Pamela Mace, Alan Matsumoto, Robert McBane, Heather Gornik, Mount Sinai School of Medicine, New York, NY
VALV

Chair: 8:00

8:30

Morning

8:20 8:30 8:40 9:00

TEST SyMPOSIUM

8:45

603

Challenging Sports Cardiology Cases in younger Athletes Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N230 CME/CNE Hours: 1.5 Anne M. Dubin, Palo Alto, CA Reginald L. Washington, Denver, CO Case Presentation: 17 year-old Collegiate Soccer Player with Long QT Martin ORiordan, Ardmore, PA Abnormal ECGs in Adolescent Athletes: Long QT, WPW, Brugada Anne M. Dubin, Palo Alto, CA Case Presentation: 35 year-old Rugby Player with Syncope and Frequent PVC/NSVT Mike Slawnych, Calgary, Canada Sports Cardiology for the Faint-Hearted: The Athlete with Syncope Domenico Corrado, Padova, Italy Case Presentation: 21 year-old Male Basketball Player with Hyper Trabeculated LV Joseph Jenkins Thompson, Lexington, KY Is It Athletic Heart Syndrome or Pathological Hypertrophy? Aaron L. Baggish, Boston, MA

9:00

Co-Chairs: 8:00 8:05 8:30

9:15

8:35 9:00

SELF-DIRECTED

1501

9:05

Heart Songs at ACC.12: A Self-Paced Multimedia Learning Experience Saturday, March 24, 2012, 9:00 a.m. 5:00 p.m. McCormick Place, Vista Room Lobby CME/CNE Hours: 2 Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod Touch, iPad or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video ACC.12 Final Program 113

VASC ORAL

931

New Insights in Peripheral Vascular Disease Saturday, March 24, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N229 CME/CNE Hours: 1.5 James B. Froehlich, Ann Arbor, MI 9313 Long-term Coffee Consumption Is Associated with Improved Endothelial Function in Elderly Individuals: Ikaria Study Evangelos Oikonomou, Gerasimos Siasos, Christine Chrysohoou, Dimitris Tousoulis, Marina Zaromitidou, Elias Gialafos, Konstantinos Zisimos, Stamatios Kioufis, Georgios Marinos, Nikolaos Papageorgiou, Athanasios G. Papavassiliou, Christos Pitsavos, Christodoulos Stefanadis, University of Athens Medical School, Department of Cardiology, Hippokration General Hospital, Athens, Greece

Chair: 8:00

Saturday, March 24, 2012 ACC.12

program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individuals need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds. Co-Chairs: Michael J. Barrett, Blue Bell, PA, Ginger K. OSullivan, Allentown, PA, Matthew W. Martinez, Allentown, PA, Justin Roberts, Allentown, PA From Targeting Errors to UNOS: How Quality and Databases Can Impact Clinical Care Saturday, March 24, 2012, 10:30 a.m. Noon McCormick Place South, S105a CME/CNE Hours: 1.5 Robert H. Beekman, Cincinnati, OH Ralf Holzer, Columbus, OH 9013 Improving Survival By Targeting Errors Frederic Jacques, Osami Honjo, Michael-Alice Moga, Francesco Grasso, Kenji Baba, Edward Hickey, Tilman Humpl, Steven Schwartz, Christopher Caldarone, Andrew Redington, Glen Van Arsdell, The Hospital for Sick Children (SickKids), Toronto, Canada 9014 Vitamin D Status in Neonates Undergoing Cardiac Operations: Relationship to Cardiopulmonary Bypass and Outcomes Eric Matthew Graham, Sarah N. Taylor, Sinai Zyblewski, Bethany Wolf, Scott Bradley, Bruce W. Hollis, Francis X. McGowan, Jr, Andrew Atz, Medical University of South Carolina, Charleston, SC 9015 Progressive Left Ventricular Changes Predict the Likelihood of Survival in Pediatric Dilated Cardiomyopathy: Findings from the Pediatric Cardiomyopathy Registry Paul Fraser Kantor, Endel Orav, James Wilkinson, Steven Webber, Charles Canter, Steven Colan, Jeffrey Towbin, Melanie Everitt, Elfriede Pahl, Stephanie Ware, Beth Kaufman, Paolo Rusconi, Jacqueline Lamour, John Jefferies, Linda Addonizio, Steven Lipshultz, University of Miami, Miller School of Medicine, Miami, FL, Hospital for Sick Children, Toronto, Canada 9016 Pediatric Heart Transplantation from Donors with Depressed Ventricular Function: An Analysis of the United Network of Organ Sharing Database Joseph William Rossano, Kimberly Lin, Stephen Paridon, J. William Gaynor, Robert Shaddy, Beth Kaufman, Childrens Hospital of Philadelphia, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA 9017 Identified Mortality Risk Factors Associated with Presentation, Initial Hospitalization, and Interstage Period for the Norwood Operation: A Report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative Russell R. Cross, Ashraf Harahsheh, Robert McCarter, Gerard Martin, Childrens National Medical Center, Washington, DC 11:45 9018 IMPACT Registry (IMproving Pediatric and Adult Congenital Treatment): First Data Report Gerard R. Martin, Lisa Bergersen, Lee Benson, Robert Beekman, Ralf Holzer, Frank Ing, Kathy Jenkins, John Moore, Richard Ringel, Jonathan Rome, Carlos Ruiz, Robert Vincent, Childrens National Medical Center, Washington, DC, Childrens Hospital, Boston, MA Pharmacology Program: Cardiovascular Implications of Dietary Supplements Saturday, March 24, 2012, 10:30 a.m. Noon McCormick Place North, N427 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-149-L04-P Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL Lynne Braun, Chicago, IL, Steven P. Dunn, Charlottesville, VA, Arshad Jahangir, Phoenix, AZ Cardiovascular Implications of Dietary Supplements Rhonda M. Cooper-Dehoff, Gainesville, FL Panel Discussion

PREV SyMPOSIUM

Morning

733

CCS ORAL

Co-Chairs: Panelists: 10:30 11:30

901

Co-Chairs: 10:30

noon

noon SeSSionS
ACC-i2/TCT EXPERTS

10:45

2301

Atypical Thrombotic ACS Case Reviews Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 Richard C. Becker, Durham, NC A. Michael Lincoff, Cleveland, OH Ali Ataya, Cleveland, OH, Daniel Gutteridge, Flint, MI, Nael Hawwa, Cleveland, OH, Taiyeb M. Khumri , Kansas City, MO, Yukio Mizuguchi, Kobe, Japan David J. Moliterno, Lexington, KY, Peter B. Berger, Danville, PA Chronic Total Occlusions and Left Main Case Reviews Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5 David E. Kandzari, Atlanta, GA Patrick L. Whitlow, Cleveland, OH Stephen Y. Chen, Augusta, GA, Michael E. Halkos, Atlanta, GA, Tesfaldet T. Michael, Dallas, TX, Koyu Sakai, Kitakyushu, Japan James Aaron Grantham, Kansas City, MO, Corrado Tamburino, Catania, Italy, Davide Capodanno, Catania, Italy

Co-Chairs: Case Presenters: Panelists:

11:00

ACC-i2/TCT EXPERTS

2302

11:15

Co-Chairs: Case Presenters: Panelists:

11:30

114 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

ACC-i2/TCT EXPERTS

2303

Coronary Imaging Case Reviews Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S103b CME/CNE Hours: 1.5 John McB Hodgson, Wilkes-Barre, PA Morton J. Kern, Orange, CA Joon Hyung Doh, Goyang, South Korea, Yu Kataoka, Cleveland, OH, Paula de Lima Santos Eryazici, Chicago, IL, Syed Rab, Atlanta, GA, Hiroyuki Nagai, Osaka, Japan Akiko Maehara, New York, NY, Marco A. Costa, Cleveland, OH, Giulio G. Guagliumi, Bergamo, Italy TAVR: Procedural Aspects and Best Practices Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Steven J. Yakubov, Columbus, OH E. Murat Tuzcu, Cleveland, OH Debate: General Anesthesia is Best Balthasar Eberle, Bern, Switzerland Debate: Conscious Sedation is Better Augusto Pichard, Washington, DC Panel Discussion Debate: Location Hybrid OR Todd M. Dewey, Dallas, TX Debate: Location Cardiac Cath Lab Helen Eltchaninoff, Rouen, France Panel Discussion Debate: Imaging with Flouro is Sufficient G. Alain Cribier, Rouen, France Debate: Echo Imaging is Required Mark J. Monaghan, London, United Kingdom Panel Discussion Assessing Results: VARC and RE-VARC Patrick W. Serruys, Rotterdam, Netherlands Durability and Valve-in-Valve Josep Rodes-Cabau, Quebec, Canada The Low-risk Patient: New Trials Martin B. Leon, New York, NY Nursing Considerations Maria Held, Cleveland, OH Acute Venous Thromboembolic Disease Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Raghu Kolluri, Springfield, IL Samuel Z. Goldhaber, Boston, MA VTE Treatment Guidelines: What a Venous Interventionalist Must Know The American Heart Association Consensus Statement Are they Different from the American College of Chest Physician Guidelines? M. Sean McMurtry, Edmonton, AB

12:27

Thrombolysis & Anticoagulation for Extensive DVT: The Science & Clinical Practice Anthony J. Comerota, Toledo, OH Appropriate Patient Selection and Access Site Selection for Venous Intervention: Tips and Tricks Mahmood K. Razavi, Orange, CA Pharmaco-Mechanical Thrombectomy Devices: When to Use What Gregory J. Mishkel, Springfield, IL Central Venous Occlusions and Upper Extremity Venous Interventions Tino Pena, Miami, FL IVC Filters: What Are the Indications and Implications Robert Schainfeld, Waltham, MA Interventional Management of Acute Pulmonary Embolism Appropriate Patient Selection Speaker TBD Panel Discussion

Co-Chairs: Case Presenters:

12:39

12:51

Panelists:

1:03 1:13 1:25

ACC-i2/TCT SyMPOSIUM

2606

Co-Chairs: 12:15 12:20 12:25 12:30 12:35 12:40 12:45 12:50 12:55 1:05 1:15 1:25 1:35
ACC-i2/TCT SyMPOSIUM

1:35
ACS SyMPOSIUM

604

Controversies in ACS Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S404 CME/CNE Hours: 1.5 Debate: Radial versus Femoral Access for ACS Patients Undergoing Early Invasive Strategy

NooN

Co-Chairs: 12:15 12:27 12:39

Ajay J. Kirtane, New York, NY Sunil V. Rao, Durham, NC Femoral Access Is Tried and True: No Need to Change Now David Alan Cox, Allentown, PA Radial Access Is Preferred in the ACS Patient David E. Kandzari, Atlanta, GA Debate Summary Ajay J. Kirtane, New York, NY Debate: Platelet Reactivity and Genotype Testing: An Aid to Clinical Decision-making or an Investigational Tool

Chair: 12:45 12:57 1:09

Gregg W. Stone, New York, NY Time for Personalized Medicine Is Now Paul A. Gurbel, Baltimore, MD Not Ready for Prime Time Sanjay Kaul, Los Angeles, CA Debate Summary Gregg W. Stone, New York, NY Debate: Therapeutic Hypothermia: Cooling Heads and Hearts Improves Outcomes

Co-Chairs: 1:15 1:27 1:39

2607

William W. ONeill, Miami, FL Ivan Rokos, Altadena, CA Evidence Is Clearcut Timothy D. Henry, Minneapolis, MN Evidence Is Shaky Benjamin M. Scirica, Boston, MA Debate Summary William W. ONeill, Miami, FL

Co-Chairs: 12:15

ACC.12 Final Program 115

Saturday, March 24, 2012 ACC.12

ARR EXPERTS

206

Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation: How to Decide? Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S503 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-068-L01-P Michael M. Ezekowitz, Wynnewood, PA John Eikelboom, Hamilton, Canada, Gerald V. Naccarelli, Hershey, PA, Salim Yusuf, Hamilton, Canada Atrial Fibrillation and Heart Failure: A Dynamic Duo Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S502 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-069-L01-P Denis Roy, Montreal, Canada John G. F. Cleland, Cottingham, United Kingdom, Anne B. Curtis, Buffalo, NY, Prakash C. Deedwania, Fresno, CA, Bengt Herweg, Tampa, FL, J. Marcus Wharton, Charleston, SC Imaging Patients with Pericardial Disease Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Allan L. Klein, Cleveland, OH Ron Blankstein, Boston, MA, James C. Carr, Chicago, IL, Jae K. Oh, Rochester, MN Cardiovascular Magnetic Resonance in Myocarditis Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Robert W. W. Biederman, Pittsburgh, PA Raymond J. Kim, Durham, NC Role of CMR in Children with Myocarditis Michael D. Taylor, Cincinnati, OH CMR Tissue Characterization in Myocarditis Matthias Friedrich, Calgary, Canada CMR and Prognosis in Myocarditis Raymond Y. K. Kwong, Boston, MA Future Developments in CMR Imaging Sequences for Myocarditis Andrew E. Arai, Bethesda, MD Clinical Evaluation of the Patient with Myocarditis Dennis M. McNamara, Pittsburgh, PA

ISCHEM SyMPOSIUM

606

Revascularization in SIHD: Integrating New Evidence Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S401a CME/CNE Hours: 1.5 Cindy L. Grines, Royal Oak, MI Michael J. Mack, Plano, TX Revascularization (Or Not) in the Patient with Heart Failure? Robert O. Bonow, Chicago, IL Question and Answer Revascularization in Diabetics: Back to the Drawing Board? Robert H. Jones, Durham, NC Question and Answer Revascularization in the Patient with Normal LV Function: Who, How and When? David R. Holmes, Jr., Rochester, MN Question and Answer Pharmacology Program: Pharmacologic Considerations in the Setting of PCI Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N427 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-150-L04-P Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL Paul Dobesh, Omaha, NE, Douglas E. Drachman, Boston, MA Pharmacologic Considerations in the Setting of PCI Sarah A. Spinler, Philadelphia, PA Panel Discussion Everything you Wanted to Know about ABIM Recertification (and more...) Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N226 CME Hours: 1.5 Steve R. Ommen, Rochester, MN Why Maintenance of Certification (MOC)? Steve R. Ommen, Rochester, MN Current MOC Part IV Requirements and How to Achieve Them William J. Oetgen, Alexandria, VA Evolutions in MOC: What to Expect in the Future John Gordon Harold, Los Angeles, CA What the College Can Do to Help: Question and Answer Women in Cardiology Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 Cant get everything done? Constantly overwhelmed? During this special session with acclaimed life coach, Jill Farmer, WIC members will learn how to be more productive, peaceful, and connected to the things that really matter. Ms. Farmers 45-minute talk will

Chair: Panelists:

Co-Chairs: 12:15 12:35 12:45 1:05 1:15

Case Presenter: Peter Kowey, Wynnewood, PA

HF EXPERTS

207

Chair: Panelists:

1:35
ISCHEM SyMPOSIUM

Case Presenter: Maya E. Guglin, Tampa, FL

734

NooN

IMAG EXPERTS

Co-Chairs: Panelists: 12:15 1:15

LIFELONG SyMPOSIUM

208

Chair: Panelists:

Case Presenter: K. Maganti, Chicago, IL

IMAG SyMPOSIUM

605

607

Co-Chairs: 12:15 12:33 12:51 1:09 1:27

Chair: 12:15 12:25 12:55 1:25

PRACTICE SyMPOSIUM

608

116 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

be followed by a Q & A Session moderated by members of the ACCs Women in Cardiology Council. Chair: 12:15 1:00
PRACTICE SyMPOSIUM QUAL SyMPOSIUM

Carol Warnes, Rochester, MN Theres Not Enough Time! And Other Lies We Tell Ourselves Jill Farmer, Saint Louis, MO Panel Discussion

610

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational Research Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Anthony N. DeMaria, San Diego, CA Spencer B. King, Atlanta, GA Keynote Address: Trends and Direction in Cardiovascular Medicine David R. Holmes, Jr., Rochester, MN Translation Clinical Research in Clinical Practice Anthony N. DeMaria, San Diego, CA ISCTR/ACCs Mission in Cardiovascular Translational Research Nabil Dib, Gilbert, AZ Challenges and Opportunities in Cardiovascular Translational Research Jack Lewin, Washington, DC ISCTR/ACC Translational Research Scholarship Spencer B. King, Atlanta, GA Educating the Educators: Bootcamp for Cardiology Fellowship Program Directors and Coordinators Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S405a CME Hours: 1.5 Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK Welcome and Overview Marcia J. Jackson, Santee, SC, Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK Focus on ACC Education Rick A. Nishimura, Rochester, MN, Patrick T. OGara, Boston, MA, Mary Ellen Beliveau, Washington, DC ACGME and the 2012 Requirements James A. Arrighi, Povidence, RI Heart Failure: ABIM and ACGME Updates Marvin A. Konstam, Boston, MA Fit Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 1: Finding the Right Job Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N227b CME Hours: 1.5 Pros and Cons: Large Academic Medical Center Charanjit S. Rihal, Rochester, MN Pros and Cons: Large Private Practice Group, Self-Owned C. Michael Valentine, Lynchburg, VA Pros and Cons: Hospital-Owned Cardiology Group Thomas D. Stuckey, Greensboro, NC, B. Hadley Wilson, Charlotte, NC Pros and Cons: Solo Practitioner Eric B. Carlson, Greenville, NC Pros and Cons: Non-Traditional Practice Michael R. Bristow, Aurora, CO Discussion with Audience Question and Answer ACC.12 Final Program 117

Co-Chairs:
609

The Challenges in Daily Practice Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5 Blair D. Erb, Bozeman, MT

12:15

Co-Chairs: 12:15 12:33 12:51 1:09 1:27

Michael K. Schroyer, Zionsville, IN

MOC and MOL: Where Are We Headed? John Gordon Harold, Los Angeles, CA Who Decides What Quality Is? John E. Brush, Norfolk, VA Core Measure and Beyond Michael K. Schroyer, Zionsville, IN Data Collection for Beginners Cathleen Biga, Woodridge, IL Pinnacle, AUC and Beyond: Making the ACC Tools Work for you Blair D. Erb, Bozeman, MT
PREV SyMPOSIUM

12:40 1:00 1:15 1:30

SPECIAL SPECIAL

103

NooN

611

Is There a Role for HDL Therapy: Are We AIMing Too HIGH? Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S100c CME/CNE Hours: 1.5 Michael H. Davidson, Chicago, IL Richard H. Karas, Boston, MA AIM-HIGH: Case Closed for HDL? William E. Boden, Buffalo, NY AIM HIGH in Context: From ARBITER to HPS2-THRIVE Allen J. Taylor, Washington, DC Should We Reconsider Fibrates? Michael H. Davidson, Chicago, IL Current Status of CETP Inhibitors Christie M. Ballantyne, Houston, TX HDL Form and Function Prediman K. Shah, Los Angeles, CA Apo A1 Mimetics and HDL Infusions Prediman K. Shah, Los Angeles, CA

Co-Chairs: 12:15

Co-Chairs: 12:15 12:30 12:45 1:00 1:15 1:30

12:30

12:45 1:30

SPECIAL SPECIAL

104

12:15 12:30 12:45

QUAL EXPERTS

209

Getting Access to Data: Successful Examples from the NCDR Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Tracy Wang, Durham, NC

Chair: Panelists:

Case Presenter: Robert W. Yeh, Boston, MA Paul Chan, Kansas City, MO, Thomas M. Maddox, Denver, CO, Amy Leigh Miller, Boston, MA, John S. Rumsfeld, Denver, CO, Thomas Tehsin Tsai, Denver, CO

1:00 1:15 1:30

Saturday, March 24, 2012 ACC.12

VALV EXPERTS

210

Organic Mitral Regurgitation Case-Management Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Robert J. Siegel, Los Angeles, CA Thoralf M. Sundt, Boston, MA Harold M. Burkhart, Rochester, MN, Amar Krishnaswamy, Cleveland, OH, Vuyisile Nkomo, Rochester, MN Blase A. Carabello, Houston, TX, Robert J. Siegel, Los Angeles, CA The Spectrum of Degenerative Mitral Valve: From Imaging to Treatment Saturday, March 24, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Elyse Foster, San Francisco, CA Brian P. Griffin, Cleveland, OH New Insights into the Pathophysiology of MVP Albert Alain Hagege, Paris, France Asymptomatic Degenerative MR: Who Should Undergo Valve Repair? Maurice Enriquez-Sarano, Rochester, MN Role of 3-D TEE in the Operating Room for Mitral Repair Salvatore Costa, Lebanon, NH Repair of Degenerative MR: A Perfect Solution? Rakesh Suri, Rochester, MN E-Clip of MVP Is Useful in My Practice Francesco Maisano, Milan, Italy ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2010 Update (A1-K) Saturday, March 24, 2012, 12:30 p.m. 3:00 p.m. McCormick Place South, S105a CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Chair:

Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC. Chair: Paul Sorajja, Rochester, MN MOC Faculty: Elizabeth A. Jackson, Ann Arbor, MI, Sherry Saxonhouse, Charlotte, NC
LIFELONG MOC

Co-Chairs: Case Presenters: Panelists:

VALV SyMPOSIUM

612

804

Co-Chairs: 12:15 12:33

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2011 Update (A1-L) Saturday, March 24, 2012, 12:30 p.m. 3:00 p.m. McCormick Place South, S105d CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC. Ralph J. Verdino, Philadelphia, PA

NooN

12:51 1:09 1:27

LIFELONG MOC

803

MOC Faculty: Emmanouil S. Brilakis, Dallas, TX, Jesus Almendral, New Brunswick, NJ

118 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

Afternoon SeSSionS
ACC-i2/TCT CASE REVIEW

2201

Live and Taped Case Session I: Multivessel PCI- Physiology and Imaging Saturday, March 24, 2012, 2:00 p.m. 5:00 p.m. McCormick Place North, Hall B, ACC.12 Main Tent CME/CNE Hours: 3 Gary S. Mintz, Washington, DC William Fuller Fearon, Stanford, CA Sigmund Silber, Zell, Germany, Ajay J. Kirtane, New York, NY, Eric R. Bates, Ann Arbor, MI, Marco A. Costa, Cleveland, OH, Manish Parikh, New York, NY, Alan C. Yeung, Palo Alto, CA, David J. Moliterno, Lexington, KY, John McB Hodgson, Wilkes-Barre, PA Live Case from Northwestern Memorial Hospital, Chicago, IL Charles J. Davidson, Chicago, IL FFR after FAME-I and FAME-II: The Appropriate Use of Physiology in the Cath Lab in 2012 William Fuller Fearon, Stanford, CA The Exploding World of Intravascular Imaging: IVUS, OCT, NIRS, etc Practical Use during PCI Gary S. Mintz, Washington, DC Panel Discussion Taped Case from the University of Texas Southwestern Medical Center, Dallas, TX Emmanouil S. Brilakis, Dallas, TX

Artery Disease Presenting with Acute Myocardial Infarction Complicated by Cardiogenic Shock Matthew Cavender, Penny Houghtaling, Elizabeth Lieber, Michael Kiernan, Melanie Maytin, Andrew Rassi, Patrick Whitlow, Venu Menon, Stephen Ellis, Mehdi Shishehbor, Cleveland Clinic, Cleveland, OH 2:55 3:00 250212 Panel Discussion 250213 Reference Coronary Flow Velocity Reserve Determined after Primary Percutaneous Coronary Intervention for a First Acute Anterior Myocardial Infarction is an Independent Predictor of Cardiac Mortality at Long Term Follow-up Tim P. van de Hoef, Matthijs Bax, Martijn Meuwissen, Peter Damman, Ronak Delewi, Robbert de Winter, Karel Th Koch, Carl Schotborgh, Jos Henriques, Jan Tijssen, Jan Piek, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Haga Teaching Hospital, The Hague, The Netherlands 250214 Panel Discussion 250215 Impact of Bivalirudin and Paclitaxeleluting Stents in Patients with STEMI Undergoing Primary PCI of the Left Anterior Descending Artery: The HORIZONS-AMI Trial Jochen Woehrle, Helen Parise, Roxana Mehran, Gregg Stone, University of Ulm, Ulm, Germany, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 250216 Panel Discussion Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early Thrombosis Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 Steven R. Bailey, San Antonio, TX Alan C. Yeung, Palo Alto, CA Mechanisms and Findings in Restenosis and Early Stent Thrombosis: IVUS, VH-IVUS, OCT, Spectroscopy, and Beyond Lisette Jensen, Odense, Denmark Does Acute Stent Malapposition Cause Restenosis or Early Stent Thrombosis? Neil J. Weissman, Washington, DC IVUS Predictors of Restenosis and Early Stent Thrombosis: What are the Ideal Stent-Implantation Endpoints? Soo-Jin Kang, Suwon, Republic of Korea OCT Predictors of Restenosis and Early Stent Thrombosis: Including an Update from the MGH-OCT Registry Ik-Kyung Jang, Boston, MA Is there a Role for CT Angiography in Long-term Stent Assessment (Restenosis and/or Stent Thrombosis)? Szilard Voros, Atlanta, GA When and How Should In-stent Restenosis Be Treated? FFR, IVUS and Other Data Habib Samady, Atlanta, GA

Co-Chairs: Panelists:

2:00 3:30

3:10 3:15

3:45

4:00 4:15

3:25
ACC-i2/TCT ORAL

2502

Acute Myocardial Infarction Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S103b CME/CNE Hours: 1.5 Stephen G. Ellis, Cleveland, OH Jose P. Henriques, Amsterdam, Netherlands Dmitriy N. Feldman, New York, NY, Timothy A. Sanborn, Evanston, IL, Bimmer E. Claessen, Amsterdam, Netherlands year in Review Speaker TBD 25027 Initial Ambulance Transport of ST-Elevation Myocardial Infarction (STEMI) to Rural Hospitals Leads to Better Door In-Door Out and First Door to Balloon Reperfusion Times within 90 Minutes B. Hadley Wilson, Angela Humphrey, Robert Haber, William Downey, John Cedarholm, Glen Kowalchuk, Michael Rinaldi, Denise Miller, Jennifer Sarafin, Kevin Collier, J. Garvey, Sanger Heart & Vascular Institute at Carolinas Medical Center, Charlotte, NC 25028 Panel Discussion 25029 The Role of Primary Multivessel Intervention in Acute Myocardial Infarction Complicated by Cardiogenic Shock Darren Mylotte, Thierry Lefevre, Hlne Eltchaninoff, Nicolas Briole, Karim Tazarourte, Alain Margenet, Dominique Thbert, Yves Louvard, Marie-Claude Morice, Philippe Garot, Institut Cardiovasculaire Paris Sud, Massy, France 250210 Panel Discussion 250211 Outcomes of Culprit versus Multivessel Intervention in Patients with Multivessel Coronary

ACC-i2/TCT SyMPOSIUM

2608

Co-Chairs: Panelists:

Co-Chairs: 2:00

AFTERNOON

2:00 2:15

2:12

2:24

2:25 2:30

2:36

2:48

2:40 2:45

3:00

ACC.12 Final Program 119

Saturday, March 24, 2012 ACC.12

3:10 3:15 3:20 3:25
ACC-i2/TCT SyMPOSIUM

Case Presentation Jinman Cho, Seoul, Republic of Korea Case Presentation William J. Kostis, Boston, MA Case Presentation Ozgur Bayturan, Izmir, Turkey Panel Discussion Hemodynamics and Angiography I (Basic Issues) Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Maurice Enriquez-Sarano, Rochester, MN, John W. Hirshfeld, Philadelphia, PA Hemodynamics of MR Pre- and Post-Percutaneous Therapy Ted Feldman, Evanston, IL Pitfalls in the Assessment of AS Severity Zachary Gertz, Havertown, PA Cath Assessment of TAVR, BAV, and Complications Raj R. Makkar, Los Angeles, CA Integrating Echo into the Percutaneous Valve Procedures Frank E. Silvestry, Wayne, PA Hemodynamics of IABP, Mitral, Tricuspid and Pulmonary Stenosis Morton J. Kern, Orange, CA Hemodynamic Pitfalls Zoltan G. Turi, Camden, NJ Renal Interventions for Hypertension and Renal Function Preservation Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Gregory J. Mishkel, Springfield, IL Douglas E. Drachman, Boston, MA CORAL, ASTRAL & STAR: Good News, Bad News Jeffrey W. Olin, New York, NY eGFR Is Not a Valid Estimate of Renal Function in Patients with Atherosclerotic Renal Artery Disease Ryan Madder, Troy, MI How to Predict Improved Blood Pressure after Renal Stenting Jason H. Rogers, Sacramento, CA How to Predict Improved Renal Function after Renal Stenting Stephen Textor, Rochester, MN Is Renal Sympathetic Denervation a Viable Option for Treating Hypertension Krishna J. RochaSingh, Springfield, IL Panel Discussion Interventional Featured Clinical Studies II Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5 Hector M. Garcia, Rotterdam, Netherlands Giora Weisz, New York, NY Ron Waksman, Washington, DC, Daniel J. McCormick, Moorestown, NJ

2:00

A Prospective Randomized Study Using Optical Coherence Tomography to Assess Endothelial Coverage and Neointimal Proliferation at 6-months after Implantation of a Coronary Everolimus-eluting Stent Compared with a Bare Metal Stent Postdilated with a Paclitaxel-Eluting Balloon (OCTOPUS Trial) Tudor C. Poerner, Sylvia Otto, Florian Janiak, Johannes Gassdorf, Hans R. Figulla, University Hospital of Jena, Jena, Germany Panel Discussion Visual-Functional Mismatch between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, Soo-Jin Kang, Jung-Min Ahn, Eun-Bo Shim, Young-Tae Kim, Sung-Cheol Yoon, Haegeun Song, Jong-Young Lee, Won-Jang Kim, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seong-Wook Park, Asan Medical Center, Seoul, South Korea, Kangwon National University, Chuncheon, South Korea Panel Discussion Sirolimus-eluting Stent with Biodegradable Polymer versus Sirolimus Eluting Stent with Durable Polymer for the Treatment of Patients with de novo Coronary Artery Lesions (EVOLUTION): A Randomized Non-inferiority Trial Junbo Ge, Lei Ge, Juying Qian, Guosheng Fu, Huiliang Liu, Genshan Ma, Yitong Ma, Weiyi Fang, Hui Li, Yujie Zhou, Yongwen Qin, Yigang Li, Lianqun Cui, Chengzhi Lu, Bin Liu, Jifei Tang, Zheng Zhang, Meixiang Xiang, Xuefeng Guang, Dadong Zhang, Qing He, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, Peoples Republic of China Panel Discussion Late Benefit of Intra-Aortic Balloon Counterpulsation during High-risk Percutaneous Coronary Intervention: Long-term Mortality Data from the Balloon Pumpassisted Coronary Intervention Study (BCIS-1) Divaka Perera, Rod Stables, Kalpa DeSilva, Matthew Lumley, Daa Zugwitz, Lucy Clack, Martyn Thomas, Simon Redwood, Kings College London, London, United Kingdom, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom Panel Discussion Biodegradable Polymer Drug-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS Randomized Trials at 4-years Robert A. Byrne, Giulio Stefanini, Patrick Serruys, Antoinette de Waha, Bernhard Meier, Steffen Massberg, Peter Juni, Stephan Windecker, Adnan Kastrati, Deutches Herzzentrum, Munich, Germany, Bern University Hospital, Bern, Switzerland Panel Discussion 2-year Clinical Outcomes from the Pivotal RESOLUTE US Study Laura Mauri, Martin Leon, Donald Cutlip, Jeffrey Popma, Peter Fitzgerald, Joseph Massaro, Alan Yeung, Brigham and Womens

2609

2:10 2:15

Co-Chairs: 2:00 2:15 2:30 2:45 3:00 3:15

ACC-i2/TCT SyMPOSIUM

2:25 2:30

2610

Co-Chairs: 2:00 2:15

2:40 2:45

AFTERNOON

2:30 2:45 3:00

2:55 3:00

3:15
ACC-i2/TCT SyMPOSIUM

2645

Co-Chairs: Panelists:

3:10 3:15

120 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

Hospital, Boston, MA, Stanford University Medical Center, Palo Alto, CA 3:25
ACS EXPERTS

2:30 2:40 2:50 3:05

ARR EXPERTS

Promoting Cardiopoiesis to Enhance Cell Therapy in Chronic Heart Failure Andre Terzic, Rochester, MN Does the Route of Application Matter for Clinical Effects of Cell Therapy Nabil Dib, Gilbert, AZ Pathway to IND Steve Winitsky, Silver Spring, MD Panel Discussion Management of Difficult AF: When to Change Drugs, When to Give Up Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S503 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-073-L01-P Leslie A. Saxon, Los Angeles, CA David Callans, Philadelphia, PA, Robert C. Kowal, Dallas, TX, Andrea Natale, Austin, TX Can Remote Disease Management Improve Clinical Outcomes? Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Christopher Liu, New York, NY Niraj Varma, Cleveland, OH What Is the Evidence from Clinical Trials? George H. Crossley, Nashville, TN Utilization of Heart Failure Diagnostics: Can We Minimize Heart Failure Admissions? William T. Abraham, Columbus, OH How to Use Monitoring Technologies in the Management of Atrial Fibrillation Paul A. Levine, Sylmar, CA Monitoring Outcomes Using Remote Monitoring Databases David L. Hayes, Rochester, MN Cost-Benefit Ratio Mark H. Schoenfeld, New Haven, CT
ARR

Panel Discussion Optimal STEMI Management from Presentation to Post-Discharge Care Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S504a CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-072-L01-P Charanjit S. Rihal, Rochester, MN Somjot Singh Brar, Los Angeles, CA, Bojan Cercek, Los Angeles, CA, Cindy L. Grines, Royal Oak, MI, Freek W. A. Verheugt, Amsterdam, Netherlands State-of-the-Art in STEMI Care Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S404 CME/CNE Hours: 1.5 C. Michael Gibson, Boston, MA Ajay J. Kirtane, New York, NY Pre-hospital Triage and Emergency Medical System Activation for STEMI: The Clock Starts Ticking Early Ivan Rokos, Altadena, CA Time to Reperfusion across Systems of Care: The Role of PCI, Lytics, Transfer and Adjunctive Therapies Duane S. Pinto, Boston, MA, Timothy D. Henry, Minneapolis, MN Guidelines Debate ACC/AHA Guidelines Are Evidence-based, Userfriendly and Pragmatic Elliott M. Antman, Boston, MA, Jean-Pierre L. Bassand, Besancon, France, Paul Wayne Armstrong, Edmonton, Canada Featured Lecture: Progress in STEMI Whats Next? Valentin Fuster, New York, NY Moderated Summary C. Michael Gibson, Boston, MA
ACS

211

Chair: Panelists:

212

Case Presenter: Tamim Nazif, New York, NY Chair: Panelists:

Case Presenter: Brian Powell, Rochester, MN

ACS SyMPOSIUM

613

ARR SyMPOSIUM

Co-Chairs: 2:00

614

Co-Chairs: 2:00 2:18

2:12

2:36 2:36

2:36

3:06 3:21

2:54 3:12

AFTERNOON

SyMPOSIUM

618

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular Therapies Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Andreas M. Zeiher, Frankfurt, Germany Andre Terzic, Rochester, MN Regeneration Enhancement in Acute Myocardical Infarction: Advancing Stem Call Therapy Andreas M. Zeiher, Frankfurt, Germany Refractory Angina: A Stem Cell Approach from Bench to Phase 3 Clinical Trials Douglas W. Losordo, Chicago, IL Cardiac-derived Stem Cells: From Product Development to Clinical Application Eduardo Marban, Los Angeles, CA

SyMPOSIUM

615

Challenges in the Management of Supraventricular Tachycardia Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S403 CME/CNE Hours: 1.5 Bindi K. Shah, Philadelphia, PA Atrial Flutter Sei Iwai, Stony Brook, NY Atrial Tachycardia Arising from Pulmonary Veins Atul Verma, Toronto, Canada AV Nodal Re-Entry Tachycardia Melvin M. Scheinman, San Francisco, CA SVT in the Presence of an Accessory Pathway Eric N. Prystowsky, Indianapolis, IN Focal Atrial Tachycardia Bradley P. Knight, Chicago, IL

Co-Chairs: 2:00

Chair: 2:00 2:12 2:18 2:36 2:54

2:10

2:20

ACC.12 Final Program 121

Saturday, March 24, 2012 ACC.12

ARR SyMPOSIUM

735

Pharmacology Program: Pharmacotherapy of New Antithrombotics Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N427 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-151-L04-P Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL Pharmacotherapy of New Antithrombotics Joseph S. Alpert, Tucson, AZ Panel Discussion Jonathan L. Halperin, New York, NY, Michael Gulseth, Sioux Falls, SD Quality, Safety and Resources Enhancing Pediatric Cardiovascular Care Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N231 CME/CNE Hours: 1.5 Jean A. Connor, Boston, MA Gerard Martin, Washington, DC Increasing Access to Care and Evaluation of Quality for Pediatric Nurse Practitioner Managed Cardiac Clinics Theresa A. Saia, Boston, MA Radiation Risk for Pediatric Patients in the Catheterization Laboratory, the Evidence and Measurement of Risk Ralf Holzer, Columbus, OH Optimizing Growth of the Cardiovascular Infant Jeffrey Anderson, Cincinnati, OH Enhancing a Distraction Free Environment the Redzone Medication Safety Initiative Jeanne Ahern, Boston, MA Clinical Handoffs: Models That Can Be Safely and Practically Implemented Kshitij P. Mistry, Charlotte, NC Quality Improvement amongst Cardiovascular Programs in Developing Countries Kathy J. Jenkins, Boston, MA

Co-Chairs: 2:00

Wai Hong Wilson Tang, Cleveland, OH Maya E. Guglin, Tampa, FL What Truly Is Cardiorenal Syndrome? Novel Insights into the Pathophysiology and Subtypes of Cardiorenal Syndrome Javed Butler, Atlanta, GA Question and Answer Predictors of Response to ADHF Treatment and Development of Cardiorenal Syndrome Gregg C. Fonarow, Los Angeles, CA Question and Answer Aggressive versus Conservative Diuresis in Treatment of ADHF: The Benefit versus Risk G. Michael Felker, Durham, NC Question and Answer What Changes during Therapy of ADHF? From Patient Symptoms to Physical Findings and Biomarkers Biykem Bozkurt, Houston, TX Question and Answer Novel Therapeutic Targets and Strategies for Nonresponders to Initial ADHF Therapy Maria Rosa Costanzo, Naperville, IL Question and Answer

Co-Chairs: 2:00 3:00 Panelists:

2:15 2:18

2:33 2:36

CCS SyMPOSIUM

2:51 2:54

616

Co-Chairs: 2:00

3:09 3:12

3:27
IMAG EXPERTS

2:15

214

2:30 2:45

Current Topics in Cardiac CT Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Joao A. C. Lima, Baltimore, MD

Chair:

Case Presenters: Mouaz H. Al-Mallah, Riyadh, Saudi Arabia, John P. Reilly, New Orleans, LA Panelists: C. Richard Conti, Gainesville, FL, Richard T. George, Monkton, MD, Harvey S. Hecht, New York, NY, Robert C. Hendel, Miami, FL Multimodality Imaging of Hypertrophic Cardiomyopathy Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Barry J. Maron, Minneapolis, MN Steve R. Ommen, Rochester, MN Cardiac MR in Diagnosis and Management of HCM Karin Dill, Chicago, IL Catheterization and Hemodynamics in Diagnosis and Management of HCM Rick A. Nishimura, Rochester, MN Echocardiography in the Diagnosis and Management of HCM Sherif F. Nagueh, Houston, TX Nuclear Imaging in the Diagnosis and Management of HCM Vasken Dilsizian, Baltimore, MD Computed Tomography in the Diagnosis and Managment of HCM Milind Y. Desai, Cleveland, OH

3:00

AFTERNOON

3:15

IMAG SyMPOSIUM

619

HF EXPERTS

213

From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support Devices Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S502 CME/CNE Hours: 1.5 Mariell Jessup, Philadelphia, PA Michael A. Acker, Philadelphia, PA, David DeNofrio, Boston, MA, William W. ONeill, Miami, FL, Francis D. Pagani, Ann Arbor, MI Cardiorenal Syndrome in Heart Failure: From Definition to Management Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406b CME/CNE Hours: 1.5

Co-Chairs: 2:00 2:18

Chair: Panelists:

Case Presenter: Jeffrey Teuteberg, Pittsburgh, PA 2:36 2:54 3:12

HF SyMPOSIUM

617

122 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

ISCHEM SyMPOSIUM

620

Stable Ischemic Heart Disease in Women: Are They Really from Venus? Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S401a CME/CNE Hours: 1.5 Sharon L. Mulvagh, Rochester, MN Carl Pepine, Gainesville, FL What Does Ischemia without Obstructive CAD Really Mean? Martha Gulati, Columbus, OH Question and Answer Autoimmune Disorders in Women and Their Role in CAD Rekha Mankad, Rochester, MN Question and Answer Treating Women and Men: Whats Different and Whats the Same? C. Noel Bairey Merz, Los Angeles, CA Question and Answer Putting it All Together: How to Choose the Best Test Leslee J. Shaw, Atlanta, GA Question and Answer Core Curriculum: Congenital Heart Disease Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Alex J. Auseon, Columbus, OH Congenital Heart Disease I: Simple M. Regina Lantin-Hermoso, Houston, TX Congenital Heart Disease II: Complex Jennifer Grando-Ting, Hummelstown, PA Cardiovascular Disease and Pregnancy Karen K. Stout, Seattle, WA Question and Answer Core Curriculum: Congestive Heart Failure Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 John A. McPherson, Nashville, TN Evaluation and Management of Acute Decompensated CHF: Systolic and Diastolic Akshay S. Desai, Boston, MA Evaluation and Management of Chronic CHF: Systolic and Diastolic Larry A. Allen, Aurora, CO PHTN: Evaluation and Management Anne Marie Valente, Boston, MA Question and Answer ACC/MedAxiom/ACCA: Physician/Hospital Integration 101 Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5

Co-Chairs: 2:00 2:15 2:30 2:45 3:00 3:15

Jerome L. Hines, Hinsdale, IL Dipti Itchhaporia, Newport Beach, CA Contracts 2012: What Models Exist to Integrate with My Hospital Suzette Jaskie, Grand Rapids, MI Negotiating 101: Defining Physician Value Matthew Phillips, Austin, TX Creating Value through Integration Charles L. Brown, III, Atlanta, GA Avoiding Pitfalls Cathleen Biga, Woodridge, IL The Fallout of Integration on Patients C. Michael Valentine, Lynchburg, VA Renegotiating the Contract Howard T. Walpole, Nashville, TN

Co-Chairs: 2:00 2:15 2:22 2:37 2:45

PREV SyMPOSIUM

3:00 3:07 3:22

LIFELONG CORE

622

Emerging Trends in Atherosclerosis Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S100c CME/CNE Hours: 1.5 Peter Ganz, San Francisco, CA Roxana Mehran, New York, NY Multimodality Plaque Imaging Valentin Fuster, New York, NY Prevention Strategies William S. Weintraub, Newark, DE Risk Factor Control Sidney Smith, Jr., Chapel Hill, NC Invasive Imaging of Subclinical Disease Gregg W. Stone, New York, NY Pathogenesis of Atherosclerosis Renu Virmani, Gaithersburg, MD Evaluation of Vascular Function Joseph A. Vita, Boston, MA

Co-Chairs: 2:00 2:15 2:30 2:45 3:00 3:15

805

Chair: 2:00 2:25 2:50 3:15

LIFELONG CORE

QUAL EXPERTS

215

806

When Should a Medicine or Device Stop Being Used in Practice? Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S501a CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-075-L01-P Robert W. Yeh, Boston, MA Robert G. Hauser, Minneapolis, MN, Steven E. Nissen, Cleveland, OH, Frederic S. Resnic, Boston, MA, Paul D. Varosy, Denver, CO Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and Coordinators Saturday, March 24, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S405a CME Hours: 1.5 Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK Faculty Development Joseph S. Green, Washington, DC, Marcia J. Jackson, Santee, SC

AFTERNOON

Chair: 2:00

Chair: Panelists:

Case Presenter: Scott Wright, Rochester, MN

2:25 2:50 3:15

PRACTICE SyMPOSIUM

SPECIAL SPECIAL

106

621

Co-Chairs: 2:00

ACC.12 Final Program 123

Saturday, March 24, 2012 ACC.12

2:00 Satellite Session for Fellowship Program Coordinators Tabitha Fineberg, Boston, MA Faculty Lounge, S100, Conference Room A Self Assessment David Davis, Washington, DC FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 2: Launching a Successful Career Saturday, March 24, 2012, 2:00 p.m. 3:15 p.m. McCormick Place North, N227b CME Hours: 1.25 Early Career Funding Opportunities C. William Balke, San Francisco, CA Question and Answer Social Media to Promote Clinical Research Robert A. Harrington, Durham, NC Question and Answer Evolution of Technology and Medicine: Using Handheld Technology to Improve Patient Care Kirk T. Spencer, Chicago, IL Evolution of Technology and Medicine: How IT Can be Used to Improve Patient Care Amy Leigh Miller, Boston, MA Question and Answer Legends of Cardiovascular Medicine Lecture Series 43rd Annual Louis F. Bishop Lecture Saturday, March 24, 2012, 2:00 p.m. 3:00 p.m. McCormick Place North, N426 CME/CNE Hours: 1 Lawrence H. Cohn, Boston, MA Introduction of Dr. Magdi H. yacoub Lawrence H. Cohn, Boston, MA 43rd Annual Louis F. Bishop Lecture: In Search of Excellence Magdi H. Yacoub, Harefield, Middlesex, United Kingdom One-on-One Interview with Dr. Magdi H. yacoub Lawrence H. Cohn, Boston, MA Audience Question and Answer ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2011 Update (A1-L) Saturday, March 24, 2012, 3:30 p.m. 6:00 p.m. McCormick Place South, S105a CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite 124 GO for ACC.12! Chair: to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC. Steve R. Ommen, Rochester, MN MOC Faculty: James C. Fang, Cleveland, OH, Samuel Asirvatham, Rochester, MN
LIFELONG MOC

3:00
SPECIAL SPECIAL

107

2:00 2:20 2:25 2:45 2:50

3:00

808

3:10
SPECIAL LEGENDS

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy Cardiovascular Disease 2010 Update (A1-K) Saturday, March 24, 2012, 3:30 p.m. 6:00 p.m. McCormick Place South, S105d CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.

401

Chair: 2:00 2:05

AFTERNOON

2:35 2:50
LIFELONG MOC

807

Chair:

Andrew Wang, Durham, NC

MOC Faculty: Julia H. Indik, Tucson, AZ, Mehdi H. Shishehbor, Cleveland, OH

ACC.12 Saturday, March 24, 2012

SPECIAL SPECIAL

107A

FIT Forum I: Mix n Mingle Saturday, March 24, 2012, 3:30 p.m. 4:30 p.m. McCormick Place South, Hall A, Bistro ACC CME/CNE Hours: 0 Pharmacology Program: Pharmacologic Considerations with Antiarrhythmic Drugs, and Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy? Saturday, March 24, 2012, 4:00 p.m. 6:00 p.m. McCormick Place North, N427 CME/CNE/CPE Hours: 2 ACPE No. 0012-9999-152-04-P Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL Pharmacologic Considerations with Antiarrhythmic Drugs James Tisdale, Indianapolis, IN Panel Discussion Melanie T. Gura, OH, Kristen K. Patton, Seattle, WA, Cynthia Sanoski, Philadelphia, PA Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy? Matthew K. Ito, San Diego, CA Panel Discussion Robert Lee Page, II, Aurora, CO, Janet B. Long, Providence, RI, Karol E. Watson, Redondo Beach, CA Vascular Access Challenges and Complications Case Reviews Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5 Tift Mann, Raleigh, NC Robert J. Applegate, Winston-Salem, NC Robert Dieter, Chicago, IL, Shigenori Ito, Nagoya, Japan, Sangeeta Mandapaka, Charleston, WV, Gopi Manthripragada, Los Angeles, CA, Mohammad Reza Movahed, Tucson, AZ Ian C. Gilchrist, Hershey, PA,Harold L. Dauerman, Shelburne, VT, James C. Blankenship, Danville, P Unusual Cases of Acute Coronary Syndromes Case Reviews Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S103b CME/CNE Hours: 1.5 John W. Hirshfeld, Philadelphia, PA, William J. French, Torrance, CA Natasha Purai Arora, Detroit, MI, Sam Mcelwee, Birmingham, AL, Syed Tanveer Rab, Atlanta, GA, Adurthy Ananth Shankar, Syracuse, NY, Lauren Simprini, Washington, DC Neal S. Kleiman, Houston, TX, James E. Tcheng, Durham, NC, A. Michael Lincoff, Cleveland, OH

ACC-i2/TCT SyMPOSIUM

2611

ARR SyMPOSIUM

Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up II: Very Late Stent Thrombosis and Late Catch-up Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 Renu Virmani, Gaithersburg, MD Evelyn Regar, Rotterdam, Netherlands Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from IVUS Studies Yasuhiro Honda, Stanford, CA Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from OCT Studies Ik-Kyung Jang, Boston, MA In-stent Neoatherosclerosis: Time Course, Pathologic Findings in BMS and DES, and Pathologic Validation of OCT Studies Gaku Nakazawa, Isehara, Japan In-stent Neoatherosclerosis in BMS Mitsuyasu Terashima, Kobe, Japan In-stent Neoatherosclerosis in DES Soo-Jin Kang, Suwon, Republic of Korea Bioabsorbable Stents: IVUS, RF-IVUS, OCT, CT Angiographic, and Physiologic Assessment John A. Ormiston, Auckland, New Zealand Case Presentation Masamichi Takano, Chiba, Japan Case Presentation Jingbo Hou, Harbin, China Panel Discussion Hemodynamics II (HOCM) Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Srihari S. Naidu, New York, NY Ulrich Sigwart, Geneva, Switzerland

736

Co-Chairs: 4:30

4:42

Co-Chairs: 4:00 4:45 Panelists: 5:00

4:54

5:06 5:18 5:30

5:45 Panelists:

5:42 5:47 5:52

ACC-i2/TCT SyMPOSIUM

ACC-i2/TCT EXPERTS

2305

Co-Chairs: Case Presenters:

2612

Co-Chairs: 4:30 4:45 5:00 5:15 5:30

AFTERNOON

Hemodynamic Assessment of HOCM Michael A. Fifer, Boston, MA Case Presentation: HOCM, Ideal for Surgery Milind Y. Desai, Cleveland, OH Myomectomy Should be the First Choice for Most Patients Nicholas G. Smedira, Cleveland, OH Case Presentation: HOCM, Ideal for Alcohol Septal Ablation Quang T. Bui, Philadelphia, PA Why Alcohol Septal Ablation Should be the First Choice for Most Patients Carey D. Kimmelstiel, Boston, MA Panel Discussion

Panelists:

ACC-i2/TCT EXPERTS

2306

Co-Chairs: Case Presenters:

5:45

Panelists:

ACC.12 Final Program 125

Saturday, March 24, 2012 ACC.12

ACC-i2/TCT SyMPOSIUM

2613

Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease: In Collaboration with the Society of Vascular Surgery Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Michael R. Jaff, Boston, MA Peter Gloviczki, Rochester, MN Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The Cardiologists Perspective William A. Gray, New York, NY Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The SVS Guidelines John J. Ricotta, Washington, DC Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 Peter Gloviczki, Rochester, MN Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 Robert M. Bersin, Seattle, WA The Future of Endovascular Repair of Thoracic and Thoracoabdominal Aneurysms Gustavo Oderich, Rochester, MN Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The Cardiologists Perspective John R. Laird, El Macero, CA Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The SVS Perspective Sean Lyden, Cleveland, OH Endovascular First for Infrainguinal Peripheral Arterial Disease? The SVS Perspective Michael S. Conte, San Francisco, CA Endovascular First for Infrainguinal Peripheral Arterial Disease? The Cardiologists Perspective Michael R. Jaff, Boston, MA

5:06 5:12 5:18 5:30

Optimal Antiplatelet: Overview of Prasugrel Stephen D. Wiviott, Boston, MA Optimal Antiplatelet: Overview of Ticagrelor Stefan K. James, Uppsala, Sweden Moderated Discussion Agents on the Horizon: Back to the Future (Current Role of GP IIb/IIIa Receptor Antagonists) Sarah A. Spinler, Philadelphia, PA Agents on the Horizon: Novel Oral Agents (Anti-Xa or IIa, TRA) William Dager, San Francisco, CA Agents on the Horizon: Novel Intravenous Agents (P2y12 Antagonists, Elinogrel, Aptamer) David J. Moliterno, Lexington, KY Moderated Discussion
ARR

Co-Chairs: 4:30

5:36 5:42

4:40

5:48

4:50

EXPERTS

216

5:00

The Risk versus Benefit of DFT Testing Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Andrea M. Russo, Moorestown, NJ Martin C. Burke, Chicago, IL, Jeanne E. Poole, WA, William H. Sauer, Aurora, CO Management of Complications of Pacemakers and Leads Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S403 CME/CNE Hours: 1.5 Charles L. Byrd, Fort Lauderdale, FL Laurence Mark Epstein, Boston, MA What Can Go Wrong with the Implantation of a Device? Laurence Mark Epstein, Boston, MA Clinical Presentation, Diagnostic Clues and Management of Late Perforations Alaa A. Shalaby, Pittsburgh, PA Management of Device Infections: When Is Medical Therapy Appropriate? David L. Hayes, Rochester, MN Potential Complications/Ramifications Associated with Lead Extraction Charles L. Byrd, Fort Lauderdale, FL Optimal Strategies for the Management of Antiplatelet and Anticoagulation Medications Prior to Cardiac Device Implantation in Patients with Atrial Fibrillation or Prosthetic Valves Christine Tompkins, Baltimore, MD

Chair: Panelists:

5:10

Case Presenter: Noel G. Boyle, Los Angeles, CA

5:20

ARR SyMPOSIUM

624

5:30

5:40

Co-Chairs: 4:30 4:48

5:50

AFTERNOON

ACS SyMPOSIUM

623

Adjunctive Pharmacology in ACS: Anticoagulants and Antiplatelet Agents Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S404 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-134-L04-P Peter B. Berger, Danville, PA Hyeon-Cheol Gwon, Seoul, Republic of Korea Optimal Anticoagulant: Overview of UFH Marc Cohen, Newark, NJ Optimal Anticoagulant: Overview of Bivalirudin Gregg W. Stone, New York, NY Optimal Anticoagulant: Overview of LMWH Gilles Montalescot, Paris, France Moderated Discussion Optimal Antiplatelet: Overview of Clopidogrel Malcolm Bell, Rochester, MN

5:06

5:24

Co-Chairs: 4:30 4:36 4:42 4:48 5:00

5:42

126 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

ARR SyMPOSIUM

627

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Tissue Engineering Saturday, March 24, 2012, 4:30 p.m. 5:30 p.m. McCormick Place North, N228 CME/CNE Hours: 1 Karen L. Christman, La Jolla, CA Magdi H. Yacoub, Harefield, Middlesex, United Kingdom Role of Tissue Engineering in Cardiovascular Medicine Magdi H. Yacoub, Harefield, Middlesex, United Kingdom Tissue Engineering Approaches to Cardiovascular Devices: From Bench to Bedside Todd McAllister, Navoto, CA Materials for Cardiac Repair: The Product and the Animal Model William Wagner, Pittsburgh, PA Injectable Materials for Treating Myocardial Infarction and Peripheral Artery Disease Karen L. Christman, La Jolla, CA Panel Discussion

HF SyMPOSIUM

626

Management of Acute Decompensated Heart Failure: From Hemodynamic Subsets to Appropriate Treatment Strategies Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S406b CME/CNE Hours: 1.5 Mihai Gheorghiade, Chicago, IL Classification and Subclassification of ADHF Anju Nohria, Boston, MA Question and Answer Is There a Role for Hemodynamic Characterization in ADHF Biykem Bozkurt, Houston, TX Question and Answer Role of Biomarkers in Management of ADHF Wai Hong Wilson Tang, Cleveland, OH Question and Answer Current Strategies in Volume Management of ADHF G. Michael Felker, Durham, NC Question and Answer Inotropes, Vasodilators and Novel Treatment Strategies in ADHF John R. Teerlink, San Francisco, CA Question and Answer

Co-Chairs:

Chair: 4:30 4:45 4:48 5:03 5:06 5:21 5:24 5:39 5:42

4:30

4:45

4:55 5:05

5:15
CCS SyMPOSIUM

625

Updates on Care in the Congenital Heart Disease Patients Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N231 CME/CNE Hours: 1.5 Randall M. Bryant, Jacksonville, FL Michael Earing, Milwaukee, WI Newer Antiarrhythmic and Anticoagulant Therapy and Potential Applications for Adults with Congenital Heart Disease Karen K. Stout, Seattle, WA The Use of Leadless Subcutaneous Defibrillators in Congenital Heart Disease Charles Berul, Washington, DC Update on the Changing Approaches and Outcomes for Immunosuppression in Heart Transplant Patients Lori West, Edmonton, Canada Outcomes after Wider Application of the Cone Reconstruction for the Tricuspid Insufficiency: What Do We Know and What Do We Need to Know? Joseph A. Dearani, Rochester, MN Ventricular Assist Device: Current Indications and Options David Morales, TX

5:57
IMAG EXPERTS

Co-Chairs: 4:30

218

Myocardial Perfusion Imaging: Picking the Right Test Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 John R. Lesser, Minneapolis, MN Richard T. George, Monkton, MD, Rory Hachamovitch, Cleveland, OH, W. Gregory Hundley, Winston Salem, NC, Joao A. C. Lima, Baltimore, MD Multi-Modality Imaging: Chest Pain in the Emergency Department Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Sanjiv Kaul, Portland, OR Leslee J. Shaw, Atlanta, GA Case Presentation Michael C. Kontos, Glen Allen, VA Lets Start with a CTA... Harvey S. Hecht, New York, NY Myocardial Perfusion Imaging for the Emergency Department Patient Raymond J. Gibbons, Rochester, MN A Stress Echo, of Course Farooq A. Chaudhry, New York, NY What about Radiation Safety? Gilbert Raff, Royal Oak, MI Panel Discussion/Question and Answer

Chair: Panelists:

Case Presenter: Julius M. Gardin, Hackensack, NJ

4:48

AFTERNOON

5:06

IMAG SyMPOSIUM

5:24

628

Co-Chairs: 4:30 4:36 4:54

5:42

HF EXPERTS

217

Heart Failure Disease Management: Issues for 2012 Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S502 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-084-L01-P Robin Trupp, Tampa, FL

5:12 5:30 5:42

Chair: Panelists:

Case Presenter: Paul A. Heidenreich, Palo Alto, CA Gregg C. Fonarow, Los Angeles, CA, Sara Paul, Hickory, NC, Ileana L. Pina, Cleveland Heights, OH, Kismet Rasmusson, Salt Lake City, UT

ACC.12 Final Program 127

Saturday, March 24, 2012 ACC.12

ISCHEM SyMPOSIUM

629

Stable Ischemic Heart Disease: Whats New in the Guidelines (and What Should Be)? Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S401a CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-135-L04-P Joaquin Cigarroa, Portland, OR Wanpen Vongpatanasin, Dallas, TX BP: How Low Should We Go and How Do We Get There? Rhonda M. Cooper-DeHoff, Gainesville, FL Dyslipidemia: Recent Trials That Should Change the Guidelines Robert P. Giugliano, Boston, MA PCI: Too Much, Too Little, or Too Late? John Bittl, Ocala, FL CABG: When Is Cold Steel the Best Deal? Michael Jessen, Dallas, TX SIHD: Is There Really Anything New? Joanne M. Foody, Boston, MA Core Curriculum: Echocardiography Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Alex J. Auseon, Columbus, OH Cardiomyopathies and Pericardial Disease Sangeeta B. Shah, New Orleans, LA Valvular Heart Disease Rosario Freeman, Seattle, WA Diastology Issam A. Mikati, Chicago, IL Question and Answer Core Curriculum: Cardiac Electrophysiology Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 Bindi K. Shah, Philadephia, PA Atrial Fibrillation and the SVTs Sherry Saxonhouse, Charlotte, NC Sudden Cardiac Death: Epidemiology, Evaluation and Management Ralph J. Verdino, Philadelphia, PA Pacing and AICD Device Therapy Guidelines Oussama M. Wazni, Solon, OH Question and Answer Information Technology, Medicine and the Future Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5 Cathleen Biga, Woodridge, IL Frank Leonard Mikell, Springfield, IL I Hate My EHR: Is There a Better System? Michael J. Mirro, Fort Wayne, IN Meaningful Use: What It Means for the Practicing Cardiologist Cathleen Biga, Woodridge, IL

5:06 5:24 5:42

PREV SyMPOSIUM

ICD-10: Can They Make This Any More Complicated? Linda Gates-Striby, Indianapolis, IN CPOE: The Good, the Bad, and the Ugly Frank Leonard Mikell, Springfield, IL Question and Answer Hypertension Guidelines 2012 Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S100c CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-136-L04-P Thomas D. Giles, Metairie, LA Suzanne Oparil, Birmingham, AL Updates and New Guidelines for Hypertension Management in 2012 Suzanne Oparil, Birmingham, AL Initial Drug Choices in Low-risk and High-risk Populations Kenneth A. Jamerson, Ann Arbor, MI Should Target Blood Pressure Change in the New Guidelines? William C. Cushman, Memphis, TN Treatment of Hypertension in Diabetes and Chronic Kidney Disease George L. Bakris, Chicago, IL Lifestyle Modification John D. Bisognano, Rochester, NY Hypertension in Ethnic Minorities Ronald G. Victor, Los Angeles, CA
QUAL

Co-Chairs: 4:30 4:48 5:06 5:24 5:42

631

Co-Chairs: 4:30

4:45 5:00 5:15 5:30 5:45

LIFELONG CORE

809

Chair: 4:30 4:55 5:20 5:45

LIFELONG CORE

EXPERTS

219

Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE Registry Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S501a CME/CNE Hours: 1.5 John E. Brush, Norfolk, VA Suzanne V. Arnold, Kirkwood, MO, Blair D. Erb, Bozeman, MT, David Crockett May, Lewisville, TX, Thomas M. Maddox, Denver, CO Educating the Educators: Symposium for Cardiology Fellowship Program Directors and Coordinators Saturday, March 24, 2012, 4:30 p.m. 6:30 p.m. McCormick Place South, S405a CME Hours: 2 Chittur A. Sivaram, Oklahoma City, OK ABIM Milestones and Competencies William Iobst, Philadelphia, PA, Eric S. Williams, Indianapolis, IN Research Training during Fellowship Joseph A. Hill, Dallas, TX, Chittur A. Sivaram, Oklahoma City, OK , Sunil V. Rao, Durham, NC Fellowship Match Changes, Fellow Learning Portfolio and In-Training Examination Jeffrey T. Kuvin, Boston, MA Follow-Up On Previous Projects

810

Chair: Panelists:

Case Presenter: William J. Oetgen, Alexandria, VA

AFTERNOON

Chair: 4:30 4:55 5:20 5:45

PRACTICE SyMPOSIUM

SPECIAL SPECIAL

109

Chair: 4:30 5:10

630

Co-Chairs: 4:30 4:48

5:40

6:10

128 GO for ACC.12!

ACC.12 Saturday, March 24, 2012

6:25 Wrap-Up Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK, Marcia J. Jackson, Santee, SC FIT Forum II: Jeopardy Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N227b CME Hours: 1.5 Kyle W. Klarich, Rochester, MN, Marvin A. Konstam, Boston, MA, Padmini Varadarajan, Redlands, CA Ischemic Mitral Regurgitation Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Vuyisile Nkomo, Rochester, MN John Gorcsan, Pittsburgh, PA, Judy W. Hung, Boston, MA, Saibal Kar, Los Angeles, CA Steven F. Bolling, Ann Arbor, MI, Paul A. Grayburn, Dallas, TX, Suzanne J. Wingate, Silver Spring, MD Valve Repair: How to Achieve Success Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Maurice Enriquez-Sarano, Rochester, MN Patrick M. McCarthy, Chicago, IL Echo to Select Patients for Mitral and Aortic Repair Sunil V. Mankad, Rochester, MN Durability of Mitral Repair: What Is the Truth? David H. Adams, New York, NY Thorascopic Mitral Repair Is the Easiest Clark Hargrove, Philadelphia, PA Mitral Regurgitation with Atrial Fibrillation: Worth the Repair and MAZE? Patrick M. McCarthy, Chicago, IL What Is an Advanced Valve Repair Center? Harold M. Burkhart, Rochester, MN
VASC SyMPOSIUM

to Place Carotid Stents? William A. Gray, New York, NY 5:30 5:45

VALV SyMPOSIUM

Do We Need More Carotid Revascularization Clinical Trials? Joshua A. Beckman, Boston, MA Panel Discussion Translational Research Symposium with the International Society for Cardiovascular Translational Research: Devices Saturday, March 24, 2012, 5:30 p.m. 6:50 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Nicolas A. F. Chronos, Atlanta, GA Mitchell W. Krucoff, Durham, NC Percutaneous and Other Approaches to Aortic Vavle Replacement: From Bench to Bedside James Fonger, Atlanta, GA Percuteanous Mitral Valve Repair: From Bench to Bedside David Reuter, Kirkland, WA Wireless Approaches to Physiological Monitoring: From Bench to Bedside Jay S. Yadav, Atlanta, GA Removing Barriers to Device Innovation Mitchell W. Krucoff, Durham, NC Pathway to IDE and 510K Bram D. Zuckerman, Rockville, MD Panel Discussion Summary and Closing Remarks Anthony N. DeMaria, San Diego, CA
ARR

SPECIAL SPECIAL

110

Judges:

633

VALV EXPERTS

220

Co-Chairs: 5:30

Chair: Case Presenters: Panelists:

5:40 5:50 6:00 6:10 6:25 6:40

VALV SyMPOSIUM

632

Co-Chairs: 4:30 5:06 5:24 4:48

SyMPOSIUM

1601

Critical Links in Atrial Fibrillation: Priorities in Risk Assessment, Treatment and Patient Education Saturday, March 24, 2012, 6:00 p.m. 9:00 p.m. Fairmont Hotel, International Ballroom CME/CNE Hours: 2.5

Afternoon

5:42

Co-Chairs: 6:00 6:30 6:45

Jonathan L. Halperin, New York, NY Stuart A. Winston, Ann Arbor, MI Dinner Welcome and Overview Jonathan L. Halperin, New York, NY The New Science of Atrial Fibrillation Pharmacotherapy Christopher B. Granger, Durham, NC Using Performance and Medical Record Data to Improve Practice Patrick J. Daley, Jr., Fort Wayne, IN Current and Future Performance Measures for Atrial Fibrillation: What is Expected Now and How Will Expectations Change in the Future? N.A. Mark Estes, III, Boston, MA A New ERA for the Physician: How Performance Improvement CME Enhances Atrial Fibrillation Risk Assessment and Treatment Joseph P. Drozda, Jr., St. Louis, MO

743

Carotid Artery Disease: Is the Picture Clarifying? Saturday, March 24, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Ruth Bush, Temple, TX Jonathan L. Halperin, New York, NY Stroke Risk in the Symptomatic and Asymptomatic Internal Carotid Artery. Where Are We Today? Naomi Hamburg, Boston, MA Novel Technologies in the Assessment of Stroke Risk in Asymptomatic Carotid Artery Disease Ahmed A. Tawakol, Boston, MA Hostile Necks: What Defines the High Surgical Risk and High Stent Risk Patient? Sriram S. Iyer, New York, NY After CREST, Is it the Procedure or the Operator? Should All In-practice Interventionists Be Allowed

Co-Chairs: 4:30

7:10 7:25

4:45

eVening

7:45

5:00

5:15

ACC.12 Final Program 129

Saturday, March 24, 2012 ACC.12

8:05 The Impact of Improved Communication and Educational Tools on Patient Outcomes Stuart A. Winston, Ann Arbor, MI Case-Based Panel Discussion and Q&A Concluding Remarks Adjournment
PREV CLINICAL FOCUS

7:40 8:05

Appropriate Use of Echocardiography for Aortic Stenosis Robert Hendel, Miami, FL A Surgeons Perspective on Treating Aortic Stenosis: What is Acceptable Risk for Open Surgical Replacement? Michael Mack, Dallas, TX TAVR: An Experts Perspective and Case Studies E. Murat Tuczu, Cleveland, OH The Asymptomatic Patient with Severe Aortic Stenosis Patrick OGara, Boston, MA Concluding Remarks Aaron Kugelmass, Boston, MA

8:20 8:50 9:00

8:30 8:55 9:20

1602

First Line of Defense: Risk Factors and Prevention in the Cardiology Practice A Master Class for the Community Cardiologist Saturday, March 24, 2012, 6:30 p.m. 9:30 p.m. Fairmont Hotel, Gold Room CME/CNE Hours: 2.5 Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply.

Chair: 6:30 7:00 7:05 7:20 7:40 8:00 8:15 8:35 8:50

Nanette Kass Wenger, Atlanta, GA Registration and Dinner Introduction and General Remarks Nanette Kass Wenger, Atlanta, GA Hypertension Management in Contemporary Practice Suzanne Oparil, Birmingham, AL Case Discussion/Questions and Answers Managing Dyslipidemia and Atherosclerotic Risk Michael H. Davidson, Chicago, IL Case Discussion/Questions and Answers Managing Cardiovascular Risk in Patients with Type2 Diabetes Mark Stolar, Chicago, IL Case Discussion/Questions and Answers Stable Ischemic Heart Disease : Risk Recognition and Assessment, Diagnosis and Treatment Benjamin M. Scirica, Boston, MA Case Discussion/Questions and Answers Concluding Remarks Nanette Kass Wenger, Atlanta, GA

9:10 9:25

VALV CLINICAL FOCUS

1604

Championing Care for the Patient with Aortic Stenosis: The Role of Cardiologists and Primary Care from Recognition to Recovery Saturday, March 24, 2012, 6:30 p.m. 9:30 p.m. Fairmont Hotel, Imperial Ballroom CME/CNE Hours: 2.5 Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply.

eVening

6:30 7:00 7:10

Registration and Dinner Introduction Aaron Kugelmass, Boston, MA Aortic Stenosis in 2012 Has the Paradigm Changed? Natural History and Therapeutic Options Blase Carabello, Houston, TX

130 GO for ACC.12!

ACC.12 Learning Destination Presentations

Saturday, March 24, 2012

Learning Destinations are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.* Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag.

CardioSmart Forum

South Building, Hall A2, CV Theater, #22097 11:15 a.m. 12:15 p.m. Eat What you Love, Love What you Eat: How to Break your EatRepent-Repeat Cycle Part of the CardioSmart: Hot Topics for Better Patient Outcomes Series Michelle May, MD, CSP, Phoenix, AZ Founder and CEO, Am I Hungry? Mindful Eating Workshops

12:15 p.m. 12:35 p.m. Applying Personalized Medicine in the Cath Lab by Tailoring Treatment to Patient Risks John A. Spertus, MD, MPH, FACC, Kansas City, MO Professor, Daniel J. Lauer Missouri Endowed Chair in Metabolism and Vascular Disease Research, University of Missouri, Kansas City; Director, Cardiovascular Education and Outcomes Research, Mid America Heart Institute 12:35 p.m. 12:55 p.m. Robotic-Assisted PCI: Opportunities for Improved Precision and Efficiency George W. Vetrovec, MD, FACC, FSCAI, Richmond, VA Professor of Medicine, VCU Pauley Heart Center at Virginia Commonwealth University; Executive of Board of Directors, Virginia Commonwealth University Health System 12:55 p.m. 1:15 p.m. Heart-Derived Cells for the Treatment of Acute Myocardial Infarction Eduardo Marbn, MD, PhD, FACC, Los Angeles, CA Director, Cedars-Sinai Heart Institute, Mark S. Siegel Family Professor 1:15 p.m. 1:45 p.m. Genetic Testing 101: What Are the Benefits? Jeffrey A. Towbin, MD, FACC, FAAP, FAHA, Cincinnati, OH Executive Co-Director, The Heart Institute; Kindervelt-Samuel Kaplan Professor and Chief, Pediatric Cardiology, Cincinnati Children's Hospital Medical Center 1:45 p.m. 3:45 p.m. Educational content including taped cases, physician interviews, panel discussions and more 3:45 p.m. 4:15 p.m. Moderated Discussion: Viability of Robotic TECAB Moderator: James B. McClurken, MD, FACC, FACS, FCCP, FESC, Philadelphia, PA Professor of Surgery, Director of Performance Improvement, Cardiothoracic Surgery, Temple University Health System Panelists: Johannes O. Bonatti, MD, FETCS, Baltimore, MD Professor of Surgery, Director of Coronary Surgery and Advanced Coronary Interventions, University of Maryland Medical Center; Ralph J. Damiano, Jr., MD, FACC, St. Louis, MO John M. Shoenberg Professor of Surgery, Chief of Cardiac Surgery, Washington University in St. Louis School of Medicine 4:15 p.m. 4:30 p.m. Educational content including taped cases, physician interviews, panel discussions and more

The Heart of Innovation Featured Learning Destination

South Building, Hall A1, #1076 9:30 a.m. 10:15 a.m. Educational content including taped cases, physician interviews, panel discussions and more 10:15 a.m. 10:35 a.m. Autologus Stem Cells Therapy for the Treatment of Refractory Angina Timothy D. Henry, MD, FACC, Minneapolis, MN Director of Research, Minneapolis Heart Institute Foundation; Interventional Cardiologist, Minneapolis Heart Institute/Abbott Northwestern Hospital; Professor of Medicine, University of Minnesota School of Medicine 10:35 a.m. 10:55 a.m. Stem Cells and Biomatrixes Anthony N. DeMaria, MD, MACC, San Diego, CA Judith and Jack White Chair in Cardiology, Founding Director, Sulpizio Cardiovascular Center, University of California San Diego 10:55 a.m. 11:15 a.m. The Regulatory Pathway of Cellular Therapy Steve Winitsky, MD, Rockville, MD Medical Officer, U.S. Food and Drug Administration, CBER/OCTGT/DCEPT 11:15 a.m. 11:35 a.m. ePHR COPE The Use of PHR to Engage Patients Post-Coronary Revascularization Michael J. Mirro, MD, FACC, Fort Wayne, IN Cardiologist, Fort Wayne Cardiology 11:35 a.m. 11:55 a.m. Role of Real-Time 3D TEE Integration for Complex Transcatheter SHD Repairs John D. Carroll, MD, FACC, FSCAI, Aurora, CO Professor of Medicine, Director of Interventional Cardiology, University of Colorado; Medical Director, Cardiac and Vascular Center, University of Colorado Hospital 11:55 a.m. 12:15 p.m. Digital Intervention JoAnne M. Foody, MD, FACC, FAHA, Boston, MA Medical Director, Cardiovascular Wellness Program, Brigham and Womens Hospital

ACC.12 Final Program 131

Saturday, March 24, 2012 ACC.12

Industry-Expert Theater
South Building, Hall A1, #22042 10:15 a.m. 11:15 a.m. (Morning Coffee Break) Pradaxa (Dabigatran Etexilate Mesylate) Capsules Alan K. Jacobson, MD, Loma Linda, CA Director, Anticoagulation Services and Staff Cardiologist, Loma Linda VA Medical Center, Loma Linda University School of Medicine

Philips Healthcare
Interactive Learning Lab #22035 9:30 a.m. 10:30 a.m. Speckle Tracking Today for Myocardial Deformation A Hands-On Guided Workshop Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover, MA Senior Director, Cardiology; Philips Healthcare 11:00 a.m. Noon How Can Cardiology Informatics Enrich My Electronic Health Records Strategy? James E. Tcheng, MD, FACC, Durham, NC Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System 12:30 p.m. 1:30 p.m. Discussing Optimizing Patient Safety and Radiation Exposure with Use of XperSwing with Radial Artery Access for Coronary Angiography John C. Messenger, MD, FACC, FSCAI, Denver, CO Associate Professor of Medicine, Director, Cardiac Catheterization Labs, University of Colorado Hospital 3:30 p.m. 4:30 p.m. Clinical Application of Real-Time 3D TEE for Percutaneous Structural Heart Interventions David Liang, MD, PhD, Palo Alto, CA Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Los Angeles, CA Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center

Presented by Boehringer Ingelheim Pharmaceuticals, Inc.

12:30 p.m. 1:30 p.m. (Mid-Day Break) Next Generation DES: Evolving the Treatment Paradigm Peter J. Fitzgerald, MD, PhD, FACC, Palo Alto, CA Director, Center for Cardiovascular Technology, Stanford University; Alan Yeung, MD, Palo Alto, CA Professor Med Center Line, Medicine Cardiovascular Medicine, Stanford University; Krishna Rocha-Singh, MD, FACC, Springfield, IL Medical Director, Prairie Education & Research Cooperative

Presented by Medtronic, Inc.

3:30 p.m. 4:30 p.m. (Afternoon Coffee Break) Treating a Patient at Risk for SCD after PCI Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator Sunil V. Rao, MD, Durham, NC Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Laboratories, Durham VA Medical Center

Presented by ZOLL

Interactive Learning Labs

Interactive Learning Lab #23027

South Building, Hall A1, #22027, #22035, #23027

Terumo Interventional Systems and The Medicines Company

Interactive Learning Lab #22027 9:30 a.m. 10:30 a.m. Hands-On Radial Access Simulation 10:45 a.m. 11:45 a.m. Hands-On Radial Access Simulation Noon 1:00 p.m. Optimizing your Outpatient PCI: What you Need to Know and Consider 1:00 p.m. 2:00 p.m. Hands-On Radial Access Simulation 2:30 p.m. 3:30 p.m. Hands-On Radial Access Simulation

Actelion Pharmaceuticals US, Inc.

9:30 a.m. 11:30 a.m. Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program Wayne J. Franklin, MD, FACC, Houston, TX Director, Texas Adult Congenital Heart Program, Texas Childrens Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA Director, Boston Adult Congenital Heart Service, Childrens Hospital, Brigham & Womens Hospital, Harvard Medical School 12:30 p.m. 2:15 p.m. PAH: A Case-Based Exploration of Management Strategies Michael Earing, MD, Milwaukee, WI Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI Aurora St. Lukes Medical Center

* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

132 GO for ACC.12!

CardioSource
Mobile App
Powered by Skyscape

2012 American College of Cardiology. W1205

FREE CardioSource Mobile App

The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals! Download CardioSources most popular and clinically relevant content on your mobile device today for FREE!

Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device. Visit ACC Central, Booth #10027

ACC is Your CardioSource

You can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.
Visit ACC Central, Booth 10027, to nd out about: Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients. Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice. Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can nd out how to get more involved, discover the newest membership bene ts, pay dues and more. Advocacy and Practice Support: Learn more about the ACCs efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time. Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your ngertips. Also, learn about other applications available for those on the go.

Fast. Informative. Convenient.

Visit ACC Central at Booth 10027

SAVE
Select Self-Assessment Tools and Live Courses

15% off

2012 American College of Cardiology. X1253

Join us for a whole new learning experience in a whole new city as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.

www.accscientificsession.org

2012 American College of Cardiology A1304

TM

Help Shape the Future of CardioSmart

(and win a free iPad!)
e ACC is re-launching CardioSmart, and we want your input. tools to improve the patient-clinician relationship. e new CardioSmart will provide If youre a practicing clinician, come and tell us what you need. It only takes ve minutes. Well give you a token of our appreciation and enter you in a drawing to win an iPad!

Visit ACC Central, Booth #10027

Sunday, March 25

Sunday March 25

ACC.12

Sunday, March 25

ACC is Your CardioSource

You can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.
Visit ACC Central, Booth 10027, to nd out about: Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients. Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice. Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can nd out how to get more involved, discover the newest membership bene ts, pay dues and more. Advocacy and Practice Support: Learn more about the ACCs efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time. Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your ngertips. Also, learn about other applications available for those on the go.

Fast. Informative. Convenient.

Visit ACC Central at Booth 10027

SAVE
Select Self-Assessment Tools and Live Courses

15% off

2012 American College of Cardiology. X1253

ACC.12 Scientific Session

Sunday, March 25, 2012

Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning SeSSionS
ACC-i2/TCT OrAl

9:15

2500

Outcomes in Patients Treated with TAVr Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N227b CME/CNE Hours: 1.5 Stephen R. Ramee, New Orleans, LA Allan Schwartz, New York, NY Ganesh Manoharan, Belfast, United Kingdom, Nicolas Dumonteil, Toulouse, France, Jan Kovac, Leicestershire, United Kingdom 25006 Year in review Martin B. Leon, New York, NY 25007 The Importance of Vascular Complications after Trans-Femoral Trans-catheter Aortic Valve replacement (TAVr): Insights from the PArTNEr Trial Philippe Genereux, John Webb, Jeffrey Moses, Susheel Kodali, Mathew Williams, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY 25008 Panel Discussion 25009 Incidence, Predictors and Impact of Bleeding Events after Transcatheter Aortic Valve replacement (TAVr) Compared to Surgical Aortic Valve replacement (SAVr): Insights from the PArTNEr Trial Philippe Genereux, Lars Svensson, Susheel Kodali, Mathew Williams, Jeffrey Moses, Michael Mack, D. Craig Miller, E. Murat Tuzcu, John Webb, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY 250010 Panel Discussion 250011 Incidence and Impact of Acute Kidney Injury (AKI) Post Trans-catheter Aortic Valve replacement (TAVr) Using the New Valve Academic research Consortium (VArC) Criteria Philippe Genereux, Susheel Kodali, Martin Leon, A. Garvey Rene, Benoit Daneault, Jean-Michel Paradis, Philip Green, Isaac George, Rebecca Hahn, Ajay Kirtane, Jeffrey Moses, Craig Smith, Mathew Williams, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY 250012 Panel Discussion 250013 Transcatheter Aortic Valve Implantation for Patients with Bicuspid Severe Aortic Valve Stenosis Kentaro Hayashida, Thierry Lefvre, Bernard Chevalier, Thomas Hovasse, Mauro Romano, Philippe Garot, Arnaud Farge, Patrick Donzeau-Gouge, Erik Bouvier, Bertrand Cormier, Marie-Claude Morice, Institut Cardiovasculaire Paris Sud, Massy, France 250014 Panel Discussion 9:25
ACC-i2/TCT OrAl

Co-Chairs: Panelists:

250015 Prevalence and Impact of Myocardial Injury following Transfemoral and Transapical Transcatheter Aortic Valve replacement Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC 250016 Panel Discussion Adjunct Pharmacology Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S101a CME/CNE Hours: 1.5 George W. Vetrovec, Richmond, VA Kimberly A. Skelding, Danville, PA, Peter B. Berger, Danville, PA, Usman Baber, New York, NY 25016 Dual Antiplatelet Therapy and long-term Clinical Outcomes after Primary PCI: The HOrIZONS-AMI Trial Georgios J. Vlachojannis, Roxana Mehran, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce Brodie, Martin Fahy, Ran Kornowski, Bernard Gersh, Helen Parise, George Dangas, Gregg Stone, Cardiovascular Research Foundation, New York, NY, Mount Sinai Medical Center, New York, NY 25017 Panel Discussion 25018 Individualized Bleeding risk Estimates Prior to PCI Impact Physicians Use of Bivalirudin in High-risk Patients Seshu Rao, Adnan Chhatriwalla, kevin kennedy, Carole Decker, Elizabeth Gialde, John Spertus, Steven Marso, Saint Lukes Mid America Heart Institute, Kansas City, MO, University of Missouri Kansas City, Kansas City, MO 25019 Panel Discussion 250110 Impact of Ejection Fraction on Mortality in Patients Undergoing PCI: A Patient-level Pooled Analysis from the rEPlACE-2, ACUITY and HOrIZONS-AMI Trials Jennifer Yu, George Dangas, Usman Baber, Georgios Vlachojannis, Tim Clayton, Stuart Pocock, Frederick Feit, David Cox, Bruce Brodie, A. Lincoff, Efthymios Deliargyris, Bernard Gersh, C. Michael Gibson, Roxana Mehran, Gregg Stone, Mount Sinai Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY 250111 Panel Discussion 250112 The loss-of-function Impact of CYP2C19*2 vs. *3 Allele in Patients Undergoing PCI Treated with High Maintenance-dose Clopidogrel of 150 mg/day: The results of the ACCEl-DOUBlE-2N3 Study Young-Hoon Jeong, udaya tantry, Yonghwi Park, Seok-Jae Hwang, Kevin Bliden, Choong Hwan Kwak, Jin-Yong Hwang, Paul Gurbel, Sinai Center for Thrombosis Research, Baltimore, MD, Gyeongsang Natl Univ Hosp, Jinju, South Korea ACC.12 Final Program 137

Morning

8:00 8:15

2501

Chair: Panelists: 8:00

8:25 8:30

8:10 8:15

8:40 8:45

8:25 8:30

8:55 9:00

8:40 8:45

9:10

Sunday, March 25, 2012 ACC.12

9:00 9:05 250113 Panel Discussion 250114 Impact of Point-of-Care Platelet Function Testing among Patients with and without ACS Undergoing PCI with Drug-Eluting Stents: An ADAPT-DES Sub-study Ajay J. Kirtane, Michael Rinaldi, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY 250115 Panel Discussion 250116 Does Platelet Function Testing Add Significant Incremental risk Stratification to Unselected Patients Undergoing DES Implantation? The ADAPT-DES Study Ajay J. Kirtane, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Michael Rinaldi, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY 250117 Panel Discussion PCI in Complex lesions Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Samin K. Sharma, New York, NY Etsuo Tsuchikane, Toyohashi, Japan Panayiotis Avraamides, Nicosia, Cyprus, Robert Pyo, Bayside, NY, Emmanouil S. Brilakis, Dallas, TX 25046 Year in review David E. Kandzari, Atlanta, GA 25047 A report from Japanese Multicenter registry Data for Clinical results of retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions ATSUNORI OKAMURA, Masahisa Yamane, Makoto Muto, Tsutomu Fujita, Tetsuo matsubara, Yasumi Igarashi, Shigeru Nakamura, Toshiya Muramatsu, Mitsunori Abe, Etsuo Tsuchikane, Toyohashi Heart Center, Toyohashi, Japan, Sakurabashi Watanabe Hospital, Osaka, Japan 25048 Panel Discussion 25049 Natural History of Side Branch Jailed By Drug Eluting Stent Masahiro Yamawaki, Toshiya Muramatsu, Yasunari Sakamoto, Hideyuki Takimura, Hiroshi Ishimori, Reiko Tsukahara, Saiseikai Yokohama City Eastern, Yokohama, Japan 250410 Panel Discussion 250411 Is Double Stenting the Optimal Treatment for Complex Coronary Bifurcation lesions? Ricardo A. Costa, Fausto Feres, Rodolfo Staico, 8:25 J. Ribamar Costa, Jr, Dimytri Siqueira, Alexandre Abizaid, Luiz F. Tanajura, Amanda Sousa, J. Eduardo Sousa, Antonio Colombo, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, EMO GVM Centro Cuore Columbus, Milan, Italy 8:55 9:00 250412 Panel Discussion 250413 long-term Clinical results of Adverse Outcomes after Drug-eluting Stent Implantation for Bifurcation lesions in a real-World Practice results from the COBIS (Coronary Bifurcation Stenting) II registry Jeong Hoon Yang, Pil Sang Song, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Hyo-Soo Kim, Seung-Woon Rha, Cheol Woong Yu, Jong-Seon Park, Jin-Ok Jeong, Hyeon-Cheol Gwon, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea 250414 Panel Discussion 250415 The ESTrOFA-lM registry: Comparison of Paclitaxel-eluting Stents and Everolimus-eluting Stents in left Main Coronary Artery Disease results at 3-years Follow-up Jose de la Torre Hernandez, Angel Sanchez-Recalde, Bruno Garcia del Blanco, Manuel Jimenez Navarro, Federico Gimeno, Ramon Calvino, Neus Salvatella, Tamara Garcia Camarero, Felipe Hernandez, Fernando Rivero, Jose Moreu, Jose R. Rumoroso, Francisco Bosa, Monica Masotti, Victoria Martin, Juan A. Bullones, Arsenio Gallardo, Jose A. Fernandez Diaz, Victor Aragon, ESTROFA study group, Spain, Spain 250416 Panel Discussion PCI in Complex Patients Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S102c CME/CNE Hours: 1.5 Carlo Di Mario, London, United Kingdom Corrado Tamburino, Catania, Italy William S. Weintraub, Newark, DE, Brian P. ONeill, Miami, FL, Eugenia Nikolsky, Haifa, Israel 25056 Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention within One-year of Coronary Artery Bypass Grafting Surgery Mark A. Kotowycz, Anirban Choudhury, Lauren M. Morrison, mark osten, Vladimir Dzavik, Chris Overgaard, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, Toronto, Canada 25057 Panel Discussion 25058 CorPath-PrECISE: Final results of the First Pivotal Study for robotically-enhanced PCI Giora Weisz, Christopher Metzger, Ronald Caputo, Juan Granada, J. Marshall, Mark Reisman, George Vetrovec, Ron Waksman, Jeffrey Moses, Joseph Carrozza, NewYork Presbyterian Hospital - Columbia University Medical Center, New York, NY 25059 Panel Discussion

Morning

9:15 9:20

9:10 9:15

9:25
ACC-i2/TCT OrAl

2504

9:25
ACC-i2/TCT OrAl

Co-Chairs: Panelists: 8:00 8:15

2505

Co-Chairs: Panelists: 8:00

8:25 8:30

8:10 8:15

8:40 8:45

138 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

8:30 250510 Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography and Intervention Binita Shah, Nicholas Amoroso, Xingchen Mai, Jeffrey Lorin, Ann Danoff, Steven Sedlis, New York University School of Medicine, New York, NY, VA New York Harbor Healthcare System, New York Campus, New York, NY 250511 Panel Discussion 250512 The Impact of Anemia on 6-month Angiographic and 1-year Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention Ji Young Park, Seung-Woon Rha, Amro Elnagar, Byoung Geol Choi, sung il Im, Sunwon Kim, Jin Oh Na, Seongwoo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Hong-Seog Seo, Chang Gyu Park, Dong Joo Oh, Cardiology Department, Eulji General Hospital, Seoul, South Korea, Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea 250513 Panel Discussion 250514 Characteristics, In-Hospital and long-term Clinical Outcomes of Nonagenarian AMI Patients Compared with Octogenarian AMI Patients Ki Hong Lee, Young Keun Ahn, Myung Ho Jeong, Donghan Kim, Shung Chull Chae, Young Jo Kim, Jei Keon Chae, Myeong Chan Cho, Chong Jin Kim, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea 250515 Panel Discussion 250516 The Effect of Drug-eluting Stents on Clinical and Angiographic Outcomes in renal Failure Patients with Dialysis: Multicenter registry in Asia Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Hans Yeo, Wasan Udayachalerm, Damras Tresukosol, Sudaratana Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan 250517 Panel Discussion Intravascular Diagnostics Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S106b CME/CNE Hours: 1.5 Alexandra J. Lansky, New Haven, CT Jagat Narula, New York, NY Elias Sanidas, New York, NY, Jennifer Yu, New York, NY 25086 Does Aggressive Statin Therapy reduce Coronary Atherosclerotic Plaque lipid Content? results from reduction in YEllow Plaque by Aggressive lipid lOWering Therapy (YEllOW) Trial Annapoorna Subhash Kini, Pedro Moreno, Jason Kovacic, Atul Limaye, Ziad Ali, Joseph Sweeny, Usman Baber, George Dangas, Samin Sharma, Mount Sinai Medical Center, New York City, NY Panel Discussion 25087 The Impact of Sex Differences on Fractional Flow reserve-Guided Percutaneous Coronary Intervention: A FAME Substudy Hyun-Sook Kim, 9:25
ACC-i2/TCT OrAl

Pim Tonino, Bernard De Bruyne, Andy Yong, Jennifer Tremmel, Nico Pijls, William Fearon, Stanford University Medical Center, Palo Alto, CA, Hallym University Sacred Heart Hospital, Anyang, South Korea 8:25 8:30 25088 Panel Discussion 25089 A New Method for Assessing Neointimal Coverage after Drug-eluting Stent Implantation Using Three-dimensional Optical Coherence Tomography Byeong-Keuk Kim, Jinyong Ha, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea 250810 Panel Discussion 250811 Coronary Computed Tomographic Angiography Morphologic Characteristics of lipid-core Plaques Identified by Intracoronary Near-infrared Spectroscopy James L. Smith, Ryan Madder, A Neil Bilolikar, Simon Dixon, James Goldstein, William Beaumont Hospital, Royal Oak, MI, Spectrum Health, Grand Rapids, MI 250812 Panel Discussion 250813 Spectroscopic Detection of Fibrous Cap Thickness Overlying lipid Core Coronary Plaques with a Catheter-Based Near-infrared Spectroscopy System Sean Madden, Joel Raichlen, James Muller, Infraredx, Inc., Burlington, MA 250814 Panel Discussion 250815 Impact of Early and late Stent Malapposition on long-term Clinical Outcomes: Three-year Follow-up from the HOrIZONS-AMI IVUS Sub-study Tadayuki Yakushiji, Gary Mintz, Bernhard Witzenbichler, Giulio Guagliumi, Ecaterina Cristea, Ovidiu Dressler, Roxana Mehran, Gregg Stone, Akiko Maehara, Cardiovascular Research Foundation, New York, NY 250816 Panel Discussion Vascular Access Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S103b CME/CNE Hours: 1.5 Mehdi H. Shishehbor, Cleveland, OH Robert J. Applegate, Winston-Salem, NC Jason H. Rogers, Sacramento, CA, Alexios P. Dimas, Athens, Greece, Samir B. Pancholy, Chinchilla, PA 25106 Year in review Zoltan G. Turi, Camden, NJ 25107 Economic Impact of Transradial Percutaneous Coronary Intervention David M. Safley, Dmitri Baklanov, Rebecca Mills, John House, Steven Marso, Saint Lukes Mid America Heart Institute, Kansas City, MO, University of Missouri Kansas City, Kansas City, MO 25108 Panel Discussion 25109 Adequate Screening Can reduce radial Access Failure rates in ST-Elevation Myocardial Infarction Patients Undergoing Primary ACC.12 Final Program 139

8:40 8:45

Morning

8:40 8:45

8:55 9:00

8:55 9:00

9:10 9:15

9:10 9:15

9:25
ACC-i2/TCT OrAl

2508

2510

Co-Chairs: Panelists: 8:00

Co-Chairs: Panelists: 8:00 8:15

8:10 8:15

8:25 8:30

Sunday, March 25, 2012 ACC.12

Percutaneous Coronary Intervention Jean-Pierre Dery, Marie-Pier Bouchard, Ugo Dery, Melanie Roy, Josep Rodes-Cabau, Stephane Rinfret, Eric Larose, Gerald Barbeau, Jacques Rouleau, Louis Roy, Bernard Noel, can nguyen, Onil Gleeton, Guy Proulx, Jean-Rock Boudreault, Robert DeLa Rochellire, Sunil Rao, Olivier Bertrand, Quebec Heart and Lung Institute, Quebec City, Canada, Duke University Clinical Research Institute, Durham, NC 8:40 251010 Panel Discussion 251011 risk of Brain Injury related to Silent Cerebral Embolization during Diagnostic Coronary Angiography: Direct Comparison between right radial and left radial Approach Andrea Pacchioni, Antonio Mugnolo, Carlo Penzo, Dimitrios Nikas, Salvatore Sacc, Luca Favero, Bernhard Reimers, Francesco Versaci, Divisione di Cardiologia, Ospedale Civile, Mirano, Italy 251012 Panel Discussion 251013 large-bore Common Femoral Arterial Access Using Fluoroscopic Guidance with Computed Tomographic Angiography Overlay: Safe Entry and Exit Bryce Einhorn, Chad Kliger, Vladimir Jelnin, Leandro Maranan, Howard Cohen, Itzhak Kronzon, Carlos Ruiz, Lenox Hill Heart and Vascular Institute, New York, NY 251014 Panel Discussion 251015 Major Bleeding Impacts Death Following Percutaneous Coronary Intervention: Insights from the NCDr Adnan Chhatriwalla, Amit Amin, kevin kennedy, John House, Sunil Rao, John Messenger, David Cohen, Steven Marso, Saint Lukes Mid America Heart Institute, Kansas City, MO 251016 Panel Discussion Abnormalities of the Atrium Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Jonathan M. Tobis, Los Angeles, CA Maurice Buchbinder, La Jolla, CA Conditions Associated with PFO Speaker TBD Pros and Cons of Closure for Stroke Anthony Furlan, Cleveland, OH Pros and Cons of Closure for Migraine with Aura Jonathan Tobis, Los Angeles, CA lAA Device Closure PrO: Preferred Therapy for AF Ken Huber, Kansas City, MO lAA Device Closure CON: It Should Not be Done Sanjay Kaul, Los Angeles, CA Panel Discussion 9:00 8:45
ACS OrAl ACS ExPErTS

221

Complications of AMI Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Prediman K. Shah, Los Angeles, CA Judith S. Hochman, New York, NY, Roger J. Laham, Boston, MA, Melchior Seyfarth, Muenchen, Germany, Holger Thiele, Leipzig, Germany What Impacts Outcomes in ACS? From Genes to Plaque Morphology to Environment. Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S401a CME/CNE Hours: 1.5 Venu Menon, Cleveland, OH Doron Zahger, Beer Sheva, Israel 9163 The Year in review Robert P. Giugliano, Boston, MA 9164 Characteristics and Clinical Significance of Angiographically Mild lesions in ACS: Insights from the PrOSPECT Study Sorin J. Brener, Gary Mintz, Ecaterina Cristea, Giora Weisz, Akiko Maehara, John McPherson, Steven Marso, Naim Farhat, Hans E. Botker, Ovidiu Dressler, Ke Xu, Barry Templin, Zhen Zhang, Alexandra Lansky, Bernard de Bruyne, Patrick Serruys, Gregg Stone, New York Methodist Hospital, Brooklyn, NY, Cardiovascular Research Foundation, New York, NY 9165 Timing of Angiography and Clinical Outcomes after Fibrinolysis: A Patient-level Analysis of randomized Early Invasive Clinical Trials Mina Madan, Mary Tan, Sigrun halvorsen, Cynthia M. Westernout, Warren Cantor, Michel R. Le May, Francesco Borgia, Federico Piscione, Carlo Di Mario, Bruno Scheller, Paul Armstrong, Francisco Fernandez-Aviles, Pedro L. Sanchez, John Graham, Andrew Yan, Shaun Goodman, Sunnybrook Health Sciences Centre, Toronto, Canada, Canadian Heart Research Centre, Toronto, Canada 9166 The Effects of Hurricane Katrina on Acute Myocardial Infarction Five Years after the Storm John Moscona, Sumit Tiwari, Kartik Munshi, Sudesh Srivastav, Patrice Delafontaine, Anand Irimpen, Tulane University Heart and Vascular Institute, New Orleans, LA 9167 Coronary Plaque Characteristics in Patients with Diabetes Mellitus Who Presented with Acute Coronary Syndrome: Optical Coherence Tomography Study Jingbo Hou, Lei Xing, Haibo Jia, zhigang han, Shuang Yang, Lingbo Meng, Koji Kato, Tiashi Yonetsu, Soo Joong Kim, Hang Lee, Shaosong Zhang, Yu Bo, Ik-Kyung Jang, Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, Peoples Republic of China, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 9168 Telomere length and Cardiovascular Outcomes Christian T. Ruff, Jessica Mega, David

Chair: Panelists:

Case Presenter: Steven M. Stevens, Los Angeles, CA

Morning

8:45

916

Co-Chairs: 8:00 8:15

8:55 9:00

9:10 9:15

8:30

9:25
ACC-i2/TCT SYMPOSIUM

2614

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

9:15

140 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

Morrow, Benjamin Scirica, Edward C. Frackelton, Hakon Hakonarson, Kevin Crowley, Charles Contant, Christopher Cannon, Eugene Braunwald, Marc Sabatine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA
Arr ExPErTS

Columbia, MO, McMaster University and Hamilton Health Scineces, Hamilton, Canada 9:03 9048 Evaluation of recombinant Activated Factor Vii, Prothrombin Complex Concentrate and Fibrinogen Concentrate to reverse Apixaban in a rabbit Model Martin Anne-Cline, Le-Bonniec Bernard, Lecompte thomas, Fischer Anne-Marie, Emmerich Joseph, Samama Charles marc, Godier Anne, HIA val de grce, Paris, France, INSERM 765, Paris, France

222

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Genetic Syndromes for the Clinician (HCM, Brugada, long QT) Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Jeffrey A. Towbin, Cincinnati, OH Michael J. Ackerman, Rochester, MN, Bernard J. Gersh, Rochester, MN, Arthur J. Moss, Rochester, NY Joint Oral Arrhythmias Session of the Heart rhythm Society and the American College of Cardiology: Management of the Patient with Atrial Fibrillation Anticoagulation and Prevention of Stroke Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Anne M. Gillis, Calgary, Canada Julia H. Indik, Tucson, AZ 9043 The Year in review Anne M. Gillis, Calgary, Canada 9044 Stroke risk in Post-menopausal Women with Atrial Fibrillation in the Womens Health Initiative: A Validation and Comparison of the CHADS2 and CHA 2DS2-VASc risk Scores JoEllyn Carol Moore M. Abraham, Sylvia Wassertheil-Smoller, Joseph Larson, Mina Chung, J. D. Curb, Anne Curtis, Kamakshi Lakshminarayan, Jonathan Newman, Marco Perez, Kathryn Rexrode, Nawar Shara, Allen Solomon, Marcia L. Stefanick, James C. Torner, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH, Womens Health Initiative, Bethesda, MD 9045 The CHA 2DS2-VASc Score Identifies AF Patients with A CHADS2 Score of 0 or 1 Treated with Antiplatelet Therapy Who Are Unlikely to Benefit from Oral Anticoagulant Therapy Michiel Coppens, John Eikelboom, Robert Hart, Salim Yusuf, Gregory Lip, Paul Dorian, Olga Shestakovska, Stuart Connolly, Population Health Research Institute, McMaster University, Hamilton, Canada 9046 Dabigatran and Myocardial Infarction, Drug or Class Effect: Meta-Analysis of randomized Trials with Oral Direct Thrombin Inhibitors Ramin Artang, Eric Rome, Humberto Vidaillet, University of Nebraska Medical Center, Omaha, NE, Marshfield Clinic, Marshfield, WI 9047 Bleeding with Aspirin and Apixaban in Patients Unsuitable for Vitamin K Antagonist Therapy: The AVErrOES Study Greg C. Flaker, John Eikelboom, Stuart Connolly, Salim Yusuf, Gregory Lip, Robert Hart, University of Missouri,

Morning

9:15

Chair: Panelists:

Arr OrAl

904

9049 Efficacy and Safety of Apixaban Compared with Warfarin According to CHADS2 and HASBlED risk Scores for Stroke Prevention in Atrial Fibrillation Renato D. Lopes, Sana Al-Khatib, Lars Wallentin, Hongqiu Yang, Jack Ansell, J. Donald Easton, Cetin Erol, Justin Ezekowitz, Bernard Gersh, Stefan Hohnloser, Elaine Hylek, Cecilia Bahit, John Horowitz, Raffaele De Caterina, Puneet Mohan, Dragos Vinereanu, Christopher Granger, John Alexander, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
CCS

SYMPOSIUM

634

Co-Chairs: 8:00 8:15

Preoperative Assessment of Patients on the Single Ventricle Pathway: Special Problems, Creative Solutions Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N231 CME/CNE Hours: 1.5 John F. Rhodes, Durham, NC Mark Scheurer, Charleston, SC Case Presentation Joshua Kanter, DC Pre-Glenn Assessment in the Current Era: Significance of the Sano and Hybrid Stage 1 Modifications Henri Justino, Houston, TX Systemic-to-Pulmonary Arterial Collaterals: Do They Matter and What Should We Do About Them? Mathew Gillespie, Philadelphia, PA Considerations in Single Ventricle Patients with Heterotaxy Doff B. McElhinney, Boston, MA Non-Invasive Pre-Glenn and Pre-Fontan Assessment: When Is Catheterization Not Indicated? David W. Brown, Boston, MA

Co-Chairs: 8:00 8:10

8:30

8:50 9:10

8:27

HF SYMPOSIUM

635

8:39

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Pharmacological Treatment of Systolic and Diastolic Heart Failure Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S406b CME/CNE Hours: 1.5 William H. Gaasch, Burlington, MA Dennis M. McNamara, Pittsburgh, PA Stage A Thomas J. Wang, Boston, MA Stage B Marvin A. Konstam, Boston, MA Stage C Barry H. Greenberg, San Diego, CA HF-PEF Michael R. Zile, Charleston, SC Question and Answer ACC.12 Final Program 141

Co-Chairs: 8:00 8:20 8:40 9:00 9:20

8:51

Sunday, March 25, 2012 ACC.12

IMAG ExPErTS

223

Cardiac PET: Incorporation into Daily Practice Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Sharmila Dorbala, Boston, MA Karthikeyan Ananthasubramaniam, West Bloomfield, MI, Timothy M. Bateman, Kansas City, MO, Rob S. B. Beanlands, Ottawa, Canada, Panithaya Chareonthaitawee, Rochester, MN, Marcelo F. Di Carli, Boston, MA Joint Oral Session of the American Society of Echocardiography and the American College of Cardiology: Newest Applications of Echo to Clinical Practice Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Theodore P. Abraham, Baltimore, MD Susan E. Wiegers, Philadelphia, PA 9073 The Year in review Imaging Jonathan R. Lindner, Portland, OR 9074 Diastolic Function and Survival in Patients with Severe Aortic Stenosis and Normal left Ventricular Ejection Fraction Omar Khalique, Yat Wa Li, Robert Belkin, MD, Wilbert Aronow, Cesare Russo, Chul Ahn, Mala Sharma, Columbia University Medical Center, New York, NY, New York Medical College, Valhalla, NY 9075 Deformation Imaging Is an Independent Predictor of Outcomes in Asymptomatic Aortic Stenosis with Normal Ejection Fraction Teerapat Yingchoncharoen, Gibby Conrad, Brian Griffin, L. Leonardo Rodriguez, Richard Grimm, Thomas Marwick, Cleveland Clinic, Cleveland, OH 9077 Activation Imaging: A Novel Approach to Three-dimensional Mechanical Mapping Using Speckle Tracking Strain Toshinari Onishi, Tetsuari Onishi, Mohamed Ahmed, Josef Marek, Samir Saba, David Schwartzman, John Gorcsan, University of Pittsburgh, Pittsburgh, PA 9078 Accurate Quantification of Chronic Mitral regurgitation by Automated True 3-D Proximal Isovelocity Surface Area Using real-Time Volume Color Flow Doppler Transthoracic Echocardiography: In Vitro and Clinical Validation Paaladinesh Thavendiranathan, Shizhen Liu, Saurabh Datta, Thomas Ryan, Stephen Igo, Matthew S. Jackson, Nathalie De Michelis, Stephen Little, Mani Vannan, The Ohio State University, Columbus, OH, The Methodist DeBakey Heart & Vascular Center, Houston, TX

lIFElONG SYMPOSIUM

731

Chair: Panelists:

CCA Team-Based Maintenance of Certification Sunday, March 25, 2012, 8:00 a.m. 10:30 a.m. McCormick Place South, S105d CME/CNE/CPE Hours: 2.5 ACPE No. 0012-9999-12-080-l04-P Jane A. Linderbaum, Rochester, MN Michael G. Clark, Bedford, TX

Case Presenter: Ritesh Dhar, Detroit, MI

Chair: Co-Chair:

MOC Faculty: Rhonda M. Cooper-DeHoff, Gainesville, FL, Eileen M. Handberg, Gainesville, FL

PHTN OrAl

Morning

IMAG OrAl

912

907

Whats New in Pulmonary Hypertension Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Gautam V. Ramani, Baltimore, MD Stacy Mandras, New Orleans, LA 9123 The Year in review Pulmonary Hypertension Michael A. Mathier, Pittsburgh, PA 9124 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A retrospective Analysis Marwan Badri, Wajeeha Saeed, Ankush Lahoti, Jason Salamon, Eric Gnall, Ronald Zolty, Rizwan Sardar, Lankenau Medical Center, Wynnewood, PA, Montefiore Medical Center, New York, NY 9125 Does Obesity Affect Brain Natriuretic Peptide levels in Patients with Pulmonary Arterial Hypertension? Omar Batal, Kyle Buchanan, Andrea Elliott, Jonathon Wertz, Matthew Lander, Anthi Katsouli, David Ishizawar, Michael Mathier, Angel Lopez-Candales, University of Pittsburgh Medical Center, Pittsburgh, PA 9126 Prognostic Factors in Pulmonary Hypertension: The Obesity Paradox Barak Zafrir, Waseem Shehadeh, Nabia Salman, Yochai Adir, Offer Amir, Lady Davis Carmel Medical Center, Haifa, Israel, Lin Medical Center, Haifa, Israel 9127 The Prognostic Ability of Pulmonary Arterial Capacitance Exceeds that of Pulmonary Vascular resistance in Advanced left-sided Heart Failure Matthias Dupont, Wilfried Mullens, Yuping Wu, Wai Hong Tang, Cleveland Clinic Foundation, Cleveland, OH, Cleveland State University, Cleveland, OH 9128 Impaired Global right Ventricular longitudinal Strain Predicts long-term Adverse Outcomes in Patients with Primary Pulmonary Hypertension Jae-Hyeong Park, Margaret Park, Samar Farha, Jacqueline Sharp, Erika Lundgrin, Suzy Comhair, Wai Hong Tang, Serpil C. Erzurum, James Thomas, Cleveland Clinic, Cleveland, OH

Co-Chairs: 8:00 8:15

Co-Chairs: 8:00 8:15

8:30

8:30

8:45

9:00

9:00

9:15

9:15

PrEV OrAl

911

Prevention: Focus on lipids Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S100c CME/CNE Hours: 1.5 James A. De Lemos, Dallas, TX Neil Stone, Winnetka, IL 9113 The Year in review Prevention Christie M. Ballantyne, Houston, TX

Co-Chairs: 8:00

142 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

8:12 9114 Safety Profile of Statin-Treated Patients with lDl-C < 30mg/dl Brendan Everett, Samia Mora, Joseph Grossbard, Jean MacFadyen, Paul Ridker, Brigham and Womens Hospital, Boston, MA, Harvard Medical School, Boston, MA 9115 The Effects of Co-administering a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, rEGN727/SAr236553, with 10 and 80 mg Atorvastatin Compared to 80 mg Atorvastatin Alone in Patients with Primary Hypercholesterolemia (NCT: 01288469) Eli M. Roth, James McKenney, Corinne Hanotin, Gaelle Asset, Evan Stein, Sanofi-aventis US, Inc, Bridgewater, NJ, Regeneron Pharmaceuticals, Inc, Tarrytown, NY 9116 lack of Association between Polymorphisms in the SLCO1B1 Gene and Clinical Myalgia following rosuvastatin Therapy Jacqueline Suk Danik, Jean MacFadyen, Fredrik Nyberg, Paul Ridker, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, AstraZeneca, MoIndal, Sweden 9117 The Association between lower levels of low-density lipoprotein Cholesterol and Cancer Predates the Diagnosis of Cancer by 18 Years Paul Michael Lavigne, Haseeb Jafri, Richard Karas, Tufts Medical Center, Boston, MA, Johns Hopkins University, Baltimore, MD 9118 lipid Transfer to High Density lipoproteins in Type 2 Diabetic Patients with and without Coronary Artery Disease Marlia C O Sprandel, Whady Hueb, Antonio Casella-Filho, Alexandre Segre, Paulo Cury Rezende, Ana L O Carvalho, Desiderio Favarato, Raul C. Maranho, Jose Ramires, Roberto Kalil-Filho, Heart Institute University of Sao Paulo, Sao Paulo, Brazil 9119 The Effect of Statins on Skeletal Muscle Function Beth A. Parker, Jeffrey A. Capizzi, Adam Grimaldi, Donna Polk, Priscilla M. Clarkson, Stephanie M. Cole, Justin Keadle, Stuart Chipkin, Linda S. Pescatello, Kathleen Simpson, C. Michael White, Paul Thompson, Hartford Hospital, Hartford, CT 91110 ETC-1002 lowers lDl-C and Beneficially Modulates Other Cardio-Metabolic risk Factors in Hypercholesterolemic Subjects with Either Normal or Elevated Triglycerides Christie M. Ballantyne, Michael Davidson, Diane MacDougall, Janice Margulies, Lorenzo DiCarlo, Roger Newton, Baylor College of Medicine, Houston, TX, Esperion Therapeutics, Inc., Plymouth, MI
SPECIAl QUAl ExPErTS QUAl OrAl

913

Insights and Innovations to Improve Cardiac risk Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N229 CME/CNE Hours: 1.5 Thomas M. Maddox, Denver, CO John S. Rumsfeld, Denver, CO 9133 The Year in review Quality of Care John S. Rumsfeld, Denver, CO 9134 Impact of Massachusetts Health reform on Preventable Admissions for the Previously Insured Karen Joynt, David C. Chan, Ashish K. Jha, Brigham and Womens Hospital, Boston, MA, Harvard School of Public Health, Boston, MA 9135 Total Medical Costs Avoided with Apixaban versus Aspirin Treatment among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin: Based on the Averroes Trial results Alpesh N. Amin, Steven Deitelzweig, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham, University of California, Irvine, Orange, CA 9136 Immediate Impact of a 10week Middle School Intervention to Improve Health Behaviors and reduce Cardiovascular risk Factors: Project Healthy Schools in Michigan Taylor F. Eagle, Roopa Gurm, Cydni Smith, Nicole Corriveau, Jean Du-Russel-Weston, LaVaughn Palma-Davis, Susan Aaronson, Caren Goldberg, Eva Kline-Rogers, Elizabeth Jackson, Kim Eagle, University of Michigan, Ann Arbor, MI 9137 Patterns of Early Thienopyridine Use among Contemporary STEMI and NSTEMI Patients in the US: Insights from ACTION registry-Get with the Guidelines Matthew William Sherwood, Tracy Wang, Matthew Roe, Pankaj Madan, Szu-Po Peng, James de Lemos, Eric Peterson, Stephen Wiviott, Duke University Medical Center, Durham, NC, Brigham and Womens Hospital/Harvard Medical School, Boston, MA 9138 Effectiveness of a Clinical Decision Support System Incorporating a Validated QT Interval Prolongation risk Score for reducing the risk of QT Interval Prolongation in Hospitalized Patients James Tisdale, Heather Wroblewski, Joanna Kingery, Brian Overholser, Tate N. Trujillo, Richard Kovacs, Purdue University, Indianapolis, IN, Indiana University, Indianapolis, IN late-Breaking Clinical Trials II Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, Hall B, ACC.12 Main Tent CME/CNE Hours: 1.5 George D. Dangas, New York, NY Robert A. Harrington, Durham, NC Gilles Montalescot, Paris, France, Erik Magnus Ohman, Durham, NC, Philippe Gabriel Steg, Paris, France, Alexander G. Turpie, Dundas, Canada Outcomes of Non-Primary PCI at Hospitals with and without On-site Cardiac Surgery: CPOrT-E Trial Final Medical Outcomes Thomas Aversano, Johns Hopkins University, Baltimore, MD ACC.12 Final Program 143

8:25

Co-Chairs: 8:00 8:15

Morning

8:38

8:30

8:51

8:45

9:04

9:00

9:17

9:15

9:30

224

Tools to Improve Care Transition: The Hospital to Home (H2H) Experience Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Harlan M. Krumholz, New Haven, CT Larry A. Allen, Aurora, CO, Ileana L. Pina, Cleveland Heights, OH, Adrian F. Hernandez, Durham, NC, Mary N. Walsh, Indianapolis, IN

SPECIAl

304

Co-Chairs: Panelists:

Chair: Panelists:

Case Presenter: John E. Brush, Norfolk, VA 8:00

Sunday, March 25, 2012 ACC.12

8:15 8:22 Panel Discussion INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI Gregg W. Stone, Akiko Maehara, Bernhard Witzenbichler, Jan Godlewski, Ecaterina Cristea, Helen Parise, Jan Henk Dembrink, Andrzej Ochala, Steven Wolff, Saqib Chowdhary, Magdi El-Omar, Thomas D Neunteuff, D. Christopher Metzger, C. Michael Gibson, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY Panel Discussion randomized Comparison of Adding Cilostazol versus Doubling the Dose of Clopidogrel after receiving Percutaneous Coronary Intervention: The HOST-ASSUrE randomized Trial Kyung Woo Park, Hyo Soo Kim, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Seoul National University Hospital, Seoul, South Korea Panel Discussion A Multifaceted Intervention to Narrow the EvidenceBased Gap in the Treatment of ACS: Main results from the BrIDGE-ACS Cluster randomized Trial Otavio Berwanger, Helio Guimaraes, Alexandre Cavalcanti, Ligia Laranjeira, Eliana Santucci, Ana Zazula, Uri Flato, Marcos Tenuta, Alessandra Kodama, Elivane Victor, Mariana Carballo, Vera Mira, Luiz Mota, Eric Peterson, Renato Lopes, Research Institute of Cardiac Hospital (HCor), Sao Paulo, Brazil, Brazilian Clinical Research Institute, Sao Paulo, Brazil Panel Discussion Young Investigators Award Competition: ACCF/ Herman K. Gold Young Investigators Award in Molecular and Cellular Cardiology Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S105a CME/CNE Hours: 1.5 Douglas Sawyer, Nashville, TN Michael T. Chin, Seattle, WA Cam Patterson, Chapel Hill, NC Funding for the ACCF/Herman K. Gold Young Investigators Award in Molecular and Cellular Cardiology session was provided by a grant from CVPath Institute and the family of Herman K. Gold 8:00 4054 Correlation between Circulating Angiogenic Cell Mobilizations and recovery of Coronary Flow reserve in Patients with Acute Myocardial Infarction Han Saem Jeong, Soon Jun Hong, Jae Hyoung Park, Jong-Ho Kim, Seung Cheol Choi, Chul-Min Ahn, Je Sang Kim, Do-Sun Lim, Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, South Korea 8:45 8:15 4055 Novel role of Anticoagulant Heparan Sulfate in Antithrombin Anti-Inflammatory Signaling Nicole C. Smits, Dartmouth Medical School, Hanover, NH 4056 Protein Kinase-C Beta Activation Contributes to Impaired Endothelial Insulin Signaling in Humans with Diabetes Mellitus Corey E. Tabit, Sherene M. Shenouda, Monika Holbrook, Alissa A. Frame, Matthew A. Kluge, Mai-Ann Duess, Brian H. Kim, Aaron D. Levit, Aaron Held, James L. Rosenzweig, Neil B. Ruderman, Joseph A. Vita, Naomi M. Hamburg, Boston University School of Medicine, Boston, MA 4057 Telethonin Mutations Associated with Brugada Syndrome reduce Cardiac Sodium Currents Isik Turker, Takeru Makiyama, Takeshi Ueyama, Wataru Shimizu, Minoru Horie, Matteo Watta, Peng-Sheng Chen, Tomohiko Ai, Indiana University, Indianapolis, IN
TEST OrAl

8:30

Morning

8:37 8:44

8:45

8:59 9:06

914

Diagnostic Testing: Sports Cardiology Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Rachel J. Lampert, New Haven, CT Brian Olshansky, Iowa City, IA 9143 The Year in review Diagnostic Testing: Sports Barry J. Maron, Minneapolis, MN 9144 re-appraisal of Electrocardiogram Interpretation in Young Athletes: Should Axis Deviation and Voltage Criterion for Atrial Enlargement Be Catergorised as Abnormal in Athletes Sabiha Gati, Saqib Ghani, Abbas Zaidi, Nabeel Sheikh, Michael Papadakis, nicolene van nierkerk, lucia chen, matthew reed, Sanjay Sharma, St. Georges University, London, United Kingdom 9145 left Ventricular Dimensions Derived by Echocardiography Correlate with Body Mass Index in a large Population of Multiethnic Athletes Screened in the Texas Adolescent Athlete Heart Screening registry (TAAHSr) Silvana M. Lawrence, Harold W. Kohl, III, Patrick W. Austin, Kim A. Frost, Jennifer Y. Hutchings, Arnold Fenrich, Eva M. Garcia, James Guerrero, George P. Rodgers, Baylor College of Medicine, Houston, TX, Championship Hearts Foundation, Austin, TX 9146 Global longitudinal Strain by Speckle Tracking in Middle Aged Athletically Trained Subjects with ECG repolarization Abnormalities during Exercise Stress Test Emilia E. DElia, Silvia Celada, Daniele Poggio, Valentina Casali, Carla Auguadro, Giuseppe Specchia, Monza Polyclinic, Monza, Italy 9147 Do We Need Ethnicity-Specific Guidelines for Pre-participation Screening of Athletes? Nabeel Sheikh, Michael Papadakis, Saqib Ghani, Abbas Zaidi, Sabiha Gati, Navin Chandra, Rachel Bastiaenen, Lynne Millar, Noel Emmanuel, Sanjay Sharma, St. Georges University of London, London, United Kingdom

Co-Chairs: 8:00 8:15

9:21
SPECIAl SPECIAl

405

8:30

Chair: Judges:

9:00

144 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

9:15 9148 The Impact of Exercise Training on left Ventricular Torsion is Sport-Specific: A New Twist on the Morganroth Hypothesis Rory B. Weiner, Adolph Hutter, Gregory Lewis, Francis Wang, Brant Berkstresser, Thomas Wang, Michael Picard, Aaron Baggish, Massachusetts General Hospital, Boston, MA, Harvard University Health Services, Cambridge, MA
VAlV OrAl VAlV SElF-DIrECTED

1502

Heart Songs at ACC.12: A Self-Paced Multimedia learning Experience Sunday, March 25, 2012, 9:00 a.m. 5:00 p.m. McCormick Place, Vista Room Lobby CME/CNE Hours: 2 Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod Touch, iPad or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individuals need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.

915

Valvular Oral Sunday, March 25, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N427 CME/CNE Hours: 1.5 Joseph Maalouf, Rochester, MN David Messika-Zeitoun, Paris, France 9153 The Year in review Valvular Maurice Enriquez-Sarano, Rochester, MN 9154 Transcatheter Aortic Valve Implantation (TAVI) in Patients with low-Flow, low-Gradient Aortic Stenosis Alexander Lauten, Ralf Zahn, Jochen Senges, Hans R. Figulla, on behalf of the German Transcatheter Aortic ValveInterventionsRegistry Investigators, University Heart Center Jena, Department of Cardiology, Jena, Germany, Institut fuer Herzinfarktforschung, Ludwigshafen, Germany 9155 long-term Survival following Aortic Valve replacement among High-risk Elderly Patients in the United States: Insights from the STS Adult Cardiac Surgery Database, 1991 - 2007 J. Matthew Brennan, Fred Edwards, Yue Zhao, Sean OBrien, Pamela Douglas, eric D. peterson, Duke Clinical Research Institute, Durham, NC 9156 Predictive Factors and Clinical Consequences of Persistent left Bundle Branch Block following Transcatheter Aortic Valve Implantation with a Balloon-expandable Valve Marina Urena, Michael Mok, Luis Nombela-Franco, Robert DeLarochellire, Daniel Doyle, Eric Larose, Ignacio Ignacio Amat-Santos, Mlanie Ct, Philippe Pibarot, Franois Philippon, Eric Dumont, Josep Rods-Cabau, Laval Heart&Lung Institute, Qubec, Canada 9157 Prognostic Value of Brain Natriuretic Peptide in Elderly Patients with Aortic Stenosis (The COFrASA-GENErAC Study) Claire Cimadevilla, Caroline Cueff, Nadia Berjeb, Bernard Iung, Alex Vahanian, David Messika-Zeitoun, Bichat Hospital, Paris, France 9158 Aortic Valve Calcium Score by Computed Tomography in Predicting Perivalvular Aortic Insufficiency Post Transcatheter Aortic Valve Implantation (TAVI) Junsoo Alex Lee, Tania Singh, Itsik Ben Dor, Rebecca Torguson, Petros Okubagzi, Lowell Satler, Steven Goldstein, Allen Taylor, William Guy Weigold, Augusto Pichard, Zuyue Wang, Gaby Weissman, Ron Waksman, Washington Hospital Center, Washington, DC, Georgetown University Hospital, Washington, DC

Morning

Co-Chairs: 8:00 8:15

8:30

8:45

Co-Chairs:

Michael J. Barrett, Blue Bell, PA Larry E. Jacobs, Allentown, PA Andrew M. Freeman, Denver, CO Tyler Seto, Los Angeles, CA Bruce A. Feldman, Allentown, PA Bioresorbable Vascular Scaffolds Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S106b CME/CNE Hours: 1.5 Ron Waksman, Washington, DC Patrick Serruys, Rotterdam, Netherlands Alaide Chieffo, Milan, Italy, Juan Granada, Orangeburg, NY 25036 The Year in review Patrick W. Serruys, Rotterdam, Netherlands 25037 Comparisons of Safety Profile between Durable and Biodegradable Polymer Based Drugeluting Stents in Porcine Coronary Artery Model Takeshi Ijichi, Gaku Nakazawa, Toshiro Shinke, Daisuke Matsumoto, Hiromasa Otake, Sho Torii, Ayako Yoshikawa, Junya Shite, Yuji Ikari, Tokai University School of Medicine, Isehara, Kanagawa, Japan 25038 Panel Discussion ACC.12 Final Program 145

9:00

ACC-i2/TCT OrAl

2503

Co-Chairs: Panelists: 10:45 11:00

9:15

11:10

Sunday, March 25, 2012 ACC.12

11:10 25039 Differential Vascular Healing Patterns with rapid Absorption Biodegradable Polymer Sirolimuseluting Stents versus Durable Polymer Everolimuseluting Stents Tomohisa Tada, Robert Byrne, Rezarta Cuni, Lamin King, Michael Joner, Albert Schomig, Adnan Kastrati, Deutsches Herzzentrum Munchen, Munich, Germany 250310 Panel Discussion 250311 First Sequential Assessment at 6-months and 2-years of the 2nd Generation Absorb Everolimus-eluting Bioresorbable Scaffold: A Multi-Imaging Modality Study Yoshinobu Onuma, Cecile Dorange, Karine Miquel-Hebert, Patrick W. Serruys, the ABSORB B investigators, Thorax centre, Rotterdam, The Netherlands, Abbott Vascular Belgium, Diegem, Belgium 250312 Panel Discussion 250313 Vascular response of the Segments Adjacent to the Proximal and Distal Edges of the ABSOrB Everolimus-eluting Bioresorbable Vascular Scaffold: 6-months and 1-year Follow-up Assessment: A Serial Intravascular Ultrasound radiofrequency Data Analysis from the First in Man ABSOrB Cohort B Trial Bill D. Gogas, Patrick W. Serruys, Vasim Farooq, Salvatore Brugaletta, Maria Radu, Jung Ho Heo, Robert Jan M. van Geuns, Evelyn Regar, Bernard de Bruyne, Bernard Chevalier, Leif Thuesen, Jacques Koolen, Stefan Windecker, Karine Miquel-Hebert, Cecile Dorange, Richard Rapoza, John Ormiston, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands 250314 Panel Discussion 250315 Evaluation of the ABSOrB Everolimuseluting Bioresorbable Vascular Scaffold (ABSOrB BVS) in the Treatment of Patients with de Novo Native Coronary Artery lesions: 2-year Clinical results of ABSOrB Cohort B Trial Dariusz Dudek, Jagiellonian University Medical College, Krakow, Poland 250316 Panel Discussion Drug-eluting Stents Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 Andreas M. Zeiher, Frankfurt, Germany Gennaro Sardella, Rome, Italy Didier Carrie, Toulouse, France, Ozgen Dogan, Brooklyn, NY 25066 The Year in review Matthew J. Price, La Jolla, CA 25067 longitudinal Stent Deformation: Quantitative Coronary Angiographic Analysis from the Perseus WH and Platinum WH randomized Controlled Clinical Trials Dean J. Kereiakes, Louis Cannon, David Kandzari, Carey Kimmelstiel, Ian Meredith, Jeffrey Popma, Gregg Stone, Paul Teirstein, Stefan Verheye, Dominic Allocco, Keith Dawkins, Christ Hospital Heart & Vascular Center/ Lindner Center for Research & Education at The Christ Hospital, Cincinnati, OH 11:10 11:15 25068 Panel Discussion 25069 Stent Thrombosis: Insights on Outcomes, Predictors and Impact of Dual Antiplatelet Therapy Interruption from the SPIrIT II, SPIrIT III, SPIrIT IV and COMPArE Trials Elvin Kedhi, Gregg Stone, Dean Kereiakes, Patrick Serruys, Helen Parise, Martin Fahy, Charles Simonton, Krishnan Sudhir, Poornima Sood, Pieter Smits, Maasstad Hospital, Rotterdam, The Netherlands 250610 Panel Discussion 250611 Definite and Probable Stent Thrombosis after revascularization with Everolimus- and Sirolimus-eluting Stents: From the SOrT OUT IV Trial Lisette Okkels Jensen, Per Thayssen, Michael Maeng, Hans-Henrik Tilsted, Anne Kaltoft, Knud Hansen, Evald Christiansen, Anders Junker, Jan Ravkilde, Leif Thuesen, Jens Lassen, Odense University Hospital, Odense, Denmark 250612 Panel Discussion 250613 Two-year results of the PlATINUM randomized Trial Comparing Platinum Chromium PrOMUS Element and Cobalt Chromium PrOMUS/ xIENCE V Everolimus-eluting Stents in de Novo Coronary Artery lesions Gregg W. Stone, Paul Teirstein, Ian Meredith, Alain Bouchard, Didier Carri, Helge Mllmann, Keith Oldroyd, Jack Hall, Dominic Allocco, Keith Dawkins, Columbia University Medical Center, New York, NY 250614 Panel Discussion 250615 Ten-year Follow-up of the Desire registry: A Single-center Perspective on Drug-eluting Stents a Decade later Jos de Ribamar Costa, Amanda Sousa, Adriana Moreira, Ricardo Costa, Manuel Cano, Galo Maldonado, Bruno Palmieri, J. Eduardo Sousa, Hospital do Corao, Sao Paulo, Brazil 250616 Panel Discussion Imaging in TAVr Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5 Eric Van Belle, F-59037 Lille, France James K. Min, New York, NY Bernhard Reimers, Mirano, Italy 25076 The Year in review Rebecca T. Hahn, New York, NY 25079 Integrated 3D Echo-x-ray Image Guidance for Structural Heart Interventions Stacey D. Clegg, James Chen, Ernesto Salcedo, Robert Quaife, John Carroll, University of Colorado Hospital, Aurora, CO 250710 Panel Discussion 250711 reduction of Para-Valvular regurgitation with Post-Dilatation following Balloon-Expandable Transcatheter Aortic Valve replacement Benoit Daneault, Elana Koss, Rebecca Hahn, Susheel Kodali,

11:20 11:25

Morning

11:25 11:30

11:35 11:45

11:40 11:45

11:55 12:00

11:55 12:00

12:10
ACC-i2/TCT OrAl

12:10
ACC-i2/TCT OrAl

2506

2507

Co-Chairs: Panelists: 10:45 11:00

Co-Chairs: Panelist: 10:45 11:05

11:15 11:20

146 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

Mathew Williams, Philippe Genereux, Jean-Michel Paradis, Isaac George, Craig Smith, Jeffrey Moses, Martin Leon, Columbia University Medical Center, New York, NY 11:30 11:35 250712 Panel Discussion 250713 Differences in Clinical Outcomes Based on Adherence to Valve Sizing Criteria Using 2D Echocardiography or 3D Computed Tomography in Patients Undergoing Transcatheter Aortic Valve Implantation Nicolo Piazza, Alexander Hill, Gernot Brockmann, Anke Opitz, Domenico Mazzitelli, Yacine Elhmidi, Hendrik Ruge, Sabine Bleiziffer, Rudiger Lange, German Heart Centre, Munich, Germany, Medtronic, Inc., Mounds View, MN 250714 Panel Discussion 250715 regional Apical Motion Abnormality Early after Transapical Aortic Valve replacement: Prevalence and Outcome Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Ana Laynez Carnicero, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC 250716 Panel Discussion Prevention and Treatment of restenosis Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Christodoulos Stefanadis, Athens, Greece David J. Moliterno, Lexington, KY Tayo A. Addo, Dallas, TX, Manish Parikh, New York, NY, Emilia Solinas, Italy 25096 The Year in review Alexandre Abizaid, Sao Paulo, Brazil 25097 Compassionate Use of a Paclitaxel Coated Balloon Catheter in Patients with refractory Coronary In-stent restenosis Yvonne P. Clever, Bruno Scheller, Michael Bhm, Bodo Cremers, Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany 25098 Panel Discussion 25099 Sequent Please World Wide registry: Efficacy of Paclitaxel Coated Balloon Angioplasty for Treatment of Drug-eluting Stent restenosis Compared with Bare-metal Stent restenosis Jochen Woehrle, Wolfgang Motz, Sven Moebius-Winkler, Matthias Leschke, Christian Opitz, Waqas Ahmed, Paul Barragan, Jean-Philippe Simon, Graham Cassel, Luis Elbal, Bruno Scheller, University of Ulm, Ulm, Ghana 250910 Panel Discussion 250911 long-term Quantitative Coronary Angiographic Assessment of Sirolimus-eluting Stents in Very late Target lesion revascularization David Anthony Burke, Alexandra Almonacid, Jeffrey Popma, Beth Israel Deaconess Medical Center, Boston, MA 250912 Panel Discussion 11:45 250913 Statin reduces late Tlr (beyond 1-year) late Catch-up Phenomenon as well as early Tlr (within 1-year) after Sirolimus-eluting StentIimplantation: From J-Cypher registry Yoshihiro Katoh, Masahiro Natsuaki, Yoshihisa Nakagawa, Takeshi Kimura, Saiseikai Noe Hospital, Osaka, Japan, Department of the Cardiology, Kyoto, Japan 250914 Panel Discussion 250915 A Novel Method for Capturing Endothelial Progenitor Cells (EPCs) by Coronary Stents: Application of Vascular Endothelial Growth Factor (VEGF)-bound Platform Shu Takabatake, Toshinari Tsubokawa, Takehisa Matsuda, Masakazu Yamagishi, Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan, Kanazawa Institute of Technology, Kanazawa, Japan 250916 Panel Discussion Outcomes in Patients Treated with PCI Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S103b CME/CNE Hours: 1.5 Hugo A. Katus, Heidelberg, Germany Jan Kovac, Leicestershire, United Kingdom Issam D. Moussa, Jacksonville, FL, Davide Capodanno, Jacksonville, FL, Germano DiSciascio, Rome, Italy Year in review Laura Mauri, Boston, MA 25117 CrP levels 180 Days after PCI for ACS, but Not Earlier, Predict late Adverse Cardiac Events Independent of Plaque Characteristics: The PrOSPECT Study Christopher Kelly, Giora Weisz, Akiko Maehara, Gary Mintz, John McPherson, Stefan Verheye, Ke Xu, Martin Fahy, Barry Templin, Bernard De Bruyne, Patrick Serruys, Gregg Stone, NewYorkPresbyterian Hospital / Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY 25118 Panel Discussion 25119 Acute Complications of Non-primary PCI at Hospitals with and without On-site Cardiac Surgery: Cport-E Project Thomas Aversano, Johns Hopkins University, Baltimore, MD 251110 Panel Discussion 251111 Contemporary Incidence and Predictors of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights from the NCDr Cath-PCI registry Thomas Tsai, Uptal Patel, Tara I. Chang, Kevin F. Kennedy, Frederick Masoudi, Michael Matheny, Mikhail Kosiborod, John Messenger, John Rumsfeld, John Spertus, Denver VA Medical Center / U of Colorado Denver, Denver, CO, Mid America Heart Institute, Kansas City, MO 251112 Panel Discussion 251113 Cost-Effectiveness of Transradial Percutaneous Coronary Intervention: ACC.12 Final Program 147

11:55 12:00

Morning

11:45 11:50

12:10
ACC-i2/TCT OrAl

2511

12:00
ACC-i2/TCT OrAl

Co-Chairs: Panelists:

2509

Co-Chairs: Panelists: 10:45 11:00

10:45 11:00

11:10 11:15

11:10 11:15

11:25 11:30

11:25 11:30

11:40 11:45

11:40

Sunday, March 25, 2012 ACC.12

A Decision-analytic Model Amit P. Amin, Steven P. Marso, Adnan Chhatriwalla, David Safley, kevin kennedy, John House, Rebecca Mills, Adam Salisbury, John Spertus, David Cohen, Dmitri Baklanov, Mid America Heart Institute, Saint Lukes Hospital, Kansas City, MO 11:55 12:00 251114 Panel Discussion 251115 The Epidemiology and Outcomes of Percutaneous Coronary Intervention before High-risk Non-cardiac Surgery: Insights from the BMC2 registry Palaniappan Muthappan, Dean Smith, Herbert Aronow, Kim Eagle, David Wohns, James Fox, David Share, Hitinder Gurm, University of Michigan Cardiovascular Center, Ann Arbor, MI 251116 Panel Discussion Congenital/Pediatric Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Michael J. Landzberg, Boston, MA William E. Hellenbrand, New York, NY Spectrum/Overview of Pulmonary Valve Disorders Jeffrey Meadows, Boston, MA Outcomes of Melody Valve Implantation in the rVOT Doff B. McElhinney, Boston, MA Outcomes of Sapien Valve Implantation in the rVOT Ziyad M. Hijazi, Chicago, IL Device Closure of Congenital VSD Wolfgang A. K. Radtke, Wilmington, DE PDA in Children and Adults Johnn W. M. Moore, San Diego, CA Coarctation: Percutaneous Therapy Should be First line Daniel S. Levi, Los Angeles, CA Coarctation: Surgery remains the Preferred Option Joseph A. Dearani, Rochester, MN Panel Discussion Improving Outcomes in ACS. Insights from Basic Science and Preclinical research. Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N227b CME/CNE Hours: 1.5 Aamer Abbas, El Paso, TX Jesse Currier, Los Angeles, CA 9173 Ultrasound-induced Stimulation of Microbubbles reduces Scar Formation and Improves left-ventricular Function after Acute Myocardial Infarction in Mice Alexander Ghanem, Jonas Drner, Georg Nickenig, Dept. of Cardiology, Univ. of Bonn, Bonn, Germany 9174 Human Umbilical Vein Endothelial Cells Attenuate the left Ventricular remodeling after Acute Myocardial Infarction in rats via a regulation of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinases Balance by Endothelial Nitric Oxide Synthase Young Keun Ahn, Jin-Sook Kwon,
Arr OrAl

Yong Sook Kim, Ae Shin Cho, Hyang Hee Cho, Jeong Sook Kim, Moon Hwa Hong, Wan Seok Kang, Jang-Whan Bae, Myung Ho Jeong, Myeong-Chan Cho, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea 11:15 9175 No Association of Paraoxonase-1 Q192r and Thrombotic Events during Dual Anti-platelet Therapy in Patients after Acute Myocardial Infarction Jeffrey JW Verschuren, Heln Boden, Judith A. Wessels, B. L. van der Hoeven, Henk-Jan Guchelaar, Martin Schalij, Johan Jukema, Leiden University Medical Center, Leiden, The Netherlands 9177 Novel role for Bioactive lipids in Stem Cell Mobilization during Myocardial Ischemia: A Potential Therapeutic Target Ahmed Abdel-Latif, Anush K. Karapetyan, Khaled Ziada, Manjula Sunkara, Ewa K. Zuba-Surma, Samy Selim, Susan Smyth, Mariusz Z. Ratajczak, Andrew J. Morris, University of Kentucky, Lexington, KY, University of Louisville, Louisville, KY 9178 Development of Ultrasound responsive Thrombus-targeting Drug Delivery System for Coronary Thrombolysis Hiroyuki Kawata, Tsunenari Soeda, Yasuhiro Takemoto, Ji-Hee Sung, Yoshiko Uesugi, Yasuhiko Tabata, Keiji Kato, Kenichi Ishigami, Manabu Horii, Shiro Uemura, Yoshihiko Saito, Nara Medical University, Kashihara, Japan Cardiac MrI for the Treatment and Evaluation of Arrhythmias Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S404 CME/CNE Hours: 1.5 Aiden Abidov, Tucson, AZ Kristen K. Patton, Seattle, WA 9183 The role of Magnetic resonance Imaging in Identifying Patients with Cardiac Sarcoidosis and Preserved left Ventricular Function in Predicting Future Ventricular Arrhythmias Thomas Crawford, Sinan Sarsam, Gisela Mueller, Sanjaya Gupta, Timir Baman, Karl Ilg, Diego Belardi, Mohamad Sinno, William Sauer, Khaled Abdul-Nour, Henry Kim, Mouaz AI-Mallah, Joseph Schuller, Fred Morady, Frank Bogun, University of Michigan Health System, Ann Arbor, MI, Henry Ford Hospital, Detroit, MI 9184 Myocardial Infarct Heterogeneity Assessed by late Gadolinium-enhanced Cardiovascular Magnetic resonance (lGE-CMr) Is Associated with the Development of Ventricular Tachycardias after Acute Myocardial Infarction Lourens Robbers, Ronak Delewi, Michiel Kemme, Robin Nijveldt, Aernout Beek, Alexander Hirsch, Anja Van Der Laan, Pieter van der Vleuten, Jan Piek, Felix Zijlstra, Albert van Rossum, VU University Medical Center, Amsterdam, The Netherlands, Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands 9185 Mitral regurgitation recovery and Atrial reverse remodeling following Pulmonary Vein Isolation Procedure in Patients with Atrial Fibrillation: A Proof of Concept Clinical Observation

Morning

11:45

12:10
ACC-i2/TCT SYMPOSIUM

2615

Co-Chairs: 10:45 10:57 11:09 11:21 11:33 11:45 11:57 12:09

ACS OrAl

12:00

918

Co-Chairs: 10:45

917

Co-Chairs: 10:45

11:00

11:00

11:15

148 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

Cardiac MrI Study Sahadev T. Reddy, M, William Belden, Mark Doyle, Diane Vido, Ronald Williams, M, June Yamrozik, Moneal Shah, Robert Biederman, The Gerald McGinnis Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA 11:30 9186 Indication of Fat Pad Modification for Patients with Atrial Fibrillation: An Approach by the Extent of Fibrosis on left Atrium Obtained from late Gadolinium Enhancement MrI Koji Higuchi, Mehmet Akkaya, Joshua Blauer, Kavitha Damal, Chankevin Tek, Nathan Burgon, Eugene Kholmovski, Rob MacLeod, Nassir Marrouche, Comprehensive Arrhythmia Research & Management Center, University of Utah, Salt Lake City, UT 9187 Catheter Ablation Guided By real-time Magnetic resonance Imaging: Initial Clinical Applications Peter Nordbeck, Meinrad Beer, Mark E. Ladd, Harald H. Quick, Wolfgang R. Bauer, Oliver Ritter, University Hospital Wuerzburg, Wuerzburg, Germany 9188 Acute Identification of Gaps in Atrial radiofrequency Ablation lesion Sets Using MrI Ravi Ranjan, Eugene Kholmovski, Sathya Vijayakumar, Joshua Blauer, Kamal Vij, Rob MacLeod, Nassir F. Marrouche, University of Utah, Salt Lake City, UT Joint Oral Session of the Heart rhythm Society and the American College of Cardiology: Cardiac Arrest and the Care of the ICD Patient Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Sana Al-Khatib, Durham, NC Paul J. Wang, Stanford, CA 9194 Temporal Trends in Quality of Care among ICD recipients: Insights from the NCDr ICD registry John A. Dodson, Jeptha P. Curtis, Yongfei Wang, Stephen C. Hammill, Paul Varosy, Rachel Lampert, Yale University School of Medicine, New Haven, CT 9195 Inappropriate Therapy for Atrial Flutter/ Fibrillation Is lower with Dual- than SingleChamber ICD in MADIT-CrT Nitesh Sood, Arthur Moss, Scott Mcnitt, Christopher Clyne, University of Connecticut/Hartford Hospital, Hartford, CT, University of Rochester, Rochester, NY 9196 Gender Differences in Inappropriate Device Therapies from MADIT Christine Tompkins, Scott McNitt, James Daubert, Paul Wang, Arthur Moss, Wojciech Zareba, University of Rochester Medical Center, Rochester, NY 9197 riata ICD lead Failure: results of the Manufacturers Analysis of returned leads Robert G. Hauser, Linda Kallinen, Minneapolis Heart Institute Foundation, Minneapolis, MN 9198 Follow-up riata Screening in Northern Ireland Emily Hodkinson, Vivek Kodoth, Kyle Ashfield, Carol Wilson, Ernest Lau, David McEneaney, Michael Roberts, Royal Victoria Hospital, Belfast, United Kingdom, Craigavon Cardiac Centre, Craigavon, United Kingdom
CCS SYMPOSIUM

637

Post-Operative Glenns and Fontans: Navigating Turbulent Waters Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N231 CME/CNE Hours: 1.5 Andrew Atz, Charleston, SC Jacqueline Kreutzer, Pittsburgh, PA Case Presentation Henri Justino, Houston, TX Take Action When the Post Operative Fontan Isnt What You Hoped For Jacqueline Kreutzer, Pittsburgh, PA Outcomes: Update from the Pediatric Heart Network (PHN) Single Ventricle reconstruction (SVr) Trial John F. Rhodes, Durham, NC The Blue Glenn Aimee K. Armstrong, Ann Arbor, MI role of the Catheterization lab for the Failing Fontan Joshua Kanter, Washington, DC Adults with Congenital Heart Disease: Imaging Predictors, Evolving Therapies and Outcomes Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Michael H. Crawford, San Francisco, CA William R. Davidson, Hershey, PA 9203 The Year in review Congenital Cardiology Solutions Thomas P. Graham, Jr., Franklin, TN 9204 Cancer in Adults with Congenital Heart Disease Compared to the General Population Michelle Gurvitz, Louise Pilote, Patrick Lawler, Mark Eisenberg, Raluca Ionescu-Ittu, Ariane Marelli, Childrens Hospital Boston, Boston, MA 9205 Echocardiographic Predictors of Outcome in Eisenmenger Syndrome Pamela Moceri, Konstantinos Dimopoulos, Emmanouil Liodakis, Aleksander Kempny, Gerhard-Paul Diller, Wei Li, Michael Gatzoulis, Royal Brompton Hospital, London, United Kingdom, University Hospital of Nice, Nice, France 9206 Can Selective Pulmonary Vasodilator Therapy Be Used to Target Pulmonic regurgitation? results of the Pinot Noir Trial Stephen A. Hart, Ganesh Devendra, Yuli Kim, Vidyasagar Kalahasti, Scott Flamm, Richard Krasuski, Cleveland Clinic, Cleveland, OH 9207 Is Pregnancy Associated with Adverse right Ventricular remodeling in Women with repaired Tetralogy of Fallot? Gabriele Egidy Assenza, Anne Marie Valente, Daiana Cassater, Jenna Schreier, Katherine Economy, Dionne Graham, Massimo Volpe, Nancy Barker, Tal Geva, Michael Landzberg, Anne Marie Valente, Childrens Hospital Boston, Boston, MA 9208 right Atrial Size Predicts Arrhythmia and Death in Patients with repaired Tetralogy of Fallot Beatrice Bonello, Aleksander Kempny, Anselm Uebing, Wei Li, Philip Kilner, Dudley J. Pennell, Michael Gatzoulis, Gerhard-Paul Diller, Sonya Babu-Narayan, BRU Ressearch Unit, Royal Brompton Hospital, London, United Kingdom ACC.12 Final Program 149

Co-Chairs: 10:45 10:55

Morning

11:15

11:45

11:35 11:55

12:00

CCS OrAl

920

Co-Chairs: 10:45 11:00

Arr OrAl

919

Co-Chairs: 11:00

11:15

11:15

11:30

11:30

11:45

11:45

12:00

12:00

Sunday, March 25, 2012 ACC.12

HF ExPErTS

225

Heart Failure Care for the Very Old: What Are the Key Issues for Success? Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S502 CME/CNE Hours: 1.5 Suzanne J. Wingate, Silver Spring, MD Ali Ahmed, Birmingham, AL, Jalal K. Ghali, Detroit, MI, Robert Lee Page, II, Aurora, CO, Michael W. Rich, Saint Louis, MO Joint Oral Session of the Heart Failure Society of America and the American College of Cardiology: Individualizing Pharmacological Therapy in Heart Failure Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S406b CME/CNE Hours: 1.5 Akshay S. Desai, Boston, MA Barry M. Massie, San Francisco, CA 9213 The Year in review Heart Failure Barry M. Massie, San Francisco, CA 9214 Beta-1 Adrenergic receptor Genotype Ser49Gly Is Associated with Beta-Blocker Survival Benefit in Patients with Heart Failure Jasmine Talameh, Amanda Garrand, Jalal Ghali, Ron M. Oren, Stephanie Dunlap, Adrian Van Bakel, Ileana Pina, J. Herbert Patterson, Carla Sueta, Frank McGrew, Alan Miller, Todd Schwartz, Kirkwood Adams, University of North Carolina-Chapel Hill, Chapel Hill, NC 9215 The Association of Beta-blocker Use and Selectivity with Outcomes in Heart Failure Patients with Chronic Obstructive Pulmonary Disease: Findings from the Organized Program to Initiate life-saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Robert J. Mentz, Daniel Wojdyla, Mona Fiuzat, Karen Chiswell, Tariq Ahmad, Gregg Fonarow, Christopher OConnor, Duke University Medical Center, Durham, NC, Duke Clinical Research Institute, Durham, NC 9216 Influence of Baseline and Worsening renal Function on Efficacy of Spironolactone in Patients with Severe Heart Failure Enrolled in the randomized Aldactone Evaluation Study Orly Vardeny, Faiez Zannad, Bertram Pitt, Scott Solomon, University of Wisconsin, Madison, WI, Brigham and Womens Hospital, Boston, MA 9217 Autologous CD133+ Bone Marrow Cells and Bypass Grafting for regeneration of Ischemic Myocardium: results of the Cardio133 Trial Boris Alexander Nasseri, Marian Kukucka, Michael Dandel, Wolfram Ebell, Roland Hetzer, Christof Stamm, Deutsches Herzzentrum Berlin, Berlin, Germany, Berlin Center for Regenerative Therapies, Berlin, Germany 9218 ranolazine for the Treatment of Diastolic Heart Failure in Patients with Preserved Ejection Fraction: results from the rAlI-DHF Study Lars Maier, Rolf Wachter, Frank Edelmann, Beth 11:00
HF OrAl

Layug, Ewa Karwatowska-Prokopczuk, Luiz Belardinelli, Gerd Hasenfuss, Claudius Jacobshagen, University of Goettingen, Goettingen, Germany, Gilead, Foster City, Palo Alto, CA Improving Patient Selection for Device-Based Therapies Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S405 CME/CNE Hours: 1.5 Mark H. Drazner, Dallas, TX Scott Silvestry, Philadephia, PA 9223 The Impact of Myocardial Scar by Cardiac Magnetic resonance in Patients with Non-Ischemic Dilated Cardiomyopathy referred for an Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death Tomas G. Neilan, Otavio Coelho-Filho, Stephan Danik, Daniel J. Verdini, Tokuda Michifumi, Ravi Shah, Usha Tedrow, William Stevenson, Michael Jerosch-Herold, Brian Ghoshhajra, Raymond Kwong, Brigham and Womens Hospital, Boston, MA, Massachusettes General Hospital, Boston, MA 9224 Baseline Burden of Heart Failure limits Duration of Benefit of ICD for Medicare recipients Soko Setoguchi, Chih-Ying Chen, Lynne Stevenson, John Seeger, Lauren Williams, Jessica Jalbert, Andrew Rothman, Garrick Stewart, Brigham and Womens Hospital, Boston, MA, Duke Clinical Research Institute, Durham, NC 9225 Impact of remote, Wireless Pulmonary Artery Hemodynamic Monitoring in Patients with Atrial Fibrillation and Chronic Heart Failure: Insights from the CHAMPION Trial Alan B. Miller, John Teerlink, Peter Carson, Wayne Levy, Eugene Chung, Edward Gilbert, Brad Jeffries, Jay Yadav, Susan Neville, Pam Cowart, Phillip Adamson, William Abraham, university of florida, jacksonville, FL 9226 Cardiac resynchronization Therapy Benefits Patients Eighty-years of Age or Older Evan C. Adelstein, John Gorcsan, Sandeep Jain, Samir Saba, University of Pittsburgh, Pittsburgh, PA 9227 Improvement in Ejection Fraction Predicts Survival following Cardiac resynchronization Therapy in Patients with Both left Bundle and Non-left Bundle Branch Block Morphologies Jack Rickard, Bruce Lindsay, Niraj Varma, Mina Chung, Greg Jackson, Bryan Baranowski, Wai Hong Tang, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH 9228 Impact of AV- and VV-Delay Optimization in Patients Treated with Cardiac resynchronization Therapy: A Meta-Analysis Dominique Auger, Ulas Hke, Jeroen Bax, Eric Boersma, Victoria Delgado, LUMC, Leiden, The Netherlands, Centre Hospitalier de lUniversit de Montral, Montreal, Canada

Chair: Panelists:

Case Presenter: Sarah J. Goodlin, Salt Lake City, UT

922

Morning

Co-Chairs: 10:45

HF OrAl

921

Co-Chairs: 10:45 11:00

11:15

11:15

11:30

11:30

11:45

11:45

12:00

12:00

150 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

IMAG SYMPOSIUM

638

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Cardiomyopathy A Comprehensive Echocardiographic Approach Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Alex J. Auseon, Columbus, OH James D. Thomas, Cleveland, OH Insights into lV Mechanics Using Advanced Echo Imaging James D. Thomas, Cleveland, OH Importance of Diastolic Function in Patients with Cardiomyopathy Sherif F. Nagueh, Houston, TX Dont Forget the right Ventricle Lawrence G. Rudski, Montreal, Canada Echo Assessment of the left Atrium as reservoir, Pump and Embolic Teresa S.M. Tsang, Vancouver, Canada Echocardiography in Guiding Cardiac resynchronization Therapy Theodore P. Abraham, Baltimore, MD Echo Is the Only Test Needed in Assessment of Patients with Cardiomyopathy: Comparison with Other Imaging Modalities Mario J. Garcia, Bronx, NY Cardiac CT: Toward a Better Understanding of CAD Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S403 CME/CNE Hours: 1.5 Dipan J. Shah, Houston, TX Eric J. Velazquez, Durham, NC 9243 The Significance of Non-Obstructive Coronary Artery Disease upon Multi-Detector Computed Tomography in Patients Presenting with Acute Chest Pain Roy Beigel, Sella Brosh, Orly Goitein, Einat Gutman, Amit Segev, Eli Konen, Dan Oieru, Hanoch Hod, Shlomi Matetzky, The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 9244 A Comparison of Outcomes with Coronary Artery Calcium in Unselected Populations: The Multi-ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf recall Study (HNr) Matthew J. Budoff, Stefan Mhlenkamp, Robyn McClelland, Joseph Delaney, Marcus Bauer, Heinz Karl Jockel, Hagen Kalsch, Richard Kronmal, Khurram Nasir, Susanne Moebus, Raimund Erbel, Los Angeles Biomedical Research Institute, Torrance, CA, University of Duisburg-Essen, Essen, Germany 9245 Does Noncalcified Plaque Improve the Diagnostic and Prognostic Utility of Coronary CT Angiography? A Study of Propensity-Matched Individuals with Similar Coronary Calcium Scores from the Prospective Multicenter International CONFIrM registry Rine Nakanishi, Heidi Gransar, Daniel S. Berman, Victor Cheng, Damini Dey, Troy LaBounty, Fay Lin, Stephan Achenbach, Mouaz 11:45 11:30

Al-Mallah, Matthew J. Budoff, Filippo Cademartiri, Tracy Callister, Kavitha Chinnaiyan, Benjamin J. W. Chow, Augustin Delago, Martin Hadamitzky, Joerg Hausleiter, Gilbert Raff, Todd Villines, Leslee J. Shaw, Allison Dunning, James K. Min, Departments of Imaging and Medicine, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 9246 A Previously Validated Peripheral Gene Expression Score is Mostly Determined by Non-Calcified Plaque and luminal Stenosis as Assessed by Quantitative, 3-Dimensional Measurements by CT Angiography in the MultiCenter, Prospective COMPASS Study Szilard Voros, Gregory Thomas, Alexandra Lansky, John McPherson, Michael Elashoff, Sarah Rinehart, Andrea Johnson, Steven Rosenberg, Integrated Cardiovascular Research Group, Atlanta, GA, CardioDx, Palo Alto, CA 9247 Hypertensive Individuals Have an Increased Prevalence of Coronary Artery Disease and risk of Adverse Events: A Comparison of 15,091 Individuals from CONFIrM (Coronary Computed Tomographic Angiography Evaluation for Clinical Outcomes: An International Multicenter registry) Troy M. LaBounty, Stephan Achenbach, Mouaz Al-Mallah, Daniel Berman, Matthew Budoff, Filippo Cademartiri, Tracy Callister, Victor Cheng, Kavitha Chinnaiyan, Benjamin Chow, Augustin DeLago, Allison Dunning, Millie Gomez, Martin Hadamitzky, Joerg Hausleiter, Philipp Kaufmann, Fay Lin, Gilbert Raff, Leslee Shaw, Todd Villines, James Min, Cedars-Sinai Medical Center, Los Angeles, CA 9248 Prospective Evaluation of the Updated 2010 ACCF Cardiac CT Appropriate Use Criteria William Guy Weigold, Michael Rich, Daisuke Utsunomiya, Lauren Simprini, Gaby Weissman, Allen Taylor, Washington Hospital Center and MedStar Health Research Institute, Washington, DC, Georgetown University School of Medicine, Washington, DC Who Said Theres Nothing New? Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5 Subhash Banerjee, Dallas, TX Ellen Keeley, Charlottesville, VA 9233 The Year in review Chronic Coronary Artery Disease/Stable Ischemic Heart Disease Steven R. Bailey, San Antonio, TX 9234 Effects of AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, on low-Density lipoprotein Cholesterol in Subjects Taking Statins: A Phase 1, randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study Clapton Dias, Adam Shaywitz, Blaire Cooke, Stephen Uy, Maurice Emery, John Gibbs, Caroline Crispino, Karen Smirnakis, Brian Smith, Bing Gao, Scott Wasserman, Evan Stein, Amgen Inc, Thousand Oaks, CA, Metabolic and Atherosclerosis Research Center, Cincinnati, OH 9235 Sustained Clinical Improvements after Intramyocardial Injection of Mesenchymal Stromal ACC.12 Final Program 151

Co-Chairs: 10:45 11:00 11:15 11:30

Morning

11:45

12:00

IMAG OrAl

924

Co-Chairs: 10:45

12:00

ISCHEM OrAl

923

11:00

Co-Chairs: 10:45

11:00

11:15

11:12

Sunday, March 25, 2012 ACC.12

Cells in Patients with Severe Stable Coronary Artery Disease: 24-months Follow-up Anders Bruun Mathiasen, Mandana Haack-Srensen, Erik Jorgensen, Jens Kastrup, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 11:24 9236 Instantaneous Wave-free ratio (iFr) Has a Similar Diagnostic Efficiency to Fractional Flow reserve (FFr) in Single and Multi-vessel Disease: Secondary Analysis of Advise (Adenosine Vasodilator Independent Stenosis Evaluation) Study Justin E. Davies, Sayan Sen, Javier Escaned, Carlo Di Mario, Rafael Mila, Iqbal Malik, Darrel Francis, Alun Hughes, Jamil Mayet, Imperial College, London, United Kingdom, Hospital Clinico San Carlos, Madrid, Spain 9237 Sitagliptin Improves regional Myocardial Function during Dobutamine Stress in Type 2 Diabetes Mellitus and Coronary Artery Disease Liam M. McCormick, Anna Kydd, Philip Read, Stephen Hoole, David Dutka, Department of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom 9238 A Peripheral Blood Gene Expression Score for Coronary Artery Disease in Non-diabetic Patients Identifies Patients at low-risk for Major Cardiovascular Events and Interventional Procedures in the Next 12 Months William E. Kraus, Szilard Voros, Robert S. Schwartz, Stephen Ellis, Ron Waksman, Naeem Tahirkheli, Hsiao Lieu, Michael R. Elashoff, Steven Rosenberg, John McPherson, Alexandra Lansky, Eric Topol, Duke University, Durham, NC, CardioDx, Inc., Palo Alto, CA 9239 Comparison of Fractional Flow reserve versus Instant Wave-Free ratio for Assessment of Coronary Artery Stenosis Severity in routine Practice Colin Berry, Marcel vant Veer, William Fearon, Petr Kala, Nils Witt, Stelios Pyxaras, Pim Tonino, Bernard De Bruyne, Nico Pijls, Keith Oldroyd, University of Glasgow, Glasgow, United Kingdom
PrACTICE PErI OrAl

11:15

9255 Prognostic Utility of Contrast-enhanced Cardiovascular Magnetic resonance in Hypertrophic Cardiomyopathy: An International Multicenter Study Raymond H. Chan, Barry Maron, iacopo olivotto, Gabriele Assenza, M, Susie Hong, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, Earl Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center/PERFUSE Core Laboratories, Boston, MA, Tufts Medical Center, Boston, MA 9256 The Impact of Colchicine on the Incidence and recurrence of Pericardial Inflammation: A Comprehensive Meta-Analysis of All randomized Clinical Trials Mahboob Alam, Salman Bandeali, Waleed Kayani, henry huang, Salim Virani, Kodangudi Ramanathan, Hani Jneid, Memphis Veterans Affairs Medical Center / University of Tennessee Health Sciences Center, Memphis, TN, Baylor College of Medicine, Houston, TX 9257 Characteristics of 2067 Patients Hospitalized with Peripartum Cardiomyopathy David Peter Kao, Eileen Hsich, Joann Lindenfeld, University of Colorado School of Medicine, Aurora, CO, Cleveland Clinic, Cleveland, OH 9258 Heart rate Variability and the Substrate for Ventricular Tachycardia in Arrhythmogenic right Ventricular Cardiomyopathy Pasquale Santangeli, Antonio Dello Russo, Michela Casella, Gemma Pelargonio, Luigi Di Biase, Pietro Santarelli, Stefano Bartoletti, Rong Bai, Prasant Mohanty, Sanghamitra Mohanty, Agnes Pump, Andrea Natale, Texas Cardiac Arrhythmia Institute, Austin, TX, Catholic University of the Sacred Heart, Rome, Italy ACC/MedAxiom/ACCA: Physician/Hospital Integration: Making It Work Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Jerome L. Hines, Hinsdale, IL Marc E. Shelton, Springfield, IL Marc E. Shelton, Springfield, IL, Howard T. Walpole, Nashville, TN, Donald E. Casey, Morristown, NJ, R. Terry Heath, Indianapolis, IN Update on the ATP IV Guidelines Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Christie M. Ballantyne, Houston, TX Neil Stone, Winnetka, IL

Morning

11:36

11:30

11:48

11:45

12:00

12:00

925

All That Glitters in Myocardial and Pericardial Disease Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Patricia A. Uber, Baltimore, MD 9253 The Year in review Pericardial/Myocardial Disease Leslie T. Cooper, Rochester, MN 9254 Female Gender Is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy Susie N. HongZohlman, Raymond Chan, Barry Maron, iacopo olivotto, Gabriele E. Assenza, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, E. Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center, Boston, MA, Tufts Medical Center, Boston, MA

ExPErTS

226

Co-Chairs: Panelists:

Chair: 10:45 11:00

PrEV ExPErTS

227

Co-Chairs:

Case Presenters: James H. Stein, Madison, WI, Salim S. Virani, Bellaire, TX Panelists: C. Noel Bairey Merz, Los Angeles, CA, Patrick E. McBride, Madison, WI, Jennifer Robinson, Iowa City, IA, Neil Stone, Winnetka, IL

152 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

PrEV OrAl

926

renal Sympathetic Denervation: A Novel Therapy for Hypertension? Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 George L. Bakris, Chicago, IL Suzanne Oparil, Birmingham, AL 9263 long-term Follow-up of Catheter-based renal Sympathetic Denervation for resistant Hypertension Confirms Durable Blood Pressure reduction Henry Krum, Neil Barman, Markus Schlaich, Paul Sobotka, Murray Esler, Felix Mahfoud, Monash University and The Alfred Hospital, Melbourne, Australia 9264 renal Sympathetic Denervation for Treatment of resistant Hypertension: One-year results from the Symplicity HTN-2 randomized Controlled Trial Murray D. Esler, Henry Krum, Markus Schlaich, Roland Schmieder, Michael Bohm, Paul Sobotka, Baker IDI Heart and Diabetes Institute, Melbourne, Australia 9265 6-months Follow-up in a real life Situation after renal Denervation Willemien Verloop, Wilko Spiering, Pierfrancesco Agostoni, Pieter Stella, Kevin Onsea, P. Doevendans, Michiel voskuil, UMC Utrecht, Utrecht, The Netherlands 9266 Effects of renal Sympathetic Denervation on 24-hour Blood Pressure Variability Axel Bauer, Christine Zuern, Konstantinos Rizas, Christian Eick, Meinrad Gawaz, Eberhard-Karls-Universitt Tbingen, Tuebingen, Germany 9267 Percutaneous renal Denervation for resistant Hypertension: real World Outcomes Darren Mylotte, Hakim Benamer, Thierry Unterseeh, Yves Louvard, Marie Claude Morice, Philippe GArot, Thierry Lefevre, Institut Cardiovasculaire Paris Sud, Paris, France 9268 Chronic Effects of Percutaneous renal Sympathetic Denervation on renal Hemodynamics and Plasma Norepinephrine levels Using a Novel Catheter for radiofrequency Ablation I. Tatsis, Konstantinos P. Tsioufis, Vasilios Papademetriou, K. Dimitriadis, D. Tsiachris, C. Thomopoulos, Euljoon Park, C. Stefanadis, First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece Cardiovascular risk Assessment and rehabilitation Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S401a CME/CNE Hours: 1.5 Alison Bailey, Lexington, KY Elizabeth A. Jackson, Ann Arbor, MI 9273 The Association of Anthropometric Obesity Measures with CT-measured Non-alcoholic Fatty liver Disease in the Multi-ethnic Study of Atherosclerosis Geoffrey H. Tison, Michael Blaha, Khurram Nasir, Roger Blumenthal, Moyses Szklo, Jingzhong Ding, Matthew Budoff, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD

11:00

Co-Chairs: 10:45

9274 Comparative Effectiveness of U.S. Population Screening Strategies for Coronary Heart Disease (CHD): Evaluation of Framingham risk Score (FrS), Society for Heart Attack Prevention and Education (SHAPE), Texas Heart Attack Prevention Bill, JUPITEr, and Treat-All Approaches Benjamin Z. Galper, Y. Claire Wang, Andrew J. Einstein, Brigham and Womens Hospital Department of Cardiovascular Medicine, Boston, MA, Columbia University Medical Center, Department of Cardiology, New York, NY 9275 Is Body Fat Protective in a Population with Preserved Ejection Fraction? Alban De Schutter, Carl Lavie, Dharmendrakumar Patel, Richard Milani, Ochsner Health System, New Orleans, LA, Cleveland Clinic Florida, Weston, FL 9276 Cardiac rehabilitation reduces Mortality following Coronary Artery Bypass: A 10-year Community Study Quinn R. Pack, Kashish Goel, Brian Lahr, Kevin Greason, Ray Squires, Randal Thomas, Mayo Clinic, Rochester, MN 9277 lifetime risk Algorithm Identifies More Patients with Carotid and Femoral Plaques than 10-year or 30-year Framingham risk Algorithms John Postley, Yanting Luo, Nathan Wong, Julius Gardin, Columbia University, New York, NY 9278 Optimizing the Incremental Predictive Value of Coronary Calcium: MESA versus Framingham 10-year or lifetime Cardiovascular risk? Allen J. Taylor, Todd Villines, Medstar Heart Institute, Washington, DC, Walter Reed National Military Medical Center, Washington, DC U.S. Health System reform: Whats Missing? Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S100c CME/CNE Hours: 1.25 Jack Lewin, Washington, DC Richard E. Anderson, Napa, CA, James W. Fasules, Washington, DC, Jerry D. Kennett, Columbia, MO, Kavita Patel, Washington, DC Introduction: U.S. Health System reform Whats Missing? Jack Lewin, Washington, DC Medical liability reform Richard E. Anderson, Napa, CA Payment reform Kavita Patel, Washington, DC Panel Discussion Improving PCI Outcomes Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 David J. Cohen, Kansas City, MO Paul D. Varosy, Denver, CO 9283 Prevalence and Outcomes of radial and Femoral Approaches to Percutaneous Coronary Intervention: Insights from the National Veterans Affairs Clinical Assessment, reporting and Tracking Program Antonio Gutierrez, Thomas Tsai, Maggie Stanislawski, Mladen Vidovich, Walter ACC.12 Final Program 153

11:15

Morning

11:00

11:30

11:45

11:15

12:00

11:30

11:45

QUAl SYMPOSIUM

650

Chair: Panelists:

12:00

10:45 10:50 11:15

PrEV OrAl

11:40
QUAl OrAl

927

Co-Chairs: 10:45

928

Co-Chairs: 10:45

Sunday, March 25, 2012 ACC.12

Woody, Christopher Bryson, Deepak Bhatt, John Rumsfeld, Sunil Rao, Duke Clinical Research Institute, Durham, NC 11:00 9284 Non-system reasons for Delay in Door-toBalloon Time and In-hospital Mortality: A report from the National Cardiovascular Data registry Rajesh V. Swaminathan, Tracy Wang, Lisa Kaltenbach, Luke Kim, Robert Minutello, Dmitriy Feldman, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, Duke Clinical Research Institute, Durham, NC 9285 Do Extreme risk Cases Impact Hospitals risk-Adjusted PCI Mortality ratings? results from the NCDr Eric D. Peterson, Dadi (David) Dai, Sean OBrien, J. Matthew Brennan, Kalon Ho, Frederick Masoudi, John Messenger, W. Douglas Weaver, Duke Clinical Research Institute, Durham, NC 9286 Gender and Bleeding risk following Percutaneous Coronary Interventions: A Contemporary report from the NCDr Stacie L. Daugherty, Sunghee Kim, Lauren Thompson, Sunil Rao, Sumeet Subherwal, Thomas Tsai, John Messenger, Frederick Masoudi, University of Colorado Denver, Aurora, CO 9287 Geospatial Analysis of Percutaneous Coronary Intervention Hospitals James R. Langabeer, Timothy Henry, Jami Delli Fraine, Jamie Emert, Richard King, Leilani Stuart, Wendy Segrest, University of Texas Health Science Center, Houston, TX 9288 Hospital Characteristics Associated with Providing Optimal Medical Therapy for Percutaneous Coronary Intervention Patients: A report from the NCDr William Borden, John Spertus, Alvin I. Mushlin, Matthew Roe, Lisa Kaltenbach, Rita Redberg, Weill Cornell Medical College, New York, NY Young Investigators Award Competition: Physiology, Pharmacology and Pathology Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S105a CME/CNE Hours: 1.5 Sanjay Rajagopalan, Columbus, OH Daniel A. Duprez, Minneapolis, MN Arshed A. Quyyumi, Atlanta, GA 4064 Platelet Inhibitory Effect of Clopidogrel in Patients Treated with Omeprazole, Pantoprazole or Famotidine: A Prospective randomized Crossover Study Yaron Arbel, tasmc cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 4065 Mitral leaflet Changes following Myocardial Infarction: Evidence for Maladaptive remodeling Favoring Ischemic Mitral regurgitation Jonathan Beaudoin, Jacob Dal-Bianco, Elena Aikawa, Joyce Bischoff, Luis Guerrero, Suzanne Sullivan, Jill Wylie-Sears, Jacob Aaron, Robert A. Levine, Massachusetts General Hospital, Boston, MA, Harvard Medical School, Boston, MA 11:45 11:15 4066 right to left Shunting through Patent Foramen Ovale during Simulated Episodes of Obstructive Sleep Apnea Tomas Konecny, Amber D. Khann, Jan Novak, Abdi A. Jama, Jan Bukartyk, Marek Orban, Tomas Kara, Barry A. Borlaug, Virend K. Somers, Guy Reeder, Mayo Clinic, Rochester, MN 4067 QT-rr Hysteresis is Caused by Differential Autonomic States during Exercise and recovery Daniel J. Pelchovitz, Jason Ng, Alexandru B. Chicos, Daniel W. Bergner, Jeffrey J. Goldberger, Northwestern University Feinberg School of Medicine, Chicago, IL 4068 Traumatic lower Extremity Amputations Cause Disturbed Blood Flow in The Infrarenal Aorta leading to Abdominal Aortic Aneurisms Alexander V. Smolensky, Stephanie ClementGuinaudeau, John N. Oshinski, William R. Taylor, Emory University School of Medicine, Atlanta, GA Diagnostic Testing; ECG and Cardiopulmonary Exercise Testing Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Paul Kligfield, New York, NY John Wells Askew, Rochester, MN 9293 The Year in review Diagnostic Testing Michael S. Lauer, Bethesda, MD 9294 Determinants of VE/VCO2 Slope in Normal Individuals: Ventilatory Efficiency Is Modifiable with Endurance Training Ryan M. Murphy, Rory B. Weiner, Stacyann S. Hough, Paul P. Pappagianopoulos, David M. Systrom, Adolph M. Hutter, Aaron L. Baggish, Gregory D. Lewis, Massachusetts General Hospital, Boston, MA 9295 Heart rate versus rr Interval recovery after Exercise: Which Is More Physiologic? Jeffrey J. Goldberger, Haris Subacius, Jason Ng, Northwestern University, Chicago, IL 9296 Validation of a Cardiopulmonary Exercise Test Score in Heart Failure Jonathan N. Myers, Ricardo Oliveira, Marco Guazzi, Paul Chase, Daniel Bensimhon, Euan Ashley, Daniel Forman, Mary Ann Peberdy, Erin West, Ross Arena, VA Palo Alto Health Care System, Palo Alto, CA 9297 Cardiorespiratory Fitness and Short-term Outcomes with Coronary Artery Bypass Graft Surgery James L. Smith, Thomas A. Verrill, Judy A. Boura, Marc P. Sakwa, Francis L. Shannon, Barry Franklin, William Beaumont Hospital, Royal Oak, MI 9298 Impact of Utilizing a Women-based Formula for the Calculation of Chronotropic response during Exercise Treadmill Testing in Women: long-term Outcome Sahar S. Abdelmoneim, Sharon Mulvagh, Laurie Barr, Quinn Pack, Martha Gulati, Thomas Allison, Mayo Clinic, Rochester, MN, The Ohio State University, Columbus, OH

11:30

Morning

11:15

11:45

11:30

TEST OrAl

929

11:45

Co-Chairs: 10:45 11:00

12:00

11:15

SPECIAl SPECIAl

406

11:30

Chair: Judges: 10:45

11:00

12:00

154 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

VAlV OrAl

930

Valvular Oral Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place North, N427 CME/CNE Hours: 1.5 Arsene J. Basmadjian, Montreal, Canada Vuyisile Nkomo, Rochester, MN 9303 ACCESS EUrOPE: A Post-market Study of the MitraClip System for the Treatment of Significant Mitral regurgitation (Mr) in Europe: Analysis of Outcomes at 6-months Francesco Maisano, Olaf Franzen, Stephan Baldus, Joerg Hausleiter, Christian Butter, Ulrich Schafer, Giovanni Pedrazzini, Gian Paolo Ussia, Horst Sievert, Lars Soendergaard, Wolfgang Schillinger, on behalf of the ACCESS EUROPE Investigators, San Rafaelle Hospital, Milano, Italy 9304 The relationship between the Magnitude of reduction in Mitral regurgitation Severity and left Ventricular and left Atrial Volumes Post-Treatment with the MitraClip Device Paul Grayburn, Chithra Sangli, Joseph Massaro, Laura Mauri, Neil Weissman, Donald Glower, Ted Feldman, Elyse Foster, on behalf of the EVEREST II Investigators, Baylor Univ Medical Center, Dallas, TX 9305 long-term Impact of repeat Percutaneous Mitral Commissurotomy on the Need for Surgery in Mitral Stenosis: Insights from a Series of 912 Patients with a 20-year Follow-up Claire Bouleti, Bernard Iung, Dominique Himbert, David MessikaZeitoun, Eric Brochet, eric garbarz, Alex Vahanian, Bichat Hospital, Paris, France 9306 Mitral regurgitation of Degenerative as Opposed to Functional Origin Negatively Impacts Outcomes of MitraClip Therapy: Single-Center Experience with 255 Consecutive Patients Volker Rudolph, Edith Lubos, Daniel Lubs, Malgorzata Knap, Michael Schlter, Stefan Blankenberg, Stefan Blankenberg, Stephan Baldus, University Heart Center Hamburg, Hamburg, Germany 9307 risk Factors for Progression of Mitral Annulus Calcification: The Multi-ethnic Study of Atherosclerosis Sammy Elmariah, Matthew Budoff, Joseph AC Delaney, Khurram Nasir, Yasmin Hamirani, Richard Kronmal, Valentin Fuster, Jonathan Halperin, Kevin OBrien, Massachusetts General Hospital, Boston, MA 9308 Prevalence of Significant Tricuspid regurgitation and Its Clinical Significance in Patients with Successful Percutaneous Mitral Valvuloplasty for Mitral Stenosis: results from 12-year Follow-up of One Center Prospective registry Seung-Pyo Lee, Hyung-Kwan Kim, Kyung-Hee Kim, Ji-Hyun Kim, Hyo Eun Park, Yong-Jin Kim, Dae Won Sohn, Seoul National University Hospital, Seoul, South Korea

VASC OrAl

932

Co-Chairs: 10:45

New Insights in Perpheral Vascular Disease and Year in review Sunday, March 25, 2012, 10:45 a.m. 12:15 p.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Joshua A. Beckman, Boston, MA Soo Hyun Kim, Avon, OH 9323 The Year in review Vascular Michael R. Jaff, Boston, MA 9324 Two Methods of Calculating Ankle Brachial Index: Differences in Predicting Peripheral Arterial Disease Burden Bassem M. Chehab, Vinodh Jeevanantham, Sravanthi Nagavalli, Edgar Austria, Rakesh Shrivastava, Mark Wiley, Peter Tadros, Jayant Nath, Buddhadeb Dawn, Kamal Gupta, University of Kansas Medical Center, Kansas City, KS 9325 Is There a Smoking Gun? The Impact of Tobacco Use on Peripheral Vascular Intervention Indications and Outcomes: Observations from Blue Cross Blue Shield of Michigan Cardiovascular Consortium Shea Elizabeth Hogan, Khan Munir, Hitinder Gurm, Jeffrey Rubin, M. Ashraf Mansour, P. Michael Grossman, University of Michigan, Ann Arbor, MI, Harper University Hospital, Detroit, MI 9326 Vulnerable Plaque in Atherosclerosis Is Characterized by Microvasculature Involving the Vessels Derived from Vasa Vasorum Interna Mie Kurata, Ehime University Graduate School of Medicine, Toon city, Ehime, Japan 9327 National Institute of Health Stroke Scale (NIHSS) Should be the Outcome Measure of Choice When Utilizing the Care registry John H. Lee, kevin kennedy, Christopher White, Ochsner Heart and Vascular Institute, New Orleans, LA

Co-Chairs: 10:45 11:00

Morning

11:00

11:15

11:15

11:30

noon

11:30

11:45

11:45

noon SeSSionS
ACC-i2/TCT SYMPOSIUM

646

12:00

Interventional Cardiovascular Medicine in 2012: An Update for the Non-Interventionalist and the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lecture Sunday, March 25, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Gregg W. Stone, New York, NY E. Murat Tuzcu, Cleveland, OH Introduction to the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lecture Douglas P. Zipes, Indianapolis, IN Douglas P. Zipes, MD, Distinguished Young Scientist lecture: Incidence, Mechanisms, Predictors and Clinical Significance of Periprocedural Myocardial Infarction Due to Percutaneous Coronary Intervention Duk-Woo Park, Seoul, Republic of Korea, Discussion Coronary Artery Disease Intervention in the Patient with Stable Angina George D. Dangas, New York, NY ACC.12 Final Program 155

Co-Chairs: 12:15

12:20

12:40 12:45

Sunday, March 25, 2012 ACC.12

12:57 1:09 1:21 1:33 ACS, Optimal Adjunct Pharmacology Dean J. Kereiakes, Cincinnati, OH Imaging and Physiology Gary S. Mintz, Washington, DC Endovascular Intervention Michael R. Jaff, Boston, MA Adult Structural and Valvular Intervention Alan Zajarias, Saint Louis, MO Cardiac Care Team Session I: Keynote Address Sunday, March 25, 2012, 12:30 p.m. 1:00 p.m. McCormick Place South, S103b CME/CNE Hours: 1 Janet Fredal Wyman, Detroit, MI Keynote Address: Team-based Care David R. Holmes, Jr., Rochester, MN Discussion Aortic Valve Case reviews Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 John G. Webb, Vancouver, Canada Allan Schwartz, New York, NY Itsik Ben-Dor, Washington, DC, Sammy Elmariah, Boston, MA, Amar Krishnaswamy, Cleveland, OH, Atman P. Shah, Chicago, IL Vasilis Babaliaros, Atlanta, GA, Raoul Bonan, Montreal, Canada, Raj R. Makkar, Los Angeles, CA Coronary Complications Case reviews Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Paul S. Teirstein, La Jolla, CA Jeffrey J. Popma, Newton, MA Hajime Iwama, Nara, Japan, Gautam Kumar, Atlanta, GA, Sunil Naik, Southfield, MI, Sowmya Sreekanth, New York, NY, Sergio Gustavo Tarbine, Curitiba, Brazil David Alan Cox, Allentown, PA, Stephen G. Ellis, Cleveland, OH,James Bernard Hermiller, Indianapolis, IN Multivessel and Hemodynamic Support Case reviews Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5 Igor F. Palacios, Boston, MA Zoltan G. Turi, Camden, NJ David Bartov, Mineola, NY, Carlos Deluca, Buenos Aires, Argentina, Sammy Elmariah, Boston, MA, Saurabh Kumar Gupta, New Delhi, India, Suresh Vijaybasappa Patted, Belgaum, India John Hirschfeld, Philadelphia, PA, Nicola Corjava, Stamford, CT, Charles J. Davidson, Chicago, IL 1:33
ACC-i2/TCT SYMPOSIUM

2616

Endovascular Intervention for Venous Disease Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 John Rundback, Teaneck, NJ Kenneth Rosenfield, Boston, MA Patient Selection and Indications for Endovascular Intervention in Acute DVT Kenneth Rosenfield, Boston, MA Debate: Provisional Stenting is the Treatment of Choice for Acute DVT Stephan Wicky, Boston, MA Debate: Primary Stenting is the Treatment of Choice for Acute DVT Mohsen Sharifi, Mesa, AZ IVC Filter Placement and retrieval: Indication, Types and Technique Tino Pena, Miami, FL Endoluminal Ablative Therapy of Saphenous Venous System Step-by-Step laser or rF, or Does it Matter Raghu Kolluri, Springfield, IL Case Presentation: Endovascular Intervention to Treat Acute Venous Thromboembolism Robert Schainfeld, Waltham, MA Platelet Inhibition in 2012: What You Need To Know Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S106b CME/CNE Hours: 1.5 C. Michael Gibson, Boston, MA Neal S. Kleiman, Houston, TX Debate: Genotyping and Point of Care Platelet Function Testing Are ready for Prime Time Dominick J. Angiolillo, Jacksonville, FL Debate: Genotyping and Point of Care Platelet Function Testing Are Not Yet Clinically Useful Marc Steven Sabatine, Boston, MA Optimizing DAPT Matthew J. Price, La Jolla, CA DAPT: Issues regarding Duration, Safe Interruption and Discontinuation Laura Mauri, Boston, MA Triple Therapy: DAPT plus Thrombin Inhibition Harvey D. White, Auckland 1142, New Zealand New Insights into Drug-Drug Interactions Paul A. Gurbel, Baltimore, MD Novel Strategies for Anticoagulation and Platelet Inhibition David J. Moliterno, Lexington, KY Panel Discussion

Co-Chairs: 12:30

ACC-i2/TCT SPECIAl

12:43 12:55 1:07 1:20

2101

Chair: 12:30 12:50

ACC-i2/TCT ExPErTS

2308

NooN

Co-Chairs: Case Presenters: Panelists:

ACC-i2/TCT SYMPOSIUM

2617

Co-Chairs: 12:30

ACC-i2/TCT ExPErTS

2309

12:40

Co-Chairs: Case Presenters: Panelists:

12:50 1:00 1:10 1:20 1:30 1:40

ACS SYMPOSIUM

ACC-i2/TCT ExPErTS

2310

Co-Chairs: Case Presenters:

639

The Future of ACS Clinical Trials Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S404 CME/CNE Hours: 1.25 Paul Wayne Armstrong, Edmonton, Canada Robert A. Harrington, Durham, NC Clinical Trial Endpoints Today and Tomorrow Sunil V. Rao, Durham, NC

Co-Chairs: 12:30

Panelists:

156 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

12:42 12:54 Clinical Trials in the Age of Comparative Effectiveness Sanjay Kaul, Los Angeles, CA The Current and Future State of Clinical Trial Funding: The role of Industry and Non-Industry Sources Robert A. Harrington, Durham, NC Clinical Trials in the Trenches: Is it Worth Being a Site in a Trial Any More? US Perspective Giora Weisz, New York, NY Clinical Trials in the Trenches: OUS Perspective Lars Wallentin, Uppsala, Sweden Summary Paul Wayne Armstrong, Edmonton, Canada
Arr SYMPOSIUM HF ExPErTS

228

Cardiac Mr for the Evaluation of the Heart Failure Patient Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S502 CME/CNE Hours: 1.25 Subha V. Raman, Columbus, OH Sanjeev A. Francis, Boston, MA, Mario J. Garcia, Bronx, NY, Matthias Friedrich, Calgary, Canada Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Issues in the Diagnosis and Treatment of Chronic Ambulatory Heart Failure Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S406b CME/CNE Hours: 1.25 David DeNofrio, Boston, MA G. Michael Felker, Durham, NC Imaging the Heart Failure Patient: Which Patients and What Modality: Echo Scott D. Solomon, Boston, MA Imaging the Heart Failure Patient: Which Patients and What Modality: Nuclear James E. Udelson, Boston, MA Imaging the Heart Failure Patient: Which Patients and What Modality: Mr Joao A. C. Lima, Baltimore, MD The Evolving role of Biomarkers in the Management of Heart Failure Patients James L. Januzzi, Jr., Boston, MA Exercise and the Heart Failure Patient: Why, Who and How? Ileana L. Pina, Cleveland Heights, OH

1:07

Chair: Panelists:

Case Presenter: Erik Schelbert, Pittsburgh, PA

1:20 1:32

HF SYMPOSIUM

641

640

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Investigation and Management of Syncope Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N426 CME/CNE Hours: 1.25 Julia H. Indik, Tucson, AZ Robert S. Sheldon, Calgary, Canada risk Stratification of the Patient who Presents with Syncope David G. Benditt, Minneapolis, MN The role of Tilt Table Testing and Ilrs Andrew D. Krahn, London, Canada Management of Neuromediated Syncope Carlos A. Morillo, Hamilton, Canada Treatment of Postural Tachycardia Syndrome (POTS) Satish Raj, Nashville, TN Question and Answer

Co-Chairs: 12:30

Co-Chairs: 12:30 12:45 1:00 1:15 1:30

CCS SPECIAl

12:45

NooN

1:00

1:15

301

Career & Mentoring Session for Pediatric and Congenital Cardiologists Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N231 CME/CNE Hours: 1.25 Jeffrey A. Towbin, Cincinnati, OH Charles Berul, Washington, DC, Mark B. Lewin, Seattle, WA, Lloyd Y. Tani, Salt Lake City, UT Welcome and Introduction Jeffrey A. Towbin, Cincinnati, OH How Do You Choose a Fourth Year Fellowship? Mark B. Lewin, Seattle, WA How I Found the right Mentor John L. Jefferies, Cincinnati, OH Financing and Health Care reform James W. Fasules, Washington, DC How Do I Interview for a Job? Girish S. Shirali, Charleston, SC Panel Discussion: Choosing a Job and lasting in It Question and Answer

1:30

HF SYMPOSIUM

642

Chair: Panelists: 12:30 12:35 12:45 12:55 1:05 1:15 1:35

Cardiotoxicity of Cancer Chemotherapy: Molecular Basis and Strategies for Early Detection and Prevention Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S405 CME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-137-l01-P Anceta Fadol, Houston, TX Edward T. Yeh, Houston, TX Cardiotoxicity of Cancer Chemotherapeutic Agents: The Extent and Magnitude of Problem and Clinical Evidence Daniel J. Lenihan, Nashville, TN Cellular Basis of Myocardial Injury and left Ventricular Dysfunction with Cancer Chemotherapy Raymond R. Russell, New Haven, CT Monitoring of left Ventricular Function during Chemotherapy Davinder Jassal, Winnipeg, Canada Biomarkers for Cardiotoxicity Bonnie Ky, Philadelphia, PA Novel Methods to Prevent and Image Cardiotoxicity Ban-An Khaw, Boston, MA

Co-Chairs: 12:30

12:45

1:00

1:15 1:30

ACC.12 Final Program 157

Sunday, March 25, 2012 ACC.12

IMAG SYMPOSIUM

643

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Interventional Echocardiography Evolving role in Patient Management Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S406a CME/CNE Hours: 1.25 Issam A. Mikati, Chicago, IL Patricia A. Pellikka, Rochester, MN Echo in the EP lab (lAA Closure Devices) Frank E. Silvestry, Wayne, PA Echo in the Cath lab (Mr, TAVI, Perivalvular regurgitation Closure) Rebecca T. Hahn, New York, NY Echo in Assessment of Heart Failure Devices Jerry Estep, Houston, TX Echo in the Interventional ACHD lab (ASD, VSD) Frank E. Silvestry, Wayne, PA Question and Answer

lIFElONG MOC

811

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy ACC General Cardiology Module Part A Sunday, March 25, 2012, 12:30 p.m. 3:00 p.m. McCormick Place South, S105a CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.

Co-Chairs: 12:30 12:46

1:02 1:18 1:34

IMAG SYMPOSIUM

644

NooN

Cost-Effective Imaging in Patients with Chronic CAD Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S403 CME/CNE Hours: 1.25 Kirsten E. Fleischmann, San Francisco, CA R. Parker Ward, Chicago, IL What Is Cost-Effective Imaging? Rita F. Redberg, San Francisco, CA role of CMr Christopher M. Kramer, Charlottesville, VA role of Nuclear Imaging Rory Hachamovitch, Cleveland, OH role of CT Matthew J. Budoff, Torrance, CA role of Echo Pamela S. Douglas, Durham, NC Managing High-risk Patients with Stable Ischemic Heart Disease Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S401a CME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-138-l04-P Bernard J. Gersh, Rochester, MN Rhondalyn McLean, Baltimore, MD Diabetic Patients: replacing Fallacies with Facts Darren K. McGuire, Dallas, TX Question and Answer Chronic Kidney Disease: What Should I Do for These Patients? Amy W. Williams, Rochester, MN Question and Answer Elderly Patients: Treatment Pearls and Pitfalls Karen P. Alexander, Durham, NC Question and Answer Minorities: How Does race/Ethnicity Affect Our Approach? Keith C. Ferdinand, Atlanta, GA Question and Answer

Co-Chairs: 12:30 12:45 1:00 1:15 1:30

ISCHEM SYMPOSIUM

Chair:

Jeffrey J. Cavendish, San Diego, CA

MOC Faculty: Maya E. Guglin, Tampa, FL, John A. McPherson, Nashville, TN

lIFElONG MOC

645

812

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy ACC General Cardiology Module Part B Sunday, March 25, 2012, 12:30 p.m. 3:00 p.m. McCormick Place South, S105d CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study

Co-Chairs: 12:30 12:42 12:48 1:00 1:07 1:20 1:26 1:38

158 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC. Chair: Kyle W. Klarich, Rochester, MN MOC Faculty: Douglas E. Drachman, Boston, MA, Jeffrey T. Kuvin, Boston, MA
PErI ExPErTS

12:30

Prevalence and Significance of Pulomary Hypertension in left Ventricular Dysfunction Selma Mohammed, Rochester, MN Approach to the Dyspneic Patient with Echocardiographic Evidence of Pulmonary Hypertension: PAH, HFpEF or Both? Paul Forfia, Philadelphia, PA Characterization of PH in lVD: Beyond resting Hemodynamic Measurements Gregory D. Lewis, Boston, MA lessons learned from Continuous Pulmonary Arterial Pressure Measurements in Heart Failure Patients: Emerging roles for Implantable Monitoring Devices Robert C. Bourge, Birmingham, AL Targeted Therapy for Pulmonary Hypertension in left Ventricular Dysfunction Marc J. Semigran, Boston, MA Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part I: Making the Electronic Health record Meaningful and Useful A Washington Perspective Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N227b CME/CNE Hours: 1.25 John R. Windle, Omaha, NE Alfred A. Bove, Philadelphia, PA, Michael J. Mirro, Fort Wayne, IN, James E. Tcheng, Durham, NC Introduction to Keynote Speaker Jack Lewin, Washington, DC A View from the Top: Meaningful Use Present and Future Farzad Mostashari, Washington, DC Panel Discussion

12:45

1:00

1:15

1:30

229

Grasping the Complexity of Myocardial and Pericardial Diseases Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S505 CME/CNE Hours: 1.25 Jae K. Oh, Rochester, MN Alex J. Auseon, Columbus, OH, Scott Silvestry, Philadephia, PA, Mauricio Velez, Detroit, MI William Little, Winston Salem, NC, Sunil V. Mankad, Rochester, MN The New Hypertrophic Cardiomyopathy Practice Guidelines Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N226 CME/CNE Hours: 1.25 Harry M. Lever, Solon, OH Steve R. Ommen, Rochester, MN Genetic Testing: The Basics and What You and Your Patient Need to Know Michael J. Ackerman, Rochester, MN Echocardiography: 2-D, Doppler and Strain Imaging Milind Y. Desai, Cleveland, OH Cardiac MrI: Diagnosis and risk Stratification Martin S. Maron, Boston, MA The Importance of Myocardial Ischemia Perry M. Elliott, London, United Kingdom risk Stratification: Who Gets an ICD? Matthew W. Martinez, Allentown, PA Septal reduction Therapy: Surgery or Ablation? Paul Sorajja, Rochester, MN

PrACTICE SYMPOSIUM

Chair: Case Presenters: Panelists:

647

NooN

PErI SYMPOSIUM

Chair: Panelists: 12:30 12:35 1:15

PrEV ExPErTS

648

Co-Chairs: 12:30

12:42 12:55 1:07 1:20 1:32

230

Management of Hypertension in the Elderly Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S501a CME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-128-l01-P George L. Bakris, Chicago, IL Stanley S. Franklin, Irvine, CA, Carey D. Kimmelstiel, Boston, MA, Marvin Moser, Scarsdale, NY FIT Forum III: How to Write and Evaluate Medical Journal Articles Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N229 CME/CNE Hours: 1.25 Anthony N. DeMaria, San Diego, CA How to Write Publishable Papers (with Examples of Dos and Donts) Anthony N. DeMaria, San Diego, CA Discussion with Audience Question and Answer ACC.12 Final Program 159

Chair: Panelists:

Case Presenter: Michael Chen, Seattle, WA

SPECIAl SPECIAl

PHTN SYMPOSIUM

649

Emerging Approaches to Pulmonary Hypertension with left Ventricular Dysfunction Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place South, S402 CME/CNE Hours: 1.25 Teresa De Marco, San Francisco, CA Michael A. Mathier, Pittsburgh, PA

111

Chair: 12:30 12:45

Co-Chairs:

Sunday, March 25, 2012 ACC.12

12:55 1:10 1:20 1:35
TEST SYMPOSIUM

How to revise Your Manuscript Jagat Narula, New York, NY Discussion with Audience Question and Answer Evaluating a research Paper: What Constitutes a Good review Spencer B. King, Atlanta, GA Discussion with Audience Question and Answer role of Exercise Treadmill Testing in 2012 Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N230 CME/CNE Hours: 1.25 Brian G. Abbott, East Greenwich, RI Gerald F. Fletcher, Jacksonville, FL Standard Treadmill Assessment: Whats the role for a low-Tech Test in a High-Tech World? Todd D. Miller, Rochester, MN risk Stratification: looking Beyond the ECG during Stress Testing Michael S. Lauer, Bethesda, MD Pearls and Pitfalls in Exercise Testing Daniel E. Forman, Boston, MA Approach to Stress Testing in Patients with Pacemakers, Defibrillators and resynchronization Devices Derek V. Exner, Calgary, Canada Cardiopulmonary Exercise Testing: Indications and Utility Ross Arena, Albuquerque, NM Question and Answer Co-Chairs: 1:00 1:12 1:24 1:36 1:48 2:00 2:12 2:24
ACC-i2/TCT SPECIAl ACC-i2/TCT SPECIAl

Afternoon SeSSionS

2102

Cardiac Care Team Session II: Cath lab of Tomorrow Pathway to a High-risk Aortic Valve Program Sunday, March 25, 2012, 1:00 p.m. 2:30 p.m. McCormick Place South, S103b CME/CNE Hours: 1 Marian Hawkey, New York, NY Janet Fredal Wyman, Detroit, MI Setting up an Aortic Valve Program Sandra Lauck, Vancouver, Canada Who is the Severe Aortic Stenosis Patient? Marian Hawkey, New York, NY Gathering the Data/Coordinating the Assessment Process Jasminka Stegic, Los Angeles, CA Psychosocial Issues with High risk Aortic Stenosis Martina Speight, Stanford, CA Inter-professional Decision-making: Playing in the Same Sandbox Todd M. Dewey, Dallas, TX Preparing Your Cath lab for an Aortic Valve Program Michael Guiry, New York, NY Anticipating Post-procedure Needs Pre-procedure Susan Schnell, New York, NY Panel Discussion Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist I: Mitral and Aortic Valve (with remote Demonstrations from the Seattle Science Foundation) Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102c CME/CNE Hours: 1.5

651

Co-Chairs: 12:30

12:42 12:54 1:06

NooN

1:18 1:30
VAlV SYMPOSIUM

652

Controversies in Valve Disease I Sunday, March 25, 2012, 12:30 p.m. 1:45 p.m. McCormick Place North, N427 CME/CNE Hours: 1.25 Blase A. Carabello, Houston, TX William A. Zoghbi, Houston, TX TAVI Should Be reserved for Inoperable Patients Thoralf Sundt, Boston, MA TAVI Should Not Be reserved for Inoperable Patients Martin B. Leon, New York, NY Summary Mitral E-Clip Is a reasonable Option for Functional Mr Saibal Kar, Los Angeles, CA Mitral E-Clip Is Not a reasonable Option for Functional Mr Robert Dion, Belgium Summary

2131

Co-Chairs: 12:30

Remote Mark Reisman, Seattle, WA Demonstrator: Co-Chairs: Panelists: 2:00 2:15 2:20 2:25 2:40 2:55 3:00 3:05 3:20 3:25 Nicolo Piazza, Montreal, Canada Ted Feldman, Evanston, IL Saibal Kar, Los Angeles, CA, Frank E. Silvestry, Wayne, PA Mitral Valve Anatomy Mark Reisman, Seattle, WA Mitral Valve Case Presentation Speaker TBD Case Presentation: Mitral Annuloplasty Steven L. Goldberg, Seattle, WA Mitral Valve Devices Mark Reisman, Seattle, WA Aortic Valve Anatomy Mark Reisman, Seattle, WA Case Presentation: Transfemoral of Balloon Expandable TAVr Susheel Kodali, New York, NY Case Presentation: Transapical of Balloon Expanding TAVr Michael J. Mack, Plano, TX Anatomical Prespectives for a Balloon Expandable Aortic Valve Mark Reisman, Seattle, WA Case Presentation: Transfemoral of a Self Expandable TAVr Nicolo Piazza, Montreal, Canada Anatomical Perspectives for a Self Expandable TAVr Mark Reisman, Seattle, WA

Afternoon

12:43 1:02 1:08 1:21 1:40

160 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

ACC-i2/TCT CASE rEVIEW

2202

live and Taped Case Session II: left Main and Bifurcation- Complex PCI Sunday, March 25, 2012, 2:00 p.m. 5:00 p.m. McCormick Place North, Hall B, ACC.12 Main Tent CME/CNE Hours: 3 Dean J. Kereiakes, Cincinnati, OH Raj R. Makkar, Los Angeles, CA Alexandre Abizaid, Sao Paulo, Brazil, Manish Parikh, New York, NY, Alaide Chieffo, Milan, Italy, Matthew J. Price, La Jolla, CA, John A. Ormiston, Auckland, New Zealand, John M. Lasala, Saint Louis, MO, SeungJung Park, Seoul, Republic of Korea live Case from the University of Pennsylvania, Philadelphia, PA Howard C. Herrmann, Philadelphia, PA Surgery versus PCI for lMCA revascularization: The Surgeons Perspective David Taggart, Oxford, United Kingdom Surgery versus PCI for lMCA revascularization: The Interventionalists Perspective David E. Kandzari, Atlanta, GA Panel Discussion Practical Approach to Non-left Main Bifurcation Disease: Techniques and Outcomes Corrado Tamburino, Catania, Italy Taped Case from Baylor, Houston, Tx Neal S. Kleiman, Houston, TX Imaging Transcatheter Aortic Valve Procedures I: Intra- and Post-procedural Imaging Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 William J. Stewart, Cleveland, OH Victoria Delgado, Leiden, Netherlands Multi-modality Imaging for Intra-procedural THV Positioning: Balloon-expandable THV Susheel Kodali, New York, NY Multi-modality Imaging for Intra-procedural THV Positioning: Self-expanding THV Nicolo Piazza, Montreal, Canada Multi-modality Imaging for Intra-procedural THV Positioning: Is TEE Necessary for TAVr? Sherif F. Nagueh, Houston, TX Predicting and Managing TAVr Complications: Nuances in Evaluation and Management of Perivalvular leak Stamatios Lerakis, Atlanta, GA Predicting and Managing TAVr Complications: Hemodynamic Emergencies the role of TEE Rebecca T. Hahn, New York, NY Post-procedural Imaging of Embolic Events: CT, MrI, Transcranial Doppler TBD Post-procedural CT Evaluation: What Have We learned? Jonathan Leipsic, Vancouver, Canada Panel Discussion: THV Misadventures and Their Management

ACC-i2/TCT SYMPOSIUM

2619

Emerging Technologies Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 Mathew Williams, New York, NY Alan Zajarias, Saint Louis, MO large Bore Femoral Artery Closure Vasilis Babaliaros, Atlanta, GA Percutaneous Transapical TAVr/Closure Devices Lars G. Svensson, Cleveland, OH Embolic Protection during TAVr John G. Webb, Vancouver, Canada New Mitral repair and replacement Technology Jason H. Rogers, Sacramento, CA PFO and lAA Devices Horst Sievert, Frankfurt, Germany New Aortic Valves: Transfemoral Steven R. Bailey, San Antonio, TX New Aortic Valves: Transapical Thomas Walther, Bad Nauheim, Germany New Imaging Technology: Echo 4-D, ICE Itzhak Kronzon, New York, NY Minimally Invasive Aortic repair and replacement Eric Roselli, Cleveland, OH Peripheral Artery Disease: Superficial Femoral Artery Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 D. Christopher Metzger, Kingsport, TN Peter Angelopoulos, Garden City, NY What is the role of Covered Stents for Iliac and Fem-Pop Stenosis/Occlusions in 2012? Matthew T. Menard, Boston, MA Debate: Provisional Stenting is the Treatment of Choice for 710 cm Fem-Pop lesions Speaker TBD Debate: Primary Stenting is the Treatment of Choice for 710 cm Fem-Pop lesions Mehdi H. Shishehbor, Cleveland, OH Step-by-Step Approach to long Superficial Femoral Artery Occlusion: What Are the Options? Ivan P. Casserly, Aurora, CO Drug Eluting Balloons: Where Do We Stand in 2012? Herbert Aronow, Ypsilanti, MI Case-based Presentation: How to Manage In-stent restenosis and Complications Associated with Fem-Pop Endovascular Intervention Peter Angelopoulos, Garden City, NY

Co-Chairs: Panelists:

Co-Chairs: 2:00 2:10 2:20 2:30 2:40 2:50 3:00 3:10 3:20

2:00

3:30

3:40

3:50 4:00

4:15

ACC-i2/TCT SYMPOSIUM

ACC-i2/TCT SYMPOSIUM

2620

2618

Co-Chairs: 2:00

Co-Chairs: 2:00

AFTERNOON

2:15

2:10

2:30

2:20

2:45

2:30

3:00 3:15

2:40

2:50 3:00 3:10

ACC.12 Final Program 161

Sunday, March 25, 2012 ACC.12

ACC-i2/TCT SYMPOSIUM

2621

Chronic Total Occlusions Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S106b CME/CNE Hours: 1.5 Jeffrey W. Moses, New York, NY Masahiko Ochiai, Kanagawa, Japan Accessory Imaging (MSCT and/or IVUS) in Procedural Planning and Execution Yuji Oikawa, Tokyo, Japan Step-by-Step Moderately Difficult Antegrade Techniques Alfredo R. Galassi, Aicastello, Italy Step-by-Step retrograde Techniques Etsuo Tsuchikane, Toyohashi, Japan Dissection and re-entry Facilitated CTO-PCI James Aaron Grantham, Kansas City, MO A Multitechnique Case (the Hybrid Approach) William L. Lombardi, Bellingham, WA Complications and Pitfalls of CTO-PCI TBD

Arr ExPErTS

232

Co-Chairs: 2:00

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Optimizing the Management of the Patient with Implantable Devices Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Bruce L. Wilkoff, Cleveland, OH Kenneth A. Ellenbogen, Richmond, VA, Derek V. Exner, Calgary, Canada, Bernard Thibault, Montreal, Canada Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation Prevention of Stroke Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Richard I. Fogel, Carmel, IN Anne M. Gillis, Calgary, Canada role of Anticoagulants Michael M. Ezekowitz, Wynnewood, PA risk Stratification for Stroke: CHADs2 versus CHA 2DS2-VASc A. John Camm, London, United Kingdom risk Stratification for Bleeding Complications: HASBlED vs. ATrIA Study Greg C. Flaker, Columbia, MO Implementing the AF Guidelines into Clinical Practice Eric N. Prystowsky, Indianapolis, IN Question and Answer

Chair: Panelists:

2:15 2:30 2:45 3:00 3:15

ACS ExPErTS

Arr SYMPOSIUM

654

Co-Chairs: 2:00 2:20

231

Management of Chest Pain in the Emergency Department Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Ezra A. Amsterdam, Sacramento, CA Kim A. Eagle, Ann Arbor, MI, Judd Hollander, Philadelphia, PA, James K. Min, New York, NY State-of-the-Art in Non ST Elevation ACS Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S404 CME/CNE Hours: 1.5 James A. De Lemos, Dallas, TX Shaun G. Goodman, Toronto, Canada Emerging Tools for risk Assessment in NSTE ACS Bertil Lindahl, Uppsala, Sweden Navigating Antiplatelet and Antithrombotic Choices in the Generic Clopidogrel Era Stefan K. James, Uppsala, Sweden Selection and Timing for Invasive Therapy in NSTE ACS Alexandra J. Lansky, New York, NY Safety Cost and Quality Are the New Drivers of NSTE ACS Care Matthew T. Roe, Durham, NC ACS Guidelines Are Evidence-Based, User-Friendly and Practical Alice K. Jacobs, Boston, MA ACS Guidelines Are Not Evidence-Based, UserFriendly and Practical James M. Brophy, Montreal, Canada Discussion

Chair: Panelists:

2:40

Case Presenter: Mario Goessl, Rochester, MN 3:00 3:20

ACS SYMPOSIUM

653

CCS lEGENDS

402

Co-Chairs:

legends of Cardiovascular Medicine lecture Series 2012 Dan G. McNamara lecture Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N228 CME/CNE Hours: 1.5 Kathy J. Jenkins, Boston, MA Roberta G. Williams, Los Angeles, CA Welcome and Overview of Session Kathy J. Jenkins, Boston, MA reflecting on McNamara lecture Daniel J. Murphy, Palo Alto, CA Introduction of Dr. Jane Somerville Roberta G. Williams, Los Angeles, CA 2012 Dan G. McNamara lecture: Fifty Years with Cardiac Surgeons Jane Somerville, London, United Kingdom Question and Answer Carole A. Warnes, Rochester, MN Panel Discussion: lifelong Care of the CHD Patient Kathy J. Jenkins, Boston, MA Gerard R. Martin, Washington, DC, Daniel J. Murphy, Palo Alto, CA, Jane Somerville, London, United Kingdom, James S. Tweddell, Milwaukee, WI, Carole A. Warnes, Rochester, MN, Roberta G. Williams, Los Angeles, CA

AFTERNOON

2:00 2:15

Co-Chairs: 2:00 2:05 2:10 2:15

2:30 2:45 3:00 3:10

2:45 3:05 Chair: Panelists:

3:20

162 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

HF SYMPOSIUM

655

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: The Growing role of Devices in Heart Failure Management ICD, CrT, Hemodynamic Monitoring and Ultrafiltration Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406b CME/CNE Hours: 1.5 Andrew E. Epstein, Philadelphia, PA Mandeep R. Mehra, Baltimore, MD Current Indications and Outcomes with ICD Therapy Arthur J. Moss, Rochester, NY Optimal Use of Cardiac resynchronization Therapy Jagmeet Singh, Boston, MA Current and Future role of Implantable Hemodynamic Monitoring William T. Abraham, Columbus, OH Advantages and Pitfalls of Ultrafiltration Therapy Bradley Bart, Minneapolis, MN Question and Answer

IMAG SYMPOSIUM

657

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Healthcare reform Impact on Imaging Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Thomas John Ryan, Columbus, OH Impact of HCr on Imaging: Current Status Benjamin F. Byrd, III, Nashville, TN What to Expect and What to do About It Michael H. Picard, Boston, MA Appropriate Use Criteria, Quality and the Available Evidence Neil J. Weissman, Washington, DC HCr: Impact on Technology Patricia A. Pellikka, Rochester, MN Panel Discussion

Co-Chairs: 2:00 2:20 2:40

Chair: 2:00 2:15 2:30 2:45 3:00

IMAG SYMPOSIUM

3:00 3:20
HF SYMPOSIUM

658

656

The NHlBI Heart Failure Clinical Trials Network: A New Paradigm for Investigation and Training Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S405 CME/CNE Hours: 1.5 Eugene Braunwald, Boston, MA Alice M. Mascette, Bethesda, MD The Changing Face of Heart Failure in the United States and Implications for Clinical Trials Douglas L. Mann, Saint Louis, MO The Structure and Mission of the NHlBI Network Alice M. Mascette, Bethesda, MD Study Design and Outcome Analysis in Clinical Heart Failure Trials: Selecting Meaningful Endpoints Kerry Lee, Durham, NC Clinical Implications of Competed Network Clinical Trials (DOSE-HF, rElAx, CArESS) Margaret M. Redfield, Rochester, MN Ongoing and Planned Network Clinical Trials: Focus on Innovative Therapies Elizabeth Ofili, Atlanta, GA Ancillary Studies and Biomarkers in Network Trials Robb D. Kociol, Durham, NC

radionuclide Imaging in the Heart Failure Patient Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S403 CME/CNE Hours: 1.5 James E. Udelson, Boston, MA Kim Allan Williams, Detroit, MI Myocardial Perfusion Imaging in the Heart Failure Patient Gary V. Heller, Hartford, CT Assessment of lV Function in the Heart Failure Patient E. Gordon DePuey, III, New York, NY Selecting Patients for Coronary revascularization: Should We Assess Viability? Robert O. Bonow, Chicago, IL Guiding Device Therapy in Heart Failure Mark I. Travin, Pleasantville, NY Molecular Imaging in the Heart Failure Patient Vasken Dilsizian, Baltimore, MD Heart Failure in Stable Ischemic Heart Disease: Not for the Weak of Heart Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S502 CME/CNE Hours: 1.5 Brooks Edwards, Rochester, MN Mustafa Ahmed, Jacksonville, FL, Erin Bohula, Boston, MA, J. Jacob Mancuso, San Antonio, TX Juan M. Aranda, Gainesville, FL, Akshay S. Desai, Boston, MA, James C. Fang, Cleveland, OH, Daniel P. Judge, Baltimore, MD Master Clinician I: Discussion of Three Complex real World Cases Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S401a CME/CNE Hours: 1.5 James B. McClurken, Philadelphia, PA Marc E. Shelton, Springfield, IL

Co-Chairs: 2:00 2:18 2:36

Co-Chairs: 2:00

2:15 2:30

2:54 3:12

AFTERNOON

2:45

ISCHEM ExPErTS

3:00 3:15

234

Chair: Case Presenters: Panelists:

IMAG ExPErTS

233

role of CMr in Valvular Heart Disease Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Raymond J. Kim, Durham, NC Tandeep K. Bhatti, New York, NY, Lubna Choudhury, Chicago, IL Mario J. Garcia, Bronx, NY, Seth Uretsky, New York, NY

Chair: Case Presenters: Panelists:

lIFElONG SYMPOSIUM

659

Co-Chairs:

ACC.12 Final Program 163

Sunday, March 25, 2012 ACC.12

Panelists: R. Michael Benitez, Baltimore, MD, Allan S. Jaffe, Rochester, MN, Joseph V. Messer, Chicago, IL, Shahbudin H. Rahimtoola, Los Angeles, CA, Stephen D. Wiviott, Boston, MA Case Presentation: MI or Not? Allan S. Jaffe, Rochester, MN Panel Discussion Case Presentation: Complex Mr James B. McClurken, Philadelphia, PA Panel Discussion Case Presentation: Apical Ballooning? Marc E. Shelton, Springfield, IL Panel Discussion Core Curriculum: General Cardiology Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Bindi K. Shah, Philadephia, PA Pre-Operative Cardiac risk Stratification Joshua A. Beckman, Boston, MA Basic Concepts of Stress Testing: When, Which Test and What Do the results Tell You Karthikeyan Ananthasubramaniam, West Bloomfield, MI Interventional Cardiology for the NonInterventionalist Sunil V. Rao, Durham, NC Question and Answer Core Curriculum: Valvular Heart Disease Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 Alex J. Auseon, Columbus, OH Aortic Stenosis/ Aortic Insufficiency Maurice Enriquez-Sarano, Rochester, MN Mitral Stenosis/Mitral regurgitation Stephen H. Little, Houston, TX Selection and Management Issues of the Prosthetic Valve Salvatore Costa, Lebanon, NH Question and Answer
PrEV PErI SYMPOSIUM

3:00 3:15

The role of Alcohol Septal Ablation Paul Sorajja, Rochester, MN The Utility of the ICD Bernard J. Gersh, Rochester, MN
PHTN

2:00 2:20 2:30 2:50 3:00 3:20

lIFElONG COrE

SYMPOSIUM

662

Pulomary Hypertension Management in Special Populations Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Hamang M. Patel, New Orleans, LA Frances A. Rogers, Philadelphia, PA Pulmonary Hypertension in Congenital Heart Disease Michael Landzberg, Boston, MA Chronic Thromboembolic Pulmonary Hypertension William R. Auger, San Diego, CA Pulmonary Hypertension in Pregnancy Dianne Lynn Zwicke, Milwaukee, WI Pulmonary Hypertension in Connective Tissue Disease Hunter Clay Champion, Pittsburg, PA Question and Answer Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part II: EHr Implementation lessons from the Trenches Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N227b CME/CNE Hours: 1.5 James E. Tcheng, Durham, NC Jay H. Alexander, Deerfield, IL, Lee R. Goldberg, Philadelphia, PA, R. Jeffrey Westcott, Seattle, WA Cardiology Private Practice EHr lessons Jay H. Alexander, Deerfield, IL large Hospital System Implementation Lee R. Goldberg, Philadelphia, PA Epic and Centricity EHrs R. Jeffrey Westcott, Seattle, WA Panel Discussion Dietary Approaches for CVD Prevention: Matching the Diet to the Patient Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Michael J. Wong, Los Angeles, CA Erin Michos, Baltimore, MD, Malissa Jane Wood, Boston, MA Catherine Christie, Jacksonville, FL, Amy Locke, Ann Arbor, MI, Elif Oral, Ann Arbor, MI, Neil Stone, Winnetka, IL

Co-Chairs: 2:00 2:20 2:40 3:00 3:20

PrACTICE SYMPOSIUM

813

Chair: 2:00 2:25

660

2:50 3:15
lIFElONG COrE

Chair: Panelists: 2:00 2:20 2:40 3:00

814

Chair: 2:00

AFTERNOON

2:25 2:50 3:15

661

Controversies in Hypertrophic Cardiomyopathy Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N427 CME/CNE Hours: 1.5 Steve R. Ommen, Rochester, MN HCM Is Predominantly a Disease of lVOT Obstruction Martin S. Maron, Boston, MA The Devil Is in Diastole in HCM William McKenna, London, United Kingdom Medical Therapy for Difficult Symptoms Mark V. Sherrid, Mamaroneck, NY The Case for Surgical Myectomy Joseph A. Dearani, Rochester, MN

ExPErTS

235

Chair: 2:00 2:15 2:30 2:45

Chair: Case Presenters: Panelists:

164 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

PrEV SYMPOSIUM

663

resistant Hypertension Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S100c CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-139-l04-P Thomas D. Giles, Metairie, LA William B. White, Farmington, CT How to Detect Pseudo resistance and White Coat Hypertension William B. White, Farmington, CT Detection and Management of Hyperaldosteronism Wanpen Vongpatanasin, Dallas, TX When and How to Assess for renovascular Disease Stephen Textor, MN role of New vs Old Anti-hypertensive Drug Classes William Elliott, Yakima, WA Baroreflex Activation Therapy and renal Sympathetic Denervation Henry Krum, Prahran, Victoria, Australia Use of Generic Medications in the Management of resistant Hypertension Rhonda M. CooperDeHoff, Gainesville, FL

ACC-i2/TCT SPECIAl

2103

Co-Chairs: 2:00 2:15 2:30 2:45 3:00

Cardiac Care Team Session III: Medications and Other Techniques to Manage the Patient in the Cath lab Sunday, March 25, 2012, 2:30 p.m. 3:30 p.m. McCormick Place South, S103b CME/CNE Hours: 1 Lisa A. Riggs, Kansas City, MO Antiplatelet Therapy: Which One, When? Laura Mauri, Boston, MA The Dos and Donts of Beta Blockers in AMI Non-pharmacologic Techniques in Your Nursing Toolkit for Pain and Anxiety David J. Moliterno, Lexington, KY Non-pharmacologic Interventions to reduce Cardiac Procedure Stress Timm Reed, Ft. Wayne, IN Business Meeting of the College Sunday, March 25, 2012, 3:00 p.m. 3:15 p.m. McCormick Place, ACC Member Lounge CME/CNE Hours: 0 David R. Holmes, Jr., Rochester, MN Thad Waites, Hattiesburg, MS Richard A. Chazal, Fort Myers, FL Alfred A. Bove, Philadelphia, PA Cardiac Care Team Session IV: Same Day Discharge for PCI Sunday, March 25, 2012, 3:30 p.m. 5:00 p.m. McCormick Place South, S103b CME/CNE Hours: 1 Caroline Lloyd Doherty, Philadelphia, PA Sandra M. Oliver-McNeil, Farmington Hills, MI State of the Evidence of Outpatient PCI Gregory J. Dehmer, Temple, TX Teamwork to Same Day Discharge: Developing the Program Denise A. Rhodes, Hershey, PA

Chair: 2:30 2:50

3:10

SPECIAl SPECIAl

302

3:15

Co-Chairs:

QUAl SYMPOSIUM

664

Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology: Ethnic and racial Disparities in Cardiovascular Disease A Call to Action Sunday, March 25, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5 T. David Gbadebo, Chattanooga, TN Hector O. Ventura, New Orleans, LA Pharmacogenomics of Heart Failure in AfricanAmericans Dennis M. McNamara, Pittsburgh, PA Question and Answer Cardiovascular Disease in Hispanics: Special Considerations Carlos Jose Rodriguez, WinstonSalem, NC Question and Answer racial and Ethnic Disparities in the Complications of Atrial Fibrillation David E. Bush, Baltimore, MD Question and Answer The Importance of registries in reducing Cardiovascular Disparities Eric Peterson, Durham, NC Question and Answer Cardiovascular Disparities under Health Care reform: What Have We learned? Michelle Albert, Boston, MA Question and Answer Keeping PACE Initiative Karol E. Watson, Los Angeles, CA Question and Answer

ACC-i2/TCT SPECIAl

2104

Co-Chairs: 2:00 2:12 2:15

Co-Chairs: 3:30 3:45 4:05 4:25 4:45

lIFElONG MOC

AFTERNOON

2:27 2:30 2:42 2:45

Case Selection: Vascular and Coronary Anatomy Issues David Wohns, Grand Rapids, MI A Cost and Sense Analysis: Is Outpatient PCI a Win-Win? Denise K. Busman, Grand Rapids, MI Panel Discussion ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy ACC General Cardiology Module Part B Sunday, March 25, 2012, 3:30 p.m. 6:00 p.m. McCormick Place South, S105a CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, ACC.12 Final Program 165

815

2:57 3:00

3:12 3:15 3:27

Sunday, March 25, 2012 ACC.12

please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC. Chair: Sunil V. Mankad, Rochester, MN MOC Faculty: Brian Powell, Rochester, MN, Allen J. Taylor, Washington, DC
lIFElONG MOC ACC-i2/TCT ExPErTS

2311

Endovascular Case reviews Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S102b CME/CNE Hours: 1.5 William A. Gray, New York, NY Christopher J. White, New Orleans, LA Karthik Challa, Charleston, WV, Suresh Davis, Hyderabad, India, Takayuki Ishihara, Amagasaki, Japan, Michael Nuyles, Dyer, IN, Yoshimitsu Soga, Kitakyushu, Japan John R. Laird, El Macero, CA , Mehdi H. Shihehbor, Cleveland, OH Imaging Transcatheter Mitral Valve Procedures Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S101a CME/CNE Hours: 1.5 Robert J. Siegel, Los Angeles, CA Frank E. Silvestry, Wayne, PA Mitral Valve Imaging and Anatomy for Percutaneous Intervention: What do Interventionalists really Need to Know/See? Frank E. Silvestry, Wayne, PA 3D Imaging in the Cath lab: What Does it really Add? Do We really Need It? Rebecca T. Hahn, New York, NY Mitral Valve repair Cases: Mitraclip (Best, Worst, Complications) Saibal Kar, Los Angeles, CA Imaging for Percutaneous repair of Mr in Europe: lessons learned from Functional and High-risk Cases Olaf Franzen, Copenhagen, Denmark Challenges in Assessment of Percutaneous MV repair (before, during, after), How Do We really Know if We Fixed the Problem? Elyse Foster, San Francisco, CA Panel Discussion Peripheral Artery Disease: Critical limb Ischemia Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S103c CME/CNE Hours: 1.5 Tyrone J. Collins, New Orleans, LA Matthew T. Menard, Boston, MA Critical limb Ischemia Open vs Endo: What Does the Data Tell Us? Michael S. Conte, San Francisco, CA Debate: Drug-eluting Coronary Stents are the Treatment of Choice for Below-knee lesions Andrew J. Feiring, Milwaukee, WI Debate: Drug-eluting Coronary Stents are NOT the Treatment of Choice for Below-knee lesions TBD Peripheral Stem Cell Therapy: Clinical Trial results for Critical limb Ischemia Douglas W. Losordo, Chicago, IL

Co-Chairs: Case Presenters

Panelists:

ACC-i2/TCT SYMPOSIUM

2622

Co-Chairs: 4:30

816

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy ACC General Cardiology Module Part A Sunday, March 25, 2012, 3:30 p.m. 6:00 p.m. McCormick Place South, S105d CME Hours: 2.5 ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.

4:45

5:00 5:15

5:30

5:45
ACC-i2/TCT SYMPOSIUM

AFTERNOON

2623

Co-Chairs: 4:30

4:45

5:00 5:15

Chair:

Biykem Bozkurt, Houston, TX

MOC Faculty: Andrew D. Krahn, London, Canada, Matthew W. Martinez, Allentown, PA 166 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

5:30 Management of Complications Associated with Endovascular Intervention for Tibial Artery Disease Nicholas J. Ruggiero, II, Philadelphia, PA Case-based Presentation: Tips and Tricks for Pedal, Tibial and Antegrade Access TBD Vascular Access and Outcomes following PCI for ACS: What You Should Know Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S106b CME/CNE Hours: 1.5 Thierry Lefevre, Massy, France Tift Mann, Raleigh, NC Does Access Site Influence Bleeding Complication rates and Mortality following PCI for ACS Sunil V. Rao, Durham, NC Are There Specific Patient Cohorts Where radial Access is Preferred? Insights from the rIVAl and Other Trials Sanjit S. Jolly, West Hamilton, Canada Defining the Transradial learning Curve: Should low Volume Operators Utilize this Technique? Ian C. Gilchrist, Hershey, PA Complications and Pitfalls of Transradial Access: Multiple Illustrative Case Examples Jean-Pierre Dery, Quebec, Canada In Search of the Optimal Vascular Access for PCI in ACS: radial is Best Harold L. Dauerman, Shelburne, VT In Search of the Optimal Vascular Access for PCI in ACS: Femoral is Better Shing-Chiu Wong, New York, NY Debate: Vascular Closure Devices VCD are Useful for Improving Patient Satisfaction and Clinical Outcomes Timothy A. Sanborn, Evanston, IL Debate: Vascular Closure Devices VCD are Clinically Unproven with Added Costs Zoltan G. Turi, Camden, NJ
ACS SYMPOSIUM

5:10 5:15 5:25 5:30

Panel Discussion Making Sense of Comparative Effectiveness and Noninferiority Analysis Helen Parise, New York, NY Panel Discussion Meta-analyses and Observational Studies: Where do They Belong in the Evidentiary Hierarchy? Peter Juni, Berne, Switzerland Panel Discussion Balancing Benefit-risk Tradeoffs: Qualitative Judgment or Quantitative Precision? Sanjay Kaul, Los Angeles, CA Panel DIscussion
Arr

5:45

ACC-i2/TCT SYMPOSIUM

2624

5:40 5:45

Co-Chairs: 4:30

5:55

SYMPOSIUM

4:42

666

4:54

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation Management of the Arrhythmia Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N426 CME/CNE Hours: 1.5 Hugh Calkins, Baltimore, MD Richard L. Page, Seattle, WA rate Control: Targets and Drug Choices Mario Talajic, Montreal, QC rhythm Control: Selecting the Appropriate Anti-arrhythmic Drug Richard I. Fogel, Carmel, IN Upstream Therapies for Prevention: Is There a role? Anne M. Gillis, Calgary, Canada Ablation of AF: Who and When to refer? Douglas L. Packer, Rochester, MN Question and Answer

Co-Chairs: 4:30 4:50 5:10 5:30 5:50

CCS SYMPOSIUM

5:06

5:18

5:28

5:38

5:49

667

The Great Debates Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N231 CME/CNE Hours: 1.5 Bryan C. Cannon, Rochester, MN Arwa S. Saidi, Gainesville, FL Digoxin Is First line Therapy for Newborns with SVT Stephen P. Seslar, Seattle, WA Digoxin Is Not the First line Therapy for Newborns with SVT Edward P. Walsh, Boston, MA Indications for Pulmonary Valve replacement in Tetralogy of Fallot Apply to Pulmonary regurgitation after Balloon Valvuloplasty David M. Harrild, Boston, MA Indications for Pulmonary Valve replacement in Tetralogy of Fallot Do Not Apply to Pulmonary regurgitation after Balloon Valvuloplasty Judith Therrien, Canada Stimulants Can Be Used in Patients with Congenital Heart Disease John Kugler, NE Stimulants Can Not Be Used in Patients with Congenital Heart Disease Randall M. Bryant, Jacksonville, FL

AFTERNOON

Co-Chairs: 4:30 4:42 5:00

665

literature Interpretation and Statistical Pitfalls in ACS Trials Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S402 CME/CNE Hours: 1.5 Sanjay Kaul, Los Angeles, CA Debabrata Mukherjee, El Paso, TX David J. Cohen, Kansas City, MO, Ajay J. Kirtane, New York, NY, Helen Parise, New York, NY Playing with P Values: Misplaced Emphasis on Significance Testing Sanjay Kaul, Los Angeles, CA Panel Discussion Composite Endpoints: How to Interpret Them? Stuart Pocock, London, United Kingdom Panel Discussion Subgroup Analyses: Informative or a Minefield of Optical Illusions? Salim Yusuf, Hamilton, Canada

Co-Chairs: Panelists: 4:30 4:40 4:45 4:55 5:00

5:12

5:30 5:42

ACC.12 Final Program 167

Sunday, March 25, 2012 ACC.12

CCS SYMPOSIUM

668

ACHD for the General Cardiologist Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N230 CME/CNE Hours: 1.5 William R. Davidson, Hershey, PA Michael J. Landzberg, Boston, MA The Imaging Approach to the Adult with repaired CHD Karen K. Stout, Seattle, WA The Approach to Arrhythmia Management in the Adult with repaired CHD Paul Khairy, Montreal, Canada Adult with TOF: Get with the Guidelines Anne Marie Valente, Boston, MA Management of ASDs in Adulthood Curtis J. Daniels, Columbus, OH Question and Answer

5:42

Antibodies Post-transplant: Screening, Diagnosis and Current Treatment Options Josef Stehlik, Salt Lake City, UT
HF

Co-Chairs: 4:30 4:50

SYMPOSIUM

671

Personalized Medicine and the Future of Medical Care Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S404 CME/CNE Hours: 1.5 Geoffrey S. Ginsburg, Durham, NC Jennifer L. Hall, Minneapolis, MN Whole Genome Sequencing and the Impact on Clinical Care in the Next Decade Elizabeth McNally, Chicago, IL Sequencing and Personalized Medicine Howard Jacob, Milwakuee, WI Protemoics and Personalized Medicine Jennifer Van Eyk, Baltimore, MD Determining the Cost-Effectiveness of Genetic Testing Mark A. Hlatky, Stanford, CA Predicting the Future of Care for Individuals with Heart Failure Jeffrey A. Towbin, Cincinnati, OH

Co-Chairs: 4:30

5:10 5:30 5:50

HF SYMPOSIUM

4:48 5:06 5:24 5:42

669

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Management of Advanced Heart Failure and Transplantation Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S406b CME/CNE Hours: 1.5 Donna M. Mancini, New York, NY Randall C. Starling, Cleveland, OH Medical Management Lynne Warner Stevenson, Boston, MA Cardiorenal Syndrome: Mechanisms and Management Barry M. Massie, San Francisco, CA lVADs: Which Patients? Which Device? What results? Keith D. Aaronson, Ann Arbor, MI Update on Transplantation: Patient Selection, Post-transplant Management Sharon Hunt, Palo Alot, CA regenerative Therapy: Is it a Dream? Leslie W. Miller, Tampa, FL

IMAG SYMPOSIUM

Co-Chairs: 4:30 4:48 5:06 5:24

672

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Echo in 2012 What You Need to Know to Keep Up Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S406a CME/CNE Hours: 1.5 Allan L. Klein, Cleveland, OH Thomas Richard Porter, Omaha, NE Case Presentation: Hand-Held Echocardiography in 2012 Rosa Sicari, Pisa, Italy review of Current Data and Future Use Kirk T. Spencer, Chicago, IL Case Presentation: 3-D Echocardiography in 2012 Judy W. Hung, Boston, MA review of Current Data and Future Use Judy W. Hung, Boston, MA Case Presentation: Appropriate Use Criteria for Echocardiography in 2012 R. Parker Ward, Chicago, IL review of Current Data and Future Considerations Neil J. Weissman, Washington, DC Question and Answer

Co-Chairs: 4:30 4:40 4:55 5:05 5:20

AFTERNOON

5:42

HF SYMPOSIUM

670

Heart Transplantation: Challenges in 2012 Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S405 CME/CNE Hours: 1.5 Jon A. Kobashigawa, Los Angeles, CA Michael Shullo, Pittsburgh, PA Who Is a Candidate for Heart Transplantion? 2012 Criteria Ravi Ramani, Pittsburgh, PA Calcineurin-Free Immunosuppression after Transplantation: Why and Which Patients? Sean Patrick Pinney, New York, NY Single Agent Immunosuppression: How low Can You Go? David Baran, Newark, NJ Transplanting the Untransplantable: Technology and Pharmacology for Managing the Highly Sensitized Pre-transplant Patient Savitri Fedson, Chicago, IL

Co-Chairs: 4:30 4:48

5:30 5:45

5:06 5:24

168 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

lIFElONG SYMPOSIUM

737

Master Clinician: Clinical Cases II Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S401a CME/CNE Hours: 1.5 John M. Miller, Indianapolis, IN Eric S. Williams, Indianapolis, IN Douglas E. Drachman, Boston, MA, Bernard J. Gersh, Rochester, MN, Michael J. Mack, Plano, TX, John M. Miller, Indianapolis, IN, Thomas John Ryan, Columbus, OH Case Presentation: A 60 year-old Man with Heart Failure, Chest Pain and a Murmur Panel Discussion Case Presentation: A 56 Year-old Woman with Palpitations and Shock Panel Discussion Case Presentation: A 36 Year-old Woman with Near-Syncope Panel Discussion Core Curriculum: Coronary Artery Disease Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N226 CME/CNE Hours: 1.5 Paul Sorajja, Rochester, MN Evaluation and Management of Unstable Angina/ NSTEMI Michael Peter Hudson, Detroit, MI Evaluation and Management of STEMI Malcolm Bell, Rochester, MN Management of Chronic CAD: Medical Therapy vs. PCI vs. CABG Eric R. Bates, Ann Arbor, MI Question and Answer Core Curriculum: Nuclear Cardiology Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N229 CME/CNE Hours: 1.5 Alex J. Auseon, Columbus, OH risk Stratification and Prognosis Alex J. Auseon, Columbus, OH Myocardial Perfusion Imaging for Viability: SPECT and PET Mouaz H. Al-Mallah, Riyadh, Saudi Arabia CTA and Cardiac Mr: Basic Concepts Mushabbar A. Syed, Oak Park, IL Question and Answer

PErI ExPErTS

236

Genetic Evaluation of Cardiomyopathy Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S505 CME/CNE Hours: 1.5 Ray E. Hershberger, Miami, FL Michael J. Ackerman, Rochester, MN, Ray E. Hershberger, Miami, FL, Calum A. MacRae, Boston, MA Teresa Kruisselbrink, Rochester, MN, William McKenna, London, United Kingdom Future Compensation Under Health Care reform Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N227b CME/CNE Hours: 1.5 Paul Casale, Lancaster, PA Gregory D. Timmers, Springfield, IL Patrick J. White, South Lyon, MI Fee for Service: Will It Survive Gregory S. Thomas, Dana Point, CA Your Fee Schedule: Why and How You Get Paid Now Cathleen Biga, Woodridge, IL New Payment Models Paul Casale, Lancaster, PA Value-based Purchasing Gregory D. Timmers, Springfield, IL Question and Answer

Co-Chairs: Panelists:

Chair: Case Presenters: Panelists:

4:30 4:50 5:00 5:20 5:30 5:50

lIFElONG COrE

PrACTICE SYMPOSIUM

673

Co-Chairs:

4:30 4:50 5:10 5:30 5:50

PrEV ExPErTS

817

Chair: 4:30 4:55 5:20 5:45

lIFElONG COrE

237

reducing Disparities in Cardiovascular Preventive Care Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S501a CME/CNE Hours: 1.5 Keith C. Ferdinand, Atlanta, GA Rosario Freeman, Seattle, WA, Kenneth A. Jamerson, Ann Arbor, MI Eileen M. Handberg, Gainesville, FL, Jennifer H. Mieres, Lake Success, NY, Ileana L. Pina, Cleveland Heights, OH, Clyde W. Yancy, Chicago, IL Whats New in the ACCF/AHA Guidelines Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place North, N228 CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-140-l04-P Jeffrey L. Anderson, Murray, UT Update on ACCF/AHA Clinical Practice Guideline Methodology Alice K. Jacobs, Boston, MA 2011 ACCF/AHA/SCAI Guideline on Percutaneous Coronary Intervention Glenn Levine, Houston, TX Question and Answer 2011 ACCF/AHA Guideline on Coronary Artery Bypass Graft Surgery Peter K. Smith, Durham, NC Question and Answer 2011 ACCF/AHA Focused Update on Peripheral Artery Disease Alan T. Hirsch, Minneapolis, MN ACC.12 Final Program 169

Chair: Case Presenters: Panelists:

AFTERNOON

818

Chair: 4:30 4:55

PrEV SYMPOSIUM

675

Chair: 4:30 4:45 5:00 5:05 5:20 5:25

5:20 5:45

Sunday, March 25, 2012 ACC.12

5:35 5:40 5:55
PrEV SYMPOSIUM

Question and Answer 2012 ACCF/AHA Guideline on ST-Elevation Myocardial Infarction Patrick T. OGara, Boston, MA Question and Answer The Difficult-to-Manage lipid Patient Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S100c CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-147-l04-P Andrew M. Kates, Saint Louis, MO Jeffrey T. Kuvin, Boston, MA Robert Sidney Rosenson, New York, NY, Anne C. Goldberg, St. Louis, MO Case Presentation Donna M. Polk, Hartford, CT Panel Discussion Audience Question and Answer Case Presentation Elizabeth A. Jackson, Ann Arbor, MI Panel Discussion Audience Question and Answer The role of Therapeutic Hypothermia in the Treatment of Cardiac Arrest Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S502 CME/CNE Hours: 1.5 Co-Chairs: John A. McPherson, Nashville, TN Barbara T. Unger, Minneapolis, MN

SPECIAl SYMPOSIUM

744A

Clinical Decision Making for Fellows in Training: Part A Sunday, March 25, 2012, 4:30 p.m. 5:50 p.m. McCormick Place South, S403 CME/CNE Hours: 1.25 John E. Brush, Norfolk, VA David R. Holmes, Jr., Rochester, MN Rick A. Nishimura, Rochester, MN Patrick T. OGara, Boston, MA Management of late Complications in Adult Congenital Heart Disease: Surviving the Storm Robert J. Mentz, Sudarshan Rajagopal, Tariq Ahmad, Christopher H. Swan, Duke University Medical Center, Durham, NC Questions and Answers Searching for the Etiology of Non-Ischemic Cardiomyopathy: When Zebras and Horses run Together Nada Shaban, Saneka Chakravarty, Alireza Hosseini Khalili, Sabeena Arora, Richard Soucier, Hoffman Heart and Vascular Institute, St. Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT Questions and Answers High Output HF Secondary to a Hemodialysis Arteriovenous Fistula Dawn Scantlebury, Mayo Clinic, Rochester, MN Questions and Answers Too Severe or Not Too Severe: Grading Aortic Stenosis Ahmad M. Jeroudi, Sameer A. Gafoor, Gautam Kumar, Emory University, Atlanta, GA Questions and Answers Hypertrophic Cardiomyopathy or Hypertensive Heart Disease? Diagnostic Challenge in Older Patients Suspected of HCM and Therapeutic Implications Farbod Raiszadeh, Krysthel Engstrom-Koch, Mario J. Garcia, Montefiore Einstein Heart Center, New York, NY, Jacobi Medical Center, New York, NY Questions and Answers Clinical Decision Making for Fellows in Training: Part B Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S403 CME/CNE Hours: 1.5 Novel Presentation of Ventricular Tachycardia Due to Invasion of the right Ventricle by Aspergillosis Kyle G. Ulveling, Jamil Y. Abuzetun, Venkata M. Alla, W. Paul Biddle, Aryan Mooss, The Cardiac Center of Creighton University Medical Center, Omaha, NE Current of Injury Found Guilty of Perjury in a Case of Myocardial Infraction Committed by Non-hodgkin lymphoma Morteza Farasat, Nada M. Shaban, Nishant Sethi, Carolyn Ray, Anthony F. Posteraro, III, Anita M. Kelsey, Saint Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT

Co-Chairs:

730

4:30

Co-Chairs: Panelists: 4:30 4:40 4:55 5:15 5:25 5:40

SPECIAl ExPErTS

4:40 4:46

4:56 5:02

263

5:12 5:18

5:28 5:34

Case Presenters: Jason Neil Katz, Morrisville, NC, Karl B. Kern, Tucson, AZ, Paul McMullan, New Orleans, LA, Michael R. Mooney, Minneapolis, MN, Nainesh C. Patel, Allentown, PA, David Seder, Portland, ME

AFTERNOON

SPECIAl lEGENDS

403

legends of Cardiovascular Medicine lecture Series Third Annual James T. Dove lecture Sunday, March 25, 2012, 4:30 p.m. 5:30 p.m. McCormick Place North, N427 CME/CNE Hours: 1 The James T. Dove Lecture is supported by the James T. Dove Fund

5:44
SPECIAl SYMPOSIUM

744B

Chair: 4:30 4:35

Prediman K. Shah, Los Angeles, CA Introduction of Dr. Valentin Fuster Prediman K. Shah, Los Angeles, CA Third Annual James T. Dove lecture: Transition from Cardiovascular Disease to Health (2012 2020): The Challenge of Identifying Subclinical Disease Valentin Fuster, New York, NY One-on-One Interview with Dr. Valentin Fuster Prediman K. Shah, Los Angeles, CA Audience Question and Answer 5:50

5:05 5:20

5:50

170 GO for ACC.12!

ACC.12 Sunday, March 25, 2012

5:50 Out-of-Hospital Cardiac Arrest Due to a Concealed Diagnosis: Clinical Decision-making from the Hospital to Home Manoj Kesarwani, Mohan N. Viswanathan, University of Washington, Seattle, WA Early repolarization and Anomalous right Coronary Artery: A Perfect Storm for Sudden Cardiac Death Andrew Choi, Gaby Weissman, Robert Lowery, Susan ODonoghue, Edriss Charaf, Federico Asch, Washington Hospital Center, Washington, DC, Georgetown University Medical Center, Washington, DC A Case of Multiple Medical Issues and Percutaneous Coronary Intervention for restenosis: Is less Sometimes More? Amit Noheria, Sanjay Kaul, Cedars-Sinai Medical Center, Los Angeles, CA Severe Coronary Spasm and Sudden Cardiac Death: Is There a Concensus for Management? Tarek M. Mousa, Emmanuel N. Moustakakis, Gregory Gustafson, Seth E. Goldbarg, Chong H. Park, New York Hospital Medical Center of Queens, New York, NY, Cornell University Weill Medical College, New York, NY Mitral Valve Endocarditis in the Setting of Hypertrophic Cardiomyopathy Neha Yadav, John H Stroger Hospital of Cook County, Chicago, IL When Are Patients with Amyloidosis Eligible for Heart Transplant? Michael A. Burke, Rodney H. Falk, Lynne W. Stevenson, Brigham and Womens Hospital, Boston, MA Heart Failure and Mitral regurgitation Murali K. Senapathi, Gerard P. Aurigemma, Dennis Tighe, University of Massachusetts Medical Center, Worcester, MA Dyspnea and Hemoptysis following Aortic and Mitral Valve Surgery with Atrial Fibrillation Ablation: Expanding the Differential Diagnosis Megan Coylewright, Terrence D. Welch, Samuel J. Asirvatham, Mayo Clinic, Rochester, MN
TEST ExPErTS ACC-i2/TCT SPECIAl

2105

5:50

Cardiac Care Team V: Structural Heart Disease Mitral Valve Sunday, March 25, 2012, 5:00 p.m. 6:00 p.m. McCormick Place South, S103b CME/CNE Hours: 1 Julie A. Logan, La Jolla, CA Martina Speight, Stanford, CA Pathophysiology: Understanding Mitral Anatomy Russell A. Brandwein, New York, NY When to Treat: Guidelines the Cardiologist Should live by Steven F. Bolling, Ann Arbor, MI What Is on the Horizon Julie A. Logan, La Jolla, CA

Co-Chairs: 5:00 5:20 5:40

ACS ClINICAl FOCUS

5:50

5:50

1605

Innovations in Translation: Acute Coronary Syndromes Sunday, March 25, 2012, 6:30 p.m. 9:30 p.m. Fairmont Hotel, Imperial Ballroom CME/CNE Hours: 2.5 Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply.

5:50

5:50

6:30 7:00

registration and Dinner Program Overview and Introductions Ajay Kirtane, New York, NY Focus #1: Pharmacoinvasive Management in NSTEACS

5:50

Moderator: Panelists: 7:05 7:20 Moderator: Panelists: 7:50 8:05

Sunil Rao, Durham, NC Ajay Kirtane, New York, NY, Dirk Sibbing, Munich, Germany Antiplatelet and Antithrombotic Strategies in NSTEACS Dirk Sibbing, Munich, Germany Case review and Panel Discussion Focus #2: Pharmacologic Therapy in STEMI Gilles Montalescot, Paris, France Stefan James, Uppsala, Sweden, Stephen D. Wiviott, Boston, MA Navigating Antithrombic and Antiplatelet Agents in STEMI Stefan James, Uppsala, Sweden Panel Discussion Focus #3: Systems of Care for Patients with Acute Coronary Syndromes

5:50

261

Cardiac Dilemmas in Athletes Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S503 CME/CNE Hours: 1.5 Richard J. Kovacs, Indianapolis, IN Adolph M. Hutter, Boston, MA, Jonathan Rhodes, Boston, MA, Malissa Jane Wood, Boston, MA Paolo Enzo Angelini, Houston, TX, Jeffrey Hastings, Dallas, TX, Melanie S. Sulistio, Dallas, TX Aortic Stenosis Case Management Sunday, March 25, 2012, 4:30 p.m. 6:00 p.m. McCormick Place South, S504a CME/CNE Hours: 1.5 Jean G. Dumesnil, Sainte Foy, Canada Marian Hawkey, New York, NY, Aaron V. Kaplan, Lebanon, NH Kevin Greason, Rochester, MN, David Messika-Zeitoun, France, Igor F. Palacios, Boston, MA

Afternoon

Chair: Panelists: Case Presenters:

VAlV ExPErTS

Moderator: Panelists: 8:35

Gregg Stone, New York, NY Duane S. Pinto, Boston, MA, James A. de Lemos, Dallas, TX Primary PCI vs Fibrinolytics: Making the right Choice for Individual Patients Duane S. Pinto, Boston, MA Panel Discussion Concluding remarks Ajay Kirtane, New York, NY

238

Chair: Panelists: Case Presenters:

eVening

8:50 9:20

ACC.12 Final Program 171

Arr ClINICAl FOCUS

1603

Joint Session of the Heart rhythm Society of America and the American College of Cardiology Innovations in Translation: Atrial Fibrillation Sunday, March 25, 2012, 6:30 p.m. 9:30 p.m. Fairmont Hotel, International Ballroom CME/CNE Hours: 2.5 Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply.

Chair: 6:30 7:00 7:05 7:35 8:05 8:35 8:55 9:15

Peter Kowey, Wynnewood, PA registration and Dinner Opening remarks, General Introduction and Overview Peter Kowey, Wynnewood, PA Emerging Concepts in Stroke Prevention Kenneth A. Ellenbogen, Richmond, VA rate vs. rhythm Control: Which Strategy is Best for my Patient? Albert L. Waldo, Cleveland, OH Achieving rate Control N. A. Mark Estes, Boston, MA Achieving rhythm Control Pharmacologic Options Eric N. Prystowsky, Indianapolis, IN Achieving rhythm Control Non-pharmacologic Options Douglas L. Packer, Rochester, MN Questions and Answers Peter Kowey, Wynnewood, PA

eVening

172 GO for ACC.12!

ACC.12 Learning Destination Presentations

Sunday, March 25, 2012

Learning Destinations are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.* Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag

CV Innovations Educational Forum

South Building, Hall A2, CV Theater, #22097

Device Development & Innovation

9:30 a.m. 10:45 a.m. 9:30 a.m. 9:45 a.m. Translational Considerations for Medtech Financing and International Strategies Nic Chronos, MD, FACC, FESC, FFAHA, FRCP, Atlanta, GA President, St. Josephs Translational Research Institute 9:45 a.m. 9:55 a.m. Selecting the Right Experimental Models for Device Testing and Validation Juan F. Granada, MD, New York, NY Executive Director and Chief Scientific Officer, The Jack H. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation 9:55 a.m. 10:05 a.m. Device Strategies for the Management of Hypertension Todd Brinton, MD, Palo Alto, CA Clinical Assistant Professor of Medicine (Cardiology) and Lecturer in Bioengineering, Stanford University 10:05 a.m. 10:15 a.m. Biodegradable Stents Jai Pal Singh, PhD, Atlanta, GA Chief Scientific Officer, St. Josephs Translational Research Institute 10:15 a.m. 10:30 a.m. Innovation for the Mitral Valve David Reuter, MD, PhD, Kirkland, WA Co-Founder & Chief Medical Officer, Cardiac Dimensions 10:30 a.m. 10:45 a.m. Panel Discussion

12:31 p.m. 12:39 p.m. Clinical Study Design of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT II Trial Stevan I. Himmelstein, MD, FACC, Southaven, TN Memphis Heart Clinic 12:39 p.m. 12:47 p.m. Orbital Atherectomy Case Study of Calcified Coronary Arteries Using IVUS Richard A. Shlofmitz, MD, FACC, Roslyn, NY Director, Department of Cardiology, St. Francis Hospital 12:47 p.m. 12:55 p.m. Use of Intravascular Ultrasound to Identify Calcified Coronary Lesions for Treatment Using Orbital Atherectomy before Stenting Gregg W. Stone, MD, FACC, FSCAI, New York, NY Director of Cardiovascular Research and Education, Columbia University Medical Center 12:55 p.m. 1:10 p.m. Panel Discussion

Current Approaches for Treating Calcified Peripheral Arterial Disease

1:10 p.m. 2:00 p.m. 1:10 p.m. 1:18 p.m. Prevalence and Impact of Calcium on the Management of Peripheral Arterial Disease William A. Gray, MD, New York, NY 1:18 p.m. 1:26 p.m. Unique Challenges for Treating Patients with Critical Limb Ischemia: Clinical Considerations and Lesion Morphologies Speaker to be announced 1:26 p.m. 1:34 p.m. New Approaches for Treating Critical Limb Ischemia Clinical Data Tony S. Das, MD, FACC, FACP, Dallas, TX Cardiology and Interventional Vascular Associates 1:34 p.m. 1:42 p.m. Advanced Treatment Options for Lower Extremity Peripheral Arterial Disease Jihad Mustapha, MD, Grand Rapids, MI Director of Endovascular Interventions and Research, Metro Health Hospital 1:42 p.m. 1:50 p.m. Peripheral Academic Research Consortium Definitions in Trials in the Treatment of Patients with Lower Extremity Peripheral Arterial Disease Manesh R. Patel, MD, Durham, NC Duke University 1:50 p.m. 2:00 p.m. Panel Discussion ACC.12 Final Program 173

Challenges Associated with Treating Calcified Coronary Artery Disease

12:15 p.m. 1:10 p.m. 12:15 p.m. 12:23 p.m. Complications Associated with Treating Calcified Lesions During Coronary Intervention Jeffrey W. Chambers, MD, Buffalo, NY Cardiology 12:23 p.m. 12:31 p.m. Long-Term Clinical Results of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT I Trial Puneet Khanna, MD, FACC, Rancho Mirage, CA Desert Cardiology Center

Sunday, March 25, 2012 ACC.12

The role of Innovative Technologies in a Novel Strategy to Prevent First Coronary Event
3:30 p.m. 4:30 p.m. 3:30 p.m. 3:45 p.m. Genetic Testing and Other Novel Methods to Screen for Increased Coronary risks Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute 3:45 p.m. 3:55 p.m. The role of Non-Invasive Imaging with CTA and Other Means to Identify Increased risks Szilard Voros, MD, FACC, Atlanta, GA Fuqua Heart Center at Piedmont Hospital 3:55 p.m. 4:10 p.m. The role of Invasive Imaging with IVUS, NIr, and OCT to Confirm the Presence of Vulnerable Plaques James Muller, MD, Burlington, MA Chief Medical Officer, InfraReDx, Inc. 4:10 p.m. 4:20 p.m. PrOSPECT Data: Potential local and Systemic Concepts for Stabilizing Vulnerable Plaques Charles Simonton, MD, FACC, FSCAI, Abbott Park, IL Divisional Vice President, Medical Affairs and Chief Medical Officer, Abbott Vascular 4:20 p.m. 4:30 p.m. Panel Discussion Lemberg Professor of Medicine; Director, Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine 1:20 p.m. 1:45 p.m. Devices Used for Heart Failure Leslie W. Miller, MD, FACC, Tampa, FL Professor of Medicine, Chief and Chairman, Department of Cardiovascular Sciences; CEO and Director of Cardiovascular Service, University of South Florida 1:45 p.m. 3:45 p.m. Educational content including taped cases, physician interviews, panel discussions and more 3:45 p.m. 4:15 p.m. Moderated Discussion: role of Genetics and Proteomics and How They Will Alter the Management of Heart Disease Moderator: Jennifer L. Hall, PhD, FACC, FAHA, Minneapolis, MN Associate Professor of Medicine, University of Minnesota; Director, Program in Translational Cardiovascular Genomics, Lillehei Heart Institute Developmental Biology Center Panelists: Robert Roberts, MD, MACC, FACP, FAHA, FESC, FISHR, FRCPC, FRSM, Ottawa, ON, Canada President and CEO, University of Ottawa Heart Institute; President, CEO and Chief Scientific Officer, Ottawa Heart Institute Research Corporation; Director, Ruddy Canadian Cardiovascular Genetics Centre; Professor of Medicine, University of Ottawa; Adjunct Professorship of Medicine, Baylor College of Medicine; Jennifer E. Van Eyk, PhD, Baltimore, MD Director, Johns Hopkins NHLBI Proteomics Center, Johns Hopkins School of Medicine 4:15 p.m. 4:30 p.m. Educational content including taped cases, physician interviews, panel discussions and more

The Heart of Innovation Featured Learning Destination

South Building, Hall A1, #1076 9:30 a.m. 9:45 a.m. Educational content including taped cases, physician interviews, panel discussions and more 9:45 a.m. 10:05 a.m. Presenting Options to Patients with Advanced Heart Failure Lynne Warner Stevenson, MD, FACC, Boston, MA Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Professor, Harvard Medical School 10:05 a.m. 10:30 a.m. Transcatheter Aortic Valve replacement: Where Are We and Where Do We Go? G. Alain Cribier, MD, Rouen, France Professor of Cardiology, University Hospital Charles Nicolle 10:30 a.m. 12:30 p.m. Educational content including taped cases, physician interviews, panel discussions and more 12:30 p.m. 12:55 p.m. Pharmacogenetic Development and Targeting of Cardiovascular Drugs Michael R. Bristow, MD, PhD, FACC, FAHA, Aurora, CO Professor of Medicine (Cardiology), Co-Director, CU Cardiovascular Institute, University of Colorado Anschultz Medical Campus 12:55 p.m. 1:20 p.m. Cell Therapy for Chronic Ischemic Heart Disease from Concept to Clinic Joshua M. Hare, MD, FACC, FAHA, Miami, FL Louis 174 GO for ACC.12!

Industry-Expert Theater
South Building, Hall A1, #22042 9:45 a.m. 10:45 a.m. (Morning Coffee Break) Antiplatelet Therapy Choices for High-risk PCI Patients in the Era of Generic Clopidogrel: The role of Platelet reactivity Testing The Platelet reactivity Hypothesis Paul A. Gurbel, MD , Baltimore, MD Director, Sinai Center for Thrombosis Research; Associate Professor of Medicine, Johns Hopkins University Platelet reactivity Testing: A Synthesis of the Data Matthew J. Price, MD, FACC, FSCAI, La Jolla, CA Director, Cardiac Catheterization Laboratory at Scripps Clinic; Assistant Professor at Scripps Translational Science Institute Clinical Pathways for Platelet reactivity: real World Application Speaker to be announced

Presented by Accumetrics

ACC.12 Sunday, March 25, 2012

12:30 p.m. 1:30 p.m. (Mid-Day Break) A Stroke Prevention Option in Nonvalvular Atrial Fibrillation James A. Reiffel, MD, New York, NY Professor of Clinical Medicine, Columbia University; Cardiologist, Electrophysiologist, and Co-Director ECG Laboratory, Columbia University Medical Center

Philips Healthcare

Interactive Learning Lab #22035 9:30 a.m. 10:30 a.m. Speckle Tracking Today for Myocardial Deformation A HandsOn Guided Workshop Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover MA Senior Director, Cardiology; Philips Healthcare 11:00 a.m. Noon How Can Cardiology Informatics Enrich My Electronic Health records Strategy? James E. Tcheng, MD, FACC, Durham, NC Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System 12:30 p.m. 1:30 p.m. Innovations in Cardiovascular Interventions Speaker to be announced 2:00 p.m. 3:00 p.m. Hypothermia for Cardiac Protection in Acute Myocardial Infarction David Erlinge, MD, PhD, FESC, Sweden Head, Department of Cardiology, Lund University Hospital 3:30 p.m. 4:30 p.m. Clinical Application of real-Time 3D TEE for Percutaneous Structural Heart Interventions David Liang, MD, PhD, Palo Alto, CA Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Lost Angeles, CA Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center

Presented by Janssen Pharmaceuticals Inc.

3:30 p.m. 4:30 p.m. (Afternoon Coffee Break) Emerging Procedures Today, Future Standard of Care TAVR: Starting a Program and Beyond Richard Smalling, MD, Houston, TX Director of Interventional Cardiovascular Medicine, Memorial Hermann Transradial Procedures: Fast Track to the Default Access J. Chris McClish, MD, San Angelo, TX Interventional Cardiologist, Shannon West Texas Memorial Hospital Procedures Outside the Heart: The Optimal Cath Lab Stephen Ramee, MD, New Orleans, LA Interventional Cardiologist, Ochsner Clinic Interventional Cardiology

Presented by Toshiba Medical Systems

Interactive Learning Labs

Interactive Learning Lab #23027

South Building, Hall A1, #22027, #22035, #23027

Actelion Pharmaceuticals US, Inc.

9:30 a.m. 11:30 a.m. Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program Wayne J. Franklin, MD, FACC, Houston, TX Director, Texas Adult Congenital Heart Program, Texas Childrens Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA Director, Boston Adult Congenital Heart Service, Childrens Hospital, Brigham & Womens Hospital, Harvard Medical School 12:30 p.m. 2:15 p.m. PAH: A Case-Based Exploration of Management Strategies Michael Earing, MD, Milwaukee, WI Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI Aurora St. Lukes Medical Center

Terumo Interventional Systems and The Medicines Company

Interactive Learning Lab #22027 9:30 a.m. 10:30 a.m. Hands-On radial Access Simulation 10:45 a.m. 11:45 a.m. Hands-On radial Access Simulation Noon 1:00 p.m. Optimizing your Outpatient PCI: What You Need to Know and Consider 1:00 p.m. 2:00 p.m. Hands-On radial Access Simulation 2:30 p.m. 3:30 p.m. Hands-On radial Access Simulation

* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

ACC.12 Final Program 175

Learning Destinations
Expand Your Educational Experience in These Diverse and Creative Venues
New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076

ACC.12

TM

In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care. ACC is grateful for the support of the Marquee Heart of Innovation Partner:

Helping you transform patient care through innovations and partnerships New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle. Learn strategies to help your patients change their eating patterns and improve their outcomes. CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development. Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting. Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.

More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.
Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

2012 American College of Cardiology. A12194

Monday March 26

ACC.12

Monday, March 26

Learning Destinations
Expand Your Educational Experience in These Diverse and Creative Venues
New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076

ACC.12

TM

In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care. ACC is grateful for the support of the Marquee Heart of Innovation Partner:

Monday, March 26

Helping you transform patient care through innovations and partnerships New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle. Learn strategies to help your patients change their eating patterns and improve their outcomes. CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development. Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting. Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.

More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.
Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

2012 American College of Cardiology. A12194

ACC.12 Scientific Session

Monday, March 26, 2012

Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning SeSSionS
ACC-i2/TCT SpeCiAl

8:12

2111

Fellows Bootcamp: Coronary i Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S103b CMe Hours: 1.5 Sunil V. Rao, Durham, NC Duane S. Pinto, Boston, MA Vascular Access: Femoral and Radial Approaches Robert J. Applegate, Winston-Salem, NC Balloons, Wires and Guides Adam B. Greenbaum, Detroit, MI Beyond Angiography: Using iVUS, OCT and FFR to Optimize Therapy Marco A. Costa, Cleveland, OH Tips and Tricks for Challenging Stent Delivery: Case Reviews Duane S. Pinto, Boston, MA The ABCs of pCi pharmacology Paul A. Gurbel, Baltimore, MD Roundtable Discussion Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease i Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S102c CMe/CNe Hours: 1.5 James A. Goldstein, Royal Oak, MI Jagat Narula, New York, NY, Paul Sorajja, Rochester, MN, Spencer B. King, Atlanta, GA, Neal Kleiman, Houston, TX, Simon R. Dixon, Royal Oak, MI, Gregg C. Fonarow, Los Angeles, CA, Gus J. Vlahakes, Boston, MA Changing Nature of Advanced Heart Failure: The Need for Multi-disciplinary Management James A. Goldstein, Royal Oak, MI Case presentation 1 Brian P. ONeill, Miami, FL panel Discussion Case presentation 2 Todd K. Zynda, Manhattan Beach, CA panel Discussion left Main Disease: Role of imaging for Assessment, Treatment and Follow-Up Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S101a CMe/CNe Hours: 1.5 Robert J. Russo, La Jolla, CA Massoud A. Leesar, Cincinnati, OH What do We Know about left Main Disease Subtypes and Natural History? Akiko Maehara, New York, NY

What is the Role of MSCT in the Assessment and Follow-up of left Main Disease? Stephan Achenbach, Erlangen, Germany left Main evaluation with iVUS: What Cutoff Value Should i Use? Jose de la Torre Hernandez, Santander, Spain left Main evaluation with FFR: What is the impact of Downstream Disease? John McB Hodgson, Wilkes-Barre, PA iVUS Guidance for DeS implantation to Treat lMCA Disease: Optimal endpoints and long-term Results Soo-Jin Kang, Suwon, Republic of Korea Case presentation: How Much Adenosine is enough? Michael J. Lim, Saint Louis, MO Case presentation Alaide Chieffo, Milan, Italy Case presentation Ning Guo, Xian Shaanxi, China, Cincinnati, OH panel Discussion TAVR Complications: incidence, Management, and Avoidance Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S102b CMe/CNe Hours: 1.5 Eric Roselli, Cleveland, OH Vascular Susheel Kodali, New York, NY Ai-Assessment, imaging, Treatment Raj R. Makkar, Los Angeles, CA Stroke Josep Rodes-Cabau, Quebec, Canada Conduction System Abnormalities Raoul Bonan, Montreal, Canada Coronary Occlusion/Aortic Rupture Samir R. Kapadia, Cleveland, OH Device embolization/Migration James B. Hermiller, Indianapolis, IN Transapical Wilson Y. Szeto, Philadelphia, PA panel Discussion Management of Renovascular Hypertension Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S103c CMe/CNe Hours: 1.5 Christopher J. White, New Orleans, LA Joseph M. Garasic, Jamaica Plain, MA predictors of Response to Renal Artery Revascularization Ehtisham Mahmud, San Diego, CA

8:24

Morning

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

ACC-i2/TCT SpeCiAl

8:36

8:48

9:00 9:07 9:14 9:21

ACC-i2/TCT SyMpOSiUM

2121

2626

Chair: 8:00 8:12 8:24 8:36 8:48 9:00 9:12 9:24

ACC-i2/TCT

Chair: Panelists:

8:00

8:15 8:20 8:50 8:55

ACC-i2/TCT SyMpOSiUM

SyMpOSiUM

2627

2625

Co-Chairs: 8:00

Co-Chairs: 8:00

ACC.12 Final Program 177

Monday, March 26, 2012 ACC.12

8:15 Debate: Stenting is the Treatment of Choice for 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy Christopher J. Cooper, Toledo, OH Debate: Stenting is NOT the Treatment of Choice for 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy Lance Dworkin, Providence, RI Renal Sympathetic Denervation: pros and Cons Deepak L. Bhatt, Boston, MA Renal Stenting: Avoiding Complications James S. Jenkins, River Ridge, LA Renal Stenting: Case presentations: Techniques and pitfalls Douglas E. Drachman, Boston, MA left Main Coronary intervention: State-of-the-Art Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S106b CMe/CNe Hours: 1.5 Patrick L. Whitlow, Cleveland, OH George D. Dangas, New York, NY Review of Current Data and Guidelines David E. Kandzari, Atlanta, GA Risk Stratification of lMT pCi Davide Capodanno, Jacksonville, FL Review of lMT pCi Techniques Matthew J. Price, La Jolla, CA Functional and Anatomical Assessment William Fuller Fearon, Stanford, CA Case 1: A Case with low Syntax Score Khaled M. Ziada, Lexington, KY panel Discussion Case 2: A Case with High Syntax Score Thierry Corcos, Paris, France panel Discussion
ACS SyMpOSiUM

9:00 9:12 9:25

ARR expeRTS

CHF illustrative Case presentations Annapoorna Subhash Kini, New York, NY CHF illustrative Case presentations Jose P. Henriques, Amsterdam, Netherlands Summary Annapoorna Subhash Kini, New York, NY Case-Oriented Gaps in the Guidelines: Who Should Get an iCD? Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S504a CMe/CNe Hours: 1.5 Bruce D. Lindsay, Cleveland, OH Andrew E. Epstein, Philadelphia, PA, Mark S. Kremers, Charlotte, NC, Andrea M. Russo, Moorestown, NJ Mandeep Bhargava, Cleveland, OH, Anne B. Curtis, Buffalo, NY, N. A. Mark Estes, Boston, MA, Paul A. Heidenreich, Palo Alto, CA Clinical Management of the AF patient: Treating the patient and the Health Care provider Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N226 CMe/CNe Hours: 1.5 Stephen C. Hammill, Rochester, MN Albert L. Waldo, Cleveland, OH Reducing the Risk of Anticoagulation Michael M. Ezekowitz, Wynnewood, PA Drug Therapy for Difficult AF James A. Reiffel, Scarsdale, NY When to Give Up on Sinus Rhythm Win-Kuang Shen, Phoenix, AZ Utility of patient Care pathways in AF patients Luigi Di Biase, Austin, TX Reimbursement Considerations in AF Care Richard I. Fogel, Carmel, IN
CCS

8:30

8:45

239

Morning

9:00 9:15

Chair: Case Presenters: Panelists:

ACC-i2/TCT SyMpOSiUM

2628

Co-Chairs: 8:00 8:15 8:25 8:40 8:55 9:05 9:10 9:20

ARR SyMpOSiUM

677

Co-Chairs: 8:00 8:18 8:36 8:54 9:12

676

Shock in ACS Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S401a CMe/CNe Hours: 1.5 Jose P. Henriques, Amsterdam, Netherlands Annapoorna Subhash Kini, New York, NY pathophysiology of Cardiogenic Shock and Adjunct Therapies Michael C. Kim, New York, NY Question and Answer primary pCi in STeMi: Does it Reduce Shock incidence? Sameer Mehta, Miami, FL Question and Answer Role of lV Assist Device in Cardiogenic Shock John M. Lasala, Saint Louis, MO Question and Answer portable lV Assist Devices: liFeBRiDGe, eCMO and Other Semih Buz, Berlin, Germany Question and Answer

SyMpOSiUM

678

Co-Chairs: 8:00 8:10 8:15 8:25 8:30 8:40 8:45 8:55

pulmonary Artery Stenosis Current Therapy and Future Directions: live Case Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N231 CMe/CNe Hours: 1.5 Frank F. Ing, Houston, TX Lisa T. Bergersen, Boston, MA Mathew Gillespie, Philadelphia, PA live Case: pulmonary Artery Stenosis Jonathan J. Rome, Philadelphia, PA pulmonary Artery Rehabilitation Current State of Knowledge: What Do We Need to Know to improve This procedure James E. Lock, Boston, MA Devices Studies and pMA indications in Congenital Heart Disease: past Failures, Successes and Future Directions Robert H. Beekman, Cincinnati, OH panel Discussion

Co-Chairs:

8:00 8:45

9:10

9:25

178 GO for ACC.12!

ACC.12 Monday, March 26, 2012

CCS SyMpOSiUM

679

Women with Congenital Heart Disease: Fertility, pregnancy and Menopause Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S501a CMe/CNe Hours: 1.5 Mary Canobbio, Los Angeles, CA Carole A. Warnes, Rochester, MN Biomarkers: How They Can Be Utilized during pregnancy Candice Silversides, Toronto, Canada My Cardiologist Cleared Me for pregnancy but What the Obstetrician Needs to Know Anthony Gregg, Gainesville, FL The Menopause: Not All palpitations Are Cardiac! Stephen C. Cook, Columbus, OH Difficult Decisions i Have to Make in the Care of the pregnant ACHD patient Katherine Economy, Boston, MA psychological Challenges of the Childbearing years Adrienne H. Kovacs, Toronto, Canada Question and Answer

HF SyMpOSiUM

681

Surgical Therapy of Heart Failure Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S404 CMe/CNe Hours: 1.5 Michael A. Acker, Philadelphia, PA Steven F. Bolling, Ann Arbor, MI Aortic Stenosis and low ejection Fraction Blase A. Carabello, Houston, TX Coronary Revascularization in the post-STiCH era Eric J. Velazquez, Durham, NC Mitral Regurgitation and low ejection Fraction Ted Feldman, Evanston, IL Destination Therapy for Advanced Heart Failure Bartley P. Griffith, Baltimore, MD Gene Therapy for Advanced Heart Failure Roger J. Hajjar, New York, NY Cellular Therapy of Heart Failure Daniel J. Garry, Minneapolis, MN

Co-Chairs: 8:00 8:16

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

Morning

8:32 8:48

9:04 9:20
HF expeRTS

iMAG expeRTS

240

Myocarditis: When to Biopsy, Who to Treat, Which Therapy? Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S502 CMe/CNe Hours: 1.5 Peter P. Liu, Toronto, Canada Leslie T. Cooper, Rochester, MN, Joshua M. Hare, Miami, FL, Hans Peter Schultheiss, Berlin, Germany, Guillermo Torre-Amione, TX, Jeffrey A. Towbin, Cincinnati, OH Controversies in the Management of Heart Failure Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S406b CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-141-l04-p Carl V. Leier, Columbus, OH Barry M. Massie, San Francisco, CA Anemia is a Therapeutic Target in Heart Failure Inder Anand, Minneapolis, MN Anemia is Not a Therapeutic Target in Heart Failure G. William Dec, Boston, MA Role of Diuretics in Treatment of Heart Failure: A Necessary evil Gadi Cotter, Durham, NC Diuretics Are the Best Available Treatment for Heart Failure Maya E. Guglin, Tampa, FL Serial BNp Measurements Are Useful in Heart Failure Management Alain Cohen-Solal, France Serial BNp Measurements Are Not Useless in Heart Failure Management Richard W. Troughton, Christchurch, New Zealand Discussion

241

imaging the Right Ventricle Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S505 CMe/CNe Hours: 1.5 Lawrence G. Rudski, Montreal, QC, Canada Tal Geva, Boston, MA, Subha V. Raman, Columbus, OH, Nelson B. Schiller, San Francisco, CA, Dennis A. Tighe, Worcester, MA Advanced lV Dysfunction: A Multimodality Approach Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S405 CMe/CNe Hours: 1.5 Judy W. Hung, Boston, MA Issam A. Mikati, Chicago, IL Role of MRi in Acute Heart Failure Andrew E. Arai, Bethesda, MD 3-D echo Roberto M. Lang, Chicago, IL Strain and Strain Rate imaging: A Multimodality Approach Thomas H. Marwick, Cleveland, OH echo in VAD patients William F. Armstrong, Ann Arbor, MI How and When to Assess Viability Eric J. Velazquez, Durham, NC Cardiac CT in Advanced Heart Failure Daniel S. Berman, Los Angeles, CA

Chair: Panelists:

Case Presenter: Laxmi S. Mehta, Powell, OH

Chair: Panelists:

Case Presenter: Lori Blauwet, Rochester, MN

iMAG SyMpOSiUM

682

HF SyMpOSiUM

680

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

Co-Chairs: 8:00 8:10 8:26 8:36 8:52 9:02

9:18

ACC.12 Final Program 179

Monday, March 26, 2012 ACC.12

iMAG SyMpOSiUM

683

Future Directions for Cardiac CT Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S403 CMe/CNe Hours: 1.5 Lawrence M. Boxt, Bronx, NY William Guy Weigold, Washington, DC CT Viability and infarct Detection Kelley Branch, Seattle, WA Cardiac CT for Coronary Flow James K. Min, New York, NY CT Valve Morphology and Function Mario J. Garcia, Bronx, NY CTA plaque imaging: What We Know and Where it is Headed Szilard Voros, Atlanta, GA CT imaging for plaque progression Matthew J. Budoff, Torrance, CA CCA Research Bootcamp Session i: Methods for engaging in Research Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S105d CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-121-l04-p Margo B. Minissian, Los Angeles, CA Developing a Research project: Getting Started Sandra M. Oliver-McNeil, Farmington Hills, MI Methodology Development after Determining the Research Question Eileen M. Handberg, Gainesville, FL instrument Selection and investigator Developed Case Report Forms Kay Blum, Baltimore, MD Question and Answer ACC/MedAxiom/ACCA: Cardiovascular Service lines Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S105a CMe/CNe Hours: 1.5 Michael K. Schroyer, Zionsville, IN C. Michael Valentine, Lynchburg, VA Structure and Models Keith Churchwell, Nashville, TN, Robin Steaban, Nashville, TN Defining Clinical Focus for the Future Michael K. Schroyer, Zionsville, IN Financial Opportunities/Value Based purchasing Cathleen Biga, Woodridge, IL Merging Cultures Robert Gianguzzi, Fountain Hills, AZ panel Discussion

pReV SyMpOSiUM

685

Co-Chairs: 8:00 8:18

ACC China Chapter Session: Cardiovascular Clinical Research and practice in China Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N229 CMe/CNe Hours: 1.5 Dong Zhao, Beijing, China Dipti Itchhaporia, Newport Beach, CA Opening Remarks Dong Zhao, Beijing, China Chinese Hypertension 3G Management: From Guideline to practice Li Jianping, Beijing, China Hypertension Treatment in China: China STATUS ii Study Yong Huo, Beijing, China The Return on expenditure Achieved for lipid Therapy in China Survey Yujie Zhou, Beijing, China A Randomized, Double-blinded Comparison of iopromide and iodixanol in Renally impaired patients Undergoing Cardiac Catheterization (DiReCT Study) Chen Yundai, Beijing, China Closing Remarks Jack Lewin, Washington, DC

Co-Chairs: 8:00 8:05 8:25 8:45 9:05

Morning

8:36 8:54 9:12

liFelONG BOOT CAMp

112

9:25
pReV SyMpOSiUM

686

Chair: 8:00 8:25

Global CVD prevention: Heart Disease and Risk Factors in Specific populations Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S100c CMe/CNe Hours: 1.5 Krishnaswami Vijayaraghvan, Phoenix, AZ Salim Yusuf, Hamilton, Canada CVD prevention in South Asia Krishnaswami Vijayaraghvan, Phoenix, AZ prevention Strategies in China Dayi Hu, Beijing, China prevention Trends in the Middle east Mouaz H. Al-Mallah, Riyadh, Saudi Arabia CVD prevention in South America Hector O. Ventura, New Orleans, LA Approaches to preventing CVD in Africa Elizabeth Ofili, Atlanta, GA World Wide Risk Factors: Do They Differ? Salim Yusuf, Hamilton, Canada

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

8:50 9:15
pRACTiCe SyMpOSiUM

684

Co-Chairs: 8:00 8:30 8:45 9:00 9:15

QUAl SyMpOSiUM

687

Where Will Cardiology Be in 2015? Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N427 CMe/CNe Hours: 1.5 James B. Froehlich, Ann Arbor, MI Scott Wright, Rochester, MN The Accountable Care Act (ACA) for Dummies Jack Lewin, Washington, DC Reimbursement in the era of Reform Len Nichols, Washington, DC public Reporting: What Does it Mean if My Hospital Gets A Bad Report Card? Kalon K. L. Ho, Boston, MA eHR: Meaningful Use or Meaningfully Useful? Michael S. Blum, San Francisco, CA putting it All Together: What Does This Mean for your practice? Scott Wright, Rochester, MN

Co-Chairs: 8:00 8:18 8:36 8:54 9:12

180 GO for ACC.12!

ACC.12 Monday, March 26, 2012

SpeCiAl SpeCiAl

305

Joint American College of Cardiology/New England Journal of Medicine late-Breaking Clinical Trials Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, Hall B, ACC.12 Main Tent CMe/CNe Hours: 1.5 Patrick T. OGara, Boston, MA E. Murat Tuzcu, Cleveland, OH G. Alain Cribier, Rouen, France, Thomas C. Gerber, Jacksonville, FL, C. Michael Gibson, Boston, MA, Robert A. Guyton, Atlanta, GA CORONARy: The Coronary Artery Bypass Grafting Surgery Off or On pump Revascularization Study Andre Lamy, on behalf of the CORONARY Study Investigators, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Canada panel Discussion ACRiN pA 4005: Multicenter Randomized Controlled Study of a Rapid Rule Out Strategy Using CT Coronary Angiogram Versus Traditional Care for low-risk eD patients with potential ACS Harold Litt, Chadwick Miller, Constantine Gatsonis, Brad Snyder, Harjit Singh, Laurence Gavin, Daniel Entrikin, James Leaming, Carlos Jamis-Dow, Joan Lacomis, Judd Hollander, University of Pennsylvania, Philadelphia, PA, American College of Radiology Imaging Network, Philadelphia, PA panel Discussion Oral Rivaroxaban Alone for Symptomatic pulmonary embolism: The eiNSTeiN pe Study Harry Roger Buller, Academic Medical Center, Amsterdam, The Netherlands panel Discussion late ( 2 year) Clinical and echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-risk Cohort of the pARTNeR Trial Martin Leon, John Webb, Jeffrey Moses, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Susheel K. Kodali, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY panel Discussion

8:15

Co-Chairs: Panelists:

4075 Coronary Arterial 18f-naf Uptake: A Novel Marker of plaque Biology Marc R. Dweck, Marcus WL Chow, Nikhil V. Joshi, MIchelle C. Williams, Charlotte Jones, Alison M. Fletcher, Hamish Richardson, Audrey White, Graham McKillop, Edwin JR van Beek, Nicholas A. Boon, James HF Rudd, David E. Newby, University of Edinburgh, Edinburgh, United Kingdom, Univeristy of Cambridge, Cambridge, United Kingdom 4076 impact of CT-guided Valve Sizing on post-procedural Aortic Regurgitation in Transcatheter Aortic Valve implantation Kentaro Hayashida, Erik Bouvier, Thierry Lefevre, Thomas Hovasse, Marie-Claude Morice, Bernard Chevalier, Mauro Romano, Philippe Garot, Darren Mylotte, Arnaud Farge, Patrik Donzeau-Gouge, Bertrand Cormier, Institut Cardiovasculaire Paris Sud, Massy, France 4077 impact of Jeopardized Myocardium on Therapeutic Benefit Associated with Completeness of Revascularization vs. Medical Therapy in patients with left Ventricular Systolic Dysfunction: A peT Myocardial perfusion and Metabolism Study Lee Fong Ling, Thomas Cook, Thomas H. Marwick, Demetrio R. Flores, Weal A. Jaber, Richard C. Brunken, Manuel D. Cerqueira, Rory Hachamovitch, Cleveland Clinic, Cleveland, OH 4078 Accuracy of Aortic Annuli Measurements Obtained from Three-dimensional echocardiography, Computed Tomography and Magnetic Resonance imaging Using an in Vitro Model Wendy Tsang, Michael G. Bateman, Lynn Weinert, Gian Pellegrini, Victor Mor-Avi, Lissa Sugeng, Hubert Yeung, Amit R. Patel, Alexander J. Hill, Paul A. Iazzo, Roberto M. Lang, University of Chicago Medical Center, Chicago, IL Joint Session of the european Society of Cardiology and the American College of Cardiology i: Management of Heart Disease in pregnancy Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N426 CMe/CNe Hours: 1.5 Michel Komajda, Paris, France John Gordon Harold, Los Angeles, CA Congenital Heart Disease Elyse Foster, San Francisco, CA Valvular Heart Disease Petronella G. Pieper, Groningen, Netherlands Cardiomyopathy and Heart Failure Uri Elkayam, Los Angeles, CA Arrhythmias Speaker TBD Hypertension Irmtraut Kruck, Ludwigsburg, Germany

8:30

Morning

8:00

8:15 8:22

8:45

9:00

8:37 8:44

8:59 9:06

SpeCiAl SyMpOSiUM

738

Co-Chairs: 8:00

9:21
SpeCiAl SpeCiAl

407

young investigators Award Competition: Clinical investigations, Congenital Heart Disease, and Cardiovascular Surgery Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N230 CMe/CNe Hours: 1.5 Marc Steven Sabatine, Boston, MA Brian H. Annex, Charlottesville, VA Nicholas L. Mills, Edinburgh, Scotland, United Kingdom 4074 Sex Differences in Arterial Stiffness and Arterial-Ventricular interactions Thais Coutinho, Patricia A. Pellikka, Iftikhar J. Kullo, Mayo Clinic, Rochester, MN

8:18 8:36 8:54 9:12

Chair: Judges: 8:00

ACC.12 Final Program 181

Monday, March 26, 2012 ACC.12

TeST SyMpOSiUM

688

Challenging Sports Cardiology Cases in Older Athletes Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N227b CMe/CNe Hours: 1.5 Joseph C. Marek, Oak Brook, IL Robert Vogel, Baltimore, MD Case presentation: NFl Combine player with Abnormal eCG Eugene H. Chung, Chapel Hill, NC This players eCG is Abnormal: What Now? Alfred A. Bove, Philadelphia, PA Case presentation: 70 year-old Veteran of 114 Marathons, S/p RCA Stent Stephen A. Siegel, New York, NY Detecting CAD in Older Athletes and What to Recommend When you Find it Paul D. Thompson, Hartford, CT Case presentation: 52 year-old Cross Country Skier with Fatigue during the Birkebeiner Thomas Allison, Rochester, MN Should Atrial Arrhythmias be Treated Differently in Athletes? Mark S. Link, Boston, MA

8:59 9:08 9:17

VAlV SelF-DiReCTeD

Surgical Aortic Valve Replacement and the Older Adult Richard J. Shemin, Los Angeles, CA Hybrid Approaches: Maximized Gain/Minimized pain? Stephen Ball, Nashville, TN Summary Discussion Heart Songs at ACC.12: A Self-paced Multimedia learning experience Monday, March 26, 2012, 9:00 a.m. 5:00 p.m. McCormick Place, Vista Room Lobby CMe/CNe Hours: 2 Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab a unique audiovisual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod Touch, iPad or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individuals need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.

Co-Chairs: 8:00

1503

Morning

8:05 8:30

8:35

9:00

9:05

VAlV expeRTS

242

Tricuspid Valve Disease Case Management Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S503 CMe/CNe Hours: 1.5 Luc Pierard, Lige, Belgium Grace Lin, Rochester, MN, Patrick M. McCarthy, Chicago, IL, Yan Topilsky, MN Vera H. Rigolin, Chicago, IL, William J. Stewart, Cleveland, OH Valvular Heart Disease in the Older Adult (with Many DRG Codes): Navigating the Options Monday, March 26, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S402 CMe/CNe Hours: 1.5 Maurice Enriquez-Sarano, Rochester, MN Daniel E. Forman, Boston, MA Case presenter Joseph Maalouf, Rochester, MN evaluating the Older Adult Cardiac patient Whos Failing Medical Therapy Jeffrey S. Borer, New York, NY Whats in the Registries: NCDR, Cath, pC and the Older Adult Ralph G. Brindis, Oakland, CA Whats in the Registries: STS Database, Valvular Outcomes and the Older Adult Frederick L. Grover, Aurora, CO Mitral Transcatheter Options and the Older Adult Martin B. Leon, New York, NY Mitral Surgical Options and the Older Adult W. Randolph Chitwood, Greenville, NC TAVi/TAVR Update David R. Holmes, Jr., Rochester, MN
ACC-i2/TCT SpeCiAl

Chair: Case Presenters: Panelists:

VAlV SyMpOSiUM

674

Co-Chairs: 8:00 8:05

Co-Chairs:

Michael J. Barrett, Blue Bell, PA Carolyn S. Lacey, Fairfield, CA Tahmeed A. Contractor, Allentown, PA Garima Sharma, Philadelphia, PA Fellows Bootcamp: Coronary ii Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S103b CMe Hours: 1.5 Susheel Kodali, New York, NY James Bernard Hermiller, Jr., Indianapolis, IN Avoiding and Treating Complications James Bernard Hermiller, Jr., Indianapolis, IN Bifurcations: Simple and Complex Thierry Lefevre, Massy, France pCi in STeMi and Shock Timothy D. Henry, Minneapolis, MN The post CABG patient: pCi via the liMA and SVG intervention Susheel Kodali, New York, NY

8:14 8:23

2112

Co-Chairs: 10:30 10:45 11:00 11:15

8:32 8:41 8:50

182 GO for ACC.12!

ACC.12 Monday, March 26, 2012

11:30 11:45
ACC-i2/TCT SpeCiAl

Chronic Total Occlusions: The Fundamentals William L. Lombardi, Bellingham, WA Roundtable Discussion Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease ii Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S102c CMe/CNe Hours: 1.5 Srihari S. Naidu, New York, NY Juan Carlos Plana, Cleveland, OH, Michael J. Lim, Saint Louis, MO, Marc J. Semigran, Boston, MA, Mauricio G. Cohen, Miami, FL, Frank Pelosi, Ann Arbor, MI, John B. OConnell, Atlanta, GA, Steven R. Bailey, San Antonio, TX, Michael J. Mack, Plano, TX The Role of interventionalists in Heart Failure: From Assist Devices to Valves Srihari S. Naidu, New York, NY Case presentation 3 James A. Watts, Boston, MA panel Discussion Case presentation 4 David Bartov, New York, NY panel Discussion Where Do We Go From Here? Morton J. Kern, Orange, CA establishing a Cardiac Catheterization imaging/ physiology program Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S101a CMe/CNe Hours: 1.5 Neil J. Weissman, Washington, DC Emmanouil S. Brilakis, Dallas, TX intravascular Ultrasonography Robert J. Russo, La Jolla, CA Optical Coherence Tomography and Near-infrared Spectroscopy Emmanouil S. Brilakis, Dallas, TX Fractional Flow Reserve Michael J. Lim, St. Louis, MO imaging for Guiding Structural Heart Disease interventions: Tee and iCe Rebecca T. Hahn, New York, NY emerging imaging Applications in the Cardiac Catheterization laboratory John D. Carroll, Aurora, CO Training of Cath lab personnel and Setup for Cath lab Based imaging Akiko Maehara, New York, NY Case presentation: intravascular imaging Kendrick A. Shunk, San Francisco, CA Case presentation: echocardiography (Tee, TTe, etc.) Amar Krishnaswamy, Cleveland, OH Case presentation: FFR Joel A. Garcia, Denver, CO panel Discussion: What Are the Appropriate Real-world indications for These procedures?

ACC-i2/TCT SyMpOSiUM

2630

Hemodynamics iii (pVl and ASD Closure) Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S102b CMe/CNe Hours: 1.5 Charanjit S. Rihal, Rochester, MN Igor F. Palacios, Boston, MA Anatomy, prevalence, pathophysiology of pVl and ASD Samir R. Kapadia, Cleveland, OH imaging Considerations: echo Nina Wunderlich, Frankfurt, Germany imaging Considerations: CT Guidance Carlos E. Ruiz, New York, NY Case presentation: Transseptal Mitral Steven L. Goldberg, Seattle, WA Case presentation: Transapical Mitral Chad Kliger, New York, NY Case presentation: Retrograde Aortic Oluseun O. Alli, Rochester, MN Overall Results of pVl Closure: US experience Paul Sorajja, Rochester, MN Overall Results of pVl Closure: european experience Horst Sievert, Frankfurt, Germany Case presentation: VSD Closure George S. Hanzel, Birmingham, MI Results post infarct VSD Closure Ziyad M. Hijazi, Chicago, IL All you Need to Know About Carotid Artery Stenting Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S103c CMe/CNe Hours: 1.5 Seemant Chaturvedi, Detroit, MI D. Christopher Metzger, Kingsport, TN Carotid Stenting Case Selection: Which patients and Which Anatomy Should be Avoided? Christopher J. White, New Orleans, LA Debate: Carotid Stenting Should be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients Kenneth Rosenfield, Boston, MA Debate: Carotid Stenting Should Not be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients Anthony J. Comerota, Toledo, OH proximal Versus Distal protection during Carotid Artery Stenting: Does it Really Matter? Marco Roffi, Geneva 1211, Switzerland Hybrid Approach to Severe Carotid and Coronary Artery Disease Case Selection Jan Van der Heyden, Nieuwegein, Netherlands Carotid Stenting: Case presentation Management of Complications William A. Gray, New York, NY

Co-Chairs: 10:30 10:45 10:55 11:05 11:10 11:15 11:20 11:30 11:40 11:50

2122

Morning

Chair: Panelists:

10:30

10:45 10:50 11:15 11:20 11:50

ACC-i2/TCT SyMpOSiUM

2629

ACC-i2/TCT SyMpOSiUM

2631

Co-Chairs: 10:30 10:40 10:50 11:00

Co-Chairs: 10:30

10:45

11:00

11:10

11:15

11:20 11:30 11:35 11:40 11:45

11:30

11:45

ACC.12 Final Program 183

Monday, March 26, 2012 ACC.12

ACC-i2/TCT SyMpOSiUM

2632

DeS: Future Directions Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S106b CMe/CNe Hours: 1.5 Gregg W. Stone, New York, NY George D. Dangas, New York, NY limitations of Current DeS: A pathologists View Renu Virmani, Gaithersburg, MD The Clinical perspective: 1st and 2nd Generation DeS Are Not perfect Ron Waksman, Washington, DC Challenges in Creating a Fully Bioresorbable effective Stent John A. Ormiston, Auckland, New Zealand Bioabsorbable Stents: Whats in the pipeline Raimund A. Erbel, Essen, Germany Bioresorbable Coatings and polymer-free DeS Alexandre Abizaid, Sao Paulo, Brazil Drug-eluting Balloons: Novel Techonology and Applications Sigmund Silber, Zell, Germany The Future is Here: BVS Update Patrick W. Serruys, Rotterdam, Netherlands panel Discussion improving STeMi Outcomes: Saving Myocardium and Attenuating Remodeling Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S401a CMe/CNe Hours: 1.5 Jane A. Linderbaum, Rochester, MN Debabrata Mukherjee, El Paso, TX The importance of ischemic Time in Assessing STeMi Treatment Outcomes Holger Thiele, Leipzig, Germany Stem Cell Therapy for Mi Warren Sherman, New York, NY Stem Cell Therapy Not for Mi Jochen Whrle, Ulm, Germany Reducing post Mi Remodeling Mitchell W. Krucoff, Durham, NC Remote ischemic preconditioning in STeMi: Fact or Fiction Hans Erik Botker, Skejby, Denmark State-of-the-Art STeMi Care Eric R. Bates, Ann Arbor, MI Summary Debabrata Mukherjee, El Paso, TX perioperative Management of patients with Cardiac implantable electronic Device Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S504a CMe/CNe Hours: 1.5 George H. Crossley, Nashville, TN

ARR SyMpOSiUM

690

Controversies in Device Therapy Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S406a CMe/CNe Hours: 1.5 Thomas F. Deering, Atlanta, GA Cara Pellegrini, San Francisco, CA Should patients with RBBB Be Considered for CRT? William T. Abraham, Columbus, OH Should All patients Have an MRi Conditional Device implanted? William R. Lewis, Cleveland, OH Should the Contraindications for Device implantation for primary prevention Be expanded? James P. Daubert, Durham, NC Should every patient Receive a Dual Chamber iCD? Bruce L. Wilkoff, Cleveland, OH Should All Chronic leads Be extracted? Charles J. Love, Columbus, OH The Genetics of Sudden Cardiac Death: What Do We Know and How Best to evaluate and Manage Such patients Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N226 CMe/CNe Hours: 1.5 Federico Gentile, Naples, Italy Arthur J. Moss, Rochester, NY Sudden Death in the General population Sumeet Chugh, Los Angeles, CA Short QT Syndrome and early Repolarization Michael Howard Gollob, London, Canada long QT Syndrome Michael J. Ackerman, Rochester, MN Brugada Syndrome Koonlawee Nadamanee, Inglewood, CA Catecholaminergic polymorphic Ventricular Tachycardia Arthur A. Wilde, Amsterdam, Netherlands pulmonary Vein Stenosis: What Are Realistic expectations? Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N229 CMe/CNe Hours: 1.5 Piers E. F. Daubeney, London, United Kingdom James E. Lock, Boston, MA Case presentation Jeffrey Darst, Aurora, CO epidemiology and Natural History of pulmonary Vein Stenosis: evolution in Our Understanding Anna Seale, London, United Kingdom pathology and pathogenesis of pulmonary Vein Stenosis: How Well Do We Know This enemy? Stephen Sanders, Boston, MA Surgery for pulmonary Vein Stenosis: Outcomes and expectations in the Current era Christopher Caldarone, Toronto, Canada Transcatheter pulmonary Vein interventions: Do They Help? How and When? Alan William Nugent, Dallas, TX

Co-Chairs: 10:30 10:42

Co-Chairs: 10:30 10:48 11:06

Morning

10:54

11:06 11:16 11:26 11:36 11:48

ACS SyMpOSiUM

11:24 11:42

ARR SyMpOSiUM

691

Co-Chairs: 10:30 10:48 11:06 11:24 11:42

689

Co-Chairs: 10:30

10:43 10:55 11:13 11:27 11:41 11:55

ARR expeRTS

CCS SyMpOSiUM

692

Co-Chairs: 10:30 10:48

243

11:06

Chair: Panelists:

Case Presenter: Michael Robert Gold, Charleston, SC Mina Chung, Cleveland, OH, Melanie T. Gura, Akron, OH, Jeanne E. Poole, Seattle, WA

11:24

11:42

184 GO for ACC.12!

ACC.12 Monday, March 26, 2012

CCS SyMpOSiUM

693

Challenging imaging issues in Congenital Heart Disease Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N231 CMe/CNe Hours: 1.5 Nancy Ayres, Houston, TX William Mahle, Atlanta, GA When 3-D imaging Can Make a Difference Girish S. Shirali, Charleston, SC Quantification of Collateral Flow in Congenital Heart Disease: When and How Ashwin Prakash, Boston, MA What Stress imaging Adds to echocardiography in CHD Luc Mertens, Toronto, Canada Cardiac MRi of Complex Congenital Heart Disease: Rules to live By Andrew Powell, Boston, MA

iMAG SyMpOSiUM

696

Cardiac CT in 2012: State-of-the-Art Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S405 CMe/CNe Hours: 1.5 Ricardo C. Cury, Miami, FL Jack A. Ziffer, Miami, FL Calcium Scoring in the Age of CT Angiography Khurram Nasir, New Haven, CT Cardiac Computed Tomographic Angiography: Diagnosis and prognosis of CAD Benjamin J. W. Chow, Ottawa, Canada

Co-Chairs: 10:30 10:48

Co-Chairs: 10:30 10:48

Morning

11:24 11:42

11:06 11:24 11:42

ischemic Chest pain in the eR Ronald P. Karlsberg, Beverly Hills, CA Cardiac CT Radiation exposures Sandra Halliburton, Cleveland, OH Advances in CT Hardware Stephan Achenbach, Erlangen, Germany Role of echo in the evaluation and Management of patients with Mitral Regurgitation Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S403 CMe/CNe Hours: 1.5 Judy W. Hung, Boston, MA Robert A. Levine, Boston, MA How echo Has Aided in Our Understanding of MR Robert A. Levine, Boston, MA Role of echo during percutaneous interventions Judy W. Hung, Boston, MA Qualitative versus Quantitative Approaches to Severity Paul A. Grayburn, Dallas, TX Debate: 3-D echo is indispensible for intraoperative evaluation Roberto M. Lang, Chicago, IL 3-D echo is Not indispensible for intraoperative evaluation Patrick M. McCarthy, Chicago, IL physiology of Myxomatous Disease: insights from 3-D echo Sunil V. Mankad, Rochester, MN leadership and Governance Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S503 CMe/CNe Hours: 1.5 Suzette Jaskie, Grand Rapids, MI Matthew Phillips, Austin, TX Robert Campbell, Atlanta, GA, C. Michael Valentine, Lynchburg, VA, Blair D. Erb, Bozeman, MT, Matthew Phillips, Austin, TX, Suzette Jaskie, Grand Rapids, MI Womens Cardiovascular Health Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S501a CMe/CNe Hours: 1.5 Laxmi S. Mehta, Columbus, OH Stacie L. Daugherty, Aurora, CO, Jennifer H. Mieres, Lake Success, NY Claire S. Duvernoy, Ann Arbor, MI, Jennifer H. Mieres, Lake Success, NY, Mary N. Walsh, Indianapolis, IN ACC.12 Final Program 185

HF SyMpOSiUM

694

lVAD as Destination Therapy for Advanced Heart Failure Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S406b CMe/CNe Hours: 1.5 Joseph G. Rogers, Durham, NC Randall C. Starling, Cleveland, OH Current State and Up and Coming in MCS Paul J. Mather, Philadelphia, PA When to Support Andrew Boyle, Milwaukee, WI Modeling Risk Assessment Jennifer Cowger, MI BTT and DT: is There a Difference? Jeffrey Teuteberg, Pittsburgh, PA long-term Support: What Are the pitfalls? Shashank Desai, Fairfax, VA Transitioning Back to the Community Kathleen Grady, Chicago, IL

iMAG SyMpOSiUM

697

Co-Chairs: 10:30 10:45 11:00 11:15 11:30 11:45

Co-Chairs: 10:30 10:45 11:00 11:15 11:27 11:45

HF SyMpOSiUM

695

Management of peripartum Cardiomyopathy: Update 2012 Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S404 CMe/CNe Hours: 1.5 Uri Elkayam, Los Angeles, CA Kismet Rasmusson, Salt Lake City, UT Racial Differences in Risk and Outcomes in peripartum Cardiomyopathy Kalgi A. Modi, Shreveport, LA Bromocriptine and Recovery Julie Damp, Nashville, TN Risk of Subsequent pregnancies Angela Kealey, Canada internet as Clinical Resource and Research Tool Jordan Safirstein, NJ NHlBi ppCM Network and the ipAC Study Dennis M. McNamara, Pittsburgh, PA

pRACTiCe expeRTS

Co-Chairs: 10:30

244

Co-Chairs: Panelists:

10:48 11:06 11:24 11:42

pReV expeRTS

245

Chair: Case Presenters: Panelists:

Monday, March 26, 2012 ACC.12

pReV SyMpOSiUM

698

Vitamins and Supplements in Cardiovascular Disease prevention Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S100c CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-142-l04-p Lynne Braun, Chicago, IL Elizabeth A. Jackson, Ann Arbor, MI Vitamin D and CVD Erin Michos, Baltimore, MD Dietary Supplements: Use and Misuse Rhonda M. Cooper-DeHoff, Gainesville, FL Role of integrative Medicine in CVD prevention Sara Warber, Ann Arbor, MI intensive lifestyle Changes for the Treatment of Coronary Heart Disease Dean Ornish, Sausalito, CA Joint Symposium of the preventive Cardiovascular Nurses Association and the American College of Cardiology Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S105d CMe/CNe Hours: 1.5 Barbara Fletcher, Jacksonville Beach, FL Welcome and Symposium Objectives Barbara Fletcher, Jacksonville Beach, FL Maximizing Team efforts for improving patient Outcomes Alan S. Brown, Naperville, IL improving patient Adherence to Complex Regimens Cindy Lamendola, Palo Alto, CA patient Centeredness: What Does it Mean in prevention? Suzanne Hughes, Akron, OH Team-based patient Care: Adhering to Guidelines Sidney Smith, Jr., Chapel Hill, NC patient education in 2012 Sherry Bumpus, Ann Arbor, MI Discussion/Question and Answer lies, Damned lies and Statistics: pitfalls in literature interpretation Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N427 CMe/CNe Hours: 1.5 Robert A. Harrington, Durham, NC Sharon-Lise T. Normand, Boston, MA Non-inferiority Studies Ralph B. DAgostino, Boston, MA propensity Scores and instrumental Variables Robert W. Yeh, Boston, MA Secondary endpoints and Subgroup Analyses in Clinical Trials Salim Yusuf, Hamilton, Canada Reclassification and Discrimination Michael Pencina, Boston, MA Small effect Size and Number Needed to Treat Sanjay Kaul, Los Angeles, CA

QUAl SyMpOSiUM

742

The Future of Cardiovascular Diseases: Where Are We Going (and Where Do We Want to Go) Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N426 CMe/CNe Hours: 1.5 John Gordon Harold, Los Angeles, CA William A. Zoghbi, Houston, TX United Nations Summit: The prevention of Noncommunicable Diseases among Women Nanette Kass Wenger, Atlanta, GA Million Hearts: preventing a Million Hearts Attacks and Strokes in Five years Janet S. Wright, Baltimore, MD Transformation of Cardiovascular practice and Care in the emerging World Jack Lewin, Washington, DC Global prevention of Cardiovascular Diseases Dorairaj Prabhakaran, New Delhi, India panel Discussion late-Breaking Clinical Trials iV Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, Hall B, ACC.12 Main Tent CMe/CNe Hours: 1.5 Peter A. Brady, Rochester, MN Karol E. Watson, Los Angeles, CA Christie M. Ballantyne, Houston, TX, C. Noel Bairey Merz, Los Angeles, CA, Jorge Plutzky, Boston, MA Comparison of Bariatric Surgical procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in patients with Moderate Obesity: 1-year STAMpeDe Trial Results Philip Raymond Schauer, Sangeeta Kashyap, Kathy Wolski, Stacy Brethauer, John Kirwanj, Claire Pothier, Susan Thomas, Beth Abood, Steven Nissen, Deepak Bhatt, Cleveland Clinic, Cleveland, OH panel Discussion A Mendelian Randomized Controlled Trial of long-term Reduction in low-density lipoprotein Cholesterol Beginning early in life Brian Anthony Ference, Nitin Mahajan, Issa Alesh, Wonsuk Yoo, Karolina K. Mirowska, Abhishek Mewada, Luis Afonso, Joel Kahn, Kim Williams, John Flack, Wayne State University School of Medicine, Detroit, MI panel Discussion A Randomized, Double-blind, placebo-controlled Trial of the Safety and efficacy of a Monoclonal Antibody to proprotein Convertase Subtilisin/Kexin Type 9 Serine protease, ReGN727/SAR236553, in patients with primary Hypercholesterolemia (NCT: 01288443) James McKenney, Michael Koren, Dean Kereiakes, Corinne Hanotin, ANNE-CATHERINE FERRAND, Evan Albert Stein, Regeneron Pharmaceuticals, Incorporated, Tarrytown, NY, Sanofi-aventis US Incorporated, Bridgewater, NJ panel Discussion

Co-Chairs: 10:30

Co-Chairs: 10:30

Morning

10:48 11:06 11:24

10:50

11:10 11:30 11:50

SpeCiAl SpeCiAl

pReV SyMpOSiUM

699

306

Chair: 10:30 10:35 10:50 11:05 11:20 11:35 11:50

QUAl SyMpOSiUM

Co-Chairs: Panelists: 10:30

10:45 10:52

700

Co-Chairs: 10:30 10:48 11:06 11:24 11:42

11:07 11:14

11:29

186 GO for ACC.12!

ACC.12 Monday, March 26, 2012

11:36 pacemaker Therapy in patients with Neurallymediated Syncope and Documented Asystole Michele Brignole, on the behalf of the ISSUE-3 Investigators, Ospedali del Tigullio, Lavagna, Italy panel Discussion young investigators Award Competition: Cardiovascular Health Outcomes and population Genetics Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N230 CMe/CNe Hours: 1.5 Paul Chan, Kansas City, MO Rajendra Mehta, Ann Arbor, MI Leslee J. Shaw, Atlanta, GA 408 4 Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy Chad R. Brodt, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL 408 5 An indirect pooled Comparison of Clinical endpoints with eplerenone and Other Aldosterone Antagonists in Heart Failure: A Systematic Review Saurav Chatterjee, Chaim Moeller, Nidhi Shah, Oluwaseyi Bolorunduro, Norbert Moskovits, Edgar Lichstein, Debabrata Mukherjee, Maimonides Medical Center, Brooklyn,NY, NY, Texas Tech University Health Sciences Center, El Paso, TX 408 6 Vitamin D Deficiency is Associated with Diastolic Dysfunction in Children with Chronic Kidney Disease Amit Patange, Rudolph Valentini, Wei Du, Michael Pettersen, Childrens Hospital of Michigan, Detroit, MI 408 7 Differences in the Outcome of patients Undergoing percutaneous Coronary interventions at Teaching versus Non-teaching Hospitals Amneet Sandhu, Dean Smith, Hitinder S. Gurm, University of Michigan, Ann Arbor, MI 408 8 Cardiac Transplantation in African Americans: A Single Center experience Prakash Goutham Suryanarayana, Hannah Copeland, Mark Friedman, Jack Copeland, University of Arizona, Tucson, AZ, University of California San Diego, San Diego, CA integrative Medicine Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place North, N227b CMe/CNe Hours: 1.5 Jeffery Dusek, Minneapolis, MN Erminia Guarneri, La Jolla, CA A proactive, personalized preventive Approach to Cardiovascular Disease Erminia Guarneri, La Jolla, CA integrative Cardiology: Translating Science into improved Clinical Care Kevin Barrows, San Francisco, CA Chair: Panelists: 11:10 Rationale for Use of integrative Medicine along with Conventional Cardiac Care Courtney Baechler, St. Paul, MN The evidence Base for Use of integrative Medicine for Cardiovascular patients: Model of inpatient integrative Medicine Jeffery Dusek, Minneapolis, MN Question and Answer eCGs in Athletes: The Great eCG Screening Debate and Challenging Cases Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S502 CMe/CNe Hours: 1.5 Sanjay Sharma, London, United Kingdom Joseph Atallah, Edmonton, Canada, Anthony Magalski, Leawood, KS, Barry J. Maron, Minneapolis, MN, Antonio Pelliccia, Rome, Italy To eCG or Not To eCG: All Athletes Should Be Screened Antonio Pelliccia, Rome, Italy To eCG or Not To eCG: All Athletes Should Not Be Screened Barry J. Maron, Minneapolis, MN interpretation of eCGs in Athletes (with ARS) Christine E. Lawless, Chicago, IL panel Discussion Complications of interventions for Valvular Heart Disease Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S505 CMe/CNe Hours: 1.5 Maurice Enriquez-Sarano, Rochester, MN Raoul Bonan, Montreal, Canada, Todd M. Dewey, Dallas, TX Kevin Greason, Rochester, MN, David Messika-Zeitoun, Paris, France Challenging Cases in Anticoagulation Management: Spotlight on the Novel Anticoagulants Monday, March 26, 2012, 10:30 a.m. Noon McCormick Place South, S105a CMe/CNe Hours: 1.5 Heather L. Gornik, Cleveland, OH Samuel Z. Goldhaber, Boston, MA, Jonathan L. Halperin, New York, NY, John Heit, Rochester, MN, Jeffrey I. Weitz, Hamilton, Canada

11:51
SpeCiAl SpeCiAl

11:30

408

11:50
TeST expeRTS

Morning

262

Chair: Judges: 10:30

10:30 10:45 11:10 11:10

VAlV expeRTS

10:45

11:00

246

11:15

Chair: Case Presenters: Panelists:

11:30

VASC expeRTS

264

SpeCiAl SyMpOSiUM

Chair: Panelists:

741

Case Presenter: Aditya M. Sharma, Cleveland, OH

Co-Chairs: 10:30

10:50

ACC.12 Final Program 187

Monday, March 26, 2012 ACC.12

noon SeSSionS
ACC-i2/TCT iNTl. lUNCH

1:20 1:32

502

Joint Session of the Argentine Society of Cardiology and the American College of Cardiology: Carotids Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N226 CMe/CNe Hours: 1.5 John R. Laird, El Macero, CA Carlos M. Barrero, Buenos Aires, Argentina Cesar A. Belziti, Buenos Aires, Argentina, Jorge Atilio Belardi, Buenos Aires, Argentina introduction John R. Laird, El Macero, CA Carotid Disease: Argentine perspective Oscar A. Mendiz, Buenos Aires, Argentina Carotid Disease: US perspective William A. Gray, New York, NY Aortic Disease: Argentine perspective Juan Carlos Parodi, Buenos Aires, Argentina Aortic Disease: US perspective Robert M. Bersin, Seattle, WA lower extremity Vascular Disease: Argentinian perspective Daniel H. Berrocal, Buenos Aires, Argentina lower extremity Vascular Disease: US perspective Mehdi H. Shishehbor, Cleveland, OH Conclusion Carlos M. Barrero, Buenos Aires, Argentina Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Drug-eluting Stents From the early Beginning to New Stent platforms Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N426 CMe/CNe Hours: 1.5 Patrick T. OGara, Boston, MA Jadelson P. Andrade, Salvador-Bahia, Brazil Antonio CP Chagas, Sao Paulo, Brazil introduction Patrick T. OGara, Boston, MA From the Beginning Up to the Second Generation of Drug-eluting Stents: A Decade of learning Luiz Alberto Mattos, Sao Paolo, Brazil Current pattern of DeS Utilization in the United States Ron Waksman, Washington, DC Durable polymers versus Biodegradable Ones: Which is the Best for Device Selection? Pedro A. Lemos, Sao Paulo, Brazil impact of Changing Health Care economics in the United States on Future Use of Drug-eluting Stents David J. Cohen, Kansas City, MO Bioabsorbable everolimus-eluting Stent Research program: State-of-the-Art in 2012 Alexandre Abizaid, Sao Paulo, Brazil

Rationale and Design of the Absorb iii Trial Stephen G. Ellis, Cleveland, OH Conclusion Jadelson P. Andrade, Salvador-Bahia, Brazil Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Coronary Total Occlusions Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N228 CMe/CNe Hours: 1.5 Jack Lewin, Washington, DC Dayi Hu, Beijing, China Jung Han Yoon, Seoul, Republic of Korea introduction Jack Lewin, Washington, DC Current Status of Antegrade Approach for CTO pCi in China Yaling Han, Shenyang, Liaoning, China Complex Antegrade CTO Case example Dimitri Karmpalotis, Atlanta, GA TRi in China and for CTO lesions: Strategic and Technical experience YueJin Yang, Beijing, China prognosis of Successful CTO pCi James Aaron Grantham, Kansas City, MO Retrograde Approach in CTO Jiyan Chen, Guangzhou, China Radial pCi: is it Best Suited for AMi? Michael C. Kim, New York, NY Retrograde CTO Case example William L. Lombardi, Bellingham, WA Conclusion Dayi Hu, Beijing, China Joint Session of the Korean Society of Cardiology and the American College of Cardiology: Treating Complex lesions Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N229 CMe/CNe Hours: 1.5 Martin B. Leon, New York, NY Ki-Bae Seung, Seoul, Republic of Korea introduction Martin B. Leon, New York, NY left Main Case presentation Duk-Woo Park, Seoul 138-736, Republic of Korea left Main Revascularization Decisions: What is on the Horizon? David E. Kandzari, Atlanta, GA left Main lecture Seung-Jung Park, Songpa-Ku Seoul, Republic of Korea imaging Guided Optimal pCi Case presentation Jang-Ho Bae, Daejeon, Republic of Korea imaging Guided Optimal pCi lecture Myeong-Ki Hong, Seoul, Republic of Korea AMi Case presentation Young Keun Ahn, Gwangju, Republic of Korea

ACC-i2/TCT iNTl. lUNCH

Co-Chairs: Panelists: 12:15 12:20 12:32 12:44 12:56 1:08

505

Co-Chairs: Panelists: 12:15 12:20 12:32 12:44 12:56 1:08 1:15 1:20 1:32
ACC-i2/TCT iNTl. lUNCH

NooN

1:20 1:32

ACC-i2/TCT iNTl. lUNCH

503

511

Co-Chairs: Panelist: 12:15 12:20

Co-Chairs: 12:15 12:20 12:25 12:35 12:45 1:00 1:10

12:32 12:44

12:56

1:08

188 GO for ACC.12!

ACC.12 Monday, March 26, 2012

1:25 1:35 AMi lecture Myung Ho Jeong, Gwang Ju, Republic of Korea Conclusion Ki-Bae Seung, Seoul, Republic of Korea Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: Devices: ASDs, VSDs, perivalvular leaks Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S505 CMe/CNe Hours: 1.5 E. Murat Tuzcu, Cleveland, OH Omer Kozan, Izmir, Turkey introduction E. Murat Tuzcu, Cleveland, OH percutaneous Closure of Multiple ASD Case presentation Erdogan Ilkay, Ankara, Turkey percutaneous Closure of Multiple ASD Omer Goktekin, Eskisehir, Turkey Muzaffer Degertekin, Istanbul, Turkey, John F. Rhodes, Durham, NC VSD Closure in Complex Cases Case presentation Oktay Ergene, Izmir, Turkey VSD Closure in Complex Cases Levent Saltik, Istanbul, Turkey Baris Okcun, Istanbul, Turkey, Larry A. Latson, Cleveland, OH percutaneous large prosthetic Mitral Valvular leak Closure Case presentation Cevat Kirma, Istanbul, Turkey percutaneous large prosthetic Mitral Valvular leak Closure Mehmet Okzan, Istanbul, Turkey Kudret Aytemir, Ankara, Turkey, Charanjit S. Rihal, Rochester, MN Conclusion Omer Kozan, Izmir, Turkey ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy interventional Cardiology 2010 Update (B2-K) Monday, March 26, 2012, 12:15 p.m. 2:45 p.m. McCormick Place South, S105a CMe Hours: 2.5 Please refer to the full session listing, listed on page 192, for additional session information.
ACC-i2/TCT expeRTS ACC-i2/TCT expeRTS

2314

Structural Case Reviews Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S102b CMe/CNe Hours: 1.5 Carlos E. Ruiz, New York, NY Peter C. Block, Atlanta, GA Sammy Elmariah, Boston, MA, Prabhu Channabasappa Halkati, Belgaum, India, Pranav Loyalka, Houston, TX, Thomas S. Metkus, Baltimore, MD, Anvesha Singh, Derby, United Kingdom Steven R. Bailey, San Antonio, TX, Zahid Amin, Rush, IL, Samir R. Kapadia, Cleveland, OH Shock and Hemodynamic Support Case Reviews Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S102c CMe/CNe Hours: 1.5 William W. ONeill, Miami, FL Srihari S. Naidu, New York, NY M Chadi Alraies, Cleveland, OH, Joanne Ilustre, Park Ridge, IL, Andrew Edward Kott, Chicago, IL, Emanuele Meliga, Turin, Italy, Syed Tanveer Rab, Atlanta, GA Biswajit Kar, Houston, TX, Erik Magnus Ohman, Durham, NC, Simon R. Dixon, Royal Oak, MI Controversies in Vascular and endovascular Medicine Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S103c CMe/CNe Hours: 1.5 Lawrence A. Garcia, Boston, MA Robert Schainfeld, waltham, MA Renal Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions Herbert Aronow, Ypsilanti, MI Asymptomatic Carotid Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions Marco Roffi, Geneva 1211, Switzerland Deep Venous Thrombosis: Optimal patient Selection and Techniques for endovascular interventions Mohsen Sharifi, Mesa, AZ Acute Stroke intervention: Optimal patient Selection and Techniques for endovascular interventions Alex Abou-Chebl, Louisville, KY iliac and Femoral TASC C/D lesions: Optimal patient Selection and Techniques for endovascular interventions Sahil A. Parikh, Cleveland, OH panel Discussion

Co-Chairs: Case Presenters:

ACC-i2/TCT iNTl. lUNCH

518

Panelists:

Co-Chairs: 12:15 12:20 12:25 Panelists: 12:45 12:50 Panelists: 1:15

ACC-i2/TCT expeRTS

2315

Co-Chairs: Case Presenters:

Panelists:

NooN

ACC-i2/TCT SyMpOSiUM

2633

1:20 Panelists: 1:40

ACC-i2/TCT MOC

Co-Chairs: 12:15

12:30

819

12:45

1:00

2313

Non-Coronary Complications Case Reviews Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S101a CMe/CNe Hours: 1.5 Ziyad M. Hijazi, Chicago, IL Larry Latson, Hollywood, FL Frank J. Arena, Hammond, LA, Gamini Galappatthy, Colombo, Sri Lanka, Ankur Kalra, Camden, NJ, Rikesh Patel, San Antonio, TX, Suresh Vijaybasappa Patted, Belgaum, India Quang T. Bui, Torrance, CA, Jose Wiley, New York, NY, John M. Lasala, Saint Louis, MO

1:15

1:30

Co-Chairs: Case Presenters:

Panelists:

ACC.12 Final Program 189

Monday, March 26, 2012 ACC.12

ACC-i2/TCT SyMpOSiUM

2634

Non-ST-elevation ACS in 2012: What you Need To Know Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S106b CMe/CNe Hours: 1.5 Dean J. Kereiakes, Cincinnati, OH Christopher P. Cannon, Boston, MA Routine invasive Treatment Strategy Keith A. A. Fox, Edinburgh, Scotland, United Kingdom Optimal periprocedural pharmacotherapy for pCi in NSTeACS David J. Moliterno, Lexington, KY Revascularization Strategy(s) for NSTeACS Sorin J. Brener, Brooklyn, NY Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Radial Access Sunil V. Rao, Durham, NC Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Femoral Access Shing-Chiu Wong, New York, NY Specific Risk Cohorts for Consideration Roxana Mehran, New York, NY panel Discussion

ARR iNTl. lUNCH

501

Co-Chairs: 12:15 12:30 12:45 1:00

Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Risk Stratification for Sudden Cardiac Death Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S403 CMe/CNe Hours: 1.5 Stuart Winston, Ann Arbor, MI Shunichi Miyazaki, Osaka, Japan introduction to Session Stuart Winston, Ann Arbor, MI introduction: The Burden of Cardiovascular Disease in the Region, Membership in the Society and initiatives Ongoing or planned Shunichi Miyazaki, Osaka, Japan Noninvasive Testing in Conjunction with lV Function is the Best predictor Eric N. Prystowsky, Indianapolis, IN lV Function Alone is the Best predictor Tohru Masuyama, Nishinomiya, Japan iCDs Should be Used More Judiciously in the primary prevention population Alfred E. Buxton, Boston, MA prophylactic iCD implantation is the Best Way to Reduce the Risk for SCD Takashi Kurita, Tokyo, Japan Conclusion: New insights Gained from the Japanese College of Cardiology experience

Co-Chairs: 12:15 12:20

12:30

1:10

12:45 1:00

1:20 1:30

NooN

ACS iNTl. lUNCH

513

Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: ACS improving Outcomes Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S404 CMe/CNe Hours: 1.5 Eric R. Bates, Ann Arbor, MI Carlos R. Martinez-Sanchez, Mexico City, Mexico Erick Alexanderson, Mexico, DF, Mexico introduction to Session Eric R. Bates, Ann Arbor, MI STeMi Juan P. Verdejo, Mexico City, Mexico Guidelines for ACS: Translating the evidence to Best practice Jeffrey L. Anderson, Murray, UT Treatment Strategy of the Acute Coronary Syndrome patient with left Main Disease Jorge Gaspar-Hernandez, Mexico, DF, Mexico implementing Clinical practice Guidelines in ACS to improve Clinical Outcomes Eric D. Peterson, Chapel Hill, NC How to Select the Best Antiplatelet Therapy in Acute Coronary Syndrome Jose Luis Leiva Pons, San Luis Potosi, Mexico Conclusion: New insights Gained from the Mexican Society of Cardiology experience

1:15

1:30

Co-Chairs:

ARR iNTl. lUNCH

509

12:15 12:20 12:30 12:45

Joint Session of the Cardiological Society of india and the American College of Cardiology: AF Medical, ep, Surgical Options Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S401a CMe/CNe Hours: 1.5 Dipti Itchhaporia, Newport Beach, CA Samuel K. Mathew, Chennai, India introduction to Session Dipti Itchhaporia, Newport Beach, CA Case presentation: Nuance of AF, RHD, Moderate MS/MR in a 50 year-old Navin C. Nanda, Birmingham, AL AF Spectrum: primary and Associated With Valvular/Structural Heart Disease Sanjeev Saksena, Warren, NJ Case presentation: Rheumatic HD with AF and Valvular involvement Amit Vora, Mumbai, India Approaches to the patient with AF and Rheumatic Valvular Heart Disease Ralph J. Damiano, St. Louis, MO Approaches in india to AF Treatment in Rheumatic Heart Disease Calambur Narasimhan, Hyderabad, India New insights Gained from the Cardiological Society of india experience

Co-Chairs: 12:15 12:20

1:00

12:30

1:15

12:45 1:00

1:30

1:15

1:30

190 GO for ACC.12!

ACC.12 Monday, March 26, 2012

CCS iNTl. lUNCH

506

Joint Session of the egyptian Society of Cardiology and the American College of Cardiology: Adult Congenital Heart Disease: Where We Came from and Where We Are Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N231 CMe/CNe Hours: 1.5 Gerard R. Martin, Washington, DC Mohamed Sobhy Aly, Alexandria, Egypt introduction to Session Gerard R. Martin, Washington, DC Changing the Face of ACHD in egypt Magdi H. Yacoub, Harefield, Middlesex, United Kingdom Where We Are Now: The epidemiology and ACHD Databases in North America Paul Khairy, Montreal, Canada Multimodality Non-invasive imaging for Assessment of Adult Congenital Heart Disease Magdy Rashwan, Alexandria, Egypt Cath like an egyptian Congenital interventionalist Makram R. Ebeid, Jackson, MS Catheter intervention in Adult Congenital Heart Disease: Cairo University experience Khaled Sorour, Cairo, Egypt Conclusion: New insights Gained from the egyptian Society of Cardiology experience

iMAG iNTl. lUNCH

507

Joint Session of the German Cardiac Society and the American College of Cardiology: imaging evolving Strategies Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S406b CMe/CNe Hours: 1.5 William A. Zoghbi, Houston, TX Christoph Bode, Freiburg, Germany introduction to Session William A. Zoghbi, Houston, TX Case presentation: imaging evolving Strategies Orlando Escarcega, Philadelphia, PA emerging imaging Modalities in Guiding Valvular interventions Linda D. Gillam, New York, NY imaging: Cardiac Vessels Raimund A. Erbel, Essen, Germany Role of 3-D echo Frank E. Silvestry, Wayne, PA imaging: Myocardium Georg Ertl, Wuerzburg, Germany Conclusion: New insights Gained from the German Cardiac Society experience Joint Session of the British Cardiovascular Society and the American College of Cardiology: NiCe Guidelines Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N427 CMe/CNe Hours: 1.5 John Gordon Harold, Los Angeles, CA Iain A. Simpson, Southampton, United Kingdom introduction to Session John Gordon Harold, Los Angeles, CA introduction to Guideline preparation: A UK perspective Huon Gray, Southampton, United Kingdom Biomarkers of ischemia: Clinical practice and Guidelines David A. Morrow, Boston, MA Stable Angina: A UK perspective Robert A. Henderson, Nottingham, United Kingdom international participation in NiH and NHS Studies: Not Always NiCe (Applicability, ethical and Financial Considerations) Richard A. Lange, San Antonio, TX ACS: A UK perspective Mark A. de Belder, Middlesbrough, United Kingdom Conclusion: New insights Gained from the British Cardiovascular Society experience

Co-Chairs: 12:15 12:20 12:30

Co-Chairs: 12:15 12:20 12:30 12:45 1:00 1:15 1:30

12:45

1:00 1:15

iSCHeM iNTl. lUNCH

NooN

1:30

508

HF iNTl. lUNCH

517

Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Heart Failure Devices to Transplantation Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S501a CMe/CNe Hours: 1.5 Juan M. Aranda, Gainesville, FL Nicolas Manito, Barcelona, Spain introduction to Session Juan M. Aranda, Gainesville, FL Heart Failure: Devices to Transplantation Akshay S. Desai, Boston, MA Contemporary pharmacologic Management of Advanced Heart Failure Lee R. Goldberg, Philadelphia, PA Current indications and Controversies in CRT Juan Delgado, Madrid, Spain Hemodynamic Monitoring Devices in Heart Failure Robert C. Bourge, Birmingham, AL Destination lVAD and Current Role for Heart Transplantation Javier Segovia, Madrid, Spain Conclusion: New insights Gained from the Spanish Society of Cardiology experience

Co-Chairs: 12:15 12:20

Co-Chairs: 12:15 12:20 12:30

12:30 12:45 1:00

12:45 1:00 1:15 1:30

1:15 1:30

ACC.12 Final Program 191

Monday, March 26, 2012 ACC.12

liFelONG MOC

819

ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy interventional Cardiology 2010 Update (B2-K) Monday, March 26, 2012, 12:15 p.m. 2:45 p.m. McCormick Place South, S105a CMe Hours: 2.5 Paul Sorajja, Rochester, MN

of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
pReV iNTl. lUNCH

Chair:

MOC Faculty: John A. McPherson, Nashville, TN, Alan Zajarias, Saint Louis, MO ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
liFelONG MOC

512

Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant Hypertension Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S504a CMe/CNe Hours: 1.5 Richard A. Chazal, Fort Myers, FL Kui-Hian Sim, Sarawak, Malaysia introduction to Session Richard A. Chazal, Fort Myers, FL Challenging Cases from Malaysia Wan Azman Wan Ahmad, Malaya, Malaysia Hypertension Strategies: From Simple to Complex David J. Becker, Philadelphia, PA percutaneous Renal interventions Robaayah Zambahari, Kuala Lumpur, Malaysia Sequential Selections: Choosing/Adding Agents Marc E. Shelton, Springfield, IL Conclusion: New insights Gained from the National Heart Association of Malaysia experience

NooN

Co-Chairs: 12:15 12:20 12:45 1:00 1:15 1:30

820

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easyClinical Cardiac electrophysiology, 2010 Update (B3-K) Monday, March 26, 2012, 12:15 p.m. 2:45 p.m. McCormick Place South, S105d CMe Hours: 2.5 Peter A. Brady, Rochester, MN

pReV iNTl. lUNCH

516

Chair:

MOC Faculty: Kristen K. Patton, Seattle, WA, Sherry Saxonhouse, Charlotte, NC ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start Co-Chairs: 12:15 12:22 12:39 12:56

Joint Session of the South American Society of Cardiology and the American College of Cardiology: prevention Assessing and educating across Regions Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S502 CMe/CNe Hours: 1.5 Ralph G. Brindis, Oakland, CA Maria Paniagua de Decoud, Asuncion, Paraguay introduction to Session Ralph G. Brindis, Oakland, CA Heart Failure in South America Hector O. Ventura, New Orleans, LA Cardio-prevention Strategies in South America Paola Varleta, Santiago, Chile Utilizing imaging for Cardiovascular prevention Miguel A. Quinones, Houston, TX

192 GO for ACC.12!

ACC.12 Monday, March 26, 2012

1:13 Diet, exercise, Vitamins and Other Non-prescription Therapeutics Jorge Lerman, Buenos Aires, Argentina Conclusion: New insights Gained from the South American Society of Cardiology experience
pReV SyMpOSiUM QUAl iNTl. lUNCH

515

1:30

Joint Session of the Saudi Heart Association and the American College of Cardiology: Quality Registries Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N227b CMe/CNe Hours: 1.5 Frederick A. Masoudi, Denver, CO Hani Najm, Riyadh, Saudi Arabia introduction to Session Frederick A. Masoudi, Denver, CO Case Outcomes: Quality Registries Paul D. Varosy, Denver, CO establishing a Useful Quality Registry John S. Rumsfeld, Denver, CO Acute Heart Failure: Real life versus Clinical Trials Khalid F. Alhabib, Riyadh, Saudi Arabia Heart Function Clinic: Real life versus Clinical Trials Abdelfatah A. Elasfar, Riyadh, Saudi Arabia Using Registry Data to inform Quality improvement Hitinder S. Gurm, Ann Arbor, MI Conclusion: New insights Gained from the Saudi Heart Association experience

701

Role of physical Activity in CVD prevention Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S100c CMe/CNe Hours: 1.5 Barbara Fletcher, Jacksonville Beach, FL Elizabeth A. Jackson, Ann Arbor, MI Biophysiological effects of physical Activity on CVD Reduction Gerald Fletcher, Jacksonville, FL physical Activity in primary prevention Vera Bittner, Birmingham, AL Role of exercise Following ACS Barry A. Franklin, Royal Oak, MI Use of the internet to improve physical Activity Caroline Richardson, Ann Arbor, MI issues of Adherence and Quality of life Jane Nelson Worel, Middleton, WI

Co-Chairs: 12:15 12:20 12:30 12:45 1:00 1:15 1:30

Co-Chairs: 12:15 12:33 12:51 1:09 1:27

NooN

QUAl iNTl. lUNCH

510

Joint Session of the israel Heart Society and the American College of Cardiology: pCi Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place North, N230 CMe/CNe Hours: 1.5 George D. Dangas, New York, NY Chaim Lotan, Jerusalem, Israel introduction to Session George D. Dangas, New York, NY Case presentation: Strategies to Reduce Bleeding in patients with ACS undergoing pCi Aryeh Shalev, Los Angeles, CA Aaron D. Kugelmass, Springfield, MA, Amit Segev, Tel Aviv, Israel panel Discussion establishing a Useful pCi Registry to inform Outcomes John C. Messenger, Aurora, CO Case presentation: Treatment of the Non-culprit lesion in patients with ACS STeMi and NSTeMi Mony Shuvy, Jerusalem, Israel Aaron D. Kugelmass, Springfield, MA, Yoseph Rozenman, Holon, Israel panel Discussion Qi examples to improve pCi Outcomes Steven P. Marso, Kansas City, MO Conclusion: New insights Gained from the israel Heart Society experience

SpeCiAl SpeCiAl

113

FiT Forum iV: Guidance for the First Steps of your Cardiology Career Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S402 CMe Hours: 1.5 Welcome Justin Matthew Bachmann, Dallas, TX How Do you pass the Boards? David E. Winchester, Gainesville, FL Another perspective on Boards Joseph G. Murphy, Rochester, MN Question and Answer interviewing Tips and Contract Negotiations Susan Childs, Rougement, NC Question and Answer Financial planning for Future Cardiologists Michael F. Merrill, Portland, OR Financial planning for Future Cardiologists Anders Ramstad, Portland, OR Question and Answer

Co-Chairs: 12:15 12:20

12:15 12:20 12:30 12:40 12:45 1:10 1:15 1:27 1:40

VAlV iNTl. lUNCH

Panelists: 12:25 12:40 12:55

Panelists: 1:00 1:15 1:30

504

Joint Session of the Canadian Cardiovascular Society and the American College of Cardiology: Repairs/Replacement: Catheter-based or (Minimally invasive) Surgery Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S405 CMe/CNe Hours: 1.5 David R. Holmes, Jr., Rochester, MN Blair J. ONeill, Edmonton, Canada introduction to Session David R. Holmes, Jr., Rochester, MN

Co-Chairs: 12:15

ACC.12 Final Program 193

Monday, March 26, 2012 ACC.12

12:20 Three-Dimensional echocardiographic imaging of Catheter-based Valve Treatment Joseph Maalouf, Rochester, MN Minimally invasive Mitral Repair W. Randolph Chitwood, Greenville, NC TAVi: World-wide and Canadian Results and existing and Changing indications Josep Rodes-Cabau, Quebec, Canada periprosthetic Regurgitation Closure Charanjit S. Rihal, Rochester, MN Structural Heart Disease interventions: Now and Over the Next Ten years Anita W. Asgar, Montreal, Canada Conclusion: New insights Gained from the Canadian Cardiovascular Society experience
VASC iNTl. lUNCH

1:00 1:15
ACC-i2/TCT CASe ReVieW

Multi-vessel pCi Guided FFR William Fuller Fearon, Stanford, CA perforation Thomas Tu, Louisville, KY live and Taped Case Sesion iii: Valvular Heart Disease Monday, March 26, 2012, 12:30 p.m. 2:30 p.m. McCormick Place North, Hall B, ACC.12 Main Tent CMe/CNe Hours: 2 John G. Webb, Vancouver, Canada Michael J. Mack, Plano, TX James Bernard Hermiller, Indianapolis, IN, Rebecca T. Hahn, New York, NY, Jonathon Leipsic, Vancouver, BC, Ganesh Manoharan, Belfast, United Kingdom, G. Alain Cribier, Rouen, France, John Carroll, Aurora, CO, Vasilis Babaliaros, Atlanta, GA, Augusto Pichard, Washington, DC live Case from the University of pennsylvania, philadelphia, pA Howard C. Herrmann, Philadelphia, PA Requirements for a Successful TAVR program: The Multi-disciplinary Heart Team and Beyond Samir R. Kapadia, Cleveland, OH A Surgeons perspective of Aortic Valve Therapy in the era of TAVR Vinod H. Thourani, Atlanta, GA Status Update on Transcatheter Mitral Valve Therapies Ted Feldman, Evanston, IL panel Discussion Taped Case from Cedars-Sinai Medical Center, los Angeles, CA Saibal Kar, Los Angeles, CA Fellows Bootcamp: Structural Heart Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S103b CMe Hours: 1.5 Raoul Bonan, Montreal, Canada D. Scott Lim, Charlottesville, VA Adult Congenital intervention (ASD/pFO.) D. Scott Lim, Charlottesville, VA Transseptal Technique: Hemodynamic Aortic and Mitral Valve Raoul Bonan, Montreal, Canada TAVi and BAV Jeffrey J. Popma, Newton, MA percutaneous Mitral Repair and Replacement Anita W. Asgar, Montreal, Canada left Appendage Closure Saibal Kar, Los Angeles, CA Roundtable Discussion

12:30 12:45

2203

1:00 1:15

Co-Chairs: Panelists:

1:30

514

Joint Session of the pakistan Cardiac Society and the American College of Cardiology: VTe, pHTN Monday, March 26, 2012, 12:15 p.m. 1:45 p.m. McCormick Place South, S503 CMe/CNe Hours: 1.5 Shahbudin H. Rahimtoola, Los Angeles, CA Azhar Faruqui, Karachi, Pakistan introduction to Session Shahbudin H. Rahimtoola, Los Angeles, CA A Case of Recurrent VTe Resulting in pHTN Syed Zahid Jamal, Karachi, Pakistan Clinical Recognition and prevention of DVT Khan Shah Zaman, Karachi, Pakistan Venous Thromboembolism (VTe) as it Related to Chronic Thromboembolic Disease William R. Auger, San Diego, CA US experience with endovascular Management of DVT Riyaz Bashir, Philadelphia, PA Medical Management and Device Treatment of Chronic Recurrent VTe Syed Zahid Jamal, Karachi, Pakistan Conclusion: New insights Gained from the pakistan Cardiac Society experience

12:30

1:15

Co-Chairs:

noon

12:15 12:20 12:30 12:45

1:25 1:35 1:50 2:00

ACC-i2/TCT SpeCiAl

1:00 1:15

2114

AFTERNOON

Co-Chairs: 2:00 2:15 2:30

1:30

Afternoon SeSSionS
ACC-i2/TCT SpeCiAl

2:45 3:00 3:15

2113

Fellows Bootcamp: Case Reviews Monday, March 26, 2012, 12:30 p.m. 1:30 p.m. McCormick Place South, S103b CMe Hours: 1 Thomas Tu, Louisville, KY Ajay J. Kirtane, New York, NY pCi left Main Radial pCi Sunil V. Rao, Durham, NC i Cant Get the *?@# Stent There Ajay J. Kirtane, New York, NY

Co-Chairs: 12:30 12:45

194 GO for ACC.12!

ACC.12 Monday, March 26, 2012

ACC-i2/TCT SpeCiAl

2132

Anatomy and Transcatheter Therapy for the Structural Heart interventionalist ii: left Atrial Appendage Closure, pFO, ASD and Transseptal puncture (with Remote Demonstrations from the Seattle Science Foundation) Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102c CMe/CNe Hours: 1.5

2:38

The Role of imaging in THV Choice: its Not Just about the Annulus Self-expanding THV Ganesh Manoharan, Belfast, United Kingdom The Role of imaging in THV Choice: its Not Just about the Annulus imaging Clues to Select one Valve Over the Other Stamatios Lerakis, Atlanta, GA panel Discussion: Which imaging Modality is the Most Useful in TAVR? CT-MRi Paul Schoenhagen, Cleveland, OH panel Discussion: Which imaging Modality is the Most Useful in TAVR? Tee Robert J. Siegel, Los Angeles, CA panel Discussion: Which imaging Modality is the Most Useful in TAVR? Fluoroscopy/Angiography Augusto Pichard, Washington, DC imaging Approach to Choosing Vascular Access: Femoral Artery, Subclavian Artery, Aortic or Apical Access Dominik Fleischmann, Stanford, CA Role of imaging in predicting and preventing Stroke Samir R. Kapadia, Cleveland, OH Spotlight Session on TAVR Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S102b CMe/CNe Hours: 1.5 D. Craig Miller, Stanford, CA Lars G. Svensson, Cleveland, OH How to Choose patients for TAVR vs Open AVR Blase A. Carabello, Houston, TX The procedure Working Together, the Heart Valve Team Concept, is it Real? Michael J. Mack, Plano, TX Training Requirements: Training, Site Readiness the Societys View Helene Eltchaninoff, Rouen, France Debate:TAVR The Future is Bright, TAVR Will Grow Well Beyond the inoperable patient Martin B. Leon, New York, NY Debate: TAVR TAVR Will Remain limited to inoperable and Very High Risk patients Due to Complications Neil E. Moat, London, United Kingdom Can We Afford TAVR: impact on Hospitals and CMS David J. Cohen, Kansas City, MO Management of Symptomatic Severe Carotid Artery Disease Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S103c CMe/CNe Hours: 1.5 Daniel G. Clair, Cleveland, OH Jay S. Yadav, Atlanta, GA patient and equipment Selection to Optimize Carotid Stent Outcomes in Symptomatic patients Gary S. Roubin, New York, NY

2:44

2:50

Remote Mark Reisman, Seattle, WA Demonstrator: Co-Chairs: Panelists: John D. Carroll, Aurora, CO Carlos E. Ruiz, New York, NY Ziyad M. Hijazi, Chicago, IL, Steven J. Yakubov, Columbus, OH, Michael J. Landzberg, Boston, MA, Matthew J. Price, La Jolla, CA, Horst Sievert, Frankfurt, Germany, Saibal Kar, Los Angeles, CA pFO and ASD Anatomy Mark Reisman, Seattle, WA Case presentation: pFO John D. Carroll, Aurora, CO Case presentation: ASD Ziyad M. Hijazi, Chicago, IL Anatomical perspectives for pFO and ASD Devices Mark Reisman, Seattle, WA left Atrial Appendage Anatomy Mark Reisman, Seattle, WA Case presentation: left Atrial Appendage Closure Device Saibal Kar, Los Angeles, CA Case presentation: left Atrial Appendage Closure Device Horst Sievert, Frankfurt, Germany Case presentation: left Atrial Appendage ligation Device Steven J. Yakubov, Columbus, OH Anatomical perspectives of left Atrial Appendage Devices Mark Reisman, Seattle, WA panel Discussion imaging Transcatheter Aortic Valve procedures ii: Selecting the Best patient, Valve and Vascular Approach Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S101a CMe/CNe Hours: 1.5 Augusto Pichard, Washington, DC Igor F. Palacios, Boston, MA life after pARTNeR: Where We Go from Here Martin B. Leon, New York, NY Aortic Valve Anatomy: Understanding the Transcatheter Valve landing Zone Jeffrey J. Popma, Newton, MA patient Selection for TAVR: Role of echocardiography Robert J. Siegel, Los Angeles, CA The Role of MRi and CT for the Aortic Valvular Complex and Arteries Paul Schoenhagen, Cleveland, OH The Role of imaging in THV Choice: its Not Just about the Annulus Balloon-expandable THV Robert R. Moss, Vancouver, Canada

2:58

3:06

2:00 2:15 2:20 2:25 2:40 2:55 3:00 3:05 3:10 3:25
ACC-i2/TCT SyMpOSiUM

3:14

3:22

ACC-i2/TCT SyMpOSiUM

2636

Co-Chairs: 2:00 2:15

2:30

2635

2:45

AFTERNOON

3:00

Co-Chairs: 2:00 2:08

3:15

ACC-i2/TCT SyMpOSiUM

2:16 2:24

2637

Co-Chairs: 2:00

2:32

ACC.12 Final Program 195

Monday, March 26, 2012 ACC.12

2:15 2:30 Acute Stroke Therapy: State-of-the-Art Stephen R. Ramee, New Orleans, LA Debate: Carotid Stenting Should be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients Herbert D. Aronow, Ypsilanti, MI Debate: Carotid Stenting Should Not be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients Anthony J. Comerota, Toldeo, OH Case presentation: When and How to Treat Common Carotid, Subclavian and innominate Stenosis Douglas E. Drachman, Boston, MA panel Discussion State-of-the-Art STeMi: All you Need to Know Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S106b CMe/CNe Hours: 1.5 Erik Magnus Ohman, Durham, NC Bruce R. Brodie, Greensboro, NC Optimizing Time to Treatment for STeMi: emphasis on Total ischemic Time Alice K. Jacobs, Boston, MA Optimal Adjunctive pharmacotherapy for primary pCi George Dangas, New York, NY Strategies for Thrombus Removal C. Michael Gibson, Boston, MA Mechanical Support for Treatment of Cardiogenic Shock and Hemodynamic instability John M. Lasala, Saint Louis, MO protective and Reparative Therapies in STeMi Timothy D. Henry, Minneapolis, MN illustrative Case example and panel Discussion Eric R. Bates, Ann Arbor, MI
ARR SyMpOSiUM HF SyMpOSiUM CCS expeRTS

Co-Chairs: 2:00 2:18 2:36 2:54 3:12

Stefan H. Hohnloser, Frankfurt am Main, Germany Robert Myerburg, Miami, FL The ederly patient Steven M. Markowitz, New York, NY The Athlete with Syncope Andrew E. Epstein, Philadelphia, PA patients with Structural Heart Disease and lVeF >35% Robert Myerburg, Miami, FL patients with a Family History of Sudden Cardiac Death Hugh Calkins, Baltimore, MD eCG Features That May indicate a potenitally life Threatening Arrhythmia as the Cause for Syncope Joseph Edward Marine, Baltimore, MD Acquired Heart Disease in Childhood epidemiology: Current and Future Management Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S501a CMe/CNe Hours: 1.5 Jane Newburger, Boston, MA Sarah De Ferranti, Boston, MA, Peter Morelli, Stoneybrook, NY, Masato Takahashi, CA, Lloyd Y. Tani, Salt Lake City, UT Cardiac Resynchronization Therapy: Whom to Refer for implantation? Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406b CMe/CNe Hours: 1.5 James P. Daubert, Durham, NC Marc Pfeffer, Boston, MA Mechanical and eletrical effects of Cardiac Resynchronization Therapy David Spragg, Baltimore, MD echocardiographic evidence for CRT effects on Myocardial Structure and Function Scott D. Solomon, Boston, MA Role of QRS Duration and Morphology in Selecting patients for CRT-D Wojciech Zareba, Rochester, NY effect of CRT on Heart Failure and Arrhythmia endpoints Michael Robert Gold, Charleston, SC CRT in Atrial Fibrillation patients: Feasibility and effects Jonathan S. Steinberg, New York, NY panel Discussion

2:45

3:00

3:15
ACC-i2/TCT SyMpOSiUM

2638

247

Co-Chairs: 2:00 2:15 2:30 2:45

Chair: Panelists:

Case Presenter: Agustin E. Rubio, Seattle, WA

704

3:00 3:15

Co-Chairs: 2:00

AFTERNOON

702

Sudden Cardiac Death Risk Stratification in Heart Failure: past, present and Future Directions Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S406a CMe/CNe Hours: 1.5 A. John Camm, London, United Kingdom Assessment of lV Function Sumeet Chugh, CA Markers of Autonomic Tone Marek Malik, Surrey, United Kingdom T Wave Alternans Richard L. Verrier, Boston, MA electrophysiologic Study Ralph J. Verdino, Philadelphia, PA imaging to predict Sudden Death: Going Beyond the ejection Fraction Alan H. Kadish, Chicago, IL Genomics Dawood Darbar, Nashville, TN

2:16

2:32 2:48 3:04 3:20

HF SyMpOSiUM

Chair: 2:00 2:15 2:30 2:45 3:00 3:15

ARR SyMpOSiUM

705

Understanding the Complexity of the Right Ventricle: Challenges and progress Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S404 CMe/CNe Hours: 1.5 Teresa De Marco, San Francisco, CA Srinivas Murali, Pittsburgh, PA Decompensated Right Heart Failure: pharmacologic Support Paul R. Forfia, Philadelphia, PA

703

Syncope in Special populations Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N227b CMe/CNe Hours: 1.5

Co-Chairs: 2:00

196 GO for ACC.12!

ACC.12 Monday, March 26, 2012

2:13 2:26 2:40 2:53 The Right Ventricle in pAH: The Determinant Factor Vallerie V. McLaughlin, Ann Arbor, MI Assessing the RV during exercise Gregory D. Lewis, Boston, MA Decompensated Right Heart Failure: Mechanical Approaches Myung H. Park, Baltimore, MD evaluation and Management of Right Heart Failure in Severe lV Dysfunction: is the RV Healthy enough for Advanced Therapies? Marc A. Simon, Pittsburgh, PA Clinical Scenarios of Concordant and Discordant RV and lV Failure Navin Rajagopalan, Lexington, KY Question and Answer
HF SyMpOSiUM

3:15

echo Assessment of the Tricuspid Valve Muhamed Saric, New York, NY

iMAG

SyMpOSiUM

708

Advances in Nuclear Cardiology: Current and Future Applications Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S403 CMe/CNe Hours: 1.5 George A. Beller, Charlottesville, VA E. Gordon DePuey, III, New York, NY Advances in SpeCT Hardware and Software: Where Are We and What is Applicable ? Milena J. Henzlova, New York, NY Radiation Reduction in SpeCT: How to Maximize the yield with protocols and Technology Advances John J. Mahmarian, Houston, TX Non-Coronary Advances in SpeCT: emerging Role of MiBG imaging in Heart Failure Risk Stratification Mark I. Travin, Pleasantville, NY BMipp SpeCT imaging in Acute Chest pain imaging Vasken Dilsizian, Baltimore, MD SpeCT in Cardiac Dyssynchrony Ernest V. Garcia, Atlanta, GA Molecular Applications of SpeCT imaging: Atherosclerosis, Apoptosis and Beyond Albert J. Sinusas, New Haven, CT Transitioning from ACS to Stable ischemic Heart Disease Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S401a CMe/CNe Hours: 1.5 Donna M. Polk, Hartford, CT Nanette Kass Wenger, Atlanta, GA Antiplatelet Therapy: From Start to Finish Stephen D. Wiviott, Boston, MA Question and Answer Risk Stratification: Who Gets What and When? Rita F. Redberg, San Francisco, CA Question and Answer Sexual Activity: is Dont Ask, Dont Tell the Best policy? Richard A. Lange, San Antonio, TX Question and Answer Cardiac Rehabilitation: Why Break a Sweat? Vera Bittner, Birmingham, AL Question and Answer Core Curriculum: Cardiac Catheterization Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N226 CMe/CNe Hours: 1.5 Zoltan G. Turi, Camden, NJ Angiography: Approach to interpretation and pitfalls Ajay J. Kirtane, New York, NY

Co-Chairs: 2:00

3:07 3:20

2:15

706

Joint Symposium of the italian Federation of Cardiology and the pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial Fibrillation Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N230 CMe/CNe Hours: 1.5 Gerald V. Naccarelli, Hershey, PA Marino Scherillo, Benevento, Italy Catheter Ablation for Atrial Fibrillation: patient Selection, efficacy and Anticoagulation Management Francis E. Marchlinski, Bala Cynwyd, PA Atrial Fibrillation Management: The Current Guidelines Sandeep K. Jain, Pittsburgh, PA The Role of New Antithrombotic Drugs in the Treatment of Atrial Fibrillation Salvatore Novo, Rome, Italy New insights in the pathogenesis of Atrial Fibrillation Francesco Romeo, Rome, Italy Question and Answer

2:30

2:45 3:00 3:15

Co-Chairs: 2:00

2:20 2:40

iSCHeM SyMpOSiUM

709

3:00 3:20
iMAG SyMpOSiUM

Co-Chairs: 2:00 2:15 2:23 2:38 2:45 3:00 3:08 3:23

liFelONG CORe

AFTERNOON

707

Management of the patient with Valvular Heart Disease: Role of echo Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S405 CMe/CNe Hours: 1.5 Linda D. Gillam, New York, NY Judy W. Hung, Boston, MA Management of Degenerative Mitral Regurgitation Using 2-D and 3-D echocardiography Vera H. Rigolin, Chicago, IL ischemic Mitral Reurgitation Assessment by echocardiography Judy W. Hung, Boston, MA patient prosthesis Mismatch: Diagnosis and Scope of the problem Philippe Pibarot, Sainte Foy, Canada Stress echocardiography in Management of Valvular Heart Disease Luc Pierard, Lige, Belgium Update on prosthetic Valve Assessment by echocardiography Guidelines Stephen H. Little, Houston, TX

Co-Chairs: 2:00

2:15 2:30

2:45

821

Chair: 2:00

3:00

ACC.12 Final Program 197

Monday, March 26, 2012 ACC.12

2:25 2:50 3:15
liFelONG CORe

left Heart Hemodynamics: HCM, Aortic and Mitral Disease Morton J. Kern, Orange, CA Cardiac Constriction, Restriction, and Tamponade Barry Borlaug, Rochester, MN Question and Answer Core Curriculum: preventive Cardiology Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N229 CMe/CNe Hours: 1.5 Karthikeyan Ananthasubramaniam, West Bloomfield, MI lipids and Cardiovascular Disease Elizabeth A. Jackson, Ann Arbor, MI Diabetes and Cardiovascular Disease David Aguilar, Houston, TX Hypertension and Cardiovascular Disease Andrew M. Kates, Saint Louis, MO Question and Answer
pHTN

2:35 2:50

lifelong education Eric S. Williams, Indianapolis, IN Roundtable Discussion: Rising to the Challenge What Will (Should) Training and education look like in 2022? Justin Matthew Bachmann, Dallas, TX, Lisa A. Mendes, Brentwood, TN, Rick A. Nishimura, Rochester, MN, Chittur A. Sivaram, Oklahoma City, OK, Eric S. Williams, Indianapolis, IN Research: Novel Diagnostic and Therapeutic Strategies for the Future

Panelists:

822

Chair: 2:00 2:25 2:50 3:15

3:15 3:30 3:45

Academic Cardiovascular Research: Where Are We Today? Douglas L. Mann, St. Louis, MO perspective of the NHlBi Sonia I. Skarlatos, Bethesda, MD Roundtable Discussion: Rising to the Challenge What Will (Should) Academic CV Research look like in 2022? Robert O. Bonow, Chicago, IL, James A. De Lemos, Dallas, TX, Douglas L. Mann, Saint Louis, MO, Gordon Tomaselli, Baltimore, MD Break Delivery of Superior, Coordinated Clinical Care efficient, Cost-effective, Coordinated Care in the Academic Setting Marvin A. Konstam, Boston, MA Roundtable Discussion: What Will (Should) Clinical Cardiovascular Care in an Academic Setting look like in 2022? Joseph P. Drozda, Saint Louis, MO, Blair D. Erb, Bozeman, MT, Gregory Ehle, Burlington, VT, Marvin A. Konstam, Boston, MA, Richard J. Kovacs, Indianapolis, IN, Jack Lewin, Washington, DC, Margo B. Minissian, Los Angeles, CA Core principles That Define Our Mission Quo Vadis Academis? David R. Holmes, Jr., Rochester, MN Roundtable Discussion: What Will (Should) the Academic Mission Be in 2022? Pamela S. Douglas, Durham, NC, David R. Holmes, Jr., Rochester, MN, Joseph A. Hill, Dallas, TX, Jack Lewin, Washington, DC Summary and Closing Remarks Joseph A. Hill, Dallas, TX
pReV

Panelists:

expeRTS

249

pearls and Caveats in Managing patients with pulmonary Hypertension Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S505 CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-129-l01-p Michael A. Mathier, Pittsburgh, PA Michael Cuttica, Chicago, IL, Robert P. Frantz, Rochester, MN, Mardi Gomberg-Maitland, Chicago, IL issues That Have Caused Medical professional liability Claims: Are you at Risk? A Special presentation from The Doctors Company Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S504a CMe/CNe Hours: 1.5 Richard A. Chazal, Fort Myers, FL

4:05 4:20

Chair: Panelists:

Case Presenter: Dana McGlothlin, San Francisco, CA

4:35

Panelists:

pRACTiCe expeRTS

248

AFTERNOON

5:00 5:10 Panelists:

Chair:

Case Presenters: Robin Diamond, Napa, CA, David B. Troxel, Napa, CA

pRACTiCe SyMpOSiUM

710

impact of Healthcare policy on the Academic Cardiovascular Mission Monday, March 26, 2012, 2:00 p.m. 5:30 p.m. McCormick Place South, S402 CMe/CNe Hours: 3.5 Joseph A. Hill, Dallas, TX Marvin A. Konstam, Boston, MA Welcome and introduction Joseph A. Hill, Dallas, TX Training the Next Generation of Cardiovascular practitioners

5:30

Co-Chairs: 2:00

expeRTS

250

2:05 2:20

Training Cardiovascular Specialists in 2012 Chittur A. Sivaram, Oklahoma City, OK perspective of ACGMe Thomas J. Nasca, Chicago, IL education for a lifetime

labile Hypertension: evaluation and Management Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S502 CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-130-l01-p Franz H. Messerli, New York, NY Ronald G. Victor, Los Angeles, CA, Wanpen Vongpatanasin, Dallas, TX Joshua A. Beckman, Boston, MA, Suzanne Oparil, Birmingham, AL, Andrew R. Weintraub, Boston, MA

Chair: Case Presenters: Panelists:

198 GO for ACC.12!

ACC.12 Monday, March 26, 2012

pReV SyMpOSiUM

711

Joint Symposium of the American Association of Clinical endocrinologists and the American College of Cardiology: Cardiologists as endocrinologists emerging Management of the Diabetic patient Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S100c CMe/CNe Hours: 1.5 Samuel Dagogo-Jack, Memphis, TN Mikhail Kosiborod, Leawood, KS The Comprehensive Approach to Treating Diabetes Samuel Dagogo-Jack, Memphis, TN improving Metabolic Risk Factors through lifestyle Vera Bittner, Birmingham, AL Goals and Drugs for Glycemic Management: Cardiologists perspective Amit Khera, Dallas, TX Glycemic Control in the inpatient Setting: Consensus or Confusion? Steven P. Marso, Kansas City, MO Cardiovascular effects of New Agents in the Management of Diabetes Elif Oral, Ann Arbor, MI Bariatric Surgery: Cure for Obesity? Peter A. McCullough, Novi, MI

2:50 3:05 3:20

SpeCiAl leGeNDS

early Career/Kenya Gerald S. Bloomfield, Durham, NC project Healthy Schools: A Community/Health System Collaboration Kim A. Eagle, Ann Arbor, MI African initiatives Edward P. Havranek, Denver, CO legends of Cardiovascular Medicine lecture Series 11th Annual Maseri-Florio international lecture Monday, March 26, 2012, 2:00 p.m. 3:00 p.m. McCormick Place North, N231 CMe/CNe Hours: 1 Gregg W. Stone, New York, NY Welcome, introduction of Dr. Attilio Maseri and History of the Maseri-Florio international lecture Jack Lewin, Washington DC Founder, Maseri-Florio endowment Fund of the American College of Cardiology Attilio Maseri, Florence, Italy introduction of Named lecturer/legend Gregg W. Stone, New York, NY 11th Annual Maseri-Florio international lecture: personal insights leading to Scientific Developments Antonio Colombo, Milan, Italy One-on-One interview with Dr. Antonio Colombo Gregg W. Stone, New York, NY Question and Answer
VAlV

Co-Chairs: 2:00 2:15 2:30 2:45

404

Chair: 2:00

2:04

3:00 3:15

2:05 2:07

QUAl SyMpOSiUM

712

Bringing evidence to the Bedside: Making Guidelines More Accessible to Clinicians Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N427 CMe/CNe Hours: 1.5 Jeffrey Anderson, Cincinnati, OH Frederick A. Masoudi, Denver, CO Do Guidelines Contain enough level i evidence? Sanjay Kaul, Los Angeles, CA Balancing COi and Committee Responsibility Robert A. Harrington, Durham, NC incorporating evidence into a living Guideline Document Scott Wright, Rochester, MN Bridging Guidelines and practice with Appropriate Use Criteria Frederick A. Masoudi, Denver, CO Accessibility of Guidelines for Clinicians Patrick T. OGara, Boston, MA

2:37 2:50

Co-Chairs: 2:00 2:18 2:36 2:54 3:12

expeRTS

251

Complex Valvular Heart Disease Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place South, S503 CMe/CNe Hours: 1.5 Sorin Pislaru, Rochester, MN Gilbert Habib, Marseille, France, Joseph Maalouf, Rochester, MN, Josep Rodes-Cabau, Quebec, Canada Mario J. Garcia, Bronx, NY, Bernard Iung, Paris, France Calcific Aortic Stenosis: Diagnosis and Treatment in the 21st Century Monday, March 26, 2012, 2:00 p.m. 3:30 p.m. McCormick Place North, N426 CMe/CNe Hours: 1.5 David Newby, Edinburgh, Scotland, United Kingdom Andrew Wang, Durham, NC The Role of epidemiology Risk Factors for Secondary prevention of Calcific Aortic Valve Disease Catherine M. Otto, Seattle, WA The Cellular Mechanisms of Calcific Aortic Valve Disease Nalini Marie Rajamannan, Chicago, IL The Role 3-D and 4-D echo imaging in Aortic Valve Disease Jae K. Oh, Rochester, MN The Role of TAVi in Calcific Aortic Valve Disease Peter C. Block, Atlanta, GA

Chair: Case Presenters: Panelists:

VAlV SyMpOSiUM

AFTERNOON

714

QUAl SyMpOSiUM

713

Making a Difference: Cardiology leadership in the Community and the World Monday, March 26, 2012, 2:00 p.m. 3:35 p.m. McCormick Place North, N228 CMe/CNe Hours: 1.5 Valentin Fuster, New York, NY Eva M. Kline-Rogers, Ann Arbor, MI project My Heart your Heart Thomas C. Crawford, Ann Arbor, MI indian Health Service James M. Galloway, Chicago, IL partners in Health Gene Bukhman, Boston, MA

Co-Chairs: 2:00

Co-Chairs: 2:00 2:15 2:30

2:22 2:44 3:07

ACC.12 Final Program 199

Monday, March 26, 2012 ACC.12

ACC-i2/TCT MOC

823

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy interventional Cardiology 2011 Update (B2-l) Monday, March 26, 2012, 3:00 p.m. 5:30 p.m. McCormick Place South, S105a CMe Hours: 2.5 Please refer to the full session listing, listed below, for additional session information.

are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules. Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
ACC-i2/TCT SyMpOSiUM

liFelONG MOC

823

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy interventional Cardiology 2011 Update (B2-l) Monday, March 26, 2012, 3:00 p.m. 5:30 p.m. McCormick Place South, S105a CMe Hours: 2.5 Mehdi H. Shishehbor, Cleveland, OH

Chair:

MOC Faculty: John P. Reilly, New Orleans, LA, Subhash Banerjee, Dallas, TX ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an open seating policy will apply. Attendees must be enrolled in the ABIMs MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment. For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may power up to access relevant question modules.
2640

Mitral interventions Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S102b CMe/CNe Hours: 1.5 Ted Feldman, Evanston, IL Peter C. Block, Atlanta, GA echo Anatomy for percutaneous MR Therapy Nina Wunderlich, Frankfurt, Germany Defining High-risk in MV Surgery Maurice Enriquez-Sarano, Rochester, MN pitfalls in Current Studies of percutaneous Therapy for MR Gregg W. Stone, New York, NY percutaneous Therapy (MitraClip and Carollion) is Best for High-risk RM patients Olaf Franzen, Copenhagen, Denmark Surgery is the Best Therapy for High Risk MR patients Steven F. Bolling, Ann Arbor, MI panel Discussion importance of Bleeding in patients with CV Disease: A personalized Approach for Treatment Strategies Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S103b CMe/CNe Hours: 1.5 Robert A. Harrington, Durham, NC Roxana Mehran, New York, NY importance of Bleeding Thomas Tehsin Tsai, Denver, CO predictors of Bleeding in ACS and elective pCi Steven Vahe Manoukian, Nashville, TN

Co-Chairs: 3:45 4:00 4:15 4:30

AFTERNOON

Access to the online modules will also be available for participants for a short period of time following the annual meeting. Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
liFelONG MOC

4:45 5:00
ACC-i2/TCT SyMpOSiUM

824

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easyClinical Cardiac electrophysiology, 2011 Update (B3-l) Monday, March 26, 2012, 3:00 p.m. 5:30 p.m. McCormick Place South, S105d CMe Hours: 2.5 Peter N. Smith, Marshfield, WI

2641

Co-Chairs: 3:45 3:58

Chair:

MOC Faculty: Byron Kwock Lee, San Francisco, CA, Bindi K. Shah, Philadephia, PA ACCFs Maintenance of Certification Sessions allows you to easily obtain ABIMs Maintenance of Certification (MOC) points during at ACC.12. Tickets 200 GO for ACC.12!

ACC.12 Monday, March 26, 2012

4:11 New Anti-platelet Agents: Which Drug and for Whom; Balancing Bleeding and ischemia Deepak L. Bhatt, Boston, MA Use of Risk Scores for Stratification: is it Feasbile? Which is the ideal Score To Use? Steven P. Marso, Kansas City, MO Bleeding Definitions: Which Component of Bleeding Matters? Roxana Mehran, New York, NY Strategies to Reduce Bleeding Complications in pCi: The Radial Approach Sanjit S. Jolly, West Hamilton, Canada panel Discussion endovascular Management of erectile Dysfunction Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S103c CMe/CNe Hours: 1.5 J. Michael Bacharach, Sioux Falls, SD Andrew J. Feiring, Milwaukee, WI Appropriate patient Selection for pudendal Artery intervention Krishna J. Rocha-Singh, Springfield, IL patient Assessment to Diagnose Obstructive Atherosclerosis as the Cause of erectile Dysfunction Aravinda Nanjundappa, Charleston, WV Outcomes of the ZeN Trial: What Did We learn James P. Zidar, Raleigh, NC panel Discussion ACS: New insights and Novel Therapies Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S106b CMe/CNe Hours: 1.5 A. Michael Lincoff, Cleveland, OH Eric R. Bates, Ann Arbor, MI Determining the Adequacy of Myocardial Reperfusion in STeMi: Clinical, Angiographic and Tomographic Measures of Reperfusion Correlation with Time to Treatment and Total ischemic Time Manesh R. Patel, Durham, NC Adjunctive Therapies to Mitigate ischemiaReperfusion injury William W. ONeill, Miami, FL limitations of Clopidogrel platelet inhibition: prevalence and Mechanisms prevalence and Mechanisms Paul A. Gurbel, Baltimore, MD limitations of Clopidogrel platelet inhibition: Therapeutic Options: New insights from GRAViTAS, TRiGGR-pCi, ARCTiC and ReClOSe-2 ACS Dominick J. Angiolillo, Jacksonville, FL Appropriate Utilization of Novel Anti-thrombotic Agents in ACS: Ticagrelor, Vorapaxar Lars Wallentin, Uppsala, Sweden The Role of platelet Gpiib/iiia Blockade in ACS: Valuable Adjunct Jochen Woehrle, Ulm, Germany The Role of platelet Gpiib/iiia Blockade in ACS: Not Necessary Gilles Montalescot, Paris, France panel Discussion ACC.12 Final Program 201
ARR SyMpOSiUM ARR SyMpOSiUM

715

4:24

Challenges in the Management of Ventricular Arrhythmias Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S406a CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-143-l04-p Alfred E. Buxton, Boston, MA Paul A. Friedman, Rochester, MN Ventricular ectopy in the patient with a Structurally Normal Heart Francis E. Marchlinski, Bala Cynwyd, PA Ablation of Ventricular Tachycardia in ischemic Cardiomyopathy William G. Stevenson, Boston, MA Ablation of Ventricular Tachycardia in Non-ischemic Cardiomyopathy Kalyanam Shivkumar, Los Angeles, CA All patients with iCD Shocks for VT Should Undergo Catheter Ablation David J. Wilber, Maywood, IL All patients with iCD Shocks for VT Should Not Undergo Catheter Ablation Paul A. Friedman, Rochester, MN issues in Cardiac Resynchronization Therapy Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N227b CMe/CNe Hours: 1.5 Melanie T. Gura, Akron, OH Ralph J. Verdino, Philadelphia, PA CRT for patients with NyHA i or ii Andrew E. Epstein, Philadelphia, PA Reducing Atrial Fibrillation and Hospitalization with CRT Jonathan S. Steinberg, New York, NY Gender Disparities with CRT Jennifer E. Cummings, Akron, OH Management of the CRT Non-Responder William T. Abraham, Columbus, OH Management of AF patients Referred for CRT implant: Ablation of Atrial Fibrillation versus AV Node Ablation Andrea Natale, Austin, TX Targeted left Ventricular lead placement to improve Response to CRT Fakhar Z. Khan, Cambridge, United Kingdom

4:37 4:50

Co-Chairs: 3:45

5:03
ACC-i2/TCT SyMpOSiUM

4:03 4:21

2642

4:39 4:54

Co-Chairs: 3:45 4:05

716

4:25 5:05
ACC-i2/TCT SyMpOSiUM

Co-Chairs: 3:45 4:00 4:15 4:30 4:45

2643

Co-Chairs: 3:45

AFTERNOON

3:57 4:09

5:00

CCS expeRTS

4:19

252

Golden Moments: When is the Right Time to intervene in Congenital Heart Disease? Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S501a CMe/CNe Hours: 1.5 Daniel J. Murphy, Palo Alto, CA Bryan C. Cannon, Rochester, MN, Mark E. Galantowicz, Columbus, OH, Thomas K. Jones, Seattle, WA, Mark B. Lewin, Seattle, WA, William R. Morrow, Little Rock, AR, Anne Marie Valente, Boston, MA

Chair: Panelists:

4:29

Case Presenter: Charles Shepard, Minneapolis, MN

4:41 4:51 5:01

Monday, March 26, 2012 ACC.12

HF SyMpOSiUM

717

improving Outcomes and Reducing Heart Failure Readmissions Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S406b CMe/CNe Hours: 1.5 Katherine J. Hoercher, Cleveland, OH Rene J. Alvarez, Pittsburgh, PA Heart Failure Readmissions: Scope of the problem Gregg C. Fonarow, Los Angeles, CA Does Telemonitoring Help prevent Readmissions? Harlan M. Krumholz, New Haven, CT Do implanted Device (Defibrillators and pacemakers) Help prevent Readmissions? Niraj Varma, Cleveland, OH Does Hemodynamic Monitoring Help prevent Readmissions? Robert C. Bourge, Birmingham, AL Transition from Hospital to Home Sara Paul, Hickory, NC performance Measures: Do they Assess Quality? Nancy M. Albert, Cleveland, OH Discussion

4:03 4:21 4:39 4:57

Assessment of ischemia and Viability Daniel C. Lee, Chicago, IL Molecular imaging David E. Sosnovik, Charlestown, MA Role of MRi in Valvular Heart Disease Dipan J. Shah, Houston, TX expanding Role of CMR in interventional Cardiology Dara Kraitchman, Baltimore, MD Controversies in intravascular imaging Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S101a CMe/CNe Hours: 1.5 John McB Hodgson, Wilkes-Barre, PA Jonathan M. Tobis, Los Angeles, CA Assessing lesion Severity: FFR is the Gold Standard Habib Samady, Atlanta, GA Assessing lesion Severity: Are There any Anatomic Critieria iVUS or OCT That Can be Used instead of FFR? Bon Kwon Koo, Chongno-gu, Seoul, Republic of Korea Assessing lesion Severity: Can Cardiovascular CT provide insight into Stenosis Severity? Szilard Voros, Atlanta, GA panel Discussion with Case presentations Habib Samady, Atlanta, GA Case presentation Itsik Ben-Dor, Rockville, MD Case presentation Muzaffer Degertekin, Istanbul, Turkey Distal embolization during pCi: Definition of the problem: Frequency, Clinical Setting, Clinical predictors, etc. Simon R. Dixon, Royal Oak, MI Distal embolization during pCi: predicting Distal embolization Using Grayscale iVUS, RF-iVUS, OCT, and NiRS Emmanouil S. Brilakis, Dallas, TX Distal embolization during pCi: prediction of Distal embolization Based on CTA Yukio Ozaki, Toyoake, Japan Optimal endpoints for Stent implantation and Guidance: A Review of the iVUS literature Kenichi Fujii, Nishinomiya Hyogo, Japan Optimal endpoints for Stent implantation and Guidance: Can OCT Replace iVUS in Optimizing Stent implantation? Marco A. Costa, Cleveland, OH panel Discussion Core Curriculum: Vascular Disease Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N226 CMe/CNe Hours: 1.5 Alex J. Auseon, Columbus, OH peripheral Arterial Disease Douglas E. Drachman, Boston, MA Aortopathies Emile R. Mohler, III, Philadelphia, PA

Co-Chairs: 3:45 3:58 4:12

ACC-i2/TCT SyMpOSiUM

2639

Co-Chairs: 3:45 3:55

4:25 4:38 4:51 5:03

HF SyMpOSiUM

4:05

718

Controversies in Treatment of Comorbidities in Heart Failure: paradoxes and Challenges in Treatment Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S404 CMe/CNe Hours: 1.5 Biykem Bozkurt, Houston, TX Akshay S. Desai, Boston, MA Diabetes and Heart Failure David Aguilar, Houston, TX Question and Answer Obesity and Heart Failure Tamara Horwich, Los Angeles, CA Question and Answer Hypertension and Heart Failure Biykem Bozkurt, Houston, TX Question and Answer Sleep Apnea and Heart Failure Shahrokh Javaheri, Cincinnatti, OH Question and Answer Atrial Fibrillation and Heart Failure Maya E. Guglin, Tampa, FL Question and Answer

4:10 4:15 4:20 4:25

Co-Chairs: 3:45 4:00 4:03

4:30

AFTERNOON

4:18 4:21 4:36 4:39 4:54 4:57 5:12

iMAG SyMpOSiUM

4:40

4:45

4:55

5:05
liFelONG

719

emerging Applications of CMR Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S403 CMe/CNe Hours: 1.5 W. Gregory Hundley, Winston Salem, NC Sanjay Prasad, London, England, United Kingdom New Approaches to Quantitate Systolic Function Michael Markl, Chicago, IL

CORe

825

Chair: 3:45 4:10

Co-Chairs: 3:45

202 GO for ACC.12!

ACC.12 Monday, March 26, 2012

4:35 5:00
liFelONG CORe

Carotid and Cerebrovascular Disease Michael R. Jaff, Boston, MA Question and Answer Core Curriculum: landmark Trials Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N229 CMe/CNe Hours: 1.5 Karthikeyan Ananthasubramaniam, West Bloomfield, MI landmark Trials in Hyperlipidemia Anand Rohatgi, Dallas, TX landmark Trials in Heart Failure David E. Lanfear, Detroit, MI landmark Trials in ACS Stephen D. Wiviott, Boston, MA landmark Trials in electrophysiology Joseph Edward Marine, Baltimore, MD Question and Answer
peRi

pHTN expeRTS

254

pulmonary Hypertension Tools for the Cardiologist Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S504a CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-131-l01-p Ronald J. Oudiz, Torrance, CA Paul Forfia, Philadelphia, PA, Gregory D. Lewis, Boston, MA, Vallerie V. McLaughlin, Ann Arbor, MI Beyond Statins: lDl Management in the Challenging patient Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S100c CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-146-l04-p Amit Khera, Dallas, TX Donna M. Polk, Hartford, CT Role of Genetic Testing Christie M. Ballantyne, Houston, TX Dietary effects and phytosterols Michael J. Blaha, Baltimore, MD Combination Therapy: When and Which Ones? Jennifer Robinson, Iowa City, IA lDl Apheresis as a Treatment Option Patrick M. Moriarty, Kansas City, KS Mipomersen and pCSK9 inhibitors Evan A. Stein, Cincinnati, OH

826

Chair: Case Presenters:

pReV SyMpOSiUM

Chair: 3:45 4:05 4:25 4:45 5:05

729

Co-Chairs: 3:45 4:03 4:21 4:39 4:57

expeRTS

253

Challenges in Hypertrophic Cardiomyopathy: Case Studies Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S505 CMe/CNe Hours: 1.5 Barry J. Maron, Minneapolis, MN Martin S. Maron, Boston, MA, Matthew W. Martinez, Allentown, PA, Paul Sorajja, Rochester, MN Perry M. Elliott, London, United Kingdom, Harry M. Lever, Cleveland, OH, William McKenna, London, United Kingdom, Ulrich Sigwart, Geneva, Switzerland New Directions in the evaluation and Management of the Cardiomyopathies Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N231 CMe/CNe Hours: 1.5 Nancy K. Sweitzer, Madison, WI Hector O. Ventura, New Orleans, LA Familial Dilated Cardiomyopathy Syndromes: What is the Role for Genetic Testing? Neal Lakdawala, Boston, MA peripartum Cardiomyopathy: New Concepts in pathophysiology and Management Uri Elkayam, Los Angeles, CA Myocarditis and Other Reversible Causes of Cardiomyopathy Leslie T. Cooper, Rochester, MN Cardiac Sarcoidosis: Diagnosis, evaluation and Management: Whom Should We Treat? Andrew M. Freeman, Denver, CO Arrhythmogenic Right Ventricular Cardiomyopathy: Genetics, pathophysiology, imaging and Management Hugh Calkins, Baltimore, MD Multidisciplinary evaluation of patients with Cardiomyopathies Rodney Falk, Boston, MA Question and Answer

Chair: Case Presenters: Panelists:

pReV SyMpOSiUM

745

peRi SyMpOSiUM

720

World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and its protective effect on Cardiovascular Disease Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S405 CMe/CNe Hours: 1.5 George D. Dangas, New York, NY George Parharidis, Athens, Greece introduction to Session George D. Dangas, New York, NY The Role of Sodium and potassium in CV Health George L. Bakris, Chicago, IL The Role of Cardiovascular imaging in Coronary Heart Disease Petros Nihoyannopoulos, London, United Kingdom An Overview of the Cypriot Contribution to the Diet Panayiotis Avraamides, Nicosia, Cyprus Cardiovascular Mortality in Greece Vlassios N. Pyrgakis, Nerantza Corinthias, Greece effects of Diet, exercise and Weight loss on inflammation Christie M. Ballantyne, Houston, TX Question and Answer

AFTERNOON

Co-Chairs: 3:45

Co-Chairs: 3:45 3:50 4:05

3:59

4:13 4:27

4:20 4:35 4:50 5:05

4:41

4:55 5:10

ACC.12 Final Program 203

Monday, March 26, 2012 ACC.12

QUAl SyMpOSiUM

721

Transforming Health Care Delivery through CV Registries Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N427 CMe/CNe Hours: 1.5 Eva M. Kline-Rogers, Ann Arbor, MI Eric D. Peterson, Durham, NC The SCAAR Registry Stefan K. James, Uppsala, Sweden The Danish Registry experience Leif Thuesen, Aarhus, Denmark BMC2: The Michigan pCi Registry Hitinder S. Gurm, Ann Arbor, MI MSTCVS: The Michican Surgical Registry Richard L. Prager, Ann Arbor, MI CART-Cl: The VA Cath lab Quality program Thomas M. Maddox, Denver, CO Mandatory participation and Reporting of Registry Data Ralph G. Brindis, Oakland, CA

4:15 4:30 4:45 5:00 5:05 5:10

TeST expeRTS

Future of Cardiac Magnetic Resonance Dudley J. Pennell, London, United Kingdom Coronary CT Angiography: Beyond Coronary Stenosis James K. Min, New York, NY New Directions in Cardiac peT-CT David E. Newby, Edinburgh, Scotland, United Kingdom Noninvasive Cardiac imaging in Great Britain S. Richard Underwood, London, United Kingdom Noninvasive Cardiac imaging in the US Daniel S. Berman, Los Angeles, CA Discussion Stress Testing in Women Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S502 CMe/CNe Hours: 1.5 Alison Bailey, Lexington, KY C. Noel Bairey Merz, Los Angeles, CA, Martha Gulati, Columbus, OH, Jennifer H. Mieres, Lake Success, NY, Leslee J. Shaw, Atlanta, GA, Nanette Kass Wenger, Atlanta, GA Advanced Hemodynamics for Valvular Heart Disease Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place South, S503 CMe/CNe Hours: 1.5 Salvatore Costa, Lebanon, NH Jean G. Dumesnil, Sainte Foy, Canada, Rick A. Nishimura, Rochester, MN, Luc Pierard, Lige, Belgium Salvatore Costa, Lebanon, NH, Steve R. Ommen, Rochester, MN importance of Registries for Valve Disease: A Glimpse into the ACC Future Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N426 CMe/CNe Hours: 1.5 David J. Malenka, Lebanon, NH Hector I. Michelena, Rochester, MN What ACC Needs to Do for Valve Registries David R. Holmes, Jr., Rochester, MN The euro-Heart Survey: What is the picture of Valve Disease practice in europe Bernard Iung, Paris, France MiDA: The Research and the practice in an international Registry of MR Francesco Grigioni, Italy The UK TAVi Registry Jan Kovac, Leicestershire, United Kingdom The Canadian Registry of TAVi Josep Rodes-Cabau, Quebec, Canada

Co-Chairs: 3:45 4:00 4:15 4:30 4:45 5:00

255

Chair: Panelists:

Case Presenter: Janet B. Long, Providence, RI

QUAl SyMpOSiUM

722

Applying Newer Cardiovascular Agents to Older Adults Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N228 CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-144-l04-p Michael Chen, Seattle, WA Tracy Wang, Durham, NC pharmacology in Older Adults Jeffrey Washam, Durham, NC pCi Medications in Older Adults Harold L. Dauerman, Shelburne, VT polypharmacy and Adherence Jeffrey Washam, Durham, NC AF Anticoagulants in Older Adults James B. Froehlich, Ann Arbor, MI Does My 90 year-old patient Need a Statin? Michael W. Rich, Saint Louis, MO Aldosterone Blockade in Older Adults Milton Packer, Dallas, TX Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of Cardiology Monday, March 26, 2012, 3:45 p.m. 5:15 p.m. McCormick Place North, N230 CMe/CNe Hours: 1.5 Daniel S. Berman, Los Angeles, CA Ronald P. Karlsberg, Beverly Hills, CA S. Richard Underwood, London, United Kingdom Twinning of BCS and the California Chapter of the ACC Huon Gray, Southampton, United Kingdom New Frontiers in echocardiography Anthony N. DeMaria, San Diego, CA

VAlV expeRTS

Co-Chairs: 3:45 4:00 4:15 4:30 4:45 5:00

256

Chair: Case Presenters: Panelists:

AFTERNOON

VAlV SyMpOSiUM

723

Co-Chairs: 3:45 4:03

SpeCiAl SyMpOSiUM

740

Co-Chairs:

4:21

3:45 3:50

4:39 4:57

204 GO for ACC.12!

ACC.12 Monday, March 26, 2012

ACC-i2/TCT CliNiCAl FOCUS

1607

Joint Session of the American Association for Thoracic Surgery, the Society of Thoracic Surgery and the American College of Cardiology: Multidisciplinary Approach to the High-risk Aortic Stenosis patient Monday, March 26, 2012, 5:45 p.m. 9:05 p.m. McCormick Place South, S401a CMe/CNe Hours: 2.5 Registration and Dinner Ralph J. Damiano, St. Louis, MO E. Murat Tuzcu, Cleveland, OH Todd M. Dewey, Dallas, TX| Raoul Bonan, Montreal, Canada TAVR: Where Are We in 2012 Balloon expandable Valve Samir R. Kapadia, Cleveland, OH Self expanding Valve Gregory P. Fontana, Los Angeles, CA panel Discussion Risk Assessment of an Aortic Stenosis patient Who is a Candidate for TAVR Vinod H. Thourani, Atlanta, GA pearls from echocardiography Rebecca T. Hahn, New York, NY Cant do without CT imaging Jonathan Leipsic, Vancouver, Canada panel Discussion Complications, impact, precautions, Management Vascular Trauma and Bleeding Wilson Y. Szeto, Philadephia, PA Stroke Josep Rodes-Cabau, Quebec, Canada Aortic Regurgitation Jeffrey J. Popma, Newton, MA panel Discussion Debates Debate: TAVR Should be Reserved only for inoperable patients Todd M. Dewey, Dallas, TX Debate: TAVR Should be Reserved only for inoperable patients Thierry Lefevre, Massy, France panel Discussion Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients D. Craig Miller, Stanford, CA Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients Martin B. Leon, New York, NY panel Discussion

SpeCiAl SpeCiAl

307

61st Annual Convocation Monday, March 26, 2012, 6:30 p.m. 8:00 p.m. McCormick Place North, Hall B, ACC.12 Main Tent

5:45 Co-Chairs:

6:15 6:25 6:35 6:45 6:55 7:05 7:15 7:25 7:35 7:45 7:55 8:05 8:15

8:25 8:35

8:45

8:55

evening

ACC.12 Final Program 205

ACC.12 Learning Destination Presentations

Monday, March 26, 2012

Learning Destinations are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.* Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag

CV Innovations Educational Forum

South Building, Hall A2, CV Theater, #22097 9:30 a.m. 10:30 a.m.

The Role of Nanotechnology in Cardiovascular Diseases

9:30 a.m. 9:40 a.m. Nanotechnology Steven Bailey, MD, San Antonio, TX University of Texas, San Antonio 9:40 a.m. 9:50 a.m. Nano particle Delivery Mauro Farrari, PhD, Houston, TX President and CEO of The Methodist Hospital Research Institute (invited) 9:50 a.m. 10:00 a.m. imaging of Stem Cells Jeff W.M. Bulte, PhD, Baltimore, MD Professor, Johns Hopkins University (invited) 10:00 a.m. 10:10 a.m. imaging of Cells and plaque Sam Wickline, MD, St. Louis, MO Professor, Washington University (invited) 10:10 a.m. 10:20 a.m. imaging of Vulnerable plaque Todd D. Giorgio, PhD, Nashville, TN Professor, Vanderbilt School of Engineering (invited) 10:20 a.m. 10:30 a.m. panel Discussion

12:30 p.m. 12:40 p.m. Role of Shock Wave/Ultrasound in Stem Cell Transplantation Andreas M. Zeiher, MD, Frankfurt, Germany Chairman, Department of Medicine III/Cardiology, University of Frankfurt 12:40 p.m. 12:50 p.m. The Regulatory pathways of Stem Cells: industry point of View Randal Mills, PhD, Columbia, MD President and Chief Executive Officer, Osiris Therapeutics 12:50 p.m. 1:00 p.m. panel Discussion

Tissue engineering
1:00 p.m. 1:40 p.m. 1:00 p.m. 1:10 p.m. The living Valve Sir Magdi Yacoub, MD, FRCS, London, United Kingdom Professor, Cardiothoracic Surgery, Imperial College 1:10 p.m. 1:20 p.m. Myocardial Matrix Karen Christman, PhD, San Diego, CA Assistant Professor of Bioengineering, University of California San Diego 1:20 p.m. 1:30 p.m. Abbott Vasculars Bioresorbable Scaffold program A New paradigm in pCi? Richard J. Rapoza, PhD, Abbott Park, IL Division Vice President of Research & Development, Abbott Vascular 1:30 p.m. 1:40 p.m. panel Discussion

Cellular Therapy
Noon 1:00 p.m. Noon 12:10 p.m. Very Small embryonic-like Stem Cells for Cardiovascular Repair Wojtek Wojakowski, MD, Katowice, Poland Third Division of Cardiology, Medical University of Silesia 12:10 p.m. 12:20 p.m. Methods of Stem Cell Therapy and Future Direction Nabil Dib, MD, MSc, FACC, Gilbert, AZ Director, Heart Sciences Center 12:20 p.m. 12:30 p.m. ischemia Tolerant Mesenchymal Stem Cell Nicholai Tankovich, MD, PhD, San Diego, CA President and Chief Medical Officer, Stemedica Cell Technologies, Inc.

personalized Medicine
1:40 p.m. 2:00 p.m. 1:40 p.m. 1:50 p.m. personalized Medicine Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute 1:50 p.m. 2:00 p.m. A New Gene expression Test to Detect Coronary Artery Disease Mark Monane, MD, MS, FACP, Palo Alto, CA Chief Medical Officer, CardioDx

206 GO for ACC.12!

ACC.12 Monday, March 26, 2012

The Heart of Innovation Featured Learning Destination

South Building, Hall A1, #1076 9:30 a.m. 9:45 a.m. educational content including taped cases, physician interviews, panel discussions and more 9:45 a.m. 10:15 a.m. Moderated Discussion: A New Approach to Delivering Stem Cell Therapy for patients with CHF Moderator: Anthony N. DeMaria, MD, MACC, San Diego, CA Judith and Jack White Chair in Cardiology; Founding Director, Sulpizio Cardiovascular Center, University of California San Diego Panelists: Bernard J. Gersh, MB, ChB, DPhil, FACC, Rochester, MN Professor of Medicine, Cardiovascular Diseases, Mayo Clinic; Andreas M. Zeiher, MD, Frankfurt, Germany Chairman, Department of Medicine III/Cardiology, University of Frankfurt 10:15 a.m. 12:15 p.m. educational content including taped cases, physician interviews, panel discussions and more 12:15 p.m. 12:45 p.m. Biomarker Guided Heart Failure Management James L. Januzzi, Jr., MD, FACC, Cambridge, MA Director, Cardiac Intensive Care Unit, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School 12:45 p.m. 1:05 p.m. physician-patient engagement and Shared Decision Making John R. Windle, MD, FACC, Omaha, NE Professor and Chief, Internal Medicine, Division of Cardiology, University of Nebraska Medical Center 1:05 p.m. 1:25 p.m. The evolution of Radiation protection Christian E. Machado, MD, FACC, FAHA, FHRS, Detroit, MI Clinical Associate Professor, Wayne State University School of Medicine; Senior Partner, Heart Cardiology Consultants; Director, Cardiac Electrophysiology and Cardiac Rhythm Management Device Clinic, Providence Hospital 1:25 p.m. 1:45 p.m. Current Status and Future Direction of Stem Cell Therapy for Cardiovascular Disease Nabil Dib, MD, MSc, FACC, Gilbert, AZ Director, Cardiovascular Research, Heart Sciences Center; Director; Clinical Cardiovascular Cell Therapy, Associate Professor of Medicine, University of California, San Diego; Medical Director, Celebration Stem Cell Centre; President, International Society for Cardiovascular Translational Research; Editor in Chief, Journal of Cardiovascular Translational Research 1:45 p.m. 2:00 p.m. educational content including taped cases, physician interviews, panel discussions and more

Industry-Expert Theater
South Building, Hall A1, #22042 9:45 a.m. 10:30 a.m. (Morning Coffee Break) Managing Atherosclerotic Risk with a particle Focus New Recommendations and emerging Data Robert S. Rosenson, MD, New York, NY Professor, Department of Medicine/Cardiology, Director, Cardiometabolic Disorders, Mount Sinai School of Medicine

presented by lipoScience
12:30 p.m. 1:30 p.m. (lunch Break) Considerations for Radionuclide Myocardial perfusion imaging in patients with COpD/Asthma Kim Williams, MD, Detroit, MI Chair, Division of Cardiology and Professor of Medicine; Wayne State University School of Medicine

presented by Astellas pharma US, inc.

Interactive Learning Labs

philips Healthcare
Interactive Learning Lab #22035

South Building, Hall A1, #22027, #22035, #23027

9:30 a.m. 10:30 a.m. Cardiac CT The Journey from plaque Recognition to prognosis Patrick Donnelly, MD, MB BCh, MRCP, United Kingdom Consultant Cardiologist, Southeastern Health and Social Care Trust, Director Northern Ireland Cardiovascular Research Network; Honorary Senior Lecturer, The Queens University, Belfast Director, Belfast Cardiac CT Academy 11:00 a.m. Noon Benefit of Cardiac Troponin point-of-Care Testing in the emergency Department Charles B. Cairns, MD, FACEP, FAHA, Chapel Hill, NC Professor and Chair, Department of Emergency Medicine, University of North Carolina 12:30 p.m. 1:30 p.m. Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing Babak Mokhlesi, MD, MSc, Chicago, IL Associate Professor of Medicine Director, Sleep Disorders Center and Sleep Fellowship Program; Section of Pulmonary and Critical Care, University of Chicago

Terumo interventional Systems and The Medicines Company

Interactive Learning Lab #22027 9:30 a.m. 10:30 a.m. Hands-On Radial Access Simulation 10:30 a.m. 11:00 a.m. Optimizing your Outpatient pCi: What you Need to Know and Consider 11:30 a.m. 12:30 p.m. Hands-On Radial Access Simulation

* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit. ACC.12 Final Program 207

Manage your heart health with

TM

CardioSmart National Care Initiative

Impacting healthy lifestyles and providing patients everyday strategies for heart health.

Small changes add up to big results over time.

2012 American College of Cardiology Z1207

Everyday Strategies for Heart Health. Go to www.CardioSmart.org today.

Visit ACC Central - Booth #10027.

Brought to you by:

Tuesday March 27

ACC.12

Tuesday, March 27

Visit us at ACC Central Booth 10027

WHAT
quality chasm?
With guidelines-focused clinical registries from the NCDR, youll always know which quality improvement steps to take and when to take them.

Tuesday, March 27

Achieving quality care is your challenge. Take it on with NCDR.

www.ncdr.com/takeiton

NCDR is an initiative of the American College of Cardiology Foundation, with partnering support from the following organizations: CARE RegistryThe Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/ Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI RegistryThe Society for Cardiovascular Angiography and Interventions; ICD RegistryHeart Rhythm Society; IMPACT RegistryThe Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE RegistryMedAxiom; STS/ACC TVT RegistryAn initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION RegistryGWTGAn initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine. 2012 American College of Cardiology Foundation. All rights reserved. B12016

ACC.12 Scientific Session

Tuesday, March 27, 2012

Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning SeSSionS
ACS SympoSium CCS SympoSium

728

Joint Symposium of the American Association for Clinical Chemistry and the American College of Cardiology: How to use Cardiac Biomarkers Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N230 CmE/CNE Hours: 1.5 Allan S. Jaffe, Rochester, MN L. Kristin Newby, Durham, NC What Every Clinician Should Know about measuring Cardiac Troponin Fred S. Apple, Minneapolis, MN using Cardiac Troponin Clinically Allan S. Jaffe, Rochester, MN Question and Answer What Every Clinician Should Know about measuring Natriuretic peptides John C. Burnett, Rochester, MN using Cardiac Natriuretic peptides Clinically James L. Januzzi, Jr., Boston, MA Question and Answer

724

Complex Conotruncal malformations: What the Surgeon Needs to Know and How to Get the information Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N229 CmE/CNE Hours: 1.5 Leo Lopez, New York, NY James S. Tweddell, Milwaukee, WI Complex Conotruncal malformations: pathologic Considerations Paul M. Weinberg, Philadelphia, PA Complex Conotruncal malformations: The Whole picture Meryl Cohen, Philadelphia, PA Double outlet Right Ventricle with Straddling Atrioventricular Valves: Surgical Considerations Pedro Del Nido, Boston, MA Double outlet Right Ventricle with Complete Atrioventricular Septal Defect: What i Need for a Two Ventricle Repair Francois G. Lacour-Gayet, New York, NY Transposition of the Great Arteries with Ventricular Septal Defect and pulmonary Stenosis: Surgical options Victor O. Morell, Pittsburgh, PA

Morning

Co-Chairs: 8:00 8:18 8:36

Co-Chairs: 8:00 8:15 8:30 8:45 9:00 9:15

ARR SympoSium

8:54

9:12

747

Antithrombotic Therapies for Atrial Fibrillation: Current State-of-the-Art Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S404 CmE/CNE Hours: 1.5 Samuel Z. Goldhaber, Boston, MA Julia H. Indik, Tucson, AZ Who Should Get Anti-thrombotic Rx for AF: CHADs2 vs. CHA 2DS2-VASc and All Those Not meeting Trial Criteria Jonathan L. Halperin, New York, NY pros and Cons of Thrombin inhibitor versus. Warfarin Samuel Z. Goldhaber, Boston, MA pros and Cons of Xa inhibitor versus Warfarin Lars Wallentin, Uppsala, Sweden Time in Therapeutic Range for Warfarin: Effect of Home monitoring Jack E. Ansell, New York, NY putting it All Together: What Should We Do Now? A. John Camm, London, United Kingdom panel Discussion

CCS SympoSium

725

Co-Chairs: 8:00

Coming of Age: The HLHS Turns 21 Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N231 CmE/CNE Hours: 1.5 Karen S. Kuehl, Washington, DC Erwin N. Oechslin, Toronto, ON HLHS: At the Beginning. Peter Lang, Cambridge, MA HLHS: What We Have Learned about the physiology Jack Rychik, Philadelphia, PA HLHS: How imaging the HLH patient Has Changed Craig A. Sable, Washington, DC Surgical Evolution in the past Two Decades: Striving for optimal Long-Term outcome Kirk Kanter, Atlanta, GA Failing Fontan: is the Hypoplastic Left Heart patient Any Different? Gruschen R. Veldtman, Toronto, Canada

Co-Chairs: 8:00 8:18 8:36 8:54

8:15 8:30 8:45 9:00 9:15

9:12

HF EXpERTS

257

Cardiac Amyloidosis Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S502 CmE/CNE Hours: 1.5 Rodney Falk, Boston, MA Jeffrey Alexis, Rochester, NY, Morie Gertz, MN, Raymond Y. K. Kwong, Boston, MA, Joseph Selvanayagam, Adelaide, Australia, Marc J. Semigran, Boston, MA

Chair: Panelists:

Case Presenter: David C. Seldin, Boston, MA

ACC.12 Final Program 209

Tuesday, March 27, 2012 ACC.12

imAG EXpERTS

258

Echo in Assessment of Low Gradient Aortic Stenosis Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S505 CmE/CNE Hours: 1.5 Catherine M. Otto, Seattle, WA Sunil V. Mankad, Rochester, MN, Alan Zajarias, Saint Louis, MO Ian G. Burwash, Ottawa, Canada, Patrick M. McCarthy, Chicago, IL, Rick A. Nishimura, Rochester, MN, Catherine M. Otto, Seattle, WA innovations in Noninvasive Evaluation of Stable ischemic Heart Disease Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S503 CmE/CNE Hours: 1.5 Albert C. Lardo, Baltimore, MD Erin Bohula, Boston, MA, William Luke, Gainesville, FL, J. Jacob Mancuso, San Antonio, TX Theodore P. Abraham, Baltimore, MD, Daniel S. Berman, Los Angeles, CA, Shelton D. Caruthers, Saint Louis, MO, Gregory M. Lanza, Saint Louis, MO CCA Research Bootcamp Session ii: Successful Research Execution and Dissemination Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S105d CmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-122-L04-p Nancy M. Albert, Chesterland, OH optimizing the Data Collection process Desiree A. Fleck, Philadelphia, PA Submitting a Competitive Abstract Lynne Braun, Chicago, IL Disseminating Research Nancy M. Albert, Cleveland, OH Question and Answer

8:36

Empleo de Cardiodesfibriladores en Latinoamrica y uSA: Semajanzas y Diferencias Gabriel Vanerio, Montevideo, Uruguay La Circulacin pulmonar, el Ventrculo Derecho, y la Resonancia magnetica Javier Sanz, New York, NY Hipertensin pulmonar en Grandes Alturas Dante Penaloza, Lima, Peru
pREV

8:54 9:12

Chair: Case Presenters: Panelists:

Morning

SympoSium

727

iSCHEm EXpERTS

259

Joint Symposium of the American Society of Hypertension and the American College of Cardiology: Hypertension in the Critically ill patient Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S406a CmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-145-L04-p Daniel A. Duprez, Minneapolis, MN C. Venkata S. Ram, Dallas, TX perioperative Hypertension James B. Froehlich, Ann Arbor, MI Hypertension in patients with intracranial Hemorrhage Phillip B. Gorelick, Chicago, IL Hypertension in Acute ischemic Stroke Thompson Robinson, Leicester, United Kingdom Hypertensive urgency and Emergency George L. Bakris, Chicago, IL Hypertension in the Emergency Department and Critical Care unit Stanley S. Franklin, Irvine, CA Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, Hall B, ACC.12 Main Tent CmE/CNE Hours: 1.5 Elliott M. Antman, Boston, MA Michael H. Crawford, San Francisco, CA Matthew J. Budoff, Torrance, CA, Bernard J. Gersh, Rochester, MN, Alice K. Jacobs, Boston, MA, Frans J. J. Van de Werf, Leuven, Belgium Survival after pCi or CABG in older patients with Stable multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies William S. Weintraub, Maria V. Grau-Sepulveda, Jocelyn Weiss, Sean OBrien, Eric Peterson, Paul Kolm, Zugui Zhang, Lloyd Klein, Richard Shaw, Charles McKay, Laura Ritzenthaler, Jeffrey Popma, John Messenger, David Shahian, Frederick Grover, John Mayer, Cynthia M. Shewan, Kirk Garratt, Issam Moussa, George Dangas, Fred Edwards, American College of Cardiology, Washington, DC, USA, The Society of Thoracic Surgeons, Chicago, IL, USA panel Discussion multicenter Randomized Comparative Effectiveness Trial of Cardiac CT versus Alternative Triage Strategies in Acute Chest pain patients in the

Co-Chairs: 8:00 8:18 8:36 8:54 9:12

Chair: Case Presenters: Panelists:

LiFELoNG BooT CAmp

114

Chair: 8:00 8:25 8:50 9:15

pHTN SympoSium

SpECiAL SpECiAL

308

Co-Chairs: Panelists:

726

Sesion Conjunta Con La Sociedad Espanola de Cardiologa Sociedad interamerica de Cardiologa/American College of Cardiology: problemas Relevantes en Cardiologa 2012 Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S403 CmE/CNE Hours: 1.5 Vicente Bertomeu Martinez, Madrid, Spain Valentin Fuster, New York, NY Daniel Pineiro, Buenos Aires, Argentina Riesgo Cardiovascular, Como Causa de obstrucion de la microcirculacion Cerebral y Disfuncion Cognativa Valentin Fuster, New York, NY El Holter implantable: Tenemos Claras las indicaciones? Arcadio Garcia-Alberola, Madrid-Cartagena, Spain

8:00

Co-Chairs:

8:00

8:18

8:15 8:22

210 GO for ACC.12!

ACC.12 Tuesday, March 27, 2012

Emergency Department: Results from the RomiCAT ii Trial Udo Hoffmann, Quynh Truong, Hang Lee, Eric Chou, Pamela Woodard, John Nagurney, James H. Pope, Thomas Hauser, Charles White, Scott Weiner, Alexander Goehler, Pearl Zakroysky, Ruth Kirby, Douglas Hayden, Stephen Wiviott, Jerome Fleg, Scott Gazelle, David Schoenfeld, James Udelson, Massachusetts General Hospital Cardiac MR PET CT Program, Boston, MA, USA 8:37 8:44 panel Discussion Results of the immEDiATE (immediate myocardial metabolic Enhancement During initial Assessment and Treatment in Emergency Care) Trial: A Double-blind Randomized Controlled Trial of intravenous Glucose, insulin, and potassium (GiK) for ACS in Emergency medical Services Harry P. Selker, Joni R. Beshansky, Patricia R. Sheehan, Robin Ruthazer, John L. Griffith, James E. Udelson, Joseph M. Massaro, Ralph B. DAgostino, IMMEDIATE Trial Investigators, Tufts Medical Center, Boston, MA, USA panel Discussion moderate pulmonary Embolism Treated with Thrombolysis (mopETT Study) Mohsen Sharifi, Curt Bay, Laura Skrocki, Farnoosh Rahimi, Mahshid Mehdipour, Arizona Cardiovascular Consultants, Mesa, AZ, USA, A.T.Still University, Mesa, AZ, USA panel Discussion Joint Session of the European Society of Cardiology and the American College of Cardiology ii: pros and Cons of New Approaches for Antiplatelet and Anticoagulant Therapy Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place North, N426 CmE/CNE Hours: 1.5 Marc Steven Sabatine, Boston, MA New Anticoagulants Michael M. Ezekowitz, Wynnewood, PA New Antiplatelet Drugs Christopher B. Granger, Durham, NC Value of Functional Testing with Antiplatelet Drugs Thomas Cuisset, Marseille, France Value of Genetic Testing with Antiplatelet and Anticoagulant Drugs Franz-Josef Neumann, Munich, Germany Non-pharmacologic Approaches to Embolic Stroke prevention Horst Sievert, Frankfurt, Germany
SpECiAL SpECiAL VALV EXpERTS

260

Aortic Regurgitation/BAV Tuesday, march 27, 2012, 8:00 a.m. 9:30 a.m. McCormick Place South, S504a CmE/CNE Hours: 1.5 Robert O. Bonow, Chicago, IL Anthony DiScipio, Lebanon, NH, Hector I. Michelena, Rochester, MN, Agns Pasquet, Brussels, Belgium Robert O. Bonow, Chicago, IL, Joseph S. Coselli, Houston, TX, Patrick T. OGara, Boston, MA

Chair: Case Presenters: Panelists:

Morning

309

ACC.12 Closing Session: innovators in Cardiology Tuesday, march 27, 2012, 9:45 a.m. 11:45 a.m. McCormick Place North, Hall B, ACC.12 Main Tent CmE/CNE/CpE Hours: 2 ACpE No. 0012-9999-12-133-L04-p David R. Holmes, Jr., Rochester, MN Gary S. Mintz, Washington, DC, Rick A. Nishimura, Rochester, MN, Patrick T. OGara, Boston, MA, E. Murat Tuzcu, Cleveland, OH innovators in Cardiology: Regenerative Tissue perspective Kenneth Chien, Boston, MA panel Discussion innovators in Cardiology: interventional perspective Martin B. Leon, New York, NY panel Discussion innovators in Cardiology: Surgical perspective Michael J. Mack, Plano, TX panel Discussion innovators in Cardiology: imaging perspective A. Jamil Tajik, Milwaukee, WI panel Discussion innovators in Cardiology: Clinical and Translational Research Application to practice perspective Robert M. Califf, Durham, NC panel Discussion Closing Remarks David R. Holmes, Rochester, MN

Chair: Panelists:

8:59 9:06

9:45 10:05 10:08 10:28 10:31 10:51 10:54 11:14 11:17

9:21
SpECiAL SympoSium

739

Chair: 8:00 8:18 8:36 8:54

11:37 11:40

9:12

ACC.12 Final Program 211

Get Your DailY Dose of Quality at aCC.12

Learn more about ACCs quality improvement programs and how you can get involved during ACC.12

aCC Central (Booth #10027)

2012 American College of Cardiology. E1204

American College of Cardiology Industry Training Program

ACCs Industry Training Program is helping to enhance and improve your interactions with industry personnel. Comprehensive, thorough and non-biased education will help medical and device representatives to function as your partners supporting positive outcomes for your patients. Key components of the ACC Industry Training program include Cardiovascular clinical knowledge Disease mechanisms Clinical treatment options Appropriate industry/professional organization interaction Look for the Industry Training Seal on your representatives business cards.

Visit ACC Central, Booth 10027, or go to www.CardioSource.org/IndustryTraining for more information.

2012 American College of Cardiology C1206

ESC Congress 2012

munich
25-29 AUGUST
G E R M A N Y

Advance programme now available online

The European Society of Cardiology presents the worlds premier conference on the science, management and prevention of cardiovascular disease.

This years spotlight is From bench to practice

Only 5 months until your next international Cardiology Congress

32 000+ healthcare professionals from 150+ countries

Come see us h at boot 11080

1200+ faculty from around the globe 28 joint sessions organised with professional societies from the 5 continents 4 200+ abstracts to be presented
Register before 31 May at www.escardio.org

Win a free congress registration

Scan this QR code
(or visit www.escardio.org/esc2012-prizedraw) to enter the prize draw* for a free registration for ESC Congress 2012 in Munich
*Rules and regulations available at www.escardio.org Instructions: 1- Download a free QR code reader (ex: www.getscanlife.com) on to your smartphone 2- Launch the reader 3- Scan this QR code with your phone camera.

ction Intera

with th

e audie

nce

terven Live in

tions

Highly innovative poster area

2011 Key figures: 5 days of scientific sessions 400+ ESC sessions 10 800+ abstracts submitted 70 industry sponsored sessions 200 exhibiting companies + unique & unlimited opportunities to network!

www.escardio.org

Stay up-to-date with NEW official magazines of the American College of Cardiology CardioSource WorldNews and CardioSource InterventionalNews!
These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with: Perspectives from thought leaders Debates on the key controversies in medicine Practical insights into complex clinical data implications for your practice
What ACOs Mean
istance page 36 Clopidogrel Res

The Issue of

age 18 in the Elderlyp

Stents

p for Intervention

age 23

on Home Monito ringpage 13

Gregg C. Fonaro w,

MD

Suzanne Oparil, MD
on JNC 8page
31

CardioSource lNews Inter ventiona

PREMIER ISSUE
MARCH 2012

E1 VOLUME 1 | ISSU www.cswnews.org

News and Vie Your Source for

rld of Cardiolog ws from the Wo

Your Source for

C ar di o S o ur c e WorldNews
News and Vie ws from the Wo rld of Cardiolo gy

on Politics vs.

Steven E. Nissen , MD

Sciencepage 46

VOLUME 1 | ISSUE 1 www.cswnew s.org

JANUARY 201 2

PREMIER ISS UE

The New Frontier:

How the Development of TAVI

Will Change Everyt hing
CLINICAL NEWS IN THIS ISSUE:
Georges Take
Life after COURAGE
PAGE 2

T HE

NOW
JACC in a Flash 8

F U T U RE
Chriss Corner

IS

How new anticoagu lants will impact stroke prevention in AF PAGE 20

IN THIS ISSUE:
Welcome to CardioSource World News
PAGE 2

Jack In The Bac

Number Check

Novel Techniqu

es:

9 Journal Scan tdown 12 Cardiology Coun 14 ion ACCEL Intervent 15 Hot Topic

Reduction in Incidence of MI

46% 50%
How you can help your patie nts with obesity
PAGE 42

CLINICAL NEWS
Cardiology Cou ntdown 3 JACC in a Flas h 8 Journal Scan 9 ACCEL Summari es 10 Hot Topic 13 Special Meeting Coverage 14

Problems with nt PCI reimburseme

PAGE 48

ts from New data poin s NCDR database

PAGE 36

radial Grasping trans access

PAGE 42

Creating the future

PAGE 48

Jack In The Bac

Reduction in Sudden Cardiac Deaths

Interesting stats and tidbits to ponder

PAGE 36

Number Che

ck

Patient Focus

Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.

Stop by ACC CentrAl, booth #10027 to leArn more!

2012 American College of Cardiology. G1212

Save 15% off select educational products and courses purchased on site!

Visit ACC Central, Booth #10027!

2012 American College of Cardiology. J1204

Author Index

Author Index

ACC.12

CardioSource
Author Index

Mobile App
Powered by Skyscape

2012 American College of Cardiology. W1205

FREE CardioSource Mobile App

The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals! Download CardioSources most popular and clinically relevant content on your mobile device today for FREE!

Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device. Visit ACC Central, Booth #10027

ACC.12

Author Index
Aaron, Jacob: 406 154 Aaronson, Keith D.: 669 168 Aaronson, Susan: 913 6 143 Abbas, Aamer: 917 148 Abbott, Brian G.: 651 160 Abdalla, Mohamed I.: 906 8 110 Abdel-Latif, Ahmed: 917 7 148 Abdelmoneim, Sahar S.: 929 8 154 Abdul-Nour, Khaled: 918 3 148 Abe, Mitsunori: 2504 7 138 Abidov, Aiden: 918 148 Abizaid, Alexandre: 2504 11 138, 2632 184, 2202 161, 2509 6 147, 503 188 Abood, Beth: 306 186 Abou-Chebl, Alex: 2633 189 Abraham, JoEllyn C.M.: 904 4 141 Abraham, Theodore P.: 259 210, 638 151, 907 142 Abraham, William: 922 5 150 Abraham, William T.: 614 121, 655 163, 716 201, 690 184 Abuzetun, Jamil Y.: 744b 170 ACCESS EUROPE Investigators: 930 3 155 Achenbach, Stephan: 924 5 151, 2625 177, 696 185, 924 7 151 Acker, Michael A.: 213 122, 681 179 Ackerman, Michael J.: 222 141, 236 169, 648 159, 691 184 Adams, David H.: 632 129 Adams, Kirkwood: 921 4 150 Adamson, Phillip: 922 5 150 Addo, Tayo A.: 2509 147 Addonizio, Linda: 901 5 114 Adelstein, Evan C.: 922 6 150 Adir, Yochai: 912 6 142 Afonso, Luis: 2306 125, 306 186, 910 6 111 Agnihotri, Arvind: 2308 156, 2310 156 Agostoni, Pierfrancesco: 926 5 153 Aguilar, David: 203 109, 718 202, 822 198 Ahern, Jeanne: 616 122 Ahmad, Tariq: 744a 170, 921 5 150 Ahmed, Ali: 225 150 Ahmed, Mohamed: 907 7 142 Ahmed, Mustafa: 234 163, 2306 125 Ahmed, Waqas: 2509 9 147 Ahn, Chul: 907 4 142 Ahn, Chul-Min: 405 144 Ahn, Jung-Min: 2645 120 Ahn, Young Keun: 917 4 148, 2505 14 139, 511 188 Ai, Tomohiko: 405 144 AI-Mallah, Mouaz: 918 3 148 Aikawa, Elena: 406 154 Akkaya, Mehmet: 918 6 148 Al Habib, Farida: 746 105 Al Suwaidi, Jassim M.: 746 105 Al-Khatib, Sana: 904 9 141, 919 149 Al-Mallah, Mouaz: 924 5 151, 924 7 151 Al-Mallah, Mouaz H.: 214 122, 686 180, 818 169 Alam, Mahboob: 925 6 152 Albert, Michelle: 664 165 Albert, Nancy M.: 114 210, 717 202 Alesh, Issa: 306 186 Alexander, Jay H.: 660 164 Alexander, John: 904 9 141 Alexander, Karen P.: 645 158 Alexanderson, Erick: 513 190 Alexis, Jeffrey: 257 209 Alexopoulos, Dimitrios: 903 4 108, 903 7 108 Alhabib, Khalid F.: 515 193 Ali, Ziad: 2508 6 139 Alizadehasl, Azin: 746 105 Alla, Venkata M.: 744b 170 Allen, Larry A.: 224 143, 806 123 Alli, Oluseun O.: 2630 183 Allison, Thomas: 688 182, 929 8 154 Allocco, Dominic: 2506 7 146, 2506 13 146 Almendral, Jesus: 732 109, 804 118 Almonacid, Alexandra: 2509 11 147 Alpendurada, Francisco D.: 908 4 110 Alpert, Joseph S.: 732 109, 733 114, 734 116, 735 122, 736 125 Alraies, M Chadi: 2301 114, 2315 189 Alvarez, Paola: 2303 115 Alvarez, Rene J.: 717 202 Ambar, Sameer: 2310 156, 2313 189, 2314 189 Amin, Alpesh N.: 913 5 143 Amin, Amit: 2510 15 140 Amin, Amit P.: 2511 13 147 Amin, Zahid: 2314 189 Amir, Offer: 912 6 142 Amoroso, Nicholas: 2505 10 139 Amsterdam, Ezra A.: 231 162 Anand, Inder: 680 179 Ananthasubramaniam, Karthikeyan: 223 142, 813 164, 822 198, 826 203 Anderson, Allen: 2308 156 Anderson, Jeffrey: 616 122, 712 199 Anderson, Jeffrey L.: 513 190, 675 169 Anderson, Richard E.: 650 153 Andrade, Jadelson P.: 503 188 Angelini, Paolo E.: 261 171 Angelopoulos, Peter: 2620 161 Angiolillo, Dominick: 902 4 107 Angiolillo, Dominick J.: 2617 156, 2643 201 Anne, Godier: 904 8 141 Anne-Cline, Martin: 904 8 141 Anne-Marie, Fischer: 904 8 141 Annex, Brian H.: 407 181 Ansell, Jack: 904 9 141 Ansell, Jack E.: 747 209 Antman, Elliott: 902 3 107, 902 5 108 Antman, Elliott M.: 613 121, 308 210 Antoniucci, David: 903 6 108 Appelbaum, Evan: 925 4 152, 925 5 152 Apple, Fred S.: 728 209 Applegate, Robert J.: 2111 177, 2305 125, 2510 139 Aragon, Victor: 2504 15 138 Arai, Andrew E.: 605 116, 682 179 Aranda, Juan M.: 234 163, 517 191 Arbab-Zadeh, Armin: 909 8 111 Arbel, Yaron: 406 154 Arena, Frank J.: 2313 189 Arena, Ross: 651 160, 929 6 154 Armstrong, Aimee K.: 637 149 Armstrong, Paul: 916 5 140 Armstrong, Paul W.: 613 121, 639 156, 639 156 Armstrong, William F.: 682 179 Arnold, Alice M.: 905 5 109 Arnold, Suzanne V.: 219 128 Aronow, Herbert: 2511 15 147 Aronow, Herbert D.: 2637 195, 2620 161, 2633 189 Aronow, Wilbert: 907 4 142 Arora, Natasha P.: 2306 125 Arora, Rajat: 2310 156, 2313 189 Arora, Rajat: 2314 189 Arora, Sabeena: 744a 170 Arrighi, James A.: 103 117 Artang, Ramin: 904 6 141 Arzamendi, Dabit: 2310 156, 2314 189 Asamoto, Lisa: 908 5 110 Asch, Federico: 744b 170 Asgar, Anita W.: 2114 194, 504 193 Ashfield, Kyle: 919 8 149 Ashley, Euan: 929 6 154 Asirvatham, Samuel: 807 124 Asirvatham, Samuel J.: 744b 170 Askew, John W.: 929 154 Assenza, M, Gabriele: 925 5 152 Assenza, Gabriele E.: 925 4 152 Asset, Gaelle: 911 5 143

ACC.12 Final Program 217

Author Index ACC.12

Last Name, First Name: Session # Page #
Atallah, Joseph: 262 187 ataya, ali: 2301 114 Ataya, Ali: 2315 189 Atsma, Douwe: 906 3 109 Attubato, Michael: 931 5 113 Atz, Andrew: 637 149, 901 4 114 Auger, Dominique: 922 8 150 Auger, William R.: 514 194, 662 164 Auguadro, Carla: 914 6 144 Aurigemma, Gerard P.: 744b 170 Auseon, Alex J.: 638 151, 229 159, 805 123, 809 128, 814 164, 818 169, 825 202 Austin, Patrick W.: 914 5 144 Austria, Edgar: 932 4 155 Autore, Camillo: 925 5 152, 925 4 152 Aversano, Thomas: 2511 9 147, 304 143 Avraamides, Panayiotis: 2504 138, 745 203 Awata, Masaki: 2311 166 Ayres, Nancy: 693 185 Baba, Kenji: 901 3 114 Babaev, Anvar: 931 5 113 Babaliaros, Vasilis: 2203 194, 2308 156, 2619 161 Baber, Usman: 2501 137, 2508 6 139, 2501 10 137 Babu-Narayan, Sonya: 920 8 149 Bacharach, J. Michael: 2642 201, 931 8 113 Bachmann, Justin M.: 710 198, 113 193 Badimon, Juan: 902 6 108 Badri, Marwan: 912 4 142 Bae, Jang-Ho: 511 188, 2505 16 139 Bae, Jang-Whan: 917 4 148 Baechler, Courtney: 741 187 Baggish, Aaron: 914 8 144 Baggish, Aaron L.: 603 113, 929 4 154 Bahit, Cecilia: 904 9 141 Bai, Rong: 925 8 152 Bailey, Alison: 255 204, 746 105, 927 153 Bailey, Steven R.: 2608 119, 2619 161, 2122 183, 2314 189, 923 3 151 Bairey Merz, C. Noel: 227 152, 255 204, 620 123, 306 186 Baker, Joshua: 2308 156, 2310 156 Baklanov, Dmitri: 2510 7 139, 2511 13 147 Bakris, George L.: 631 128, 230 159, 727 210, 745 203, 926 153 Baldus, Stephan: 930 3 155, 930 6 155 Balke, C. William: 107 124 Ball, Stephen: 674 182 Ballantyne, Christie M.: 227 152, 729 203, 911 3 142, 911 10 143, 306 186, 611 117, 745 203 Baman, Timir: 918 3 148 Bamberg, Fabian: 909 6 111 Bandeali, Salman: 925 6 152 Banerjee, Subhash: 2302 114, 823 200, 923 151 Baran, David: 670 168 Baranowski, Bryan: 922 7 150 Barasch, Eddy: 905 6 109 Barbash, Israel: 2500 15 137, 2507 15 147 Barbeau, Gerald: 2510 9 139 Barker, Nancy: 920 7 149 Barman, Neil: 926 3 153 Baron, Julia: 2314 189 Barr, Laurie: 929 8 154 Barragan, Paul: 2509 9 147 Barrero, Carlos M.: 502 188, 502 188 Barrington, Sally: 908 3 110 Barrows, Kevin: 741 187 Bart, Bradley: 655 163 Bartoletti, Stefano: 925 8 152 Bartov, David: 2310 156, 2122 183 Bartz, Traci: 905 6 109 Bashir, Riyaz: 514 194 Basmadjian, Arsene J.: 930 155 Bassand, Jean-Pierre L.: 613 121 Bastiaenen, Rachel: 914 7 144 Batal, Omar: 912 5 142 Bateman, Michael G.: 407 181 Bateman, Timothy M.: 223 142 Bates, Eric R.: 200 107, 2638 196, 2643 201, 689 184, 2201 119, 513 190, 817 169 Batich, Christopher D.: 906 4 109 Bauer, Axel: 926 6 153 Bauer, Marcus: 924 4 151 Bauer, Wolfgang R.: 918 7 148 Bauernschmitt, Robert: 2644 107 Bax, Jeroen: 922 8 150 Bax, Matthijs: 2502 13 119 Bay, Curt: 308 210 Bayturan, Ozgur: 2608 119 Bdeir, Mohamad B.: 746 105 Beanlands, Rob S. B.: 223 142 Beaudoin, Jonathan: 406 154 Becker, Alexander: 909 6 111 Becker, Christoph: 909 6 111 Becker, David J.: 512 192 Becker, Richard: 903 8 108 Becker, Richard C.: 107A 125, 2301 114 Beckman, Joshua A.: 250 198, 813 164, 743 129, 932 155 Beek, Aernout: 918 4 148 Beekman, Robert: 901 8 114 Beekman, Robert H.: 678 178, 901 114 Beer, Meinrad: 918 7 148 Beigel, Roy: 924 3 151 Belardi, Diego: 918 3 148 Belardi, Jorge A.: 502 188 Belardinelli, Luiz: 921 8 150 Belcik, Todd: 909 4 110 Belden, William: 918 5 148 Beliveau, Mary Ellen: 103 117 Belkin, MD, Robert: 907 4 142 Bell, Malcolm: 623 126, 817 169 Beller, George A.: 708 197 Belziti, Cesar A.: 502 188 Ben Dor, Itsik: 915 8 145 Ben-Dor, Itsik: 2308 156, 2500 15 137, 2507 15 147, 2639 202 Benamer, Hakim: 926 7 153 Benditt, David G.: 640 157 Benitez, R M.: 659 163 Benkeser, David: 905 5 109 Bennett, Mosi K.: 906 7 110 Bensimhon, Daniel: 929 6 154 Benson, Lee: 901 8 114 Berger, Peter B.: 623 126, 2301 114, 2501 137 Bergersen, Lisa: 901 8 114 Bergersen, Lisa T.: 678 178 Bergmeijer, Thomas: 902 4 107 Bergner, Daniel W.: 406 154 Berjeb, Nadia: 915 7 145 Berkstresser, Brant: 914 8 144 Berman, Daniel: 924 7 151 Berman, Daniel S.: 682 179, 259 210, 740 204, 924 5 151 Bernard, Le-Bonniec: 904 8 141 Bernhardt, Peter: 908 7 110, 903 3 108 Berrocal, Daniel H.: 502 188 Berry, Colin: 923 9 152 Bersin, Robert M.: 2613 126, 502 188 Bertomeu Martinez, Vicente: 726 210 Bertrand, Olivier: 2510 9 139 Berul, Charles: 625 127, 301 157 Berwanger, Otavio: 304 143 Beshansky, Joni R.: 308 210 Bhandare, Deepti: 2306 125 Bhargava, Mandeep: 239 178 Bhatt, Deepak: 306 186, 928 3 153 Bhatt, Deepak L.: 2627 177, 2641 200, 107A 125 Bhatti, Tandeep K.: 233 163 Biagini, Elena: 925 4 152, 925 5 152 Biddle, W. P.: 744b 170 Biederman, Robert: 918 5 148 Biederman, Robert W. W.: 605 116, 909 110 Biga, Cathleen: 609 117, 630 128, 673 169, 684 180, 621 123 Bilolikar, A Neil: 2508 11 139 Bischoff, Joyce: 406 154 Bisognano, John D.: 631 128 Bittl, John: 629 128 Bittner, Vera: 701 193, 711 199, 709 197 Blaha, Michael: 927 3 153 Blaha, Michael J.: 729 203 Blankenberg, Stefan: 930 6 155, 930 6 155 Blankenship, James C.: 600 112, 600 112, 2305 125 Blankstein, Ron: 208 116, 910 3 111

218 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Blauer, Joshua: 918 8 148, 918 6 148 Blauwet, Lori: 240 179 Bleiziffer, Sabine: 2507 13 147 Bliden, Kevin: 2501 12 137 Block, Peter C.: 2640 200, 714 199, 2314 189 Bloomfield, Gerald S.: 713 199 Bluemke, David: 908 8 110 Blum, Kay: 112 180 Blum, Michael S.: 687 180 Blumenthal, Roger: 927 3 153 Bo, Yu: 916 7 140 Bode, Christoph: 507 191 Boden, Heln: 917 5 148 Boden, William E.: 611 117 Bodi, Vicente: 908 6 110 boersma, eric: 922 8 150 Bogun, Frank: 918 3 148 Bohm, Michael: 926 4 153 Bhm, Michael: 2509 7 147 Bohula, Erin: 234 163, 259 210 Bolli, Roberto: 300 112 Bolling, Steven F.: 220 129, 2640 200, 681 179, 2105 171 Bolorunduro, Oluwaseyi: 408 187 Bonaca, Marc: 902 3 107 Bonan, Raoul: 2114 194, 246 187, 2626 177, 1607 205, 2308 156 Bonanad, Clara: 908 6 110 Bonello, Beatrice: 920 8 149 Bonow, Robert O.: 260 211, 606 116, 658 163, 107A 125, 710 198 Booker, Julian: 2306 125 Boon, Nicholas A.: 407 181 Boothroyd, Derek: 903 5 108 Borden, William: 928 8 154 Borer, Jeffrey S.: 674 182 Borgia, Francesco: 916 5 140 Borlaug, Barry: 203 109, 821 197 Borlaug, Barry A.: 406 154 Bosa, Francisco: 2504 15 138 Bosmans, Johan: 2644 107 Botker, Hans E.: 916 4 140, 689 184 Bouchard, Alain: 2506 13 146 Bouchard, Marie-Pier: 2510 9 139 Boudreault, Jean-Rock: 2510 9 139 Bouleti, Claire: 930 5 155 Boura, Judy A.: 929 7 154 Bourge, Robert C.: 649 159, 517 191, 717 202 Bouvier, Erik: 2500 13 137, 407 181 Bove, Alfred A.: 302 165, 647 159, 688 182 Boxt, Lawrence M.: 683 180 Boyce, Steven: 2500 15 137, 2507 15 147 Boyle, Andrew: 694 185 Boyle, Noel G.: 216 126 Bozkurt, Biykem: 617 122, 626 127, 718 202, 816 166, 906 109 Bradley, Scott: 901 4 114 Brady, Peter A.: 306 186, 820 192 Branch, Kelley: 683 180 Brandwein, Russell A.: 2105 171 Brar, Somjot S.: 211 121 Braun, Lynne: 114 210, 698 186, 733 114 Braunwald, Eugene: 300 112, 400 106, 656 163, 902 3 107, 902 5 108, 916 8 140 Brecker, Stephen: 2644 107 Brener, Sorin J.: 2634 190, 916 4 140 Brennan, J. Matthew: 915 5 145, 928 5 154 Brethauer, Stacy: 306 186 Brignole, Michele: 306 186 Brilakis, Emmanouil: 2302 114 Brilakis, Emmanouil S.: 2201 119, 2504 138, 2629 183, 2639 202, 804 118 Brin, Kenneth P.: 600 112 Brindis, Ralph G.: 721 204, 516 192, 674 182 Brinker, Jeffrey: 909 8 111 Briole, Nicolas: 2502 9 119 Bristow, Michael R.: 104 117 Broberg, Craig S.: 202 108 Brochet, Eric: 930 5 155 Brockmann, Gernot: 2507 13 147 Brodie, Bruce: 2501 6 137, 2501 10 137, 2501 14 138, 2501 16 138 Brodie, Bruce R.: 2638 196 Brodt, Chad R.: 408 187 Brophy, James M.: 200 107, 653 162 Brosh, Sella: 924 3 151 Brown, Alan S.: 699 186 Brown, III, Charles L.: 621 123 Brown, David W.: 634 141 Brown, Patricia: 902 4 107 Brugaletta, Salvatore: 2503 13 146, 910 4 111 Brunken, Richard C.: 407 181 Brush, John E.: 219 128, 224 143, 609 117, 744a 170 Bruyne, Bernard D.: 923 9 152 Bryant, Randall M.: 625 127, 667 167 Bryson, Christopher: 928 3 153 Buchanan, Kyle: 912 5 142 Buchbinder, Maurice: 2614 140 Budoff, Matthew: 924 7 151, 927 3 153, 930 7 155 Budoff, Matthew J.: 644 158, 683 180, 924 4 151, 924 5 151, 308 210 Bui, Quang T.: 2612 125, 2313 189 Bukartyk, Jan: 406 154 Bukhman, Gene: 713 199 Buller, Harry R.: 305 181 Bullones, Juan A.: 2504 15 138 Bumpus, Sherry: 699 186 Buonamici, Piergiovanni: 903 6 108 Cademartiri, Filippo: 924 5 151, 924 7 151 Caiati, Carlo: 909 3 110 Calabresi, Marco: 2644 107 Calcagno, Simone: 2644 107 Caldarone, Christopher: 692 184, 901 3 114 Califf, Robert M.: 107A 125, 300 112, 309 211, 746 105 Calkins, Hugh: 666 167, 703 196, 720 203 Callans, David: 212 121 Callister, Tracy: 924 5 151, 924 7 151 Calvino, Ramon: 2504 15 138 Camacho, Fabian T.: 910 7 111 Camm, A. John: 654 162, 702 196, 747 209 Campbell, Robert: 244 185 Canali, Emanuele: 2644 107 Cannon, Bryan C.: 252 201, 667 167 Cannon, Christopher: 916 8 140 Cannon, Christopher P.: 2634 190, 107A 125 Cannon, Louis: 2506 7 146 Cano, Manuel: 2506 15 146 Canobbio, Mary: 679 179 Canter, Charles: 901 5 114 Cantor, Warren: 916 5 140 Capizzi, Jeffrey A.: 911 9 143 Capodanno, Davide: 2627 178, 2302 114, 2511 147 Caputo, Ronald: 2505 8 138 Carabello, Blase A.: 2636 195, 652 160, 681 179, 210 118 Carballo, Mariana: 304 143 Carlson, Eric B.: 104 117 Carr, James C.: 208 116 Carrabba, Nazario: 903 6 108 Carrie, Didier: 2506 146 Carri, Didier: 2506 13 146 Burgon, Nathan: 918 6 148 Burke, David A.: 2509 11 147 Burke, Martin C.: 216 126 Burke, Michael A.: 744b 170 Burkhart, Harold M.: 210 118, 632 129 Burnett, John C.: 728 209 Burwash, Ian G.: 258 210 Bush, David E.: 664 165 Bush, Ruth: 743 129 Busman, Denise K.: 2104 165 Butler, Javed: 617 122, 906 109 Butter, Christian: 930 3 155 Buxton, Alfred E.: 715 201, 501 190 Buz, Semih: 676 178 Byrd, III, Benjamin F.: 657 163 Byrd, Charles L.: 624 126 Byrne, Barry: 300 112 Byrne, Barry J.: 906 4 109 Byrne, Robert: 2503 9 146 Byrne, Robert A.: 2645 120

ACC.12 Final Program 219

Author Index ACC.12

Last Name, First Name: Session # Page #
Carroll, John: 2507 9 146 Carrozza, Joseph: 2505 8 138 Carson, Andrew R.: 2644 107 Carson, Peter: 922 5 150 Caruthers, Shelton D.: 259 210 Carvalho, Ana L.: 911 8 143 Casale, Paul: 673 169, 673 169 Casali, Valentina: 914 6 144 Casella, Michela: 925 8 152 Casella-Filho, Antonio: 911 8 143 Casey, Donald E.: 226 152 Cassater, Daiana: 920 7 149 Cassel, Graham: 2509 9 147 Casserly, Ivan P.: 2620 161 Cavalcanti, Alexandre: 304 143 Cavender, Matthew: 2502 11 119 Cavendish, Jeffrey J.: 811 158 Cedarholm, John: 2502 7 119 Celada, Silvia: 914 6 144 Cercek, Bojan: 211 121 Cerisano, Giampaolo: 903 6 108 Cerqueira, Manuel D.: 407 181 Chae, In-Ho: 304 143 Chae, Jei Keon: 2505 14 139 Chae, Shung Chull: 2505 14 139 Chagas, Antonio C.: 503 188 Chakravarty, Saneka: 744a 170 Challa, Karthik: 2311 166 Champion, Hunter C.: 662 164 Chan, David C.: 913 4 143 Chan, Paul: 205 112, 209 117, 408 187 Chan, Raymond: 925 4 152 Chan, Raymond H.: 925 5 152 Chandra, Navin: 914 7 144 Chang, Tara I.: 2511 11 147 Charaf, Edriss: 744b 170 Chareonthaitawee, Panithaya: 223 142 Charles marc, Samama: 904 8 141 Chase, Paul: 929 6 154 Chatterjee, Saurav: 408 187 Chaturvedi, Seemant: 2631 183 Chaudhry, Farooq A.: 628 127 Chaustre, Fabian: 908 6 110 Chazal, Richard A.: 248 198, 302 165, 512 192 Cheema, Asim: 2644 107 Chehab, Bassem M.: 932 4 155 Chen, Chih-Ying: 922 4 150 Chen, Edmond: 903 8 108 Chen, James: 2507 9 146 Chen, Jiyan: 505 188 chen, lucia: 914 4 144 Chen, Michael: 230 159, 722 204 Chen, Peng-Sheng: 405 144 Chen, Stephen Y.: 2302 114 Cheng, Victor: 924 5 151, 924 7 151 cherukupalli, Raghu: 2311 166 Cheung, Anson: 2644 107 Chevalier, Bernard: 2500 13 137, 2503 13 146, 407 181 Chhatriwalla, Adnan: 2510 15 140, 2501 8 137, 2511 13 147 Chicos, Alexandru B.: 406 154 Chieffo, Alaide: 2202 161, 2503 145, 2625 177 Chien, Kenneth: 309 211 Childs, Susan: 113 193 Chin, Derek: 2314 189 Chin, Michael T.: 405 144 Chinnaiyan, Kavitha: 924 5 151, 924 7 151 Chipkin, Stuart: 911 9 143 Chiribiri, Amedeo: 908 3 110 Chisholm, Robert: 2644 107 Chiswell, Karen: 921 5 150 Chitwood, W. Randolph: 504 193, 674 182 Cho, Ae Shin: 917 4 148 Cho, Hyang Hee: 917 4 148 Cho, Jinman: 2608 119 Cho, Myeong Chan: 2505 14 139 Cho, Myeong-Chan: 917 4 148 Choi, Andrew: 744b 170 Choi, Byoung Geol: 2505 12 139 Choi, Cheol Ung: 2505 12 139 Choi, Donghoon: 2508 9 139, 2644 107 Choi, Jin-Ho: 2504 13 138 Choi, Seung Cheol: 405 144 Choi, Seung-Hyuk: 2504 13 138 Chou, Eric: 308 210 Choudhury, Anirban: 2505 6 138 Choudhury, Lubna: 233 163 Chow, Benjamin: 924 7 151 Chow, Benjamin J.: 924 5 151 Chow, Benjamin J. W.: 696 185 Chow, Marcus W.: 407 181 Chowdhary, Saqib: 304 143 Chris, Feindel: 2644 107 Christenson, Robert: 905 4 109 Christiansen, Evald: 2506 11 146 Christie, Catherine: 235 164 Christman, Karen L.: 627 127 Chronos, Nicolas A. F.: 633 129 Chrysohoou, Christine: 931 3 113 Chu, Victor: 2644 107 Chua, Terrance: 905 8 109 Chugh, Atul: 908 8 110 Chugh, Sumeet: 691 184, 702 196 Chung, Eugene: 922 5 150 Chung, Eugene H.: 688 182 Chung, Mina: 243 184, 904 4 141, 922 7 150 Churchwell, Keith B.: 684 180 Cigarroa, Joaquin: 629 128, 910 111 CIMADEVILLA, Claire: 915 7 145 Clack, Lucy: 2645 120 Claessen, Bimmer E.: 2502 119 Clair, Daniel G.: 2637 195 Clark, Michael G.: 731 142 Clarkson, Priscilla M.: 911 9 143 Clayton, Tim: 2501 10 137 Clegg, Stacey D.: 2507 9 146 Cleland, John G. F.: 207 116 Clement-Guinaudeau, Stephanie: 406 154 Clever, Yvonne P.: 2509 7 147 Clouse, Melvin: 909 8 111 Clyne, Christopher: 919 5 149 Coelho-Filho, Otavio: 922 3 150 Cogle, Christopher: 300 112 Cohen, David: 2510 15 140, 2511 13 147 Cohen, David J.: 2636 195, 665 167, 503 188, 928 153 Cohen, Howard: 2510 13 140 Cohen, Marc: 623 126 Cohen, Mauricio G.: 2122 183 Cohen, Meryl: 724 209 Cohen-Solal, Alain: 680 179 Cohn, Lawrence H.: 401 124 Colan, Steven: 901 5 114 Cole, Stephanie M.: 911 9 143 Collier, Kevin: 2502 7 119 Collins, Tyrone J.: 2623 166 Colombo, Antonio: 2504 11 138, 2644 107, 400 106, 404 199 Comerota, Anthony J.: 2607 115, 2631 183, 2637 195 Comhair, Suzy: 912 8 142 Connolly, Stuart: 904 5 141, 904 7 141 Connor, Jean A.: 616 122 Conrad, Gibby: 907 5 142 Conrad, Michael J.: 905 7 109 Contant, Charles: 916 8 140 Conte, Michael S.: 2613 126, 2623 166 Conti, C. Richard: 214 122 Cook, E. Francis: 925 4 152 Cook, Earl Francis: 925 5 152 Cook, Stephen C.: 679 179 Cook, Thomas: 407 181 Cooke, Blaire: 923 4 151 Cooper, Christopher J.: 2627 177 Cooper, Leslie T.: 240 179, 720 203, 925 3 152 Cooper-Dehoff, Rhonda M.: 733 114 Cooper-DeHoff, Rhonda M.: 629 128, 663 165, 698 186, 731 142 Copeland, Hannah: 408 187 Copeland, Jack: 408 187 Coppens, Michiel: 904 5 141 Corcos, Thierry: 2627 178 Cormier, Bertrand: 2500 13 137, 407 181

220 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Cornel, J.H.: 903 8 108 CORONARY Study Investigators: 305 181 Corrado, Domenico: 603 113 Corriveau, Nicole: 913 6 143 Corso, Paul: 2500 15 137, 2507 15 147 Corvaja, Nicola: 2310 156 Coselli, Joseph S.: 260 211 Costa, Jr., J. Ribamar: 2504 11 138 Costa, Jos de Ribamar: 2506 15 146 Costa, Marco A.: 2111 177, 2639 202, 2201 119, 2303 115 Costa, Ricardo: 2506 15 146 Costa, Ricardo A.: 2504 11 138 Costa, Salvatore: 256 204, 612 118, 814 164 Costantini, Costantino: 2309 156 Costanza, Salvatore: 906 5 110 Costanzo, Maria Rosa: 617 122 Ct, Mlanie: 915 6 145 Cotter, Gadi: 680 179 Cotts, William: 2315 189 Courchesne, Paul: 905 3 109 Coutinho, Thais: 407 181 Cowart, Pam: 922 5 150 Cowger, Jennifer: 694 185 Cox, David: 2501 10 137, 2501 14 138, 2501 16 138 Cox, David A.: 604 115, 2309 156 Coylewright, Megan: 744b 170 Crawford, Michael H.: 308 210, 920 149 Crawford, Thomas: 918 3 148 Crawford, Thomas C.: 713 199 Crean, Andrew: 925 4 152, 925 5 152 Cremers, Bodo: 2509 7 147 Cribier, G. Alain: 2606 115, 2203 194, 305 181 Crispino, Caroline: 923 4 151 Cristea, Ecaterina: 916 4 140, 2501 14 138, 2501 16 138, 2508 15 139, 304 143 Cross, Russell R.: 901 7 114 Crossley, George H.: 243 184, 614 121 Crowley, Kevin: 916 8 140 Cueff, Caroline: 915 7 145 Cui, Lianqun: 2645 120 Cuisset, Thomas: 739 211 Cummings, Jennifer E.: 716 201 Cuni, Rezarta: 2503 9 146 Curb, J D.: 904 4 141 Currier, Jesse: 917 148 Curtis, Anne: 904 4 141 Curtis, Anne B.: 207 116, 239 178 Curtis, Jeptha P.: 919 4 149 Cury, Ricardo C.: 696 185 Cushman, William C.: 631 128 Cutlip, Donald: 2645 120 Cuttica, Michael: 249 198 DAgostino, Ralph B.: 700 186, 308 210 DElia, Emilia E.: 914 6 144 Dager, William: 623 126 Dagogo-Jack, Samuel: 711 199, 711 199 Dai, Dadi (David): 928 5 154 Dal-Bianco, Jacob: 406 154 Damal, Kavitha: 918 6 148 Damelou, Anastasia: 903 7 108 Damiano, Ralph J.: 1607 205, 509 190 Damman, Peter: 2502 13 119 Damp, Julie: 204 110, 695 185 Danciu, Sorin: 2303 115 Dandel, Michael: 921 7 150 Daneault, Benoit: 2500 11 137, 2507 11 146 Dangas, George: 2508 6 139, 2501 6 137, 2501 10 137, 308 210 Dangas, George D.: 2627 178, 2632 184, 2638 196, 646 155, 2644 107, 304 143, 510 193, 745 203 Daniels, Curtis J.: 202 108, 668 168 Danik, Jacqueline S.: 911 6 143 Danik, Stephan: 922 3 150 Danoff, Ann: 2505 10 139 Darbar, Dawood: 702 196 Darst, Jeffrey: 692 184 Datta, Saurabh: 907 8 142 Daubeney, Piers E. F.: 692 184 Daubert, James: 919 6 149 Daubert, James P.: 704 196, 690 184 Dauerman, Harold L.: 2624 167, 722 204, 2305 125 Daugherty, Stacie L.: 245 185, 928 6 154 Davendralingam, Natasha: 908 4 110 Davidson, Brian: 909 4 110 Davidson, Charles J.: 2201 119, 2310 156 Davidson, Karina: 910 5 111 Davidson, Michael: 911 10 143 Davidson, Michael H.: 611 117 Davidson, William R.: 668 168, 920 149 Davies, Justin E.: 923 6 152 Davis, David: 106 123 Davis, Suresh: 2311 166 Davlouros, Periklis: 903 4 108, 903 7 108 Dawkins, Keith: 2506 7 146, 2506 13 146, 910 4 111 Dawn, Buddhadeb: 932 4 155 de Belder, Mark A.: 508 191 de Bruyne, Bernard: 2503 13 146, 916 4 140 De Bruyne, Bernard: 2508 7 139, 2511 7 147 De Carlo, Carlotta: 2644 107 De Caterina, Raffaele: 904 9 141 De Cecco, Carlo Nicola: 925 4 152, 925 5 152 De Ferranti, Sarah: 247 196 de la Torre Hernandez, Jose: 2625 177, 2504 15 138 de Lemos, James: 913 7 143 De Lemos, James A.: 653 162, 710 198, 1605 171, 911 142 De Marco, Teresa: 649 159, 705 196 De Michelis, Nathalie: 907 8 142 De Schutter, Alban: 927 5 153 de Vries, Antoine: 906 3 109 de Vries, Ton: 910 4 111 de Waha, Antoinette: 2645 120 de Waha, Suzanne: 902 8 108 de Winter, Robbert: 2502 13 119 Dearani, Joseph A.: 2615 148, 625 127, 661 164 Dec, G. William: 680 179 Decker, Carole: 2501 8 137 Deedwania, Prakash C.: 207 116 Deering, Thomas F.: 690 184 DeFilippi, Christopher: 905 6 109 DeFilippi, Christopher R.: 905 4 109 Degertekin, Muzaffer: 2639 202, 518 189 Dehmer, Gregory J.: 2104 165 Deitelzweig, Steven: 913 5 143 Del Nido, Pedro: 724 209 DeLa Rochellire, Robert: 2510 9 139 Delafontaine, Patrice: 916 6 140 Delago, Augustin: 924 5 151 DeLago, Augustin: 924 7 151 Delaney, Joseph: 924 4 151 Delaney, Joseph A.: 930 7 155 DeLarochellire, Robert: 2644 107, 915 6 145 Delewi, Ronak: 2502 13 119, 918 4 148 Delgado, Juan: 517 191 Delgado, Victoria: 2618 161, 922 8 150 Deliargyris, Efthymios: 2501 10 137 Della Rocca, Domenico G.: 906 4 109 Delli Fraine, Jami: 928 7 154 Dello Russo, Antonio: 925 8 152 Deluca, Carlos: 2310 156 DeMaria, Anthony N.: 610 117, 633 129, 111 159, 400 106, 740 204 Dembrink, Jan Henk: 304 143 DeNofrio, David: 213 122, 641 157 DePuey, III, E. Gordon: 658 163, 708 197 Dery, Jean-Pierre: 2510 9 139, 2624 167, 903 8 108 Dery, Ugo: 2510 9 139 Desai, Akshay S.: 732 109, 234 163, 718 202, 517 191, 806 123, 921 150 Desai, Milind Y.: 648 159, 619 122, 2612 125 Desai, Shashank: 694 185 Desch, Steffen: 902 8 108 DeSilva, Kalpa: 2645 120 Deswal, Anita: 203 109 DeVarennes, Benoit: 2644 107 Devendra, Ganesh: 920 6 149 Dewey, Marc: 909 8 111 Dewey, Todd M.: 246 187, 2606 115, 1607 205, 2102 160 Dey, Damini: 924 5 151

ACC.12 Final Program 221

Author Index ACC.12

Last Name, First Name: Session # Page #
Dhar, Ritesh: 223 142 Di Biase, Luigi: 677 178, 925 8 152 Di Carli, Marcelo: 910 3 111 Di Carli, Marcelo F.: 223 142 Di Mario, Carlo: 916 5 140, 2505 138, 923 6 152 Diamond, Robin: 248 198 Dias, Clapton: 923 4 151 Dib, Nabil: 610 117, 618 121 DiCarlo, Lorenzo: 911 10 143 Dickerson, Jennifer: 204 110 Dieter, Robert S.: 2305 125 Dietz, Harry: 908 8 110 Dill, Karin: 619 122 Diller, Gerhard-Paul: 920 5 149, 920 8 149 Dilsizian, Vasken: 619 122, 658 163, 708 197 Dimas, Alexios P.: 2510 139 Dimitriadis, K.: 926 8 153 Dimopoulos, Konstantinos: 920 5 149 Ding, Jingzhong: 927 3 153 Dion, Robert: 652 160 DiSciascio, Germano: 2511 147 DiScipio, Anthony: 260 211 Dixon, Simon: 2508 11 139 Dixon, Simon R.: 2639 202, 2121 177, 2315 189 Djousse, Luc: 905 5 109 Dobesh, Paul: 734 116 Dodson, John A.: 919 4 149 Doevendans, P.: 926 5 153 Dogan, Ozgen: 2506 146 Doh, Joon Hyung: 2303 115 Doherty, Caroline L.: 2104 165 Dohi, Tomoharu: 2311 166 Donzeau-Gouge, Patrick: 2500 13 137 Donzeau-Gouge, Patrik: 407 181 Dorange, Cecile: 2503 11 146, 2503 13 146 Dorbala, Sharmila: 223 142, 910 3 111 Dorian, Paul: 904 5 141 Drner, Jonas: 917 3 148 Dote, Yoko: 2309 156 Douglas, Pamela: 915 5 145 Douglas, Pamela S.: 644 158, 710 198, 107A 125 Dovellini, Emilio Vincenzo: 903 6 108 Downey, William: 2502 7 119 Doyle, Daniel: 2644 107 Doyle, Daniel: 915 6 145 Doyle, Mark: 918 5 148 Drachman, Douglas E.: 2610 120, 2627 177, 2637 195, 734 116, 737 169, 812 158, 825 202 Drazner, Mark H.: 922 150 Dressler, Ovidiu: 2508 15 139, 916 4 140 Drozda, Joseph P.: 710 198 Du, Wei: 408 187 Du-Russel-Weston, Jean: 913 6 143 Dubin, Anne M.: 603 113 Eagle, Kim: 2511 15 147, 913 6 143, 931 8 113 Eagle, Kim A.: 231 162, 713 199, 107A 125 Eagle, Taylor F.: 913 6 143 Earing, Michael: 202 108, 625 127 Easton, J. Donald: 904 9 141 Ebeid, Makram R.: 506 191 Ebell, Wolfram: 921 7 150 Eberle, Balthasar: 2606 115 Economy, Katherine: 679 179, 920 7 149 Edelmann, Frank: 921 8 150 Edwards, Brooks: 234 163 Edwards, Fred: 308 210, 915 5 145 Egidy Assenza, Gabriele: 920 7 149 Ehle, Gregory: 710 198 Eick, Christian: 926 6 153 Eikelboom, John: 206 116, 904 5 141, 904 7 141 Einhorn, Bryce: 2510 13 140 Einstein, Andrew J.: 927 4 153 Eisenberg, Mark: 920 4 149 Eitel, Ingo: 902 8 108 El Etriby, Adel: 746 105 El-Omar, Magdi: 304 143 Elasfar, Abdelfatah A.: 515 193 Elashoff, Michael: 924 6 151 Elashoff, Michael R.: 923 8 152 Elbal, Luis: 2509 9 147 Elhmidi, Yacine: 2507 13 147 Elkayam, Uri: 695 185, 720 203, 738 181 Ellenbogen, Kenneth A.: 201 108, 232 162 Elliott, Andrea: 912 5 142 Elliott, Perry M.: 253 203, 648 159 Elliott, William: 663 165 Ellis, Stephen: 2502 11 119, 300 112, 923 8 152 Ellis, Stephen G.: 2309 156, 2502 119, 503 188 Fadol, Anceta: 642 157 Fahy, Martin: 2506 9 146, 2511 7 147, 2501 6 137 Falk, Rodney: 257 209, 720 203 Falk, Rodney H.: 744b 170 Fall, Khady: 2309 156 Fang, James C.: 203 109, 234 163, 801 105, 807 124 Fang, Weiyi: 2645 120 Fantana, Gregory P.: 2626 177 Farasat, Morteza: 744b 170 Farge, Arnaud: 2500 13 137, 407 181 Farha, Samar: 912 8 142 Dudek, Dariusz: 2503 15 146 Duess, Mai-Ann: 405 144 Duffy, Peter: 2501 14 138, 2501 16 138 Dumesnil, Jean: 2644 107 Dumesnil, Jean G.: 238 171, 256 204 Dumont, Eric: 2644 107, 915 6 145 Dumonteil, Nicolas: 2500 137 Dunlap, Stephanie: 921 4 150 Dunn, Steven P.: 733 114 Dunning, Allison: 924 5 151, 924 7 151 Dupont, Matthias: 912 7 142 Duprez, Daniel A.: 727 210, 406 154 Dusek, Jeffery: 741 187 Dutka, David: 923 7 152 Duvernoy, Claire S.: 245 185 Dvir, Danny: 2500 15 137, 2507 15 147 Dweck, Marc R.: 407 181 Dworkin, Lance: 2627 177 Dzavik, Vladimir: 2505 6 138 Elmariah, Sammy: 2308 156, 2310 156, 2314 189, 930 7 155, 902 6 108 Elnagar, Amro: 2505 12 139 Eltchaninoff, Hlne: 2502 9 119 Eltchaninoff, Helene: 2606 115, 2636 195 Emanuelsson, Hakan: 902 7 108 Emert, Jamie: 928 7 154 Emery, Maurice: 923 4 151 Emmanuel, Noel: 914 7 144 Engstrom-Koch, Krysthel: 744a 170 Enriquez-Sarano, Maurice: 246 187, 2609 120, 2640 200, 612 118, 632 129, 674 182, 814 164, 915 3 145 Entrikin, Daniel: 305 181 Epstein, Andrew E.: 201 108, 239 178, 703 196, 716 201, 655 163 Epstein, Laurence M.: 624 126 Erb, Blair D.: 219 128, 244 185, 601 112, 609 117, 710 198 Erbel, Raimund: 924 4 151 Erbel, Raimund A.: 2632 184, 507 191 Ergene, Oktay: 518 189 Erlinge, David: 902 4 107 Erol, Cetin: 904 9 141 Ertl, Georg: 507 191 Erwin, Phillip: 931 7 113 Eryazici, Paula d.: 2303 115 Erzurum, Serpil C.: 912 8 142 Escalante, Jose Luis: 906 5 110 Escaned, Javier: 923 6 152 Escarcega, Orlando: 507 191 Esler, Murray: 926 3 153 Esler, Murray D.: 926 4 153 Estep, Jerry: 643 158 Estes, N. A. M.: 239 178 Evangelista, Artur: 908 8 110 EVEREST II Investigators: 930 4 155 Everett, Brendan: 911 4 143 Everitt, Melanie: 901 5 114 Exner, Derek V.: 232 162, 651 160 Ezekowitz, Justin: 904 9 141 Ezekowitz, Michael M.: 206 116, 654 162, 677 178, 739 211

222 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Farhat, Naim: 916 4 140 Farmer, Jill: 608 116 Farooq, Vasim: 910 4 111, 2503 13 146 Faruqui, Azhar: 514 194 Fasules, James W.: 301 157, 650 153 Favarato, Desiderio: 911 8 143 Favero, Luca: 2510 11 140 Faxon, David P.: 903 108 Fearon, William: 923 9 152, 2508 7 139 Fearon, William F.: 2113 194, 2627 178, 2201 119 Fedele, Francesco: 2644 107 Fedson, Savitri: 670 168 Feigenbaum, Harvey: 107A 125 Feiring, Andrew J.: 2623 166, 2642 201 Feit, Frederick: 2501 10 137, 931 5 113 Feldman, Dmitriy: 928 4 154 Feldman, Dmitriy N.: 2502 119 Feldman, Ted: 2131 160, 2203 194, 2609 120, 2640 200, 2644 107, 681 179, 930 4 155 Felker, G. Michael: 641 157, 617 122, 626 127 Fenrich, Arnold: 914 5 144 Ferdinand, Keith C.: 237 169, 645 158 Ference, Brian A.: 306 186, 910 6 111 Feres, Fausto: 2504 11 138 Fernandez Diaz, Jose A.: 2504 15 138 Fernandez-Aviles, Francisco: 916 5 140 Fernandez-Santos, M Eugenia: 906 5 110 Ferrand, Anne-Catherine: 306 186 Fifer, Michael A.: 2612 125 Figulla, Hans R.: 2645 120, 915 4 145 Fineberg, Tabitha: 106 123 Fitzgerald, Peter: 2645 120 Fiuzat, Mona: 921 5 150 Flack, John: 306 186, 910 6 111 Flaker, Greg C.: 654 162, 904 7 141 Flamm, Scott: 908 5 110, 920 6 149 Flato, Uri: 304 143 Fleck, Desiree A.: 114 210 Fleg, Jerome: 308 210 Fleischmann, Dominik: 2635 195 Fleischmann, Kirsten E.: 644 158 Fletcher, Alison M.: 407 181 Fletcher, Barbara: 699 186, 701 193 Fletcher, Gerald: 701 193 Fletcher, Gerald F.: 651 160 Flores, Demetrio R.: 407 181 Fogel, Richard I.: 654 162, 666 167, 677 178 Foley, David: 902 4 107 Fonarow, Gregg: 921 5 150 Fonarow, Gregg C.: 217 127, 617 122, 717 202, 2121 177 Fonger, James: 633 129 Foody, Joanne M.: 601 112, 629 128 for the PARTNER Trial Investigators: 2500 7 137, 2500 9 137, 305 181 Gaasch, William H.: 635 141 Gafoor, Sameer A.: 744a 170 Galantowicz, Mark E.: 252 201 Galappatthy, Gamini: 2313 189 Galassi, Alfredo R.: 2621 162 Galati, Anastasia: 903 4 108, 903 7 108 Gallardo, Arsenio: 2504 15 138 Galloway, James M.: 713 199 Galper, Benjamin Z.: 927 4 153 Gan, Li-ming: 902 7 108 Forfia, Paul: 254 203, 649 159 Forfia, Paul R.: 705 196 Forman, Daniel: 929 6 154 Forman, Daniel E.: 651 160, 674 182 Formisano, Francesco: 925 4 152, 925 5 152 Foster, Elyse: 2622 166, 612 118, 738 181, 930 4 155 Fox, James: 2511 15 147 Fox, Keith A. A.: 200 107, 2634 190 Frackelton, Edward C.: 916 8 140 Frame, Alissa A.: 405 144 francis, darrel: 923 6 152 Francis, Sanjeev A.: 228 157 Francisco, Fernandez-Aviles: 906 5 110 Franklin, Barry: 929 7 154 Franklin, Barry A.: 701 193 Franklin, Leonardo F.: 906 4 109 Franklin, Stanley S.: 230 159, 727 210 Franklin, Wayne J.: 202 108 Frantz, Robert P.: 249 198 Franzen, Olaf: 2622 166, 2640 200, 930 3 155 Freed, Benjamin: 2308 156 Freeman, Andrew M.: 601 112, 720 203 Freeman, Rosario: 237 169, 809 128, 908 110 French, William J.: 2306 125 Friedman, Mark: 408 187 Friedman, Paul A.: 715 201, 715 201 Friedrich, Matthias: 228 157, 605 116 Froehlich, James: 931 8 113 Froehlich, James B.: 687 180, 722 204, 727 210, 931 113 Frost, Kim A.: 914 5 144 Fu, Guosheng: 2645 120 Fuernau, Georg: 902 8 108 Fujii, Kenichi: 2639 202 Fujii, Kenshi: 2303 115 Fujimoto, Hajime: 2309 156 Fujita, Masashi: 2311 166 Fujita, Tsutomu: 2504 7 138 Fujiwara, Toshiki: 909 7 111 Furlan, Anthony: 2614 140 Fuster, Valentin: 613 121, 622 123, 713 199, 726 210, 107A 125, 400 106, 403 170, 902 6 108, 930 7 155 Ganz, Peter: 622 123 Gao, Bing: 923 4 151 Garasic, Joseph M.: 2627 177 garbarz, eric: 930 5 155 Garber, Alan M.: 903 5 108 Garcia, Ernest V.: 708 197 Garcia, Eva M.: 914 5 144 Garcia, Hector: 910 4 111 Garcia, Hector M.: 2645 120 Garcia, Joel A.: 2629 183 Garcia, Lawrence A.: 2633 189 Garcia, Mario J.: 744a 170, 228 157, 233 163, 638 151, 683 180, 251 199 Garcia Camarero, Tamara: 2504 15 138 Garcia del Blanco, Bruno: 2504 15 138 Garcia-Alberola, Arcadio: 726 210 Gardin, Julius: 927 7 153 Gardin, Julius M.: 218 127 Garot, Philippe: 2500 13 137, 2502 9 119, 407 181 GArot, Philippe: 926 7 153 Garrand, Amanda: 921 4 150 Garratt, Kirk: 308 210 Garrido, Gregorio: 906 5 110 Garry, Daniel J.: 681 179 Garvey, J.: 2502 7 119 Gaspar-Hernandez, Jorge: 513 190 Gassdorf, Johannes: 2645 120 Gates-Striby, Linda: 600 112, 630 128 Gati, Sabiha: 914 7 144 Gatsonis, Constantine: 305 181 Gatzoulis, Michael: 920 5 149, 920 8 149 Gavin, Laurence: 305 181 Gawaz, Meinrad: 926 6 153 Gaynor, J. William: 901 6 114 Gazelle, Scott: 308 210 Gaztanaga, Juan: 2310 156 Gbadebo, T. David: 664 165 Ge, Junbo: 2645 120 Ge, Lei: 2645 120 Gee, Adrian: 300 112 Genereux, Philippe: 2500 7 137, 2500 9 137, 2500 11 137, 2507 11 146 Gentile, Federico: 691 184 George, Isaac: 2500 11 137, 2507 11 146 George, Richard T.: 214 122, 218 127 Gerber, Thomas C.: 305 181 Gerckens, Ulrich: 2644 107 German Transcatheter Aortic ValveInterventions-Registry Investigators: 915 4 145 Gersh, Bernard: 2501 6 137, 2501 10 137, 904 9 141 Gersh, Bernard J.: 222 141, 645 158, 661 164, 308 210, 737 169 Gershlick, Anthony: 902 107 Gertz, Morie: 257 209 Gertz, Zachary: 2609 120

ACC.12 Final Program 223

Author Index ACC.12

Last Name, First Name: Session # Page #
Geva, Tal: 241 179, 920 7 149 Ghali, Jalal: 921 4 150 Ghali, Jalal K.: 225 150 Ghanem, Alexander: 917 3 148 Ghani, Saqib: 914 7 144, 914 4 144 Ghazzal, Ziyad: 746 105 Gheorghiade, Mihai: 626 127 Ghoshhajra, Brian: 922 3 150 Gialafos, Elias: 931 3 113 Gialde, Elizabeth: 2501 8 137 Gianguzzi, Robert: 684 180 Giannarelli, Chiara: 902 6 108 Gibbons, Raymond J.: 628 127 Gibbs, John: 923 4 151 Gibson, C. Michael: 2617 156, 2638 196, 613 121, 1605 171, 2501 10 137, 304 143, 305 181, 925 4 152, 925 5 152 Gilbert, Edward: 922 5 150 Gilchrist, Ian C.: 2624 167, 2305 125 Giles, Thomas D.: 631 128, 663 165 Gillam, Linda D.: 707 197, 507 191 Gillespie, Mathew: 634 141, 678 178 Gillis, Anne M.: 654 162, 666 167, 904 141, 904 3 141 Gimeno, Federico: 2504 15 138 Ginsburg, Geoffrey S.: 602 113, 671 168 Gitt, Anselm K.: 910 8 111 Giugliano, Robert P.: 629 128, 916-3 140 Gkizas, Spyridon: 2314 189 Gleeton, Onil: 2510 9 139 Glick, Danielle: 905 4 109 Gloviczki, Peter: 2613 126 Glower, Donald: 930 4 155 Gnall, Eric: 912 4 142 Godlewski, Jan: 304 143 Goehler, Alexander: 308 210 Goel, Kashish: 927 6 153 Goessl, Mario: 231 162 Gogas, Bill D.: 2503 13 146 Goitein, Orly: 924 3 151 Goktekin, Omer: 518 189 Gold, Michael R.: 704 196, 243 184 Goldbarg, Seth E.: 744b 170 Goldberg, Anne C.: 730 170 Goldberg, Caren: 913 6 143 Goldberg, Lee R.: 517 191, 660 164 Goldberg, Sheldon: 2645 120 Goldberg, Steven L.: 2630 183, 2131 160 Goldberger, Jeffrey J.: 406 154, 929 5 154 Goldhaber, Samuel Z.: 2607 115, 107A 125, 264 187, 747 209 Goldstein, James: 2508 11 139 Goldstein, James A.: 2121 177 Goldstein, Steven: 2500 15 137, 2507 15 147, 915 8 145 Gollob, Michael H.: 691 184 Gomberg-Maitland, Mardi: 249 198 Gomes, Antoinette: 908 8 110 Gomez, Millie: 924 7 151 Goodlin, Sarah J.: 225 150 Goodman, Shaun: 916 5 140 Goodman, Shaun G.: 653 162 Gorcsan, John: 220 129, 907 7 142, 922 6 150 Gorelick, Phillip B.: 727 210 Gornik, Heather: 931 8 113 Gornik, Heather L.: 264 187 Goryo, Yutaka: 2309 156 Gottdiener, John: 905 4 109, 905 5 109 Gottdiener, John S.: 905 6 109 Gottlieb, Ilan: 909 8 111 Grady, Kathleen: 694 185 Graham, Dionne: 920 7 149 Graham, Eric M.: 901 4 114 Graham, John: 913 5 143, 916 5 140 Graham, Jr., Thomas P.: 920 3 149 Granada, Juan: 2503 145, 2505 8 138 Grando-Ting, Jennifer: 805 123 Granger, Christopher: 904 9 141 Granger, Christopher B.: 739 211 Gransar, Heidi: 924 5 151 Grantham, James A.: 2621 162, 2302 114, 505 188 Grapsas, Nikolaos: 903 4 108 Grasso, Francesco: 901 3 114 Grau-Sepulveda, Maria V.: 308 210 Gray, Bruce: 931 8 113 Gray, Huon: 404 199, 508 191, 740 204, 746 105 Gray, William A.: 2613 126, 2631 183, 2311 166, 502 188, 743 129 Grayburn, Paul: 930 4 155 Grayburn, Paul A.: 204 110, 697 185, 220 129 Greason, Kevin: 238 171, 246 187, 927 6 153 Green, Joseph S.: 106 123 Green, Philip: 2500 11 137 Greenbaum, Adam B.: 2111 177 Greenberg, Barry H.: 635 141 Greenspahn, Bruce: 2315 189 Gregg, Anthony: 679 179 Greif, Martin: 909 6 111 Griffin, Brian: 907 5 142 Griffin, Brian P.: 612 118 Griffith, Bartley P.: 681 179 Griffith, John L.: 308 210 Grigioni, Francesco: 723 204 Grimaldi, Adam: 911 9 143 Grimm, Richard: 907 5 142 Grines, Cindy L.: 211 121, 606 116 Grise, Mark: 931 8 113 Grossbard, Joseph: 911 4 143 Grossman, P. M.: 932 5 155 Grover, Frederick: 308 210 Grover, Frederick L.: 107A 125, 674 182 Gruner, Christiane: 925 4 152, 925 5 152 Gu, Xiaokui: 931 8 113 Guagliumi, Giulio: 2501 6 137, 2508 15 139 Guagliumi, Giulio G.: 2303 115 Guang, Xuefeng: 2645 120 Guarneri, Erminia: 741 187 Guazzi, Marco: 929 6 154 Guchelaar, Henk-Jan: 917 5 148 Guerrero, James: 914 5 144 Guerrero, Luis: 406 154 Guglielmotti, Angelo: 2644 107 Guglin, Maya E.: 207 116, 617 122, 680 179, 718 202, 811 158, 905 109 Guimaraes, Helio: 304 143 Guiry, Michael: 2102 160 Gulati, Ankur: 908 4 110 Gulati, Martha: 255 204, 620 123, 929 8 154 Gulseth, Michael: 735 122 Guo, Ning: 2625 177 Gupta, Kamal: 932 4 155 Gupta, Sanjaya: 918 3 148 gupta, saurabh k.: 2310 156 Gura, Melanie T.: 736 125, 243 184, 716 201 Gurbel, Paul: 2501 12 137 Gurbel, Paul A.: 2111 177, 2617 156, 2643 201, 604 115 Gurm, Hitinder: 932 5 155, 2511 15 147 Gurm, Hitinder S.: 408 187, 515 193, 721 204 Gurm, Roopa: 913 6 143 Gurvitz, Michelle: 920 4 149, 202 108 Gustafson, Gregory: 744b 170 Gustavson, Susan: 931 7 113 Gutierrez, Antonio: 928 3 153 Gutman, Einat: 924 3 151 Gutteridge, Daniel: 2301 114 Guyton, Robert A.: 305 181 Gwon, Hyeon-Cheol: 2504 13 138, 623 126 Ha, Jinyong: 2508 9 139 Haack-Srensen, Mandana: 923 5 151 Haas, Tammy: 925 4 152, 925 5 152 Haber, Robert: 2502 7 119 Habib, Gilbert: 251 199 Hachamovitch, Rory: 407 181, 218 127, 644 158, 908 5 110 Hadamitzky, Martin: 924 5 151, 924 7 151 Hagege, Albert A.: 612 118 Hahalis, George: 903 4 108, 903 7 108 Hahn, Joo-Yong: 2504 13 138 Hahn, Rebecca: 2500 11 137, 2507 11 146 Hahn, Rebecca T.: 2618 161, 2622 166, 2629 183, 643 158, 2203 194, 2507 6 146 Hakonarson, Hakon: 916 8 140 Halkati, Prabhu: 2310 156, 2313 189

224 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Halkati, Prabhu C.: 2314 189 Halkos, Michael E.: 2302 114 Hall, Jack: 2506 13 146 Hall, Jennifer L.: 602 113, 671 168 Halliburton, Sandra: 696 185 Halperin, Jonathan: 930 7 155 Halperin, Jonathan L.: 735 122, 264 187, 743 129, 747 209 halvorsen, Sigrun: 916 5 140 Hamburg, Naomi: 743 129 Hamburg, Naomi M.: 405 144 Hamirani, Yasmin: 930 7 155 Hammill, Stephen C.: 677 178, 919 4 149 Han, Eric: 2310 156 Han, Seongwoo: 2505 12 139 Han, Yaling: 505 188 han, zhigang: 916 7 140 Handberg, Eileen M.: 906 4 109, 731 142, 112 180, 237 169 Hannan, Edward: 910 7 111 Hanotin, Corinne: 306 186, 911 5 143 Hansen, Knud: 2506 11 146 Hanzel, George S.: 2630 183 Harahsheh, Ashraf: 901 7 114 Hare, Joshua M.: 240 179 Hargrove, Clark: 632 129 Harold, John G.: 609 117, 508 191, 607 116, 738 181, 742 186 Harrild, David M.: 667 167 Harrington, Robert A.: 2641 200, 639 156, 700 186, 107 124, 107A 125, 304 143, 639 156, 712 199 Hart, Robert: 904 7 141, 904 5 141 Hart, Stephen A.: 920 6 149 Harvey, James: 2303 115 Hasan, Rani K.: 909 8 111 Hasenfuss, Gerd: 921 8 150 Hashimoto, Yukihiro: 2309 156 Hassanein, Mahmoud: 746 105 Hastings, Jeffrey: 261 171 Hatzopoulos, Antonis: 300 112 Hauser, Robert G.: 201 108, 215 123, 919 7 149 Hauser, Thomas: 308 210, 925 4 152, 925 5 152 Hausleiter, Joerg: 924 5 151, 924 7 151, 930 3 155 Havranek, Edward P.: 713 199 Hawkey, Marian: 238 171, 2102 160 Hawwa, Nael: 2301 114 Hayashida, Kentaro: 2500 13 137, 407 181 Hayden, Douglas: 308 210 Hayes, David L.: 201 108, 614 121, 624 126 He, Qing: 2645 120 Heath, R. Terry: 226 152 Hecht, Harvey S.: 214 122, 628 127 Hedstrom, Erik: 908 3 110 Heidenreich, Paul A.: 217 127, 239 178 Heit, John: 264 187 Heitner, Stephen: 2313 189 Held, Aaron: 405 144 Held, Maria: 2606 115 Hellenbrand, William E.: 2615 148 Heller, Gary V.: 658 163 Hendel, Robert C.: 214 122 Henderson, Robert A.: 508 191 Henriques, Jos: 2502 13 119 Henriques, Jose P.: 2502 119, 676 178, 676 178 Henry, Timothy: 2501 14 138, 2501 16 138, 300 112, 928 7 154 Henry, Timothy D.: 2112 182, 2638 196, 613 121, 604 115 Henzlova, Milena J.: 708 197 Heo, Jung Ho: 2503 13 146 Hermiller, James B.: 2203 194, 2309 156 Hermiller, Jr., James B.: 2112 182, 2626 177 Hernandez, Adrian F.: 224 143 Hernandez, Felipe: 2504 15 138 Herrmann, Howard C.: 2131 160, 2202 161, 2203 194 Hershberger, Ray E.: 236 169 Herweg, Bengt: 207 116 Hetzer, Roland: 921 7 150 Hewins, Benjamin: 908 4 110 Hickey, Edward: 901 3 114 Higuchi, Koji: 918 6 148 Hijazi, Ziyad M.: 2615 148, 2630 183, 2132 195, 2132 195, 2313 189 Hill, Alexander: 2507 13 147 Hill, Alexander J.: 407 181 Hill, Joseph A.: 109 128, 710 198 Himbert, Dominique: 930 5 155 Hines, Jerome L.: 226 152, 621 123 Hirsch, Alan T.: 675 169 Hirsch, Alexander: 918 4 148 Hirsch, Glenn A.: 902 107 Hirshfeld, John W.: 2609 120, 2306 125, 2310 156 Hlatky, Mark: 903 5 108 Hlatky, Mark A.: 671 168 Ho, Jennifer: 905 3 109 Ho, Kalon: 928 5 154 Ho, Kalon K.L.: 687 180 Hochman, Judith S.: 221 140, 107A 125 Hod, Hanoch: 924 3 151 Hodgson, John M.: 2625 177, 2639 202, 2201 119, 2303 115 Hodkinson, Emily: 919 8 149 Hoercher, Katherine J.: 717 202 Hoffmann, Udo: 308 210 Hogan, Shea E.: 932 5 155 Hohnloser, Stefan: 904 9 141 Hohnloser, Stefan H.: 703 196 Hke, Ulas: 922 8 150 Holbrook, Monika: 405 144 Hollander, Judd: 231 162, 305 181 Hollis, Bruce W.: 901 4 114 Holmes, David R.: 107A 125, 300 112, 302 165, 309 211, 504 193, 744a 170, 746 105 Holmes, Jr., David R.: 2101 156, 300 112, 309 211, 606 116, 610 117, 674 182, 710 198, 723 204 Holzer, Ralf: 616 122, 901 114, 901 8 114 Hombach, Vinzenz: 903 3 108 Honda, Yasuhiro: 2611 125 Hong, Moon Hwa: 917 4 148 Hong, Mun K.: 511 188 Hong, Myeong-Ki: 2508 9 139, 2644 107, 511 188 Hong, Soon Jun: 405 144 Hong, Susie: 925 5 152 Hong-Zohlman, Susie N.: 925 4 152 Honjo, Osami: 901 3 114 Hoole, Stephen: 923 7 152 Hoosain, Jamael: 2310 156 Hopkins, L. Nelson: 2618 161 Hord, Edward: 903 8 108 Horie, Minoru: 405 144 Horii, Manabu: 917 8 148 Horlick, Eric: 2644 107 Horowitz, John: 904 9 141 Horwich, Tamara: 718 202 Hosseini Khalili, Alireza: 744a 170 Hou, Jingbo: 916 7 140, 2611 125, 909 5 111 Hough, Stacyann S.: 929 4 154 Houghtaling, Penny: 2502 11 119 House, John: 2510 7 139, 2510 15 140, 2511 13 147 Hovasse, Thomas: 2500 13 137, 407 181 Hsich, Eileen: 925 7 152 Hu, Dayi: 505 188, 505 188, 686 180 Hu, Sining: 909 5 111 huang, henry: 925 6 152 Huber, Ken: 2614 140 Huber, Kurt: 903 8 108 Hudson, Michael P.: 817 169 Hueb, Whady: 911 8 143 Hughes, Alun: 923 6 152 Hughes, Suzanne: 601 112, 699 186 Humphrey, Angela: 2502 7 119 Humpl, Tilman: 901 3 114 Hundley, Greg: 908 8 110 Hundley, W. G.: 218 127, 719 202 Hung, Judy W.: 220 129, 672 168, 682 179, 697 185, 707 197 Hunt, Sharon: 669 168 Huo, Yong: 685 180 Hussain, Shazia: 908 3 110 Hutchings, Jennifer Y.: 914 5 144 Hutter, Adolph: 914 8 144 Hutter, Adolph M.: 261 171, 910 111, 929 4 154 Hwang, Jin-Yong: 2501 12 137

ACC.12 Final Program 225

Author Index ACC.12

Last Name, First Name: Session # Page #
Hwang, Seok-Jae: 2501 12 137 Hylek, Elaine: 904 9 141 Hynes, Brian: 2308 156 Iazzo, Paul A.: 407 181 Igarashi, Yasumi: 2504 7 138 Ignacio Amat-Santos, Ignacio: 915 6 145 Igo, Stephen: 907 8 142 Iida, Osamu: 2311 166 iida, Osamu: 931 4 113, 931 6 113 Ijichi, Takeshi: 2503 7 145 Ikari, Yuji: 2503 7 145 Ilg, Karl: 918 3 148 Ilkay, Erdogan: 518 189 Ilustre, Joanne: 2315 189 Im, sung il: 2505 12 139 IMMEDIATE Trial Investigators: 308 210 Inaba, Yoichi: 909 4 110 Indermuehle, Andreas: 908 3 110 Indik, Julia H.: 640 157, 747 209, 808 124, 904 141 Ing, Frank: 901 8 114 Ing, Frank F.: 678 178 Inglessis, Ignacio: 2308 156, 2310 156, 2314 189 Iobst, William: 109 128 Ionescu-Ittu, Raluca: 920 4 149 Irimpen, Anand: 916 6 140 Ishida, Masaki: 908 3 110 Ishigami, Kenichi: 917 8 148 Ishihara, Takayuki: 2311 166 Ishimori, Hiroshi: 2504 9 138 Ishizawar, David: 912 5 142 Ismail, Tevfik F.: 908 4 110 Isojima, Takuya: 2309 156 ISSUE-3 investigators: 306 186 Itchhaporia, Dipti: 621 123, 509 190, 685 180 Ito, Matthew K.: 736 125 Ito, Shigenori: 2305 125 Iung, Bernard: 251 199, 930 5 155, 723 204, 915 7 145 Iwabuchi, Masashi: 2302 114 Iwai, Sei: 615 121 Iwakura, Katsuomi: 2303 115 Iwama, Hajime: 2309 156 Iwamura, Toshiharu: 909 7 111 Ix, Joachim: 905 5 109 Iyer, Sriram S.: 743 129 Jabbour, Andrew: 908 4 110 Jaber, Weal A.: 407 181 Jackson, Elizabeth: 913 6 143 Jackson, Elizabeth A.: 701 193, 698 186, 730 170, 803 118, 822 198, 927 153 Jackson, Greg: 922 7 150 Jackson, Marcia J.: 103 117, 106 123, 109 128 Jackson, Matthew S.: 907 8 142 Jacob, Howard: 671 168 Jacob, Jasmine R.: 2310 156 Jacobs, Alice K.: 2638 196, 653 162, 308 210, 675 169 Jacobshagen, Claudius: 921 8 150 Jacques, Frederic: 901 3 114 Jaff, Michael: 931 8 113 Jaff, Michael R.: 2613 126, 2613 126, 646 155, 825 202, 932 3 155 Jaffe, Allan S.: 659 163, 728 209 Jafri, Haseeb: 911 7 143 Jahangir, Arshad: 733 114 Jain, Sandeep: 922 6 150 Jain, Sandeep K.: 706 197 Jakubowski, Joe: 902 4 107 Jakubowski, Joseph: 902 6 108 Jalbert, Jessica: 922 4 150 Jama, Abdi A.: 406 154 Jamal, Syed Z.: 514 194, 514 194 Jamerson, Kenneth A.: 237 169, 631 128 James, Stefan: 902 4 107 James, Stefan K.: 1605 171, 623 126, 653 162, 721 204 Jamis-Dow, Carlos: 305 181 Janel, Lee: 2644 107 Jang, Ik-Kyung: 2608 119, 2611 125, 909 5 111, 916 7 140 Jang, Yangsoo: 2508 9 139, 2644 107 Janiak, Florian: 2645 120 Januzzi, Jr., James L.: 641 157, 728 209 Jarolim, Petr: 905 7 109 Jaskie, Suzette: 244 185, 621 123 Jassal, Davinder: 642 157 Javaheri, Shahrokh: 718 202 Jeevanandam, Valluvan: 2308 156 Jeevanantham, Vinodh: 932 4 155 Jefferies, John: 901 5 114 Jefferies, John L.: 301 157 Jeffries, Brad: 922 5 150 Jelnin, Vladimir: 2510 13 140 Jenkins, James S.: 2627 177 Jenkins, Kathy: 901 8 114 Jenkins, Kathy J.: 616 122, 402 162 Jennings, Lisa K.: 903 8 108 Jensen, Lisette: 2608 119 Jensen, Lisette Okkels: 2506 11 146 Jeong, Han Saem: 405 144 Jeong, Jin-Ok: 2504 13 138 Jeong, Myung Ho: 917 4 148, 2505 14 139, 511 188 Jeong, Young-Hoon: 2501 12 137 Jerosch-Herold, Michael: 922 3 150 Jeroudi, Ahmad M.: 744a 170 Jessen, Michael: 629 128 Jessup, Mariell: 213 122 Jha, Ashish K.: 913 4 143 Jia, Haibo: 909 5 111, 916 7 140 Jianping, Li: 685 180 Jimenez Navarro, Manuel: 2504 15 138 Jing, Yonghua: 913 5 143 Jneid, Hani: 925 6 152 Jockel, Heinz Karl: 924 4 151 Johnson, Andrea: 924 6 151 Johnson, Paula: 245 185 Jollis, James G.: 204 110 Jolly, Sanjit S.: 2624 167, 2641 200 Jonasson, Jenny: 902 7 108 Jonathon, Leipsic: 2618 161 Joner, Michael: 2503 9 146 Jones, Charlotte: 407 181 Jones, Robert H.: 606 116 Jones, Thomas K.: 252 201 Jorgensen, Erik: 923 5 151 Joseph, Emmerich: 904 8 141 Joshi, Nikhil V.: 407 181 Joynt, Karen: 913 4 143 Juan, Gaibor C.: 2310 156 Judd, Suzanne: 910 5 111 Judge, Daniel P.: 234 163 Jukema, Johan: 917 5 148 Juni, Peter: 665 167, 2645 120 Junker, Anders: 2506 11 146 Justino, Henri: 634 141, 637 149 Kadish, Alan H.: 702 196 Kahn, Joel: 306 186 Kaji, Shuichiro: 909 7 111 Kala, Petr: 923 9 152 Kalahasti, Vidyasagar: 920 6 149 Kalil-Filho, Roberto: 911 8 143 Kallinen, Linda: 919 7 149 Kalra, Ankur: 2313 189 Kalsch, Hagen: 924 4 151 Kaltenbach, Lisa: 928 4 154, 928 8 154 Kaltoft, Anne: 2506 11 146 Kandzari, David: 2506 7 146 Kandzari, David E.: 2627 178, 604 115, 2202 161, 2302 114, 2504 6 138, 511 188 Kang, Hyun-Jae: 304 143 Kang, Soo-Jin: 2645 120, 2611 125, 2625 177, 2608 119 Kang, Wan Seok: 917 4 148 Kanter, Joshua: 634 141, 637 149 Kanter, Kirk: 725 209 Kantor, Paul F.: 901 5 114 Kanwal, Sunil: 2309 156 Kao, David P.: 925 7 152 Kapadia, Samir: 2303 115, 2308 156 Kapadia, Samir R.: 2630 183, 2635 195, 2203 194, 2314 189, 2626 177 Kaplan, Aaron V.: 238 171

226 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Kapoor, Deepak: 2302 114 Kappetein, A.: 910 4 111 Kar, biswajit: 2315 189 Kar, Saibal: 2114 194, 2131 160, 2132 195, 2132 195, 220 129, 2203 194, 2622 166, 652 160 Kara, Tomas: 406 154 Karapetyan, Anush K.: 917 7 148 Karas, Maria G.: 905 5 109 Karas, Richard: 911 7 143 Karas, Richard H.: 611 117 Karlsberg, Ronald P.: 696 185, 740 204 Karmpaliotis, Dimitrios: 505 188 Karwatowska-Prokopczuk, Ewa: 921 8 150 Kashyap, Sangeeta: 306 186 Kassimis, George: 903 7 108 Kastrati, Adnan: 2503 9 146, 2645 120 Kastrup, Jens: 923 5 151 Kataoka, Yu: 2303 115 Kates, Andrew M.: 730 170, 822 198 Kato, Keiji: 917 8 148 Kato, Koji: 916 7 140 Katoh, Yoshihiro: 2509 13 147 Katsouli, Anthi: 912 5 142 Katus, Hugo A.: 2511 147 Katz, Jason N.: 263 170 Kaufman, Beth: 901 5 114, 901 6 114 Kaufmann, Beat: 909 4 110 Kaufmann, Philipp: 924 7 151 Kaul, Sanjay: 744b 170, 2614 140, 604 115, 639 156, 665 167, 700 186, 712 199 Kaul, Sanjiv: 628 127 Kautzner, Josef: 905 7 109 Kawata, Hiroyuki: 917 8 148 Kayani, Waleed: 925 6 152 Kazi, Dhruv: 903 5 108 Keadle, Justin: 911 9 143 Kealey, Angela: 695 185 kedhi, elvin: 2506 9 146 Keeley, Ellen: 923 151 Kelly, Christopher: 2511 7 147 Kelsey, Anita M.: 744b 170 Kemme, Michiel: 918 4 148 Kempny, Aleksander: 920 5 149, 920 8 149 kennedy, kevin: 2501 8 137, 2510 15 140, 2511 13 147, 932 7 155 Kennedy, Kevin F.: 2511 11 147 Kennett, Jerry D.: 650 153 Kereiakes, Dean: 2506 9 146, 306 186 Kereiakes, Dean J.: 2634 190, 646 155, 2506 7 146, 2202 161 Kern, Karl B.: 263 170 Kern, Morton J.: 2609 120, 107A 125, 2122 183, 2303 115, 821 197 kesari, kavitha: 2301 114 Kesarwani, Manoj: 744b 170 Khairy, Paul: 668 168, 506 191 Khalique, Omar: 907 4 142 Khan, Fakhar Z.: 716 201 Khann, Amber D.: 406 154 Khaw, Ban-An: 642 157 Khera, Amit: 711 199, 729 203 Kholmovski, Eugene: 918 6 148, 918 8 148 Khumri, Taiyeb M.: 2301 114 Kiernan, Michael: 2502 11 119 Kilner, Philip: 920 8 149 Kim, Brian H.: 405 144 Kim, Byeong-Keuk: 2508 9 139, 2644 107 Kim, Chong Jin: 2505 14 139 Kim, Donghan: 2505 14 139 Kim, Eung Ju: 2505 12 139 Kim, Henry: 918 3 148 Kim, Hyo Soo: 304 143 Kim, Hyo-Soo: 2504 13 138 Kim, Hyun-Sook: 2508 7 139 Kim, Hyung-Kwan: 930 8 155 Kim, Je Sang: 405 144 Kim, Jeong Sook: 917 4 148 Kim, Ji-Hyun: 930 8 155 Kim, Jin Won: 2505 12 139 Kim, Jong-Ho: 405 144 Kim, Jung-Sun: 2508 9 139 Kim, Kyung-Hee: 930 8 155 Kim, Luke: 928 4 154 Kim, Michael C.: 676 178, 511 188 Kim, Raymond J.: 233 163, 605 116 Kim, Soo Hyun: 931 8 113, 932 155 Kim, Soo Joong: 916 7 140 Kim, Sunghee: 928 6 154 Kim, Sunwon: 2505 12 139 Kim, Won-Jang: 2645 120 Kim, Yong Sook: 917 4 148 Kim, Yong-Jin: 930 8 155 Kim, Young Jo: 2505 14 139 Kim, Young-Hak: 2645 120 Kim, Young-Tae: 2645 120 Kim, Yuli: 920 6 149 Kimmelstiel, Carey: 2506 7 146 Kimmelstiel, Carey D.: 230 159, 2612 125 Kimura, Takeshi: 2509 13 147 King, Lamin: 2503 9 146 King, Richard: 928 7 154 King, Spencer B.: 610 117, 610 117, 111 159, 2121 177 Kingery, Joanna: 913 8 143 Kini, Annapoorna S.: 2508 6 139, 676 178 Kioufis, Stamatios: 931 3 113 Kirby, Ruth: 308 210 Kirma, Cevat: 518 189 Kirtane, Ajay: 2500 11 137 Kirtane, Ajay J.: 2113 194, 604 115, 613 121, 665 167, 1605 171, 821 197, 2501 14 138, 2501 16 138, 2201 119 Kirwanj, John: 306 186 Kitzman, Dalane: 905 6 109 Kizer, Jorge: 905 5 109 Klarich, Kyle W.: 812 158, 110 129 Kleiman, Neal S.: 2617 156, 2121 177, 2202 161, 2306 125 Klein, Allan L.: 208 116, 672 168 Klein, Lloyd: 308 210 Klein, Lloyd W.: 2502 119 Kliger, Chad: 931 5 113, 2630 183, 2510 13 140 Kligfield, Paul: 929 154 Kline-Rogers, Eva: 913 6 143, 931 8 113 Kline-Rogers, Eva M.: 713 199, 721 204 Kluge, Matthew A.: 405 144 Knap, Malgorzata: 930 6 155 Knight, Bradley P.: 615 121 Ko, Young-Guk: 2508 9 139, 2644 107 Kobashigawa, Jon A.: 670 168 Koch, Karel T.: 2502 13 119 Kociol, Robb D.: 656 163 Kodali, Susheel: 2112 182, 2618 161, 2626 177, 2131 160, 2500 7 137, 2500 9 137, 2500 11 137, 2507 11 146 Kodali, Susheel K.: 305 181 Kodama, Alessandra: 304 143 Kodoth, Vivek: 919 8 149 Kohl, III, Harold W.: 914 5 144 Kohli, Payal: 902 5 108 Kolluri, Raghu: 2607 115, 2616 156 Kolm, Paul: 308 210 Komajda, Michel: 738 181 Konecny, Tomas: 406 154 Konen, Eli: 924 3 151 Konstam, Marvin A.: 103 117, 635 141, 710 198, 110 129 Kontos, Michael C.: 628 127 Koo, Bon Kwon: 2639 202 Koo, Bon-Kwon: 304 143 Koolen, Jacques: 2503 13 146 Kop, Willem: 905 6 109 Koren, Michael: 306 186 Kornowski, Ran: 2501 6 137 Kosiborod, Mikhail: 711 199, 2511 11 147 Koss, Elana: 2507 11 146 Kostis, William J.: 2608 119 Kotha, Jayaprakash: 903 8 108 Kothari, Shyam S.: 2310 156 Kotowycz, Mark A.: 2505 6 138 Kotrc, Martin: 905 7 109 Kott, Andrew E.: 2315 189 Kottam, Anupama: 2306 125 Kovac, Jan: 2314 189, 2500 137, 2511 147, 2644 107, 723 204

ACC.12 Final Program 227

Author Index ACC.12

Last Name, First Name: Session # Page #
Kovacic, Jason: 2508 6 139 Kovacs, Adrienne H.: 679 179 Kovacs, Richard: 913 8 143 Kovacs, Richard J.: 710 198, 261 171 Kowal, Robert C.: 212 121 Kowalchuk, Glen: 2502 7 119 Kowey, Peter: 206 116, 1603 172 Kozan, Omer: 518 189 Krahn, Andrew D.: 640 157, 816 166 Kraitchman, Dara: 719 202 Kramer, Christopher M.: 644 158 Krasuski, Richard: 920 6 149 Kraus, William E.: 923 8 152 Kremers, Mark S.: 239 178 Kren, Stefan: 906 5 110 Kreutzer, Jacqueline: 637 149 Krieger, Eric V.: 202 108 Krishna, Vamsi: 200 107 Krishnaswamy, Amar: 2308 156, 2629 183, 210 118 Kronenberg, Marvin: 300 112 Kronmal, Richard: 924 4 151, 930 7 155 Kronzon, Itzhak: 2510 13 140, 2619 161 Kruck, Irmtraut: 738 181 Krucoff, Mitchell W.: 633 129, 689 184 Kruisselbrink, Teresa: 236 169 Krum, Henry: 926 3 153, 663 165, 926 4 153 Krumholz, Harlan M.: 224 143, 717 202 Kuehl, Karen S.: 725 209 Kugelmass, Aaron D.: 510 193, 746 105 Kugler, John: 667 167 Kukucka, Marian: 921 7 150 Kullo, Iftikhar J.: 407 181 Kumar, Gautam: 2309 156, 744a 170 Kurata, Mie: 932 6 155 Kurita, Takashi: 501 190 Kuvin, Jeffrey T.: 103 117, 106 123, 109 128, 730 170, 812 158 Kwak, Choong Hwan: 2501 12 137 Kwok, Bernard: 905 8 109 Kwolek, Christopher J.: 2623 166 Kwon, Deborah: 908 5 110 Kwon, Hyuck-Moon: 2644 107 Kwon, Jin-Sook: 917 4 148 Kwong, Raymond: 922 3 150 Kwong, Raymond Y. K.: 257 209, 605 116 Ky, Bonnie: 642 157 Kydd, Anna: 923 7 152 LaBounty, Troy: 924 5 151 LaBounty, Troy M.: 924 7 151 Lacomis, Joan: 305 181 Lacour-Gayet, Francois G.: 724 209 Ladd, Mark E.: 918 7 148 Laham, Roger J.: 221 140 Lahoti, Ankush: 912 4 142 Lahr, Brian: 927 6 153 Lai, Dejian: 300 112 Laird, John R.: 2311 166, 2613 126, 502 188 Lakdawala, Neal: 720 203 Lakshminarayan, Kamakshi: 904 4 141 Lamendola, Cindy: 699 186 Lamour, Jacqueline: 901 5 114 Lampert, Rachel: 919 4 149 Lampert, Rachel J.: 914 144 Lamy, Andre: 305 181 Lander, Matthew: 912 5 142 Landzberg, Michael: 662 164, 920 7 149 Landzberg, Michael J.: 2615 148, 668 168, 107A 125, 2132 195 Lanfear, David E.: 826 203 Lang, Peter: 725 209 Lang, Roberto: 2308 156 Lang, Roberto M.: 682 179, 697 185, 407 181 Langabeer, James R.: 928 7 154 Lange, Richard A.: 508 191, 709 197 Lange, Rudiger: 2507 13 147 Lansky, Alexandra: 916 4 140, 923 8 152, 924 6 151 Lansky, Alexandra J.: 653 162, 2508 138 Lantin-Hermoso, M. Regina: 805 123 Lanza, Gregory M.: 259 210 Laranjeira, Ligia: 304 143 Lardo, Albert C.: 259 210 Larose, Eric: 2510 9 139, 915 6 145 Larson, Joseph: 904 4 141 larson, martin: 905 3 109 Lasala, John M.: 2638 196, 676 178, 2202 161, 2313 189 Lassen, Jens: 2506 11 146 Latson, Larry A.: 2313 189, 518 189 Lattouf, Omar M.: 746 105 Lau, Ernest: 919 8 149 Lau, Joe: 931 7 113 Lau, Yee How: 905 8 109 Lauck, Sandra: 2102 160 Lauer, Michael S.: 651 160, 929 3 154 Lauten, Alexander: 915 4 145 Lavie, Carl: 927 5 153 Lavigne, Paul M.: 911 7 143 Lawler, Patrick: 920 4 149 Lawless, Christine E.: 262 187 Lawrence, Silvana M.: 914 5 144 Laynez Carnicero, Ana: 2507 15 147 Layug, Beth: 921 8 150 Le May, Michel R.: 916 5 140 Leaming, James: 305 181 Lee, Byron K.: 824 200 Lee, Cheol Whan: 2645 120 Lee, Daniel C.: 719 202 Lee, Hang: 916 7 140, 308 210 Lee, John H.: 932 7 155 Lee, Jong-Young: 2645 120 Lee, Junsoo Alex: 915 8 145 Lee, Kerry: 656 163 Lee, Ki Hong: 2505 14 139 Lee, Randall J.: 201 108 Lee, Raymond: 905 8 109 Lee, Seung-Pyo: 930 8 155 Lee, Seung-Whan: 2645 120 Leesar, Massoud A.: 2625 177 Lefvre, Thierry: 2500 13 137 Lefevre, Thierry: 2502 9 119, 407 181, 926 7 153, 2112 182, 2624 167 Leier, Carl V.: 680 179 Leipsic, Jonathon: 2203 194, 2618 161 Leiva Pons, Jose Luis: 513 190 Lemos, Pedro A.: 503 188 Lenihan, Daniel J.: 642 157 Leon, Martin: 2500 7 137, 2500 9 137, 2500 11 137, 2507 11 146, 2645 120, 305 181 Leon, Martin B.: 2606 115, 2635 195, 2636 195, 652 160, 2500 6 137, 309 211, 511 188, 674 182 Leor, Jonathan: 746 105 lepera, mario: 909 3 110 Lerakis, Stamatios: 2618 161, 2635 195 Lerman, Jorge: 516 192 Leschke, Matthias: 2509 9 147 Lesser, John: 925 4 152, 925 5 152 Lesser, John R.: 218 127 lettieri, corrado: 2644 107 Lever, Harry M.: 253 203, 648 159 Levi, Daniel S.: 2615 148 Levine, Glenn: 675 169 Levine, Paul A.: 614 121 Levine, Robert A.: 406 154, 697 185 Levit, Aaron D.: 405 144 Levy, Daniel: 905 3 109 Levy, Samuel: 2644 107 Levy, Wayne: 922 5 150 Lewin, Jack: 610 117, 687 180, 710 198, 404 199, 505 188, 647 159, 650 153, 685 180, 742 186 Lewin, Mark B.: 252 201, 802 111, 301 157, 301 157 Lewis, Gregory: 914 8 144 Lewis, Gregory D.: 254 203, 649 159, 705 196, 929 4 154 Lewis, William R.: 601 112, 690 184 Li, Hui: 2645 120 Li, Wei: 920 8 149, 920 5 149 Li, Yat Wa: 907 4 142 Li, Yigang: 2645 120 Liberman, Henry: 2302 114 Lichstein, Edgar: 408 187 Lichtenstein, Samuel: 2644 107

228 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Lieber, Elizabeth: 2502 11 119 Lieu, Hsiao: 923 8 152 Lim, D. S.: 2114 194 Lim, Do-Sun: 405 144 Lim, Hong Euy: 2505 12 139 Lim, Michael J.: 2625 177, 2629 183, 2122 183 Lima, Joao: 908 8 110, 909 8 111 Lima, Joao A. C.: 214 122, 218 127, 641 157 Limaye, Atul: 2508 6 139 Limbruno, Ugo: 2644 107 Lin, Fay: 924 5 151, 924 7 151 Lin, Grace: 242 182 Lin, Jay: 913 5 143 Lin, Kimberly: 901 6 114 Lincoff, A.: 2501 10 137 Lincoff, A. M.: 2301 114, 2306 125, 2643 201 Lindahl, Bertil: 653 162 Lindenfeld, Joann: 925 7 152 Linderbaum, Jane A.: 689 184, 731 142 Lindner, Jonathan: 909 4 110 Lindner, Jonathan R.: 907 3 142 Lindsay, Bruce: 922 7 150 Lindsay, Bruce D.: 239 178 Ling, Lee Fong: 407 181 Link, Mark S.: 688 182 Linke, Axel: 2644 107 Liodakis, Emmanouil: 920 5 149 Lioy, Ernesto: 2644 107 Lip, Gregory: 904 5 141, 904 7 141 Lipshultz, Steven: 901 5 114 Litt, Harold: 305 181 Little, Stephen: 907 8 142 Little, Stephen H.: 707 197, 814 164 Little, William: 203 109, 229 159 Liu, Bin: 2645 120 Liu, Chia Ying: 908 8 110 Liu, Christopher: 614 121 Liu, Chunyu: 905 3 109 Liu, Huiliang: 2645 120 Liu, Peter P.: 240 179 Liu, Shizhen: 907 8 142 Liu, Ya Ni: 909 4 110 liu, yang: 906 8 110 Llacer, Angel: 908 6 110 Llanos, Alexander: 2308 156, 2310 156 Lloyd-Jones, Donald: 905 6 109 Lock, James E.: 678 178, 692 184 Locke, Amy: 235 164 Logan, Julie A.: 2105 171, 2105 171 Lomasney, Jon: 2315 189 Lombardi, William L.: 2112 182, 2621 162, 505 188 Long, Janet B.: 255 204, 736 125 Lopes, Renato: 304 143 Lopes, Renato D.: 904 9 141 Ma, Genshan: 2645 120 Ma, Yitong: 2645 120 Maalouf, Joseph: 251 199, 504 193, 674 182, 915 145 MacDougall, Diane: 911 10 143 Mace, Pamela: 931 8 113 MacFadyen, Jean: 911 4 143, 911 6 143 Mack, Michael: 2500 7 137, 2500 9 137, 305 181 Mack, Michael J.: 2122 183, 2131 160, 2636 195, 606 116, 737 169, 309 211 MacLeod, Rob: 918 6 148, 918 8 148 MacRae, Calum A.: 236 169 Madan, Mina: 916 5 140 Madan, Pankaj: 913 7 143 Madden, Sean: 2508 13 139 Madder, Ryan: 2610 120, 2508 11 139 Maddox, Thomas M.: 209 117, 219 128, 721 204, 913 143 Maeda, Mika: 909 7 111 Maehara, Akiko: 2303 115, 2508 15 139, 2511 7 147, 2625 177, 2629 183, 304 143, 916 4 140 Maeng, Michael: 2506 11 146 Magalski, Anthony: 262 187 Maganti, K: 208 116 Mahaffey, Kenneth: 903 8 108 Mahajan, Nitin: 306 186, 910 6 111 Mahfoud, Felix: 926 3 153 Mahle, William: 693 185 Mahmarian, John J.: 708 197 Mahmud, Ehtisham: 2627 177 Mai, Xingchen: 2505 10 139 Maier, Lars: 921 8 150 Maisano, Francesco: 930 3 155, 612 118 Lopez, Leo: 724 209 Lpez, M Pilar: 908 6 110 Lopez-Candales, Angel: 912 5 142 Lorin, Jeffrey: 2505 10 139 Losordo, Douglas W.: 2623 166, 618 121 Lotan, Chaim: 510 193, 746 105, 746 105 Louvard, Yves: 2502 9 119, 926 7 153 Love, Charles J.: 690 184 Lowery, Robert: 744b 170 Loyalka, Pranav: 2314 189 Lu, Chengzhi: 2645 120 Lubos, Edith: 930 6 155 Lubs, Daniel: 930 6 155 Lucisano, Luigi: 2644 107 Luke, William: 259 210 Lumley, Matthew: 2645 120 Lundgrin, Erika: 912 8 142 Luo, Yanting: 927 7 153 Lurz, Philipp: 902 8 108 Lyass, Asya: 905 3 109 Lyden, Sean: 2613 126 Makenbaeva, Dinara: 913 5 143 Makiyama, Takeru: 405 144 Makkar, Raj R.: 2609 120, 2626 177, 2202 161, 2308 156 Makris, George: 903 7 108 Maldonado, Galo: 2506 15 146 Malenka, David J.: 723 204 Malik, Iqbal: 923 6 152 Malik, Marek: 702 196 Mallorie, Amy: 908 4 110 Manankil, Marian: 2303 115 Mancini, Donna M.: 669 168 Mancone, Massimo: 2644 107 Mancuso, J. Jacob: 234 163, 259 210 Mandapaka, Sangeeta: 2305 125 Mandras, Stacy: 912 142 Manito, Nicolas: 517 191 Mankad, Rekha: 620 123 Mankad, Sunil V.: 229 159, 258 210, 632 129, 697 185, 815 165 Mann, Douglas L.: 710 198, 656 163, 746 105 Mann, Tift: 2624 167, 2305 125 Manning, Warren: 925 4 152, 925 5 152 Manoharan, Ganesh: 2203 194, 2500 137, 2635 195 Manoukian, Steven V.: 2641 200 Mansour, M. A.: 932 5 155 Manthripragada, Gopi: 2305 125 Mantzoros, Christos S.: 905 5 109 Maranan, Leandro: 2510 13 140 Maranho, Raul C.: 911 8 143 Marban, Eduardo: 300 112, 618 121 Marchlinski, Francis E.: 706 197, 715 201 Marek, Josef: 907 7 142 Marek, Joseph C.: 688 182 Marelli, Ariane: 920 4 149 Margenet, Alain: 2502 9 119 Margey, Ronan: 2308 156, 2310 156, 2314 189 Margulies, Janice: 911 10 143 Marine, Joseph E.: 703 196, 826 203 Marinos, Georgios: 931 3 113 Markl, Michael: 719 202 Markovic, Sinisa: 903 3 108 Markowitz, Steven M.: 703 196 Maron, Barry: 925 4 152, 925 5 152 Maron, Barry J.: 253 203, 619 122, 262 187, 262 187, 914 3 144 Maron, Martin: 925 4 152, 925 5 152 Maron, Martin S.: 253 203, 648 159, 661 164 Marrouche, Nassir: 918 6 148 Marrouche, Nassir F.: 918 8 148 Marshall, J.: 2505 8 138 Marso, Steven: 2501 8 137, 2510 7 139, 2510 15 140, 916 4 140 Marso, Steven P.: 2641 200, 711 199, 510 193, 2511 13 147 Martin, Daniel: 300 112

ACC.12 Final Program 229

Author Index ACC.12

Last Name, First Name: Session # Page #
Martin, Gerard: 616 122, 901 7 114 Martin, Gerard R.: 402 162, 506 191, 901 8 114 Martin, Joseph: 2303 115 Martin, Victoria: 2504 15 138 Martinez, Matthew W.: 253 203, 648 159, 816 166 Martinez-Sanchez, Carlos R.: 513 190 Martucci, Giussepe: 2644 107 Marwick, Thomas: 907 5 142, 908 5 110 Marwick, Thomas H.: 407 181, 682 179 marzullo, marco: 909 3 110 Mascette, Alice M.: 656 163 Maseri, Attilio: 404 199 masi, filippo: 909 3 110 Masotti, Monica: 2504 15 138 Masoudi, Frederick: 2511 11 147, 928 5 154, 928 6 154 Masoudi, Frederick A.: 205 112, 712 199, 515 193 Massaro, Joseph: 930 4 155, 2645 120 Massaro, Joseph M.: 308 210 Massberg, Steffen: 2645 120 Massie, Barry M.: 669 168, 680 179, 921 150, 921 3 150 Masuyama, Tohru: 501 190 Matesanz, Rafael: 906 5 110 Matetzky, Shlomi: 924 3 151 Matheny, Michael: 2511 11 147 Mather, Paul J.: 694 185 Mathew, Samuel K.: 509 190 Mathiasen, Anders B.: 923 5 151 Mathier, Michael: 912 5 142 Mathier, Michael A.: 249 198, 649 159, 912 3 142 matsubara, Tetsuo: 2504 7 138 Matsuda, Takehisa: 2509 15 147 Matsumoto, Alan: 931 8 113 Matsumoto, Daisuke: 2503 7 145 Mattos, Luiz A.: 503 188 Mauri, Laura: 2645 120, 2617 156, 2103 165, 2511 147, 930 4 155 Mavronasiou, Eleni: 903 7 108 May, David C.: 219 128 Mayer, John: 308 210 Mayet, Jamil: 923 6 152 Maytin, Melanie: 2502 11 119 Mazzaferri, Ernest: 2501 14 138, 2501 16 138 Mazzitelli, Domenico: 2507 13 147 McAllister, Todd: 627 127 McBane, Robert: 931 8 113 McBride, Patrick E.: 227 152 McCarter, Robert: 901 7 114 McCarthy, Patrick M.: 242 182, 258 210, 697 185, 632 129 McClelland, Robyn: 924 4 151 McClurken, James B.: 659 163 McCormick, Liam M.: 923 7 152 McCullough, Peter A.: 711 199 McDaniel, Michael C.: 2303 115 McElhinney, Doff B.: 2615 148, 634 141 mcelwee, sam: 2306 125 McEneaney, David: 919 8 149 McGlothlin, Dana: 249 198 McGowan, Jr, Francis X.: 901 4 114 McGrew, Frank: 921 4 150 McGuire, Darren K.: 645 158 McKay, Charles: 308 210 McKenna, William: 236 169, 253 203, 661 164 McKenney, James: 306 186, 911 5 143 McKillop, Graham: 407 181 McLaughlin, Vallerie V.: 705 196, 254 203 McLean, Rhondalyn: 645 158 McMullan, Paul: 263 170 McMurtry, M. Sean: 2607 115 McNally, Elizabeth: 671 168 McNamara, Dennis M.: 605 116, 635 141, 695 185, 664 165 Mcnitt, Scott: 919 5 149 McNitt, Scott: 919 6 149 McPherson, John: 2511 7 147, 916 4 140, 923 8 152, 924 6 151 McPherson, John A.: 806 123, 811 158, 819 192, 263 170 Meadows, Jeffrey: 2615 148 Mega, Jessica: 916 8 140 Mehdipour, Mahshid: 308 210 Mehra, Mandeep R.: 655 163 Mehran, Roxana: 200 107, 2634 190, 2641 200, 622 123, 2501 6 137, 2501 10 137, 2501 14 138, 2501 16 138, 2502 15 119, 2508 15 139 Mehrotra, Praveen: 2310 156 Mehta, Laxmi S.: 241 179, 245 185 Mehta, Rajendra: 408 187 Mehta, Sameer: 676 178 Mehta, Shamir R.: 903 108 Meier, Bernhard: 2645 120 Melenovsky, Vojtech: 905 7 109 meliga, emanuele: 2315 189 Mell, MD, Matthew W.: 903 5 108 Menard, Matthew T.: 2620 161, 2623 166 Mendes, Lisa A.: 710 198 Mendiz, Oscar A.: 502 188 Meng, Lingbo: 916 7 140 Menon, Venu: 2502 11 119, 916 140 Mentz, Robert J.: 744a 170, 921 5 150 Meredith, Ian: 2506 7 146, 2506 13 146 Merrill, Michael F.: 113 193 Mertens, Luc: 693 185 Messenger, John: 2510 15 140, 2511 11 147, 308 210, 928 5 154, 928 6 154 Messenger, John C.: 510 193 Messer, Joseph V.: 659 163 Messerli, Franz H.: 250 198 Messika-Zeitoun, David: 238 171, 246 187, 915 145, 915 7 145, 930 5 155 Metkus, Thomas S.: 2314 189 Metzger, Christopher: 2505 8 138 Metzger, D. Christopher: 304 143, 2620 161, 2631 183 Metzger, David: 2501 14 138, 2501 16 138 Meuwissen, Martijn: 2502 13 119 Mewada, Abhishek: 306 186 Michael, Tesfaldet T.: 2302 114 Michelena, Hector I.: 260 211, 723 204 Michifumi, Tokuda: 922 3 150 Michos, Erin: 235 164, 698 186 Mieres, Jennifer H.: 237 169, 245 185, 255 204 Mietus-Snyder, Michele: 746 105 Mikati, Issam A.: 643 158, 682 179, 809 128, 908 110 Mikell, Frank L.: 630 128 Mila, Rafael: 923 6 152 Milani, Richard: 927 5 153 Millar, Lynne: 914 7 144 Miller, Alan: 921 4 150 Miller, Alan B.: 922 5 150 Miller, Amy Leigh: 107 124, 209 117 Miller, Chadwick: 305 181 Miller, D. Craig: 2636 195, 2500 7 137, 2500 9 137, 305 181 Miller, Denise: 2502 7 119 Miller, Fletcher A.: 204 110 Miller, John M.: 737[page Miller, Julie: 909 8 111 Miller, Leslie W.: 669 168 Miller, Todd D.: 651 160 Mills, Nicholas L.: 407 181 Mills, Rebecca: 2510 7 139, 2511 13 147 Min, James: 924 7 151 Min, James K.: 231 162, 683 180, 2507 146, 740 204, 924 5 151 Minissian, Margo B.: 112 180, 710 198 Mintz, Gary: 2508 15 139, 2511 7 147, 916 4 140 Mintz, Gary S.: 2201 119, 2201 119, 309 211, 646 155 Minutello, Robert: 928 4 154 Miquel-Hebert, Karine: 2503 11 146, 2503 13 146 Mira, Vera: 304 143 Mirowska, Karolina K.: 306 186 Mirro, Michael J.: 630 128, 647 159 Mishkel, Gregory J.: 2607 115, 2610 120 Mistry, Kshitij P.: 616 122 Mistry, Niraj: 908 4 110 Mitchell, Justin: 2315 189 Miyashita, Yusuke: 931 4 113, 931 6 113 Miyazaki, Shunichi: 501 190, 501 190 Mizuguchi, Yukio: 2301 114 Moat, Neil E.: 2636 195 Moccetti, Tiziano: 903 8 108 Moceri, Pamela: 920 5 149

230 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Modi, Kalgi A.: 695 185 Moebius-Winkler, Sven: 2509 9 147 Moebus, Susanne: 924 4 151 Moeller, Chaim: 408 187 Moga, Michael-Alice: 901 3 114 Mohammed, Selma: 649 159 Mohan, Puneet: 904 9 141 Mohanty, Prasant: 925 8 152 Mohanty, Sanghamitra: 925 8 152 Mhlenkamp, Stefan: 924 4 151 Mohler, III, Emile R.: 825 202 Mok, Michael: 915 6 145 Moliterno, David: 903 8 108 Moliterno, David J.: 2201 119, 2301 114, 2509 147, 2617 156, 2634 190, 623 126, 2103 165 Mllmann, Helge: 2506 13 146 Monaghan, Mark J.: 2606 115 Monmeneu, JVicente: 908 6 110 Montalescot, Gilles: 2643 201, 623 126, 1605 171, 304 143 Mooney, Michael R.: 263 170 Moore, John: 901 8 114 Moore, Johnn W. M.: 2615 148 Mooss, Aryan: 744b 170 Mor-Avi, Victor: 407 181 Mora, Samia: 911 4 143 Morady, Fred: 918 3 148 Morales, David: 625 127 Moravec, Christine: 906 7 110 Moreira, Adriana: 2506 15 146 Morel, Marie-angle: 910 4 111 Morell, Victor O.: 724 209 Morelli, Peter: 247 196 Moreno, Pedro: 2508 6 139 Moreu, Jose: 2504 15 138 Moriarty, Patrick M.: 729 203 Morice, Marie Claude: 926 7 153 Morice, Marie-Claude: 2500 13 137, 2502 9 119, 407 181 Morillo, Carlos A.: 640 157 Morris, Andrew J.: 917 7 148 Morrison, Lauren M.: 2505 6 138 Morrow, David: 902 3 107, 905 7 109, 916 8 140 Morrow, David A.: 300 112, 508 191 Morrow, William R.: 252 201 Morton, Geraint: 908 3 110 Moscona, John: 916 6 140 Moser, Marvin: 230 159 Moses, Jeffrey: 2500 7 137, 2500 9 137, 2500 11 137, 2505 8 138, 2507 11 146, 305 181 Moses, Jeffrey W.: 2621 162 Moshkevich, Solomon: 903 5 108 Moskovits, Norbert: 408 187 Moss, Arthur: 919 5 149, 919 6 149 Moss, Arthur J.: 222 141, 655 163, 691 184 Moss, Richard: 906 8 110 Moss, Robert R.: 2635 195 Mostashari, Farzad: 647 159 Mota, Luiz: 304 143 Motz, Wolfgang: 2509 9 147 Mountis, Maria: 906 7 110 Mousa, Tarek M.: 744b 170 Moussa, Issam: 308 210 Moussa, Issam D.: 2511 147 Moustakakis, Emmanuel N.: 744b 170 Movahed, Mohammad R.: 2305 125 Moye, Lem: 300 112 Mueller, Gisela: 918 3 148 Mugnolo, Antonio: 2510 11 140 Mukamal, Kenneth J.: 905 5 109 Mukherjee, Debabrata: 408 187, 665 167, 689 184, 689 184 Mullens, Wilfried: 912 7 142 Muller, James: 2508 13 139 Mulvagh, Sharon: 929 8 154 Mulvagh, Sharon L.: 620 123 Munir, Khan: 932 5 155 Munshi, Kartik: 916 6 140 Muntner, Paul: 910 5 111 Murali, Srinivas: 705 196 Muramatsu, Toshiya: 2504 7 138, 2504 9 138 Murphy, Daniel J.: 252 201, 402 162 Murphy, Joseph G.: 113 193 Murphy, Ryan M.: 929 4 154 Murphy, Sabina: 902 3 107, 902 5 108 Murray, Sarah S.: 2644 107 Murthy, Venkatesh: 910 3 111 Mushlin, Alvin I.: 928 8 154 Muthappan, Palaniappan: 2511 15 147 Muthuchamy, Mariappan: 906 8 110 Muto, Makoto: 2504 7 138 Myerburg, Robert: 703 196, 703 196 Myers, Jonathan N.: 929 6 154 Mylotte, Darren: 2502 9 119, 407 181, 926 7 153 Na, Jin Oh: 2505 12 139 Naccarelli, Gerald V.: 206 116, 706 197 Nadamanee, Koonlawee: 691 184 Nagai, Hiroyuki: 2303 115 Nagavalli, Sravanthi: 932 4 155 Nagel, Eike: 908 3 110 Nagueh, Sherif F.: 2618 161, 619 122, 638 151 nagurney, john: 308 210 Naidu, Srihari: 2310 156 Naidu, Srihari S.: 2122 183, 2315 189, 2612 125 Naik, Sunil: 2309 156 Naito, Masaki: 2309 156 Najm, Hani: 515 193, 746 105 Nakagawa, Yoshihisa: 2509 13 147 Nakamura, Shigeru: 2504 7 138 Nakamura, Sunao: 2505 16 139 Nakanishi, Rine: 924 5 151 Nakatani, Shimpei: 2303 115 Nakazawa, Gaku: 2503 7 145, 2611 125 Nanda, Navin C.: 509 190 Nanjundappa, Aravinda: 2305 125, 2311 166, 2607 115, 2642 201 Nanto, Kiyonori: 931 4 113 Naofumi, Doi: 2309 156 Narasimhan, Calambur: 509 190 Narula, Jagat: 111 159, 2121 177 Nasir, Khurram: 696 185, 924 4 151, 927 3 153, 930 7 155 Nasseri, Boris A.: 921 7 150 Natale, Andrea: 716 201, 212 121, 925 8 152 Natarajan, Madhu: 2644 107 Nath, Jayant: 932 4 155 Nathan, Sandeep: 2308 156 Natsuaki, Masahiro: 2509 13 147 Naya, Masanao: 910 3 111 Nazif, Tamim: 211 121 Neilan, Tomas G.: 922 3 150 Neish, Steven R.: 802 111 Nelson Worel, Jane: 701 193 Neumann, Franz-Josef: 739 211, 2501 14 138, 2501 16 138 Neunteuff, Thomas D: 304 143 Neville, Susan: 922 5 150 Newburger, Jane: 247 196, 107A 125 Newby, David: 714 199 Newby, David E.: 407 181, 740 204 Newby, L. Kristin: 728 209 Newman, Jonathan: 904 4 141 Newton, Roger: 911 10 143 Ng, Jason: 406 154, 929 5 154 nguyen, can: 2510 9 139 Nicholas, Michael: 2311 166 Nicholls, Stephen: 2303 115 Nichols, Len: 687 180 Nickenig, Georg: 917 3 148 Nihoyannopoulos, Petros: 745 203 Niinuma, Hiroyuki: 909 8 111 Nijveldt, Robin: 918 4 148 Nikas, Dimitrios: 2510 11 140 Nikolsky, Eugenia: 2505 138 Nishimura, Rick A.: 103 117, 256 204, 258 210, 619 122, 710 198, 107A 125, 309 211, 744a 170, 801 105 Nissen, Steven: 306 186 Nissen, Steven E.: 215 123, 107A 125 Nkomo, Vuyisile: 210 118, 220 129, 930 155 Nobuyoshi, Masakiyo: 2302 114 Noel, Bernard: 2510 9 139 Noheria, Amit: 744b 170

ACC.12 Final Program 231

Author Index ACC.12

Last Name, First Name: Session # Page #
Nohria, Anju: 626 127 Nombela-Franco, Luis: 915 6 145 Noohi Bezanjani, Feridoun: 746 105 Nordbeck, Peter: 918 7 148 Normand, Sharon-Lise T.: 700 186 Novak, Jan: 406 154 Novo, Salvatore: 706 197 Nugent, Alan W.: 692 184 Nunez, Julio: 908 6 110 Nuyles, Michael: 2311 166 Nyberg, Fredrik: 911 6 143 Nylander, Sven: 902 7 108 OBrien, Kevin: 930 7 155 OBrien, Sean: 308 210, 915 5 145, 928 5 154 OConnell, John B.: 2122 183 OConnor, Christopher: 921 5 150 ODonoghue, Susan: 744b 170 OGara, Patrick T.: 103 117, 260 211, 712 199, 107A 125, 305 181, 309 211, 503 188, 675 169, 744a 170, 801 105 ONeill, Blair J.: 504 193 ONeill, Brian P.: 2121 177, 2505 138 ONeill, William W.: 213 122, 2643 201, 604 115, 2315 189 ORiordan, Martin: 603 113 Ochala, Andrzej: 304 143 Ochiai, Masahiko: 2621 162 Oderich, Gustavo: 2613 126 Oechslin, Erwin N.: 725 209 Oetgen, William J.: 219 128, 607 116 Ofili, Elizabeth: 686 180, 656 163 Ogawa, Hisao: 2505 16 139 Ogle, James: 2314 189 Oh, Dong Joo: 2505 12 139 Oh, Jae K.: 208 116, 229 159, 714 199 Ohman, Erik M.: 2638 196, 2315 189, 304 143 Oieru, Dan: 924 3 151 Oikawa, Yuji: 2621 162 Oikonomou, Evangelos: 931 3 113 Okamoto, Shin: 2311 166 OKAMURA, ATSUNORI: 2504 7 138, 2303 115 Okubagzi, Petros: 915 8 145 Oldroyd, Keith: 2506 13 146, 923 9 152 Olin, Jeffrey: 931 7 113 Olin, Jeffrey W.: 2610 120, 931 8 113 Oliveira, Ricardo: 929 6 154 Oliver-McNeil, Sandra M.: 112 180, 2104 165 Olivotto, Iacopo: 925 4 152, 925 5 152 Olshansky, Brian: 914 144 Ommen, Steve R.: 256 204, 607 116, 607 116, 619 122, 648 159, 661 164, 801 105, 807 124 Onishi, Tetsuari: 907 7 142 Onishi, Toshinari: 907 7 142 Onsea, Kevin: 926 5 153 Pacchioni, Andrea: 2510 11 140 Pack, Quinn: 929 8 154 Pack, Quinn R.: 927 6 153 Packer, Douglas L.: 666 167 Packer, Milton: 722 204 Pagani, Francis D.: 213 122 Page, Richard L.: 666 167 Page, II, Robert L.: 225 150, 736 125 Pahl, Elfriede: 901 5 114 Palacios, Igor: 2308 156, 2310 156 Palacios, Igor F.: 2630 183, 2635 195, 2310 156, 238 171 Palma-Davis, LaVaughn: 913 6 143 Palmieri, Bruno: 2506 15 146 Pancholy, Samir B.: 2510 139 Paniagua de Decoud, Maria: 516 192 Papadakis, Michael: 914 4 144, 914 7 144 Papademetriou, Vasilios: 926 8 153 Papageorgiou, Nikolaos: 931 3 113 Papavassiliou, Athanasios G.: 931 3 113 Papp, Andrea: 910 8 111 Pappagianopoulos, Paul P.: 929 4 154 Pappas, Christos: 903 4 108 Paradis, Jean-Michel: 2500 11 137, 2507 11 146 Parharidis, George: 745 203 Paridon, Stephen: 901 6 114 Parikh, Manish A.: 2201 119, 2202 161, 2509 147 Parikh, Sahil A.: 2633 189 Onuma, Yoshinobu: 2503 11 146 Oparil, Suzanne: 926 153, 631 128, 250 198 Opitz, Anke: 2507 13 147 Opitz, Christian: 2509 9 147 Oral, Elif: 235 164, 711 199 Orav, Endel: 901 5 114 Orban, Marek: 406 154 Oren, Ron M.: 921 4 150 Ormiston, John: 2503 13 146 Ormiston, John A.: 2611 125, 2632 184, 2202 161 Ornish, Dean: 698 186 Orsinelli, David: 204 110 Oshinski, John N.: 406 154 Osten, Mark: 2505 6 138, 2644 107 Otake, Hiromasa: 2503 7 145 Otto, Catherine M.: 714 199, 258 210 Otto, Sylvia: 2645 120 Ou, Narith: 732 109 Oudiz, Ronald J.: 254 203 Overgaard, Chris: 2505 6 138 Overholser, Brian: 913 8 143 Owens, Douglas K.: 903 5 108 Ozaki, Yukio: 2639 202 Ozkan, Mehmet: 518 189 Parise, Helen: 665 167, 2501 6 137, 2501 14 138, 2501 16 138, 2502 15 119, 2506 9 146, 304 143, 665 167 Park, Chang Gyu: 2505 12 139 Park, Chong H.: 744b 170 Park, Duk-Woo: 2645 120, 646 155, 511 188 Park, Euljoon: 926 8 153 Park, Hyo Eun: 930 8 155 Park, Jae Hyoung: 405 144 Park, Jae-Hyeong: 912 8 142 Park, Ji Young: 2505 12 139 Park, Jong-Seon: 2504 13 138 Park, Kyung Woo: 304 143 Park, Margaret: 912 8 142 Park, Myung H.: 705 196 Park, Seong-Wook: 2645 120, 2645 120 Park, Seung-Jung: 2645 120, 2202 161, 511 188 Park, Yonghwi: 2501 12 137 Parker, Beth A.: 911 9 143 Parodi, Juan Carlos: 502 188 Parra, David: 732 109, 733 114, 734 116, 735 122, 736 125 Pasquet, Agns: 260 211 Passeri, Jonathan: 2308 156, 2310 156 Patange, Amit: 408 187 Patel, Amit R.: 407 181 Patel, Dharmendrakumar: 927 5 153 Patel, Hamang M.: 662 164 Patel, Kavita: 650 153 Patel, Manesh R.: 205 112, 2643 201 Patel, Nainesh C.: 263 170 Patel, Rikesh: 2313 189 Patel, Uptal: 2511 11 147 Patrick, Jonathan: 2306 125 Patrick-Lake, Bray: 601 112 Patted, Suresh: 2314 189 Patted, Suresh V.: 2310 156, 2313 189 Patterson, Cam: 405 144 Patterson, J. Herbert: 921 4 150 Patton, Kristen K.: 736 125, 918 148, 820 192 Paul, Jonathan: 2308 156 Paul, Sara: 217 127, 717 202 Peberdy, Mary Ann: 929 6 154 Pedrazzini, Giovanni: 930 3 155 Pehlivanoglu, Seckin: 518 189 Pelargonio, Gemma: 925 8 152 Pelchovitz, Daniel J.: 406 154 Pellegrini, Cara: 690 184 Pellegrini, Gian: 407 181 Pelliccia, Antonio: 262 187, 262 187 Pellikka, Patricia A.: 407 181, 643 158, 657 163 Pelosi, Frank: 2122 183 Pena, Tino: 2607 115, 2616 156 Penaloza, Dante: 726 210 Pencina, Michael: 700 186, 905 3 109

232 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Peng, Szu-Po: 913 7 143 Penn, Marc: 300 112 Pennacchi, Mauro: 2644 107 Pennell, Dudley: 908 4 110 Pennell, Dudley J.: 920 8 149, 740 204 Penzo, Carlo: 2510 11 140 Pepine, Carl: 620 123, 300 112 Pepine, Carl J.: 906 4 109 Perera, Divaka: 2645 120, 908 3 110 Perez, Marco: 904 4 141 Perin, Emerson C.: 300 112 Peruga, Jan Z.: 2501 6 137 Pescatello, Linda S.: 911 9 143 Petersen, John W.: 906 4 109 Peterson, Eric: 664 165, 304 143, 308 210, 913 7 143 Peterson, Eric D.: 721 204 peterson, eric D.: 915 5 145 Peterson, Eric D.: 513 190, 928 5 154 Peterson, Mark: 2644 107 Pettersen, Michael: 408 187 Pfeffer, Marc: 704 196 Philippon, Franois: 915 6 145 Phillips, Matthew: 244 185, 244 185, 621 123 Phillips, Tierney: 2644 107 Piana, Robert N.: 600 112 Piazza, Nicolo: 2507 13 147, 2618 161, 2131 160 Pibarot, Philippe: 915 6 145, 707 197, 2644 107 Picard, Michael: 914 8 144 Picard, Michael H.: 657 163 Pichard, Augusto: 2606 115, 2635 195, 2203 194, 2308 156, 2500 15 137, 2507 15 147, 2635 195, 915 8 145 Piek, Jan: 2502 13 119, 918 4 148 Pieper, Petronella G.: 738 181 Pierard, Luc: 242 182, 256 204 Pierucci, Daniela: 2644 107 Pijls, Nico: 923 9 152, 2508 7 139 Pijnappels, Danil: 906 3 109 Pilote, Louise: 920 4 149 Pina, Ileana: 921 4 150 Pina, Ileana L.: 217 127, 224 143, 237 169, 641 157 Pineiro, Daniel: 726 210 Pinney, Sean P.: 670 168 Pinto, Duane S.: 2111 177, 613 121, 1605 171 Piscione, Federico: 916 5 140 Pislaru, Sorin: 251 199 Pitsavos, Christos: 931 3 113 Pitt, Bertram: 107A 125, 921 6 150 Placentino, Filippo: 2644 107 Plakomyti, Theodora E.: 903 4 108 Plana, Juan C.: 2122 183 Plutzky, Jorge: 306 186 Pocock, Stuart: 665 167, 2501 10 137 Poerner, Tudor C.: 2645 120 Poggio, Daniele: 914 6 144 Polk, Donna: 911 9 143 Polk, Donna M.: 709 197, 729 203, 730 170 Pollice, Paolo: 909 3 110 Poole, Jeanne E.: 216 126, 243 184 Pope, James H.: 308 210 Popma, Jeffrey: 2506 7 146, 2509 11 147, 2645 120, 308 210 Popma, Jeffrey J.: 2114 194, 2635 195, 2309 156 Popovic, Zoran: 908 5 110 Porter, Thomas R.: 672 168 Porvasnik, Stacy L.: 906 4 109 Posteraro, III, Anthony F.: 744b 170 Postley, John: 927 7 153 Pothier, Claire: 306 186 Powell, Alex: 2623 166 Powell, Andrew: 693 185 Powell, Brian: 212 121, 815 165 Prabhakaran, Dorairaj: 742 186 Prager, Richard L.: 721 204 Prakash, Ashwin: 693 185 Prasad, Sanjay: 719 202, 908 4 110 Pratap, T.: 2306 125 Price, Matthew J.: 2617 156, 2627 178, 2644 107, 2132 195, 2202 161, 2506 6 146 Primitivo, Stefano Giuseppe: 909 3 110 Prince, Martin: 908 8 110 Proulx, Guy: 2510 9 139 Providencia, Luis: 903 8 108 Prystowsky, Eric N.: 615 121, 654 162, 501 190 Pump, Agnes: 925 8 152 Puri, Rishi: 2303 115 Puskas, John: 2302 114 Pyo, Robert: 2504 138 Pyrgakis, Vlassios N.: 745 203 Pyxaras, Stelios: 923 9 152 Qian, Juying: 2645 120 Qin, Yongwen: 2645 120 Quagliara, Donato: 909 3 110 Quaife, Robert: 2507 9 146 Quick, Harald H.: 918 7 148 Quinones, Miguel A.: 516 192 Quyyumi, Arshed A.: 406 154 Rab, Syed: 2303 115 Rab, Syed T.: 2306 125, 2315 189 Raber, Lorenz: 910 4 111 Raby, Khether E.: 205 112 Radtke, Wolfgang A. K.: 2615 148 Radu, Maria: 2503 13 146 Raff, Gilbert: 924 5 151, 628 127, 924 7 151 Rahimi, Farnoosh: 308 210 Rahimtoola, Shahbudin H.: 514 194, 659 163 Raichlen, Joel: 2508 13 139 Raiszadeh, Farbod: 744a 170 Raj, Satish: 640 157 Rajagopal, Sudarshan: 744a 170 Rajagopalan, Navin: 705 196 Rajagopalan, Sanjay: 406 154 Rajamannan, Nalini M.: 714 199 Rakowski, Harry: 925 4 152, 925 5 152 Ram, C. Venkata S.: 727 210 Ramachandran, Vasan: 905 3 109 Raman, Subha V.: 241 179, 228 157 Ramanathan, Kodangudi: 925 6 152 Ramani, Gautam V.: 912 142 Ramani, Ravi: 670 168 Ramee, Stephen R.: 2637 195, 2500 137 Ramires, Jose: 911 8 143 Ramkisoensing, Arti: 906 3 109 Ramstad, Anders: 113 193 Ranjan, Ravi: 918 8 148 Rao, Seshu: 2501 8 137 Rao, Sunil: 2510 9 139, 2510 15 140, 928 3 153, 928 6 154 Rao, Sunil V.: 109 128, 2111 177, 2113 194, 2624 167, 2634 190, 604 115, 639 156, 1605 171, 813 164 Rapezzi, Claudio: 925 5 152, 925 4 152 Rapoza, Richard: 2503 13 146 Rashwan, Magdy: 506 191 Rasmusson, Kismet: 217 127, 695 185 Raspanti, Silvia: 903 6 108 Rassi, Andrew: 2502 11 119 Ratajczak, Mariusz Z.: 917 7 148 Ravkilde, Jan: 2506 11 146 Ray, Carolyn: 744b 170 Razavi, Mahmood K.: 2607 115 Read, Philip: 923 7 152 Reardon, Michael: 2203 194 Redberg, Rita: 928 8 154 Redberg, Rita F.: 644 158, 709 197 Reddy, M, Sahadev T.: 918 5 148 Redfield, Margaret M.: 203 109, 656 163, 107A 125 Redheuil, Alban: 908 8 110 Redington, Andrew: 901 3 114 Redwood, Simon: 2645 120 reed, matthew: 914 4 144 Reed, Timm: 2103 165 Reeder, Guy: 406 154 Regar, Evelyn: 2503 13 146, 2611 125 Reiffel, James A.: 677 178 Reilly, John P.: 214 122, 823 200 Reimers, Bernhard: 2507 146, 2510 11 140 Reisman, Mark: 2131 160, 2132 195, 2505 8 138 Rene, A. Garvey: 2500 11 137 Resar, Jon: 2314 189 Resnic, Frederic S.: 215 123 Reuter, David: 633 129

ACC.12 Final Program 233

Author Index ACC.12

Last Name, First Name: Session # Page #
Rexrode, Kathryn: 904 4 141 Rezende, Paulo C.: 911 8 143 Rha, Seung-Woon: 2504 13 138, 2505 12 139 Rhee, Ceron: 903 5 108 Rhodes, Denise A.: 2104 165 Rhodes, John F.: 634 141, 637 149, 518 189 Rhodes, Jonathan: 261 171 Rich, Michael: 924 8 151 Rich, Michael W.: 225 150, 722 204 Richardson, Caroline: 701 193 Richardson, Hamish: 407 181 Richman, Joshua: 910 5 111 Rickard, Jack: 922 7 150 Ricotta, John J.: 2613 126 Ridker, Paul: 911 4 143, 911 6 143 Riggs, Lisa A.: 2103 165 Rigolin, Vera H.: 242 182, 707 197 Rihal, Charanjit S.: 104 117, 211 121, 504 193, 518 189, 200 107, 2630 183 Rinaldi, Michael: 2501 14 138, 2501 16 138, 2502 7 119 Rinehart, Sarah: 924 6 151 Rinfret, Stephane: 2510 9 139 Ringel, Richard: 901 8 114 Ritter, Oliver: 918 7 148 Ritzenthaler, Laura: 308 210 Rivero, Fernando: 2504 15 138 Rizas, Konstantinos: 926 6 153 Rizzo, Caterina: 909 3 110 Robbers, Lourens: 918 4 148 Roberts, Michael: 919 8 149 Roberts, Robert: 602 113 Robinson, Jennifer: 227 152, 729 203 Robinson, Thompson: 727 210 Rocha-Singh, Krishna J.: 2610 120, 2642 201 Rochitte, Carlos: 909 8 111 Rodes-Cabau, Josep: 2644 107, 251 199, 2510 9 139, 2606 115, 2626 177, 504 193, 723 204 Rods-Cabau, Josep: 915 6 145 Rodgers, George P.: 914 5 144 Rodgers, Jo E.: 732 109 Rodrigo, Maria E.: 2306 125 Rodriguez, Carlos J.: 664 165 Rodriguez, L. Leonardo: 907 5 142 Rodrguez-Abella, Hugo: 906 5 110 Roe, Matthew: 913 7 143, 928 8 154 Roe, Matthew T.: 653 162 Roffi, Marco: 2631 183, 2633 189 Rogers, Frances A.: 662 164 Rogers, Jason H.: 2619 161, 2510 139, 2610 120 Rogers, Joseph G.: 694 185 Rohatgi, Anand: 826 203 Rokos, Ivan: 613 121, 604 115 Romano, Mauro: 2500 13 137, 407 181 Saba, Samir: 907 7 142, 922 6 150 Sabatine, Marc: 916 8 140 Sabatine, Marc S.: 2617 156, 407 181, 739 211 Sabbah, Hani N.: 746 105 Sable, Craig A.: 725 209 Sacc, Salvatore: 2510 11 140 Rome, Eric: 904 6 141 Rome, Jonathan: 901 8 114 Romeo, Francesco: 906 4 109, 706 197 Rorick, Tyrus: 903 8 108 Roselli, Eric: 2619 161, 2626 177 Rosenberg, Steven: 923 8 152, 924 6 151 Rosenfield, Kenneth: 2616 156, 2631 183, 2310 156 Rosenson, Robert S.: 730 170 Rosenzweig, James L.: 405 144 Rossano, Joseph W.: 901 6 114 Roth, Eli M.: 911 5 143 Rothman, Andrew: 922 4 150 Rottbauer, Wolfgang: 903 3 108, 908 7 110 Roubin, Gary S.: 2637 195 Rouleau, Jacques: 2510 9 139 Rowin, Ethan: 925 4 152, 925 5 152 Roy, Denis: 207 116 Roy, Louis: 2510 9 139 Roy, Melanie: 2510 9 139 Rozehnal, John: 905 7 109 Rozenman, Yoseph: 510 193 Rubin, Jeffrey: 932 5 155 Rubio, Agustin E.: 247 196 Rudd, James H.: 407 181 Ruderman, Neil B.: 405 144 Rudolph, Volker: 930 6 155 Rudski, Lawrence G.: 241 179, 638 151 Ruff, Christian T.: 916 8 140 Ruge, Hendrik: 2507 13 147 Ruggiero, II, Nicholas J.: 2623 166 Ruiz, Carlos: 2510 13 140, 901 8 114 Ruiz, Carlos E.: 2630 183, 2132 195, 2314 189 Rumoroso, Jose R.: 2504 15 138 Rumsfeld, John: 2511 11 147, 928 3 153 Rumsfeld, John S.: 209 117, 515 193, 913 143, 913 3 143 Rundback, John: 2616 156 Rusconi, Paolo: 901 5 114 Russell, Raymond R.: 642 157 Russo, Andrea M.: 216 126, 239 178 Russo, Cesare: 907 4 142 Russo, Mark: 2308 156 Russo, Robert J.: 2625 177, 2629 183 Ruthazer, Robin: 308 210 Ryan, Thomas: 907 8 142 Ryan, Thomas J.: 657 163, 737 169 Rychik, Jack: 725 209 Saeed, Wajeeha: 912 4 142 Safford, Monika: 910 5 111 Safirstein, Jordan: 695 185 Safley, David: 2511 13 147 Safley, David M.: 2510 7 139 Saia, Theresa A.: 616 122 Saidi, Arwa S.: 667 167 Saito, Yoshihiko: 917 8 148 Sakai, Koyu: 2302 114 Sakamoto, Yasunari: 2504 9 138 Saksena, Sanjeev: 509 190 Sakwa, Marc P.: 929 7 154 Salamon, Jason: 912 4 142 Salcedo, Ernesto: 2507 9 146 Salisbury, Adam: 2511 13 147 Salman, Nabia: 912 6 142 Saltik, Levent: 518 189 Salustri, Alessandro: 746 105 Salvatella, Neus: 2504 15 138 Samady, Habib: 2608 119, 2639 202 Sanborn, Timothy A.: 2624 167, 2502 119 Sanchez, Pedro L.: 916 5 140 Sanchez, Pedro L: 906 5 110 Sanchez-Recalde, Angel: 2504 15 138 Sanchis, Juan: 908 6 110 Sanders, Stephen: 692 184 Sandhu, Amneet: 408 187 Sangli, Chithra: 930 4 155 Sanidas, Elias: 2508 139 Sanoski, Cynthia: 736 125 Santangeli, Pasquale: 925 8 152 Santarelli, Pietro: 925 8 152 Santini, Alberto: 903 6 108 Santoro, Daniela: 909 3 110 Santos-Gallego, Carlos: 902 6 108 Santucci, Eliana: 304 143 Sanz, Javier: 726 210 Sarafin, Jennifer: 2502 7 119 Sardar, Rizwan: 912 4 142 SARDELLA, GENNARO: 2644 107 Sardella, Gennaro: 2506 146 Saric, Muhamed: 707 197 Sarsam, Sinan: 918 3 148 Satler, Lowell: 2308 156, 2500 15 137, 2507 15 147, 915 8 145 Sato, Kei: 931 6 113, 2311 166 Saudye, Hammad: 2315 189 Sauer, William: 918 3 148 Sauer, William H.: 216 126 Sawyer, Douglas: 405 144 Saxena, Anita: 2310 156 Saxon, Leslie A.: 212 121 Saxonhouse, Sherry: 803 118, 810 128, 820 192 Scantlebury, Dawn: 744a 170

234 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Schafer, Ulrich: 930 3 155 Schainfeld, Robert: 2607 115, 2616 156, 2633 189 Schalij, Martin: 906 3 109, 917 5 148 Schauer, Philip R.: 306 186 Schauwecker, Peter: 903 3 108 Scheinman, Melvin M.: 615 121 Schelbert, Erik: 228 157 Scheller, Bruno: 2509 7 147, 2509 9 147, 916 5 140 Scherillo, Marino: 706 197 Scheurer, Mark: 634 141 Schiller, Nelson B.: 241 179 Schillinger, Wolfgang: 930 3 155 Schlaich, Markus: 926 3 153, 926 4 153 Schlter, Michael: 930 6 155 Schmieder, Roland: 926 4 153 Schnell, Susan: 2102 160 Schoenfeld, David: 308 210 Schoenfeld, Mark H.: 614 121 Schoenhagen, Paul: 2635 195 Schomig, Albert: 2503 9 146 Schotborgh, Carl: 2502 13 119 Schreier, Jenna: 920 7 149 Schrezenmeier, Hubert: 903 3 108 Schroyer, Michael K.: 609 117, 684 180 Schuler, Gerhard: 902 8 108 Schuller, Joseph: 918 3 148 Schulman, Steven: 2314 189 Schultheiss, Hans Peter: 240 179 Schultz, Gregory: 906 4 109 Schuster, Andreas: 908 3 110 Schwartz, Allan: 2203 194, 2308 156, 2500 137 Schwartz, Robert S.: 923 8 152 Schwartz, Steven: 901 3 114 Schwartz, Todd: 921 4 150 Schwartzman, David: 907 7 142 Schwarz, Klaus: 903 3 108 Sciagr, Roberto: 903 6 108 Scirica, Benjamin: 902 3 107, 916 8 140 Scirica, Benjamin M.: 604 115 Seale, Anna: 692 184 Seder, David: 263 170 Sedlis, Steven: 2505 10 139 Seeger, John: 922 4 150 Segev, Amit: 510 193, 924 3 151 Segovia, Javier: 517 191 Segre, Alexandre: 911 8 143 Segrest, Wendy: 928 7 154 Seldin, David C.: 257 209 Seliger, Stephen: 905 4 109, 905 6 109 Selim, Samy: 917 7 148 Selker, Harry P.: 308 210 Selvanayagam, Joseph: 257 209 Semigran, Marc J.: 257 209, 649 159, 2122 183, 905 109 Sen, Sayan: 923 6 152 Senapathi, Murali K.: 744b 170 Senges, Jochen: 910 8 111, 915 4 145 Seo, Hong-Seog: 2505 12 139 Sera, Fusako: 2311 166 Serruys, Patrick: 916 4 140, 2506 9 146, 2511 7 147, 2645 120, 910 4 111 Serruys, Patrick W.: 2503 11 146, 2606 115, 2632 184, 2503 145, 2503 6 145, 2503 13 146 Seslar, Stephen P.: 667 167 Sethi, Nishant: 744b 170 Sethi, Sanjum S.: 931 7 113 Setoguchi, Soko: 922 4 150 Seung, Ki-Bae: 511 188 Seyfarth, Melchior: 221 140 Sezer, Murat: 518 189 Shaban, Nada: 744a 170 Shaban, Nada M.: 744b 170 Shaddy, Robert: 901 6 114 Shah, Atman P.: 2308 156 Shah, Bindi K.: 615 121, 810 128, 813 164, 824 200 Shah, Binita: 2505 10 139, 931 5 113 Shah, Dipan J.: 719 202, 924 151 Shah, Moneal: 918 5 148 Shah, Nidhi: 408 187 Shah, Prediman K.: 221 140, 403 170, 611 117 Shah, Rashmee: 903 5 108 Shah, Ravi: 922 3 150 Shah, Sangeeta B.: 809 128 Shahian, David: 308 210 Shalaby, Alaa A.: 624 126 Shalev, Aryeh: 510 193 Shankar, Adurthy A.: 2306 125 Shannon, Francis L.: 929 7 154 Shara, Nawar: 904 4 141 Share, David: 2511 15 147 Sharifi, Mohsen: 308 210, 2616 156, 2633 189 Sharma, Aditya M.: 264 187 Sharma, Amit: 2311 166 Sharma, Mala: 907 4 142 Sharma, Samin: 2508 6 139 Sharma, Samin K.: 2504 138 Sharma, Sanjay: 262 187, 914 4 144, 914 7 144 Sharp, Jacqueline: 912 8 142 Shaw, Leslee: 924 7 151 Shaw, Leslee J.: 255 204, 620 123, 628 127, 408 187, 924 5 151 Shaw, Richard: 308 210 Shaywitz, Adam: 923 4 151 Sheehan, Patricia R.: 308 210 Shehadeh, Waseem: 912 6 142 Sheikh, Nabeel: 914 7 144, 914 4 144 Sheldon, Robert S.: 640 157 Shelton, Marc E.: 226 152, 512 192, 659 163 Shemin, Richard J.: 674 182 Shen, Win-Kuang: 677 178 Shenouda, Sherene M.: 405 144 Shepard, Charles: 252 201 Sherman, Warren: 689 184, 2309 156 Sherrid, Mark V.: 661 164 Sherwood, Matthew W.: 913 7 143 Shestakovska, Olga: 904 5 141 Shewan, Cynthia M.: 308 210 Shim, Eun-Bo: 2645 120 Shimbo, Daichi: 910 5 111 Shimizu, Wataru: 405 144 Shin, Dong-Ho: 2508 9 139, 2644 107 Shinke, Toshiro: 2503 7 145 Shirali, Girish S.: 301 157, 693 185 Shishehbor, Mehdi: 2502 11 119 Shishehbor, Mehdi H.: 2620 161, 2311 166, 2510 139, 502 188, 808 124, 823 200 Shite, Junya: 2503 7 145 Shivkumar, Kalyanam: 715 201 Shrivastava, Rakesh: 932 4 155 Shullo, Michael: 670 168 Shunk, Kendrick A.: 2629 183 Shuvy, Mony: 510 193 Siasos, Gerasimos: 931 3 113 Sibbing, Dirk: 1605 171 Sicari, Rosa: 672 168 Siddiqui, Danish: 2306 125 Siegel, Robert J.: 210 118, 2622 166, 2635 195 Siegel, Stephen A.: 688 182 Sievert, Horst: 930 3 155, 2619 161, 2630 183, 2132 195, 2132 195, 739 211 Sigwart, Ulrich: 253 203, 2612 125 Silber, Sigmund: 2632 184, 2201 119 Silversides, Candice: 679 179 Silvestry, Frank E.: 2609 120, 2622 166, 2622 166, 2131 160, 507 191, 643 158 Silvestry, Scott: 229 159, 922 150 Sim, David: 905 8 109 Sim, Kui-Hian: 512 192 Sim, Ling Ling: 905 8 109 Simari, Robert: 300 112 Simon, Jean-Philippe: 2509 9 147 Simon, Marc A.: 705 196 Simonton, Charles: 2506 9 146 Simprini, Lauren: 2306 125, 924 8 151 Simpson, Iain A.: 508 191 Simpson, Kathleen: 911 9 143 Singh, Anvesha: 2314 189 Singh, Harjit: 305 181 Singh, Jagmeet: 655 163 Singh, Tania: 915 8 145 Sinno, Mohamad: 918 3 148 Sinusas, Albert J.: 708 197 Siqueira, Dimytri: 2504 11 138

ACC.12 Final Program 235

Author Index ACC.12

Last Name, First Name: Session # Page #
Siscovick, David: 905 5 109 Sivaram, Chittur A.: 710 198, 103 117, 106 123, 109 128, 710 198 Sivasubramanian, Ramakrishnan: 2310 156 Skarlatos, Sonia: 300 112 Skarlatos, Sonia I.: 710 198 Skelding, Kimberly A.: 2501 137 Skrocki, Laura: 308 210 Slater, James: 931 5 113 Slawnych, Mike: 603 113 Small, David: 902 6 108 Smedira, Nicholas G.: 2612 125 Smirnakis, Karen: 923 4 151 Smith, Brian: 923 4 151 Smith, Craig: 2500 7 137, 2500 9 137, 2500 11 137, 2507 11 146, 305 181 Smith, Cydni: 913 6 143 Smith, Dean: 408 187, 2511 15 147 Smith, James L.: 2508 11 139, 929 7 154 Smith, Peter K.: 675 169 Smith, Peter N.: 824 200 Smith, Jr., Sidney: 622 123, 699 186 Smits, Nicole C.: 405 144 Smits, Pieter: 2506 9 146 Smolensky, Alexander V.: 406 154 Smyth, Susan: 903 8 108, 917 7 148 Snyder, Brad: 305 181 Sobhy Aly, Mohamed: 506 191, 746 105 Sobotka, Paul: 926 3 153, 926 4 153 Sobotka, Paul A.: 2620 161 Soeda, Tsunenari: 917 8 148 Soendergaard, Lars: 930 3 155 Soga, Yoshimitsu: 2311 166, 931 4 113, 931 6 113 Sohn, Dae Won: 930 8 155 Solinas, Emilia: 2509 147 Solomon, Allen: 904 4 141 Solomon, Curtis: 2301 114 Solomon, Scott: 921 6 150 Solomon, Scott D.: 704 196, 641 157 Soman, Prem: 909 110 Somers, Virend K.: 406 154 Somerville, Jane: 400 106, 402 162 Song, Haegeun: 2645 120 Song, Pil Sang: 2504 13 138 Song, Young Bin: 2504 13 138 Sood, Nitesh: 919 5 149 Sood, Poornima: 2506 9 146 Sorajja, Paul: 253 203, 2630 183, 648 159, 661 164, 2121 177, 803 118, 817 169, 819 192 Sorour, Khaled: 506 191 Sosnovik, David E.: 719 202 Soucier, Richard: 744a 170 Sousa, Amanda: 2504 11 138, 2506 15 146 Sousa, J Eduardo: 2506 15 146 Sousa, J. Eduardo: 2504 11 138 Specchia, Giuseppe: 914 6 144 Speight, Martina: 2102 160, 2105 171 Spencer, Kirk T.: 672 168, 107 124 Spertus, John: 2501 8 137, 2511 11 147, 2511 13 147, 928 8 154 Spertus, John A.: 107A 125 Spiering, Wilko: 926 5 153 Spinler, Sarah A.: 623 126, 734 116 Spirito, Paolo: 925 4 152, 925 5 152 Spragg, David: 704 196 Sprandel, Marlia C.: 911 8 143 Squires, Ray: 927 6 153 Sreekanth, Sowmya: 2309 156 Srivastav, Sudesh: 916 6 140 Stables, Rod: 2645 120 Stacey, Richard: 908 8 110 Staico, Rodolfo: 2504 11 138 Stamm, Christof: 921 7 150 Stanislawski, Maggie: 928 3 153 STAR-Study-Group: 910 8 111 Starling, Randall: 906 7 110, 908 5 110 Starling, Randall C.: 669 168, 694 185 Steaban, Robin: 684 180 Stecy, Peter: 2303 115 Stefanadis, C.: 926 8 153 Stefanadis, Christodoulos: 931 3 113, 2509 147 Stefanick, Marcia L.: 904 4 141 Stefanini, Giulio: 2645 120 Steg, Philippe G.: 304 143 Stegic, Jasminka: 2102 160 Stehlik, Josef: 670 168 Stein, Evan: 911 5 143, 923 4 151 Stein, Evan A.: 729 203, 306 186 Stein, James H.: 227 152 Steinberg, Jonathan S.: 704 196, 716 201 Stella, Pieter: 926 5 153 Stevens, Steven M.: 221 140 Stevenson, Lynne: 922 4 150 Stevenson, Lynne W.: 744b 170, 669 168, 107A 125 Stevenson, William: 922 3 150 Stevenson, William G.: 715 201 Stewart, Garrick: 922 4 150 Stewart, William J.: 242 182, 2618 161 Steyerberg, Ewout W.: 910 4 111 Stio, Rocco: 2644 107 Stone, Gregg: 2501 6 137, 2501 10 137, 2501 14 138, 2501 16 138, 2502 15 119, 2506 7 146, 2506 9 146, 2508 15 139, 2511 7 147, 916 4 140 Stone, Gregg W.: 2632 184, 2640 200, 604 115, 622 123, 623 126, 646 155, 404 199, 2506 13 146, 304 143 Stone, Neil: 911 142, 227 152, 235 164, 227 152 Storey, Robert: 903 8 108 Tabata, Yasuhiko: 917 8 148 Tabit, Corey E.: 405 144 Tada, Tomohisa: 2503 9 146 Tadros, Peter: 932 4 155 Taggart, David: 2202 161 Tahirkheli, Naeem: 923 8 152 Tajik, A. Jamil: 309 211 Takabatake, Shu: 2509 15 147 Takahashi, Masato: 247 196 Takano, Masamichi: 2611 125 Takemoto, Yasuhiro: 917 8 148 Takimura, Hideyuki: 2504 9 138 Talajic, Mario: 666 167 Talameh, Jasmine: 921 4 150 Tamburino, Corrado: 2202 161, 2302 114, 2505 138, 2644 107 Tamita, Koichi: 909 7 111 Tan, Mary: 916 5 140 Tan, Ru-San: 905 8 109 Stout, Karen K.: 625 127, 668 168, 802 111, 805 123 Strony, John: 903 8 108 Stuart, Leilani: 928 7 154 Stuckey, Thomas: 2501 14 138, 2501 16 138 Stuckey, Thomas D.: 104 117 Subacius, Haris: 929 5 154 Subherwal, Sumeet: 928 6 154 Sudhir, Krishnan: 2506 9 146 Suematsu, Nobuhiro: 931 4 113, 931 6 113 Sueta, Carla: 921 4 150 Sugeng, Lissa: 407 181 Sulistio, Melanie S.: 261 171 Sullivan, Suzanne: 406 154 Sundt, Thoralf: 107A 125, 652 160 Sundt, Thoralf M.: 210 118 Sung, Ji-Hee: 917 8 148 Sunkara, Manjula: 917 7 148 Superko, Robert: 602 113 Suri, Rakesh: 612 118 Suryanarayana, Prakash Goutham: 408 187 Suzuki, Kenji: 931 4 113, 931 6 113 Suzuki, Megumi: 2309 156 Svensson, Lars: 2500 7 137, 2500 9 137, 305 181 Svensson, Lars G.: 2619 161, 2636 195 Swaminathan, Rajesh V.: 928 4 154 Swan, Christopher H.: 744a 170 Swart, Michael: 910 4 111 Sweeny, Joseph: 2508 6 139 Sweet, Wendy: 906 7 110 Sweitzer, Nancy K.: 720 203 Syed, Mushabbar A.: 818 169 Systrom, David M.: 929 4 154 Szeto, Wilson Y.: 2626 177 Szklo, Moyses: 927 3 153

236 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Tanajura, Luiz F.: 2504 11 138 Tang, Jifei: 2645 120 Tang, Wai Hong: 906 7 110, 912 7 142, 912 8 142, 922 7 150 Tang, Wai Hong W.: 617 122, 626 127 Tani, Lloyd Y.: 247 196, 301 157 Tansuphaswadikul, Sudaratana: 2505 16 139 Tantry, Udaya: 2501 12 137 Tarbine, Sergio G.: 2309 156 TASMC Cardiology: 406 154 Tatsis, I.: 926 8 153 Tawakol, Ahmed A.: 743 129 Taylor, Allen: 915 8 145, 924 8 151 Taylor, Allen J.: 611 117, 815 165, 927 8 153 Taylor, Doris: 906 5 110, 300 112 Taylor, Michael D.: 605 116 Taylor, Sarah N.: 901 4 114 Taylor, William R.: 406 154 Tazaki, Junichi: 931 4 113, 931 6 113 Tazarourte, Karim: 2502 9 119 Tcheng, James E.: 2306 125, 647 159, 660 164 Tedrow, Usha: 922 3 150 Teerlink, John: 922 5 150 Teerlink, John R.: 626 127 Teirstein, Paul: 2506 7 146, 2506 13 146 Teirstein, Paul S.: 2309 156 Teixido, Gisela: 908 8 110 Tek, Chankevin: 918 6 148 Templin, Barry: 2511 7 147, 916 4 140 Ten Berg, Jurrien: 902 4 107 Tenuta, Marcos: 304 143 Teoh, Kevin: 2644 107 Terashima, Mitsuyasu: 2611 125 Terzic, Andre: 618 121 Teuteberg, Jeffrey: 213 122, 694 185 Texter, John: 909 8 111 Textor, Stephen: 2610 120, 663 165 Thavendiranathan, Paaladinesh: 907 8 142 Thayssen, Per: 2506 11 146 the ABSORB B investigators: 2503 11 146 Thbert, Dominique: 2502 9 119 Theodoropoulos, Konstantinos C.: 903 7 108 Therrien, Judith: 667 167 Thibault, Bernard: 232 162 Thiele, Holger: 221 140, 689 184, 902 8 108 Thomas, Gregory: 903 8 108, 924 6 151 Thomas, Gregory S.: 673 169 Thomas, James: 300 112, 912 8 142 Thomas, James D.: 638 151, 638 151 thomas, Lecompte: 904 8 141 Thomas, Martyn: 2645 120 Thomas, Randal: 927 6 153 Thomas, Susan: 306 186 Thomopoulos, C.: 926 8 153 Thompson, Chris R.: 2644 107 Thompson, Joseph J.: 603 113 Thompson, Lauren: 928 6 154 Thompson, Paul: 911 9 143 Thompson, Paul D.: 688 182, 746 105 Thourani, Vinod H.: 2203 194 Thuesen, Leif: 2503 13 146, 721 204, 2506 11 146 Tian, JinWei: 909 5 111 Tighe, Dennis: 744b 170 Tighe, Dennis A.: 241 179 Tijssen, Jan: 2502 13 119 Tilsted, Hans-Henrik: 2506 11 146 Timmers, Gregory D.: 673 169, 673 169 Tisch, Rebecca: 2644 107 Tisdale, James: 913 8 143, 736 125 Tison, Geoffrey H.: 927 3 153 Tiwari, Sumit: 916 6 140 Tobis, Jonathan M.: 2614 140, 2639 202, 2614 140 Toggweiler, Stefan: 2644 107 Tomaselli, Gordon: 710 198 Tomberli, Benedetta: 925 4 152, 925 5 152 Tompkins, Christine: 624 126, 919 6 149 Tong, Carl W.: 906 8 110 Tonino, Pim: 923 9 152, 2508 7 139 Topalian, Simon: 2313 189 Topilsky, Yan: 242 182 Topol, Eric: 2644 107, 923 8 152 Torguson, Rebecca: 915 8 145, 2500 15 137, 2507 15 147 Torii, Sho: 2503 7 145 Torner, James C.: 904 4 141 Torre-Amione, Guillermo: 240 179 Tousoulis, Dimitris: 931 3 113 Towbin, Jeffrey: 901 5 114 Towbin, Jeffrey A.: 222 141, 240 179, 107A 125, 301 157, 301 157, 301 157, 671 168 Tracy, Russell: 905 5 109 Traverse, Jay: 300 112 Travin, Mark I.: 658 163, 708 197 Tremmel, Jennifer: 2508 7 139 Tresukosol, Damras: 2505 16 139 Tricoci, Pierluigi: 903 8 108 Troughton, Richard W.: 680 179 Troxel, David B.: 248 198 Trujillo, Tate N.: 913 8 143 Truong, Quynh: 308 210 Trupp, Robin: 217 127 Tsai, Thomas: 2511 11 147, 928 3 153, 928 6 154 Tsai, Thomas T.: 209 117, 2641 200 Tsang, Teresa S. M.: 638 151 Tsang, Wendy: 407 181 Tsiachris, D.: 926 8 153 Tsigkas, Grigorios: 903 4 108, 903 7 108 Tsioufis, Konstantinos P.: 926 8 153 Tsubokawa, Toshinari: 2509 15 147 Uber, Patricia: 203 109 Uber, Patricia A.: 925 152 Udayachalerm, Wasan: 2505 16 139 Udell, Jacob: 902 5 108 Udelson, James: 308 210, 925 4 152, 925 5 152 Udelson, James E.: 658 163, 641 157, 308 210 Uebing, Anselm: 920 8 149 Uematsu, Masaaki: 931 6 113, 2311 166 Uemura, Shiro: 917 8 148 Uesugi, Yoshiko: 917 8 148 Ueyama, Takeshi: 405 144 Ulveling, Kyle G.: 744b 170 Underwood, S. Richard: 740 204, 740 204 Unger, Barbara T.: 263 170 Unterseeh, Thierry: 926 7 153 Urena, Marina: 915 6 145 Uretsky, Seth: 233 163 Ussia, Gian Paolo: 930 3 155 Utsunomiya, Daisuke: 924 8 151 Uy, Stephen: 923 4 151 Vahanian, Alex: 915 7 145, 930 5 155 Valente, Anne Marie: 920 7 149, 252 201, 668 168, 806 123, 920 7 149 Valenti, Renato: 903 6 108 Valentine, C. Michael: 244 185, 621 123, 684 180, 104 117 Valentini, Rudolph: 408 187 Valgimigli, Marco: 910 4 111, 2644 107, 903 8 108 Valika, Ali: 2315 189 Van Arsdell, Glen: 901 3 114 Van Bakel, Adrian: 921 4 150 van Beek, Edwin J.: 407 181 Van Belle, Eric: 2507 146 van de Hoef, Tim P.: 2502 13 119 Van de Werf, Frans J.: 308 210 Van der Heyden, Jan: 2631 183 van der Hoeven, B. L.: 917 5 148 Van Der Laan, Anja: 918 4 148 van der Vleuten, Pieter: 918 4 148 Van Eyk, Jennifer: 671 168, 602 113 van Geuns, Robert Jan M.: 2503 13 146 van Nierkerk, Nicolene: 914 4 144 van Rossum, Albert: 918 4 148 Tsuchikane, Etsuo: 2621 162, 2504 138, 2504 7 138 Tsukahara, Reiko: 2504 9 138 Tu, Thomas: 2113 194, 2113 194 Turi, Zoltan G.: 2609 120, 2624 167, 2310 156, 2510 6 139, 821 197 Turker, Isik: 405 144 Turpie, Alexander G.: 304 143 Tuzcu, E. Murat: 2606 115, 646 155, 1607 205, 2303 115, 2308 156, 2500 7 137, 2500 9 137, 305 181, 309 211, 518 189 Tweddell, James S.: 724 209, 402 162

ACC.12 Final Program 237

Author Index ACC.12

Last Name, First Name: Session # Page #
Vanerio, Gabriel: 726 210 Vannan, Mani: 907 8 142 Varadarajan, Padmini: 110 129 Vardeny, Orly: 921 6 150 Varghese, Mithun J.: 2310 156 Varleta, Paola: 516 192 Varma, Niraj: 614 121, 717 202, 922 7 150 Varosy, Paul: 919 4 149 Varosy, Paul D.: 205 112, 215 123, 515 193, 928 153 Vavere, Andrea: 909 8 111 Veer, Marcel v.: 923 9 152 Velazquez, Eric J.: 681 179, 682 179, 924 151 Veldtman, Gruschen R.: 725 209 Velez, Mauricio: 229 159 Velianou, James L.: 2644 107 Ventura, Hector O.: 686 180, 720 203, 516 192, 664 165 Vercel, Mark: 2311 166 Verdejo, Juan P.: 513 190 Verdini, Daniel J.: 922 3 150 Verdino, Ralph J.: 702 196, 716 201, 804 118, 810 128 Vergouwe, Yvonne: 910 4 111 Verheugt, Freek W.A.: 211 121 Verheye, Stefan: 2506 7 146, 2511 7 147 Verloop, Willemien: 926 5 153 Verma, Atul: 615 121 Verrier, Richard L.: 702 196 Verrill, Thomas A.: 929 7 154 Versaci, Francesco: 2510 11 140 Verschuren, Jeffrey J.: 917 5 148 Vetrovec, George: 2505 8 138 Vetrovec, George W.: 2501 137 Victor, Elivane: 304 143 Victor, Ronald G.: 250 198, 631 128 Vidaillet, Humberto: 904 6 141 Vido, Diane: 918 5 148 Vidovich, Mladen: 928 3 153 Vij, Kamal: 918 8 148 Vijayakumar, Sathya: 918 8 148 Vijayaraghvan, Krishnaswami: 686 180, 686 180 Viles-Gonzalez, Juan: 902 6 108 Villines, Todd: 924 5 151, 924 7 151, 927 8 153 Vincent, Robert: 901 8 114 Vinereanu, Dragos: 904 9 141 Virani, Salim: 925 6 152 Virani, Salim S.: 227 152 Virmani, Renu: 2611 125, 2632 184, 622 123 Viswanathan, Mohan N.: 744b 170 Vita, Joseph A.: 405 144, 622 123 Vlachojannis, Georgios: 2501 10 137 Vlachojannis, Georgios J.: 2501 6 137 Vlahakes, Gus: 2310 156 Vlahakes, Gus J.: 2121 177 Vogel, Robert: 688 182 Volpe, Massimo: 920 7 149 von Scheidt, Fabian: 903 3 108 von Ziegler, Franz: 909 6 111 Vongpatanasin, Wanpen: 250 198, 629 128, 663 165 Vora, Amit: 509 190 Vorchheimer, David: 902 6 108 Voros, Szilard: 923 8 152, 924 6 151, 683 180, 2608 119, 2639 202 Voskuil, Michiel: 926 5 153 Vrancx, Pascal: 910 4 111 Wachter, Rolf: 921 8 150 Wage, Ricardo: 908 4 110 Wagner, Henrik: 902 4 107 Wagner, William: 627 127 Waites, Thad: 302 165 Waksman, Ron: 2308 156, 2500 15 137, 2503 145, 2505 8 138, 2507 15 147, 2632 184, 2645 120, 503 188, 915 8 145, 923 8 152 Waldo, Albert L.: 677 178, 107A 125 Wallentin, Lars: 2643 201, 639 156, 747 209, 904 9 141 Walpole, Howard T.: 621 123, 226 152 Walsh, Edward P.: 667 167 Walsh, Joseph: 2315 189 Walsh, Mary N.: 224 143, 245 185, 601 112 Walther, Thomas: 2619 161 Wan Ahmad, Wan Azman: 512 192 Wang, Andrew: 714 199, 808 124 Wang, Francis: 914 8 144 Wang, Paul: 919 6 149 Wang, Paul J.: 919 149 Wang, Thomas: 914 8 144 Wang, Thomas J.: 635 141 Wang, Tracy: 209 117, 722 204, 913 7 143, 928 4 154 Wang, Y. Claire: 927 4 153 Wang, Yongfei: 919 4 149 Wang, Zuyue: 2500 15 137, 2507 15 147, 915 8 145 Warber, Sara: 698 186 Ward, R. Parker: 644 158, 672 168 Ware, Stephanie: 901 5 114 Warnes, Carole A.: 679 179, 107A 125, 402 162, 402 162, 608 116 Washam, Jeffrey: 722 204 Washington, Reginald L.: 603 113 Wasserman, Scott: 923 4 151 Wassertheil-Smoller, Sylvia: 904 4 141 Watanabe, Tetsuya: 2311 166 Wate, Prateek S.: 906 4 109 Watson, Karol E.: 736 125, 306 186, 664 165 Watta, Matteo: 405 144 Watts, James A.: 2122 183 Wazni, Oussama M.: 810 128 Weaver, W. Douglas: 928 5 154 Webb, Gary D.: 202 108 Webb, John: 2500 7 137, 2500 9 137, 2644 107, 305 181 Webb, John G.: 2619 161, 2308 156 Webber, Steven: 901 5 114 Wei, Xufeng: 906 6 110 Weigold, William Guy: 924 8 151, 2629 183, 683 180, 915 8 145 Weinberg, Paul M.: 724 209 Weiner, Rory: 2310 156 Weiner, Rory B.: 914 8 144, 929 4 154 Weiner, Scott: 308 210 Weinert, Lynn: 407 181 Weintraub, Andrew R.: 250 198 Weintraub, William S.: 308 210, 2505 138, 622 123 Weiss, Jocelyn: 308 210 Weissman, Gaby: 744b 170, 915 8 145, 924 8 151 Weissman, Neil: 930 4 155 Weissman, Neil J.: 2608 119, 2629 183, 672 168, 657 163 Weisz, Giora: 2505 8 138, 2501 14 138, 2501 16 138, 2511 7 147, 2645 120, 639 156, 916 4 140 Weitz, Jeffrey I.: 264 187 Welch, Terrence D.: 744b 170 Wenaweser, Peter: 2644 107 Wenger, Nanette K.: 255 204, 709 197, 1602 130, 742 186, 746 105 Wertz, Jonathon: 912 5 142 Wessels, Judith A.: 917 5 148 West, Erin: 929 6 154 West, Lori: 625 127 Westcott, R. Jeffrey: 660 164 Westernout, Cynthia M.: 916 5 140 Wharton, J. Marcus: 207 116 White, Audrey: 407 181 White, C. Michael: 911 9 143 White, Charles: 308 210 White, Christopher: 932 7 155 White, Christopher J.: 2627 177, 2631 183, 2311 166 White, Harvey D.: 2617 156 White, Patrick J.: 673 169 White, William B.: 663 165 Whitlow, Patrick: 2502 11 119 Whitlow, Patrick L.: 2627 178, 2302 114, 2621 162 Wicky, Stephan: 2616 156 Wiederkehr, Daniel: 913 5 143 Wiegers, Susan E.: 907 142 Wiesneth, Markus: 903 3 108 Wilber, David J.: 715 201 Wilde, Arthur A.: 691 184 Wiley, Jose: 2313 189 Wiley, Mark: 932 4 155 Wilkinson, James: 901 5 114 Wilkoff, Bruce: 904 4 141, 922 7 150 Wilkoff, Bruce L.: 205 112, 232 162, 690 184

238 GO for ACC.12!

ACC.12 Author Index

Last Name, First Name: Session # Page #
Willenberg, Bradley J.: 906 4 109 Willerson, James: 300 112 Williams, Amy W.: 645 158 Williams, Eric S.: 109 128, 710 198, 737 169 Williams, Kim: 306 186 Williams, Kim A.: 658 163 Williams, Lauren: 922 4 150 Williams, Mathew: 2203 194, 2500 7 137, 2500 9 137, 2500 11 137, 2507 11 146, 2619 161 Williams, MIchelle C.: 407 181 Williams, Roberta G.: 402 162 Williams, M, Ronald: 918 5 148 Wilson, B. Hadley: 2502 7 119, 104 117 Wilson, Carol: 919 8 149 Winchester, David E.: 113 193 Windecker, Stefan: 2503 13 146 Windecker, Stephan: 2645 120, 910 4 111 Windle, John R.: 647 159 Wingate, Suzanne J.: 220 129, 225 150 Winitsky, Steve: 618 121 Winston, Stuart: 501 190 Winters, Kenneth: 902 4 107 Witt, Nils: 923 9 152 Wittfeldt, Ann: 902 7 108 Witzenbichler, Bernhard: 2501 6 137, 2501 14 138, 2501 16 138, 2508 15 139, 304 143 Wiviott, Stephen: 308 210, 902 3 107, 902 5 108, 913 7 143 Wiviott, Stephen D.: 623 126, 709 197, 1605 171, 659 163, 826 203 Woehrle, Jochen: 2502 15 119, 2509 9 147, 903 3 108, 908 7 110 Wohns, David: 2104 165, 2511 15 147 Whrle, Jochen: 689 184 Wojdyla, Daniel: 921 5 150 Wolf, Bethany: 901 4 114 Wolff, Steven: 304 143 Wolski, Kathy: 306 186 Wong, Michael J.: 235 164 Wong, Nathan: 927 7 153 Wong, Shing-Chiu: 2624 167, 2634 190 Wood, David: 2644 107 Wood, Malissa J.: 235 164, 261 171 Woodard, Pamela: 308 210 Woody, Walter: 928 3 153 Worle, Jochen: 2643 201 Wright, Janet S.: 742 186 Wright, Scott: 215 123, 687 180, 712 199 Wroblewski, Heather: 913 8 143 Wu, Chuntao: 910 7 111 Wu, Colin: 908 8 110 Wu, Xin: 906 8 110 Wu, Yuping: 912 7 142 Wunderlich, Nina: 2630 183, 2640 200 Wylie-Sears, Jill: 406 154 Xanthopoulou, Ioanna: 903 4 108, 903 7 108 Xiang, Meixiang: 2645 120 Xie, Aris: 909 4 110 Xing, Lei: 916 7 140 Xu, Ke: 916 4 140, 2511 7 147 Yacoub, Magdi H.: 401 124, 506 191, 627 127, 400 106 Yadav, Jay: 922 5 150 Yadav, Jay S.: 2637 195, 633 129 Yadav, Neha: 744b 170 Yakubov, Steven J.: 2132 195, 2606 115 Yakushiji, Tadayuki: 2508 15 139 Yamagishi, Masakazu: 2509 15 147 Yamane, Masahisa: 2504 7 138 Yamaoka, Terutoshi: 931 4 113, 931 6 113 Yamawaki, Masahiro: 2504 9 138 Yamrozik, June: 918 5 148 Yan, Andrew: 916 5 140 Yancy, Clyde W.: 237 169, 107A 125 Yang, Hongqiu: 904 9 141 Yang, Jeong Hoon: 2504 13 138 Yang, Shuang: 916 7 140 Yang, YueJin: 505 188 Ye, Jian: 2644 107 Ye, Siqin: 910 5 111 Yeh, Edward T.: 642 157 Yeh, Robert W.: 209 117, 215 123, 700 186 Yeo, Hans: 2505 16 139 Yetman, Angela T.: 202 108 Yeung, Alan: 2645 120 Yeung, Alan C.: 2608 119, 2201 119 Yeung, Hubert: 407 181 Yingchoncharoen, Teerapat: 907 5 142 Yonetsu, Tiashi: 916 7 140 Yong, Andy: 2508 7 139 Yoo, Wonsuk: 306 186, 910 6 111 Yoon, Jung H.: 511 188 Yoon, Jung-Han: 2644 107 Yoon, Sung-Cheol: 2645 120 Yoshida, Takayuki: 2305 125 Yoshikawa, Ayako: 2503 7 145 Yoshikawa, Junichi: 909 7 111 Yu, Bo: 909 5 111 Yu, Cheol Woong: 2504 13 138 Yu, Jennifer: 2501 10 137 Yue, Qi: 909 4 110 Yundai, Chen: 685 180 Yusuf, Salim: 206 116, 665 167, 686 180, 700 186, 904 5 141, 904 7 141 Zafar, M. Urooj: 902 6 108 Zafrir, Barak: 912 6 142 Wyman, Janet F.: 2101 156, 2102 160 Zahger, Doron: 916 140 Zahn, Ralf: 910 8 111, 915 4 145 Zaidi, Abbas: 914 7 144 Zaidi, Abbas: 914 4 144 Zajarias, Alan: 258 210, 2619 161, 646 155, 819 192 Zakroysky, Pearl: 308 210 Zaman, Khan S.: 514 194 Zambahari, Robaayah: 512 192 Zannad, Faiez: 921 6 150 Zareba, Wojciech: 704 196, 919 6 149 Zaromitidou, Marina: 931 3 113 Zaverio, Ruggeri M.: 909 4 110 Zazula, Ana: 304 143 Zeiher, Andreas M.: 618 121, 2506 146, 300 112 Zellers, Paul: 2315 189 Zeymer, Uwe: 910 8 111 Zhang, Dadong: 2645 120 Zhang, Shaosong: 909 5 111, 916 7 140 Zhang, Zhen: 916 4 140 Zhang, Zheng: 2645 120 Zhang, Zugui: 308 210 Zhao, David: 300 112 Zhao, Dong: 685 180, 685 180 Zhao, Songyang: 910 7 111 Zhao, Yan: 909 4 110 Zhao, Yue: 915 5 145 Zhong, Liang: 905 8 109 Zhou, Chunmei: 902 4 107 Zhou, Yujie: 2645 120, 685 180 Ziada, Khaled: 917 7 148 Ziada, Khaled M.: 2627 178 Zidar, James P.: 2642 201 Zieman, Susan: 905 5 109 Ziffer, Jack A.: 696 185 Zijlstra, Felix: 918 4 148 Zile, Michael R.: 635 141 Zipes, Douglas P.: 646 155, 746 105 Zisimos, Konstantinos: 931 3 113 Zoghbi, William A.: 652 160, 507 191, 742 186, 746 105 Zolty, Ronald: 912 4 142 Zuba-Surma, Ewa K.: 917 7 148 Zuckerman, Bram D.: 633 129 Zuern, Christine: 926 6 153 Zugwitz, Daa: 2645 120 Zwicke, Dianne L.: 662 164 Zyblewski, Sinai: 901 4 114 Zynda, Todd K.: 2121 177

ACC.12 Final Program 239

The American College of Cardiology

Proudly Welcomes the Newest

of the CardioSurve Panel for

Physician Members

2012

CardioSurve is a select panel of ACC members who provide important insights and perspectives on the issues that affect todays cardiovascular professionals and assist the College in listening closely to the voice of U.S. cardiologists. For more on CardioSurve and to learn about the newest panelists, visit CardioSource.org/CardioSurve.

2012 American College of Cardiology. T1105

TM

Help Shape the Future of CardioSmart

(and win a free iPad!)
e ACC is re-launching CardioSmart, and we want your input. tools to improve the patient-clinician relationship. e new CardioSmart will provide If youre a practicing clinician, come and tell us what you need. It only takes ve minutes. Well give you a token of our appreciation and enter you in a drawing to win an iPad!

Visit ACC Central, Booth #10027

See how the data connects with your practice.

Bring it all together at BOOTH 14008

Please pick up your complimentary medically relevant customized poster and informative CD.

vytorin.com

zetia.com
CARD-1023626-0000 01/12